Citrus Sinensis ID: 018311
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 358 | 2.2.26 [Sep-21-2011] | |||||||
| Q8LEB6 | 484 | Probable receptor-like pr | yes | no | 0.918 | 0.679 | 0.717 | 1e-140 | |
| Q9LRP3 | 467 | Probable receptor-like pr | no | no | 0.891 | 0.683 | 0.652 | 1e-122 | |
| Q9SJG2 | 494 | Probable receptor-like pr | no | no | 0.935 | 0.678 | 0.588 | 1e-104 | |
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.854 | 0.648 | 0.502 | 5e-84 | |
| Q6NKZ9 | 437 | Probable receptor-like se | no | no | 0.832 | 0.681 | 0.482 | 5e-72 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.790 | 0.398 | 0.385 | 2e-52 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.536 | 0.266 | 0.487 | 2e-51 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.536 | 0.294 | 0.512 | 3e-51 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.497 | 0.349 | 0.511 | 1e-50 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.494 | 0.25 | 0.5 | 9e-50 |
| >sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 497 bits (1279), Expect = e-140, Method: Compositional matrix adjust.
Identities = 249/347 (71%), Positives = 286/347 (82%), Gaps = 18/347 (5%)
Query: 1 MASDLNKSLSKTYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSR-- 58
M S LN +LS+ Y G++LW +IVI L+ +FVV+L +SLWLTFR+K SR +++++PVSR
Sbjct: 1 MGSGLNDTLSRNYNGLELWEIIVIVLSAIFVVVLAISLWLTFRRKTSRSSSNLIPVSRQI 60
Query: 59 FPVVSEEIKEIRVDQVSSSNGG--FSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLE 116
P V EEIKEIRVD+VSSSNGG + +EKF D+E EK + + DS +SGSFN+LE
Sbjct: 61 PPSVPEEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESENGDSSRSGSFNHLE 120
Query: 117 KDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRF 176
K K + S++PLTAPSPLSGLPEFSHLGWGHWFTLRDLQ ATN+F
Sbjct: 121 K--------------KDGSSVSSANPLTAPSPLSGLPEFSHLGWGHWFTLRDLQMATNQF 166
Query: 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
S+DNIIGDGGYGVVYRG L+NGT VAVKKLLNN GQADKDFRVEVEAIGHVRHKNLVRLL
Sbjct: 167 SRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLL 226
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
GYC+EGTQR+LVYEYVNNGNLEQWLRGD + YLTWEAR+KIL+GTAKALAYLHEAIEP
Sbjct: 227 GYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIEP 286
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
KVVHRDIKSSNILID+ F++KISDFGLAKLLGA KS ITTRVMGTFG
Sbjct: 287 KVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFG 333
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 439 bits (1128), Expect = e-122, Method: Compositional matrix adjust.
Identities = 225/345 (65%), Positives = 262/345 (75%), Gaps = 26/345 (7%)
Query: 1 MASDLNKSLSKTYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSRFP 60
M S L ++L+K Y ++LW +IVI L F+VIL +S+WL+FRKK R LPV++ P
Sbjct: 1 MTSQLKRTLTKRYGVLELWEIIVIALFAAFIVILVLSVWLSFRKKSKRSNATTLPVTQSP 60
Query: 61 VVSEEIKEIRVDQVSSSNGGFSVH--NEKFNDRESEKELIPQENGDDSVQSGSFNNLEKD 118
+EEIKEI VD SS+N G S +EKF + ENGD SGS +K
Sbjct: 61 RFTEEIKEISVDHGSSNNNGTSYQTLDEKFVED--------IENGDKF--SGSLE--KKP 108
Query: 119 VVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSK 178
+VGS L PS+ TAPSPL GLPE SH+GWGHWFTLRDLQ ATN FSK
Sbjct: 109 LVGSHLP------------PSTPSTTAPSPLLGLPEVSHIGWGHWFTLRDLQLATNHFSK 156
Query: 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
++IIGDGGYGVVY G L N T VAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY
Sbjct: 157 ESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 216
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
C+EGT R+LVYEY+NNGNLEQWL GDM +G+LTWEAR+K+L+GTAKALAYLHEAIEPKV
Sbjct: 217 CVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHLTWEARIKVLVGTAKALAYLHEAIEPKV 276
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
VHRDIKSSNIL+D+NFDAK+SDFGLAKLLGA ++++TRVMGTFG
Sbjct: 277 VHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSNYVSTRVMGTFG 321
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 379 bits (973), Expect = e-104, Method: Compositional matrix adjust.
Identities = 207/352 (58%), Positives = 255/352 (72%), Gaps = 17/352 (4%)
Query: 3 SDLNKSLSKTYI-----GMQLWVLIVICLAVVFVVILGV-SLWLTFRKKKSRRANDMLPV 56
S LN +SK G++LWV + + + V V+IL + SLW+TFR+K R ++ P
Sbjct: 5 SSLNAEMSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRKSRR-SSSKFPF 63
Query: 57 SRFPVVSEEIKEIRVDQVSSSNGGFSVHNEKFNDRESEKELIP-----QENGDDSVQSGS 111
++ P VS K+IRVD+ N + ND+ + K ++ + + +D++ S
Sbjct: 64 NQIPHVS---KDIRVDRAGFQNPHPESLYIEMNDKSTGKTMMSHLGRTKSSDNDTLSQCS 120
Query: 112 FNNLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQS 171
N + S GEEGG G + P+TA SPL GLPE SHLGWGHWFTLRDL+
Sbjct: 121 SVNHHERACSSHSGEEGGFGSAGR-QYGGGPVTA-SPLVGLPEISHLGWGHWFTLRDLEL 178
Query: 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
ATNRF+ N++G+GGYGVVYRG+L+NGT VAVKKLLNN GQA+K+FRVEVEAIGHVRHKN
Sbjct: 179 ATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKN 238
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
LVRLLGYCIEG R+LVYEYVN+GNLEQWL G M G LTWEARMKI+ GTA+ALAYLH
Sbjct: 239 LVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAYLH 298
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
EAIEPKVVHRDIK+SNILID+ F+AK+SDFGLAKLL +G+SHITTRVMGTFG
Sbjct: 299 EAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFG 350
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 311 bits (797), Expect = 5e-84, Method: Compositional matrix adjust.
Identities = 177/352 (50%), Positives = 223/352 (63%), Gaps = 46/352 (13%)
Query: 2 ASDLNKSLSK--TYIGMQLWVLIVICLAVVFVVILGV-SLWLTFRKKKSR-RANDMLPVS 57
A+ LN LSK + G++LWV+I I L + V+ L + SL LT R+K + RA+
Sbjct: 6 AAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRKNRKPRADFASAAI 65
Query: 58 RFPVVSEEIKEIRVDQVSSSNGGFSV------HNEKFNDRESEKELIPQENGDDSVQSGS 111
P +S+EIKEI Q S V H F+DR S E G S
Sbjct: 66 ATPPISKEIKEIVPAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGE----SRGTAS----- 116
Query: 112 FNNLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQS 171
S+ G+G PE SHLGWG W+TLR+L++
Sbjct: 117 ---------ASETASYSGSGNCG------------------PEVSHLGWGRWYTLRELEA 149
Query: 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
ATN ++N+IG+GGYG+VYRG L +GT VAVK LLNN GQA+K+F+VEVE IG VRHKN
Sbjct: 150 ATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 209
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
LVRLLGYC+EG R+LVY++V+NGNLEQW+ GD+ D LTW+ RM I+LG AK LAYLH
Sbjct: 210 LVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLH 269
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
E +EPKVVHRDIKSSNIL+D ++AK+SDFGLAKLLG+ S++TTRVMGTFG
Sbjct: 270 EGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRVMGTFG 321
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 271 bits (694), Expect = 5e-72, Method: Compositional matrix adjust.
Identities = 163/338 (48%), Positives = 213/338 (63%), Gaps = 40/338 (11%)
Query: 12 TYIGMQLWVLIVICLAVVFVVILGVSLWLTF-RKKKSRRANDMLPVSRFPVVSEEIKEIR 70
+ G+ L+++I IC + ++ L + L++ R ++RR P+VS+EI EI+
Sbjct: 17 SVFGLNLYLVIAICSVFILLISLLIFLFVCLNRVSRARRMRVKHSSGSIPLVSKEISEIK 76
Query: 71 VDQVSSSNGGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLEKDVVGSQLGEEGGN 130
+ G F N DDS G N E VV S +E +
Sbjct: 77 ------TVGKFI-------------------NSDDS--KGKIGN-EVVVVVSATSKEATS 108
Query: 131 GKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVV 190
G F S A S G E +GWG W++L+DL+ AT FS DN+IG+GGYGVV
Sbjct: 109 G----FDTLS---VASSGDVGTSE--AMGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVV 159
Query: 191 YRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRILV 248
YR +G+ AVK LLNN GQA+K+F+VEVEAIG VRHKNLV L+GYC + +QR+LV
Sbjct: 160 YRADFSDGSVAAVKNLLNNKGQAEKEFKVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLV 219
Query: 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308
YEY++NGNLEQWL GD+ LTW+ RMKI +GTAK LAYLHE +EPKVVHRD+KSSNI
Sbjct: 220 YEYIDNGNLEQWLHGDVGPVSPLTWDIRMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNI 279
Query: 309 LIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFS 346
L+D+ ++AK+SDFGLAKLLG+ S++TTRVMGTFG S
Sbjct: 280 LLDKKWNAKVSDFGLAKLLGSETSYVTTRVMGTFGYVS 317
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (524), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 129/335 (38%), Positives = 185/335 (55%), Gaps = 52/335 (15%)
Query: 11 KTYIGMQLWVLIVICL-AVVFVVILGVSLWLTFRKKKSRRANDMLPVSRFPVVSEEIKEI 69
KT G + VI L AVVF+V ++K +R D S++
Sbjct: 234 KTMAGFAIAGFAVIALMAVVFLV-----------RRKKKRNIDAYSDSQY---------- 272
Query: 70 RVDQVSSSNGGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLEKDVVGSQLGEEGG 129
+ SN FS+ ++ F L Q G +N+ ++ G+ G + G
Sbjct: 273 ----LPPSN--FSIKSDGF--------LYGQNPTKGYSGPGGYNSQQQSNSGNSFGSQRG 318
Query: 130 NGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGH-WFTLRDLQSATNRFSKDNIIGDGGYG 188
G + R S P +A +G G FT +L T FSK NI+G+GG+G
Sbjct: 319 GGGYT--RSGSAPDSAV-----------MGSGQTHFTYEELTDITEGFSKHNILGEGGFG 365
Query: 189 VVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248
VY+G+L +G VAVK+L GQ D++F+ EVE I V H++LV L+GYCI ++R+L+
Sbjct: 366 CVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLI 425
Query: 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308
YEYV N LE L G R L W R++I +G+AK LAYLHE PK++HRDIKS+NI
Sbjct: 426 YEYVPNQTLEHHLHGK--GRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANI 483
Query: 309 LIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
L+D+ F+A+++DFGLAKL + ++H++TRVMGTFG
Sbjct: 484 LLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFG 518
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 203 bits (516), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 95/195 (48%), Positives = 135/195 (69%), Gaps = 3/195 (1%)
Query: 150 SGLPEFSHLGWGH-WFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLN 208
SG P+ + LG G F+ +L T F++ NI+G+GG+G VY+G L +G VAVK+L
Sbjct: 344 SGTPDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKA 403
Query: 209 NPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDR 268
GQ D++F+ EVE I V H++LV L+GYCI R+L+YEYV+N LE L G
Sbjct: 404 GSGQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLP- 462
Query: 269 GYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
L W R++I +G+AK LAYLHE PK++HRDIKS+NIL+D+ ++A+++DFGLA+L
Sbjct: 463 -VLEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLND 521
Query: 329 AGKSHITTRVMGTFG 343
++H++TRVMGTFG
Sbjct: 522 TTQTHVSTRVMGTFG 536
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 202 bits (514), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 102/199 (51%), Positives = 136/199 (68%), Gaps = 7/199 (3%)
Query: 146 PSPLSGLPEFSHLGWGH-WFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVK 204
P P GL LG+ FT +L ATN FS+ N++G GG+G V++G L +G VAVK
Sbjct: 253 PPPSPGL----VLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVK 308
Query: 205 KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGD 264
+L GQ +++F+ EVE I V H++LV L+GYC+ G QR+LVYE+V N NLE L G
Sbjct: 309 QLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGK 368
Query: 265 MCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
R + W R+KI LG+AK L+YLHE PK++HRDIK+SNILID F+AK++DFGLA
Sbjct: 369 --GRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLA 426
Query: 325 KLLGAGKSHITTRVMGTFG 343
K+ +H++TRVMGTFG
Sbjct: 427 KIASDTNTHVSTRVMGTFG 445
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 200 bits (509), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 92/180 (51%), Positives = 129/180 (71%), Gaps = 2/180 (1%)
Query: 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA 223
FT DL AT+ FS N++G GG+G V+RG L++GT VA+K+L + GQ +++F+ E++
Sbjct: 131 FTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAEIQT 190
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
I V H++LV LLGYCI G QR+LVYE+V N LE L +R + W RMKI LG
Sbjct: 191 ISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEK--ERPVMEWSKRMKIALGA 248
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
AK LAYLHE PK +HRD+K++NILID++++AK++DFGLA+ +H++TR+MGTFG
Sbjct: 249 AKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTFG 308
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (501), Expect = 9e-50, Method: Compositional matrix adjust.
Identities = 90/180 (50%), Positives = 132/180 (73%), Gaps = 3/180 (1%)
Query: 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA 223
F+ +L ATN FS++N++G+GG+G VY+G L +G VAVK+L GQ D++F+ EVE
Sbjct: 365 FSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVET 424
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
+ + H++LV ++G+CI G +R+L+Y+YV+N +L L G ++ L W R+KI G
Sbjct: 425 LSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHG---EKSVLDWATRVKIAAGA 481
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
A+ LAYLHE P+++HRDIKSSNIL+++NFDA++SDFGLA+L +HITTRV+GTFG
Sbjct: 482 ARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFG 541
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 358 | ||||||
| 224130298 | 487 | predicted protein [Populus trichocarpa] | 0.955 | 0.702 | 0.795 | 1e-158 | |
| 225432165 | 513 | PREDICTED: probable receptor-like protei | 0.955 | 0.666 | 0.740 | 1e-145 | |
| 15238840 | 484 | protein kinase family protein [Arabidops | 0.918 | 0.679 | 0.717 | 1e-138 | |
| 297807871 | 484 | kinase family protein [Arabidopsis lyrat | 0.918 | 0.679 | 0.717 | 1e-138 | |
| 224110260 | 421 | predicted protein [Populus trichocarpa] | 0.812 | 0.691 | 0.835 | 1e-137 | |
| 255556566 | 407 | conserved hypothetical protein [Ricinus | 0.826 | 0.727 | 0.805 | 1e-136 | |
| 147780241 | 510 | hypothetical protein VITISV_037750 [Viti | 0.955 | 0.670 | 0.694 | 1e-135 | |
| 225450464 | 511 | PREDICTED: probable receptor-like protei | 0.955 | 0.669 | 0.691 | 1e-135 | |
| 224124542 | 506 | predicted protein [Populus trichocarpa] | 0.955 | 0.675 | 0.682 | 1e-134 | |
| 356565467 | 503 | PREDICTED: probable receptor-like protei | 0.955 | 0.679 | 0.716 | 1e-134 |
| >gi|224130298|ref|XP_002328575.1| predicted protein [Populus trichocarpa] gi|222838557|gb|EEE76922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 563 bits (1450), Expect = e-158, Method: Compositional matrix adjust.
Identities = 273/343 (79%), Positives = 303/343 (88%), Gaps = 1/343 (0%)
Query: 1 MASDLNKSLSKTYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSRFP 60
MASDL SL+K YIGM+ WV+I++CL +V V +L VSLWL+FRKK SRR+N+MLP+S+ P
Sbjct: 1 MASDLKNSLTKEYIGMEFWVVIMVCLGLVCVFVLFVSLWLSFRKK-SRRSNNMLPISQIP 59
Query: 61 VVSEEIKEIRVDQVSSSNGGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLEKDVV 120
V EEIKEI +DQ S++N GF N+KF+D+ESEK LI ENGDDS QSGS N++EKD V
Sbjct: 60 KVPEEIKEIGIDQNSANNDGFLSLNDKFSDKESEKVLIQLENGDDSSQSGSLNHVEKDGV 119
Query: 121 GSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDN 180
GSQ GEEGG S +PSSHP+TAPSP+SGLPEFS LGWGHWFTLRDLQ ATNRFSKDN
Sbjct: 120 GSQSGEEGGTKVASANQPSSHPITAPSPMSGLPEFSQLGWGHWFTLRDLQVATNRFSKDN 179
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
IIGDGGYGVVY+G L+NGT VAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC+
Sbjct: 180 IIGDGGYGVVYQGHLINGTPVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCM 239
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
EGTQR+LVYEYVNNGNLEQWL G M GYLTWEARMKILLGTAKALAYLHEAIEPKVVH
Sbjct: 240 EGTQRMLVYEYVNNGNLEQWLHGGMRQHGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 299
Query: 301 RDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
RDIKSSNILID+NF+AK+SDFGLAKLLGAGKSHITTRVMGTFG
Sbjct: 300 RDIKSSNILIDDNFNAKLSDFGLAKLLGAGKSHITTRVMGTFG 342
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432165|ref|XP_002267270.1| PREDICTED: probable receptor-like protein kinase At5g18500 [Vitis vinifera] gi|297736805|emb|CBI26006.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1339), Expect = e-145, Method: Compositional matrix adjust.
Identities = 260/351 (74%), Positives = 302/351 (86%), Gaps = 9/351 (2%)
Query: 1 MASDLNKSLSK-TYI-GMQLWVLIVICLAVVFVVILGV-SLWLTFRKKKSRRANDMLPVS 57
MAS L LSK T++ G+++WVL+ I + V V+IL + SL LT RKK SRRAN+ +P+S
Sbjct: 1 MASGLQAELSKKTFLFGLKVWVLVGIFVGVFIVIILLLMSLCLTSRKK-SRRANNKIPLS 59
Query: 58 RFPVVSEEIKEIRVDQVSSSNGG-----FSVHNEKFNDRESEKELIPQENGDDSVQSGSF 112
+ P +S+EIKE+RVDQVS+ N G F N+KF+D+ESEK LIP +NGD+S QSGSF
Sbjct: 60 QIPAISKEIKEVRVDQVSADNCGPHDGVFLALNDKFSDKESEKVLIPTKNGDNSSQSGSF 119
Query: 113 NNLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSA 172
N++EKD VGSQ GEE G+G ++ +RPSSHP+TAPSPL GLPEFSHLGWGHWFTLRDL+ A
Sbjct: 120 NHVEKDGVGSQSGEEVGSGTINVYRPSSHPITAPSPLIGLPEFSHLGWGHWFTLRDLELA 179
Query: 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
TNRFSK+N++G+GGYG+VYRG L+NGT VAVKKLLNN GQA+K+FRVEVEAIGHVRHKNL
Sbjct: 180 TNRFSKENVLGEGGYGIVYRGHLINGTPVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL 239
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
VRLLGYCIEGT R+LVYEYVNNGNLEQWL G M GYLTWEARMKILLGTAKALAYLHE
Sbjct: 240 VRLLGYCIEGTHRLLVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKILLGTAKALAYLHE 299
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
AIEPKVVHRDIKSSNILID+ F+AKISDFGLAKLLGAG+SHITTRVMGTFG
Sbjct: 300 AIEPKVVHRDIKSSNILIDDEFNAKISDFGLAKLLGAGRSHITTRVMGTFG 350
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15238840|ref|NP_197351.1| protein kinase family protein [Arabidopsis thaliana] gi|79328036|ref|NP_001031898.1| protein kinase family protein [Arabidopsis thaliana] gi|75330007|sp|Q8LEB6.1|Y5185_ARATH RecName: Full=Probable receptor-like protein kinase At5g18500 gi|21553648|gb|AAM62741.1| Ser Thr specific protein kinase-like protein [Arabidopsis thaliana] gi|115646738|gb|ABJ17100.1| At5g18500 [Arabidopsis thaliana] gi|332005188|gb|AED92571.1| protein kinase family protein [Arabidopsis thaliana] gi|332005189|gb|AED92572.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 497 bits (1279), Expect = e-138, Method: Compositional matrix adjust.
Identities = 249/347 (71%), Positives = 286/347 (82%), Gaps = 18/347 (5%)
Query: 1 MASDLNKSLSKTYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSR-- 58
M S LN +LS+ Y G++LW +IVI L+ +FVV+L +SLWLTFR+K SR +++++PVSR
Sbjct: 1 MGSGLNDTLSRNYNGLELWEIIVIVLSAIFVVVLAISLWLTFRRKTSRSSSNLIPVSRQI 60
Query: 59 FPVVSEEIKEIRVDQVSSSNGG--FSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLE 116
P V EEIKEIRVD+VSSSNGG + +EKF D+E EK + + DS +SGSFN+LE
Sbjct: 61 PPSVPEEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESENGDSSRSGSFNHLE 120
Query: 117 KDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRF 176
K K + S++PLTAPSPLSGLPEFSHLGWGHWFTLRDLQ ATN+F
Sbjct: 121 K--------------KDGSSVSSANPLTAPSPLSGLPEFSHLGWGHWFTLRDLQMATNQF 166
Query: 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
S+DNIIGDGGYGVVYRG L+NGT VAVKKLLNN GQADKDFRVEVEAIGHVRHKNLVRLL
Sbjct: 167 SRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLL 226
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
GYC+EGTQR+LVYEYVNNGNLEQWLRGD + YLTWEAR+KIL+GTAKALAYLHEAIEP
Sbjct: 227 GYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIEP 286
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
KVVHRDIKSSNILID+ F++KISDFGLAKLLGA KS ITTRVMGTFG
Sbjct: 287 KVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFG 333
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297807871|ref|XP_002871819.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297317656|gb|EFH48078.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 496 bits (1278), Expect = e-138, Method: Compositional matrix adjust.
Identities = 249/347 (71%), Positives = 284/347 (81%), Gaps = 18/347 (5%)
Query: 1 MASDLNKSLSKTYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSR-- 58
M S LN +LS+ Y G++LW +IVI L+ +FVV+L +SLWLTFR+K SR + ++PVSR
Sbjct: 1 MGSGLNDTLSRNYNGLELWEIIVIVLSAIFVVVLAISLWLTFRRKTSRSSTKLIPVSRQI 60
Query: 59 FPVVSEEIKEIRVDQVSSSNGG--FSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLE 116
P V EEIKEIRVD+VSSSNGG + +EKF D+E EK + + DS +SGSFN+LE
Sbjct: 61 PPTVPEEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESENGDSSRSGSFNHLE 120
Query: 117 KDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRF 176
K K + S++PLTAPSPLSGLPEFSHLGWGHWFTLRDLQ ATN+F
Sbjct: 121 K--------------KDGSSVSSANPLTAPSPLSGLPEFSHLGWGHWFTLRDLQMATNQF 166
Query: 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
S+DNIIGDGGYGVVYRG L+NGT VAVKKLLNN GQADKDFRVEVEAIGHVRHKNLVRLL
Sbjct: 167 SRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLL 226
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
GYC+EGTQR+LVYEYVNNGNLEQWLRGD + YLTWEAR+KIL+GTAKALAYLHEAIEP
Sbjct: 227 GYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIEP 286
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
KVVHRDIKSSNILID+ F++KISDFGLAKLLGA KS ITTRVMGTFG
Sbjct: 287 KVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFG 333
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110260|ref|XP_002315464.1| predicted protein [Populus trichocarpa] gi|222864504|gb|EEF01635.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 492 bits (1267), Expect = e-137, Method: Compositional matrix adjust.
Identities = 244/292 (83%), Positives = 259/292 (88%), Gaps = 1/292 (0%)
Query: 53 MLPVSRFPVVSEEIKEIRVDQVSSSNGGFSVHNEKFNDRE-SEKELIPQENGDDSVQSGS 111
M PVS P VSEEIKEI VDQ S++N GF ++KF D+E ++K LI ENGDDS QSGS
Sbjct: 1 MPPVSYMPKVSEEIKEIGVDQNSANNDGFPSLHDKFGDKEEADKVLIQLENGDDSSQSGS 60
Query: 112 FNNLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQS 171
FN++EK VGSQ GEEGG S RPSSHPLTAPSPLSGLPEFS LGWGHWFTLRDLQ
Sbjct: 61 FNHVEKVGVGSQSGEEGGTKVASVHRPSSHPLTAPSPLSGLPEFSQLGWGHWFTLRDLQV 120
Query: 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
ATNRFSKDNIIGDGGYGVVY+G ++NGT VAVKKLLNNPGQADKDFRVEVEAIGHVRHKN
Sbjct: 121 ATNRFSKDNIIGDGGYGVVYQGHMINGTPVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 180
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
LVRLLGYC+EGTQR+LVYEYVNNGNLEQWLRG M GYLTWEARMKILLGTAKALAYLH
Sbjct: 181 LVRLLGYCMEGTQRMLVYEYVNNGNLEQWLRGGMRQHGYLTWEARMKILLGTAKALAYLH 240
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
EAIEPKVVHRDIKSSNILID+NFDAKISDFGLAKLLGAGKSHITTRVMGTFG
Sbjct: 241 EAIEPKVVHRDIKSSNILIDDNFDAKISDFGLAKLLGAGKSHITTRVMGTFG 292
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255556566|ref|XP_002519317.1| conserved hypothetical protein [Ricinus communis] gi|223541632|gb|EEF43181.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 490 bits (1262), Expect = e-136, Method: Compositional matrix adjust.
Identities = 240/298 (80%), Positives = 259/298 (86%), Gaps = 2/298 (0%)
Query: 1 MASDLNKSLSKTYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSRFP 60
MASDL KSL+K Y+G+QLWVL+VICL VV VI+ VSLWLTFRKK R N MLPVS+ P
Sbjct: 1 MASDLKKSLTKQYVGIQLWVLLVICLGVVCAVIMVVSLWLTFRKKTRR--NSMLPVSQRP 58
Query: 61 VVSEEIKEIRVDQVSSSNGGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLEKDVV 120
VSEEIKEI +DQ S++NGGF N+KF+D+ESEK LI ENGDDS QSGSF +++KD V
Sbjct: 59 KVSEEIKEIGIDQNSANNGGFLSLNDKFSDKESEKVLIQLENGDDSSQSGSFTHVDKDGV 118
Query: 121 GSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDN 180
GSQLGE G S++RPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQ ATNRFSKDN
Sbjct: 119 GSQLGEGGATCTASSYRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQVATNRFSKDN 178
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
IIGDGGYGVVY+G LMNGT VAVKKLLNNPGQAD DFRVEVEAIGHVRHKNLVRLLGYCI
Sbjct: 179 IIGDGGYGVVYQGHLMNGTPVAVKKLLNNPGQADIDFRVEVEAIGHVRHKNLVRLLGYCI 238
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
EGTQR+LVYEYVNNGNLEQWL G M GYLTWEARMKILLGTAKALAYLHEAIEPKV
Sbjct: 239 EGTQRMLVYEYVNNGNLEQWLHGGMRQHGYLTWEARMKILLGTAKALAYLHEAIEPKV 296
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147780241|emb|CAN65734.1| hypothetical protein VITISV_037750 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1256), Expect = e-135, Method: Compositional matrix adjust.
Identities = 248/357 (69%), Positives = 298/357 (83%), Gaps = 15/357 (4%)
Query: 1 MASDLNKSLSKT--YIGMQLWVLIVICLAVVFVVILGV-SLWLTFRKKKSRRANDMLPVS 57
M +DLN LSK +G+++W LI I +A+ V+IL V SL LT RKK SR + D LPV+
Sbjct: 1 MTTDLNAELSKKTDVLGLKVWELIGIVVALFIVIILCVLSLCLTSRKK-SRSSRDRLPVN 59
Query: 58 RFPVVSEEIKEIRVDQVSSS-----NGGFSVHNEKFNDRESEKELI-----PQENGDDSV 107
+ P VS+EIKE+RV+QVS++ +G ++K +D+ES+K L+ +NGD+S
Sbjct: 60 QIPTVSKEIKEVRVEQVSTNEFVPRDGILLTIHDKSSDKESDKVLVHLGMGKTKNGDNSS 119
Query: 108 QSGSFNNLEKDVVGSQLGEEGGNGKVSTFRPSS-HPLTAPSPLSGLPEFSHLGWGHWFTL 166
QSGSF++LEKD GSQ GEEG +G V+ ++PSS +P+TAPSPL GLPEFSHLGWGHWFTL
Sbjct: 120 QSGSFHHLEKDGCGSQSGEEGSSGTVTVYKPSSSYPITAPSPLVGLPEFSHLGWGHWFTL 179
Query: 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH 226
RDL+ ATNRFSK+N++G+GGYGVVYRGQL+NGT VAVKK+LNN GQA+K+FRVEVEAIGH
Sbjct: 180 RDLELATNRFSKENVLGEGGYGVVYRGQLINGTPVAVKKILNNLGQAEKEFRVEVEAIGH 239
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
VRHKNLVRLLGYCIEGT R+LVYEYV+NGNLEQWL G M G+LTW+ARMKILLGTAKA
Sbjct: 240 VRHKNLVRLLGYCIEGTHRMLVYEYVSNGNLEQWLHGAMRQHGFLTWDARMKILLGTAKA 299
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
LAYLHEAIEPKVVHRDIKSSNILID++F+AK+SDFGLAKLLGAGKSHITTRVMGTFG
Sbjct: 300 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHITTRVMGTFG 356
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225450464|ref|XP_002280159.1| PREDICTED: probable receptor-like protein kinase At2g42960 [Vitis vinifera] gi|296089839|emb|CBI39658.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 487 bits (1254), Expect = e-135, Method: Compositional matrix adjust.
Identities = 247/357 (69%), Positives = 298/357 (83%), Gaps = 15/357 (4%)
Query: 1 MASDLNKSLSKT--YIGMQLWVLIVICLAVVFVVILGV-SLWLTFRKKKSRRANDMLPVS 57
M +DLN LSK +G+++W LI I +A+ ++IL V SL LT RKK SR + D LPV+
Sbjct: 1 MTTDLNAELSKKTDVLGLKVWELIGIVVALFIIIILCVLSLCLTSRKK-SRSSRDRLPVN 59
Query: 58 RFPVVSEEIKEIRVDQVSSS-----NGGFSVHNEKFNDRESEKELI-----PQENGDDSV 107
+ P VS+EIKE+RV+QVS++ +G ++K +D+ES+K L+ +NGD+S
Sbjct: 60 QIPTVSKEIKEVRVEQVSTNEFVPRDGILLTIHDKSSDKESDKVLVHLGMGKTKNGDNSS 119
Query: 108 QSGSFNNLEKDVVGSQLGEEGGNGKVSTFRPSS-HPLTAPSPLSGLPEFSHLGWGHWFTL 166
QSGSF++LEKD GSQ GEEG +G V+ ++PSS +P+TAPSPL GLPEFSHLGWGHWFTL
Sbjct: 120 QSGSFHHLEKDGCGSQSGEEGSSGTVTVYKPSSSYPITAPSPLVGLPEFSHLGWGHWFTL 179
Query: 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH 226
RDL+ ATNRFSK+N++G+GGYGVVYRGQL+NGT VAVKK+LNN GQA+K+FRVEVEAIGH
Sbjct: 180 RDLELATNRFSKENVLGEGGYGVVYRGQLINGTPVAVKKILNNLGQAEKEFRVEVEAIGH 239
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
VRHKNLVRLLGYCIEGT R+LVYEYV+NGNLEQWL G M G+LTW+ARMKILLGTAKA
Sbjct: 240 VRHKNLVRLLGYCIEGTHRMLVYEYVSNGNLEQWLHGAMRQHGFLTWDARMKILLGTAKA 299
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
LAYLHEAIEPKVVHRDIKSSNILID++F+AK+SDFGLAKLLGAGKSHITTRVMGTFG
Sbjct: 300 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHITTRVMGTFG 356
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124542|ref|XP_002330049.1| predicted protein [Populus trichocarpa] gi|222871474|gb|EEF08605.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 485 bits (1249), Expect = e-134, Method: Compositional matrix adjust.
Identities = 243/356 (68%), Positives = 295/356 (82%), Gaps = 14/356 (3%)
Query: 1 MASDLNKSLSK--TYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSR 58
MASDLN LSK +G+++W +I IC+A+ V+IL V + +KKSRR + LP S+
Sbjct: 1 MASDLNAELSKKTAILGLKVWEVIGICVALFIVIILSVLSFCLTSRKKSRRDRNHLPPSQ 60
Query: 59 FPVVSEEIKEIRVDQVSSS-----NGGFSVHNEKFNDRESEKELI-----PQENGDDSVQ 108
P VS+EI E+RV+QVS++ +G ++K +D+ES+K L+ +NGD+ +
Sbjct: 61 IPTVSKEITEVRVEQVSTNEFVPRDGILLTIHDKSSDKESDKVLVHLGMGKVKNGDNMSR 120
Query: 109 SGSFNNLEKDVVGSQLGEEGGNGKVSTFRPSS-HPLTAPSPLSGLPEFSHLGWGHWFTLR 167
SGSF++LEKD GSQ GEEG +GKV+ ++PSS +P+TAPSPLSGLPEFSHLGWGHWFTLR
Sbjct: 121 SGSFHHLEKDC-GSQSGEEGSSGKVTVYKPSSSYPITAPSPLSGLPEFSHLGWGHWFTLR 179
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV 227
DL+ ATNRFSK+N++G+GGYGVVY+G L+NGT VAVKK+LNN GQA+K+FRVEV+AIGHV
Sbjct: 180 DLELATNRFSKENVLGEGGYGVVYQGHLINGTPVAVKKILNNLGQAEKEFRVEVDAIGHV 239
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
RHKNLVRLLGYCIEGT RILVYEYVNNGNLEQWL G M GYLTWEARMK+LLGTAKAL
Sbjct: 240 RHKNLVRLLGYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKVLLGTAKAL 299
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
AYLHEAIEPKVVHRDIKSSNILID++F+AK+SDFGLAKLLGAGKSH+TTRVMGTFG
Sbjct: 300 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 355
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565467|ref|XP_003550961.1| PREDICTED: probable receptor-like protein kinase At5g18500-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 484 bits (1247), Expect = e-134, Method: Compositional matrix adjust.
Identities = 250/349 (71%), Positives = 289/349 (82%), Gaps = 7/349 (2%)
Query: 1 MASDLNKSLSK--TYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSR 58
MASDLN LS+ + G++ W L+ I + + ++IL V +KKSRR N MLP+S
Sbjct: 1 MASDLNSGLSQETSVFGLKAWELMGIIVGLFIIIILVVISICLTSRKKSRRVNGMLPLSH 60
Query: 59 FPVVSEEIKEIRVDQVSSSN----GGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNN 114
VS+EIKEIRVDQVS++N G F ++F+DR+SEK LI NG++S QSGSF +
Sbjct: 61 MLSVSDEIKEIRVDQVSANNHPQNGAFVSLYDRFSDRDSEKVLIQTNNGENSSQSGSFVH 120
Query: 115 LEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATN 174
L+KD GSQ GEE G VST+R SSHP+TAPSPL GLPEFSHLGWGHWFTLRDL+ ATN
Sbjct: 121 LKKDD-GSQSGEESGAKSVSTYRSSSHPITAPSPLCGLPEFSHLGWGHWFTLRDLELATN 179
Query: 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVR 234
RFSKDN+IG+GGYGVVY+GQL+NG+ VAVKKLLNN GQA+K+FRVEVEAIGHVRHKNLVR
Sbjct: 180 RFSKDNVIGEGGYGVVYQGQLINGSPVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVR 239
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
LLGYCIEGT R+LVYEYVNNGNLEQWL G M G+LTW+AR+KILLGTAKALAYLHEAI
Sbjct: 240 LLGYCIEGTHRLLVYEYVNNGNLEQWLHGAMRQYGFLTWDARIKILLGTAKALAYLHEAI 299
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
EPKVVHRDIKSSNILID++F+AKISDFGLAKLLGAGKSHITTRVMGTFG
Sbjct: 300 EPKVVHRDIKSSNILIDDDFNAKISDFGLAKLLGAGKSHITTRVMGTFG 348
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 358 | ||||||
| TAIR|locus:2146203 | 484 | AT5G18500 [Arabidopsis thalian | 0.916 | 0.677 | 0.729 | 1.6e-127 | |
| TAIR|locus:2027559 | 492 | AT1G56720 [Arabidopsis thalian | 0.935 | 0.680 | 0.638 | 1.5e-108 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.885 | 0.680 | 0.631 | 8.3e-106 | |
| TAIR|locus:2045620 | 494 | AT2G42960 [Arabidopsis thalian | 0.930 | 0.674 | 0.601 | 1.1e-101 | |
| TAIR|locus:2077730 | 512 | AT3G59110 [Arabidopsis thalian | 0.935 | 0.654 | 0.596 | 2.3e-101 | |
| TAIR|locus:2093591 | 467 | GPK1 "glyoxysomal protein kina | 0.701 | 0.537 | 0.710 | 1.5e-92 | |
| TAIR|locus:2132353 | 492 | AT4G02630 [Arabidopsis thalian | 0.541 | 0.394 | 0.688 | 7.4e-82 | |
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.684 | 0.519 | 0.585 | 1.9e-74 | |
| TAIR|locus:2139559 | 437 | AT4G34500 [Arabidopsis thalian | 0.748 | 0.613 | 0.522 | 2.1e-68 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.536 | 0.294 | 0.512 | 9.9e-52 |
| TAIR|locus:2146203 AT5G18500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1252 (445.8 bits), Expect = 1.6e-127, P = 1.6e-127
Identities = 254/348 (72%), Positives = 293/348 (84%)
Query: 1 MASDLNKSLSKTYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSRF- 59
M S LN +LS+ Y G++LW +IVI L+ +FVV+L +SLWLTFR+K SR +++++PVSR
Sbjct: 1 MGSGLNDTLSRNYNGLELWEIIVIVLSAIFVVVLAISLWLTFRRKTSRSSSNLIPVSRQI 60
Query: 60 -PVVSEEIKEIRVDQVSSSNGG--FSVHNEKFNDRESEKELIPQ-ENGDDSVQSGSFNNL 115
P V EEIKEIRVD+VSSSNGG + +EKF D+E EK + + ENGD S +SGSFN+L
Sbjct: 61 PPSVPEEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESENGDSS-RSGSFNHL 119
Query: 116 EKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNR 175
EK ++G + VS S++PLTAPSPLSGLPEFSHLGWGHWFTLRDLQ ATN+
Sbjct: 120 EK--------KDGSS--VS----SANPLTAPSPLSGLPEFSHLGWGHWFTLRDLQMATNQ 165
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
FS+DNIIGDGGYGVVYRG L+NGT VAVKKLLNN GQADKDFRVEVEAIGHVRHKNLVRL
Sbjct: 166 FSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRL 225
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
LGYC+EGTQR+LVYEYVNNGNLEQWLRGD + YLTWEAR+KIL+GTAKALAYLHEAIE
Sbjct: 226 LGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIE 285
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
PKVVHRDIKSSNILID+ F++KISDFGLAKLLGA KS ITTRVMGTFG
Sbjct: 286 PKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFG 333
|
|
| TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1073 (382.8 bits), Expect = 1.5e-108, P = 1.5e-108
Identities = 226/354 (63%), Positives = 277/354 (78%)
Query: 1 MASDLNKSLSK-TYI-GMQLWVLIVICLAVVFVVILGV-SLWLTFRKKKSRRANDMLPVS 57
M DL LS+ +++ G+++W +I I +A++ + IL V S LT KKKSRR+ LPV
Sbjct: 1 MGGDLKSQLSRESHVFGLKVWEVIGIAVALLIIAILSVLSCCLT-SKKKSRRSKTGLPVI 59
Query: 58 RFP-VVSEEIKEIRVDQVSSSN---G-GFSVHNEKFNDRESEKELIP---QENGDDSVQS 109
+ P VVS+EI+E+RV+ VS+SN G G + + N+++SEK ++ ++ S +S
Sbjct: 60 QTPPVVSKEIREVRVEHVSASNFAPGEGILLTIQDKNNKDSEKVMVHLDMRKKRSSSGRS 119
Query: 110 GSFNNLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDL 169
GSF++LE S EE VS S + + PSPLSGLPE SHLGWGHWFTLRDL
Sbjct: 120 GSFHHLEIIDKHSDSAEE-----VSA-SSSLYNIATPSPLSGLPE-SHLGWGHWFTLRDL 172
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH 229
++ATNRFSK+N+IG+GGYGVVYRG+LMNGT VAVKK+LN GQA+K+FRVEV+AIGHVRH
Sbjct: 173 ETATNRFSKENVIGEGGYGVVYRGELMNGTPVAVKKILNQLGQAEKEFRVEVDAIGHVRH 232
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
KNLVRLLGYCIEGT RILVYEYVNNGNLEQWL G M GYLTWEARMK+L+GT+KALAY
Sbjct: 233 KNLVRLLGYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKVLIGTSKALAY 292
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
LHEAIEPKVVHRDIKSSNILI++ F+AK+SDFGLAKLLGAGKSH+TTRVMGTFG
Sbjct: 293 LHEAIEPKVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 346
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1047 (373.6 bits), Expect = 8.3e-106, P = 8.3e-106
Identities = 211/334 (63%), Positives = 259/334 (77%)
Query: 15 GMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDM-LPVSRFPVVSEEIKEIRVDQ 73
G+++W I I +A++ +V+L V + KKKSRR+ + LP+ + PVVS+EIKE+R++
Sbjct: 3 GLKIWQAIFITIALIIIVVLSVLSFCLIWKKKSRRSKTLSLPIIQTPVVSKEIKEVRIEH 62
Query: 74 VSSSNGGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLEKDVVGSQLGEEG----G 129
V S++ F +E N+ ES+K L+ E ++ N L GS G+EG
Sbjct: 63 VVSTSSNFDPQDE--NNNESDKFLLNLE-----MEKNRENGLSSSRSGS--GKEGYLCVA 113
Query: 130 NGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGV 189
N S+ + P +PSPLSGLPE SHLGWGHWFTLRDL+ ATNRFSK+N+IG+GGYGV
Sbjct: 114 NRSTSSLYEMATP--SPSPLSGLPE-SHLGWGHWFTLRDLEIATNRFSKENVIGEGGYGV 170
Query: 190 VYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249
VYRG+L+NG+ VAVKK+LN+ GQA+K+FRVEV+AIGHVRHKNLVRLLGYCIEGT RILVY
Sbjct: 171 VYRGELVNGSLVAVKKILNHLGQAEKEFRVEVDAIGHVRHKNLVRLLGYCIEGTNRILVY 230
Query: 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNIL 309
EY+NNGNLE+WL G M GYLTWEARMK+L GT+KALAYLHEAIEPKVVHRDIKSSNIL
Sbjct: 231 EYMNNGNLEEWLHGAMKHHGYLTWEARMKVLTGTSKALAYLHEAIEPKVVHRDIKSSNIL 290
Query: 310 IDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
ID+ F+AKISDFGLAKLLG GKSH+TTRVMGTFG
Sbjct: 291 IDDRFNAKISDFGLAKLLGDGKSHVTTRVMGTFG 324
|
|
| TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1008 (359.9 bits), Expect = 1.1e-101, P = 1.1e-101
Identities = 213/354 (60%), Positives = 265/354 (74%)
Query: 3 SDLNKSLSK--TYIGMQ---LWVLIVICLAVVFVVILGV-SLWLTFRKKKSRRANDMLPV 56
S LN +SK ++ G++ LWV + + + V V+IL + SLW+TFR+K SRR++ P
Sbjct: 5 SSLNAEMSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRK-SRRSSSKFPF 63
Query: 57 SRFPVVSEEIKEIRVDQVSSSNGG-FSVHNEKFNDRESEKELIP-----QENGDDSV-QS 109
++ P VS K+IRVD+ N S++ E ND+ + K ++ + + +D++ Q
Sbjct: 64 NQIPHVS---KDIRVDRAGFQNPHPESLYIE-MNDKSTGKTMMSHLGRTKSSDNDTLSQC 119
Query: 110 GSFNNLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDL 169
S N+ E+ S GEEGG G + P+TA SPL GLPE SHLGWGHWFTLRDL
Sbjct: 120 SSVNHHER-ACSSHSGEEGGFGSAGR-QYGGGPVTA-SPLVGLPEISHLGWGHWFTLRDL 176
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH 229
+ ATNRF+ N++G+GGYGVVYRG+L+NGT VAVKKLLNN GQA+K+FRVEVEAIGHVRH
Sbjct: 177 ELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH 236
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
KNLVRLLGYCIEG R+LVYEYVN+GNLEQWL G M G LTWEARMKI+ GTA+ALAY
Sbjct: 237 KNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAY 296
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
LHEAIEPKVVHRDIK+SNILID+ F+AK+SDFGLAKLL +G+SHITTRVMGTFG
Sbjct: 297 LHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFG 350
|
|
| TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1005 (358.8 bits), Expect = 2.3e-101, P = 2.3e-101
Identities = 214/359 (59%), Positives = 270/359 (75%)
Query: 1 MASDLNKSLSKTYI-GMQLWVLIVICLAV-VFVVILG--VSLWLTFRKKKSRRANDMLPV 56
+++D++K +S + GM+LWVLI CL V FVV++ +SLW+ FR+K R ++ +LP
Sbjct: 7 LSADMSKKVSFLGLKGMKLWVLI--CLVVGTFVVLVFCILSLWIAFRRKSRRSSHKLLPF 64
Query: 57 SRFPVVSEEIKEIRVDQ---VSSSNGGFSVHN-EKFNDRESEKELI----PQENGDDSV- 107
S+ P V+ K+IRVD + N S+ N +K +DR S K + + + +DS+
Sbjct: 65 SQIPRVA---KDIRVDDRVGFQNHNENLSITNADKSSDRNSGKMMSYLGRTKSSDNDSIS 121
Query: 108 QSGSFNNLEKDVVGSQLGEEGGNGKVSTFRPSSHP---LTAPSPLSGLPEFSHLGWGHWF 164
Q S ++ E+ S GE+G G + +R +S L SPL GLPE SHLGWGHWF
Sbjct: 122 QCSSVHHHER-ACSSHSGEDGSFG--AAWRQNSLSQGGLVTASPLVGLPEISHLGWGHWF 178
Query: 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAI 224
TLRDLQ ATNRF+ +N+IG+GGYGVVY+G+L+NG VAVKKLLNN GQA+K+FRVEVEAI
Sbjct: 179 TLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLGQAEKEFRVEVEAI 238
Query: 225 GHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
GHVRHKNLVRLLGYCIEG R+LVYEYVN+GNLEQWL G M + LTWEARMKIL+GTA
Sbjct: 239 GHVRHKNLVRLLGYCIEGVNRMLVYEYVNSGNLEQWLHGAMGKQSTLTWEARMKILVGTA 298
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ALAYLHEAIEPKVVHRDIK+SNILID++F+AK+SDFGLAKLL +G+SHITTRVMGTFG
Sbjct: 299 QALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLDSGESHITTRVMGTFG 357
|
|
| TAIR|locus:2093591 GPK1 "glyoxysomal protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 922 (329.6 bits), Expect = 1.5e-92, P = 1.5e-92
Identities = 184/259 (71%), Positives = 210/259 (81%)
Query: 92 ESEKELIPQENGDDSVQSGSFNNL-EKDVVGSQLGEE--GGNGK---VSTFRPSSHP-LT 144
E KE I ++G + S+ L EK V + G++ G K V + P S P T
Sbjct: 64 EEIKE-ISVDHGSSNNNGTSYQTLDEKFVEDIENGDKFSGSLEKKPLVGSHLPPSTPSTT 122
Query: 145 APSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVK 204
APSPL GLPE SH+GWGHWFTLRDLQ ATN FSK++IIGDGGYGVVY G L N T VAVK
Sbjct: 123 APSPLLGLPEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVK 182
Query: 205 KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGD 264
KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC+EGT R+LVYEY+NNGNLEQWL GD
Sbjct: 183 KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGD 242
Query: 265 MCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
M +G+LTWEAR+K+L+GTAKALAYLHEAIEPKVVHRDIKSSNIL+D+NFDAK+SDFGLA
Sbjct: 243 MIHKGHLTWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLA 302
Query: 325 KLLGAGKSHITTRVMGTFG 343
KLLGA ++++TRVMGTFG
Sbjct: 303 KLLGADSNYVSTRVMGTFG 321
|
|
| TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 730 (262.0 bits), Expect = 7.4e-82, Sum P(2) = 7.4e-82
Identities = 135/196 (68%), Positives = 166/196 (84%)
Query: 149 LSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLN 208
LSG PE SHLGWGHW+TLR+L+ +TN F+ +N+IG GGYG+VYRG L + + VA+K LLN
Sbjct: 136 LSG-PEVSHLGWGHWYTLRELEVSTNGFADENVIGQGGYGIVYRGVLEDKSMVAIKNLLN 194
Query: 209 NPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGD-MCD 267
N GQA+K+F+VEVEAIG VRHKNLVRLLGYC+EG R+LVYEYV+NGNLEQW+ G +
Sbjct: 195 NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCVEGAHRMLVYEYVDNGNLEQWIHGGGLGF 254
Query: 268 RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ LTWE RM I+LGTAK L YLHE +EPKVVHRDIKSSNIL+D+ +++K+SDFGLAKLL
Sbjct: 255 KSPLTWEIRMNIVLGTAKGLMYLHEGLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLL 314
Query: 328 GAGKSHITTRVMGTFG 343
G+ S++TTRVMGTFG
Sbjct: 315 GSEMSYVTTRVMGTFG 330
|
|
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 751 (269.4 bits), Expect = 1.9e-74, P = 1.9e-74
Identities = 147/251 (58%), Positives = 185/251 (73%)
Query: 95 KELIPQENGDDSVQ-SGSFNNLEKDVVGSQLGEEG-GNGKVSTFRPSSHPLTAPSPLSGL 152
KE++P +N + +E VV S G G S +S+ + S G
Sbjct: 75 KEIVPAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTASASETASY---SGSGNCG- 130
Query: 153 PEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ 212
PE SHLGWG W+TLR+L++ATN ++N+IG+GGYG+VYRG L +GT VAVK LLNN GQ
Sbjct: 131 PEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQ 190
Query: 213 ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT 272
A+K+F+VEVE IG VRHKNLVRLLGYC+EG R+LVY++V+NGNLEQW+ GD+ D LT
Sbjct: 191 AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLT 250
Query: 273 WEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332
W+ RM I+LG AK LAYLHE +EPKVVHRDIKSSNIL+D ++AK+SDFGLAKLLG+ S
Sbjct: 251 WDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESS 310
Query: 333 HITTRVMGTFG 343
++TTRVMGTFG
Sbjct: 311 YVTTRVMGTFG 321
|
|
| TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 694 (249.4 bits), Expect = 2.1e-68, P = 2.1e-68
Identities = 149/285 (52%), Positives = 194/285 (68%)
Query: 61 VVSEEIKEIRVDQVSSSNGGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLEKDVV 120
V + R +V S+G + +++ ++ ++ + I N DDS G N E VV
Sbjct: 45 VCLNRVSRARRMRVKHSSGSIPLVSKEISEIKTVGKFI---NSDDS--KGKIGN-EVVVV 98
Query: 121 GSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDN 180
S +E +G F S A S G E +GWG W++L+DL+ AT FS DN
Sbjct: 99 VSATSKEATSG----FDTLS---VASSGDVGTSEA--MGWGKWYSLKDLEIATRGFSDDN 149
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
+IG+GGYGVVYR +G+ AVK LLNN GQA+K+F+VEVEAIG VRHKNLV L+GYC
Sbjct: 150 MIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEKEFKVEVEAIGKVRHKNLVGLMGYCA 209
Query: 241 EG--TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
+ +QR+LVYEY++NGNLEQWL GD+ LTW+ RMKI +GTAK LAYLHE +EPKV
Sbjct: 210 DSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTWDIRMKIAIGTAKGLAYLHEGLEPKV 269
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
VHRD+KSSNIL+D+ ++AK+SDFGLAKLLG+ S++TTRVMGTFG
Sbjct: 270 VHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVTTRVMGTFG 314
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 507 (183.5 bits), Expect = 9.9e-52, Sum P(2) = 9.9e-52
Identities = 102/199 (51%), Positives = 136/199 (68%)
Query: 146 PSPLSGLPEFSHLGWGH-WFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVK 204
P P GL LG+ FT +L ATN FS+ N++G GG+G V++G L +G VAVK
Sbjct: 253 PPPSPGLV----LGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVK 308
Query: 205 KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGD 264
+L GQ +++F+ EVE I V H++LV L+GYC+ G QR+LVYE+V N NLE L G
Sbjct: 309 QLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGK 368
Query: 265 MCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
R + W R+KI LG+AK L+YLHE PK++HRDIK+SNILID F+AK++DFGLA
Sbjct: 369 --GRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLA 426
Query: 325 KLLGAGKSHITTRVMGTFG 343
K+ +H++TRVMGTFG
Sbjct: 427 KIASDTNTHVSTRVMGTFG 445
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8LEB6 | Y5185_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7175 | 0.9189 | 0.6797 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 358 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-37 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-13 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.002 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.002 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.003 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.003 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 2e-41
Identities = 56/165 (33%), Positives = 89/165 (53%), Gaps = 10/165 (6%)
Query: 182 IGDGGYGVVYRGQLMN-GTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
+G+GG+G VY + G VA+K + + ++ E+E + + H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ LV EY G+L+ L+ + G L+ + ++ILL + L YLH ++
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 300 HRDIKSSNILIDE-NFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
HRD+K NIL+D N K++DFGL+KLL + KS + T V GT
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPA 158
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-38
Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 177 SKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNN-PGQADKDFRVEVEAIGHVRHK 230
+ +G+G +G VY+G+L VAVK L + Q ++F E + + H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N+V+LLG C E +V EY+ G+L +LR +R L+ + L A+ + YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK---NRPKLSLSDLLSFALQIARGMEYL 118
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
+HRD+ + N L+ EN KISDFGL++ L
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY 153
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-38
Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 11/161 (6%)
Query: 177 SKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHK 230
+ +G+G +G VY+G L VAVK L + Q ++F E + + H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N+V+LLG C E ++V EY+ G+L +LR L+ + L A+ + YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYL 119
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331
+HRD+ + N L+ EN KISDFGL++ L
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 59/165 (35%), Positives = 81/165 (49%), Gaps = 13/165 (7%)
Query: 181 IIGDGGYGVVYRGQLMN-GTAVAVKKL---LNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+G G +G VY+ + G VAVK L + R E+ + + H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPNIVRLI 64
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
+ LV EY G+L +L G L+ + KI L + L YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
++HRD+K NIL+DEN KI+DFGLAK L S +TT V GT
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GT 161
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-36
Identities = 57/169 (33%), Positives = 85/169 (50%), Gaps = 13/169 (7%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNLV 233
+ +G+G +G VY + G VA+K + + + E++ + ++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMKILLGTAKALAYLHE 292
RL + + LV EY G+L L+ RG L+ EAR L AL YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEAR-FYLRQILSALEYLHS 115
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+VHRD+K NIL+DE+ K++DFGLA+ L G +TT V GT
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFV-GT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 3e-35
Identities = 53/158 (33%), Positives = 80/158 (50%), Gaps = 12/158 (7%)
Query: 176 FSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRH 229
+G+G +G VY+G L T VAVK L + ++ +F E + + H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
N+VRLLG C +G +V EY+ G+L +LR LT + +++ L AK + Y
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK---HGEKLTLKDLLQMALQIAKGMEY 117
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
L VHRD+ + N L+ EN KISDFGL++ +
Sbjct: 118 LESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDI 152
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 8e-35
Identities = 54/168 (32%), Positives = 83/168 (49%), Gaps = 13/168 (7%)
Query: 180 NIIGDGGYGVVYRGQLMNG----TAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVR 234
+G+G +G VY+G+L T VAVK L + + + KDF E + + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLR-----GDMCDRGYLTWEARMKILLGTAKALAY 289
LLG C E LV EY+ G+L +LR ++ L+ + + + AK + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
L K VHRD+ + N L+ E+ KISDFGL++ + +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT 165
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 4e-28
Identities = 54/179 (30%), Positives = 87/179 (48%), Gaps = 25/179 (13%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKK--LLNNPGQADKDFRVEVEAIGHVRHKN 231
+++ ++G G +G VY G +AVK L + + + E+ + ++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 232 LVRLLGYCIEGTQR-ILVY-EYVNNGNLEQWLRG------DMCDRGYLTWEARMKILLGT 283
+VR G + + + ++ EYV+ G+L L+ + R Y R IL G
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI-RKY----TRQ-ILEG- 113
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM-GT 341
LAYLH +VHRDIK +NIL+D + K++DFG AK LG ++ T + GT
Sbjct: 114 ---LAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-26
Identities = 52/144 (36%), Positives = 75/144 (52%), Gaps = 7/144 (4%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241
IG G +G V G VAVK L ++ A F E + +RH NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDYRGQK-VAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHR 301
G +V EY+ G+L +LR R +T ++ L + + YL E VHR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 302 DIKSSNILIDENFDAKISDFGLAK 325
D+ + N+L+ E+ AK+SDFGLAK
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 9/161 (5%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
IG GG+G VY+ G VA+K + + + E++ + +H N+V+ G +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
+ + +V E+ + G+L+ L+ LT + K L YLH ++H
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIH 121
Query: 301 RDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
RDIK++NIL+ + + K+ DFGL+ L K+ T +GT
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 57/166 (34%), Positives = 90/166 (54%), Gaps = 15/166 (9%)
Query: 179 DNIIGDGGYGVVYRGQL-MNG---TAVAVKKLLNNPGQADK---DFRVEVEAIGHVRHKN 231
+ +IG G +G V RG+L + G VA+K L G +DK DF E +G H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
++RL G + +++ EY+ NG+L+++LR + G T + +L G A + YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLS 123
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
E VHRD+ + NIL++ N K+SDFGL++ L ++ TT+
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 7e-24
Identities = 54/176 (30%), Positives = 90/176 (51%), Gaps = 23/176 (13%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKK--LLNNPGQADKDFRVEVEAIGHVRHKN 231
+ ++IG G +GVVY+G L G VA+K+ L +A K E++ + +++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG------DMCDRGYLTWEARMKILLGTAK 285
+V+ +G ++ EY NG+L Q ++ + Y+ ++L G
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAV-YVY-----QVLQG--- 111
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
LAYLHE V+HRDIK++NIL ++ K++DFG+A L + V+GT
Sbjct: 112 -LAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 2e-23
Identities = 46/170 (27%), Positives = 83/170 (48%), Gaps = 7/170 (4%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRV-EVEAIGHVRHKN 231
++ IG G +G VY + +G +K++ L+N + +++ + EV+ + + H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+++ E + +V EY + G+L Q ++ + E + + AL YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
K++HRDIK NI + N K+ DFG++K+L + T V GT
Sbjct: 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-22
Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 182 IGDGGYGVVYRGQLMNG------TAVAVKKLLN-NPGQADKDFRVEVEAIGHVRHKNLVR 234
+G+G +G V+ G+ + VAVK L A KDF E E + + +H+N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLR----------GDMCDRGYLTWEARMKILLGTA 284
G C EG I+V+EY+ +G+L ++LR G LT ++I + A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+ YL VHRD+ + N L+ + KI DFG+++
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 96.0 bits (237), Expect = 4e-22
Identities = 53/163 (32%), Positives = 83/163 (50%), Gaps = 11/163 (6%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVRH-KNLVRLLG 237
+G+G +G VY + + VA+K L L + + + F E++ + + H N+V+L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
+ + LV EYV+ G+LE L+ +G L+ + IL AL YLH
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIG-RKGPLSESEALFILAQILSALEYLHSK---G 121
Query: 298 VVHRDIKSSNILIDEN-FDAKISDFGLAKLLGAGKSHITTRVM 339
++HRDIK NIL+D + K+ DFGLAKLL S + +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPAL 164
|
Length = 384 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-22
Identities = 46/146 (31%), Positives = 79/146 (54%), Gaps = 7/146 (4%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241
IG G +G+V+ G + VA+K + +++DF E + + + H LV+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHR 301
+ LV+E++ +G L +LR RG + E + + L + +AYL + V+HR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHR 124
Query: 302 DIKSSNILIDENFDAKISDFGLAKLL 327
D+ + N L+ EN K+SDFG+ + +
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFV 150
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 9e-22
Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 15/171 (8%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRV----EVEAIGHVR 228
N++ ++G+G YGVV + + G VA+KK + D+D + EV+ + +R
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLR 58
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H+N+V L + LV+EYV LE G L +A + +A+A
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIA 114
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK-SHITTRV 338
Y H ++HRDIK NIL+ E+ K+ DFG A+ L A S +T V
Sbjct: 115 YCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV 162
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 9e-22
Identities = 46/152 (30%), Positives = 80/152 (52%), Gaps = 14/152 (9%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLL---NNPGQADKDFRVEVEAIGHVRHKNLVRLLG 237
IG+G YGVVY+ + + G VA+KK+ + G R E++ + + H N+++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-ILLGTAKALAYLHEAIEP 296
LV+E+++ +L + ++ DR E+ +K L + LA+ H
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIK----DRQRGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
++HRD+K N+LI+ K++DFGLA+ G
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFG 149
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 9e-21
Identities = 49/147 (33%), Positives = 75/147 (51%), Gaps = 8/147 (5%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLLGYCI 240
+G G +G V+ G T VAVK L PG + F E + + +RH LV+L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
E +V EY++ G+L +L+ + L + + A+ +AYL +H
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 301 RDIKSSNILIDENFDAKISDFGLAKLL 327
RD+ + NIL+ EN KI+DFGLA+L+
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLI 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 1e-20
Identities = 53/173 (30%), Positives = 86/173 (49%), Gaps = 22/173 (12%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNN------PGQADKDFRVEVEAIGHVR 228
+ K +G+G YGVVY+ + G VA+KK+ + P A R E+ + ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA---LR-EISLLKELK 56
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR--MKILLGTAKA 286
H N+V+LL + LV+EY + +L+++L D + M LL +
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLSPNLIKSIMYQLL---RG 110
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM 339
LAY H +++HRD+K NILI+ + K++DFGLA+ G T V+
Sbjct: 111 LAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-20
Identities = 48/152 (31%), Positives = 83/152 (54%), Gaps = 5/152 (3%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
F+ + +G G +G V+ G N VA+K L ++ +DF+ EV+A+ +RHK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
C G ++ E + G+L +LR + L + + + A+ +AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+HRD+ + NIL+ E+ K++DFGLA+L+
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLI 154
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-20
Identities = 56/161 (34%), Positives = 88/161 (54%), Gaps = 15/161 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQL-MNG---TAVAVKKLLNNPGQADK---DFRVEVEAIGH 226
+ +K +IG G +G V+RG L M G AVA+K L PG +K DF E +G
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEASIMGQ 62
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
H N++RL G + +++ EY+ NG L+++LR G + + +L G A
Sbjct: 63 FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAG 119
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ YL + VHRD+ + NIL++ N + K+SDFGL+++L
Sbjct: 120 MKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 6e-20
Identities = 50/166 (30%), Positives = 89/166 (53%), Gaps = 16/166 (9%)
Query: 182 IGDGGYGVVYR-GQLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHKNLVRLLG 237
IG+G +G+V++ G VA+KK+ G ++ R E++A+ +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR--MKILLGTAKALAYLHEAIE 295
G+ +LV EY+ + L + LR +R + + M++LL K +AY+H
Sbjct: 67 VFPHGSGFVLVMEYMPSD-LSEVLRD--EERPLPEAQVKSYMRMLL---KGVAYMHAN-- 118
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
++HRD+K +N+LI + KI+DFGLA+L + + + + T
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVAT 163
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 6e-20
Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKL-LNNPGQADKDFRVEVEAIGHVR 228
+F K +G+G +G V + G VAVK L + Q DF E+E + +
Sbjct: 7 KFIKQ--LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64
Query: 229 HKNLVRLLGYCIEGTQRI--LVYEYVNNGNLEQWLRG--DMCDRGYLTWEARMKILLGTA 284
H+N+V+ G C + R L+ EY+ +G+L +L+ D + L +
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQIC 119
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
K + YL + +HRD+ + NIL++ KISDFGLAK+L K + +
Sbjct: 120 KGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVK 169
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 31/199 (15%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLL-NNPGQADKDFRVEVEAIGHV 227
RF ++ +G+G +G VY+G+L + T+VA+K L N + ++FR E E + +
Sbjct: 8 RFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWL--RGDMCDRGYLTWEARMKILLGTAK 285
+H N+V LLG C + +++EY+ +G+L ++L D G + + +K L
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL---D 122
Query: 286 ALAYLHEAIE----------PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335
+LH AI+ VHRD+ + N L+ E KISDFGL++ S
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD---IYSADY 179
Query: 336 TRVMGTFGDFSVTLLRNMP 354
RV S+ +R MP
Sbjct: 180 YRVQSK----SLLPVRWMP 194
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-19
Identities = 56/169 (33%), Positives = 86/169 (50%), Gaps = 8/169 (4%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLN--NPGQADKDFRV-EVEAIGHVRHKNLVRLL 236
IG G +G V + + + + V K ++ N + +K V EV + ++H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 237 GYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
I+ + + L V EY G+L Q ++ +R Y+ E +IL AL H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 295 EPK--VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+P V+HRD+K +NI +D N + K+ DFGLAK+LG S T V GT
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 51/172 (29%), Positives = 90/172 (52%), Gaps = 17/172 (9%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKD------FRVEVEAIGHV 227
R+ K +G+G Y VVY+ G VA+KK+ + KD R E++ + +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQEL 59
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-ILLGTAKA 286
+H N++ LL + LV+E++ +LE+ ++ D+ + A +K +L T +
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIK----DKSIVLTPADIKSYMLMTLRG 114
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
L YLH ++HRD+K +N+LI + K++DFGLA+ G+ +T +V
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQV 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-19
Identities = 54/161 (33%), Positives = 79/161 (49%), Gaps = 21/161 (13%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK--KLLNNPGQAD---KDFRVEVEAIGHVR 228
R+ K ++G G +G VY G L +G AVK L ++ K E+ + ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEA-RM---KILLGTA 284
H N+V+ LG E + E V G+L + L+ G R+ +ILLG
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLG-- 114
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
L YLH+ VHRDIK +NIL+D N K++DFG+AK
Sbjct: 115 --LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-19
Identities = 53/177 (29%), Positives = 79/177 (44%), Gaps = 20/177 (11%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKN 231
R+ + N IG G +G VY L G +AVK++ K+ E++ + ++H N
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG-----DMCDRGYLTWEARMKILLGTAKA 286
LV+ G + + + EY + G LE+ L + R Y LL +
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY------TLQLL---EG 111
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
LAYLH +VHRDIK +NI +D N K+ DFG A L + + V G
Sbjct: 112 LAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 5e-19
Identities = 55/176 (31%), Positives = 86/176 (48%), Gaps = 27/176 (15%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD-FRV----EVEAIGHVRH 229
+ K IG+G YG VY+ + G VA+KK+ + +K+ F + E++ + +RH
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRH 57
Query: 230 KNLVRLLGYCIE--GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR----MKILLGT 283
N+VRL +V+EY ++ L G + E++ MK LL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEY-----MDHDLTGLLDSPEVKFTESQIKCYMKQLL-- 110
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL-GAGKSHITTRV 338
+ L YLH ++HRDIK SNILI+ + K++DFGLA+ + T RV
Sbjct: 111 -EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-19
Identities = 53/154 (34%), Positives = 79/154 (51%), Gaps = 17/154 (11%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
IG G YG VY+ + + G VA+K + PG + + E+ + RH N+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 241 EGTQRILVYEYVNNGNLE---QWLRGDMCDR--GYLTWEARMKILLGTAKALAYLHEAIE 295
+ +V EY G+L+ Q RG + + Y+ E L G LAYLHE
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRET----LKG----LAYLHET-- 120
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329
+HRDIK +NIL+ E+ D K++DFG++ L A
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 9e-19
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 15/148 (10%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241
+G G +GVV+ G+ VA+K ++ ++ DF E + + + H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA----KALAYLHEAIEPK 297
+V EY+ NG L +LR +G L + LL +A+ YL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRE---RKGKL----GTEWLLDMCSDVCEAMEYLESN---G 120
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAK 325
+HRD+ + N L+ E+ K+SDFGLA+
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 53/158 (33%), Positives = 86/158 (54%), Gaps = 13/158 (8%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
TNR+ +G G +G+V + + G VA+KK++ P A + +R E++ + H+R
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H+N++ L I + I + +L + L ++ ++ + +IL G L
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFL-YQILRG----LK 122
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
Y+H A VVHRD+K SNILI+EN D KI DFGLA++
Sbjct: 123 YVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 19/168 (11%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVR 228
K ++G G +G VY+G + VA+K L +A+K+ E + V
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMKILLGTAK 285
H ++VRLLG C+ +Q L+ + + G L ++R ++ + L W ++ AK
Sbjct: 68 HPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AK 120
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333
++YL E ++VHRD+ + N+L+ KI+DFGLAKLL +
Sbjct: 121 GMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 48/148 (32%), Positives = 75/148 (50%), Gaps = 8/148 (5%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLLGYCI 240
+G G +G V+ G N T VAVK L PG D KDF E + + +RH L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL--KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
+V E + G+L ++L+G L + + A +AYL +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIH 126
Query: 301 RDIKSSNILIDENFDAKISDFGLAKLLG 328
RD+ + N+L+ EN K++DFGLA+++
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIK 154
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 2e-18
Identities = 57/187 (30%), Positives = 84/187 (44%), Gaps = 41/187 (21%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHK 230
R+ IG G YGVV G VA+KK+ N + A + R E++ + H+RH+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHE 59
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGN------------LEQWLRGDMCDRGYLTWEARMK 278
N++ LL IL + N L + ++ LT + ++
Sbjct: 60 NIIGLL--------DILRPPSPEDFNDVYIVTELMETDLHKVIK----SPQPLT-DDHIQ 106
Query: 279 -ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG---AGKSHI 334
L + L YLH A V+HRD+K SNIL++ N D KI DFGLA+ + K +
Sbjct: 107 YFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 335 T----TR 337
T TR
Sbjct: 164 TEYVVTR 170
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-18
Identities = 55/146 (37%), Positives = 80/146 (54%), Gaps = 11/146 (7%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
IIG+G +G V +G+ G VAVK + + QA F E + + HKNLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ I V E ++ GNL +LR R ++ ++ L A+ + YL K+V
Sbjct: 69 LHNGLYI-VMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122
Query: 300 HRDIKSSNILIDENFDAKISDFGLAK 325
HRD+ + NIL+ E+ AK+SDFGLA+
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 6e-18
Identities = 52/173 (30%), Positives = 80/173 (46%), Gaps = 24/173 (13%)
Query: 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAI-GH 226
L T F +IG+G YG VY+ + G VA+K +++ +++ + E + +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKY 59
Query: 227 VRHKNLVRLLG------YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-- 278
H N+ G Q LV E G++ D+ +G R+K
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT-----DLV-KGLRKKGKRLKEE 113
Query: 279 ----ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
IL T + LAYLHE KV+HRDIK NIL+ +N + K+ DFG++ L
Sbjct: 114 WIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-18
Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 18/159 (11%)
Query: 182 IGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G+G +G V+ + N VAVK L + A KDF E E + +++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDR---------GYLTWEARMKILLGTAKA 286
G C+EG I+V+EY+ +G+L ++LR D LT + I A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+ YL VHRD+ + N L+ EN KI DFG+++
Sbjct: 133 MVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 7e-18
Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 10/167 (5%)
Query: 176 FSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVR 234
F +G+G YG VY+ G VA+K + ++ E+ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
G + T +V EY G++ ++ + ++ LT E IL T K L YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKT-LTEEEIAAILYQTLKGLEYLHSN- 118
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
K +HRDIK+ NIL++E AK++DFG++ L + T V+GT
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 8e-18
Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 27/173 (15%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQAD-KDFRVEVE---AI 224
R + +G+G +G V + + + + VAVK L ++ + D D E+E I
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 225 GHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGYLT 272
G +HKN++ LLG C + +V EY +GNL +LR LT
Sbjct: 73 G--KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 273 WEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+ + A+ + +L K +HRD+ + N+L+ E+ KI+DFGLA+
Sbjct: 131 QKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 9e-18
Identities = 51/146 (34%), Positives = 76/146 (52%), Gaps = 9/146 (6%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLGYCI 240
IG G +G VY+G L T VAVK + K F E E + H N+V+L+G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK-VV 299
+ +V E V G+L +LR + LT + +++ L A + YL E K +
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYL----ESKNCI 115
Query: 300 HRDIKSSNILIDENFDAKISDFGLAK 325
HRD+ + N L+ EN KISDFG+++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 16/183 (8%)
Query: 165 TLRDLQSATNRFSK-DNI--IGDGGYGVVYRG-QLMNGTAVAVKKL-LNNPGQADKDFRV 219
L+D+ S + N+ IG+G G VY+ G VA+KK+ L Q +
Sbjct: 7 ALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIIN 64
Query: 220 EVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK- 278
E+ + +H N+V + G + +V EY++ G+L + + + E ++
Sbjct: 65 EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT---QNFVRMN-EPQIAY 120
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
+ + L YLH V+HRDIKS NIL+ ++ K++DFG A L KS + V
Sbjct: 121 VCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV 177
Query: 339 MGT 341
GT
Sbjct: 178 -GT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 49/158 (31%), Positives = 79/158 (50%), Gaps = 28/158 (17%)
Query: 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFR----VEVEAIGHVRHKNLVRLL 236
+G G GVVY+ + G A+KK+ D++FR E++ + +V+
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKI---HVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 237 G-YCIEGTQRILVYEYVNNGNLEQWLRGD------MCDRGYLTWEARMKILLGTAKALAY 289
G + EG I V EY++ G+L L+ + Y+ +IL G L Y
Sbjct: 66 GAFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVL--AYIAR----QILKG----LDY 114
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
LH + ++HRDIK SN+LI+ + KI+DFG++K+L
Sbjct: 115 LHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-17
Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 180 NIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+ +G G YG VY G VAVK L + ++F E + ++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
C ++ E++ GNL +LR C+R + + + + A+ YL +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKK---NF 125
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLL 327
+HRD+ + N L+ EN K++DFGL++L+
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLM 154
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 51/166 (30%), Positives = 75/166 (45%), Gaps = 17/166 (10%)
Query: 182 IGDGGYGVVYRG--QLMNGT--AVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLL 236
+G G +G V +G + +G VAVK L A K F E + + H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWL--RGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
G C +G +LV E G L ++L R ++ A +AYL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK- 114
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
VHRD+ + N+L+ AKISDFG+++ LGAG + G
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 51/178 (28%), Positives = 79/178 (44%), Gaps = 26/178 (14%)
Query: 181 IIGDGGYGVVYRGQLM-NGTAVAVK----KLLNNPGQADKDFRVEVEAIGHV-RHKNLVR 234
IIG+G + V + A+K + L + E E + + H +++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI-EKEVLTRLNGHPGIIK 66
Query: 235 LLGYCIEGTQRI-LVYEYVNNGNLEQWLR-----GDMCDRGYLTWEARMKILLGTAKALA 288
L Y + + + V EY NG L Q++R + C R Y +ILL AL
Sbjct: 67 LY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAA-----EILL----ALE 116
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFS 346
YLH ++HRD+K NIL+D++ KI+DFG AK+L S + + T D
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 64/196 (32%), Positives = 99/196 (50%), Gaps = 36/196 (18%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKD------FRVEVEAIGHV 227
F K N IG+G YG+VYR + +G VA+KK+ ++N ++D R E+ + ++
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN----ERDGIPISSLR-EITLLLNL 63
Query: 228 RHKNLVRLLGYCIEGTQR---ILVYEYVNNGNLEQWLRGDMCDRGYLTW-EARMK-ILLG 282
RH N+V L + G LV EY EQ L + D + E+++K ++L
Sbjct: 64 RHPNIVELK-EVVVGKHLDSIFLVMEYC-----EQDL-ASLLDNMPTPFSESQVKCLMLQ 116
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+ L YLHE ++HRD+K SN+L+ + KI+DFGLA+ G +T +V
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV---- 169
Query: 343 GDFSVTLLRNMPILVF 358
VTL P L+
Sbjct: 170 ----VTLWYRAPELLL 181
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-17
Identities = 55/180 (30%), Positives = 83/180 (46%), Gaps = 33/180 (18%)
Query: 176 FSKDNI-----IGDGGYGVVYRGQ---LMNG---TAVAVKKLLNNPG-QADKDFRVEVEA 223
+ ++NI IG G +G V++ + L+ T VAVK L DF+ E
Sbjct: 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGY- 270
+ H N+V+LLG C G L++EY+ G+L ++LR R
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 271 -----LTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
L+ ++ I A +AYL E K VHRD+ + N L+ EN KI+DFGL++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-17
Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 182 IGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G+G +G V+ + N VAVK L A +DF+ E E + ++H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLR-----------GDMCDRGYLTWEARMKILLGTA 284
G C EG ++V+EY+ +G+L ++LR G+ G LT + I A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+ YL VHRD+ + N L+ + KI DFG+++
Sbjct: 133 SGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-17
Identities = 53/164 (32%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 179 DNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQADK---DFRVEVEAIGHVRHKN 231
+ +IG G +G V RG+L VA+K L G +K DF E +G H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
++ L G + +++ E++ NG L+ +LR + G T + +L G A + YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335
E VHRD+ + NIL++ N K+SDFGL++ L S T
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 7e-17
Identities = 52/171 (30%), Positives = 86/171 (50%), Gaps = 14/171 (8%)
Query: 176 FSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRH---K 230
+ + +IG G YG VYRG + G VA+K + L+ P D + EV + +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N+ + G ++G + ++ EY G++ ++ Y++ I+ AL Y+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYIS-----VIIREVLVALKYI 117
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
H+ V+HRDIK++NIL+ + K+ DFG+A LL S +T V GT
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-16
Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 13/171 (7%)
Query: 176 FSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKL-LNNPGQADKDFRV-EVEAIGHVRHKNL 232
F N IG G +GVV++ + + A+K++ L+ + +++ + E + + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDR--GYLTWEARMKILLGTAKALAYL 290
+R ++ + +V EY NG+L + L+ W ++ILLG LA+L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHL 117
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
H K++HRDIKS N+ +D + KI D G+AKLL ++ ++GT
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 23/171 (13%)
Query: 181 IIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
++G G YG+VY + L +A+K++ + + E+ +++H+N+V+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 240 IEGTQRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMK-----ILLGTAKALAYLH 291
E + E V G+L LR G + D E + IL G L YLH
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDN-----EQTIIFYTKQILEG----LKYLH 125
Query: 292 EAIEPKVVHRDIKSSNILIDENFDA-KISDFGLAKLLGAGKSHITTRVMGT 341
+ ++VHRDIK N+L++ KISDFG +K L AG + T GT
Sbjct: 126 DN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGT 172
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 26/166 (15%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKD----------FRVEVEA 223
++ K +IG G YG VY + G +AVK++ A + R E+E
Sbjct: 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61
Query: 224 IGHVRHKNLVRLLGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARM--KI 279
+ + H N+V+ LG+ E T+ L EYV G++ C R Y +E ++
Sbjct: 62 LKDLDHLNIVQYLGF--ETTEEYLSIFLEYVPGGSIGS------CLRTYGRFEEQLVRFF 113
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+ LAYLH ++HRD+K+ N+L+D + KISDFG++K
Sbjct: 114 TEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-16
Identities = 51/161 (31%), Positives = 80/161 (49%), Gaps = 15/161 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQADK---DFRVEVEAIGH 226
+ + +IG G +G V G+L VA+K L G +K DF E +G
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQ 61
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
H N++ L G + ++V EY+ NG+L+ +LR G T + +L G A
Sbjct: 62 FDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASG 118
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ YL + VHRD+ + NIL++ N K+SDFGL+++L
Sbjct: 119 MKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-16
Identities = 54/147 (36%), Positives = 76/147 (51%), Gaps = 11/147 (7%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
IG G +G V G G VAVK + N+ QA F E + +RH NLV+LLG
Sbjct: 13 TIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 240 IEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
+E + +V EY+ G+L +LR R L + +K L +A+ YL
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAK 325
VHRD+ + N+L+ E+ AK+SDFGL K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 17/163 (10%)
Query: 182 IGDGGYGVVYRGQLMNGTA----VAVKKLL-NNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+GDG +GVV RG+ VAVK L + DF E + + H+NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 237 GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT--WEARMKILLGTAKALAYLHEA 293
G + T + +V E G+L LR D ++ + ++I A + YL
Sbjct: 63 GVVL--THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK 116
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
+ +HRD+ + NIL+ + KI DFGL + L + H
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 13/148 (8%)
Query: 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA 223
T+ D+ S+ ++N+I G G Y+G+ + V K +N+ + E+
Sbjct: 683 ITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEIND---VNSIPSSEIAD 736
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
+G ++H N+V+L+G C L++EY+ NL + LR L+WE R KI +G
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGI 789
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILID 311
AKAL +LH P VV ++ I+ID
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIID 817
|
Length = 968 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-16
Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 182 IGDGGYGVVYRGQLMNGTA------VAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G+G +G V+ + N + VAVK L + A KDF+ E E + +++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCD------------RGYLTWEARMKILLGT 283
G C +G I+V+EY+ +G+L ++LR D +G L + I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
A + YL VHRD+ + N L+ N KI DFG+++
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-16
Identities = 48/170 (28%), Positives = 86/170 (50%), Gaps = 9/170 (5%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRV-EVEAIGHVRHKN 231
F +G G YG VY+ + L + A+K++ L + Q +++ V E+ + V H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
++ ++G + +V EY G+L + + R + + +I + + L LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
E K++HRD+KS+NIL+ N KI D G++K+L K ++ +GT
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 8e-16
Identities = 52/171 (30%), Positives = 84/171 (49%), Gaps = 23/171 (13%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLL---NNPGQADKDFRV---EVEAIGHVRH 229
++K ++G G YG VY G G +AVK++ +N A+K++ EV+ + ++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG-----DMCDRGYLTWEARMKILLGTA 284
N+V+ LG C++ + E+V G++ L + Y +IL G
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-----QILDG-- 114
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335
+AYLH VVHRDIK +N+++ N K+ DFG A+ L H T
Sbjct: 115 --VAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 9e-16
Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 177 SKDNI-----IGDGGYGVVYRGQL--MNGTA----VAVKKLLNNPGQADK-DFRVEVEAI 224
+D+I +G G +G VY G +G A VAVK L + + D+ DF +E +
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 225 GHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGY---LTWEARMKILL 281
H+N+VRL+G E R ++ E + G+L+ +LR + LT + +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD---AKISDFGLAK 325
AK YL E +HRDI + N L+ AKI+DFG+A+
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 182 IGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVR 234
+G G +G+VY G T VA+K + N ++ +F E + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDM------CDRGYLTWEARMKILLGTAKALA 288
LLG G ++V E + G+L+ +LR G T + +++ A +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
YL K VHRD+ + N ++ E+ KI DFG+ + +
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 50/148 (33%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLLGYCI 240
+G G +G V+ G T VA+K L PG + F E + + +RH+ LV+L Y +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 69
Query: 241 EGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ I +V EY++ G+L +L+G+M YL + + A +AY+ V
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 124
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLL 327
HRD++++NIL+ EN K++DFGLA+L+
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLI 152
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 7e-15
Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 31/161 (19%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIG-------------HV 227
IG+G YGVVY+ + + G VA+KK+ R+E E G +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-----------RLETEDEGVPSTAIREISLLKEL 55
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
H N+VRLL + LV+E+++ +L++++ D L L + +
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
AY H +V+HRD+K N+LID K++DFGLA+ G
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 52/164 (31%), Positives = 87/164 (53%), Gaps = 21/164 (12%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKL--LNNPGQADKDFRVEVEAIGHVR 228
F K ++G G +G VY+G + VA+K+L +P +A+K+ E + V
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVD 67
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMKILLGTAK 285
+ ++ RLLG C+ T + L+ + + G L ++R ++ + L W ++ AK
Sbjct: 68 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 120
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329
+ YL E ++VHRD+ + N+L+ KI+DFGLAKLLGA
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 8e-15
Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRV-EVEAIGHV-RHKNLVRLLGY 238
+GDG +G VY + G VA+KK+ ++ + EV+++ + H N+V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-ILLGTAKALAYLHEAIEPK 297
E + V+EY+ GNL Q ++ + E+ ++ I+ + LA++H+
Sbjct: 67 FRENDELYFVFEYME-GNLYQLMKDR--KGKPFS-ESVIRSIIYQILQGLAHIHKH---G 119
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAK 325
HRD+K N+L+ KI+DFGLA+
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-15
Identities = 46/146 (31%), Positives = 73/146 (50%), Gaps = 7/146 (4%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNN-PGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
++G G +G V++G L + T VAVK + P + F E + H N+V+L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ +V E V G+ +LR + L + +K L A +AYL +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 300 HRDIKSSNILIDENFDAKISDFGLAK 325
HRD+ + N L+ EN KISDFG+++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 36/175 (20%)
Query: 171 SATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKD------FRVEVEA 223
S + +G+G +G VY+ Q+ G VA+KK+L +KD R E++
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALR-EIKI 60
Query: 224 IGHVRHKNLVRLLGYCIE---GTQRI-----LVYEYVN---NGNLE-QWLRGDMCD-RGY 270
+ ++H N+V L+ +E ++R +V Y++ +G LE ++ + Y
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY 120
Query: 271 LTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
M LL + + YLHE ++HRDIK++NILID KI+DFGLA+
Sbjct: 121 ------MLQLL---EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 49/150 (32%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 180 NIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLLG 237
+IG G VVY L N VA+K++ Q + R EV+A+ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
+ G + LV Y++ G+L ++ RG L +L K L YLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---G 122
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+HRDIK+ NIL+ E+ KI+DFG++ L
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASL 152
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 26/175 (14%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL---NNPGQADKDFRVEVEAIGHVRHK 230
++ K + IG+G YGVV++ + G VA+KK + ++P R E+ + ++H
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR-EIRMLKQLKHP 60
Query: 231 NLVRLLGYCIEGTQRI----LVYEYVNN---GNLEQWLRGDMCDRGYLTWEARMKILLGT 283
NLV L IE +R LV+EY ++ LE+ RG + KI+ T
Sbjct: 61 NLVNL----IEVFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLI-----KKIIWQT 109
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
+A+ + H+ +HRD+K NILI + K+ DFG A++L T V
Sbjct: 110 LQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 11/157 (7%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVRHKN 231
F K IG+G YGVVY+ + + G VA+KK+ G R E+ + + H N
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+LL + LV+E+++ +L++++ D + L + LA+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
+V+HRD+K N+LI+ K++DFGLA+ G
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 42/132 (31%), Positives = 66/132 (50%), Gaps = 15/132 (11%)
Query: 201 VAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257
VAVK L P +D +DF EV+ + + N+ RLLG C ++ EY+ NG+L
Sbjct: 49 VAVKVLR--PDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 258 EQWLR-------GDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310
Q+L+ G C+ L++ + + A + YL VHRD+ + N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLV 163
Query: 311 DENFDAKISDFG 322
+N+ KI+DFG
Sbjct: 164 GKNYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 30/177 (16%)
Query: 176 FSKDNI-----IGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQAD-KDFRVEV 221
FS+D + +G+G +G V + + VAVK L ++ + D D E+
Sbjct: 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 71
Query: 222 EAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG------------DMCDR 268
E + + +HKN++ LLG C + ++ EY + GNL ++LR
Sbjct: 72 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131
Query: 269 GYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+T++ + A+ + YL K +HRD+ + N+L+ EN KI+DFGLA+
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 48/158 (30%), Positives = 83/158 (52%), Gaps = 12/158 (7%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLL---NNPGQADKDFRVEVEAIGHVRHK 230
++ K IG+G YG V++ + VA+K++ ++ G R E+ + ++HK
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHK 59
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N+VRL + LV+EY + +L+++ D C G + E + K LA+
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYF--DSC-NGDIDPEIVKSFMFQLLKGLAFC 115
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
H V+HRD+K N+LI++N + K++DFGLA+ G
Sbjct: 116 HSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 16/156 (10%)
Query: 181 IIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQA--DKDFRVEVEAIGHVRHKNLVRLLG 237
++G+G YG+V + + G VA+KK L + K E+ + +RH+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 238 YCIEGTQRILVYEYVNN---GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
+ LV+E+V++ +LE++ G L K L + + + H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-------LDESRVRKYLFQILRGIEFCHSH- 119
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330
++HRDIK NIL+ ++ K+ DFG A+ L A
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 15/157 (9%)
Query: 181 IIGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLV 233
+G G +G V+ + T V VK L + +FR E++ + HKN+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLR-----GDMCDRGYLTWEARMKILLGTAKALA 288
RLLG C E ++ EY + G+L+Q+LR + L+ + ++ + A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+L A + VHRD+ + N L+ + K+S L+K
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 8e-14
Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 25/164 (15%)
Query: 180 NIIGDGGYGVVYRGQLMN-GTAVAVKKL---LNNPGQADKDFRVEVEAIGHVR---HKNL 232
IG+G YG VY+ + +N G VA+KK+ L+ G R E+ + + H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63
Query: 233 VRLLGYCI-----EGTQRILVYEYVNNGNLEQWLRGDMC-DRGYLTWEAR--MKILLGTA 284
VRLL C + LV+E+V+ +L +L C G + M+ LL
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL--SKCPKPGLPPETIKDLMRQLL--- 117
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
+ + +LH ++VHRD+K NIL+ + KI+DFGLA++
Sbjct: 118 RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 182 IGDGGYGVVYRGQLMNGTAVA---VKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLLG 237
IG+G +G V G+ G + A VK+L + ++ F EV+ + H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA----KALAYLHEA 293
CIE +LV E+ G+L+ +LR +RG + A+ +L A L +LH+A
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRS---NRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
+H D+ N + + KI D+GLA
Sbjct: 120 ---DFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 18/188 (9%)
Query: 178 KDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL---NNPGQADK---DFRVEVEAIGHVRHK 230
K +G G + Y+ + + GT +AVK++ N + ++ R E+ + + H
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
+++R+LG E + L E++ G++ L G + + L+YL
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYL 119
Query: 291 HEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLLGA---GKSHITTRVMGTFGDFS 346
HE +++HRD+K +N+LID +I+DFG A L A G +++GT +
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 347 VTLLRNMP 354
+LR
Sbjct: 177 PEVLRGEQ 184
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 38/182 (20%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKL--LNNPGQADKDFRVEVEAIGHVRHKN 231
R+ + IG+G YG+V G VA+KK+ + + R E++ + +H+N
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHEN 64
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNL--------------EQWLRGDMCDRGYLTWEARM 277
++ +L R +E N+ + Q L D Y ++
Sbjct: 65 IIGILD-----IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQ--YFLYQ--- 114
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
IL + L Y+H A V+HRD+K SN+L++ N D KI DFGLA++ A H T
Sbjct: 115 -IL----RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTG 164
Query: 338 VM 339
+
Sbjct: 165 FL 166
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 32/174 (18%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH----------VRHK 230
+G G +G V + G A+K L K ++ + + H + H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVL-------KKKKIIKRKEVEHTLTERNILSRINHP 53
Query: 231 NLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKAL 287
+V+L Y + T+ LV EY G L L G + E R + AL
Sbjct: 54 FIVKLH-YAFQ-TEEKLYLVLEYAPGGELFSHLS----KEGRFS-EERARFYAAEIVLAL 106
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
YLH +++RD+K NIL+D + K++DFGLAK L + S T GT
Sbjct: 107 EYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 50/149 (33%), Positives = 74/149 (49%), Gaps = 22/149 (14%)
Query: 198 GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR--ILVYEYVNNG 255
G VAVKKL ++ + +DF E+E + ++H N+V+ G C +R LV EY+ G
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 256 NLEQWLRGDMCDRGYLT-WEARM---KILLGTA---KALAYLHEAIEPKVVHRDIKSSNI 308
+L R YL R+ K+LL + K + YL + VHRD+ + NI
Sbjct: 93 SL----------RDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNI 139
Query: 309 LIDENFDAKISDFGLAKLLGAGKSHITTR 337
L++ KI DFGL K+L K + R
Sbjct: 140 LVESENRVKIGDFGLTKVLPQDKEYYKVR 168
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 53/162 (32%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 180 NIIGDGGYGVVYRGQLMN----GTA---VAVKKLLNN-PGQADKDFRVEVEAIGHVRHKN 231
N +G G +G VY G + G+ VAVK L Q K+F E + + H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGY---LTWEARMKILLGTAKALA 288
+V+LLG C+ + ++ E + G+L +LR +R LT + + I L AK
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 289 YLHEAIEPKVVHRDIKSSNILIDE-NFDA----KISDFGLAK 325
YL + +HRD+ + N L+ E +DA KI DFGLA+
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 21/175 (12%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV---------EVEAI 224
++ K +IG G +G VY G +G +AVK++ A R E+ +
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 225 GHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM--KILLG 282
++H+N+V+ LG ++ + EYV G++ L Y +E + +
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN------YGAFEETLVRNFVRQ 114
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
K L YLH ++HRDIK +NIL+D KISDFG++K L A T
Sbjct: 115 ILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 7/144 (4%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241
+G G +GVV+ G+ VA+K + N +++DF E + + + H LV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHR 301
+V E++ NG L +LR +G L+ + + + + + YL +HR
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHR 124
Query: 302 DIKSSNILIDENFDAKISDFGLAK 325
D+ + N L+ K+SDFG+ +
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 43/176 (24%), Positives = 87/176 (49%), Gaps = 21/176 (11%)
Query: 175 RFSKDNIIGDGGYG--VVYRGQLMNGTAVAVKKL----LNNPGQADKDFRVEVEAIGHVR 228
+ ++G G +G +YR + + + V K++ L+ + +D E+ + ++
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKER--RDALNEIVILSLLQ 57
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWL---RGDMCDRGYLTWEARMKILLGTAK 285
H N++ + ++ ++ EY N G L + +G + + + W L
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVS 112
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
A++Y+H+A ++HRDIK+ NI + + K+ DFG++K+LG+ S T V+GT
Sbjct: 113 AVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRV---EVEAIGHVRH 229
F+ IG G +G VY+ VA+K + + +A+ + E++ + R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRS 58
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+ + G ++G++ ++ EY G+ L+ D Y+ + IL L Y
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-----ILREVLLGLEY 113
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
LHE +HRDIK++NIL+ E D K++DFG++
Sbjct: 114 LHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 19/146 (13%)
Query: 201 VAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQ 259
VAVK L + + A DF EV+ + ++ N++RLLG C++ ++ EY+ NG+L Q
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 260 WLRGDMCDRG---------------YLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK 304
+L D +++ + + + L A + YL VHRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLA 165
Query: 305 SSNILIDENFDAKISDFGLAKLLGAG 330
+ N L+ EN KI+DFG+++ L AG
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAG 191
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 28/180 (15%)
Query: 180 NIIGDGGYGVVYRGQLMNG---TAVAVKKLLNNPGQAD-KDFRVEVEAI---GHVRHKNL 232
++IG+G +G V + ++ A+K++ + D +DF E+E + GH H N+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNI 70
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC---DRGY---------LTWEARMKIL 280
+ LLG C L EY +GNL +LR D + L+ + +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
A+ + YL + + +HRD+ + NIL+ EN+ AKI+DFGL++ G+ + MG
Sbjct: 131 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 183
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-13
Identities = 45/148 (30%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLLGYCI 240
+G G +G V+ G T VA+K L G + F E + ++H LVRL Y +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQHPRLVRL--YAV 69
Query: 241 EGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ I ++ EY+ NG+L +L+ + LT + + A+ +A++ +
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYI 124
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLL 327
HRD++++NIL+ E KI+DFGLA+L+
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI 152
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 32/160 (20%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHKNLVRLLG 237
IG G YG+V VA+KK+ N N A + R E++ + H+ H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 238 YCIEGTQR------ILVYEYVNNGNLEQWLRG------DMCDRGYLTWEARMKILLGTAK 285
+ R +VYE ++ +L Q +R D C Y ++ +L G
Sbjct: 72 -IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQ--YFLYQ----LLRG--- 120
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
L Y+H A V+HRD+K SN+L++ N D KI DFGLA+
Sbjct: 121 -LKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 11/148 (7%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
+G+G +G V+ G T VAVK L PG + + F E + + +RH LV+L Y +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL--KPGTMSPESFLEEAQIMKKLRHDKLVQL--YAV 69
Query: 241 EGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ I +V EY++ G+L +L+ + L + + A +AY+ +
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYI 124
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLL 327
HRD++S+NIL+ + KI+DFGLA+L+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLI 152
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-13
Identities = 48/179 (26%), Positives = 85/179 (47%), Gaps = 21/179 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAI-------G 225
+ + ++G G +G VY + G +AVK++ + + EV A+
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQV--PFDPDSPETKKEVNALECEIQLLK 59
Query: 226 HVRHKNLVRLLGYCIEGTQRILVY-EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
+++H+ +V+ G C+ + + ++ EY+ G+++ L+ +T + +IL G
Sbjct: 60 NLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG-- 116
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT--TRVMGT 341
+ YLH +VHRDIK +NIL D + K+ DFG +K L S T V GT
Sbjct: 117 --VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-13
Identities = 46/147 (31%), Positives = 70/147 (47%), Gaps = 10/147 (6%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNN-PGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
IG G +G V+ G+L + T VAVK P F E + H N+VRL+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK-V 298
+ +V E V G+ +LR + ++K L+ + A E +E K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGP-------RLKVKELIQMVENAAAGMEYLESKHC 115
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAK 325
+HRD+ + N L+ E KISDFG+++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 30/167 (17%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNN-----PGQADKDFRVEVEAIGHVR 228
++K IG+G YGVVY+G+ G VA+KK+ L + P A + E+ + ++
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQ 57
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVN---NGNLEQWLRGDMCD----RGYLTWEARMKILL 281
H N+V L ++ ++ L++E+++ L+ +G D + YL +IL
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYL-----YQILQ 112
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
G + + H +V+HRD+K N+LID K++DFGLA+ G
Sbjct: 113 G----ILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 30/174 (17%)
Query: 179 DNIIGDGGYGVVYRGQ------LMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKN 231
+G+G +G V + T VAVK L N ++ +D E + V H +
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLR----------GDMCDRGYLTWEA------ 275
+++L G C + +L+ EY G+L +LR G +R +
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 276 RMKILLGTA----KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
M L+ A + + YL E K+VHRD+ + N+L+ E KISDFGL++
Sbjct: 125 TMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 30/177 (16%)
Query: 176 FSKDNII-----GDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQAD-KDFRVEV 221
F +D ++ G+G +G V R + VAVK L +N D D E+
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 222 EAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDR 268
E + + +HKN++ LLG C + ++ EY GNL ++LR
Sbjct: 69 ELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 269 GYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
L+++ + A+ + YL + +HRD+ + N+L+ E+ KI+DFGLA+
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 43/145 (29%), Positives = 81/145 (55%), Gaps = 9/145 (6%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLLG-YC 239
+GDG +G VY+ + A+A K++ + + +D+ VE+E + H +V+LLG +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+G I++ E+ G ++ + DRG + ++ I +AL YLH K++
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIML--ELDRGLTEPQIQV-ICRQMLEALQYLHSM---KII 132
Query: 300 HRDIKSSNILIDENFDAKISDFGLA 324
HRD+K+ N+L+ + D K++DFG++
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 14/150 (9%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLN-NPGQADKDFRVEVEAIGHVRHKNLVRLL-GYC 239
+GDG +G VY+ Q A K++ + +DF VE++ + +H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR--MKILLGTAKALAYLHEAIEPK 297
E IL+ E+ + G L+ + +RG + R + +L +AL +LH K
Sbjct: 73 YENKLWILI-EFCDGGALDSIM--LELERGLTEPQIRYVCRQML---EALNFLHSH---K 123
Query: 298 VVHRDIKSSNILIDENFDAKISDFGL-AKL 326
V+HRD+K+ NIL+ + D K++DFG+ AK
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKN 153
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 25/166 (15%)
Query: 182 IGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHV-RHKN 231
+G+G +G V + + VAVK L ++ D D E+E + + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG----------DMCD--RGYLTWEARMKI 279
++ LLG C + ++ EY + GNL ++LR D C LT++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
A+ + YL K +HRD+ + N+L+ E+ KI+DFGLA+
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 9e-13
Identities = 44/146 (30%), Positives = 81/146 (55%), Gaps = 11/146 (7%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLL-GYC 239
+GDG +G VY+ Q +A K+++ + + +D+ VE++ + H N+V+LL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYLHEAIEPKV 298
E IL+ E+ G ++ M + E +++++ T +AL YLHE K+
Sbjct: 73 YENNLWILI-EFCAGGAVD----AVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KI 124
Query: 299 VHRDIKSSNILIDENFDAKISDFGLA 324
+HRD+K+ NIL + D K++DFG++
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 9e-13
Identities = 50/158 (31%), Positives = 82/158 (51%), Gaps = 24/158 (15%)
Query: 180 NIIGDGGYGVVYRGQLM----NGTAVAVKKL--LNNPGQADKDFRVEVEAIGHVRHKNLV 233
+IG G +G VY G L+ AVK L + + + ++ F E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 234 RLLGYCI--EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG----TAKAL 287
LLG C+ EG+ ++V Y+ +G+L ++R + T +K L+G AK +
Sbjct: 60 SLLGICLPSEGSP-LVVLPYMKHGDLRNFIRSE-------THNPTVKDLIGFGLQVAKGM 111
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
YL K VHRD+ + N ++DE+F K++DFGLA+
Sbjct: 112 EYLASK---KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 9/151 (5%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKL----LNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
IG G + VVY+ L++G VA+KK+ + + + E++ + + H N+++ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDHPNVIKYL 68
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
IE + +V E + G+L + ++ + + K + AL ++H
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK--- 125
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+++HRDIK +N+ I K+ D GL +
Sbjct: 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFF 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 23/156 (14%)
Query: 182 IGDGGYGVVYR------GQLMNGTAVAVKKLLNNPGQA-DKDFRVEVEAIGHVRHKNLVR 234
+G G GVV + G++M AVK + +A K E++ + +V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIM-----AVKTIRLEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMKILLGTAKALAYLH 291
G + EY++ G+L++ L+ G + +R L KI + K L YLH
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPER-ILG-----KIAVAVLKGLTYLH 117
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
E K++HRD+K SNIL++ K+ DFG++ L
Sbjct: 118 EKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 49/153 (32%), Positives = 77/153 (50%), Gaps = 19/153 (12%)
Query: 180 NIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV----EVEAIGHVRHKNLVR 234
N IG G G VY+ G A+K + G + R E+E + V H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
+ ++ E+++ G+LE + D +L AR +IL G +AYLH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEG---THIADEQFLADVAR-QILSG----IAYLHRR- 187
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+VHRDIK SN+LI+ + KI+DFG++++L
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218
|
Length = 353 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 47/148 (31%), Positives = 78/148 (52%), Gaps = 10/148 (6%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLLGYCI 240
+G G +G V+ G N T VAVK L PG + F E + ++H LVRL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL--KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK-VV 299
+ ++ EY+ G+L +L+ D + G + + A+ +AY IE K +
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAY----IERKNYI 125
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLL 327
HRD++++N+L+ E+ KI+DFGLA+++
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVI 153
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK--DFRVEVEAIGHVRHKNLV 233
F+K IG G +G VY+G V K+++ D+ D + E+ + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
R G ++GT+ ++ EY+ G+ L+ + Y+ IL K L YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 120
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ +HRDIK++N+L+ E D K++DFG+A L
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 49/163 (30%), Positives = 80/163 (49%), Gaps = 11/163 (6%)
Query: 182 IGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLLG 237
+G G +G V +G VA+K L N ++ +D E E + + + +VR++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
C E +LV E + G L ++L G + +T ++++ + + YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---N 115
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
VHRD+ + N+L+ AKISDFGL+K LGA S+ R G
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 36/136 (26%), Positives = 68/136 (50%), Gaps = 6/136 (4%)
Query: 201 VAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQ 259
VAVK L + + A DF E++ + +++ N++RLLG C+ ++ EY+ NG+L Q
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 260 WL-----RGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314
+L + + +L + + + VHRD+ + N L+ ++
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHY 166
Query: 315 DAKISDFGLAKLLGAG 330
KI+DFG+++ L +G
Sbjct: 167 TIKIADFGMSRNLYSG 182
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 49/156 (31%), Positives = 83/156 (53%), Gaps = 19/156 (12%)
Query: 181 IIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVR 234
++G G +G VY+G + VA+K L G +A+ +F E + + H +LVR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWL---RGDMCDRGYLTWEARMKILLGTAKALAYLH 291
LLG C+ T + LV + + +G L ++ + ++ + L W ++ AK + YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
E ++VHRD+ + N+L+ KI+DFGLA+LL
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 41/171 (23%), Positives = 84/171 (49%), Gaps = 11/171 (6%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRHKN 231
++ K ++G G +G+V+ + + + K + + + E + + + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
++ +E ++V EY G L ++++ C L + + + AL ++H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQ-KRC-NSLLDEDTILHFFVQILLALHHVH 118
Query: 292 EAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLLGAGKSHITTRVMGT 341
+ ++HRD+K+ NIL+D++ KI DFG++K+L + KS T V+GT
Sbjct: 119 TKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYT-VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 45/172 (26%), Positives = 83/172 (48%), Gaps = 20/172 (11%)
Query: 182 IGDGGYGVVYRGQLMNGTA---VAVK--KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+G+G +G V GQL + VAVK K+ +DF E + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 237 GYCIEGTQR------ILVYEYVNNGNLEQWLR----GDMCDRGYLTWEARMKILLGTAKA 286
G C++ + +++ ++ +G+L +L GD YL + +K + A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ--YLPTQMLVKFMTDIASG 124
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
+ YL +HRD+ + N +++EN + ++DFGL+K + G + R+
Sbjct: 125 MEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI 173
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 25/165 (15%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHK 230
R+ IG G YGVV +G VA+KK+ + P A + R E++ + H +H
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHD 64
Query: 231 NLVRLLGYCIEGTQRILVYEYVN--------NGNLEQWLRGDMCDRGYLTWEARMKILLG 282
N++ I R ++ + +L + D LT E L
Sbjct: 65 NII-----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSD----QPLTEEHIRYFLYQ 115
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ L Y+H A V+HRD+K SN+L++E+ + +I DFG+A+ L
Sbjct: 116 LLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 4e-12
Identities = 40/138 (28%), Positives = 71/138 (51%), Gaps = 11/138 (7%)
Query: 201 VAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQ 259
VAVK L + + A DF E++ + ++ N++RLL CI ++ EY+ NG+L Q
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 260 WL-------RGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE 312
+L + D +++ + + A + YL VHRD+ + N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK 165
Query: 313 NFDAKISDFGLAKLLGAG 330
N+ KI+DFG+++ L +G
Sbjct: 166 NYTIKIADFGMSRNLYSG 183
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 52/158 (32%), Positives = 86/158 (54%), Gaps = 27/158 (17%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLLN---NPGQADKDFRVEV---EAIGHVRHKNLVR 234
+G G YG+V++ VA+KK+ + N A + FR E+ + +G H N+V+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGD--HPNIVK 71
Query: 235 LLG-YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCD---RGYLTWEARMKILLGTAKALAY 289
LL E + I LV+EY+ +L +R ++ + + Y+ ++ LL KAL Y
Sbjct: 72 LLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQ-----LL---KALKY 122
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+H V+HRD+K SNIL++ + K++DFGLA+ L
Sbjct: 123 IHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-12
Identities = 40/144 (27%), Positives = 73/144 (50%), Gaps = 7/144 (4%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241
+G G +GVV G+ VA+K ++ ++ +F E + + + H+ LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHR 301
+V EY++NG L +LR +++ + +AYL + +HR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 302 DIKSSNILIDENFDAKISDFGLAK 325
D+ + N L+D+ K+SDFGL++
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 46/154 (29%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 179 DNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKNLV 233
IG+G +G VY+G M+ AVAVK N + ++ F E + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
+L+G E I V E G L +L+ + + L + + + ALAYL
Sbjct: 71 KLIGVITENPVWI-VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK 126
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ VHRDI + N+L+ K+ DFGL++ L
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-12
Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 15/161 (9%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLG 237
IG G +G VY + + VA+KK+ + Q++ +D EV + +RH N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCD--RGYLTWEARMKILLGTAKALAYLHEAIE 295
+ LV EY D+ + + L I G + LAYLH
Sbjct: 83 CYLREHTAWLVMEYCLGS------ASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH-- 134
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
+ +HRDIK+ NIL+ E K++DFG A L+ S + T
Sbjct: 135 -ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGT 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-12
Identities = 47/148 (31%), Positives = 77/148 (52%), Gaps = 11/148 (7%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLLGYCI 240
+G G +G V+ G T VA+K L PG + F E + + +RH LV L Y +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAV 69
Query: 241 EGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ I +V E++ G+L +L+ D YL + + A +AY+ +
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYI 124
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLL 327
HRD++++NIL+ +N KI+DFGLA+L+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLI 152
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 54/174 (31%), Positives = 86/174 (49%), Gaps = 32/174 (18%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKL--LNNPGQADKDFRVEVEAIGHV 227
RF ++ +G+ +G +Y+G L + VA+K L +NNP Q +F+ E + +
Sbjct: 8 RFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-QQWGEFQQEASLMAEL 64
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWL--RGDMCDRGYLTWEARMKILLGTAK 285
H N+V LLG + +++EY+N G+L ++L R D G + E GT K
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED------GTVK 118
Query: 286 ALA----YLHEAIEPKV----------VHRDIKSSNILIDENFDAKISDFGLAK 325
+ +LH AI+ VH+D+ + NILI E KISD GL++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 51/150 (34%), Positives = 88/150 (58%), Gaps = 17/150 (11%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+G+G Y V++G+ + VA+K +L + G R EV + +++H N+V L +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTL--H 69
Query: 239 CIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL-GTAKALAYLHEAIE 295
I T+R LV+EY+++ +L+Q+L D C G L +KI + + L+Y H+
Sbjct: 70 DIIHTERCLTLVFEYLDS-DLKQYL--DNC--GNLMSMHNVKIFMFQLLRGLSYCHKR-- 122
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAK 325
K++HRD+K N+LI+E + K++DFGLA+
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 8e-12
Identities = 47/152 (30%), Positives = 82/152 (53%), Gaps = 13/152 (8%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+G+G Y VY+G+ G VA+K L G R E+ + ++H+N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66
Query: 239 CIEGTQRILVYEYVNNGNLEQWL--RGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
+ +LV+EY++ +L++++ G T ++ LL K +A+ HE
Sbjct: 67 IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL---KGIAFCHEN--- 119
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
+V+HRD+K N+LI++ + K++DFGLA+ G
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 179 DNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRHKN 231
+ I+G G +G + RG L VA+ L G +DK F E +G H N
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTL--RAGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+VRL G G ++V EY++NG L+ +LR G L M +L G A + YL
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLS 124
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFG 322
E VH+ + + +L++ + KIS F
Sbjct: 125 EM---GYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-12
Identities = 46/169 (27%), Positives = 87/169 (51%), Gaps = 18/169 (10%)
Query: 169 LQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIG-HV 227
L+ F ++G+G YG VY+G+ + +A K+++ G +++ + E+ + +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 228 RHKNLVRLLGYCIEGT------QRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMK 278
H+N+ G I+ Q LV E+ G++ ++ G+ ++ + R +
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-E 119
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
IL G L++LH+ KV+HRDIK N+L+ EN + K+ DFG++ L
Sbjct: 120 ILRG----LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 9e-12
Identities = 50/159 (31%), Positives = 82/159 (51%), Gaps = 19/159 (11%)
Query: 178 KDNIIGDGGYGVVYRG-QLMNG----TAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKN 231
K ++G G +G VY+G + +G VA+K L N +A+K+ E + V
Sbjct: 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMKILLGTAKALA 288
+ RLLG C+ T + LV + + G L ++R + + L W ++ AK ++
Sbjct: 71 VCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMS 123
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
YL E ++VHRD+ + N+L+ KI+DFGLA+LL
Sbjct: 124 YLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 9e-12
Identities = 42/172 (24%), Positives = 85/172 (49%), Gaps = 17/172 (9%)
Query: 181 IIGDGGYGVVYRGQLM--NGTA--VAVKKL-LNNPGQAD-KDFRVEVEAIGHVRHKNLVR 234
I+G+G +G V GQL +G+ VAVK + L+ ++ ++F E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 235 LLGYCIEGTQR------ILVYEYVNNGNLEQWLRGDMCDRG--YLTWEARMKILLGTAKA 286
L+G C E + +++ ++ +G+L +L L + +K ++ A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
+ YL +HRD+ + N ++ E+ ++DFGL+K + +G + R+
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 18/176 (10%)
Query: 179 DNIIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHV-RHKNLV 233
+++IG+G +G V R + A+K L + D +DF E+E + + H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC---------DRGYLTWEARMKILLGTA 284
LLG C + EY GNL +LR + G + ++L +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
+ E + +HRD+ + N+L+ EN +KI+DFGL++ G+ + MG
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMG 178
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 33/160 (20%)
Query: 182 IGDGGYGVVYRGQLM----NGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRH-KNLVRL 235
IG G +G V + M +GT +AVK++ + K ++++ + +V+
Sbjct: 12 IGRGAFGTVNK---MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 236 LG---------YCIE--GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
G C+E Y+YV + + E KI + T
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVY-----------EVLKSVIPEEILGKIAVATV 117
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
KAL YL E E K++HRD+K SNIL+D N + K+ DFG++
Sbjct: 118 KALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 13/161 (8%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTA----VAVKKLLNNPG-QADKDFRVEVEAIGH 226
K ++G G +G V++G + G + VA+K + + G Q ++ + A+G
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+ H +VRLLG C G LV + G+L +R R L + + + AK
Sbjct: 66 LDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKG 121
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ YL E ++VHR++ + NIL+ + +I+DFG+A LL
Sbjct: 122 MYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 25/166 (15%)
Query: 182 IGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHV-RHKN 231
+G+G +G V + + T VAVK L ++ + D D E+E + + +HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG------------DMCDRGYLTWEARMKI 279
++ LLG C + ++ EY + GNL ++LR L+++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
A+ + YL K +HRD+ + N+L+ E+ KI+DFGLA+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 16/171 (9%)
Query: 178 KDNIIGDGGYGVV--YRGQLMN---GTAVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKN 231
K ++G+G +G V Y N G VAVK L GQ + ++ E+ + + H+N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 232 LVRLLGYCIEGTQRI--LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+V+ G C E + L+ EYV G+L +L + L + + +AY
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAY 122
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
LH +HRD+ + N+L+D + KI DFGLAK + G + R G
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 48/172 (27%), Positives = 88/172 (51%), Gaps = 18/172 (10%)
Query: 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIG 225
L L+ F ++G+G YG VY+G+ + +A K+++ +++ ++E+ +
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67
Query: 226 -HVRHKNLVRLLGYCIEGT------QRILVYEYVNNG---NLEQWLRGDMCDRGYLTWEA 275
+ H+N+ G I+ + Q LV E+ G +L + +G+ ++ +
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127
Query: 276 RMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
R +IL G LA+LH KV+HRDIK N+L+ EN + K+ DFG++ L
Sbjct: 128 R-EILRG----LAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 16/153 (10%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
+G G YG VY+ + L G AVK + PG + E+ + +H N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 241 EGTQRILVYEYVNNGNLEQ--WLRGDM--CDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
+ + EY G+L+ + G + Y+ E T + LAYLH +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRE--------TLQGLAYLHSKGK- 127
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329
+HRDIK +NIL+ +N D K++DFG+A + A
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVAAKITA 158
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 27/177 (15%)
Query: 180 NIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRV----EVEAIGHVRHKNLV 233
IG+G YG VY+ + G VA+KK+ L+N + F + E++ + + H+N+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNHRNIV 69
Query: 234 RLLGYCIEGTQRI----------LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
L + + LV+EY+++ +L L + ++ MK LL
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLL-- 126
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI-TTRVM 339
+ L Y H+ +HRDIK SNIL++ K++DFGLA+L + +S T +V+
Sbjct: 127 -EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH 226
D +S + F K IG+G G+V G VAVKK+ Q + EV +
Sbjct: 16 DPRSYLDNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRD 72
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+H N+V + + G + +V E++ G L D+ + E + L KA
Sbjct: 73 YQHPNIVEMYSSYLVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLAVLKA 127
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322
L++LH V+HRDIKS +IL+ + K+SDFG
Sbjct: 128 LSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-11
Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 28/180 (15%)
Query: 180 NIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPGQAD-KDFRVEVEAI---GHVRH 229
++IG+G +G V + ++ M+ A+K++ + D +DF E+E + GH H
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDA---AIKRMKEYASKDDHRDFAGELEVLCKLGH--H 55
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC---------DRGYLTWEARMKIL 280
N++ LLG C L EY +GNL +LR + + ++L
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
A + + + +HRD+ + NIL+ EN+ AKI+DFGL++ G+ + MG
Sbjct: 116 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 171
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTA-----------VAVKKLLNNPGQADKD-FRVEV 221
N S +G G +G V + TA VAVK L ++++ E+
Sbjct: 35 NNLSFGKTLGAGAFGKV-----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSEL 89
Query: 222 EAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKIL 280
+ + H+ H+N+V LLG C G +++ EY G+L +LR +LT E +
Sbjct: 90 KIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFS 147
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
AK +A+L +HRD+ + N+L+ KI DFGLA+
Sbjct: 148 YQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 49/149 (32%), Positives = 82/149 (55%), Gaps = 15/149 (10%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+G+G Y VY+G+ + G VA+K++ G R E + ++H N+V L +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTL--H 69
Query: 239 CIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
I T++ L V+EY++ +L+Q++ D C G R+ L + LAY H+
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYM--DDCGGGLSMHNVRL-FLFQLLRGLAYCHQR--- 122
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAK 325
+V+HRD+K N+LI E + K++DFGLA+
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 44/149 (29%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+ +G+G G V + +L N + K + NP + R E+E + +V+
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSPYIVKYY 65
Query: 237 GYCI-EGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARM-KILLGTAKALAYLHEA 293
G + E + I + EY G+L+ + + RG E + KI K L+YLH
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFG 322
K++HRDIK SNIL+ K+ DFG
Sbjct: 125 ---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 47/170 (27%), Positives = 83/170 (48%), Gaps = 32/170 (18%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRV----EVEAIGHVR 228
+++ K IG G +G V++ + VA+KK+L + F + E++ + ++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME--NEKEGFPITALREIKILQLLK 69
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDR---GYLTW----------EA 275
H+N+V L+ C R Y N +L + C+ G L+ +
Sbjct: 70 HENVVNLIEIC-----RTKATPY-NRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK 123
Query: 276 RMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
MK+LL L Y+H K++HRD+K++NILI ++ K++DFGLA+
Sbjct: 124 VMKMLL---NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGT--AVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNL 232
F+K IG G +G V++G + N T VA+K + L +D + E+ + +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
+ G ++GT+ ++ EY+ G+ LR D + +L K L YLH
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHS 119
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
K +HRDIK++N+L+ E D K++DFG+A L
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 8e-11
Identities = 49/148 (33%), Positives = 79/148 (53%), Gaps = 13/148 (8%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+G+G Y V++G+ + VA+K +L + G R EV + ++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 72
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL-GTAKALAYLHEAIEPK 297
LV+EY++ +L+Q+ M D G + +KI L + LAY H K
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQY----MDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAK 325
V+HRD+K N+LI+E + K++DFGLA+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 9e-11
Identities = 40/164 (24%), Positives = 79/164 (48%), Gaps = 14/164 (8%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMNGT-----AVAVKKLLNNPGQADKDFRV-EVEAIGHVR 228
R + +++ +G +G ++ G L++ V VK + ++ + + E + +
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 229 HKNLVRLLGYCIEGTQRILV-YEYVNNGNLEQWLRG--DMCDRGYLTWEARMKILLGT-- 283
H+N++ +L CIE + V Y Y+N GNL+ +L+ + + +
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
A ++YLH+ V+H+DI + N +IDE KI+D L++ L
Sbjct: 127 ACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDL 167
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 52/156 (33%), Positives = 86/156 (55%), Gaps = 17/156 (10%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKNL 232
+ K + +G+G Y VY+G+ + VA+K +L + G R EV + ++H N+
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANI 66
Query: 233 VRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL-GTAKALAY 289
V L + I T++ LV+EY++ +L+Q+L D C G +K+ L + L Y
Sbjct: 67 VTL--HDIIHTEKSLTLVFEYLDK-DLKQYL--DDC--GNSINMHNVKLFLFQLLRGLNY 119
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
H KV+HRD+K N+LI+E + K++DFGLA+
Sbjct: 120 CHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 18/163 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ--LMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVR 228
+++ K IG+G YGVVY+ + + N T +A+KK+ + G R E+ + ++
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNET-IALKKIRLEQEDEGVPSTAIR-EISLLKEMQ 59
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM--KILLGTAKA 286
H N+VRL + LV+EY L+ L+ M R+ L +
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRG 114
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDA-KISDFGLAKLLG 328
+AY H +V+HRD+K N+LID +A K++DFGLA+ G
Sbjct: 115 IAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154
|
Length = 294 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 44/172 (25%), Positives = 82/172 (47%), Gaps = 12/172 (6%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKK-----LLNNPGQADKDFRVEVEAIGHVRH 229
F + IG G + VYR L++G VA+KK L++ +A D E++ + + H
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNH 61
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
N+++ IE + +V E + G+L + ++ + + + K + AL +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+H +V+HRDIK +N+ I K+ D GL + + K+ ++GT
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 57/187 (30%), Positives = 90/187 (48%), Gaps = 36/187 (19%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRV----EVEAIGHVRHK 230
+ K N I +G YGVVYR + G VA+KKL + F + E+ + ++H
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK--EKEGFPITSLREINILLKLQHP 64
Query: 231 NLVRL----LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCD--RGYLTWEAR--MKILLG 282
N+V + +G ++ + +V EYV E L+ M + +L E + M LL
Sbjct: 65 NIVTVKEVVVGSNLD--KIYMVMEYV-----EHDLKSLMETMKQPFLQSEVKCLMLQLL- 116
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+A+LH+ ++HRD+K+SN+L++ KI DFGLA+ G+ T V
Sbjct: 117 --SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLV---- 167
Query: 343 GDFSVTL 349
VTL
Sbjct: 168 ----VTL 170
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 15/157 (9%)
Query: 182 IGDGGYGVVYRGQLMNGTA--VAVKKL-LNNPG------QADKDFRVEVEAIG----HVR 228
+G G +G VY+ + N +A+K++ ++NP + DK V + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H N+VR +E + +V + + L + + T E I + AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
YLH+ E ++VHRD+ +NI++ E+ I+DFGLAK
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 11/184 (5%)
Query: 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIG 225
L L T+ + IG G YG VY+ ++A K+L+ D++ E +
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ 73
Query: 226 HV-RHKNLVRLLGYCIE-----GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK- 278
+ H N+V+ G + G Q LV E N G++ + ++G + G EA +
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG-LLICGQRLDEAMISY 132
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
IL G L +LH +++HRD+K +NIL+ K+ DFG++ L + + T V
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 339 MGTF 342
F
Sbjct: 190 GTPF 193
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 15/165 (9%)
Query: 182 IGDGGYGVVYRGQL-MNGTA--VAVKKLLN---NPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G G +G V +G M + VAVK L N +P D+ R E + + + +VR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR-EANVMQQLDNPYIVRM 61
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
+G C E +LV E G L ++L+ + ++T + +++ + + YL E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET-- 114
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
VHRD+ + N+L+ AKISDFGL+K LGA +++ + G
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 12/152 (7%)
Query: 182 IGDGGYGVVYRGQLMNG---TAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLG 237
IG+G +G V G++ +G V VK+L + Q F E + ++H NL++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRG-YLTWEARM--KILLGTAKALAYLHEAI 294
C E T +LV E+ G+L+ +LR C + +T + ++ A L +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRS--CRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
+H D+ N L+ + KI D+GL+
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-10
Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 12/169 (7%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV-EVEAIGHVRHKNL 232
++++ IG G G VY + G VA+K++ N Q K+ + E+ + +H N+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNI 78
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
V L + G + +V EY+ G+L + D G + R + +AL +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHS 133
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+V+HRDIKS NIL+ + K++DFG + +S +T V GT
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 14/173 (8%)
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV-EVEAIG 225
D + RF K IG G G VY + G VA+K++ N Q K+ + E+ +
Sbjct: 16 DPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMR 71
Query: 226 HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
++ N+V L + G + +V EY+ G+L + D G + R + +
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----Q 126
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
AL +LH +V+HRDIKS NIL+ + K++DFG + +S +T V
Sbjct: 127 ALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 9/143 (6%)
Query: 198 GTAVAVKKLL-NNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR--ILVYEYVNN 254
G VAVK L + G D + E+E + ++ H+N+V+ G C E L+ E++ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314
G+L+++L + + + + ++K + K + YL + VHRD+ + N+L++
Sbjct: 93 GSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 146
Query: 315 DAKISDFGLAKLLGAGKSHITTR 337
KI DFGL K + K + T +
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVK 169
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK--DFRVEVEAIGHVRHKNLV 233
F+K IG G +G V++G V K+++ D+ D + E+ + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
+ G ++ T+ ++ EY+ G+ D+ + G L IL K L YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHSE 120
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
K +HRDIK++N+L+ E+ + K++DFG+A L
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 18/160 (11%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHK 230
R+ +IG G YGVV G VA+KK+ + + A + R E++ + +RH
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHP 59
Query: 231 NLVRLLGYCIEGTQR-----ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
++V + + ++R +V+E + + +L Q ++ + LT E L +
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN----DDLTPEHHQFFLYQLLR 114
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
AL Y+H A V HRD+K NIL + + KI DFGLA+
Sbjct: 115 ALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 9e-10
Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 15/150 (10%)
Query: 182 IGDGGYGVVYRGQLMN-GTAVAVKKL----LNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
I G YG V+ + + G A+K + + Q D+ E + + + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVL-TERDILSQAQSPYVVKLY 59
Query: 237 GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
Y +G + + LV EY+ G+L L + G L + + AL YLH
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSN-- 112
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAK 325
++HRD+K NILID N K++DFGL+K
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSK 141
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 19/152 (12%)
Query: 182 IGDGGYGVVYRGQLMNGTAVA---VKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLLG 237
IG+G +G V ++ T VA VK+L N +++ F + + ++H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 238 YCIEGTQRILVYEYVNNGNL------EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
C+E +LV+EY G+L EQW R + L RM + A + ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN----SQLLLLQRMACEI--AAGVTHMH 116
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323
+ +H D+ N + + K+ D+G+
Sbjct: 117 KH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 20/158 (12%)
Query: 182 IGDGGYGVVYRGQ-LMNGTA-VAVKKL---LNNPGQADKDFRVEVEAIGHVR---HKNLV 233
IG+G YG V++ + L NG VA+K++ G R EV + H+ H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67
Query: 234 RLLGYCI-----EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
RL C T+ LV+E+V+ +L +L + + G T E ++ + L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPGVPT-ETIKDMMFQLLRGLD 124
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
+LH +VVHRD+K NIL+ + K++DFGLA++
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 19/162 (11%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHKN 231
R+ IG+G +G +Y + + + V K ++ P + + + EV + ++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM-----KILLGTAKA 286
+V E + +V EY + G+L + R + RG L E ++ +I LG
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMK--RINR-QRGVLFSEDQILSWFVQISLG---- 113
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLL 327
L ++H+ K++HRDIKS NI + +N AK+ DFG+A+ L
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 26/172 (15%)
Query: 171 SATNRFS-KDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIG-- 225
S + R+ K +G+G YG V + + G VA+KK+ D R V G
Sbjct: 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64
Query: 226 -----------HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWE 274
++H+N++ L+ +EG LV + + +L++ + DR E
Sbjct: 65 FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV-----DRKIRLTE 118
Query: 275 ARMK-ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+++K ILL L LH+ +HRD+ +NI I+ KI+DFGLA+
Sbjct: 119 SQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 181 IIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV-----EVEAIGHVRHKNLVR 234
++G G +G VY G +AVK++ +P + V E++ + ++RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 235 LLGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
G + ++ L EY+ G+++ L+ G LT + + ++YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS 124
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVT 348
+ +VHRDIK +NIL D + K+ DFG +K I T M G SVT
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASK-------RIQTICMSGTGIKSVT 170
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 51/173 (29%), Positives = 74/173 (42%), Gaps = 20/173 (11%)
Query: 196 MNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL-VYEY 251
M G VA+K L + + + FR E + H N+V LL + V+EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI- 310
V L + L D G L +++L ALA H +VHRD+K NI++
Sbjct: 61 VPGRTLREVLAAD----GALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVS 113
Query: 311 --DENFDAKISDFGLAKLL-GAGKSHI-----TTRVMGTFGDFSVTLLRNMPI 355
AK+ DFG+ LL G + + TT V+GT + LR P+
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 16/157 (10%)
Query: 182 IGDGGYGVVYRG---QLMNG---TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVR 234
+G G +G+VY G ++ G T VAVK + + ++ +F E + ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCD------RGYLTWEARMKILLGTAKALA 288
LLG +G ++V E + +G+L+ +LR + R T + +++ A +A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
YL+ K VHRD+ + N ++ +F KI DFG+ +
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 15/158 (9%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQ----ADKDFRVEVEAIGHVRH 229
R++ +G G YG V G VA+KKL + P Q A + +R E+ + H++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYR-ELTLLKHMQH 73
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCD-RGYLTWEARMKILL-GTAKAL 287
+N++ LL T + E+ + + +++ D+ G+ E +++ L+ L
Sbjct: 74 ENVIGLLDVF---TSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
Y+H A ++HRD+K N+ ++E+ + KI DFGLA+
Sbjct: 131 KYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 7/158 (4%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL---NNPGQADKDFRVEVEAIGHVRHKN 231
F + IG G + VYR L++ VA+KK+ +A +D E++ + + H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+++ L IE + +V E + G+L Q ++ + + K + A+ ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329
+V+HRDIK +N+ I K+ D GL + +
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV-EVEAIG 225
D + RF K IG G G VY + G VA++++ N Q K+ + E+ +
Sbjct: 17 DPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMR 72
Query: 226 HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
++ N+V L + G + +V EY+ G+L + D G + R + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----Q 127
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323
AL +LH +V+HRDIKS NIL+ + K++DFG
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 182 IGDGGYGVV-YRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
IG+G G+V + G VAVKK+ Q + EV + H+N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
G + +V E++ G L D+ + E + L +AL+YLH V+H
Sbjct: 90 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIH 141
Query: 301 RDIKSSNILIDENFDAKISDFGL 323
RDIKS +IL+ + K+SDFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 11/159 (6%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLG 237
IG G +G VY + + N VA+KK+ + Q++ +D EV + +RH N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
+ LV EY G+ L + L + G + LAYLH
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSH---N 135
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
++HRD+K+ NIL+ E K+ DFG A ++ + T
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGT 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 21/160 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHK 230
+ + K +G+G Y VY+G+ +NG VA+K +L G R E + ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDR-----GYLTWEARMKILLGTAK 285
N+V L LV+EYV+ D+C G L E L +
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHT---------DLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
L+Y+H+ ++HRD+K N+LI + + K++DFGLA+
Sbjct: 115 GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 18/171 (10%)
Query: 181 IIGDGGYGVVY----RGQLMNGTAVAVKKL----LNNPGQADKDFRVEVEAIGHVRHKNL 232
++G G YG V+ G G A+K L + + + R E + + VR
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 233 VRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYL 290
+ L Y + ++ L+ +YVN G L L R + T E+ +++ + AL +L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHL----YQREHFT-ESEVRVYIAEIVLALDHL 121
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
H+ +++RDIK NIL+D ++DFGL+K A + GT
Sbjct: 122 HQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 55/190 (28%), Positives = 94/190 (49%), Gaps = 34/190 (17%)
Query: 168 DLQSATNRFSK-DNIIGDGGYGVVYRGQLMNGT-AVAVKKLLNNPGQADKDFRVEVEAIG 225
D+ + N+ K NIIG+G +GVVY ++ + VA+KK+L +P +++ + +
Sbjct: 59 DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MK 114
Query: 226 HVRHKNLVRLLGY----CIEGTQRIL----VYEYVNNGNLEQWLRGDMCDRGYLTWEARM 277
++ H N++ L Y C + ++ + V E++ Q + M + Y +
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI-----PQTVHKYM--KHYARNNHAL 167
Query: 278 KILL------GTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA-KISDFGLAKLLGAG 330
+ L +ALAY+H + HRD+K N+LID N K+ DFG AK L AG
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224
Query: 331 K---SHITTR 337
+ S+I +R
Sbjct: 225 QRSVSYICSR 234
|
Length = 440 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 46/156 (29%), Positives = 78/156 (50%), Gaps = 22/156 (14%)
Query: 182 IGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRV---EVEAIGHVRHKNLVRLLG 237
IG G YG VY+ + +N G A+K + PG+ DF V E+ + +H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 238 YCIEGTQRILVYEYVNNGNLEQ--WLRGDMCDR--GYLTWEARMKILLGTAKALAYLHEA 293
+ + + E+ G+L+ + G + + Y++ E T + L YLH
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRE--------TLQGLYYLHSK 125
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329
+ +HRDIK +NIL+ +N K++DFG++ + A
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQITA 158
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 35/210 (16%)
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNGT------AVAVKKLLNN-PGQADKDFRVE 220
++ +T RF ++ +G+ +G VY+G L AVA+K L + G ++F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 221 VEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWL--RGDMCDRGYLTWEARMK 278
++H N+V LLG + +++ Y ++ +L ++L R D G + +K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 279 ----------ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
I+ A + +L VVH+D+ + N+L+ + + KISD GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 329 A-------GKSHITTRVMG----TFGDFSV 347
A G S + R M +G FS+
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSI 205
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 26/61 (42%), Positives = 35/61 (57%), Gaps = 10/61 (16%)
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG--------LAKLLGA 329
KI + KAL YLH + V+HRD+K SN+LI+ N K+ DFG +AK + A
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164
Query: 330 G 330
G
Sbjct: 165 G 165
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 23/162 (14%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVRHK 230
R+ + IG G G+V + G VAVKKL N A + +R E+ + V HK
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHK 80
Query: 231 NLVRLLGY-----CIEGTQRILVYEYVNNGNLEQWLRGDMCDR--GYLTWEARMKILLGT 283
N++ LL +E Q + + + + NL Q + ++ YL ++ +L G
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQ----MLCG- 135
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+ +LH A ++HRD+K SNI++ + KI DFGLA+
Sbjct: 136 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 6e-09
Identities = 45/176 (25%), Positives = 84/176 (47%), Gaps = 11/176 (6%)
Query: 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV-EVE 222
T+ + ++++ IG G G V+ + G VA+K++ N Q K+ + E+
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEIL 68
Query: 223 AIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
+ +++ N+V L + G + +V EY+ G+L + D + R +
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL--- 125
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
+AL +LH +V+HRDIKS N+L+ + K++DFG + +S +T V
Sbjct: 126 --QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 42/160 (26%), Positives = 79/160 (49%), Gaps = 15/160 (9%)
Query: 176 FSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV-----EVEAIGHVRH 229
+ + ++G G +G VY + G +A K++ +P + V E++ + +++H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 230 KNLVRLLGYCIEGTQRILV--YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
+ +V+ G + ++ L EY+ G+++ L+ G LT K + +
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGM 119
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+YLH + +VHRDIK +NIL D + K+ DFG +K L
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 18/158 (11%)
Query: 182 IGDGGYGVVYRGQLMNG-------TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLV 233
+G G +G+VY G + G T VA+K + ++ +F E + ++V
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEA-----RMKILLG-TAKAL 287
RLLG +G +++ E + G+L+ +LR + +A +M + G A +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
AYL+ K VHRD+ + N ++ E+F KI DFG+ +
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 7e-09
Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 17/156 (10%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEA-----IGHVRHKNLVRL 235
IG G YG VY+ + +G VA+K + + E + H N+VRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 236 LGYCI-----EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
+ C T+ LV+E+V+ +L +L D L E ++ + L +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
H +VHRD+K NIL+ K++DFGLA++
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARI 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 22/162 (13%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQ----ADKDFRVEVEAIGHVRH 229
R+ + +G G YG V G VAVKKL + P Q A + +R E+ + H++H
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYR-ELRLLKHMKH 75
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG-DM-----CDRGYLTWEARMKILLGT 283
+N++ LL E N+ L L G D+ C + LT + ++
Sbjct: 76 ENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI 129
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+ L Y+H A ++HRD+K SN+ ++E+ + KI DFGLA+
Sbjct: 130 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 46/164 (28%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLL---NNPGQADKDFRVEVEAIGHVRH 229
+R+ + +G G YG V G VA+KKL + A + +R E+ + H+ H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDH 73
Query: 230 KNLVRLL-----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
+N++ LL +E Q + LV + +L ++ C + L+ + ++
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVK---CQK--LSDDHIQFLVYQI 127
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ L Y+H A ++HRD+K SNI ++E+ + KI DFGLA+
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHT 168
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 182 IGDGGYGVVYR-GQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGY- 238
IG G YG V++ NG+ AVK +L+ D++ E + + H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 239 ----CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA-KALAYLHEA 293
G Q LV E N G++ ++G RG E + +L A L +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKG-FLKRGERMEEPIIAYILHEALMGLQHLHVN 143
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
K +HRD+K +NIL+ K+ DFG++ L + + T V F
Sbjct: 144 ---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 47/175 (26%), Positives = 70/175 (40%), Gaps = 19/175 (10%)
Query: 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRV-----EVEAIGHVRH 229
F +IG G +G V Q A+K + N + + V E + + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYM--NKQKCVEKGSVRNVLNERRILQELNH 59
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALA 288
LV L + LV + + G+L L + E ++K + AL
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-----SQKVKFSEEQVKFWICEIVLALE 114
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
YLH ++HRDIK NIL+DE I+DF +A + +TT GT G
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPG 164
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 49/158 (31%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 179 DNIIGDGGYGVVY-----RGQLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHK 230
D IG G +GVV+ R +G VA+KK+ N N + FR E++ + +H
Sbjct: 5 DRPIGYGAFGVVWSVTDPR----DGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHD 59
Query: 231 NLVRLLGYCIEGTQRILVYE--YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
N++ L I I +E YV ++ L + L+ + L + L
Sbjct: 60 NVLSALD--ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLK 117
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
YLH A ++HRDIK N+L++ N KI DFGLA++
Sbjct: 118 YLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 44/143 (30%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
IG+G G+V + +G VAVKK+ Q + EV + +H+N+V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
G + +V E++ G L D+ + E + L KAL+ LH V+H
Sbjct: 88 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIH 139
Query: 301 RDIKSSNILIDENFDAKISDFGL 323
RDIKS +IL+ + K+SDFG
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 15/155 (9%)
Query: 181 IIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV-----EVEAIGHVRHKNLVR 234
++G G +G VY G +AVK++ +P + V E++ + ++ H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 235 LLGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
G + +R L E++ G+++ L+ G LT K + ++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS 124
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ +VHRDIK +NIL D + K+ DFG +K L
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 28/159 (17%)
Query: 182 IGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVR-HKNLVR 234
+G G YG+V + VA+KK+ N + A + R E++ + H R HKN+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNITC 66
Query: 235 LLGYCI---EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTAKA 286
L I + +YE + +L Q +R LT +A + IL G
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ----PLT-DAHFQSFIYQILCG---- 117
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
L Y+H A V+HRD+K N+L++ + + KI DFGLA+
Sbjct: 118 LKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
IG+G G+V + +G VAVK + Q + EV + +H+N+V + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
G + ++ E++ G L D+ + L E + +AL YLH V+H
Sbjct: 89 VGEELWVLMEFLQGGALT-----DIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIH 140
Query: 301 RDIKSSNILIDENFDAKISDFGL 323
RDIKS +IL+ + K+SDFG
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGF 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 11/165 (6%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKN 231
F+ IG G +G VY + + VA+KK+ + Q++ +D EV+ + ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+ G + LV EY G+ L + L I G + LAYLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
++HRDIK+ NIL+ E K++DFG A + S + T
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGT 184
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 39/150 (26%), Positives = 74/150 (49%), Gaps = 9/150 (6%)
Query: 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLLG 237
+ +G G +G V+ T VAVK + PG + F E + ++H LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
+ I+ E++ G+L +L+ D + L + A+ +A++ +
Sbjct: 69 VVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQR---N 122
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+HRD++++NIL+ + KI+DFGLA+++
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVI 152
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 3e-08
Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNP-----GQADKDFRVEVEAIGHVRHKNLVRLL 236
+G G +G V + K+L+ Q + E + +RH LV L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN-EKRILQSIRHPFLVNLY 67
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM---KILLGTAKALAYLHEA 293
G + + LV EYV G L LR R AR +++L AL YLH
Sbjct: 68 GSFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPV-ARFYAAQVVL----ALEYLHSL 120
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+V+RD+K N+L+D + KI+DFG AK +
Sbjct: 121 ---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV 151
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 52/181 (28%), Positives = 85/181 (46%), Gaps = 18/181 (9%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGY 238
++G+G +G Q +N K + P A +D R E + ++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF-KE 65
Query: 239 CIEGTQRI-LVYEYVNNGNLEQWL---RGDM-CDRGYLTWEARMKILLGTAKALAYLHEA 293
E + +V EY + G+L Q + RG + + L W +M + + ++HE
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK 119
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353
+V+HRDIKS NI + +N K+ DFG A+LL + ++ T V GT + NM
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 354 P 354
P
Sbjct: 176 P 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 58/182 (31%), Positives = 86/182 (47%), Gaps = 19/182 (10%)
Query: 181 IIGDGGYG-VVYRGQLMNGTAVAVKKL-----LNNPGQADKDFRVEVEAI-GHVRHKNLV 233
+IG G +G V+ + ++G AVK L LN Q K E + +V+H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ--KHIMAERNVLLKNVKHPFLV 59
Query: 234 RLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
L Y + T+++ V ++VN G L L+ + R + AR A AL YLH
Sbjct: 60 GL-HYSFQTTEKLYFVLDFVNGGELFFHLQRE---RSFPEPRARFYAA-EIASALGYLHS 114
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352
+V+RD+K NIL+D ++DFGL K G +S TT GT + ++R
Sbjct: 115 I---NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 353 MP 354
P
Sbjct: 171 QP 172
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 24/160 (15%)
Query: 182 IGDGGYGVVYRGQL-------MNGTAVAVKKLLNNPGQADKDFRVEVEAIG---HVRHKN 231
+G G + +Y+G L + G V +L G +D E + HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
LV+L G C+ + I+V EYV G L+ +L ++ ++ ++ + A AL YL
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLE 118
Query: 292 EAIEPKVVHRDIKSSNILI-----DENF--DAKISDFGLA 324
+ K+VH ++ NIL+ +E + K+SD G+
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 10/184 (5%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTA-VAVKKLLNNPGQAD-KDFRV-EVEAIGHVRHK 230
N+F ++G+G YGVV + + VA+KK ++ + K+ + E++ + ++ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N+V L + LV+EYV LE L +M + G + R I KA+ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPN-GVPPEKVRSYIY-QLIKAIHWC 116
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLL 350
H+ +VHRDIK N+LI N K+ DFG A+ L G + T + T S LL
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173
Query: 351 RNMP 354
P
Sbjct: 174 LGAP 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 35/105 (33%), Positives = 48/105 (45%), Gaps = 10/105 (9%)
Query: 222 EAIGHVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKIL 280
E RH LV L C + + V EY G+L + D+ + A +L
Sbjct: 54 ETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL 112
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
L YLHE K+V+RD+K N+L+D KI+DFGL K
Sbjct: 113 -----GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK 149
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 4/63 (6%)
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
K+ + KAL YL E + V+HRD+K SNIL+D + + K+ DFG++ L K+ TR
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173
Query: 338 VMG 340
G
Sbjct: 174 SAG 176
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 8e-08
Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 22/155 (14%)
Query: 182 IGDGGYGVV-YRGQLMNGTAVAVKKLLNNPGQAD----KDFRVEVEAIGHVRHKNLVRLL 236
+G G YG V G VA+KKL P Q++ + +R E+ + H++H+N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYR-ELRLLKHMKHENVIGLL 80
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-----WEARMKILL-GTAKALAYL 290
+ ++ L G D G L E R++ L+ K L Y+
Sbjct: 81 DVFTPDLS----LDRFHDFYLVMPFMG--TDLGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
H A ++HRD+K N+ ++E+ + KI DFGLA+
Sbjct: 135 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 25/166 (15%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL---NNPGQADKDFRVEVEAIGHVRHKN 231
+ K IG+G YG VY+ + G VA+KK + G R E+ + +
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESI 61
Query: 232 -LVRLLGYCIEGTQR-------ILVYEYVNNGNLEQWLRGDMCDRGY---LTWEARMKIL 280
+VRLL +E + LV+EY+++ +L++++ D RG L + +
Sbjct: 62 YIVRLL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFM--DSNGRGPGRPLPAKTIKSFM 116
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA-KISDFGLAK 325
K +A+ H+ V+HRD+K N+L+D+ KI+D GL +
Sbjct: 117 YQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 54/167 (32%), Positives = 84/167 (50%), Gaps = 25/167 (14%)
Query: 174 NRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVRH 229
R+ IG G G+V + G VA+KKL N A + +R E+ + V H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNH 74
Query: 230 KNLVRLLGY-----CIEGTQRI-LVYEYVNNGNLEQWLRGDM-CDR-GYLTWEARMKILL 281
KN++ LL +E Q + LV E ++ NL Q ++ D+ +R YL ++ +L
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQ----MLC 129
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
G + +LH A ++HRD+K SNI++ + KI DFGLA+ G
Sbjct: 130 G----IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 48/159 (30%), Positives = 70/159 (44%), Gaps = 11/159 (6%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLG 237
IG G +G VY VAVKK+ + Q + +D EV+ + ++H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
++ LV EY G+ L + L I G + LAYLH
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---N 141
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
++HRDIK+ NIL+ E K++DFG A S + T
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGT 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 13/148 (8%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+G+G Y VY+G +NG VA+K + G R E + ++H N+V LL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIV-LLHD 70
Query: 239 CIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
I + + V+EY++ +L Q++ + G L + + LAY+H
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYM---IQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---H 123
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAK 325
++HRD+K N+LI + K++DFGLA+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 24/163 (14%)
Query: 175 RFSKDNIIGDGGYGVV---YRGQLMNGTAVAVKKLLNNPGQ----ADKDFRVEVEAIGHV 227
R+ +G G YG V Y +L VAVKKL + P Q A + +R E+ + H+
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQ--KVAVKKL-SRPFQSLIHARRTYR-ELRLLKHM 71
Query: 228 RHKNLVRLL-----GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
+H+N++ LL IE + + + +L ++ C + L+ E ++
Sbjct: 72 KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK---CQK--LSDEHVQFLIYQ 126
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+ L Y+H A ++HRD+K SN+ ++E+ + +I DFGLA+
Sbjct: 127 LLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 41/170 (24%)
Query: 182 IGDGGYGVVYRGQLMN---GTAVAVKKLLNNPGQADKDFRV--------EVEAIGHVRHK 230
IG G YG VY+ + N G A+KK + DK+ E+ + ++H+
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALLRELKHE 62
Query: 231 NLVRLLGYCIEGTQRI--LVYEYVNNGNLE--QWLR---GDMCDRGY---LTWEARMKIL 280
N+V L+ +E + L+++Y + + ++ R L W+ IL
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----IL 118
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLAKL 326
G + YLH V+HRD+K +NIL+ E KI D GLA+L
Sbjct: 119 NG----VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 48/181 (26%), Positives = 79/181 (43%), Gaps = 17/181 (9%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA-----IGHVRHKNLVRL 235
+IG G +G V + + + K+L K + + A + +++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 236 LGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYLHEA 293
Y + +++ V +YVN G L L+ + C E R + A A+ YLH
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL-----EPRARFYAAEVASAIGYLHSL 115
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353
+++RD+K NIL+D ++DFGL K G T+ GT + +LR
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 354 P 354
P
Sbjct: 172 P 172
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 27/156 (17%)
Query: 182 IGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHV----------RHK 230
+G GGYG V+ + + G VA+K++ K ++ + HV + +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRM-------KKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 231 NLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
LV+LL Y + + + L EYV G+ R + + G L+ + + +A+
Sbjct: 62 WLVKLL-YAFQDDEYLYLAMEYVPGGDF----RTLLNNLGVLSEDHARFYMAEMFEAVDA 116
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
LHE +HRD+K N LID + K++DFGL+K
Sbjct: 117 LHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 49/176 (27%), Positives = 74/176 (42%), Gaps = 39/176 (22%)
Query: 174 NRFSKDNIIGDGGYGVVY------RGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV 227
+ F +IG G +G V+ GQ+ A+K L K ++ I HV
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQV-----YAMKVLR-------KSDMIKRNQIAHV 48
Query: 228 RHKN----------LVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWE-A 275
R + +V+L Y + + + LV EY+ G+L L + E A
Sbjct: 49 RAERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL----IRKDVFPEETA 103
Query: 276 RMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331
R I A+ + L + +HRDIK NILID + K++DFGL K + K
Sbjct: 104 RFYI----AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 5e-07
Identities = 52/173 (30%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 175 RFSKDNIIGDGGYGVV---YRGQLMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVR 228
R+ IG G G+V Y L VA+KKL N A + +R E+ + V
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 74
Query: 229 HKNLVRLLGY-----CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
HKN++ LL +E Q + + + + NL Q ++ + L E +L
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQM 128
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
+ +LH A ++HRD+K SNI++ + KI DFGLA+ AG S + T
Sbjct: 129 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMT 176
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 23/181 (12%)
Query: 182 IGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFR---VEVEAIGHVRHKNLVRLLG 237
+G GG+G V Q+ G A KKL + K + E + + V + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59
Query: 238 YCIEG-TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM-----KILLGTAKALAYLH 291
Y E LV +N G+L+ + ++ + G+ EAR +I+ G L +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFP--EARAIFYAAQIICG----LEHLH 112
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLR 351
+ ++V+RD+K N+L+D++ + +ISD GLA L GK I R GT G + +L+
Sbjct: 113 QR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK-IKGRA-GTPGYMAPEVLQ 167
Query: 352 N 352
Sbjct: 168 G 168
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDF----RVEVEAIGHVRHKNLVRLLG 237
I G +G VY G+ N + + K++ +K+ + E +A+ + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY- 70
Query: 238 YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
Y ++ + LV EY+ G+++ L GY E +K + A AL YLH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH--- 123
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKL 326
++HRD+K N+LI K++DFGL+K+
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 43/167 (25%), Positives = 80/167 (47%), Gaps = 12/167 (7%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHKNL 232
F K + +G G GVV++ + +KL++ P ++ R E++ + +
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYI 65
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
V G + + E+++ G+L+Q L+ G + + K+ + K L YL E
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL--GAGKSHITTR 337
+ K++HRD+K SNIL++ + K+ DFG++ L S + TR
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 166
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 33/111 (29%), Positives = 59/111 (53%), Gaps = 7/111 (6%)
Query: 218 RVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR- 276
R EV + +++H N+V+ E +V +Y G+L + + RG L E +
Sbjct: 47 RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ---RGVLFPEDQI 103
Query: 277 MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ + AL ++H+ K++HRDIKS NI + ++ K+ DFG+A++L
Sbjct: 104 LDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 25/87 (28%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
+ V H +L + G C+ G++ I+V E+V +G L+ LR ++G + ++ +
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQL 126
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILI 310
A AL+YL + +VH ++ + NIL+
Sbjct: 127 ASALSYLEDK---NLVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 18/155 (11%)
Query: 181 IIGDGGYGVVYRGQLMNG--------TAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
++G G YG V+ + ++G V K + + + R E + + H+R
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 233 VRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYL 290
+ L Y + ++ L+ +Y+N G L L R E ++I G AL +L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHL----SQRERFK-EQEVQIYSGEIVLALEHL 121
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
H+ +++RDIK NIL+D N ++DFGL+K
Sbjct: 122 HKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 175 RFSKDNIIGDGGYGVV---YRGQLMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVR 228
R+ IG G G+V Y L VA+KKL N A + +R E+ + V
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 81
Query: 229 HKNLVRLLGY-----CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
HKN++ LL +E Q + + + + NL Q ++ + L E +L
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQM 135
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
+ +LH A ++HRD+K SNI++ + KI DFGLA+ G
Sbjct: 136 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+ HK+LV G C+ G + I+V EYV G+L+ +L+ + + ++W+ L AK
Sbjct: 56 LSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK-NLINISWK------LEVAKQ 108
Query: 287 LAY-LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332
LA+ LH + + H ++ + N+L+ D K + KL G S
Sbjct: 109 LAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 50/168 (29%), Positives = 71/168 (42%), Gaps = 29/168 (17%)
Query: 181 IIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVR---------HK 230
+IG G +G V Q + G A+KKL K +E E + HVR
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKL-------RKSEMLEKEQVAHVRAERDILAEADN 60
Query: 231 NLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWL-RGDMCDRGYLTWEARMKILLGTAKALA 288
V L Y + + L+ EY+ G++ L + D T E + T A+
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT-----FTEEETRFYIAETILAID 115
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
+H+ +HRDIK N+L+D K+SDFGL G KSH T
Sbjct: 116 SIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTE 158
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 30/83 (36%), Positives = 41/83 (49%), Gaps = 9/83 (10%)
Query: 250 EYVNNGNLEQWLRGDMCDRGYL-TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308
EY G L LR DRG + AR + A YLH +++RD+K N+
Sbjct: 73 EYCLGGELWTILR----DRGLFDEYTARF-YIACVVLAFEYLHNR---GIIYRDLKPENL 124
Query: 309 LIDENFDAKISDFGLAKLLGAGK 331
L+D N K+ DFG AK L +G+
Sbjct: 125 LLDSNGYVKLVDFGFAKKLKSGQ 147
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 24/79 (30%), Positives = 41/79 (51%), Gaps = 7/79 (8%)
Query: 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSS 306
LV EY+N G+ ++ G L + + + + LH+ ++HRDIK
Sbjct: 74 LVMEYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPE 126
Query: 307 NILIDENFDAKISDFGLAK 325
N+LID+ K++DFGL++
Sbjct: 127 NLLIDQTGHLKLTDFGLSR 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 48/168 (28%), Positives = 73/168 (43%), Gaps = 17/168 (10%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA-----IGHVRHKNLVRL 235
+IG G +G V + K+L K + + A + +V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 236 LGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYLHEA 293
Y + ++ V +YVN G L L+ + R + E R + A AL YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHLQRE---RSFP--EPRARFYAAEIASALGYLHSL 115
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+++RD+K NIL+D ++DFGL K G S T+ GT
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+G G GVV + Q + +KL++ P ++ R E++ + +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGA 71
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
+ + E+++ G+L+Q L+ + + E K+ + + LAYL E + ++
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLRE--KHQI 125
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLL--GAGKSHITTR 337
+HRD+K SNIL++ + K+ DFG++ L S + TR
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 166
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 18/179 (10%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFR---VEVEAIGHVRHKNLVRLLG 237
+G GG+G V Q+ G A KKL + K + VE + V H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 238 YCIE-GTQRILVYEYVNNGNLEQWLRG-DMCDRGYLTWEA---RMKILLGTAKALAYLHE 292
Y + T LV +N G+L + D + G+ A +I+ G L +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHLHQ 115
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLR 351
++++RD+K N+L+D + + +ISD GLA L G+S T GT G + LL+
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQ 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 5/87 (5%)
Query: 247 LVYEYVNNGNLEQWLRG-DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKS 305
LV +Y N G+L Q ++ +R + EA + + + L +H ++HRDIKS
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI----QVLLAVHHVHSKHMIHRDIKS 171
Query: 306 SNILIDENFDAKISDFGLAKLLGAGKS 332
+NIL+ N K+ DFG +K+ A S
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAATVS 198
|
Length = 496 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 15/112 (13%)
Query: 220 EVEAIGHVRHKNLVRLLGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARM 277
E + V H ++RL + E QR L + EYV G L +LR + G +
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR----NSG--RFSNST 102
Query: 278 KILLGT--AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ + AL YLH ++V+RD+K NIL+D+ K++DFG AK L
Sbjct: 103 GLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 42/150 (28%), Positives = 77/150 (51%), Gaps = 15/150 (10%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRV-EVEAIGHVR-HKNLVRLLGY 238
IG+G + V + Q G A+K + + ++ + E++A+ + H N++RL+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 239 CIE-GTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-ILLGTAKALAYLHEAIE 295
+ T R+ LV+E ++ NL + ++G R E R+K + K+L ++H
Sbjct: 67 LFDRKTGRLALVFELMD-MNLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHRN-- 119
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+ HRDIK NILI ++ K++DFG +
Sbjct: 120 -GIFHRDIKPENILIKDDI-LKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 42/151 (27%), Positives = 66/151 (43%), Gaps = 14/151 (9%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA-----IGHVRHKNLVRL 235
+IG G +G V + K+L K + + + +V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 236 LGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
+ + ++ V +Y+N G L L+ + C +L AR A AL YLH
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHLQRERC---FLEPRARF-YAAEIASALGYLHSL- 115
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+V+RD+K NIL+D ++DFGL K
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 26/78 (33%), Positives = 45/78 (57%), Gaps = 6/78 (7%)
Query: 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNIL 309
E+++ G+L+Q L+ G + KI + + L YL E + K++HRD+K SNIL
Sbjct: 79 EHMDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNIL 132
Query: 310 IDENFDAKISDFGLAKLL 327
++ + K+ DFG++ L
Sbjct: 133 VNSRGEIKLCDFGVSGQL 150
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 24/148 (16%)
Query: 201 VAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI-------------- 246
VAVKK++ Q+ K E++ I + H N+V++ +
Sbjct: 33 VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92
Query: 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSS 306
+V EY+ E L + ++G L+ E + + L Y+H A V+HRD+K +
Sbjct: 93 IVQEYM-----ETDLANVL-EQGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPA 143
Query: 307 NILID-ENFDAKISDFGLAKLLGAGKSH 333
N+ I+ E+ KI DFGLA+++ SH
Sbjct: 144 NVFINTEDLVLKIGDFGLARIVDPHYSH 171
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 15/179 (8%)
Query: 182 IGDGGYGVVYRGQLMN-GTAVAVKKL----LNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+G GG+G V Q+ N G A KKL L +K +E E + V +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKS-GEKMALLEKEILEKVNSPFIVNL- 58
Query: 237 GYCIEG-TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
Y E T LV +N G+L+ + ++ +RG L E + + +LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIY-NVGERG-LEMERVIHYSAQITCGILHLHSM-- 114
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMP 354
+V+RD+K N+L+D+ + ++SD GLA L GK+ T+ GT G + +L+ P
Sbjct: 115 -DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 9e-06
Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 25/170 (14%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN---- 231
F +IG G +G V Q + V K+L +AD +E E +GH+R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR---KADM---LEKEQVGHIRAERDILV 56
Query: 232 ------LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
+V++ + L+ E++ G++ L + LT E + T
Sbjct: 57 EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVL 112
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335
A+ +H+ +HRDIK N+L+D K+SDFGL G K+H T
Sbjct: 113 AIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCT--GLKKAHRT 157
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 36/102 (35%), Positives = 50/102 (49%), Gaps = 15/102 (14%)
Query: 228 RHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARM---KILLGT 283
RH L L Y + R+ V EY N G L L + R + AR +I+
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVS-- 106
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
AL YLH VV+RD+K N+++D++ KI+DFGL K
Sbjct: 107 --ALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 18/155 (11%)
Query: 181 IIGDGGYGVVYRGQLMNG--------TAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
++G G YG V+ + + G V K L + + R E + HVR
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 233 VRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYL 290
+ L Y + ++ L+ +YV+ G + L R + E ++ G AL +L
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFS-EDEVRFYSGEIILALEHL 121
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
H+ +V+RDIK NIL+D ++DFGL+K
Sbjct: 122 HKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 56/176 (31%), Positives = 82/176 (46%), Gaps = 28/176 (15%)
Query: 174 NRFSKDNIIGDGGYGVVY--RGQLMNGTAVAVKK------LLNNPGQADKDFRVEVEAIG 225
F +I +G YG VY R + A+KK +L N Q + F VE + +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETR-QRFAMKKINKQNLILRN--QIQQVF-VERDILT 56
Query: 226 HVRHKNLVRLLGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWE-ARMKILLG 282
+ +V + +C T+R L V EYV G+ L+ + G L + ARM
Sbjct: 57 FAENPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLK----NIGALPVDMARM-YFAE 109
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
T AL YLH +VHRD+K N+LI K++DFGL+K+ G +TT +
Sbjct: 110 TVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNL 159
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 22/155 (14%)
Query: 181 IIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFR---VEVEAIGHVRHKNLVRLL 236
++G G +G V +L +G AVK L + D D E + R+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 237 GYCIEGTQRIL-VYEYVNNGNL----EQWLRGDMCDRGYLTWEARMKILLG-TAKALAYL 290
C + R+ V E+VN G+L ++ R D EAR + AL +L
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---------EARARFYAAEITSALMFL 112
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
H+ +++RD+K N+L+D K++DFG+ K
Sbjct: 113 HDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 23/79 (29%), Positives = 43/79 (54%), Gaps = 6/79 (7%)
Query: 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKS 305
+ E+++ G+L++ + G + E KI + + L YL+ +++HRDIK
Sbjct: 79 CMCMEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKP 132
Query: 306 SNILIDENFDAKISDFGLA 324
SNIL++ K+ DFG++
Sbjct: 133 SNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 31/128 (24%), Positives = 57/128 (44%), Gaps = 9/128 (7%)
Query: 197 NGTAVAVKKLLNNPGQADKDFRV---EVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253
T VAVKK+ N + +D ++ E+ ++H N++ + I ++ +V +
Sbjct: 24 TNTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN 313
G+ E L+ + L A IL AL Y+H +HR +K+S+IL+ +
Sbjct: 83 YGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGD 137
Query: 314 FDAKISDF 321
+S
Sbjct: 138 GKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 34/133 (25%), Positives = 56/133 (42%), Gaps = 22/133 (16%)
Query: 204 KKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG 263
KK++ K E++ + + H+ ++ L ++ Y + +
Sbjct: 120 KKVIVKAVTGGKTPGREIDILKTISHRAIINL------------IHAYRWKSTVCMVMPK 167
Query: 264 DMCD-------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316
CD G L E + I +ALAYLH ++HRD+K+ NI +DE +A
Sbjct: 168 YKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENA 224
Query: 317 KISDFGLAKLLGA 329
+ DFG A L A
Sbjct: 225 VLGDFGAACKLDA 237
|
Length = 392 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 37/108 (34%), Positives = 52/108 (48%), Gaps = 11/108 (10%)
Query: 220 EVEAIGHVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK 278
E + + RH L L Y + R+ V EYVN G L L R + E R +
Sbjct: 45 ESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTR 98
Query: 279 ILLG-TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
AL YLH K+V+RD+K N+++D++ KI+DFGL K
Sbjct: 99 FYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 12/179 (6%)
Query: 181 IIGDGGYG-VVYRGQLMNGTAVAVKKL-LNNPGQAD-KDFRVEVEAIGHVRHKNLVRLL- 236
++G G YG V +G +KKL L N + + K E + + ++H N+V
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR-MKILLGTAKALAYLHEAIE 295
+ E +V + G+L L+ +G L E + ++ + A AL YLHE
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEK-- 121
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMP 354
++HRD+K+ N+ + K+ D G+A++L + + + ++GT S L N P
Sbjct: 122 -HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFSNKP 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 52/181 (28%), Positives = 82/181 (45%), Gaps = 11/181 (6%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADK--DFRVEVEAIGHVRHKNL 232
F + ++G GG+G V Q+ G A K+L + K + + I +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 233 VRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
V L Y E + LV +N G+L+ + +M + G+ + L A+ L L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIY-NMGNPGF----EEERALFYAAEILCGLE 116
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLR 351
+ V+RD+K NIL+D+ +ISD GLA + G+S I RV GT G + +L
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLN 174
Query: 352 N 352
N
Sbjct: 175 N 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 6e-05
Identities = 26/122 (21%), Positives = 47/122 (38%), Gaps = 13/122 (10%)
Query: 207 LNNPGQADKDFRVEVEAIGHVRHKNLV--RLLGYCIEGTQRILVYEYVNNGNLEQWLRGD 264
+N + D EV + + K L ++L L+ E++ L++
Sbjct: 28 INPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDE----- 82
Query: 265 MCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
++ E + I A+ LA LH+ + H D+ NIL+D+ I D+ A
Sbjct: 83 ------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
Query: 325 KL 326
Sbjct: 137 GY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 24/164 (14%)
Query: 181 IIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFR---VEVEAIGHV-RHKNLVRL 235
++G G +G V+ +L A+K L + D D VE + H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 236 LGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYL---TWEARMKILLGTAKALAYL 290
YC T+ L V EY+N G+L ++ C + L T+ A +I+ G L +L
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQS--CHKFDLPRATFYA-AEIICG----LQFL 112
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK--LLGAGKS 332
H +V+RD+K NIL+D + KI+DFG+ K +LG K+
Sbjct: 113 HSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 52/182 (28%), Positives = 89/182 (48%), Gaps = 13/182 (7%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRV---EVEAIGHVRHKN 231
F + ++G GG+G V Q+ G A KKL + K + E + + V +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 232 LVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
+V L Y E + LV +N G+L+ + M + G+ E R + A+ L
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFE--EGRA--VFYAAEICCGL 115
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLL 350
+ + ++V+RD+K NIL+D++ +ISD GLA + G++ I RV GT G + ++
Sbjct: 116 EDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVV 173
Query: 351 RN 352
+N
Sbjct: 174 KN 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 8e-05
Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 25/158 (15%)
Query: 181 IIGDGGYGVVYRGQLMNGT------AVAV-KKLLNNPGQADKDF-RVEVEAIGHVRHKNL 232
++G GGYG V++ + + G A+ V KK Q D + E + V+H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGD---MCDRG--YLTWEARMKILLGTAKAL 287
V L+ G + L+ EY++ G L L + M D YL+ +I L AL
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-----EISL----AL 113
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+LH+ +++RD+K NIL+D K++DFGL K
Sbjct: 114 EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 32/104 (30%), Positives = 49/104 (47%), Gaps = 19/104 (18%)
Query: 228 RHKNLVRLLGYCIEGTQRI-LVYEYVNNGNL----EQWLRGDMCDRGYLTWEARMKILLG 282
+H L +L C + R+ V EYVN G+L ++ R D E R +
Sbjct: 54 KHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFD---------EPRARFYAA 103
Query: 283 -TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
L +LHE +++RD+K N+L+D KI+DFG+ K
Sbjct: 104 EIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 49/168 (29%), Positives = 69/168 (41%), Gaps = 17/168 (10%)
Query: 181 IIGDGGYGVVYRGQLMNGTAV-AVKKLLNNPGQADKDFR---VEVEAIGHVRHKNLVRLL 236
++G G +G V +L V A+K L + D D E + + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 237 GYCIEGTQRIL-VYEYVNNGNLE-QWLRGDMCDRGYLTWEARMKILLG-TAKALAYLHEA 293
C + R+ V EYVN G+L Q R D E R + AL +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD------EPRSRFYAAEVTLALMFLHRH 115
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
V++RD+K NIL+D K++DFG+ K G TT GT
Sbjct: 116 ---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGT 159
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 47/154 (30%), Positives = 68/154 (44%), Gaps = 26/154 (16%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD----FRVEVEAIGHVRHKNLVRLL 236
+IG G +G V +L N V K+LN + FR E + + + ++ + L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ-WITTL 66
Query: 237 GYCIEGTQRI-LVYEYVNNGNL-------EQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
Y + + LV +Y G+L E L DM R YL A M I + + L
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYL---AEMVIAIDSVHQLH 122
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322
Y VHRDIK NIL+D N +++DFG
Sbjct: 123 Y---------VHRDIKPDNILMDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 37/108 (34%), Positives = 50/108 (46%), Gaps = 11/108 (10%)
Query: 220 EVEAIGHVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK 278
E + + RH L L Y + R+ V EY N G L L R + E R +
Sbjct: 45 ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERAR 98
Query: 279 ILLG-TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
AL YLH VV+RDIK N+++D++ KI+DFGL K
Sbjct: 99 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 17/184 (9%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----H 229
F ++G GG+G V Q+ G A KKL + K + E A+ R +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKRILEKVN 58
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
V L Y E + LV +N G+L+ + +M + G+ + + A+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY-NMGNPGF----DEQRAIFYAAELCC 113
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVT 348
L + ++V+RD+K NIL+D+ +ISD GLA + G++ + RV GT G +
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPE 171
Query: 349 LLRN 352
++ N
Sbjct: 172 VINN 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 26/66 (39%), Positives = 38/66 (57%), Gaps = 10/66 (15%)
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
+I+LG L ++H VV+RD+K +NIL+DE+ +ISD GLA K H +
Sbjct: 105 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-- 155
Query: 338 VMGTFG 343
+GT G
Sbjct: 156 -VGTHG 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 33/159 (20%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPG---QADKDFRVEVEAIG--------HVRHK 230
+G G YG VY K+L+ P A K+ R+E++ + HK
Sbjct: 9 LGKGNYGSVY-------------KVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHK 55
Query: 231 ----NLVRLLG-YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
+V G + IEG + + EY++ G+L++ L + + +I K
Sbjct: 56 AVSPYIVDFYGAFFIEGAVYMCM-EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVK 113
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
L +L E E ++HRD+K +N+L++ N K+ DFG++
Sbjct: 114 GLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 41/176 (23%), Positives = 81/176 (46%), Gaps = 31/176 (17%)
Query: 176 FSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQAD-------KDFRVEVEAI 224
F+ ++G G +G V QL + VAVK L +AD ++F E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-----KADIFSSSDIEEFLREAACM 55
Query: 225 GHVRHKNLVRLLGYCIEGTQR------ILVYEYVNNGNLEQWLRGDMCDRG----YLTWE 274
H N+++L+G + + +++ ++ +G+L +L M G L +
Sbjct: 56 KEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL--MSRIGEEPFTLPLQ 113
Query: 275 ARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330
++ ++ A + YL +HRD+ + N +++EN ++DFGL+K + +G
Sbjct: 114 TLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG 166
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 33/92 (35%), Positives = 45/92 (48%), Gaps = 9/92 (9%)
Query: 236 LGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYLHEA 293
L Y + R+ V EY N G L L R + E R + AL YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLHS- 113
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
E VV+RD+K N+++D++ KI+DFGL K
Sbjct: 114 -EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 13/105 (12%)
Query: 226 HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
V HK++V L G C+ + I+V E+V G L+ ++ LT + K+ A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLAS 116
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILI-DENFDA------KISDFGL 323
AL+YL + +VH ++ + NIL+ E D K+SD G+
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 9/117 (7%)
Query: 236 LGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
L C + T R+ LV EYVN G+L M + L E AL +LHE
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDL----MFHMQRQRKLPEEHARFYAAEICIALNFLHER- 115
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLR 351
+++RD+K N+L+D + K++D+G+ K G G T+ GT + +LR
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILR 169
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 18/40 (45%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
+A+ YLHE +++HRDIK+ NI I+ D + DFG A
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 25/170 (14%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN--LV 233
F +IG G +G V Q + + K+L +AD +E E + H+R + LV
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR---KADM---LEKEQVAHIRAERDILV 56
Query: 234 RLLG-------YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
G Y + + + L+ E++ G++ L + L+ EA + T
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVL 112
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335
A+ +H+ +HRDIK N+L+D K+SDFGL G K+H T
Sbjct: 113 AIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCT--GLKKAHRT 157
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 16/40 (40%), Positives = 24/40 (60%), Gaps = 3/40 (7%)
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
A YLH +++RD+K N+L+D K++DFG AK
Sbjct: 130 AFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 26/187 (13%)
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD---FRVEVEAI 224
D +S N + IG+G +G V+ + K ++ G +++ +EV +
Sbjct: 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVM 66
Query: 225 GHVRHKNLVRLLG-YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
++HKN+VR + + + Q++ ++ E+ + G+L + ++ G + A + I
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 283 TAKALAYLHEAIE----PKVVHRDIKSSNILID-------------ENFD----AKISDF 321
ALAY H + +V+HRD+K NI + N + AKI DF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 322 GLAKLLG 328
GL+K +G
Sbjct: 187 GLSKNIG 193
|
Length = 1021 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 27/74 (36%), Positives = 42/74 (56%), Gaps = 10/74 (13%)
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
+I+LG L ++H VV+RD+K +NIL+DE+ +ISD GLA K H +
Sbjct: 105 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-- 155
Query: 338 VMGTFGDFSVTLLR 351
+GT G + +L+
Sbjct: 156 -VGTHGYMAPEVLQ 168
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 20/155 (12%)
Query: 182 IGDGGYGVVYRGQLMNGT--AVAVKKL----LNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G G +G V N VA+K+ + Q D F E + + ++ H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-ERKILNYINHPFCVNL 96
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDM---CDRGYLTWEARMKILLGTAKALAYLHE 292
G + + LV E+V G +LR + D G + A++ ++ ++L
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-YAAQIVLIFEYLQSL----- 150
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+V+RD+K N+L+D++ K++DFG AK++
Sbjct: 151 ----NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181
|
Length = 340 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 25/59 (42%), Positives = 31/59 (52%), Gaps = 4/59 (6%)
Query: 287 LAYLHEAI----EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
LA L AI + VHRDIK N+LID K++DFG A L A K + +GT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGT 166
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 23/65 (35%), Positives = 39/65 (60%), Gaps = 9/65 (13%)
Query: 277 MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
+++LLG + Y+H+ +++HRD+K+ NI + N KI DFG+++LL G + T
Sbjct: 113 IQLLLG----VHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLAT 163
Query: 337 RVMGT 341
GT
Sbjct: 164 TFTGT 168
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 15/41 (36%), Positives = 24/41 (58%), Gaps = 3/41 (7%)
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+ L YLH +++HRD+K+ NI I++ I D G A+
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 17/152 (11%)
Query: 180 NIIGDGGYGVVYRG-QLMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNLVRLLG 237
I+G G G VY+ L+ +AVK + L+ + K E+E + ++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 238 -YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
+ +E RI + E+++ G+L+ + + +I + K L YL
Sbjct: 67 AFFVE--NRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL-- 114
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
K++HRD+K SN+L++ K+ DFG++ L
Sbjct: 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 19/35 (54%), Positives = 22/35 (62%), Gaps = 2/35 (5%)
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333
+HRDIK NILID K+SDFGL+ G K H
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS--TGFHKQH 155
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 19/103 (18%)
Query: 176 FSKDN-----IIGDGGYGVVYR------GQLMNGTAVAVKKLLNNPGQADKDFR----VE 220
F +DN +G G +G V G+ N VAVK L + A D R E
Sbjct: 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS---AHTDEREALMSE 91
Query: 221 VEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR 262
++ + H+ +HKN+V LLG C G +++ EY G+L +LR
Sbjct: 92 LKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 134
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 25/72 (34%), Positives = 39/72 (54%), Gaps = 5/72 (6%)
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
IL G + L YLH+ +HR+IK+S+ILI D +S GL+ L ++ +V
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKV 160
Query: 339 MGTFGDFSVTLL 350
+ F FS ++L
Sbjct: 161 VYDFPQFSTSVL 172
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 15/25 (60%), Positives = 19/25 (76%)
Query: 299 VHRDIKSSNILIDENFDAKISDFGL 323
+HRDIK NILID + K++DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 19/42 (45%), Positives = 28/42 (66%), Gaps = 3/42 (7%)
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
A AL +LH +++RD+K NIL+DE K++DFGL+K
Sbjct: 108 ALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 23/62 (37%), Positives = 33/62 (53%), Gaps = 4/62 (6%)
Query: 264 DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323
D+ + LT E + AK + +L K +HRD+ + NIL+ EN KI DFGL
Sbjct: 170 DLY-KKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGL 225
Query: 324 AK 325
A+
Sbjct: 226 AR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 30/145 (20%), Positives = 63/145 (43%), Gaps = 14/145 (9%)
Query: 190 VYRGQLMNGTAVAV---KKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR- 245
+Y+G N V + KK E++ + + N++++ G+ I+
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 246 ---ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRD 302
L+ EY G L + L + L+++ ++ + + K L L++ +++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKN 148
Query: 303 IKSSNILIDENFDAKISDFGLAKLL 327
+ S + L+ EN+ KI GL K+L
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKIL 173
|
Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 34/132 (25%), Positives = 59/132 (44%), Gaps = 23/132 (17%)
Query: 203 VKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL--------LGYCIEGTQRILVYEYVNN 254
+ K + +A E+ A+G + H+N++++ Y I +Y ++ +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255
Query: 255 GNLEQWLRGDMCDRGYLTWEAR--MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE 312
W DR L + R MK LL A+ Y+H+ K++HRDIK NI ++
Sbjct: 256 EAF-DWK-----DRPLL-KQTRAIMKQLLC---AVEYIHDK---KLIHRDIKLENIFLNC 302
Query: 313 NFDAKISDFGLA 324
+ + DFG A
Sbjct: 303 DGKIVLGDFGTA 314
|
Length = 501 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 38/137 (27%), Positives = 63/137 (45%), Gaps = 4/137 (2%)
Query: 189 VVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248
V RG VA +LN+ QA R E+ + H +V+ + +L+
Sbjct: 85 VATRGSDPKEKVVAKFVMLNDERQAAYA-RSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143
Query: 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308
EY + G+L + ++ + + L ++ LL LA L E K++HRD+KS+NI
Sbjct: 144 MEYGSGGDLNKQIKQRLKEH--LPFQEYEVGLLFYQIVLA-LDEVHSRKMMHRDLKSANI 200
Query: 309 LIDENFDAKISDFGLAK 325
+ K+ DFG +K
Sbjct: 201 FLMPTGIIKLGDFGFSK 217
|
Length = 478 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 17/95 (17%)
Query: 238 YCIEGTQRIL--VYEYVNNGNL----EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+C T+ L V EY+N G+L + R D + E I+ G L +LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE----IICG----LQFLH 113
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
+ +++RD+K N+L+D++ KI+DFG+ K
Sbjct: 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE 145
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 16/152 (10%)
Query: 181 IIGDGGYGVVYRGQLMNGTAV----AVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+IG G Y V +L + VKK L N + + E + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 237 GYCIEGTQRIL-VYEYVNNGNL--EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
C + R+ V EYVN G+L + + + + A + + AL YLHE
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHER 115
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+++RD+K N+L+D K++D+G+ K
Sbjct: 116 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 16/29 (55%), Positives = 21/29 (72%)
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAK 325
K +HRD+ + NIL+ EN KI DFGLA+
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 29/174 (16%)
Query: 181 IIGDGGYGVVYRGQLMNGTAV----AVKKLLNNPGQADKDFRVEVEAIGHV-----RHKN 231
+IG G Y V +L + +KK L N + D D+ V+ HV H
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDE-DIDW---VQTEKHVFETASNHPF 57
Query: 232 LVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARM---KILLGTAKAL 287
LV L C + R+ V E+V+ G+L ++ R AR +I L AL
Sbjct: 58 LVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISL----AL 109
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+LHE +++RD+K N+L+D K++D+G+ K G T+ GT
Sbjct: 110 NFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 16/29 (55%), Positives = 21/29 (72%)
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAK 325
K +HRD+ + NIL+ EN KI DFGLA+
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 27/83 (32%), Positives = 40/83 (48%), Gaps = 13/83 (15%)
Query: 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARM---KILLGTAKALAYLHEAIEPKVVHRDI 303
LV ++N G L L+ + + AR ++L AL LH+ V++RD+
Sbjct: 70 LVLAFINGGELFHHLQREGR---FDLSRARFYTAELLC----ALENLHKF---NVIYRDL 119
Query: 304 KSSNILIDENFDAKISDFGLAKL 326
K NIL+D + DFGL KL
Sbjct: 120 KPENILLDYQGHIALCDFGLCKL 142
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 27/189 (14%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----H 229
F ++G GG+G V Q+ G A KKL + K + E A+ + +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKQILEKVN 58
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARM-----KILLGT 283
V L Y E + LV +N G+L+ + +M + G+ E R +I G
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFD--EERAVFYAAEITCG- 114
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
L LH ++V+RD+K NIL+D+ +ISD GLA + G++ I RV GT G
Sbjct: 115 ---LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVG 166
Query: 344 DFSVTLLRN 352
+ +++N
Sbjct: 167 YMAPEVVKN 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 358 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.98 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.96 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.95 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.95 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.95 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.95 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.95 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.95 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.95 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.95 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.95 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.95 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.95 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.95 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.95 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.95 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.95 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.95 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.95 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.95 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.95 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.95 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.94 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.94 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.94 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.94 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.94 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.94 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.94 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.94 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.94 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.94 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.94 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.94 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.94 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.94 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.94 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.94 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.94 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.94 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.94 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.94 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.94 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.94 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.94 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.94 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.94 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.93 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.93 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.93 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.93 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.93 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.93 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.93 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.93 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.93 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.93 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.93 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.93 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.93 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.93 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.93 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.92 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.92 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.92 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.91 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.88 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.88 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.87 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.86 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.6 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.41 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.39 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.35 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.34 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.32 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.21 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.19 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.95 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.89 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.88 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.87 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.8 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.73 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.7 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.62 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.46 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.38 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.32 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.24 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.23 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.21 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.17 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.15 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.14 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.12 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.08 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.94 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.91 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.9 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.76 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.65 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.57 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.52 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.46 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.45 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.28 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.01 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.98 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.89 | |
| PLN02236 | 344 | choline kinase | 96.78 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.76 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 96.68 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.67 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.66 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.41 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.3 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.24 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.18 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.01 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.83 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.66 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.53 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.38 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.29 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.06 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.82 | |
| PF02439 | 38 | Adeno_E3_CR2: Adenovirus E3 region protein CR2; In | 94.75 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 94.63 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.52 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.11 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.72 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.68 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=308.47 Aligned_cols=174 Identities=30% Similarity=0.499 Sum_probs=155.9
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC--CCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN--PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.+|...+.||.|+||+||+|++ .++..||||.+... ..+..+.+..|+++|+.++|||||.+++++++++.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 5688888899999999999976 56789999998655 34555668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC------CcEEEeeecCc
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN------FDAKISDFGLA 324 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~------~~~kl~DFGla 324 (358)
||.||||.+|++. ++.+++.++..+..|+|.||++||++ +||||||||+||||+.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999984 45799999999999999999999999 99999999999999764 56899999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
|.+.++. ...+.+|+|.|||||+++.+.|+
T Consensus 163 R~L~~~~--~a~tlcGSplYMAPEV~~~~~Yd 192 (429)
T KOG0595|consen 163 RFLQPGS--MAETLCGSPLYMAPEVIMSQQYD 192 (429)
T ss_pred hhCCchh--HHHHhhCCccccCHHHHHhcccc
Confidence 9997644 46779999999999999888775
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=313.02 Aligned_cols=190 Identities=54% Similarity=0.932 Sum_probs=165.9
Q ss_pred CccchHhhHHHhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEE
Q 018311 161 GHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240 (358)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 240 (358)
...|++.++..++++|.....||+|+||.||+|...+|..||||++........++|..|+.++.+++|||+|+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 45689999999999999999999999999999999999999999886654431566999999999999999999999999
Q ss_pred eCC-EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEe
Q 018311 241 EGT-QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKIS 319 (358)
Q Consensus 241 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~ 319 (358)
+.+ +.+||+|||++|+|.+.|+..... .++|..+++|+.++|+||+|||..+.+.|||||||++|||||+++++||+
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 988 599999999999999999864322 78999999999999999999999877889999999999999999999999
Q ss_pred eecCceecCCCCceeeeecccccCCchhhhccC
Q 018311 320 DFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 320 DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
|||+|+.......+......||.+|+|||++..
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~ 252 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST 252 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhcc
Confidence 999997654312222221289999999999965
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=303.24 Aligned_cols=179 Identities=28% Similarity=0.440 Sum_probs=158.5
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
..+..+.++||+|-||+|++|+...+.+||||+++..... ...+|.+|+++|.+|+||||++++|+|..++.+|+|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 3556778999999999999999988899999999877654 448999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
|++|||.+||.++.... +..+...+|+.||+.||+||.+. ++|||||.++|||++.++++||+|||++|.++.+.
T Consensus 617 mEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999998763322 45566788999999999999998 99999999999999999999999999999998877
Q ss_pred ce-eeeecccccCCchhhhccCCCcc
Q 018311 332 SH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.+ ...+.+-...|||||.+....++
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFt 717 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFT 717 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhcccc
Confidence 65 56677888999999998765543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=296.51 Aligned_cols=177 Identities=27% Similarity=0.434 Sum_probs=155.2
Q ss_pred cCCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCCCc-------chHHHHHHHHHHhcCCCCccccccceEEeCCE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQ-------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 244 (358)
...|.+.+.||+|+||.|.+|. .++|+.||||.+.+.... ...+.++|+++|++|+|||||++++++..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3567788999999999999994 578999999998644311 12335789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC---CcEEEeee
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN---FDAKISDF 321 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~---~~~kl~DF 321 (358)
.||||||++||+|.+++.. ++.+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999974 45678888899999999999999999 99999999999999766 88999999
Q ss_pred cCceecCCCCceeeeecccccCCchhhhccCCCcccC
Q 018311 322 GLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPILVF 358 (358)
Q Consensus 322 Gla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~ 358 (358)
|+|+..+. ...+.++||||.|.|||++.++.+.+|
T Consensus 324 GlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~ 358 (475)
T KOG0615|consen 324 GLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYY 358 (475)
T ss_pred chhhcccc--ceehhhhcCCccccChhheecCCeecc
Confidence 99999874 446888999999999999999887764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=288.93 Aligned_cols=175 Identities=26% Similarity=0.356 Sum_probs=155.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.++||+|+||+|+.++. .+++.+|+|.+++..- ...+....|..+|..++||+||.++..|++.+.+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 5789999999999999999965 5688999999865532 23455778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+.||+|+..|+ ..+.+++..+..++.+|+.||.|||++ +||||||||+|||||++|+++|+||||++..-.
T Consensus 105 d~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 105 DYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred eccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999998 446689999999999999999999999 999999999999999999999999999996432
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. ...+.+++||+.|||||++.+++|.
T Consensus 178 ~-~~~t~tfcGT~eYmAPEil~~~gy~ 203 (357)
T KOG0598|consen 178 D-GDATRTFCGTPEYMAPEILLGKGYD 203 (357)
T ss_pred C-CCccccccCCccccChHHHhcCCCC
Confidence 2 3345669999999999999999885
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=286.81 Aligned_cols=172 Identities=28% Similarity=0.431 Sum_probs=154.7
Q ss_pred CcccceecCCccEEEEEEEE-eCCcEEEEEEecCC-CCcchHHHHHHHHHHhcCCCCccccccceEEeCC-EEEEEEeec
Q 018311 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN-PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-QRILVYEYV 252 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lv~e~~ 252 (358)
++..+.||+|..|+||+|.+ .+++.+|+|.+..+ .....+++.+|++++.+++||+||.+||.|..+. ..+++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 44578999999999999976 46888999999544 3445678999999999999999999999999998 599999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
++|+|.+++.. -+++++...-+|+.+|++||.|||. + +||||||||+|+|++..|++||||||.++.+-..
T Consensus 161 DgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 161 DGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred CCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999974 3669999999999999999999996 5 9999999999999999999999999999998654
Q ss_pred ceeeeecccccCCchhhhccCCCccc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPILV 357 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~~ 357 (358)
..++++||..|||||.+.|..|.+
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~ 256 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSV 256 (364)
T ss_pred --hcccccccccccChhhhcCCcCCc
Confidence 678899999999999999999975
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=293.61 Aligned_cols=175 Identities=33% Similarity=0.552 Sum_probs=151.0
Q ss_pred CcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcc--hHHHHHHHHHHhcCCCCccccccceEEeCC-EEEEEEeec
Q 018311 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA--DKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-QRILVYEYV 252 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lv~e~~ 252 (358)
+...+.||+|+||+||++.+.....||+|++....... .++|.+|+.+|.+++|||||+++|+|.++. ..++|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34456799999999999999655559999997554222 468999999999999999999999999877 799999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eeeCCCCCCcEEEcCCC-cEEEeeecCceecCCC
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK-VVHRDIKSSNILIDENF-DAKISDFGLAKLLGAG 330 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-ivHrDlk~~NiLl~~~~-~~kl~DFGla~~~~~~ 330 (358)
++|+|.++|+.. ....+++..++.++.+||+||.|||++ + |||||||++|||++.++ ++||||||+++.....
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999864 356799999999999999999999998 7 99999999999999998 9999999999987654
Q ss_pred CceeeeecccccCCchhhhccC--CCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRN--MPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~--~~~~ 356 (358)
. ...+...||+.|||||++.+ .+|+
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~ 224 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYT 224 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCC
Confidence 3 22344799999999999994 4664
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=290.42 Aligned_cols=173 Identities=27% Similarity=0.438 Sum_probs=156.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC---CCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
.+|...+.||+|||+.||.++. .+|+.||+|++.+. .....+.+.+||++.+.|+|||||+++++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5789999999999999999987 88999999998543 2334566888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
|+|+.++|..+++ .++.+++.+++++..||+.||.|||++ +|+|||||..|++|+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999997 457799999999999999999999999 999999999999999999999999999999874
Q ss_pred CCceeeeecccccCCchhhhccCCC
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.. ....+.+|||.|.|||++.+..
T Consensus 171 ~~-Erk~TlCGTPNYIAPEVl~k~g 194 (592)
T KOG0575|consen 171 DG-ERKKTLCGTPNYIAPEVLNKSG 194 (592)
T ss_pred cc-cccceecCCCcccChhHhccCC
Confidence 32 3456799999999999998653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=266.97 Aligned_cols=171 Identities=27% Similarity=0.363 Sum_probs=152.8
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcch---HHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|+..+.||.|+||.|.+++. .+|.-+|+|.+.+..-... +-...|..+|+.+.||+++++++.+.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 5678889999999999999975 4588899999865432222 33567999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||.+||.|+.+|++ .+++++..++.++.||+.||+|||+. .|++|||||+|||||.+|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999984 45699999999999999999999999 999999999999999999999999999999854
Q ss_pred CCceeeeecccccCCchhhhccCCCc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
. +-+.||||.|+|||+++.+||
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~y 218 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGY 218 (355)
T ss_pred c----EEEecCCccccChHHhhcCCC
Confidence 3 668999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=272.97 Aligned_cols=181 Identities=28% Similarity=0.416 Sum_probs=155.6
Q ss_pred CCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCC--CCcchHHHHHHHHHHhcCCCCccccccc-eEEeCCE-EEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNN--PGQADKDFRVEVEAIGHVRHKNLVRLLG-YCIEGTQ-RILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~-~~~~~~~-~~lv 248 (358)
.+|++.++||.|.||+||++. ..+|..+|.|.+.-. ..+..+++..|+.+|++|+|||||++++ .+..+.+ +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457888999999999999995 578999999998632 2344567889999999999999999999 4444455 8999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
||||.+|||.+.++......+.+++.++++++.|++.||..+|.+. ++ |+||||||.||+|+.+|.+||+||||++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999766667788999999999999999999999832 24 99999999999999999999999999999
Q ss_pred cCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 327 LGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 327 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+.... ......+|||.||+||.+.+.+|-
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~ 206 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYN 206 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCC
Confidence 86533 345568999999999999999984
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=277.35 Aligned_cols=175 Identities=27% Similarity=0.475 Sum_probs=159.2
Q ss_pred cCCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCCCcchHH---HHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~---~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
..+|++.+.||+|.||.|-+|. ...|+.||||.+++..-+..++ +++||+||..|+||||+.++.+|++.+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3689999999999999999995 4789999999998776554444 67899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||..+|+|.+|+. .++.|++.++..++.||..|+.|||.+ +++|||||.+|||+|.++++||+||||+-.+.
T Consensus 132 MEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999998 456799999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.++ ...+++|+|-|.+||++.|.||.
T Consensus 205 ~~k--fLqTFCGSPLYASPEIvNG~PY~ 230 (668)
T KOG0611|consen 205 DKK--FLQTFCGSPLYASPEIVNGTPYK 230 (668)
T ss_pred ccc--HHHHhcCCcccCCccccCCCCCC
Confidence 443 35679999999999999999995
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=279.33 Aligned_cols=174 Identities=31% Similarity=0.381 Sum_probs=153.8
Q ss_pred cCCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeC--CEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRIL 247 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 247 (358)
.+.|+.+++||+|+||.||+|+ ..+|+.||+|+++-.. .....-..+||.||++|.||||++|.+..... ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4668889999999999999996 5789999999997544 34445667899999999999999999998876 78999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
|+|||++ ||.-++.. ..-.+++.++..++.|++.||+|||++ +|+|||||.+|||||++|.+||+|||||+.+
T Consensus 196 VFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999965 99888864 233589999999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCceeeeecccccCCchhhhccCC
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
........+..+-|..|.|||+|+|.
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~ 294 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGA 294 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCC
Confidence 87766667778889999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=280.09 Aligned_cols=177 Identities=29% Similarity=0.457 Sum_probs=154.0
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
..++..+.||+|.||+||.|.+.....||+|.++.. ....++|.+|+++|++|+|+|||+++++|..++.+|||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 334567899999999999999987779999999765 3445789999999999999999999999999899999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
.|+|.+||+.. ....+...+.+.++.|||.||+||+++ ++|||||+++|||+++++.+||+||||||....+...
T Consensus 285 ~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 285 KGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred cCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 99999999863 456688899999999999999999999 9999999999999999999999999999976655544
Q ss_pred eeeecccccCCchhhhccCCCcc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......-...|+|||.+.-..+.
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS 382 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFS 382 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcc
Confidence 44444446799999999866543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=275.52 Aligned_cols=176 Identities=27% Similarity=0.446 Sum_probs=154.7
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC----CC-cchHHHHHHHHHHhcCC-CCccccccceEEeCCEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN----PG-QADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 245 (358)
.++|.+.+.||+|+||.|+.|.. .++..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 36899999999999999999965 57899999966443 11 23355678999999999 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-CcEEEeeecCc
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLA 324 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~-~~~kl~DFGla 324 (358)
++||||+.+|+|++++.+ .+++.+..+.+++.|++.|++|||++ +|+||||||+|+|++.+ +++||+|||++
T Consensus 96 ~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999984 46688999999999999999999999 99999999999999999 99999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCC-cc
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMP-IL 356 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~-~~ 356 (358)
.... .......+.+||+.|+|||++.+.+ |.
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~ 200 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYS 200 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcC
Confidence 9874 2233567899999999999999988 74
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=278.02 Aligned_cols=174 Identities=29% Similarity=0.448 Sum_probs=157.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|-+.+.||+|+||.||||+. .+.+.||+|.+.+.. .+..+.+.+|++++++++||||+.++++|++..++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5678889999999999999964 567889999886544 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+.| +|+.+|. ..+.++++.+..++.+++.||.|||+. +|+|||+||+|||++..+++|+||||+||....+
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9966 9999998 456799999999999999999999999 9999999999999999999999999999998765
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
....+.+.|||-|||||++.+.||.
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd 178 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYD 178 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCcc
Confidence 4567789999999999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=259.37 Aligned_cols=171 Identities=30% Similarity=0.405 Sum_probs=147.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|+.+.++|+|+||.||+|+. .+|+.||||++..... ...+-..+|+++|++|+|||+|.++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4678888999999999999975 5699999999976543 334556789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
||+..-|.+ |.. ....++.+....++.|++.|+.|+|++ ++|||||||+||||+.++.+||||||+||.+...
T Consensus 82 ~~dhTvL~e-Le~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDHTVLHE-LER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecchHHHHH-HHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 997755544 432 334488899999999999999999999 9999999999999999999999999999999742
Q ss_pred CceeeeecccccCCchhhhccC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
....+..+-|..|.|||++.|
T Consensus 155 -gd~YTDYVATRWYRaPELLvG 175 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVG 175 (396)
T ss_pred -cchhhhhhhhhhccChhhhcc
Confidence 224556788999999999998
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=265.60 Aligned_cols=169 Identities=32% Similarity=0.553 Sum_probs=144.1
Q ss_pred CcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHh--cCCCCccccccceEEeCC----EEEEEE
Q 018311 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIG--HVRHKNLVRLLGYCIEGT----QRILVY 249 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~--~l~HpnIv~l~~~~~~~~----~~~lv~ 249 (358)
.+..+++|+|.||.||+|++ +++.||||++.. ...+.|+.|-+|.. .++|+||++++++-...+ +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 34468999999999999998 458999998843 34466777777765 568999999999877655 889999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI------EPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
||.+.|+|.+||+.+ .++|....+|+..+++||+|||... .++|+|||||++|||+.+|+++.|+||||
T Consensus 288 ~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999853 4899999999999999999999643 57899999999999999999999999999
Q ss_pred ceecCCCCce-eeeecccccCCchhhhccCC
Q 018311 324 AKLLGAGKSH-ITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 324 a~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~ 353 (358)
|..+.++... ..-.-+||..|||||++.|.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEga 393 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA 393 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence 9999866543 23347999999999999874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=270.53 Aligned_cols=178 Identities=25% Similarity=0.293 Sum_probs=152.8
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcch---HHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
..++|+.+++||+|+||+||+|+. .+|..+|+|++++...... +-.+.|-.+|....+|.||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 447799999999999999999965 5799999999977653332 446779999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||++|||+..+|. ..+.|++..+..++.+++.|+.-+|+. |+|||||||+|+|||..|++||+||||+.-+
T Consensus 219 iMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999998 456799999999999999999999999 9999999999999999999999999998543
Q ss_pred CC----------------------CCce-----e-------------------eeecccccCCchhhhccCCCcc
Q 018311 328 GA----------------------GKSH-----I-------------------TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~----------------------~~~~-----~-------------------~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. .... . ....+|||.|+|||+++|..|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 21 0000 0 0136799999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=246.58 Aligned_cols=173 Identities=29% Similarity=0.440 Sum_probs=150.2
Q ss_pred CCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.+|...++||+|.||.||+|+ ..+|+.||||+++..... ......+||+.|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467888999999999999996 478999999999755422 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
||+ .||+..++. ....++..+...++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+|+.+++.
T Consensus 82 fm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 995 599999985 345688899999999999999999999 9999999999999999999999999999998865
Q ss_pred CceeeeecccccCCchhhhccCCC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
... ....+-|..|.|||++-|.+
T Consensus 155 ~~~-~~~~V~TRWYRAPELLfGsr 177 (318)
T KOG0659|consen 155 NRI-QTHQVVTRWYRAPELLFGSR 177 (318)
T ss_pred Ccc-cccceeeeeccChHHhccch
Confidence 433 22337788999999988764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=285.93 Aligned_cols=180 Identities=29% Similarity=0.455 Sum_probs=156.1
Q ss_pred CCCcccceecCCccEEEEEEEE------eCCcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
.+.+..+.||+|.||+||+|+. .+...||||.++..... ..++|++|+++++.++|||||+|+|+|..++..|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 4556678999999999999974 34567999999877765 6789999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcE
Q 018311 247 LVYEYVNNGNLEQWLRGDMCD----------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~ 316 (358)
||+|||..|||.+||+.+... +..|+..+.+.||.|||.||.||-++ .+|||||+.+||||+++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 999999999999999753211 23488899999999999999999999 99999999999999999999
Q ss_pred EEeeecCceecCCCCceeee-ecccccCCchhhhccCCCcc
Q 018311 317 KISDFGLAKLLGAGKSHITT-RVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 317 kl~DFGla~~~~~~~~~~~~-~~~Gt~~y~APE~l~~~~~~ 356 (358)
||+||||+|.++..+..... +..-...||+||.|+-..|+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT 683 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT 683 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc
Confidence 99999999999876654333 44556799999999877664
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=269.90 Aligned_cols=178 Identities=29% Similarity=0.401 Sum_probs=153.8
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 246 (358)
..++|.+++.||+|+|++|++|+. .+++.+|||++.+.- ....+-..+|-..|.+| .||.|++|+..|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 347899999999999999999964 678999999885432 22234466788899999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+|+||+++|+|.+++.+ -+.+++.+...++.+|+.||+|||++ |||||||||+|||||++|++||+|||.|+.
T Consensus 151 FvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999984 36699999999999999999999999 999999999999999999999999999999
Q ss_pred cCCCCce------------eeeecccccCCchhhhccCCCcc
Q 018311 327 LGAGKSH------------ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 327 ~~~~~~~------------~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+.+.... ....++||..|.+||+|...+..
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~ 265 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAG 265 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCC
Confidence 8743221 11458999999999999987653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=273.11 Aligned_cols=173 Identities=24% Similarity=0.372 Sum_probs=155.4
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
-|++++.||+|+-|.|.+|++ .+|+.+|||.+.+.. ......+.+||-+|+.+.||||+++++++++..++|+|+|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 467789999999999999975 789999999985542 2223567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++|.|+++|. ..+.+++.++.+++.||+.|+.|||.. +|+||||||+|+|||.++.+||+|||+|...-++
T Consensus 93 yv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred ecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999998 457799999999999999999999998 9999999999999999999999999999986554
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+ ...+.||+|.|+|||++.|+||.
T Consensus 166 k--lLeTSCGSPHYA~PEIV~G~pYd 189 (786)
T KOG0588|consen 166 K--LLETSCGSPHYAAPEIVSGRPYD 189 (786)
T ss_pred c--cccccCCCcccCCchhhcCCCCC
Confidence 4 45678999999999999999995
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=269.82 Aligned_cols=176 Identities=24% Similarity=0.305 Sum_probs=153.0
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 247 (358)
.++|.+.++||+|+||.|++++. .+++.+|||.+++.. ....+....|.+++... +||.+++++..|.+++++|.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 46789999999999999999986 457889999998765 23445577788888766 59999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||+.|||+..+. ..+.+++..+..++..|+.||.|||++ +|||||||.+|||||.+|++||+||||++..
T Consensus 447 vmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999954433 335689999999999999999999999 9999999999999999999999999999985
Q ss_pred CCCCceeeeecccccCCchhhhccCCCccc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPILV 357 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~ 357 (358)
-. ....+++++|||.|||||++.+.-|+-
T Consensus 519 m~-~g~~TsTfCGTpey~aPEil~e~~Yt~ 547 (694)
T KOG0694|consen 519 MG-QGDRTSTFCGTPEFLAPEVLTEQSYTR 547 (694)
T ss_pred CC-CCCccccccCChhhcChhhhccCcccc
Confidence 42 233688999999999999999999873
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=255.14 Aligned_cols=173 Identities=31% Similarity=0.457 Sum_probs=148.1
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCC--EEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT--QRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lv~e 250 (358)
.+|...+.||+|+||.||++... +|...|||.+........+.+.+|+++|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677899999999999999764 48999999986553333567899999999999999999999855544 6899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCcEEEeeecCceecCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKLLGA 329 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~-~~~~kl~DFGla~~~~~ 329 (358)
|+++|+|.+++.+.. +.+++..+.++..|++.||.|||++ ++|||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999998542 2699999999999999999999999 9999999999999999 79999999999998764
Q ss_pred --CCceeeeecccccCCchhhhccC
Q 018311 330 --GKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 330 --~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
..........||+.|||||++.+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~ 195 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRN 195 (313)
T ss_pred ccccccccccccCCccccCchhhcC
Confidence 22223445899999999999994
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=263.00 Aligned_cols=176 Identities=24% Similarity=0.364 Sum_probs=157.0
Q ss_pred hcCCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
....|...++||+|..|.||.|. ..+++.||||++........+-+..|+.+|+..+|+|||++++.|...+++|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 34668888999999999999995 46788999999977666656667899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
||++|+|.+.+.+ ..+++.+...|+.+++.||+|||.+ +|+|||||.+|||++.+|.+||+|||+|..+...
T Consensus 351 ym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred ecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999998864 3388999999999999999999999 9999999999999999999999999999998654
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. ...+.+|||.|||||++...+|-
T Consensus 423 ~~-KR~TmVGTPYWMAPEVvtrk~YG 447 (550)
T KOG0578|consen 423 QS-KRSTMVGTPYWMAPEVVTRKPYG 447 (550)
T ss_pred cC-ccccccCCCCccchhhhhhcccC
Confidence 43 45568999999999999988773
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=240.25 Aligned_cols=176 Identities=27% Similarity=0.408 Sum_probs=154.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++++.||+|-||.||+|+. +++..||+|++.+.. .....++.+|+++-..|+||||++++++|.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 5688899999999999999964 678899999885432 334567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||.+.|+|...|+.. ....+++.....+..|+|.|+.|+|.+ +++||||||+|+|++..+.+||+|||-+..-..
T Consensus 102 Eya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999854 334588888899999999999999998 999999999999999999999999998877542
Q ss_pred CCceeeeecccccCCchhhhccCCCccc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPILV 357 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~ 357 (358)
+ ...+.+||..|.+||+..+..++-
T Consensus 177 ~---kR~tlcgt~dyl~pEmv~~~~hd~ 201 (281)
T KOG0580|consen 177 N---KRKTLCGTLDYLPPEMVEGRGHDK 201 (281)
T ss_pred C---CceeeecccccCCHhhcCCCCccc
Confidence 2 345789999999999999988753
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=247.87 Aligned_cols=173 Identities=28% Similarity=0.353 Sum_probs=147.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcc--hHHHHHHHHHHhcCCCCccccccceEEe--CCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA--DKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv 248 (358)
+.|+..+.|++|+||.||+|+. ++++.||+|+++...... --.-.+||.+|.+++|||||.+..+... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4577789999999999999965 678899999997544221 1235789999999999999999888764 4679999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
||||+. ||..++.. ...++...++..+..|+++|++|||.. .|+|||||++|+|+++.|.+||+||||||.++
T Consensus 156 Me~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999965 99998874 335688899999999999999999999 99999999999999999999999999999987
Q ss_pred CCCceeeeecccccCCchhhhccCCC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.... ..+..+-|..|.|||+++|.+
T Consensus 229 sp~k-~~T~lVVTLWYRaPELLLG~~ 253 (419)
T KOG0663|consen 229 SPLK-PYTPLVVTLWYRAPELLLGAK 253 (419)
T ss_pred CCcc-cCcceEEEeeecCHHHhcCCc
Confidence 6533 355678899999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=262.03 Aligned_cols=173 Identities=26% Similarity=0.344 Sum_probs=151.3
Q ss_pred cCCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCCCcchHH--HHHHHHHHhcCC-CCccccccceEEeCC-EEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD--FRVEVEAIGHVR-HKNLVRLLGYCIEGT-QRIL 247 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l~-HpnIv~l~~~~~~~~-~~~l 247 (358)
-++|...++||.|+||.||+|+ ..++..||||++++.... .++ -.+|++-|.+|+ ||||+++.+++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4789999999999999999996 467899999999765543 333 357999999998 999999999999888 8999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
|||||+ -+|.++++.+ +..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.+
T Consensus 88 VfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 999994 5999999863 56799999999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCceeeeecccccCCchhhhccCCCc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.... ..+..+-|..|.|||+++...|
T Consensus 161 ~Skp--PYTeYVSTRWYRAPEvLLrs~~ 186 (538)
T KOG0661|consen 161 RSKP--PYTEYVSTRWYRAPEVLLRSGY 186 (538)
T ss_pred ccCC--CcchhhhcccccchHHhhhccc
Confidence 6433 3556788999999999987543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=249.42 Aligned_cols=171 Identities=30% Similarity=0.439 Sum_probs=141.6
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHH--HHHHHhcCCCCccccccceEEeC----CEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRV--EVEAIGHVRHKNLVRLLGYCIEG----TQRI 246 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~--E~~~l~~l~HpnIv~l~~~~~~~----~~~~ 246 (358)
..+..+.+.||+|.||+||+|.| .|..||||.+.... ...+.+ ||.....|+|+||+.+++.-..+ +++|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 35677889999999999999999 68889999985442 233444 44445567999999999876543 5789
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeeCCCCCCcEEEcCCCcEEEeee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA-----IEPKVVHRDIKSSNILIDENFDAKISDF 321 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~ivHrDlk~~NiLl~~~~~~kl~DF 321 (358)
||.+|.+.|||+|||.. ..++.+..++++..+|.||++||.. ..|.|.|||||+.|||+.+++.+.|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 99999999999999963 4588899999999999999999953 3678999999999999999999999999
Q ss_pred cCceecCCCCce---eeeecccccCCchhhhccC
Q 018311 322 GLAKLLGAGKSH---ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 322 Gla~~~~~~~~~---~~~~~~Gt~~y~APE~l~~ 352 (358)
|||......... ..+..+||-.|||||++..
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhh
Confidence 999886554332 3466899999999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=258.00 Aligned_cols=176 Identities=23% Similarity=0.303 Sum_probs=149.4
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||+||+|.. .+++.||+|.+.... ......+..|+.++..++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3688899999999999999975 468899999986432 222345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999974 35688999999999999999999999 999999999999999999999999999986532
Q ss_pred CCc----------------------------------eeeeecccccCCchhhhccCCCcc
Q 018311 330 GKS----------------------------------HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~----------------------------------~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
... ......+||+.|+|||++.+.+|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~ 214 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN 214 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC
Confidence 110 011245899999999999888763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=254.03 Aligned_cols=169 Identities=27% Similarity=0.439 Sum_probs=146.9
Q ss_pred cceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCC
Q 018311 179 DNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (358)
.++||.|.||+||-|++ ++|+.||||.+.+.. .+....++.|+.||+++.||.||.+...|++.+..++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 48999999999999965 679999999986543 344467889999999999999999999999999999999999 66
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc---CCCcEEEeeecCceecCCCCc
Q 018311 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID---ENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 256 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~---~~~~~kl~DFGla~~~~~~~~ 332 (358)
|+.+.+... ..++|++.....++.||+.||.|||.+ +|+|+||||+|||+. ...++||||||+||+++....
T Consensus 648 DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 648 DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 776665432 557799999999999999999999999 999999999999995 446899999999999986543
Q ss_pred eeeeecccccCCchhhhccCCCc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
...++|||.|+|||+++++.|
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGy 743 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGY 743 (888)
T ss_pred --hhhhcCCccccCHHHHhhccc
Confidence 456899999999999999876
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=257.29 Aligned_cols=178 Identities=21% Similarity=0.246 Sum_probs=152.0
Q ss_pred HHHhcCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCE
Q 018311 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 169 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 244 (358)
+....++|++.+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|+.++..++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3344578999999999999999999864 57899999885421 2223457789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999999863 2378889999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCC
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
+.+............||+.|+|||++.+.+
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 219 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQG 219 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccC
Confidence 987544333345678999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=243.55 Aligned_cols=176 Identities=25% Similarity=0.345 Sum_probs=148.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCc-cccccceEEeCC------
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKN-LVRLLGYCIEGT------ 243 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~------ 243 (358)
..|+..++||+|+||+||+|+. .+|+.||+|++.-.... ......+|+.++.+|+|+| |+.+++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4466678899999999999964 67899999999755432 2345678999999999999 999999999877
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
.+++|+||+ .-||..++.........++...+..+..|++.||.|||++ +|+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 789999999 5599999986432213477788999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCCC
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
|+.+.-... ..+..++|..|.|||++.|..
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~ 196 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGST 196 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCC
Confidence 998763222 255678899999999999973
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=245.84 Aligned_cols=173 Identities=25% Similarity=0.341 Sum_probs=151.2
Q ss_pred CCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCC-CCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNN-PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
..|++.++||.|..++||+|. ...+..||||++.-. .....+.+++|+..|..++||||++++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 678999999999999999996 466799999998533 344468899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
|.+|++.++++.... .-+.+..+..|.++++.||.|||++ |.||||||+.||||+.+|.+||+|||....+....
T Consensus 106 Ma~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999986533 3389999999999999999999999 99999999999999999999999999877665433
Q ss_pred ce---eeeecccccCCchhhhcc
Q 018311 332 SH---ITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 332 ~~---~~~~~~Gt~~y~APE~l~ 351 (358)
.. ..+++.||+.|||||++.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~ 203 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLM 203 (516)
T ss_pred ceeeEeeccccCcccccChHHhh
Confidence 22 225679999999999953
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=263.72 Aligned_cols=177 Identities=29% Similarity=0.492 Sum_probs=153.1
Q ss_pred CCCcccceecCCccEEEEEEEEe----CCcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
+...+.++||.|.||+|++|.++ ....||||.|+....+ .+.+|+.|..||.++.||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 45677899999999999999763 3457999999877644 446899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
.|||++|+|..||+++ .+.+++.+..-++++||.||+||.+. +.|||||.++|||+|.+..+|++||||+|.+.
T Consensus 709 TEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999974 35688999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCceeeeecccc--cCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGT--FGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt--~~y~APE~l~~~~~~ 356 (358)
++.....+..-|. ..|.|||.+.-..+|
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFT 812 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFT 812 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccC
Confidence 6553334444443 589999999866543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=258.95 Aligned_cols=175 Identities=26% Similarity=0.402 Sum_probs=145.2
Q ss_pred CCCcccceecCCccEEEEEEEEeC--C--cE-EEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN--G--TA-VAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~--~--~~-vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 245 (358)
++....++||+|+||+||+|++.. + .. ||+|..+... ....++|..|.++|++++|||||+++|++....++
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 455667999999999999997643 2 23 8999887422 34557899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
++|||+|+||+|.++|++. ...++..+...++.+.|.||+|||++ +++||||.++|||++.++.+||+||||++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999863 33589999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.-. .........--...|+|||.+...-|
T Consensus 311 ~~~-~~~~~~~~~klPirWLAPEtl~~~~~ 339 (474)
T KOG0194|consen 311 AGS-QYVMKKFLKKLPIRWLAPETLNTGIF 339 (474)
T ss_pred CCc-ceeeccccccCcceecChhhhccCcc
Confidence 743 11111111223578999999987644
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=256.00 Aligned_cols=175 Identities=25% Similarity=0.324 Sum_probs=148.8
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|+. .+++.||+|.+.... ......+..|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3688899999999999999976 468899999986432 223355778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999874 34589999999999999999999999 999999999999999999999999999986542
Q ss_pred CCce-------------------------------------eeeecccccCCchhhhccCCCc
Q 018311 330 GKSH-------------------------------------ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 330 ~~~~-------------------------------------~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.... .....+||+.|+|||++.+..|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC
Confidence 2110 0112469999999999988765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=250.96 Aligned_cols=175 Identities=28% Similarity=0.381 Sum_probs=145.9
Q ss_pred HhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--------------cchHHHHHHHHHHhcCCCCccccc
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--------------QADKDFRVEVEAIGHVRHKNLVRL 235 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~HpnIv~l 235 (358)
...|+|++.+.||+|.||.|.+|.. .+++.||+|.+.+... ...+...+||.+|++|.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3458899999999999999999965 5789999998844321 112467889999999999999999
Q ss_pred cceEEeC--CEEEEEEeecCCCCHHHHHhcccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC
Q 018311 236 LGYCIEG--TQRILVYEYVNNGNLEQWLRGDMCDRGY-LTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE 312 (358)
Q Consensus 236 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~ 312 (358)
+.+..++ +.+|||+|||..|.+...- ..+. +++.++++++.++..||+|||.+ +||||||||.|+||++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 9998764 6799999999998875421 3344 89999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeecCceecCCCC----ceeeeecccccCCchhhhccCC
Q 018311 313 NFDAKISDFGLAKLLGAGK----SHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 313 ~~~~kl~DFGla~~~~~~~----~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+|++||+|||.+.....+. .....+.+|||.|+|||+..++
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~ 290 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGG 290 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCC
Confidence 9999999999998763321 1233458999999999999884
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=251.62 Aligned_cols=172 Identities=22% Similarity=0.306 Sum_probs=150.5
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999764 68899999986432 223456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999874 34588899999999999999999999 999999999999999999999999999988754
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. ....||+.|+|||++.+.++.
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~ 193 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHG 193 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCC
Confidence 32 246899999999999887653
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=254.43 Aligned_cols=188 Identities=26% Similarity=0.298 Sum_probs=160.2
Q ss_pred cchHhhHHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccce
Q 018311 163 WFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGY 238 (358)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 238 (358)
|-.++......+.|+.-++||+|+||+||-|+. .+|+.+|.|++.+.. .+.......|-.+|.+++.+.||.+-..
T Consensus 174 WK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 174 WKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred HHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 334444455567788899999999999999975 579999999885432 2223445679999999999999999999
Q ss_pred EEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEE
Q 018311 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318 (358)
Q Consensus 239 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl 318 (358)
|.+++.+|+||..|+||||.-.|.+. ....+++..++.++.+|+.||++||.. +||+|||||+|||||++|+++|
T Consensus 254 feTkd~LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 254 FETKDALCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred ecCCCceEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEe
Confidence 99999999999999999998877654 335699999999999999999999999 9999999999999999999999
Q ss_pred eeecCceecCCCCceeeeecccccCCchhhhccCCCccc
Q 018311 319 SDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPILV 357 (358)
Q Consensus 319 ~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~ 357 (358)
+|+|||..+..+... ...+||.+|||||++.++.|++
T Consensus 329 SDLGLAvei~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~ 365 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKPI--RGRVGTVGYMAPEVLQNEVYDF 365 (591)
T ss_pred eccceEEecCCCCcc--ccccCcccccCHHHHcCCcccC
Confidence 999999998766542 3349999999999999999874
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=253.00 Aligned_cols=174 Identities=27% Similarity=0.380 Sum_probs=154.8
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc---chHHHHHHHHHHhcCC-CCccccccceEEeCCEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 247 (358)
...|++.+.||+|.||.||+|... +|+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+.+.|++.+..++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 367888999999999999999764 4999999999765543 3357899999999998 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC----CCcEEEeeecC
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE----NFDAKISDFGL 323 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~----~~~~kl~DFGl 323 (358)
|||++.||+|++.+... .+++.++..++.|++.++.|||+. +++||||||+|+|+.. ++.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999754 289999999999999999999998 9999999999999853 35799999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+..... .......+||+.|+|||++.+.+|.
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~ 216 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYG 216 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCC
Confidence 999876 3457789999999999999988874
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=247.23 Aligned_cols=172 Identities=24% Similarity=0.315 Sum_probs=149.3
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999764 68899999985432 123356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++.. .+.+++.....++.|++.||.|||++ +++||||||+|||+++++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999974 34588899999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. .....||+.|+|||++.+..+.
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~ 176 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHN 176 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCC
Confidence 2 2345799999999999887653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=253.37 Aligned_cols=181 Identities=26% Similarity=0.378 Sum_probs=147.3
Q ss_pred cCCCcccceecCCccEEEEEEEE------eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeC-C
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG-T 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~ 243 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+..|+.++..+ +||||+++++++... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 36789999999999999999964 2356899999865432 2345688999999999 899999999988764 4
Q ss_pred EEEEEEeecCCCCHHHHHhcccC---------------------------------------------------------
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMC--------------------------------------------------------- 266 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 266 (358)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 58999999999999999874311
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce-eeeecccccCC
Q 018311 267 -DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGD 344 (358)
Q Consensus 267 -~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y 344 (358)
....+++.....++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.+...... ......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 013477888999999999999999998 9999999999999999999999999999876433222 22334567899
Q ss_pred chhhhccCCCcc
Q 018311 345 FSVTLLRNMPIL 356 (358)
Q Consensus 345 ~APE~l~~~~~~ 356 (358)
+|||++.+.+|+
T Consensus 243 ~aPE~~~~~~~~ 254 (338)
T cd05102 243 MAPESIFDKVYT 254 (338)
T ss_pred cCcHHhhcCCCC
Confidence 999999887764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=256.15 Aligned_cols=146 Identities=23% Similarity=0.289 Sum_probs=129.6
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.|+..+.||+|+||+||+|.. .+++.||+|.+.... ......+..|++++..++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999975 567899999986432 2233568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999999874 34588889999999999999999998 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=255.44 Aligned_cols=146 Identities=26% Similarity=0.342 Sum_probs=129.8
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+..|++++.+++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999975 578899999885432 223356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999873 34588899999999999999999999 999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=251.67 Aligned_cols=171 Identities=24% Similarity=0.318 Sum_probs=148.6
Q ss_pred CCCcccceecCCccEEEEEEEEeC--CcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN--GTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.+.||+|+||.||+|.... +..||+|.+.... ....+.+..|+.++..++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 568889999999999999997543 3689999885432 22345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 110 ~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999974 34588999999999999999999999 99999999999999999999999999998864
Q ss_pred CCCceeeeecccccCCchhhhccCCCc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.. .....||+.|+|||++.+..+
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~ 205 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGH 205 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCC
Confidence 32 235689999999999988765
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=254.56 Aligned_cols=176 Identities=22% Similarity=0.282 Sum_probs=147.6
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++..++||||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688899999999999999975 468899999885432 123356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++.+ .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999974 34578888899999999999999999 999999999999999999999999999854310
Q ss_pred CC------------------------------------------ceeeeecccccCCchhhhccCCCcc
Q 018311 330 GK------------------------------------------SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~------------------------------------------~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. ........||+.|+|||++.+.++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 00 0001235799999999999988764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=250.75 Aligned_cols=172 Identities=27% Similarity=0.372 Sum_probs=150.3
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+..|++++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999874 58899999986432 223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999963 34588999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......||+.|+|||++.+..+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~ 176 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYD 176 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCC
Confidence 23456899999999999987653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=253.22 Aligned_cols=180 Identities=26% Similarity=0.469 Sum_probs=150.9
Q ss_pred hHhhHHHhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeC
Q 018311 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG 242 (358)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 242 (358)
...++....+.+.+.+.||+|.||+||+|.|- | .||||.+..... ...+.|+.|+..+++-+|.||+-+.|+|..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34556666677888999999999999999984 3 489999865443 3447899999999999999999999999987
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
.. .+|+.+|+|-+|..+|+. .+..+...+...|+.|||+||.|||.+ +|||||||..||++.+++.|||+|||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred ce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence 76 999999999999999985 345588888999999999999999999 99999999999999999999999999
Q ss_pred CceecCC-CCceeeeecccccCCchhhhccCC
Q 018311 323 LAKLLGA-GKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 323 la~~~~~-~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
|+..-.- ..........|...|||||+++.+
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmq 565 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQ 565 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhc
Confidence 9865321 112234456788999999999743
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=246.04 Aligned_cols=180 Identities=28% Similarity=0.452 Sum_probs=149.7
Q ss_pred CCCcccceecCCccEEEEEEEEeC-----------------CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccc
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-----------------GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRL 235 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-----------------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l 235 (358)
++|++.+.||+|+||.||+|.+.+ +..||+|.+..... ....++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 678889999999999999997532 34699998865432 234678899999999999999999
Q ss_pred cceEEeCCEEEEEEeecCCCCHHHHHhcccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 018311 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMC---------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300 (358)
Q Consensus 236 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH 300 (358)
++++.+.+..+++|||+++|+|.+++..... ....+++.....++.|++.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 9999999999999999999999999864321 113467888999999999999999998 9999
Q ss_pred CCCCCCcEEEcCCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 301 RDIKSSNILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 301 rDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
|||||+|||+++++.+||+|||+++.+...... ......++..|+|||++.+.++.
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 218 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT 218 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC
Confidence 999999999999999999999999887554332 23445668899999998876653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=255.60 Aligned_cols=145 Identities=24% Similarity=0.332 Sum_probs=128.9
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
+|+..+.||+|+||+||+|.. .+++.||+|.+.... ......+..|+++++.++||||+++++.+.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578899999999999999975 568899999986432 1223567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
|+++|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 9999999999874 24578889999999999999999999 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=248.64 Aligned_cols=169 Identities=25% Similarity=0.259 Sum_probs=144.6
Q ss_pred ceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCC
Q 018311 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (358)
+.||+|+||.||+|.. .+|+.||+|.+.... ......+..|+.++.+++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999975 578899999986432 223345778999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceee
Q 018311 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335 (358)
Q Consensus 256 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 335 (358)
+|.+++.. .+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 99998873 34688999999999999999999999 99999999999999999999999999998643221 223
Q ss_pred eecccccCCchhhhccCCCcc
Q 018311 336 TRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 336 ~~~~Gt~~y~APE~l~~~~~~ 356 (358)
....||+.|+|||++.+.+|.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~ 173 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYG 173 (323)
T ss_pred cceecCccccChhhhcCCCCC
Confidence 456899999999999887653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-33 Score=240.94 Aligned_cols=174 Identities=25% Similarity=0.384 Sum_probs=150.0
Q ss_pred cCCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCC--CCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNN--PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
.+.|++.++||+|.|+.||+|. ..+|+.+|+|.+... .....+++.+|++|.+.|+||||+++...+......|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3568888999999999999994 467889998876422 2335578899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc---CCCcEEEeeecCcee
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID---ENFDAKISDFGLAKL 326 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~---~~~~~kl~DFGla~~ 326 (358)
|+|.|++|..-+.++ -.+++..+-.+..||+.+|.|+|.+ +|||||+||+|+|+- ..--+||+|||+|..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999998766533 3467788889999999999999999 999999999999994 344699999999999
Q ss_pred cCCCCceeeeecccccCCchhhhccCCCc
Q 018311 327 LGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 327 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+. +......++|||+|||||+++..||
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy 189 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPY 189 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCC
Confidence 98 3345667899999999999999998
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=247.96 Aligned_cols=173 Identities=25% Similarity=0.280 Sum_probs=148.5
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC---CCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||++.. .+++.||+|.+... .....+.+..|+.++..++|+||+.+++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999976 45889999998532 1223355788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++.+. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999642 34588999999999999999999999 999999999999999999999999999987755
Q ss_pred CCceeeeecccccCCchhhhccC
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
..........||+.|+|||++.+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQA 177 (331)
T ss_pred CCCccccceeccccccCHHHHhh
Confidence 43333344579999999999973
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=241.92 Aligned_cols=174 Identities=24% Similarity=0.306 Sum_probs=148.6
Q ss_pred CcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++.+++|+||+.+++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66788999999999999975 578999999886432 12234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999887542 233588999999999999999999999 99999999999999999999999999998864332
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......||+.|+|||++.+..|.
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~ 179 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYT 179 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCC
Confidence 23456799999999999987764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=245.01 Aligned_cols=169 Identities=30% Similarity=0.408 Sum_probs=139.5
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCC-----EEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-----QRILV 248 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~lv 248 (358)
.|+..+++|.|+||.||+|.. .+++.||||++..+..- -.+|+++|+.+.|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 355678999999999999976 45789999998655432 235899999999999999998887532 23579
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-CcEEEeeecCceec
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLL 327 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~-~~~kl~DFGla~~~ 327 (358)
||||+. +|.++++.....+..++...+.-+..|+.+||.|||+. +|+||||||+|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999965 99998875433455677778888999999999999998 99999999999999976 99999999999999
Q ss_pred CCCCceeeeecccccCCchhhhccCC
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
-.+.... ...-|..|.|||++.|.
T Consensus 177 ~~~epni--SYicSRyYRaPELifga 200 (364)
T KOG0658|consen 177 VKGEPNI--SYICSRYYRAPELIFGA 200 (364)
T ss_pred ccCCCce--eEEEeccccCHHHHcCc
Confidence 8766543 34668899999999885
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=252.59 Aligned_cols=180 Identities=21% Similarity=0.249 Sum_probs=152.8
Q ss_pred hhHHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeC
Q 018311 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG 242 (358)
Q Consensus 167 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 242 (358)
.++....++|++.+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|+.++..++||||+++++.+.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 34445568899999999999999999976 467889999885321 12234577899999999999999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
+..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999999863 2377888899999999999999999 99999999999999999999999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCCC
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
+++.+............||+.|+|||++.+.+
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 219 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccC
Confidence 99987644333345678999999999998653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=253.11 Aligned_cols=174 Identities=22% Similarity=0.254 Sum_probs=149.3
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
.++|++.+.||+|+||.||+|+. .+++.||+|.+.... ......+..|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 46789999999999999999976 468899999985421 22234577899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 122 ~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 122 MEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999998863 2477888999999999999999998 99999999999999999999999999998875
Q ss_pred CCCceeeeecccccCCchhhhccCCC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
...........||+.|+|||++.+.+
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~ 219 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQG 219 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCC
Confidence 44333334568999999999997653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=259.44 Aligned_cols=180 Identities=18% Similarity=0.234 Sum_probs=152.9
Q ss_pred CCCcccceecCCccEEEEEEEEe-C-CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-N-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
..|.+.+.||+|+||.||+|... + +..|++|.+..........+..|+.+++.++||||+++++++..++..|+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34788899999999999999653 3 577888877554444445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999998865433455688999999999999999999998 99999999999999999999999999999875432
Q ss_pred c-eeeeecccccCCchhhhccCCCcc
Q 018311 332 S-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. ......+||+.|+|||++.+.++.
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~ 249 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYS 249 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCC
Confidence 2 234456799999999999887764
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=246.96 Aligned_cols=173 Identities=23% Similarity=0.251 Sum_probs=148.4
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+++. .+++.||+|.+.... ......+..|+.++..++|+||+.+++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999976 467889999885421 222345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999742 34588899999999999999999998 999999999999999999999999999988765
Q ss_pred CCceeeeecccccCCchhhhccC
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
..........||+.|+|||++.+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQA 177 (331)
T ss_pred CCceeeccccCCcccCCHHHHhc
Confidence 44333345679999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=246.94 Aligned_cols=173 Identities=26% Similarity=0.314 Sum_probs=147.7
Q ss_pred CCcccceecCCccEEEEEEEE----eCCcEEEEEEecCCC----CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 245 (358)
+|++.+.||+|+||.||+++. .+++.||+|.+.+.. ....+.+..|+.++..+ +||||+.+++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999965 357899999885432 22235577899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999863 34588999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCceeeeecccccCCchhhhccCCC
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.+............||+.|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 182 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKG 182 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCC
Confidence 76544433444578999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=250.09 Aligned_cols=175 Identities=23% Similarity=0.308 Sum_probs=148.7
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
+|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+..|+.++..++||||+++++.+.+.+..|+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 578889999999999999976 468899999986432 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++|+|.+++.+ ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 82 FLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred CCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999873 34588999999999999999999999 9999999999999999999999999998765321
Q ss_pred Cc----------------------------------eeeeecccccCCchhhhccCCCcc
Q 018311 331 KS----------------------------------HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~----------------------------------~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. ......+||+.|+|||++.+.+|.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~ 214 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN 214 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC
Confidence 10 011245799999999999988764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=249.12 Aligned_cols=176 Identities=27% Similarity=0.350 Sum_probs=152.2
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+..|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999764 68999999986432 233456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999743 5688999999999999999999998 999999999999999999999999999987654
Q ss_pred CC----------------------------ceeeeecccccCCchhhhccCCCcc
Q 018311 330 GK----------------------------SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~----------------------------~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. ........||+.|+|||++.+..++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 208 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG 208 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC
Confidence 33 1123346799999999999988654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=245.90 Aligned_cols=173 Identities=24% Similarity=0.267 Sum_probs=150.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688899999999999999975 468899999986432 223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999753 24588999999999999999999999 999999999999999999999999999998765
Q ss_pred CCceeeeecccccCCchhhhccC
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
..........||+.|+|||++.+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~ 177 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTT 177 (330)
T ss_pred CCceeeecccCCccccCHHHhcc
Confidence 54434445689999999999873
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=245.49 Aligned_cols=168 Identities=26% Similarity=0.282 Sum_probs=144.1
Q ss_pred ceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCC
Q 018311 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (358)
+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999975 568999999986432 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceee
Q 018311 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335 (358)
Q Consensus 256 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 335 (358)
+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 99998863 34588999999999999999999999 99999999999999999999999999998643221 223
Q ss_pred eecccccCCchhhhccCCCc
Q 018311 336 TRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 336 ~~~~Gt~~y~APE~l~~~~~ 355 (358)
....||+.|+|||++.+..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~ 172 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDY 172 (328)
T ss_pred ccccCCcCccChhhhcCCCC
Confidence 45689999999999987765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=245.66 Aligned_cols=168 Identities=27% Similarity=0.271 Sum_probs=143.6
Q ss_pred ceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCC
Q 018311 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (358)
+.||+|+||.||++.. .+|+.||+|.+.... ......+..|++++..++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999975 468999999986432 223345678999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceee
Q 018311 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335 (358)
Q Consensus 256 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 335 (358)
+|..++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 99988863 34588999999999999999999999 99999999999999999999999999988643222 123
Q ss_pred eecccccCCchhhhccCCCc
Q 018311 336 TRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 336 ~~~~Gt~~y~APE~l~~~~~ 355 (358)
....||+.|+|||++.+.++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~ 172 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDY 172 (323)
T ss_pred ccccCCcCcCCcccccCCCC
Confidence 34679999999999988765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=243.81 Aligned_cols=167 Identities=25% Similarity=0.248 Sum_probs=143.6
Q ss_pred ecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCH
Q 018311 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (358)
Q Consensus 182 lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL 257 (358)
||+|+||.||+|.. .+++.||+|.+.... ......+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999976 457899999986432 22345677899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeee
Q 018311 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337 (358)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 337 (358)
.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 999974 34588999999999999999999998 99999999999999999999999999998643322 23445
Q ss_pred cccccCCchhhhccCCCcc
Q 018311 338 VMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 338 ~~Gt~~y~APE~l~~~~~~ 356 (358)
..||+.|+|||++.+.+|.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~ 171 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYT 171 (312)
T ss_pred ccCCcccCCHHHHcCCCCC
Confidence 6899999999999887653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=243.07 Aligned_cols=168 Identities=25% Similarity=0.263 Sum_probs=142.8
Q ss_pred ceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCC
Q 018311 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (358)
+.||+|+||.||+|.. .+++.||+|.+.... ......+..|++++..++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999975 578899999986432 223355678999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 256 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
+|..++.. ...+++..+..++.|++.||.|||+ . +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 99998863 3458899999999999999999997 6 999999999999999999999999999986432221 2
Q ss_pred eeecccccCCchhhhccCCCc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.....||+.|+|||++.+..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~ 173 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDY 173 (325)
T ss_pred cccccCCcccCCHHHHccCCC
Confidence 334679999999999988765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=251.03 Aligned_cols=177 Identities=25% Similarity=0.397 Sum_probs=155.7
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCE-EEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ-RILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-~~lv~ 249 (358)
++|..++++|+|+||.++.+++ .+++.+++|++.-.. .........|+.++++++|||||.+.+.|..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5688899999999999999965 457789999885443 2333467889999999999999999999998888 99999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
+|++||+|.+.+.+.. ...++++....++.|++.|+.|||+. +|+|||||+.||+++.+..+||.|||+|+.+.+
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999997643 35588899999999999999999988 999999999999999999999999999999987
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. ....+.+||+.||+||++.+.||=
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn 184 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYN 184 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCC
Confidence 65 245678999999999999999983
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=238.65 Aligned_cols=176 Identities=28% Similarity=0.368 Sum_probs=149.5
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++..++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999874 57889999986543 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|++++.+..+.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 998877665443 234588999999999999999999998 9999999999999999999999999999887544
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.........||+.|+|||++.+.++.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~ 179 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYG 179 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCC
Confidence 33333456799999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=235.51 Aligned_cols=172 Identities=27% Similarity=0.423 Sum_probs=150.1
Q ss_pred HhcCCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCCC----cch----HHHHHHHHHHhcC-CCCccccccceEE
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG----QAD----KDFRVEVEAIGHV-RHKNLVRLLGYCI 240 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~----~~~----~~~~~E~~~l~~l-~HpnIv~l~~~~~ 240 (358)
...++|...+.||.|..+.|.+|. ..+|+..|+|++..... ... +.-.+|+.+|+++ .||+|+.+.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 445778888999999999999985 46788999998853321 112 3345799999998 6999999999999
Q ss_pred eCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 018311 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISD 320 (358)
Q Consensus 241 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~D 320 (358)
.+...++|+|.|+.|.|+++|. ..-.++++...+|..|+..|++|||.. +||||||||+|||++++.++||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 9999999999999999999997 345689999999999999999999999 999999999999999999999999
Q ss_pred ecCceecCCCCceeeeecccccCCchhhhcc
Q 018311 321 FGLAKLLGAGKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 321 FGla~~~~~~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
||+|+.+.++.. ....+|||+|+|||.+.
T Consensus 167 FGFa~~l~~Gek--LrelCGTPgYLAPEtik 195 (411)
T KOG0599|consen 167 FGFACQLEPGEK--LRELCGTPGYLAPETIK 195 (411)
T ss_pred cceeeccCCchh--HHHhcCCCcccChhhee
Confidence 999999988764 55689999999999875
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=248.74 Aligned_cols=175 Identities=27% Similarity=0.384 Sum_probs=153.9
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
..|+..+.||+|.||.||+|.. .+++.||+|.+.-.. .....++++|+.+|..++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4577789999999999999965 678899999986443 44567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
|.+|++.+.|+ ....+.+....-+..++..|+.|||.+ +.+|||||+.|||+..+|.+||+|||.+..+....
T Consensus 93 ~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999987 334457777888999999999999999 99999999999999999999999999999886544
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. ...+++|||.|||||++++..|.
T Consensus 166 ~-rr~tfvGTPfwMAPEVI~~~~Y~ 189 (467)
T KOG0201|consen 166 K-RRKTFVGTPFWMAPEVIKQSGYD 189 (467)
T ss_pred h-ccccccccccccchhhhcccccc
Confidence 3 33789999999999999987774
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=254.29 Aligned_cols=163 Identities=30% Similarity=0.468 Sum_probs=144.2
Q ss_pred CcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCC
Q 018311 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (358)
+..++-||.|+.|.||+|++ .++.||||+++.. -..+|+-|++|+||||+.|.|+|.+..-+|||||||+.|
T Consensus 126 IsELeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 34467799999999999998 4678999987432 234788999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceee
Q 018311 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335 (358)
Q Consensus 256 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 335 (358)
-|...|+ ....++......+..+||.||.|||.+ .|||||||.-||||..+..+||+|||.++.+... ..+
T Consensus 198 qL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STk 268 (904)
T KOG4721|consen 198 QLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STK 268 (904)
T ss_pred cHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhh
Confidence 9999998 445688899999999999999999999 9999999999999999999999999999987643 234
Q ss_pred eecccccCCchhhhccCCCc
Q 018311 336 TRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 336 ~~~~Gt~~y~APE~l~~~~~ 355 (358)
-.++||..|||||+++++|.
T Consensus 269 MSFaGTVaWMAPEvIrnePc 288 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPC 288 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCc
Confidence 45899999999999999984
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=269.73 Aligned_cols=179 Identities=28% Similarity=0.443 Sum_probs=152.8
Q ss_pred CCCcccceecCCccEEEEEEEEeC--Cc----EEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN--GT----AVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~--~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
.+.+..+.||+|.||+||.|...+ +. .||+|.+.+... +...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445667899999999999997643 33 499999976653 45578999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 247 LVYEYVNNGNLEQWLRGDMC---DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
+++|||++|||..||++.+. ....++..+.+.++.+||+|+.||+++ ++|||||.++||||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987532 245688899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeeec-ccccCCchhhhccCCCc
Q 018311 324 AKLLGAGKSHITTRV-MGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 324 a~~~~~~~~~~~~~~-~Gt~~y~APE~l~~~~~ 355 (358)
||++........... .-...|||||.++..-+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF 881 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF 881 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhccc
Confidence 998876665444333 44579999999986443
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=244.36 Aligned_cols=172 Identities=25% Similarity=0.268 Sum_probs=147.1
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||++... +++.+|+|.+.+.. ......+..|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999764 57789999885321 122345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++.+. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999742 34588899999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeeeecccccCCchhhhcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
..........||+.|+|||++.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred CCcceecccccCccccCHHHHh
Confidence 4333344568999999999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=249.40 Aligned_cols=170 Identities=22% Similarity=0.250 Sum_probs=146.7
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|... ...+.+|++++++++||||+++++++......++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 36799999999999999999975 568899999643 23567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+ .++|..++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 165 ~-~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 Y-KTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred C-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 9 5799988863 34588999999999999999999998 99999999999999999999999999997654322
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
........||+.|+|||++.+.+|.
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~ 261 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYG 261 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCC
Confidence 2234457899999999999988764
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=242.43 Aligned_cols=168 Identities=27% Similarity=0.385 Sum_probs=142.7
Q ss_pred ceecCCccEEEEEEEE----eCCcEEEEEEecCCC----CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 180 NIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+.||+|+||.||+++. .+++.||+|.+.... ......+..|+.++..++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 357899999986432 12234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++|+|.+++.. .+.+.+..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999873 34578888899999999999999999 99999999999999999999999999998643322
Q ss_pred ceeeeecccccCCchhhhccCCCc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
. ......||+.|+|||++.+.++
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~ 177 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGH 177 (323)
T ss_pred C-cccccCCCccccChhhccCCCC
Confidence 1 2334679999999999987764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=238.63 Aligned_cols=147 Identities=27% Similarity=0.280 Sum_probs=131.4
Q ss_pred CCCcccceecCCccEEEEEEEEeC-CcEEEEEEecCCCCc---chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
+.|++++.||+|.-|+||+|+..+ +..+|+|.+.+..-. ...+.+.|-+||+.++||.++.||+.++.+...|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 557788999999999999998754 588999998655432 3345677999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
|||+||||..++++. ..+.+++..+..++.+|+.||+|||.. |||+|||||+||||.++|++.|+||.|+.
T Consensus 157 eyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred ecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence 999999999988764 556799999999999999999999999 99999999999999999999999999974
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=241.24 Aligned_cols=174 Identities=23% Similarity=0.266 Sum_probs=146.0
Q ss_pred CCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCC-ccccccceEEeCCEEEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHK-NLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lv~ 249 (358)
+|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|.+++..++|+ +|+.+++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999764 57889999986432 22345677899999999765 5888999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998863 34588999999999999999999998 999999999999999999999999999876432
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
... ......||+.|+|||++.+.++.
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~ 179 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYG 179 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCC
Confidence 221 23456799999999999988763
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=240.33 Aligned_cols=172 Identities=27% Similarity=0.410 Sum_probs=152.7
Q ss_pred CCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
-|.+.++||+|+||.||+|. ..+|+.+|+|++.. ....+++..|+.++++++.|++|++||.|.....+|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 35667899999999999995 46799999998743 3456788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
.|+..+.++. .++.|++.+...++...+.||+|||.. .-+|||||+.|||++.+|.+||+|||.|-.+.+...
T Consensus 112 AGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 112 AGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred CCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 9999999875 457799999999999999999999998 899999999999999999999999999988754322
Q ss_pred eeeecccccCCchhhhccCCCc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
..+++.|||.|||||+++.-.|
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY 206 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGY 206 (502)
T ss_pred hhCccccCcccccHHHHHHhcc
Confidence 3467899999999999987665
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=240.92 Aligned_cols=169 Identities=23% Similarity=0.314 Sum_probs=141.4
Q ss_pred ceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhc-CCCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGH-VRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
++||+|+||.||+|+. .+++.||+|.++... ....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999976 457889999986432 2223445567777765 4899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999998874 34588899999999999999999998 99999999999999999999999999998754322 23
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+.+++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYN 174 (316)
T ss_pred cccccCCccccCHHHHcCCCCC
Confidence 4457899999999999987753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=247.29 Aligned_cols=180 Identities=26% Similarity=0.363 Sum_probs=148.6
Q ss_pred CCCcccceecCCccEEEEEEEE------eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 245 (358)
++|++.+.||+|+||.||+|.+ .++..||+|+++... ....+.+.+|++++..+ +||||++++++|...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 5788899999999999999964 245689999986443 23345688899999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccC-----------------------------------------------------------
Q 018311 246 ILVYEYVNNGNLEQWLRGDMC----------------------------------------------------------- 266 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 266 (358)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999864321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce-
Q 018311 267 ------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH- 333 (358)
Q Consensus 267 ------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~- 333 (358)
....+++.....++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.+......
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 012478888999999999999999998 9999999999999999999999999999887543321
Q ss_pred eeeecccccCCchhhhccCCCcc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......++..|+|||++.+.+++
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~ 294 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYT 294 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCC
Confidence 22234456789999999887764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=247.58 Aligned_cols=176 Identities=25% Similarity=0.375 Sum_probs=156.2
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
...|.+.+.||+|.|+.|.++.+ .++..||+|.+.+..-. ....+.+|+++|..|+|||||+++.+...+..+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 36688899999999999999975 56899999988665432 2244788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+.+|++++||.++ +.+.+..+..++.|+.+|++|||++ .|||||||++|+||+.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999854 4566788999999999999999999 999999999999999999999999999998863
Q ss_pred CCceeeeecccccCCchhhhccCCCccc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPILV 357 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~ 357 (358)
.....+.+|++.|.|||++.|..|..
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~g 233 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDG 233 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCC
Confidence 34566789999999999999999875
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=236.86 Aligned_cols=174 Identities=26% Similarity=0.282 Sum_probs=151.0
Q ss_pred CCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCCCcchHH---HHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~---~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|..+++||+|.||.|-+|+ ..+++.+|+|.+++..-...++ -..|-++|...+||.+..+-..|...+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 668889999999999999995 5679999999997665444443 346899999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||..||.|+-.|.. ...+++.....+...|+.||.|||++ +||.||||.+|+|+|++|++||+||||++.--
T Consensus 248 eyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 248 EYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999988863 34588888889999999999999999 99999999999999999999999999998732
Q ss_pred CCceeeeecccccCCchhhhccCCCc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.....+.+++|||.|+|||++..--|
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDY 345 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDY 345 (516)
T ss_pred cccceeccccCChhhcCchhhccccc
Confidence 33445778999999999999986544
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=241.16 Aligned_cols=169 Identities=24% Similarity=0.274 Sum_probs=143.7
Q ss_pred ceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
++||+|+||.||+|+. .+++.||+|.++... ....+.+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999976 468899999986532 22335577899999888 799999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|.+++.. .+.+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 999998863 34689999999999999999999999 9999999999999999999999999999753221 122
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~ 174 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYG 174 (329)
T ss_pred cccccCCccccCHHHHcCCCCC
Confidence 3457899999999999987754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=237.03 Aligned_cols=173 Identities=27% Similarity=0.395 Sum_probs=146.4
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 67999999999999999999864 688999999864432 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
++ ++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 85 VH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 94 7888888642 34588899999999999999999999 99999999999999999999999999998654322
Q ss_pred ceeeeecccccCCchhhhccCCC
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.......||+.|+|||++.+..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~ 179 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGST 179 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCC
Confidence 1233467899999999987643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=240.08 Aligned_cols=174 Identities=24% Similarity=0.330 Sum_probs=150.7
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||.||++... ++..+|+|.+..... ...+.+.+|++++..++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 68999999999999999999764 678899998865432 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++|+|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 85 MDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999974 245888999999999999999999852 6999999999999999999999999999876432
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......||+.|+|||++.+.+++
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~ 180 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYS 180 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCC
Confidence 23456799999999999987764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=235.07 Aligned_cols=171 Identities=27% Similarity=0.303 Sum_probs=145.2
Q ss_pred ecCCccEEEEEEEE-eCCcEEEEEEecCCCCc---chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCH
Q 018311 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (358)
Q Consensus 182 lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL 257 (358)
||+|+||+||+|.. .+++.+|+|.+...... ..+.+..|+++++.++||||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999975 46889999998643221 224567899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeee
Q 018311 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337 (358)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 337 (358)
.+++.........+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.+..... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988754333445689999999999999999999999 999999999999999999999999999987754332 2334
Q ss_pred cccccCCchhhhccCCCcc
Q 018311 338 VMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 338 ~~Gt~~y~APE~l~~~~~~ 356 (358)
..||+.|+|||++.+.+++
T Consensus 157 ~~g~~~y~aPE~~~~~~~~ 175 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYD 175 (280)
T ss_pred cCCCcCccCHHHhcCCCCC
Confidence 6799999999999988764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=233.79 Aligned_cols=177 Identities=25% Similarity=0.379 Sum_probs=148.2
Q ss_pred CCCcccceecCCccEEEEEEEEe----CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+.++..++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999753 356899999876533 2335688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+|++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999742 34688999999999999999999998 99999999999999999999999999876643
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...........++..|+|||++.+.++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 186 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFS 186 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCcc
Confidence 2221112223456789999999887764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=239.91 Aligned_cols=169 Identities=25% Similarity=0.289 Sum_probs=142.9
Q ss_pred ceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+.||+|+||.||+|.. .+++.+|+|.+.... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999976 467899999986542 22334577888888776 799999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|..++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 999988863 34588999999999999999999999 99999999999999999999999999998643221 12
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~ 174 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYG 174 (329)
T ss_pred cccccCCccccCHHHHcCCCCC
Confidence 3456899999999999987664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=240.29 Aligned_cols=172 Identities=26% Similarity=0.303 Sum_probs=143.7
Q ss_pred CcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHH---hcCCCCccccccceEEeCCEEEEE
Q 018311 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAI---GHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+..|++++ .+++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56788999999999999976 468899999986432 22334566666654 567899999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|..++.. ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988753 3588999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
... .......||+.|+|||++.+..+.
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~ 179 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYT 179 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCC
Confidence 221 223457899999999999887653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=235.66 Aligned_cols=171 Identities=25% Similarity=0.400 Sum_probs=145.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5688899999999999999976 468899999886443 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
++ |+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 97 5999988642 23578889999999999999999998 99999999999999999999999999998764322
Q ss_pred ceeeeecccccCCchhhhccC
Q 018311 332 SHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~ 352 (358)
. ......|++.|+|||++.+
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~ 177 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLG 177 (288)
T ss_pred c-cccCceecccccChHHhcC
Confidence 2 2234578999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=239.10 Aligned_cols=174 Identities=22% Similarity=0.246 Sum_probs=145.7
Q ss_pred CCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC---cchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
+|.+.+.||+|+||.||+|... +++.||+|.+..... .....+..|..++..+ +|++|+.+++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677899999999999999764 578999999865421 2224456688888777 5899999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998863 34588999999999999999999998 999999999999999999999999999986432
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. .......||+.|+|||++.+.+++
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~ 179 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYG 179 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCC
Confidence 22 123456899999999999988764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=239.17 Aligned_cols=169 Identities=24% Similarity=0.283 Sum_probs=142.4
Q ss_pred ceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
++||+|+||.||+|+.. +++.||+|.+.... ......+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999764 57899999986432 22334567788888866 799999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 999998864 34588899999999999999999999 99999999999999999999999999998643322 22
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+.++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~ 174 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYG 174 (321)
T ss_pred ccccccCccccCHHHHcCCCCC
Confidence 3456799999999999887653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=238.53 Aligned_cols=169 Identities=24% Similarity=0.291 Sum_probs=144.4
Q ss_pred ceecCCccEEEEEEEE----eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 180 NIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~----~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
+.||+|+||.||+++. .+|+.+|+|.+..... .....+..|++++.+++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999964 3578999999864321 223456779999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+|+|.+++.+ ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 9999999863 34588999999999999999999998 99999999999999999999999999998764332 2
Q ss_pred eeeecccccCCchhhhccCCCcc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......||+.|+|||++.+.++.
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~ 176 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHT 176 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCC
Confidence 23456899999999999877653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=239.10 Aligned_cols=169 Identities=28% Similarity=0.354 Sum_probs=140.8
Q ss_pred ceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHH-HHhcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVE-AIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+.||+|+||+||+|.. .+++.||+|.+.... ......+..|.. ++..++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999976 468999999986432 122234445544 56789999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999998873 34588899999999999999999999 99999999999999999999999999997643222 23
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+.+++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~ 174 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYD 174 (323)
T ss_pred cccccCChhhcChhhhcCCCCC
Confidence 3456899999999999988764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=239.73 Aligned_cols=169 Identities=29% Similarity=0.358 Sum_probs=140.7
Q ss_pred ceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHH-HHhcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVE-AIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+.||+|+||+||+|.. .+|+.+|+|.+.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999975 568999999986432 222344555554 56779999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 999988863 34588999999999999999999998 99999999999999999999999999997643221 12
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+.++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~ 174 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYD 174 (325)
T ss_pred cccccCChhhCCHHHHcCCCCC
Confidence 3456899999999999987763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=252.13 Aligned_cols=168 Identities=30% Similarity=0.405 Sum_probs=146.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
..|..++.||.|+||.||-|.. .+...||||++.-... ....++..|++.|..++|||++.+.|+|......||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 4467788999999999999965 5678999999853332 33467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||| -|+-.+++.- ..+++.+.++..|+.+.+.||.|||+. +.||||||+.|||+.+.|.|||+|||.|....+
T Consensus 106 EYC-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 106 EYC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHH-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 999 5677777753 335688899999999999999999999 999999999999999999999999999988764
Q ss_pred CCceeeeecccccCCchhhhccCC
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.+.++|||.|||||+++-+
T Consensus 179 -----AnsFvGTPywMAPEVILAM 197 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAM 197 (948)
T ss_pred -----hhcccCCccccchhHheec
Confidence 4579999999999999754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=238.93 Aligned_cols=169 Identities=24% Similarity=0.302 Sum_probs=142.7
Q ss_pred ceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+.||+|+||.||+|+. .+++.||+|.+.... ......+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999976 458899999986432 22345567788888776 699999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999998874 34588999999999999999999998 99999999999999999999999999998643222 22
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+.++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~ 174 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYG 174 (320)
T ss_pred ccccccCccccCHHHHcCCCCC
Confidence 3456899999999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=239.31 Aligned_cols=173 Identities=25% Similarity=0.358 Sum_probs=149.0
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|++++..++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 68999999999999999999764 578889988765432 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++|+|.+++.. .+.+++.....++.|++.||.|||+.. +++||||||+|||+++++.+||+|||++..+...
T Consensus 85 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 85 MDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999974 345788899999999999999999742 6999999999999999999999999999876432
Q ss_pred ceeeeecccccCCchhhhccCCCc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
......|+..|+|||++.+..+
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~ 179 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHY 179 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCC
Confidence 2234679999999999988765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=252.41 Aligned_cols=181 Identities=23% Similarity=0.289 Sum_probs=151.8
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCC------
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------ 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 243 (358)
.++|.+.+.||+|+||+||+|.. .+++.||+|.+.... ......+..|+.++..++|+||++++..+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 47899999999999999999975 578999999986443 223456788999999999999999988765432
Q ss_pred --EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeee
Q 018311 244 --QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (358)
Q Consensus 244 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DF 321 (358)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEec
Confidence 36899999999999999975444455689999999999999999999999 9999999999999999999999999
Q ss_pred cCceecCCCCc-eeeeecccccCCchhhhccCCCcc
Q 018311 322 GLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 322 Gla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
|+++.+..... .......||+.|+|||++.+.+|.
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s 223 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCC
Confidence 99988754322 233457899999999999988764
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=238.86 Aligned_cols=173 Identities=22% Similarity=0.255 Sum_probs=145.3
Q ss_pred CcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEEe
Q 018311 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e 250 (358)
|+..+.||+|+||.||+|+. .+++.||+|.+.... ....+.+..|..++..+. |++|+++++++...+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 66788999999999999976 468899999986432 223355777888888885 5778889999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 82 YVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999998863 34588999999999999999999998 9999999999999999999999999999865332
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. .......||+.|+|||++.+.+++
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~ 179 (323)
T cd05615 155 G-VTTRTFCGTPDYIAPEIIAYQPYG 179 (323)
T ss_pred C-ccccCccCCccccCHHHHcCCCCC
Confidence 2 123446799999999999988764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=239.31 Aligned_cols=167 Identities=26% Similarity=0.395 Sum_probs=141.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
.+|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3466678999999999999976 4689999999865433 2346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++|+|.+.. ...+.....++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986432 245677888999999999999998 99999999999999999999999999998875322
Q ss_pred ceeeeecccccCCchhhhccC
Q 018311 332 SHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~ 352 (358)
. ......||..|+|||++..
T Consensus 223 ~-~~~~~~gt~~y~aPE~~~~ 242 (353)
T PLN00034 223 D-PCNSSVGTIAYMSPERINT 242 (353)
T ss_pred c-cccccccCccccCcccccc
Confidence 1 2344689999999999853
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=245.03 Aligned_cols=180 Identities=24% Similarity=0.379 Sum_probs=147.6
Q ss_pred CCCcccceecCCccEEEEEEEE------eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeCCEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 245 (358)
++|++.+.||+|+||.||+|.+ .++..||+|++..... .....+..|+++++.+ +||||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 5788899999999999999864 2345799999865432 2345688899999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccC-----------------------------------------------------------
Q 018311 246 ILVYEYVNNGNLEQWLRGDMC----------------------------------------------------------- 266 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 266 (358)
++||||+++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999864210
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce-eeeec
Q 018311 267 -------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH-ITTRV 338 (358)
Q Consensus 267 -------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~ 338 (358)
....+++.....++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++.+...... .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 112478888999999999999999998 9999999999999999999999999999876543322 22233
Q ss_pred ccccCCchhhhccCCCcc
Q 018311 339 MGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 339 ~Gt~~y~APE~l~~~~~~ 356 (358)
.++..|||||++.+.+|+
T Consensus 275 ~~~~~y~aPE~~~~~~~~ 292 (374)
T cd05106 275 RLPVKWMAPESIFDCVYT 292 (374)
T ss_pred CCccceeCHHHhcCCCCC
Confidence 456789999999877653
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=251.52 Aligned_cols=175 Identities=29% Similarity=0.413 Sum_probs=148.4
Q ss_pred CcccceecCCccEEEEEEE-EeCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeC------CEEEE
Q 018311 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------TQRIL 247 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~l 247 (358)
|...+.||+|+||.||+++ ..+|+.||||.+.... ....+...+|+++|++|+|||||+++++=.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4456899999999999997 6789999999986544 33446677899999999999999999876543 35689
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE--cCCCc--EEEeeecC
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI--DENFD--AKISDFGL 323 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl--~~~~~--~kl~DFGl 323 (358)
+||||++|||...|..... ...|++.+.+.++..++.||.|||.+ +|+||||||.||++ .++|+ -||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999986532 33499999999999999999999998 99999999999997 44444 79999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccC-CCcc
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRN-MPIL 356 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~ 356 (358)
||.+.++. ....+.||..|++||++.+ .+|+
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~ 202 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYT 202 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcC
Confidence 99998765 5778999999999999995 6665
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=229.28 Aligned_cols=175 Identities=22% Similarity=0.372 Sum_probs=149.6
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
++|++.+.||+|+||.||++++.++..+|+|.+... .....++..|+.++++++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788999999999999999888888999987543 3335678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+|+|.+++... ...+++.....++.|++.||.|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999998742 23588999999999999999999998 9999999999999999999999999999876543332
Q ss_pred eeeecccccCCchhhhccCCCc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
......++..|+|||++.+.++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~ 178 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKY 178 (256)
T ss_pred ccCCCCCchhhCChhhcccCcc
Confidence 2233445678999999987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=237.95 Aligned_cols=169 Identities=27% Similarity=0.347 Sum_probs=139.8
Q ss_pred ceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHH-HHhcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVE-AIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
++||+|+||.||+|+. .+++.||+|.+.... ......+..|.. ++..++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999976 468899999885432 122334555554 67889999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|..++.. ...+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 999988863 34578888999999999999999998 99999999999999999999999999998643221 12
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+.+++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~ 174 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYD 174 (321)
T ss_pred cccccCCcccCCHHHhcCCCCC
Confidence 3456899999999999887653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=237.90 Aligned_cols=169 Identities=27% Similarity=0.322 Sum_probs=138.9
Q ss_pred ceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHH-HHHhcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEV-EAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+.||+|+||+||+|... +++.||+|.+.... ......+..|. .++..++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999764 57789999886432 12223344444 456788999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|.+++.. ...+.+.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 999999874 34577888889999999999999999 99999999999999999999999999998643221 12
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+.++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~ 174 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYD 174 (325)
T ss_pred cccccCCccccCHHHHcCCCCC
Confidence 3456899999999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=236.17 Aligned_cols=169 Identities=24% Similarity=0.297 Sum_probs=141.8
Q ss_pred ceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhc-CCCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGH-VRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+.||+|+||+||+|+.. +++.||+|.+.... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999864 57899999986532 2233456667788775 4899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 999999873 24588899999999999999999998 99999999999999999999999999998643222 12
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+.++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYN 174 (316)
T ss_pred eeeecCCccccCHHHHcCCCCC
Confidence 3456899999999999987763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=237.62 Aligned_cols=169 Identities=25% Similarity=0.290 Sum_probs=143.8
Q ss_pred ceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+.||+|+||.||+|.. .+++.+|+|.+.... ....+.+..|+.++.++ +||||+.+++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999976 467899999986542 22335577899999888 699999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|..++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 999998863 34589999999999999999999999 99999999999999999999999999998643211 22
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
....+||+.|+|||++.+.++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~ 174 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYG 174 (327)
T ss_pred eecccCCcccCCHHHHCCCCCC
Confidence 3457899999999999988764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=231.93 Aligned_cols=175 Identities=25% Similarity=0.313 Sum_probs=148.0
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.|+..++||+|+||+||++.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 367789999999999999976 4688999999864321 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++|+|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++.+...
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999887642 234588999999999999999999998 9999999999999999999999999999876433
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. .....|++.|+|||++.+..++
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~ 179 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYT 179 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCC
Confidence 22 2345789999999999876653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=236.35 Aligned_cols=169 Identities=22% Similarity=0.332 Sum_probs=141.7
Q ss_pred ceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
++||+|+||.||+|+.. +++.||+|.++... ......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999764 68899999986432 22334566688887654 899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999998864 34588899999999999999999999 99999999999999999999999999997643222 23
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+.++.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYT 174 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCC
Confidence 4457899999999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=255.29 Aligned_cols=176 Identities=24% Similarity=0.399 Sum_probs=146.2
Q ss_pred cCCCcccceecCCccEEEEEEEEeCC-cEEEEEEecCCCCcchHHHHHHHHHHhcCC-CCccccccce-EEe------CC
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNG-TAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGY-CIE------GT 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~-~~~------~~ 243 (358)
..++++.++|.+|||+.||+|....+ ..+|+|++........+.+.+||++|++|+ |+|||.+++. ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 46778899999999999999988666 999999998777777788999999999997 9999999993 321 24
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
+.+|+||||.+|.|-+++..+.. ..|++.++++|++++|+|+.+||.. .++|||||||.+||||+.+++.||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 67899999999999999975532 3399999999999999999999986 77899999999999999999999999999
Q ss_pred ceecCCCC--ceee------eecccccCCchhhhcc
Q 018311 324 AKLLGAGK--SHIT------TRVMGTFGDFSVTLLR 351 (358)
Q Consensus 324 a~~~~~~~--~~~~------~~~~Gt~~y~APE~l~ 351 (358)
|.-....- .... -...-|+.|.|||++.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMID 228 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMID 228 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHh
Confidence 86533211 1100 1234689999999873
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=243.05 Aligned_cols=181 Identities=23% Similarity=0.325 Sum_probs=148.8
Q ss_pred cCCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCC-CCccccccceEEeCCE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 244 (358)
.++|.+.++||+|+||.||+|... .+..||+|++..... ...+.+.+|++++.++. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 367889999999999999999752 234799999865433 23456889999999996 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcccC----------------------------------------------------------
Q 018311 245 RILVYEYVNNGNLEQWLRGDMC---------------------------------------------------------- 266 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 266 (358)
.|+||||+++|+|.++|.+...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999999864310
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC
Q 018311 267 ----------------------------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE 312 (358)
Q Consensus 267 ----------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~ 312 (358)
....+++..+..++.|++.||.|||+. +|+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 012477888899999999999999998 9999999999999999
Q ss_pred CCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 313 NFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 313 ~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
++.+||+|||+++.+...... ......+++.|+|||++.+.+++
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 317 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT 317 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC
Confidence 999999999999876543221 22345677899999999887653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=237.35 Aligned_cols=170 Identities=28% Similarity=0.385 Sum_probs=141.9
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeC-----CEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQRI 246 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~ 246 (358)
+|++.+.||+|+||.||+|.. .++..||+|++.... ......+.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 578889999999999999975 468999999986432 22335688899999999999999999988643 2479
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||+ +++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELM-ESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecC-CCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 999999 4799998863 34588999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCc--eeeeecccccCCchhhhccC
Q 018311 327 LGAGKS--HITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 327 ~~~~~~--~~~~~~~Gt~~y~APE~l~~ 352 (358)
...... .......||+.|+|||++.+
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhc
Confidence 532221 12244689999999999876
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=230.80 Aligned_cols=174 Identities=29% Similarity=0.427 Sum_probs=142.2
Q ss_pred CCCcccceecCCccEEEEEEEE--eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcC---CCCccccccceEEe-----
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL--MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHV---RHKNLVRLLGYCIE----- 241 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~--~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~----- 241 (358)
++|++.+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|+.++..+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688899999999999999976 3467899998864432 2234566677776665 69999999998852
Q ss_pred CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeee
Q 018311 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (358)
Q Consensus 242 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DF 321 (358)
....++||||++ ++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999995 6999998643 234588999999999999999999999 9999999999999999999999999
Q ss_pred cCceecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 322 GLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 322 Gla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
|+++..... .......||+.|+|||++.+.++
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 186 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSY 186 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCC
Confidence 999886543 23445679999999999987765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=227.90 Aligned_cols=176 Identities=24% Similarity=0.389 Sum_probs=151.7
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
++|++.++||+|+||.||+|...++..||+|.+.... ...+.+..|+.+++.++|+||+++++.+...+..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 5788899999999999999998888889999875432 235678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 85 KGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 99999998753 234578889999999999999999998 9999999999999999999999999999887644333
Q ss_pred eeeecccccCCchhhhccCCCc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
......++..|+|||++.+.++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~ 181 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSF 181 (261)
T ss_pred ccCCCccceecCCHHHhccCCC
Confidence 3334456778999999987764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=239.37 Aligned_cols=172 Identities=27% Similarity=0.335 Sum_probs=146.1
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCC-----EEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-----QRI 246 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 246 (358)
+|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|++++..++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 367789999999999999975 5789999999864322 23456888999999999999999999998776 789
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||+. ++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999995 68888776 335689999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCceeeeecccccCCchhhhccCCC
Q 018311 327 LGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 327 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.............+|+.|+|||++.+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 180 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSR 180 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCC
Confidence 6544333344567899999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=231.90 Aligned_cols=171 Identities=33% Similarity=0.435 Sum_probs=145.6
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEe-----CCEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE-----GTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----~~~~ 245 (358)
.+|...+.||+|+||.|+.+.. .+|+.||+|++.+.. ....++..+|+++|+.++|+||+.+.+.+.. -...
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 5566678999999999999964 678999999997443 3345778899999999999999999998875 3578
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
|+|+|+| +.||.+.++ ....++......+..|+++||+|+|+. +++||||||.|+|++.++.+||||||+||
T Consensus 102 YiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred EEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 9999999 679999997 344588999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCC-ceeeeecccccCCchhhhccC
Q 018311 326 LLGAGK-SHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 326 ~~~~~~-~~~~~~~~Gt~~y~APE~l~~ 352 (358)
.+.... ....+..+-|..|.|||++.+
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~ 201 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLN 201 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhc
Confidence 986431 113456678999999998764
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=239.20 Aligned_cols=175 Identities=25% Similarity=0.345 Sum_probs=154.5
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcc--hHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA--DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.-|.+.+.||+|.|+.|.+|++ .+|.+||||.+.+..-.. ...+.+|++.|+.++|||||++|.+...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4567778999999999999964 689999999997665332 3457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE-cCCCcEEEeeecCceecCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI-DENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl-~~~~~~kl~DFGla~~~~~ 329 (358)
+-++|||++|+.++ ...+.+..+.+++.||+.|+.|+|+. .+|||||||+||++ .+-|-+||+|||++-.+.+
T Consensus 98 LGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999875 34488999999999999999999998 89999999999875 6778999999999988877
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+.. .++.+|+..|.|||+++|..|.
T Consensus 172 G~k--L~TsCGSLAYSAPEILLGDsYD 196 (864)
T KOG4717|consen 172 GKK--LTTSCGSLAYSAPEILLGDSYD 196 (864)
T ss_pred cch--hhcccchhhccCchhhhcCccC
Confidence 664 6678999999999999999885
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=245.01 Aligned_cols=172 Identities=23% Similarity=0.344 Sum_probs=148.4
Q ss_pred CCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-C-----CccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-H-----KNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~l~~~~~~~~~~~ 246 (358)
-+|++.++||+|+||+|-+|. ..+++.||||.+++... ...+-..|+.+|..|+ | -|+|+++++|...+++|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 378999999999999999995 46799999999876543 3455667999999997 4 48999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC--CcEEEeeecCc
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN--FDAKISDFGLA 324 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~--~~~kl~DFGla 324 (358)
||+|.+ .-+|.+||+.+.. ..++...+..|+.||+.||.+||.. +|||+||||+||||.+- ..+||+|||.|
T Consensus 265 iVfELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 999999 6699999997754 3488999999999999999999998 99999999999999643 47999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+..... ..+.+-+..|.|||+++|.||.
T Consensus 339 c~~~q~----vytYiQSRfYRAPEVILGlpY~ 366 (586)
T KOG0667|consen 339 CFESQR----VYTYIQSRFYRAPEVILGLPYD 366 (586)
T ss_pred cccCCc----ceeeeeccccccchhhccCCCC
Confidence 986532 2266788899999999999985
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=238.30 Aligned_cols=171 Identities=25% Similarity=0.303 Sum_probs=146.5
Q ss_pred cCCCcccceecCCccEEEEEEEEe---CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
..+|.+.+.||+|+||.||+|... .+..|++|.+... +...+|+++++.++||||+++++++......|++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 367999999999999999999653 3578999987543 34567999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
|++. ++|.+++. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 166 e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9994 78998884 335689999999999999999999998 999999999999999999999999999987754
Q ss_pred CCce-eeeecccccCCchhhhccCCCcc
Q 018311 330 GKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.... ......||+.|+|||++.+.+|.
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 265 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYC 265 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCC
Confidence 4322 23456899999999999988764
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=255.12 Aligned_cols=180 Identities=24% Similarity=0.340 Sum_probs=149.9
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.++||+|+||.||+|.. .+++.||+|++..... ...+++.+|++++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5789999999999999999976 4588999999865432 22456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 250 EYVNNGNLEQWLRGDMC-------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
||+++|+|.+++..... ....+++...+.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 112356677889999999999999998 99999999999999999999999999
Q ss_pred CceecCCCCc-----------------eeeeecccccCCchhhhccCCCcc
Q 018311 323 LAKLLGAGKS-----------------HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 323 la~~~~~~~~-----------------~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+++....... ......+||+.|+|||++.+.+++
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S 209 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS 209 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC
Confidence 9987621110 112235799999999999988764
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=239.17 Aligned_cols=170 Identities=22% Similarity=0.262 Sum_probs=145.8
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
..|.+.+.||+|+||.||+|... .++.||+|... ...+.+|++++++++||||+++++++..++..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 46889999999999999999764 57889999532 234568999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
.++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 243 -~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 -RSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred -CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 57999988642 24689999999999999999999999 999999999999999999999999999987654322
Q ss_pred e-eeeecccccCCchhhhccCCCcc
Q 018311 333 H-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. ......||+.|+|||++.+.+++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~ 340 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYT 340 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCC
Confidence 2 23356799999999999988764
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=233.93 Aligned_cols=176 Identities=28% Similarity=0.475 Sum_probs=145.7
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCc----EEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGT----AVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++|+..+.||+|+||.||+|.+. ++. .||+|.+.... ....+++..|+.++..++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56888999999999999999763 333 48999886543 23456788999999999999999999998764 5789
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
++||+++|+|.+++... ...+++...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999753 24578889999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCcee-eeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSHI-TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~~-~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
....... .....++..|+|||++.+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~ 189 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYT 189 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCC
Confidence 6433321 2223446789999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=233.78 Aligned_cols=169 Identities=25% Similarity=0.322 Sum_probs=142.7
Q ss_pred ceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+.||+|+||.||+|... +++.||+|.+.... ......+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999764 57899999986432 22345567788888877 699999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 999998863 34589999999999999999999999 99999999999999999999999999997632221 12
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+.++.
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~ 174 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYG 174 (318)
T ss_pred ccceecCccccCHHHhcCCCCC
Confidence 3446799999999999987763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=224.73 Aligned_cols=175 Identities=23% Similarity=0.362 Sum_probs=149.0
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
++|++.+.||+|+||.||++++.++..+|+|.+.... ...+++.+|+.++.+++||||+++++++...+..+++|||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577889999999999999988777789999886433 335678999999999999999999999998889999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+|+|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999998742 23588999999999999999999998 9999999999999999999999999999876544332
Q ss_pred eeeecccccCCchhhhccCCCc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
......++..|+|||++.+.++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~ 178 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKF 178 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcc
Confidence 2223345678999999987654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=224.73 Aligned_cols=178 Identities=25% Similarity=0.360 Sum_probs=150.7
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.++|++.+.||+|+||.||+|...+++.||+|.++... ...+++.+|+.++.+++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 36688899999999999999988778889999986543 33567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++.... ...+++.....++.|++.|+.|||+. +++|+||||+||++++++.+||+|||+++.+.....
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999997532 34588999999999999999999998 999999999999999999999999999998763322
Q ss_pred eeeeecccccCCchhhhccCCCcc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
........+..|+|||++.+.+++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~ 182 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFS 182 (261)
T ss_pred cccCCCcCceeccCccccccCCCC
Confidence 212222334589999998876653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=227.65 Aligned_cols=180 Identities=28% Similarity=0.483 Sum_probs=151.5
Q ss_pred CCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|.+.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 46788899999999999999753 3478999998655443 4567999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcE
Q 018311 247 LVYEYVNNGNLEQWLRGDM----------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~ 316 (358)
++|||+++++|.+++.... .....+++.....++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997532 1234578889999999999999999998 99999999999999999999
Q ss_pred EEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 317 KISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 317 kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
||+|||+++.+...... ......+++.|+|||++.+.+++
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 202 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT 202 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcc
Confidence 99999999876443321 23345567899999999887764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=225.02 Aligned_cols=168 Identities=29% Similarity=0.355 Sum_probs=142.1
Q ss_pred ecCCccEEEEEEEE-eCCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCH
Q 018311 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (358)
Q Consensus 182 lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL 257 (358)
||+|+||.||++.. .+|+.+|+|.+..... ...+.+..|++++.+++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999975 4689999999854321 1233456699999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeee
Q 018311 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337 (358)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 337 (358)
.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++..+.... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9888643 233488899999999999999999998 99999999999999999999999999998875433 2344
Q ss_pred cccccCCchhhhccCCCcc
Q 018311 338 VMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 338 ~~Gt~~y~APE~l~~~~~~ 356 (358)
..|++.|+|||++.+.++.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~ 172 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYS 172 (277)
T ss_pred cCCCCCccCHHHHccCCCC
Confidence 6799999999999887753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=258.26 Aligned_cols=181 Identities=24% Similarity=0.257 Sum_probs=160.0
Q ss_pred HhhHHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEe
Q 018311 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241 (358)
Q Consensus 166 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 241 (358)
+.++.....+|.+.++||+|+||.|..++. .+++.+|.|++.+.. .....-|..|-.+|..-+.+=|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 455566678899999999999999999976 568889999886522 2233558889999999899999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeee
Q 018311 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (358)
Q Consensus 242 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DF 321 (358)
..++|||||||+||||..+|.+. ..+++..+.+++..|+.||.-||+. |+|||||||+|||||.+|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999753 3699999999999999999999999 9999999999999999999999999
Q ss_pred cCceecCCCCceeeeecccccCCchhhhccCC
Q 018311 322 GLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 322 Gla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
|.|-.+...+.......+|||.|.|||+++.+
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~ 251 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQ 251 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhh
Confidence 99999887777778889999999999999754
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=226.64 Aligned_cols=177 Identities=27% Similarity=0.465 Sum_probs=153.6
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
..+|++.+.||+|+||.||+|...++..+++|.+.........++..|+.++..++||||+++++++...+..+++|||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 35688899999999999999998889999999987665555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++... ....+++.....++.|++.||.|||+. +++|+||||+||++++++.+||+|||++..+.....
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999753 234588999999999999999999998 999999999999999999999999999987653322
Q ss_pred eeeeecccccCCchhhhccCCCc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
......++..|+|||.+.+.++
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~ 181 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTF 181 (261)
T ss_pred -cccCCCCceEecCHHHHccCCC
Confidence 2223456778999999987665
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=227.56 Aligned_cols=162 Identities=20% Similarity=0.348 Sum_probs=139.6
Q ss_pred ceecCCccEEEEEEEEeCCcEEEEEEecCCCCcc---hHHHHHHHHHHhcCCCCccccccceEEe----CCEEEEEEeec
Q 018311 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA---DKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQRILVYEYV 252 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lv~e~~ 252 (358)
..||+|++|.||+|.+ +|+.||+|++....... .+.+.+|+.++.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999988 78899999987554332 3667899999999999999999999877 35789999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++|+|.+++.+ ...+++.....++.+++.||.|||+.. +++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999974 345889999999999999999999732 78899999999999999999999999998764322
Q ss_pred eeeeecccccCCchhhhccC
Q 018311 333 HITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~ 352 (358)
....|+..|+|||++.+
T Consensus 178 ---~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLND 194 (283)
T ss_pred ---ccccCcccccCHHHhhh
Confidence 24578999999999976
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=223.80 Aligned_cols=176 Identities=26% Similarity=0.389 Sum_probs=148.1
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
.+|++.+.||+|+||.||++.+.++..+|+|.+.... ....++..|++++..++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577889999999999999988777789999875432 234568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+++|.+++... ...+++.....++.|++.||.|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999998743 23588999999999999999999999 9999999999999999999999999999876543222
Q ss_pred eeeecccccCCchhhhccCCCcc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......++..|+|||++.+..+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~ 179 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFS 179 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCC
Confidence 22222345679999999877654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=226.58 Aligned_cols=173 Identities=25% Similarity=0.322 Sum_probs=146.9
Q ss_pred CcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc---chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
|+..+.||+|+||.||+|.. .+++.+|+|.+...... ....+..|+.++.+++|+||+.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778999999999999976 46889999988644322 224567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999988643 223488899999999999999999998 99999999999999999999999999998764332
Q ss_pred ceeeeecccccCCchhhhccCCCc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
. .....|+..|+|||++.+.++
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~ 178 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERY 178 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCC
Confidence 2 234579999999999988765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=226.11 Aligned_cols=174 Identities=25% Similarity=0.299 Sum_probs=147.2
Q ss_pred CcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
|+..+.||+|+||+||++.. .+++.+|+|.+..... .....+..|++++..++|+||+.+.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678999999999999976 4688999998864432 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999888642 233589999999999999999999998 99999999999999999999999999998764332
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......|+..|+|||++.+..+.
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~ 179 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYT 179 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCC
Confidence 12345799999999999877653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=230.71 Aligned_cols=169 Identities=20% Similarity=0.257 Sum_probs=143.6
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
..+|++.+.||+|+||.||+|... ++..||+|..... ....|+.++.+++||||+++++++......++|||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 357999999999999999999764 5678998864322 234689999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+ .++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 139 ~-~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 139 Y-SSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred c-CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 9 5689988864 335689999999999999999999998 9999999999999999999999999999764322
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.......||+.|+|||++.+..|.
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~ 234 (357)
T PHA03209 211 -PAFLGLAGTVETNAPEVLARDKYN 234 (357)
T ss_pred -cccccccccccccCCeecCCCCCC
Confidence 123356799999999999887763
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=224.04 Aligned_cols=176 Identities=26% Similarity=0.399 Sum_probs=148.3
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
++|++.++||+|+||.||+|...+...||+|++.... ...+++.+|++++..++||||+++++.+. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 5789999999999999999988777789999886432 23467889999999999999999998774 466899999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+|+|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.+......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99999999753 223578899999999999999999998 9999999999999999999999999999877544332
Q ss_pred eeeecccccCCchhhhccCCCcc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......++..|+|||++.+.+++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~ 181 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFT 181 (262)
T ss_pred cccCCcccceecCHhHhccCCCC
Confidence 23344567789999999877654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=241.22 Aligned_cols=171 Identities=27% Similarity=0.388 Sum_probs=139.6
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeC--------C
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--------T 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------~ 243 (358)
..+|++.+.||+|+||.||+|.. .+++.||+|++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 36799999999999999999976 468899999885432 2345699999999999999999887532 2
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-cEEEeeec
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFG 322 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~-~~kl~DFG 322 (358)
.+++||||++ ++|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 4678999996 578777754333445688999999999999999999999 999999999999998664 79999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCC
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+|+.+..... .....||+.|+|||++.+.
T Consensus 217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~ 245 (440)
T PTZ00036 217 SAKNLLAGQR--SVSYICSRFYRAPELMLGA 245 (440)
T ss_pred cchhccCCCC--cccCCCCcCccCHHHhcCC
Confidence 9987754332 2345789999999998764
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=226.94 Aligned_cols=179 Identities=27% Similarity=0.467 Sum_probs=150.1
Q ss_pred CCCcccceecCCccEEEEEEEE------eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++|.+.+.||+|+||.||++.. .++..+|+|.+........+.+..|++++.+++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5688899999999999999974 2345689998866554555678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccc---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEE
Q 018311 248 VYEYVNNGNLEQWLRGDM---------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl 318 (358)
+|||+++++|.+++.... .....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999987432 1223589999999999999999999998 9999999999999999999999
Q ss_pred eeecCceecCCCCce-eeeecccccCCchhhhccCCCc
Q 018311 319 SDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 319 ~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+|||+++.+...... ......+++.|+|||++.+..+
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 199 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 199 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCC
Confidence 999999876543321 2234456789999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=226.91 Aligned_cols=182 Identities=24% Similarity=0.393 Sum_probs=148.6
Q ss_pred hcCCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 244 (358)
..++|++.+.||+|+||.||+|... .+..||+|++..... ....++.+|+.++..++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3477999999999999999998653 346799998754332 234568899999999999999999999998899
Q ss_pred EEEEEeecCCCCHHHHHhcccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEE
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCD------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl 318 (358)
.++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998643211 23467788899999999999999998 9999999999999999999999
Q ss_pred eeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 319 SDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 319 ~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+|||+++.+...... ......+++.|+|||++.+.+++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 199 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 199 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcC
Confidence 999999876543322 12234567889999999887653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=222.23 Aligned_cols=171 Identities=27% Similarity=0.383 Sum_probs=148.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.+|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++..++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5788999999999999999976 568889999986554444566888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.+.....
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999998863 34588999999999999999999998 999999999999999999999999999987643221
Q ss_pred eeeeecccccCCchhhhccC
Q 018311 333 HITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~ 352 (358)
......|++.|+|||.+.+
T Consensus 162 -~~~~~~~~~~y~~PE~~~~ 180 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAV 180 (267)
T ss_pred -ccCccccCccccCHhHccc
Confidence 2234578999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=232.36 Aligned_cols=165 Identities=24% Similarity=0.254 Sum_probs=136.2
Q ss_pred ecCCccEEEEEEEE-eCCcEEEEEEecCCCC---cchHHHHHHHHHHhcC---CCCccccccceEEeCCEEEEEEeecCC
Q 018311 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHV---RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 182 lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
||+|+||+||+|+. .+++.||+|.+..... .....+..|..++..+ .||||+.+++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999976 4689999999854221 1223344566666655 699999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 999998873 34588999999999999999999999 99999999999999999999999999997643322 12
Q ss_pred eeecccccCCchhhhccCCC
Q 018311 335 TTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~ 354 (358)
.....||+.|+|||++.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~ 172 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEK 172 (330)
T ss_pred ccCccCCccccCHHHHcCCC
Confidence 34568999999999997653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=243.66 Aligned_cols=166 Identities=24% Similarity=0.420 Sum_probs=139.6
Q ss_pred ccceecCCccEEEEEEEE-eCCcEEEEEEec--C--CCCcchHHHHHHHHHHhcCCCCccccccceEEeCCE--EEEEEe
Q 018311 178 KDNIIGDGGYGVVYRGQL-MNGTAVAVKKLL--N--NPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ--RILVYE 250 (358)
Q Consensus 178 ~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~--~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--~~lv~e 250 (358)
..++||+|+|-+||+|.. .+|..||--.++ . ..+...++|..|+.+|+.|+||||++++.++.+... +-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 357899999999999954 467777754332 1 122334778999999999999999999999987655 678999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCcEEEeeecCceecCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~-~~~~~kl~DFGla~~~~~ 329 (358)
+|..|+|..|++++ +.++.+....|++||+.||.|||++ .|+|+|||||.+||+|+ ..|.|||+|+|||..+..
T Consensus 124 L~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999854 4577889999999999999999997 77899999999999996 568999999999999864
Q ss_pred CCceeeeecccccCCchhhhcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
.. ...++|||.|||||++.
T Consensus 199 s~---aksvIGTPEFMAPEmYE 217 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE 217 (632)
T ss_pred cc---cceeccCccccChHHHh
Confidence 33 23489999999999988
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=225.98 Aligned_cols=179 Identities=24% Similarity=0.387 Sum_probs=148.1
Q ss_pred CCCcccceecCCccEEEEEEEE-----eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
..|++.+.||+|+||.||+|.. ..+..+++|.+..... ....++.+|+++++.++||||+++++++...+..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577789999999999999974 3467899999865432 233678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC
Q 018311 248 VYEYVNNGNLEQWLRGDMC-------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~ 314 (358)
+|||+++++|.+++..... ....+++.....++.|++.||.|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853211 123478888999999999999999998 999999999999999999
Q ss_pred cEEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCc
Q 018311 315 DAKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 315 ~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.+||+|||+++.+..... .......++..|+|||++.+.++
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF 203 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCC
Confidence 999999999987654322 22344556788999999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=225.43 Aligned_cols=179 Identities=27% Similarity=0.493 Sum_probs=149.4
Q ss_pred CCCcccceecCCccEEEEEEEEeC------CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|++.+.||+|+||.||+|.... ...|++|.+..... ....++.+|++++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999997533 25799998864432 23456889999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHHhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC
Q 018311 247 LVYEYVNNGNLEQWLRGDMCD------------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~ 314 (358)
++|||+++|+|.+++...... ...+++.....++.|++.||.|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999999753211 14578889999999999999999998 999999999999999999
Q ss_pred cEEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCc
Q 018311 315 DAKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 315 ~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.+||+|||+++....... .......+++.|+|||.+.+.++
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF 203 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC
Confidence 999999999987654332 23344567889999999887665
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=227.51 Aligned_cols=173 Identities=25% Similarity=0.328 Sum_probs=147.8
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||.||++.. .++..+++|.+..... ....++.+|++++.+++||||+++++++..++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688899999999999999976 4678889888764422 2335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++... +.+++.....++.|++.||.|||+.. +++|+||||+|||+++++.+||+|||++..+....
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999999742 45889999999999999999999731 89999999999999999999999999997764322
Q ss_pred ceeeeecccccCCchhhhccCCCc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.....|+..|+|||++.+..+
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~ 175 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHY 175 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCC
Confidence 245678999999999987664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=227.64 Aligned_cols=172 Identities=26% Similarity=0.392 Sum_probs=145.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.++.+++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5688899999999999999976 4678899999864432 2334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
++ ++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 96 4888887642 34578889999999999999999998 99999999999999999999999999998754322
Q ss_pred ceeeeecccccCCchhhhccCC
Q 018311 332 SHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
. ......+|+.|+|||++.+.
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~ 179 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGS 179 (309)
T ss_pred c-ccccccccccccCCHHHhCC
Confidence 2 22345789999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=233.76 Aligned_cols=172 Identities=29% Similarity=0.313 Sum_probs=143.5
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCC------
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------ 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 243 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++..++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 37899999999999999999975 468899999986432 223456788999999999999999999886543
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
..|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMD-ANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCC-cCHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 4799999996 467666642 377888899999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
++...... ......||+.|+|||++.+..+.
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~ 200 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYK 200 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCC
Confidence 98754322 23446889999999999987763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=242.89 Aligned_cols=182 Identities=19% Similarity=0.272 Sum_probs=141.8
Q ss_pred HhcCCCcccceecCCccEEEEEEEEeC--CcEEEEEE--------------ec---CCCCcchHHHHHHHHHHhcCCCCc
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQLMN--GTAVAVKK--------------LL---NNPGQADKDFRVEVEAIGHVRHKN 231 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~--------------l~---~~~~~~~~~~~~E~~~l~~l~Hpn 231 (358)
...++|++.+.||+|+||+||+|..+. +...+.|. +. .........+.+|+.++.+++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999986532 22222221 10 111122345788999999999999
Q ss_pred cccccceEEeCCEEEEEEeecCCCCHHHHHhcccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 018311 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCD-RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (358)
Q Consensus 232 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl 310 (358)
|+++++++...+..|+++|++ .++|..++...... ...........++.|++.||.|||++ +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 999999999999999999999 56888877543211 22234566788999999999999998 99999999999999
Q ss_pred cCCCcEEEeeecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 311 DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 311 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+.++.+||+|||+++.+............||+.|+|||++.+..|.
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 346 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC 346 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCC
Confidence 9999999999999998765444344457899999999999988764
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=221.83 Aligned_cols=176 Identities=30% Similarity=0.486 Sum_probs=148.1
Q ss_pred CCCcccceecCCccEEEEEEEEeC----CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.+.||+|+||.||+|.+.. ...||+|.+..... ....++..|+.++..++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578889999999999999998642 45799998865433 3346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++++|.+++... .+.+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999753 24688999999999999999999998 99999999999999999999999999999875
Q ss_pred CCCce-eeeecccccCCchhhhccCCCc
Q 018311 329 AGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 329 ~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
..... ......++..|+|||.+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~ 185 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKF 185 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCC
Confidence 32222 2222345678999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=224.01 Aligned_cols=176 Identities=28% Similarity=0.422 Sum_probs=146.3
Q ss_pred CCCcccceecCCccEEEEEEEE-----eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEe--CCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~ 246 (358)
++|++.+.||+|+||.||+|.. .++..|++|++........+.+..|++++..++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5688899999999999999964 3578999999876655555778999999999999999999998754 34689
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999998642 34588999999999999999999998 999999999999999999999999999998
Q ss_pred cCCCCceee--eecccccCCchhhhccCCCc
Q 018311 327 LGAGKSHIT--TRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 327 ~~~~~~~~~--~~~~Gt~~y~APE~l~~~~~ 355 (358)
+........ ....++..|+|||++.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 188 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKF 188 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCc
Confidence 754332211 11223456999999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=236.11 Aligned_cols=173 Identities=23% Similarity=0.328 Sum_probs=148.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcc-----hH---HHHHHHHHHhcCC---CCccccccceEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA-----DK---DFRVEVEAIGHVR---HKNLVRLLGYCIE 241 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~-----~~---~~~~E~~~l~~l~---HpnIv~l~~~~~~ 241 (358)
..|+.++.||+|+||.|++|.+ ++...|++|.+.+..--. .+ ..-.||+||+.|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4588899999999999999976 456789999885543111 11 1335999999997 9999999999999
Q ss_pred CCEEEEEEeec-CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 018311 242 GTQRILVYEYV-NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISD 320 (358)
Q Consensus 242 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~D 320 (358)
+++.|++||-. ++-||++|+. ....+++.++..|+.||+.|+++||++ +|||||||-+||+++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999986 4669999997 345699999999999999999999999 999999999999999999999999
Q ss_pred ecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 321 FGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 321 FGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
||.|.....+. ...++||.+|+|||++.|++|.
T Consensus 714 fgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~ 746 (772)
T KOG1152|consen 714 FGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYL 746 (772)
T ss_pred ccchhhhcCCC---cceeeeeccccchhhhCCCccC
Confidence 99998865433 4578999999999999999984
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=221.03 Aligned_cols=176 Identities=24% Similarity=0.367 Sum_probs=148.5
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++.+++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 56888999999999999999888888899999865433 3467899999999999999999999875 466899999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+++|.+++.+. ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++..+......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 84 KGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999998753 234588999999999999999999998 9999999999999999999999999999887543322
Q ss_pred eeeecccccCCchhhhccCCCcc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......++..|+|||++.+.+++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~ 181 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFT 181 (260)
T ss_pred cccCCCCCccccChHHHhcCCCc
Confidence 22334456789999998876653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=220.84 Aligned_cols=178 Identities=24% Similarity=0.375 Sum_probs=150.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+..|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788899999999999999975 478899999875422 223356888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++.........+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998864332345578899999999999999999998 999999999999999999999999999988654
Q ss_pred CCceeeeecccccCCchhhhccCCCc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
... ......|++.|+|||.+.+..+
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~ 183 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGY 183 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCC
Confidence 321 2234578899999999877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=232.61 Aligned_cols=180 Identities=27% Similarity=0.378 Sum_probs=146.3
Q ss_pred CCCcccceecCCccEEEEEEEE------eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeC-CE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG-TQ 244 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~~ 244 (358)
.+|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+..|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 5789999999999999999953 2357899998864432 2235677899999999 899999999988654 56
Q ss_pred EEEEEeecCCCCHHHHHhcccCC---------------------------------------------------------
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCD--------------------------------------------------------- 267 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 267 (358)
.+++|||+++++|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999998642110
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce-eeeecccccCCch
Q 018311 268 RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFS 346 (358)
Q Consensus 268 ~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~A 346 (358)
...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.+...... ......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 12578999999999999999999998 9999999999999999999999999999887543322 2233456778999
Q ss_pred hhhccCCCcc
Q 018311 347 VTLLRNMPIL 356 (358)
Q Consensus 347 PE~l~~~~~~ 356 (358)
||++.+.+++
T Consensus 244 PE~~~~~~~~ 253 (337)
T cd05054 244 PESIFDKVYT 253 (337)
T ss_pred cHHhcCCCCC
Confidence 9999887764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=220.65 Aligned_cols=178 Identities=26% Similarity=0.404 Sum_probs=152.0
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.++|++.+.||+|+||.||+|...+++.+++|.+.... ...+++..|+.++++++||||+++++++......+++|||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46789999999999999999988778889999886543 34567899999999999999999999999889999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++... ....+++..+..++.+++.|+.|||+. +++|+||||+||++++++.+||+|||+++.+.....
T Consensus 84 ~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 84 SKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred CCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999753 224588999999999999999999998 999999999999999999999999999988754322
Q ss_pred eeeeecccccCCchhhhccCCCcc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.......++..|+|||.+.+.+++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~ 182 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFT 182 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcC
Confidence 222233456789999999876654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=227.05 Aligned_cols=179 Identities=25% Similarity=0.410 Sum_probs=147.1
Q ss_pred CCCcccceecCCccEEEEEEEEeC---------------CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccc
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN---------------GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLG 237 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~---------------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~ 237 (358)
++|++.+.||+|+||.||+|.... ...||+|.+..... .....+.+|++++.+++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 678999999999999999986532 23589998865432 23456889999999999999999999
Q ss_pred eEEeCCEEEEEEeecCCCCHHHHHhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 018311 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMC--------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNIL 309 (358)
Q Consensus 238 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiL 309 (358)
++...+..++||||+++++|.+++..... ....+++...+.++.|++.||.|||+. +++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 99999999999999999999999864311 112367889999999999999999998 9999999999999
Q ss_pred EcCCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCc
Q 018311 310 IDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 310 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+++++.+||+|||+++.+...... ......++..|+|||++.+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 208 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF 208 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc
Confidence 999999999999999876543321 2233456789999999887654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=235.81 Aligned_cols=176 Identities=23% Similarity=0.345 Sum_probs=140.9
Q ss_pred hHHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCC------CccccccceEE
Q 018311 168 DLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH------KNLVRLLGYCI 240 (358)
Q Consensus 168 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H------pnIv~l~~~~~ 240 (358)
++....++|++.++||+|+||+||+|.. .+++.||||+++... ....++..|++++..++| ++++.+++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3444568899999999999999999975 457889999986432 223455667777776654 45888888887
Q ss_pred eC-CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCC----
Q 018311 241 EG-TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENF---- 314 (358)
Q Consensus 241 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~NiLl~~~~---- 314 (358)
.. ...|+|||++ +++|.+++.+ .+.+++..+..++.|++.||.|||+ . +||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccc
Confidence 54 5789999998 7899998864 3458899999999999999999997 5 899999999999998765
Q ss_pred ------------cEEEeeecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 315 ------------DAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 315 ------------~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.+||+|||++..... .....+||+.|+|||++.+.+|.
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~ 323 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWM 323 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCC
Confidence 499999998865322 23457899999999999998764
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=222.25 Aligned_cols=167 Identities=22% Similarity=0.345 Sum_probs=144.7
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
+|++.++||+|+||.||+|.. .+++.+|+|.+.... .....++..|++++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577789999999999999975 578899999886542 233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|..+. .+++.....++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999997543 267788899999999999999998 99999999999999999999999999998765332
Q ss_pred eeeeecccccCCchhhhccCCCc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.....||..|+|||++.+..+
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~ 170 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQY 170 (279)
T ss_pred --ccCCCCChhhcCceeecCCCC
Confidence 344689999999999988765
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=226.79 Aligned_cols=170 Identities=24% Similarity=0.333 Sum_probs=137.5
Q ss_pred cceecCCccEEEEEEEEe---CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEe--CCEEEEEEeecC
Q 018311 179 DNIIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRILVYEYVN 253 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv~e~~~ 253 (358)
.++||+|+||+||+|... +++.+|+|.+.... ....+.+|++++.+++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999754 46789999886432 23457789999999999999999998864 456899999995
Q ss_pred CCCHHHHHhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----cCCCcEEEeeecCc
Q 018311 254 NGNLEQWLRGDMC-----DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLA 324 (358)
Q Consensus 254 ~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl----~~~~~~kl~DFGla 324 (358)
++|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 689888753221 123588899999999999999999999 99999999999999 46678999999999
Q ss_pred eecCCCCce--eeeecccccCCchhhhccCCC
Q 018311 325 KLLGAGKSH--ITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 325 ~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~ 354 (358)
+.+...... ......||+.|+|||++.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 191 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGAR 191 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCC
Confidence 887543221 234578899999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=235.71 Aligned_cols=179 Identities=24% Similarity=0.365 Sum_probs=146.9
Q ss_pred CCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCC-CCccccccceEEeCCEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 245 (358)
++|.+.+.||+|+||.||+|.+. .++.||+|++..... ...+.+..|++++.++. ||||+++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 56778899999999999999753 346799999975432 22356888999999997 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccC-----------------------------------------------------------
Q 018311 246 ILVYEYVNNGNLEQWLRGDMC----------------------------------------------------------- 266 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 266 (358)
++||||+++|+|.++++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999964311
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 018311 267 -----------------------------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (358)
Q Consensus 267 -----------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~ 311 (358)
....+++.....++.|++.||.|||+. +++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence 112367778899999999999999998 999999999999999
Q ss_pred CCCcEEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCc
Q 018311 312 ENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 312 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+++.+||+|||+++.+..... .......+++.|+|||.+.+.++
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 318 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY 318 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC
Confidence 999999999999987643222 12233467889999999987765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=223.90 Aligned_cols=171 Identities=28% Similarity=0.339 Sum_probs=149.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||++.. .+++.+|+|.+.... ....+.+..|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3688899999999999999976 468899999886432 223456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999874 25688999999999999999999998 999999999999999999999999999988754
Q ss_pred CCceeeeecccccCCchhhhccCCCc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
. .....|++.|+|||.+.+.++
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~ 175 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGY 175 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCC
Confidence 3 335678999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=221.68 Aligned_cols=170 Identities=26% Similarity=0.378 Sum_probs=148.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.++..++||||+++++.+...+..+++|||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 5678889999999999999975 468899999887655444566788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++.. .+.+++.+...++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..+....
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 99999999863 34688999999999999999999998 99999999999999999999999999998765322
Q ss_pred eeeeecccccCCchhhhcc
Q 018311 333 HITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~ 351 (358)
.......|++.|+|||++.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~ 179 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred cccccccCcccccChhhhc
Confidence 1234567999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=217.85 Aligned_cols=170 Identities=28% Similarity=0.420 Sum_probs=143.6
Q ss_pred ceecCCccEEEEEEEEeCCcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCHH
Q 018311 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLE 258 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~ 258 (358)
++||+|+||.||+|...++..+|+|.+...... ....+..|++++..++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 468999999999998888899999988655432 2346888999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeeec
Q 018311 259 QWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338 (358)
Q Consensus 259 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 338 (358)
+++... ...+++.....++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++....+........
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 998642 23578999999999999999999998 999999999999999999999999999987543322222223
Q ss_pred ccccCCchhhhccCCCc
Q 018311 339 MGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 339 ~Gt~~y~APE~l~~~~~ 355 (358)
.+++.|+|||++.+..+
T Consensus 155 ~~~~~y~aPE~~~~~~~ 171 (250)
T cd05085 155 QIPIKWTAPEALNYGRY 171 (250)
T ss_pred CCcccccCHHHhccCCC
Confidence 44678999999987654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=220.18 Aligned_cols=176 Identities=24% Similarity=0.383 Sum_probs=149.4
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.++|++.++||+|+||.||+|...+++.+|+|.+.... ....++..|+.++++++||||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 36788899999999999999998888999999986543 33467889999999999999999998864 56789999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++... ....+++.++..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++..+.....
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 83 ENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999998653 234588999999999999999999998 999999999999999999999999999988753333
Q ss_pred eeeeecccccCCchhhhccCCCc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.......++..|+|||++.+..+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~ 180 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTF 180 (260)
T ss_pred ccccCCcccccccCHHHhccCCc
Confidence 23334456789999999877654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=222.81 Aligned_cols=176 Identities=27% Similarity=0.419 Sum_probs=144.3
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCc----EEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGT----AVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++|++.+.||+|+||.||+|.+. +++ .+++|.+..... ....++..|+..+.+++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46788899999999999999863 344 477787754322 23356778888999999999999999875 456789
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
++||+++|+|.+++... ...+++.....++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++.+
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999742 34588999999999999999999998 9999999999999999999999999999887
Q ss_pred CCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... ......++..|+|||++.+.+++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~ 189 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYT 189 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcC
Confidence 544322 22345677899999999887663
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=224.00 Aligned_cols=179 Identities=25% Similarity=0.399 Sum_probs=149.7
Q ss_pred CCCcccceecCCccEEEEEEEEeC-----------------CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccc
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-----------------GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRL 235 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-----------------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l 235 (358)
++|++.+.||+|+||.||+|.... +..||+|.+..... ...+++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 678899999999999999986532 24589998865443 334678899999999999999999
Q ss_pred cceEEeCCEEEEEEeecCCCCHHHHHhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcE
Q 018311 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMC-------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308 (358)
Q Consensus 236 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~Ni 308 (358)
++++..++..+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 9999999999999999999999999975431 123588999999999999999999998 999999999999
Q ss_pred EEcCCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCc
Q 018311 309 LIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 309 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
++++++.+||+|||+++.+...... ......+++.|+|||++.+..+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 209 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF 209 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC
Confidence 9999999999999999876543322 2344567889999999887654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=220.75 Aligned_cols=176 Identities=28% Similarity=0.454 Sum_probs=147.0
Q ss_pred CCCcccceecCCccEEEEEEEEe----CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.+.||+|+||.||+|... .+..+|+|.++.... ...+.+..|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888999999999999999763 234799998865432 2346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++++|.+++... ...+++.+...++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999743 34588999999999999999999998 99999999999999999999999999998875
Q ss_pred CCCceeee--ecccccCCchhhhccCCCc
Q 018311 329 AGKSHITT--RVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 329 ~~~~~~~~--~~~Gt~~y~APE~l~~~~~ 355 (358)
........ ...++..|+|||++.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 186 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCcc
Confidence 43322222 2233568999999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=222.55 Aligned_cols=174 Identities=30% Similarity=0.554 Sum_probs=143.1
Q ss_pred ccceecCCccEEEEEEEEe-----CCcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 178 KDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 178 ~~~~lG~G~fg~V~~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
..+.||.|.||.||+|++. .+..|+||.+...... ..+++.+|++.+.+++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999886 3568999999654332 357899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++|+|.++|... ....+++..+..|+.|++.||.|||+. +++|+||+++||++++++.+||+|||+++......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999864 235589999999999999999999999 99999999999999999999999999999874332
Q ss_pred ce-eeeecccccCCchhhhccCCCcc
Q 018311 332 SH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. ......+...|+|||.+.+..++
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~ 183 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYT 183 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEES
T ss_pred cccccccccccccccccccccccccc
Confidence 22 23335577899999999776543
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=229.84 Aligned_cols=179 Identities=26% Similarity=0.382 Sum_probs=144.5
Q ss_pred CCCcccceecCCccEEEEEEEE------eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeC-CE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG-TQ 244 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~~ 244 (358)
++|++.+.||+|+||.||+|.+ .+++.||||.++.... .....+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 6799999999999999999963 3567899999865432 2335678899999999 689999999988654 56
Q ss_pred EEEEEeecCCCCHHHHHhcccC----------------------------------------------------------
Q 018311 245 RILVYEYVNNGNLEQWLRGDMC---------------------------------------------------------- 266 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 266 (358)
.+++|||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999864210
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce-eeeeccc
Q 018311 267 -----DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMG 340 (358)
Q Consensus 267 -----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~G 340 (358)
....+++.....++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.+...... ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 012367888899999999999999998 9999999999999999999999999999876432221 2223455
Q ss_pred ccCCchhhhccCCCc
Q 018311 341 TFGDFSVTLLRNMPI 355 (358)
Q Consensus 341 t~~y~APE~l~~~~~ 355 (358)
++.|+|||++.+..+
T Consensus 244 ~~~y~aPE~~~~~~~ 258 (343)
T cd05103 244 PLKWMAPETIFDRVY 258 (343)
T ss_pred CcceECcHHhcCCCC
Confidence 678999999887765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=231.78 Aligned_cols=173 Identities=28% Similarity=0.316 Sum_probs=144.2
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeC------
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------ 242 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 242 (358)
..++|+..+.||+|+||.||+|.. ..++.||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 347899999999999999999975 4688999999865432 2335677899999999999999999988643
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
...++||||++ ++|.+++.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 35799999996 477776652 377888899999999999999998 99999999999999999999999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+++...... ......||+.|+|||++.+..+.
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~ 196 (355)
T cd07874 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYK 196 (355)
T ss_pred ccccCCCcc--ccCCccccCCccCHHHHcCCCCC
Confidence 998765432 23456899999999999887653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-28 Score=218.24 Aligned_cols=175 Identities=27% Similarity=0.394 Sum_probs=148.8
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc-----chHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-----ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++|+..+.||+|+||.||+|.. .+++.+++|.+...... ..+.+.+|++++.+++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999975 56899999988643221 23467889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
++||+++++|.+++.. .+.+++.....++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.+
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999874 24578889999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceee--eecccccCCchhhhccCCCc
Q 018311 328 GAGKSHIT--TRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 328 ~~~~~~~~--~~~~Gt~~y~APE~l~~~~~ 355 (358)
........ ....|+..|+|||++.+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGY 184 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCC
Confidence 54322211 34568899999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=217.61 Aligned_cols=178 Identities=24% Similarity=0.399 Sum_probs=152.3
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|... +++.|++|.++... ....+.+.+|++++++++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999875 78999999885322 223467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++++|..++.........+++..+..++.+++.||.|||+. +++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999875433445688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeeeecccccCCchhhhccCCCc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
... ......|++.|+|||.+.+..+
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~ 183 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGY 183 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCC
Confidence 322 2234578999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=220.79 Aligned_cols=169 Identities=25% Similarity=0.351 Sum_probs=136.8
Q ss_pred eecCCccEEEEEEEEeC---CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCC
Q 018311 181 IIGDGGYGVVYRGQLMN---GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGN 256 (358)
Q Consensus 181 ~lG~G~fg~V~~~~~~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs 256 (358)
.||+|+||.||+|...+ ...+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 34678887654332 233567889999999999999999999999999999999999999
Q ss_pred HHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce-e
Q 018311 257 LEQWLRGDMC-DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH-I 334 (358)
Q Consensus 257 L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~-~ 334 (358)
|.+++..... .....++.....++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999975432 123356788899999999999999999 9999999999999999999999999999765433221 1
Q ss_pred eeecccccCCchhhhccC
Q 018311 335 TTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~ 352 (358)
.....+++.|+|||++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05042 159 KDCHAVPLRWLAPELVEI 176 (269)
T ss_pred cCCCCCcccccCHHHHhh
Confidence 233456778999999754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-28 Score=219.52 Aligned_cols=177 Identities=26% Similarity=0.406 Sum_probs=149.7
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
..|.+.+.||+|+||.||+|.+. +++.|++|.+... ....+++.+|++++..++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45777889999999999999764 5888999988643 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999998653 234588999999999999999999998 999999999999999999999999999988764433
Q ss_pred eeeeecccccCCchhhhccCCCcc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.......++..|+|||.+.+.+++
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~ 183 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFS 183 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCC
Confidence 222333456789999999877653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=223.71 Aligned_cols=180 Identities=24% Similarity=0.388 Sum_probs=146.4
Q ss_pred cCCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 245 (358)
.++|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++||||+++++++..++..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 468999999999999999999653 245799998754432 2234577899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEe
Q 018311 246 ILVYEYVNNGNLEQWLRGDMC------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKIS 319 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~ 319 (358)
++||||+++|+|.+++..... .....++.....++.|++.||.|||++ +++||||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999964211 123456778899999999999999998 99999999999999999999999
Q ss_pred eecCceecCCCCce-eeeecccccCCchhhhccCCCc
Q 018311 320 DFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 320 DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
|||+++.+...... ......++..|+|||.+.+.++
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~ 198 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF 198 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCC
Confidence 99999876433221 1223355778999999987665
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-27 Score=215.80 Aligned_cols=175 Identities=25% Similarity=0.360 Sum_probs=149.2
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
+|++.+.||+|+||.||+++. .+++.+++|.+.... ....+.+..|+.+++.++||||+++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 477789999999999999976 468899999885432 334467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++|+|.+++... ....+++.....++.|++.||.|||+. +++|+||||+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 999999988643 234478899999999999999999998 99999999999999999999999999998765322
Q ss_pred eeeeecccccCCchhhhccCCCc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.......|++.|+|||++.+..+
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~ 177 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPY 177 (255)
T ss_pred cccccccCCccccCHHHHccCCc
Confidence 22344678999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=223.26 Aligned_cols=179 Identities=26% Similarity=0.450 Sum_probs=150.3
Q ss_pred CCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++.+++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778899999999999999742 345688888866555455678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc
Q 018311 248 VYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD 315 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~ 315 (358)
||||+++++|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999975321 123588999999999999999999999 9999999999999999999
Q ss_pred EEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCc
Q 018311 316 AKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 316 ~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+||+|||+++....... .......++..|+|||++.+..+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 202 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 202 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC
Confidence 99999999987654332 22334567889999999987765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=220.85 Aligned_cols=172 Identities=31% Similarity=0.483 Sum_probs=146.5
Q ss_pred CcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchH--HHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADK--DFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
|+..+.||+|+||.||++... +++.+|+|.+......... ....|+.++.+++||||+++++++......+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 566889999999999999874 4668999999766543322 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++..... ..
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred ccccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 99999999972 34578999999999999999999999 999999999999999999999999999987522 22
Q ss_pred eeeeecccccCCchhhhcc-CCCc
Q 018311 333 HITTRVMGTFGDFSVTLLR-NMPI 355 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~-~~~~ 355 (358)
.......++..|+|||++. +..+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~ 176 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKY 176 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSB
T ss_pred cccccccccccccccccccccccc
Confidence 3455678899999999988 5443
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=224.73 Aligned_cols=180 Identities=27% Similarity=0.415 Sum_probs=148.1
Q ss_pred CCCcccceecCCccEEEEEEEEe--------CCcEEEEEEecCCC-CcchHHHHHHHHHHhcC-CCCccccccceEEeCC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGT 243 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 243 (358)
.+|.+.+.||+|+||.||+|+.. ++..||+|.+.... .....++..|+.++..+ +||||+++++++....
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 56888899999999999999642 24579999886443 23346788999999999 8999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~ 311 (358)
..+++|||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+||+++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~ 171 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVT 171 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEc
Confidence 99999999999999999975321 123578888999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 312 ENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 312 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+++.+||+|||+++.+...... ......+++.|+|||++.+..++
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 217 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT 217 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC
Confidence 9999999999999887543322 12234567789999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-29 Score=203.54 Aligned_cols=172 Identities=26% Similarity=0.408 Sum_probs=147.0
Q ss_pred CCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|...++||+|.||+|++|+ +.+++.||+|+++-.. ........+|+.+++.++|.|||++++....+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 56678999999999999996 5678899999986443 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
| ..+|..|... .++.++.+.+..+..|+++||.|+|++ ++.||||||+|+||+.+|++|++|||++|.++-.-
T Consensus 83 c-dqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 C-DQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred h-hHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 9 5588888764 456688999999999999999999999 99999999999999999999999999999986432
Q ss_pred ceeeeecccccCCchhhhccCCC
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
...+..+-|..|.+|+++-|..
T Consensus 156 -rcysaevvtlwyrppdvlfgak 177 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGAK 177 (292)
T ss_pred -EeeeceeeeeeccCcceeeeee
Confidence 1234456788999999987754
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=218.01 Aligned_cols=175 Identities=25% Similarity=0.389 Sum_probs=146.8
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
++|.+.+.||+|+||.||+|....+..+++|.+.... ...+.+.+|++++++++|||++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999988777789999875433 33467889999999999999999998875 466899999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.+......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999753 234578899999999999999999998 9999999999999999999999999999887543322
Q ss_pred eeeecccccCCchhhhccCCCc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
......++..|+|||.+.+..+
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~ 180 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRF 180 (260)
T ss_pred ccCCCccchhhCCHHHhccCCc
Confidence 2233456788999999887654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=223.66 Aligned_cols=180 Identities=27% Similarity=0.417 Sum_probs=148.6
Q ss_pred cCCCcccceecCCccEEEEEEEEeC------CcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeCCE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 244 (358)
.++|+..+.||+|+||.||++.... ...+|+|.+..... ....++.+|+.++.++ +||||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 4678889999999999999997632 36799998865432 2335688899999999 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC
Q 018311 245 RILVYEYVNNGNLEQWLRGDM------------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE 312 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~ 312 (358)
.+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 999999999999999986431 1235688999999999999999999998 9999999999999999
Q ss_pred CCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCc
Q 018311 313 NFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 313 ~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
++.+||+|||+++.+...... ......++..|+|||++.+..+
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 211 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY 211 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc
Confidence 999999999999987543321 1222345678999999887665
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=229.75 Aligned_cols=172 Identities=28% Similarity=0.314 Sum_probs=143.9
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeC------C
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------T 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 243 (358)
.++|++.+.||+|+||.||+|.. ..++.||+|++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 37899999999999999999975 468889999986532 23345678899999999999999999987643 3
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
..|+||||++ ++|.+++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 5799999995 578777752 277888899999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
++...... ......||+.|+|||++.+.++.
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~ 203 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYK 203 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCC
Confidence 98765432 23446789999999999887753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=215.94 Aligned_cols=176 Identities=26% Similarity=0.387 Sum_probs=150.7
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|++.+.||+|+||.||+|.. .+++.|++|.+.... .....++..|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 366788999999999999976 468899999885432 33456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++... ....+++.....++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.+....
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999753 234688899999999999999999998 99999999999999999999999999998876433
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. ......|++.|+|||++.+.+++
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~ 179 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYN 179 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCC
Confidence 2 23345789999999999887653
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=219.49 Aligned_cols=178 Identities=24% Similarity=0.385 Sum_probs=151.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|.. .++..+++|.+.... .....++..|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999975 578999999875432 223357888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++++|.+++.........+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998864333345689999999999999999999998 999999999999999999999999999987653
Q ss_pred CCceeeeecccccCCchhhhccCCCc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
... ......|+..|+|||++.+.++
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~ 183 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGY 183 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCc
Confidence 322 2234578999999999977654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=223.40 Aligned_cols=179 Identities=26% Similarity=0.424 Sum_probs=147.8
Q ss_pred CCCcccceecCCccEEEEEEEEe-----------------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccc
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-----------------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRL 235 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-----------------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l 235 (358)
++|++.+.||+|+||.||++... ++..+|+|.+..... ....++..|+.++..++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 67899999999999999998532 234689998865432 334678899999999999999999
Q ss_pred cceEEeCCEEEEEEeecCCCCHHHHHhcccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcE
Q 018311 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCD-------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308 (358)
Q Consensus 236 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~Ni 308 (358)
++++...+..+++|||+++|+|.+++...... ...+++.+...++.|++.||.|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 99999999999999999999999998753211 13477889999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCc
Q 018311 309 LIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 309 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
++++++.+||+|||+++.+...... ...+..+++.|+|||...+.++
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 209 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF 209 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc
Confidence 9999999999999999876543322 2233455678999998877665
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=218.86 Aligned_cols=166 Identities=25% Similarity=0.395 Sum_probs=144.1
Q ss_pred cceecCCccEEEEEEE-EeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEEeecCCCC
Q 018311 179 DNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEYVNNGN 256 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~~gs 256 (358)
.+.||+|+|+.|.-|. ..+|..+|||.+.+.....+.+..+|++++..++ |+||+.++++|++++.+|||||.|.||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4789999999999995 6789999999998888888889999999999995 9999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC---CcEEEeeecCceecCCCC--
Q 018311 257 LEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN---FDAKISDFGLAKLLGAGK-- 331 (358)
Q Consensus 257 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~---~~~kl~DFGla~~~~~~~-- 331 (358)
|...++++ ..+++.++.++..+|+.||.|||.+ +|.||||||+|||-.+. .-+|||||.|+.-+..+.
T Consensus 163 lLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 99999843 4588999999999999999999999 99999999999998544 358999999986543211
Q ss_pred ----ceeeeecccccCCchhhhcc
Q 018311 332 ----SHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 332 ----~~~~~~~~Gt~~y~APE~l~ 351 (358)
.....+.+|+..|||||+..
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd 259 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVD 259 (463)
T ss_pred CCCCCccccCcccchhhcchhHHh
Confidence 12234578999999999863
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=221.21 Aligned_cols=175 Identities=25% Similarity=0.450 Sum_probs=146.4
Q ss_pred CCcccceecCCccEEEEEEEE-----eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeC--CEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRI 246 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 246 (358)
.|++.+.||+|+||.||+|++ .++..||+|.+.... ......+.+|+.+++.++||||+++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999974 357889999986443 23346788999999999999999999998765 5689
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999998642 23588999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCce--eeeecccccCCchhhhccCCCc
Q 018311 327 LGAGKSH--ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 327 ~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+...... ......++..|+|||++.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 189 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKF 189 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCC
Confidence 7543321 2234556778999999887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=217.20 Aligned_cols=170 Identities=27% Similarity=0.392 Sum_probs=141.4
Q ss_pred ceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCH
Q 018311 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL 257 (358)
+.||+|+||.||+|.. .+++.+|+|.+..... .....+.+|++++..++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999976 4788999998764432 3346688999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceee-e
Q 018311 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT-T 336 (358)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~-~ 336 (358)
.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.......... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9998642 23588999999999999999999998 999999999999999999999999999987643221111 1
Q ss_pred ecccccCCchhhhccCCCc
Q 018311 337 RVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 337 ~~~Gt~~y~APE~l~~~~~ 355 (358)
...++..|+|||.+.+..+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~ 173 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRY 173 (252)
T ss_pred CCCCceeecCchhhcCCCC
Confidence 1223457999999987765
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=218.31 Aligned_cols=176 Identities=20% Similarity=0.353 Sum_probs=149.1
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.++|++.+.||+|+||.||++...++..+++|.+... ....+.+.+|+++++.++|+||+++++.+.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678899999999999999998877888999987643 2234678899999999999999999999877 7789999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 83 AKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999999753 234578888999999999999999998 999999999999999999999999999987754433
Q ss_pred eeeeecccccCCchhhhccCCCc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.......++..|+|||++.+..+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~ 180 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSF 180 (260)
T ss_pred ccccCCcccccccCHhHhccCCc
Confidence 33334456778999999987654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=219.78 Aligned_cols=170 Identities=25% Similarity=0.335 Sum_probs=139.4
Q ss_pred ceecCCccEEEEEEEEeC---CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCC
Q 018311 180 NIIGDGGYGVVYRGQLMN---GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (358)
+.||+|+||.||+|.+.+ +..+++|++..... .....+.+|+.++++++||||+++++++......++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999997643 45789998865443 23356888999999999999999999999889999999999999
Q ss_pred CHHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce-
Q 018311 256 NLEQWLRGDMC-DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH- 333 (358)
Q Consensus 256 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~- 333 (358)
+|.+++..... .....++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975322 223456778889999999999999998 9999999999999999999999999999765433222
Q ss_pred eeeecccccCCchhhhccC
Q 018311 334 ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~ 352 (358)
......|+..|+|||++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDE 176 (269)
T ss_pred cCCCcCCcccccCHhHhcc
Confidence 1233567889999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=227.69 Aligned_cols=169 Identities=25% Similarity=0.358 Sum_probs=142.9
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeC------
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------ 242 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 242 (358)
..++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|++++..++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457899999999999999999975 5678999999864332 2235577899999999999999999987643
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
...|+++|++ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 4568999998 7899887752 3488999999999999999999999 99999999999999999999999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCC
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+++..... .....||+.|+|||++.+.
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~ 190 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNW 190 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCC
Confidence 99876532 2346789999999999773
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=220.10 Aligned_cols=176 Identities=27% Similarity=0.460 Sum_probs=145.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCc----EEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGT----AVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++|++.+.||+|+||+||+|++ .++. .||+|.+..... ....++..|+.++..+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 5688899999999999999975 3444 489998865433 334678889999999999999999999875 45789
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
++||+++|+|.+++... .+.+++..++.++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++.+
T Consensus 86 ~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999998742 34588999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCcee-eeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSHI-TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~~-~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
....... .....+++.|+|||.+.+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 189 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFT 189 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCC
Confidence 5433221 1223456789999999887653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=220.61 Aligned_cols=180 Identities=24% Similarity=0.381 Sum_probs=149.9
Q ss_pred cCCCcccceecCCccEEEEEEEEeC-----CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEe-CCEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQR 245 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 245 (358)
.++|++.+.||+|+||.||+|.... +..|++|++..... .....+.+|+.++.+++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999998765 68899998865432 234668889999999999999999998876 4678
Q ss_pred EEEEeecCCCCHHHHHhcccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeee
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCD----RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DF 321 (358)
++++||+++++|.+++...... ...+++.++..++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998754222 14588999999999999999999998 9999999999999999999999999
Q ss_pred cCceecCCCCcee-eeecccccCCchhhhccCCCc
Q 018311 322 GLAKLLGAGKSHI-TTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 322 Gla~~~~~~~~~~-~~~~~Gt~~y~APE~l~~~~~ 355 (358)
|+++.+.....+. .....++..|+|||++.+.++
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 196 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY 196 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCC
Confidence 9998775544332 223456778999999987765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=222.18 Aligned_cols=178 Identities=22% Similarity=0.361 Sum_probs=146.4
Q ss_pred CCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
+|.+.+.||+|+||.||+|... .++.||+|++...... ....+..|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667889999999999999753 2478999998654332 23568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc
Q 018311 248 VYEYVNNGNLEQWLRGDM------------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD 315 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~ 315 (358)
++||+++++|.+++.... .....+++..+..++.|++.||.|||+. +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985321 1123478888999999999999999998 9999999999999999999
Q ss_pred EEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCc
Q 018311 316 AKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 316 ~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+||+|||+++.+..... .......+++.|+|||++.+..+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF 203 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCC
Confidence 99999999987654332 22334556789999999876654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-28 Score=221.19 Aligned_cols=180 Identities=27% Similarity=0.441 Sum_probs=150.4
Q ss_pred CCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
.+|...++||+|+||.||+++.. ++..+++|.+........+.+..|++++..++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999642 356789998876555556789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcE
Q 018311 248 VYEYVNNGNLEQWLRGDMC-----------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~ 316 (358)
+|||+++++|.+++..... ....+++..++.++.|++.|+.|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999875321 113578899999999999999999998 99999999999999999999
Q ss_pred EEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 317 KISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 317 kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
||+|||+++........ ......+++.|+|||.+.+.+++
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 202 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 202 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC
Confidence 99999999876543321 22334567899999999887753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=249.51 Aligned_cols=181 Identities=26% Similarity=0.377 Sum_probs=147.0
Q ss_pred HhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEe--CCEE
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQR 245 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 245 (358)
...++|++.+.||+|+||+||+|.. .++..+|+|.+.... ......+..|+.++..|+||||++++++|.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3457899999999999999999976 456788999875432 2234568889999999999999999998865 3568
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeeCCCCCCcEEEcC---------
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE----PKVVHRDIKSSNILIDE--------- 312 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~----~~ivHrDlk~~NiLl~~--------- 312 (358)
|+||||+++|+|.++|.........+++..++.|+.||+.||.|||+... .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999997543334569999999999999999999998410 25999999999999964
Q ss_pred --------CCcEEEeeecCceecCCCCceeeeecccccCCchhhhccCC
Q 018311 313 --------NFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 313 --------~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.+.+||+|||+++.+.... ......||+.|+|||++.+.
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge 216 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHE 216 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhcc
Confidence 3458999999998765332 23456899999999999654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-29 Score=236.63 Aligned_cols=178 Identities=26% Similarity=0.416 Sum_probs=152.0
Q ss_pred hHHHhcCCCcccceecCCccEEEEEEEEeC-CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 168 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
+++....++....+||-|.||.||.|.|+. ...||||.++.+ ....++|..|..+|+.++|||+|+|+|+|.....+|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 334444566777899999999999999854 567999998665 445688999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
||+|||..|+|.+||++. .+..++.-..++++.||..||+||..+ ++|||||.++|||+.++..+||+||||+|+
T Consensus 340 IiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999865 445577788899999999999999999 999999999999999999999999999999
Q ss_pred cCCCCceeeeecccccCCchhhhcc
Q 018311 327 LGAGKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 327 ~~~~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
+...........--...|.|||-+.
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLA 439 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLA 439 (1157)
T ss_pred hcCCceecccCccCcccccCccccc
Confidence 8755443333334457899999874
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=219.83 Aligned_cols=169 Identities=21% Similarity=0.368 Sum_probs=137.0
Q ss_pred eecCCccEEEEEEEEeCCc---EEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCC
Q 018311 181 IIGDGGYGVVYRGQLMNGT---AVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGN 256 (358)
Q Consensus 181 ~lG~G~fg~V~~~~~~~~~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs 256 (358)
.||+|+||.||+++..++. .+++|.+.... ....+.+.+|+.++..++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999754433 45666665433 2345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC-ceee
Q 018311 257 LEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK-SHIT 335 (358)
Q Consensus 257 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~-~~~~ 335 (358)
|.+++.+.........+.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999975432334466777889999999999999998 99999999999999999999999999986533221 1123
Q ss_pred eecccccCCchhhhccC
Q 018311 336 TRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 336 ~~~~Gt~~y~APE~l~~ 352 (358)
....|+..|+|||++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~ 175 (268)
T cd05086 159 DDKCVPLRWLAPELVGE 175 (268)
T ss_pred cCCcCcccccCchhccc
Confidence 35678899999999854
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=219.84 Aligned_cols=179 Identities=24% Similarity=0.383 Sum_probs=149.0
Q ss_pred CCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|+..+.||+|+||.||+|... +.+.+++|.+...... ..+++..|++++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999753 3467899987654433 3467899999999999999999999999888999
Q ss_pred EEEeecCCCCHHHHHhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCD-----RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DF 321 (358)
+||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754311 12589999999999999999999998 9999999999999999999999999
Q ss_pred cCceecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 322 GLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 322 Gla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
|+++..............++..|+|||.+.+..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 195 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF 195 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCC
Confidence 9987654333333344567788999999876553
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=220.39 Aligned_cols=173 Identities=28% Similarity=0.395 Sum_probs=140.6
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcC---CCCccccccceEEe-----CC
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHV---RHKNLVRLLGYCIE-----GT 243 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~-----~~ 243 (358)
+|++.+.||+|+||+||+|.. .+++.||+|.+..... .....+.+|+.++..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 478889999999999999976 4688999998864322 2224456677776655 69999999998864 34
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
..+++|||++ ++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 5799999997 5898888643 234488999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
++.+.... ......||..|+|||++.+..+
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 184 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTY 184 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCC
Confidence 98765332 2334678999999999987765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=224.10 Aligned_cols=179 Identities=27% Similarity=0.404 Sum_probs=146.2
Q ss_pred CCCcccceecCCccEEEEEEEEe--------CCcEEEEEEecCCC-CcchHHHHHHHHHHhcC-CCCccccccceEEeCC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGT 243 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 243 (358)
++|.+.+.||+|+||.||++... +...+|+|.+.... .....++..|+.++..+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57889999999999999999752 23569999886543 23345688899999999 7999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~ 311 (358)
..++||||+++|+|.+++..... ....+++.+.+.++.|++.||.|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 99999999999999999975321 123588899999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCc
Q 018311 312 ENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 312 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+++.+||+|||+++.+...... ......+++.|+|||++.+..+
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 219 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 219 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC
Confidence 9999999999999876432211 1122234578999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=220.78 Aligned_cols=180 Identities=24% Similarity=0.395 Sum_probs=149.0
Q ss_pred cCCCcccceecCCccEEEEEEEEeC------CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 245 (358)
.++|++.+.||+|+||.||+|.... +..||+|.+..... .....+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3678889999999999999997632 36799998864432 2345688899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEe
Q 018311 246 ILVYEYVNNGNLEQWLRGDMC------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKIS 319 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~ 319 (358)
++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999965322 123478889999999999999999998 99999999999999999999999
Q ss_pred eecCceecCCCCc-eeeeecccccCCchhhhccCCCc
Q 018311 320 DFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 320 DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
|||+++.+..... .......++..|+|||.+.+..+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 198 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF 198 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCC
Confidence 9999987654322 12334567889999999876654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=221.35 Aligned_cols=172 Identities=25% Similarity=0.349 Sum_probs=149.5
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
++|++.+.||+|+||.||++.. .++..+++|.+........+.+..|++++++++||||+++++.+..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 5788899999999999999976 468899999987655555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999998642 34588999999999999999999999 999999999999999999999999999877543222
Q ss_pred eeeeecccccCCchhhhccC
Q 018311 333 HITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~ 352 (358)
......|++.|+|||++.+
T Consensus 159 -~~~~~~~~~~y~~PE~~~~ 177 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVAC 177 (280)
T ss_pred -ccceeecchhhcCHHHHhh
Confidence 2334678999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=220.06 Aligned_cols=172 Identities=24% Similarity=0.342 Sum_probs=148.6
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
++|++.+.||+|+||.||+|+.. +++.+++|.+........+.+..|+.+++.++||||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999764 58899999987655555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|..++.+. ...+++..+..++.|++.+|.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 999999887642 34588999999999999999999998 99999999999999999999999999987653321
Q ss_pred eeeeecccccCCchhhhccC
Q 018311 333 HITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~ 352 (358)
.......+++.|+|||++.+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~ 184 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMC 184 (292)
T ss_pred cccceecCCccccCceeecc
Confidence 22334678999999999853
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=240.54 Aligned_cols=177 Identities=21% Similarity=0.333 Sum_probs=148.2
Q ss_pred CCCcccceecCCccEEEEEEEEeC-CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.-|.++..||.|+||.||+|..++ +...|.|.+.........++..||+||+.+.||+||+|++.|+..+.+||+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 345667889999999999997544 3445666665555666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
.||-....+.. -...|++.+...+++|++.||.|||++ +|||||||+.|||+.-+|.++|+|||.+..... ..
T Consensus 112 ~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TR 184 (1187)
T ss_pred CCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HH
Confidence 99999988764 345699999999999999999999999 999999999999999999999999998765321 11
Q ss_pred eeeeecccccCCchhhhcc-----CCCccc
Q 018311 333 HITTRVMGTFGDFSVTLLR-----NMPILV 357 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~-----~~~~~~ 357 (358)
.....++|||.|||||++. ..||.|
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDy 214 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDY 214 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchh
Confidence 2345689999999999864 456654
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=220.48 Aligned_cols=178 Identities=27% Similarity=0.408 Sum_probs=145.5
Q ss_pred CCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
+|++.+.||+|+||.||+|... ....+++|.+..... ....++..|+.++..++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999753 235688888765443 234568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 018311 248 VYEYVNNGNLEQWLRGDMC--------------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSN 307 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~N 307 (358)
+|||+++|+|.+++..... ....+++...+.++.|++.||.|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999864211 123478899999999999999999998 99999999999
Q ss_pred EEEcCCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCc
Q 018311 308 ILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 308 iLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
|++++++.+||+|||+++.+...... ......++..|+|||++.+..+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 206 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY 206 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc
Confidence 99999999999999999876433221 2233456778999999877654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=221.12 Aligned_cols=173 Identities=24% Similarity=0.361 Sum_probs=151.5
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+..|+.+++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6789999999999999999975 578999999987655555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++.+ ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999863 3478889999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeeecccccCCchhhhccCCCc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
......|++.|+|||.+.+..+
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~ 192 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAY 192 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCC
Confidence 2234578999999999988754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=218.06 Aligned_cols=162 Identities=24% Similarity=0.344 Sum_probs=135.9
Q ss_pred ceecCCccEEEEEEEEeC-------------CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 180 NIIGDGGYGVVYRGQLMN-------------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
+.||+|+||.||+|.+.. ...|++|.+..........+..|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997522 2358888876554444567888999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc-------EEEe
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD-------AKIS 319 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~-------~kl~ 319 (358)
++|||+++|+|..++... ...+++.....++.|++.||.|||+. +|+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999988642 34588999999999999999999998 9999999999999987664 8999
Q ss_pred eecCceecCCCCceeeeecccccCCchhhhccC
Q 018311 320 DFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 320 DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
|||++..+... ....|+..|+|||++.+
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~ 182 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVED 182 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcC
Confidence 99998765422 23568889999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=216.29 Aligned_cols=161 Identities=25% Similarity=0.410 Sum_probs=136.6
Q ss_pred ceecCCccEEEEEEEEeCCc-----------EEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 180 NIIGDGGYGVVYRGQLMNGT-----------AVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999875432 5777776544333 5778899999999999999999999988 788999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-------cEEEeee
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-------DAKISDF 321 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~-------~~kl~DF 321 (358)
|||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999753 22588999999999999999999998 999999999999999888 7999999
Q ss_pred cCceecCCCCceeeeecccccCCchhhhccCC
Q 018311 322 GLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 322 Gla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
|+++.+.. .....++..|+|||++.+.
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~ 179 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNG 179 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCC
Confidence 99988654 2234677889999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=215.61 Aligned_cols=168 Identities=27% Similarity=0.447 Sum_probs=138.5
Q ss_pred eecCCccEEEEEEEEe---CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCC
Q 018311 181 IIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGN 256 (358)
Q Consensus 181 ~lG~G~fg~V~~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs 256 (358)
.||+|+||.||+|.+. .+..||+|.+..... ...+++.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 355799998865433 23466889999999999999999999875 457899999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeee
Q 018311 257 LEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336 (358)
Q Consensus 257 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 336 (358)
|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.+.........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99998742 34588999999999999999999998 9999999999999999999999999999876544332222
Q ss_pred e--cccccCCchhhhccCCCc
Q 018311 337 R--VMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 337 ~--~~Gt~~y~APE~l~~~~~ 355 (358)
. ..+++.|+|||++.+.++
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKF 175 (257)
T ss_pred cCCCCCCcccCCHHHHccCCC
Confidence 2 233578999999987664
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=214.94 Aligned_cols=175 Identities=27% Similarity=0.477 Sum_probs=148.4
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
.+|++.+.||+|+||.||++.+.++..+|+|.+.... ....++..|++++..++||||+++++++......+++|||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677889999999999999988778899999886433 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+++|.+++... ...++++.+..++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999998742 34578899999999999999999998 9999999999999999999999999999876543222
Q ss_pred eeeecccccCCchhhhccCCCc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
......++.+|+|||++.+..+
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~ 178 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKY 178 (256)
T ss_pred ccCCCccchhhcCHhHhccCCc
Confidence 2223345678999999987654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=218.55 Aligned_cols=173 Identities=28% Similarity=0.412 Sum_probs=149.5
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|++.+.||+|+||.||+|.. .+++.|++|++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477889999999999999986 468999999986543 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+ +++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++..+....
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998643 25589999999999999999999998 99999999999999999999999999998876543
Q ss_pred ceeeeecccccCCchhhhccCCC
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
........|+..|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~ 176 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGAR 176 (286)
T ss_pred CCccccccCcccccCceeeeccc
Confidence 32334567899999999987543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=222.39 Aligned_cols=177 Identities=27% Similarity=0.398 Sum_probs=147.7
Q ss_pred CCCcccceecCCccEEEEEEEE------eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeCCEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 245 (358)
++|.+.+.||+|+||.||++.. ..+..+|+|.++.... ...+.+..|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 5688899999999999999964 2345799998865432 2345688999999999 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
+++|||+++|+|.++++... ...+++.+...++.|++.||.|||+. +++|+||||+|||++.++.+||+|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999997432 23488999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCce-eeeecccccCCchhhhccCCCc
Q 018311 326 LLGAGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 326 ~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.+...... ......++..|+|||++.+.++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 220 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVY 220 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCC
Confidence 76543221 2233456788999999887764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=220.66 Aligned_cols=173 Identities=23% Similarity=0.362 Sum_probs=150.8
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.+|+..+.||+|+||.||+|.. .+++.+++|.+........+.+..|+.++..+.||||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 6788999999999999999975 568899999987655555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++.+ ..+++.+...++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999863 2478889999999999999999999 999999999999999999999999999887644321
Q ss_pred eeeeecccccCCchhhhccCCCc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
......|++.|+|||.+.+..+
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~ 193 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAY 193 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCC
Confidence 1234578999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=217.15 Aligned_cols=176 Identities=24% Similarity=0.417 Sum_probs=141.0
Q ss_pred cccceecCCccEEEEEEEEeCC-c--EEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeC------CEE
Q 018311 177 SKDNIIGDGGYGVVYRGQLMNG-T--AVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------TQR 245 (358)
Q Consensus 177 ~~~~~lG~G~fg~V~~~~~~~~-~--~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~ 245 (358)
.+.+.||+|+||.||+|.+.+. . .+|+|.++... ....+.+..|++++..++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568999999999999987443 2 58999876442 23346688899999999999999999987532 246
Q ss_pred EEEEeecCCCCHHHHHhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 246 ILVYEYVNNGNLEQWLRGDMC--DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
+++|||+++|+|.+++..... ....+++.....++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999998753321 234588999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCceee-eecccccCCchhhhccCCCc
Q 018311 324 AKLLGAGKSHIT-TRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 324 a~~~~~~~~~~~-~~~~Gt~~y~APE~l~~~~~ 355 (358)
++.+........ ....+++.|+|||++.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 191 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY 191 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCc
Confidence 998754332211 22346778999999987654
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=217.26 Aligned_cols=174 Identities=28% Similarity=0.442 Sum_probs=146.1
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|++.+.||+|+||.||+|.. .++..||+|++.... ....+.+..|+.++..++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 467789999999999999976 468899999886432 22346688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
++ ++|.+++.... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 96 68988886432 235688999999999999999999998 99999999999999999999999999998765332
Q ss_pred ceeeeecccccCCchhhhccCCC
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.......+++.|+|||++.+..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~ 177 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSP 177 (285)
T ss_pred -ccccCCcccccccChHHhcCCC
Confidence 1223456789999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=213.92 Aligned_cols=175 Identities=23% Similarity=0.353 Sum_probs=150.4
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|+..+.||+|+||.||.++. .+++.+++|.+.... ....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 578899999999999999965 568899999875432 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++.... ...+++.....++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999987532 34588999999999999999999998 99999999999999999999999999998875433
Q ss_pred ceeeeecccccCCchhhhccCCCc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
. ......|++.|+|||++.+..+
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~ 178 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKY 178 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCC
Confidence 2 2345678999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=223.19 Aligned_cols=179 Identities=27% Similarity=0.411 Sum_probs=146.2
Q ss_pred CCCcccceecCCccEEEEEEEEe--------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeCC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGT 243 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 243 (358)
.+|.+.+.||+|+||.||+|+.. ....+|+|.++.... ....++..|++++.++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57888999999999999999642 245689998865432 3345688899999999 6999999999999989
Q ss_pred EEEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~ 311 (358)
..+++|||+++|+|.+++..... ....+++.....++.|++.||.|||+. +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 99999999999999999975321 124588999999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCc
Q 018311 312 ENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 312 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+++.+||+|||+++.+...... ......++..|+|||++.+.++
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 213 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY 213 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc
Confidence 9999999999999876532211 1122334568999999988765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=217.89 Aligned_cols=169 Identities=26% Similarity=0.366 Sum_probs=145.0
Q ss_pred CcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
|++.+.||+|+||.||+|... ++..+++|.+........+.+..|++++..++||||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566789999999999999764 4778888888655444556788899999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
++|..++.+ ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...... ..
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 999988764 234588999999999999999999998 99999999999999999999999999997754321 22
Q ss_pred eeecccccCCchhhhcc
Q 018311 335 TTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~ 351 (358)
.....|++.|+|||++.
T Consensus 160 ~~~~~~~~~y~aPE~~~ 176 (282)
T cd06643 160 RDSFIGTPYWMAPEVVM 176 (282)
T ss_pred cccccccccccCHhhcc
Confidence 34467899999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=233.52 Aligned_cols=179 Identities=25% Similarity=0.394 Sum_probs=151.7
Q ss_pred HhcCCCcccceecCCccEEEEEEEEeC-----CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCE
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 244 (358)
...+..+..++||+|-||.||+|.+.+ ...||||..+.+.. ...+.|..|..+|++++||||++++|+|.+ .+
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 334556677899999999999997533 23699999987553 445679999999999999999999999975 68
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.|+|||+++-|.|..||+.+ ...++..+...++.|++.||.|||+. ++|||||..+|||+...--+||+||||+
T Consensus 465 ~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred eeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 99999999999999999863 34588888999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
|.+........++..-...|||||.+.=.+++
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFT 570 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFT 570 (974)
T ss_pred hhccccchhhccccccceeecCccccchhccc
Confidence 99987665555555556799999998765543
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=216.16 Aligned_cols=175 Identities=25% Similarity=0.345 Sum_probs=145.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-----cchHHHHHHHHHHhcCCCCccccccceEEeC--CEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-----QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 245 (358)
++|++.+.||+|+||.||++.. .+++.|++|.+..... ...+.+.+|+.++.+++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5688899999999999999976 5588999998753221 1234678899999999999999999988763 467
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
+++|||+++++|.+++.. ...+++...+.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999873 23478888999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCc--eeeeecccccCCchhhhccCCCc
Q 018311 326 LLGAGKS--HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 326 ~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.+..... .......|+..|+|||++.+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCC
Confidence 7643211 11234578999999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=222.39 Aligned_cols=177 Identities=27% Similarity=0.451 Sum_probs=144.0
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCc--EEEEEEecCCC-CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGT--AVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.+.||+|+||.||+|.+. ++. .+++|.+.... ......+.+|++++.++ +||||+++++++...+..+++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888899999999999999864 444 46777765433 23345788899999999 899999999999999999999
Q ss_pred EeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcE
Q 018311 249 YEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~ 316 (358)
|||+++++|.+++..... ....+++.+++.++.|++.||.|||+. +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999974321 123578999999999999999999998 99999999999999999999
Q ss_pred EEeeecCceecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 317 KISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 317 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
||+|||+++...... ......++..|+|||++.+.++
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 200 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVY 200 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCC
Confidence 999999987532111 1122334678999999987765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=215.49 Aligned_cols=174 Identities=28% Similarity=0.449 Sum_probs=146.6
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcc---------hHHHHHHHHHHhcCCCCccccccceEEeCCE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA---------DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~---------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 244 (358)
+|.+.+.||+|+||.||+|.. .+++.+|+|.+....... .+.+..|+.++.+++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467788999999999999975 467899999886443221 2457789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.+++|||+++++|.+++.. .+.+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999974 34578889999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCce-----eeeecccccCCchhhhccCCCc
Q 018311 325 KLLGAGKSH-----ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 325 ~~~~~~~~~-----~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+.+...... ......|+..|+|||.+.+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 189 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSY 189 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCC
Confidence 887532211 1123568899999999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=218.84 Aligned_cols=173 Identities=21% Similarity=0.361 Sum_probs=146.6
Q ss_pred CCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
+|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.++.+++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5788899999999999999874 78999999886442 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|..++.... ....+++..+..++.|++.||.|||+.. +++|+||||+||+++.++.+||+|||++..+...
T Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999887431 2346899999999999999999999632 8999999999999999999999999999876432
Q ss_pred eeeeecccccCCchhhhccCC
Q 018311 333 HITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~ 353 (358)
......|++.|+|||++.+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~ 176 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSG 176 (286)
T ss_pred -ccccCCCccCccCcchhcCC
Confidence 22345688999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=214.73 Aligned_cols=171 Identities=33% Similarity=0.524 Sum_probs=147.7
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
++|++.+.||+|+||.||+|.. .++.||+|.+..... ..+.+..|+.++..++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 5688899999999999999987 478899999865544 45678899999999999999999999998999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+++|.+++... ....+++.....++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 84 KGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999753 223589999999999999999999998 999999999999999999999999999988743221
Q ss_pred eeeecccccCCchhhhccCCCc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
...++..|+|||++.+..+
T Consensus 158 ---~~~~~~~~~ape~~~~~~~ 176 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKF 176 (256)
T ss_pred ---cCCCcccccCchhhcCCcC
Confidence 2344678999999876654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=215.41 Aligned_cols=174 Identities=28% Similarity=0.427 Sum_probs=147.2
Q ss_pred CCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCc------chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
+|+..+.||+|+||.||+|...+++.+|+|.+...... ....+.+|+++++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46778999999999999998878999999988643211 124578899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++...
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999642 4578899999999999999999998 99999999999999999999999999998653
Q ss_pred CCC-----ceeeeecccccCCchhhhccCCCc
Q 018311 329 AGK-----SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 329 ~~~-----~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
... ........|+..|+|||++.+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 185 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGY 185 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCC
Confidence 211 112234578999999999987654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=216.20 Aligned_cols=177 Identities=23% Similarity=0.405 Sum_probs=143.6
Q ss_pred CcccceecCCccEEEEEEEEeC----CcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCE-----
Q 018311 176 FSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ----- 244 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 244 (358)
|.+.+.||+|+||.||+|.... +..||+|+++.... .....+..|++.+..++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999997642 36799999865432 233568899999999999999999998876544
Q ss_pred -EEEEEeecCCCCHHHHHhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeee
Q 018311 245 -RILVYEYVNNGNLEQWLRGDMC--DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (358)
Q Consensus 245 -~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DF 321 (358)
.+++|||+++|+|..++..... ....+++.....++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 7999999999999999854322 224588999999999999999999998 9999999999999999999999999
Q ss_pred cCceecCCCCcee-eeecccccCCchhhhccCCCc
Q 018311 322 GLAKLLGAGKSHI-TTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 322 Gla~~~~~~~~~~-~~~~~Gt~~y~APE~l~~~~~ 355 (358)
|+++.+....... .....++..|+|||.+.+.++
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY 192 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCC
Confidence 9998875433221 222345678999999887655
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=220.04 Aligned_cols=173 Identities=27% Similarity=0.391 Sum_probs=145.9
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++..++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5788899999999999999976 467899999986443 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
++ ++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 96 6999888642 34578899999999999999999998 99999999999999999999999999998754322
Q ss_pred ceeeeecccccCCchhhhccCCC
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
. ......+++.|+|||++.+..
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~ 180 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGST 180 (301)
T ss_pred C-cccccceeecccCcHHHhCCC
Confidence 1 223456789999999987643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=213.90 Aligned_cols=173 Identities=31% Similarity=0.428 Sum_probs=151.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
++|++.+.||+|+||.||+|.. .+++.+++|.+........+.+..|++++++++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 6788899999999999999976 457889999987655555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++..+....
T Consensus 83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 999999988742 24588999999999999999999998 99999999999999999999999999998765322
Q ss_pred eeeeecccccCCchhhhccCC
Q 018311 333 HITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.......++..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~ 176 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVE 176 (262)
T ss_pred hccccccCCccccCchhhccc
Confidence 123446789999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=219.87 Aligned_cols=183 Identities=25% Similarity=0.351 Sum_probs=150.5
Q ss_pred hHhhHHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEE--
Q 018311 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCI-- 240 (358)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-- 240 (358)
.++.+....++|++.+.||+|+||.||+|.. .+++.+|+|.+... .....++..|+.++.++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3455556678999999999999999999976 45788999987543 22345678899999999 6999999999884
Q ss_pred ---eCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEE
Q 018311 241 ---EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAK 317 (358)
Q Consensus 241 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~k 317 (358)
.++..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 34568999999999999998865433445688899999999999999999998 999999999999999999999
Q ss_pred EeeecCceecCCCCceeeeecccccCCchhhhccC
Q 018311 318 ISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 318 l~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
|+|||+++.+..... ......|++.|+|||++.+
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 198 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIAC 198 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhch
Confidence 999999987653321 2334579999999999853
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=216.47 Aligned_cols=172 Identities=28% Similarity=0.392 Sum_probs=146.6
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+..|+.++..++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999864 58899999886433 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|++++.|..++.. ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888877652 34589999999999999999999998 9999999999999999999999999999887543
Q ss_pred CceeeeecccccCCchhhhccCC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.. ......++..|+|||++.+.
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~ 175 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGD 175 (286)
T ss_pred cc-cccCcccccccCCHHHHhCC
Confidence 32 22335678899999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=216.75 Aligned_cols=175 Identities=26% Similarity=0.356 Sum_probs=145.1
Q ss_pred CCCcccceecCCccEEEEEEEEeC----CcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|.+.+.||+|+||.||+|...+ ...|++|...... ....+.+..|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 567888999999999999997643 2468999876554 3344678899999999999999999998875 567899
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++... ...+++..+..++.+++.||.|||+. +++|+||||+||+++.++.+||+|||+++.+.
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999743 23588999999999999999999998 99999999999999999999999999998875
Q ss_pred CCCceeeeecccccCCchhhhccCCCc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
...........++..|+|||.+.+.++
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~ 185 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRF 185 (270)
T ss_pred cccceecCCCCccccccChhhhccCCC
Confidence 443322333445678999999887765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=219.90 Aligned_cols=177 Identities=26% Similarity=0.277 Sum_probs=149.3
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc---chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|+..+.||+|+||.||+|... +++.+|+|.+...... ..+.+..|++++..++||||+++++.+...+..+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999764 4899999998654322 3456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+.+++|.+++... ....+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998743 234688999999999999999999998 999999999999999999999999999876542
Q ss_pred CCce----------------------------eeeecccccCCchhhhccCCCc
Q 018311 330 GKSH----------------------------ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 330 ~~~~----------------------------~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.... ......||..|+|||++.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 209 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC
Confidence 2110 1123578999999999987754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=217.16 Aligned_cols=176 Identities=30% Similarity=0.507 Sum_probs=145.3
Q ss_pred CCCcccceecCCccEEEEEEEEeC-C---cEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-G---TAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
+.|++.+.||+|+||.||+|.... + ..|++|.+.... .....+|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457788999999999999997643 3 369999886542 23346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++++|.+++... .+.+++...+.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998742 34588999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCcee--eeeccc--ccCCchhhhccCCCc
Q 018311 329 AGKSHI--TTRVMG--TFGDFSVTLLRNMPI 355 (358)
Q Consensus 329 ~~~~~~--~~~~~G--t~~y~APE~l~~~~~ 355 (358)
...... .....| +..|+|||++.+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 188 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcc
Confidence 432211 111122 457999999987765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=213.09 Aligned_cols=173 Identities=32% Similarity=0.495 Sum_probs=147.7
Q ss_pred ceecCCccEEEEEEEEeC----CcEEEEEEecCCCCcc-hHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQA-DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~----~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+.||+|+||.||+|.... +..+++|.+....... .+.+..|++++..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998753 7889999987654433 57788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 255 GNLEQWLRGDMCD-----RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 255 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
++|.+++...... ...+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999753211 36689999999999999999999998 999999999999999999999999999998765
Q ss_pred CCc-eeeeecccccCCchhhhccCCCc
Q 018311 330 GKS-HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 330 ~~~-~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
... .......+++.|+|||.+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIF 184 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCc
Confidence 332 22344667899999999887644
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=215.04 Aligned_cols=174 Identities=27% Similarity=0.413 Sum_probs=145.6
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
+++.....||+|+||.||+|.. .++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++++||+
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 4444557899999999999975 457789999887665555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCcEEEeeecCceecCC
Q 018311 253 NNGNLEQWLRGDMCDRGYL--TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKLLGA 329 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~-~~~~kl~DFGla~~~~~ 329 (358)
++++|.+++.... ..+ ++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++..+..
T Consensus 88 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 88 PGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred CCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 9999999997431 224 6788889999999999999998 9999999999999976 67999999999987643
Q ss_pred CCceeeeecccccCCchhhhccCCC
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
... ......|++.|+|||++.+.+
T Consensus 162 ~~~-~~~~~~~~~~~~aPE~~~~~~ 185 (268)
T cd06624 162 INP-CTETFTGTLQYMAPEVIDKGP 185 (268)
T ss_pred CCC-ccccCCCCccccChhhhcccc
Confidence 222 223356899999999986643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=219.06 Aligned_cols=162 Identities=23% Similarity=0.327 Sum_probs=134.0
Q ss_pred eecCCccEEEEEEEEeC-------------------------CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccc
Q 018311 181 IIGDGGYGVVYRGQLMN-------------------------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235 (358)
Q Consensus 181 ~lG~G~fg~V~~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 235 (358)
.||+|+||.||+|.... ...|++|.+.........++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999996421 13588888765444444568889999999999999999
Q ss_pred cceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-
Q 018311 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF- 314 (358)
Q Consensus 236 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~- 314 (358)
++++......++||||+++|+|..++.. ..+.+++..++.++.|++.||.|||++ +|+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 9999999999999999999999998864 234688999999999999999999998 999999999999997644
Q ss_pred ------cEEEeeecCceecCCCCceeeeecccccCCchhhhccCC
Q 018311 315 ------DAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 315 ------~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.+|++|||++...... ....++..|+|||.+.+.
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~ 195 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGG 195 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCC
Confidence 4899999998654322 224678899999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=218.37 Aligned_cols=173 Identities=27% Similarity=0.416 Sum_probs=147.4
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|+..+.||+|+||.||+|... +++.||+|.+...... ..+.+..|++++..++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999874 5889999987643322 34568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++++|..+... ...+++.....++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999988887653 23488999999999999999999998 9999999999999999999999999999886543
Q ss_pred CceeeeecccccCCchhhhccCCC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
. .......++..|+|||++.+.+
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~ 176 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDT 176 (286)
T ss_pred c-cccCcccceeeccCcHHhcccc
Confidence 3 2233456899999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=224.38 Aligned_cols=179 Identities=27% Similarity=0.411 Sum_probs=146.3
Q ss_pred CCCcccceecCCccEEEEEEEEeC--------CcEEEEEEecCCC-CcchHHHHHHHHHHhcC-CCCccccccceEEeCC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN--------GTAVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGT 243 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 243 (358)
.+|++.+.||+|+||.||+|.... +..+|+|.+.... ....+++..|++++.++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 568889999999999999996421 2368999876443 23346788999999999 7999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~ 311 (358)
..+++|||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 99999999999999999875321 223578899999999999999999998 999999999999999
Q ss_pred CCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCc
Q 018311 312 ENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 312 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+++.+||+|||+++.+...... ......++..|+|||++.+..+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 213 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY 213 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc
Confidence 9999999999999876543221 1222334578999999988765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=220.67 Aligned_cols=170 Identities=24% Similarity=0.333 Sum_probs=136.8
Q ss_pred cceecCCccEEEEEEEEe---CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEe--CCEEEEEEeecC
Q 018311 179 DNIIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRILVYEYVN 253 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv~e~~~ 253 (358)
..+||+|+||.||+|... ++..+|+|.+.... ....+.+|++++..++||||+++++++.. +...+++|||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999864 45789999886432 23457789999999999999999998854 467899999985
Q ss_pred CCCHHHHHhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----cCCCcEEEeeecCc
Q 018311 254 NGNLEQWLRGDMC-----DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLA 324 (358)
Q Consensus 254 ~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl----~~~~~~kl~DFGla 324 (358)
++|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 588887753211 223578899999999999999999998 99999999999999 56789999999999
Q ss_pred eecCCCCce--eeeecccccCCchhhhccCCC
Q 018311 325 KLLGAGKSH--ITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 325 ~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~ 354 (358)
+.+...... ......||+.|+|||++.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 191 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGAR 191 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCC
Confidence 987543322 233467899999999997743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=213.12 Aligned_cols=174 Identities=28% Similarity=0.412 Sum_probs=151.7
Q ss_pred CCCcccceecCCccEEEEEEEEeC-CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
++|+..+.||+|+||.||+|...+ +..+++|.+..... .+++.+|++++++++||||+++++++......|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678889999999999999998754 78999998865432 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++.. ....+++.....++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999864 234689999999999999999999998 999999999999999999999999999988754321
Q ss_pred eeeeecccccCCchhhhccCCCcc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......|+..|+|||++.+..++
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~ 177 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYN 177 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCC
Confidence 23445689999999999887653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=213.39 Aligned_cols=171 Identities=29% Similarity=0.417 Sum_probs=147.5
Q ss_pred CCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC-----CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP-----GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
+|+..+.||+|+||.||+|... ++..|++|.+.... ....+.+..|+.+++.++||||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999765 78999999885433 12345688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
+||+++++|.+++... ..+++.....++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999998742 4578899999999999999999998 99999999999999999999999999998865
Q ss_pred CCCceeeeecccccCCchhhhccCCC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
... ......|+..|+|||.+.+..
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~ 177 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQG 177 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCC
Confidence 432 234567899999999987654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=217.77 Aligned_cols=171 Identities=26% Similarity=0.346 Sum_probs=145.4
Q ss_pred CCcccceecCCccEEEEEEEE----eCCcEEEEEEecCCC----CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 245 (358)
+|++.+.||+|+||.||+|+. .+|..||+|.+.... ....+.+..|++++.++ +|+||+.+++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367789999999999999975 368899999986432 12335678899999999 599999999999998999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
++||||+++++|.+++.. ...+++.....++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999874 34578889999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCceeeeecccccCCchhhhccC
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
.+............|+..|+|||++.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 180 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRG 180 (290)
T ss_pred ecccccccccccccCCcccCChhhccC
Confidence 865433323345678999999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=202.90 Aligned_cols=180 Identities=24% Similarity=0.351 Sum_probs=149.6
Q ss_pred HHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEE
Q 018311 169 LQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 169 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 245 (358)
++...+....++.||+|++|.|-+-++ .+|...|+|++...- .+..+....|+.+..+. ..|.+|+++|.+......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 444455666678899999999988865 689999999996543 44557788899887765 689999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
|+.||.| ..+|..|-++-....+.+++...-+|+..+..||.|||++. .++|||+||.|||||.+|++|+||||++-
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 55888876554445667888888999999999999999975 89999999999999999999999999998
Q ss_pred ecCCCCceeeeecccccCCchhhhccCC
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.+-++- ..+...|+-.|||||.+..+
T Consensus 198 ~L~dSi--Akt~daGCkpYmaPEri~~e 223 (282)
T KOG0984|consen 198 YLVDSI--AKTMDAGCKPYMAPERINPE 223 (282)
T ss_pred eehhhh--HHHHhcCCCccCChhhcCcc
Confidence 875432 23447899999999998754
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=216.15 Aligned_cols=175 Identities=28% Similarity=0.478 Sum_probs=144.8
Q ss_pred CCCcccceecCCccEEEEEEEEeC-Cc----EEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-GT----AVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
.+|++.+.||+|+||.||+|.+.. |. .+|+|.+..... ....++.+|+.++.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999997632 32 589998765543 234678889999999999999999999987 78899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
+|||+++|+|.+++... ...+++.....++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.+
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999753 33488999999999999999999998 9999999999999999999999999999887
Q ss_pred CCCCceee-eecccccCCchhhhccCCCc
Q 018311 328 GAGKSHIT-TRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 328 ~~~~~~~~-~~~~Gt~~y~APE~l~~~~~ 355 (358)
........ ....++..|+|||.+.+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 188 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIY 188 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCc
Confidence 64332221 12233578999999877654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=232.11 Aligned_cols=167 Identities=32% Similarity=0.453 Sum_probs=146.0
Q ss_pred eecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCHHH
Q 018311 181 IIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQ 259 (358)
Q Consensus 181 ~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 259 (358)
+||+|.||+||-|+.. +....|||.+........+-+..||.+.+.|+|.|||+++|.+..++.+-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999764 455689998876666666778899999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCcEEEeeecCceecCCCCceeee
Q 018311 260 WLRGDMCDRGYL--TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITT 336 (358)
Q Consensus 260 ~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~-~~~~~kl~DFGla~~~~~~~~~~~~ 336 (358)
+|+.. .+++ .+.+.-.+.+||+.||.|||.+ .|||||||-+|||++ -.|.+||+|||.++.+.. -...+.
T Consensus 662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TE 734 (1226)
T KOG4279|consen 662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTE 734 (1226)
T ss_pred HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccc
Confidence 99853 3455 6778888999999999999999 999999999999997 578999999999998743 344677
Q ss_pred ecccccCCchhhhccCCC
Q 018311 337 RVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 337 ~~~Gt~~y~APE~l~~~~ 354 (358)
++.||..|||||++...|
T Consensus 735 TFTGTLQYMAPEvIDqG~ 752 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGP 752 (1226)
T ss_pred ccccchhhhChHhhccCC
Confidence 899999999999997665
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=213.82 Aligned_cols=170 Identities=30% Similarity=0.462 Sum_probs=144.1
Q ss_pred ceecCCccEEEEEEEEeC--C--cEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQLMN--G--TAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
++||+|+||.||+|.+.+ + ..||+|.+..... ...+++..|+.++.+++||||+++++.+.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 2 3689999876655 455788999999999999999999999988 889999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce-
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH- 333 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~- 333 (358)
++|.+++..... ..+++.....++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.+......
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999975421 4688999999999999999999998 9999999999999999999999999999987653322
Q ss_pred -eeeecccccCCchhhhccCCCc
Q 018311 334 -ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 334 -~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
......++..|+|||++.+..+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~ 177 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTF 177 (257)
T ss_pred ecccCCCCCceecCHHHhcccCc
Confidence 1223567889999999887664
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=212.84 Aligned_cols=170 Identities=32% Similarity=0.473 Sum_probs=143.6
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEE-eCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI-EGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lv~e~~ 252 (358)
.+|++.+.||+|+||.||++.. .+..+++|.+.... ..+.+..|+.++++++|+|++++++++. .++..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4688889999999999999976 47789999875432 3467889999999999999999999765 456789999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++.+. ....+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999998753 223478899999999999999999998 99999999999999999999999999998754322
Q ss_pred eeeeecccccCCchhhhccCCCc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
....++..|+|||++.+..+
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~ 176 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKF 176 (256)
T ss_pred ---CCCccceeecCHHHHccCCC
Confidence 23345678999999987755
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=218.54 Aligned_cols=178 Identities=27% Similarity=0.419 Sum_probs=143.4
Q ss_pred CCCcccceecCCccEEEEEEEEeC-C--cEEEEEEecCCC-CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-G--TAVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.+.||+|+||.||+|...+ + ..+++|.++... ....+.+..|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 568889999999999999997643 3 247888776432 23346788899999999 799999999999998999999
Q ss_pred EeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcE
Q 018311 249 YEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~ 316 (358)
|||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999965321 113588899999999999999999998 99999999999999999999
Q ss_pred EEeeecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 317 KISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 317 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
||+|||++....... .......+..|+|||++.+.++.
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 196 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYT 196 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCC
Confidence 999999987532111 11112335679999999887653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=250.81 Aligned_cols=166 Identities=30% Similarity=0.504 Sum_probs=139.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
..+...++||+|+||.||+|.. .++..||+|++...... ...|++.+++++||||++++++|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 3466678999999999999986 57899999988643322 234688999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++|+|.++++. ++|..+..++.|++.||+|||..+.++|+||||||+||+++.++..++. ||.+......
T Consensus 766 ~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 766 EGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 99999999952 7899999999999999999996555699999999999999999988886 7766543221
Q ss_pred eeeeecccccCCchhhhccCCCcc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
....||+.|+|||++.+.+|+
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~ 856 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDIT 856 (968)
T ss_pred ---CCccccccccCcccccCCCCC
Confidence 234789999999999987764
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=216.00 Aligned_cols=174 Identities=29% Similarity=0.451 Sum_probs=142.8
Q ss_pred CCC-cccceecCCccEEEEEEEE-----eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeC--CE
Q 018311 174 NRF-SKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQ 244 (358)
Q Consensus 174 ~~~-~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~ 244 (358)
++| ++.+.||+|+||+||++.. .++..||+|.+..... .....+.+|++++.+++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 7889999999999988643 3577899999865432 3446788999999999999999999988653 46
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.+++|||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccc
Confidence 8999999999999999864 2488999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCce--eeeecccccCCchhhhccCCCc
Q 018311 325 KLLGAGKSH--ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 325 ~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+.+...... ......++..|+|||++.+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~ 187 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKF 187 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCC
Confidence 876543221 1122345667999999887654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=215.55 Aligned_cols=174 Identities=26% Similarity=0.423 Sum_probs=146.1
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEeC------C
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG------T 243 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~------~ 243 (358)
+.++|+..+.||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 346788889999999999999976 457889999885443 3446788899999998 699999999998753 4
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
..+++|||+++++|.+++... ....+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 689999999999999998753 234588999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccC
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
++.+..... ......|++.|+|||++.+
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~ 185 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIAC 185 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhcc
Confidence 987643221 2345679999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=212.41 Aligned_cols=167 Identities=27% Similarity=0.427 Sum_probs=138.7
Q ss_pred eecCCccEEEEEEEE---eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCC
Q 018311 181 IIGDGGYGVVYRGQL---MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (358)
Q Consensus 181 ~lG~G~fg~V~~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (358)
.||+|+||.||+|.+ .++..+|+|.+..... ...+++..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 3578899998864432 23467889999999999999999999875 45678999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceee
Q 018311 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335 (358)
Q Consensus 256 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 335 (358)
+|.+++.. ...+++.....++.|++.||.|||++ +++||||||.||++++++.+||+|||+++.+........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999964 24588999999999999999999998 999999999999999999999999999988765433221
Q ss_pred --eecccccCCchhhhccCCCc
Q 018311 336 --TRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 336 --~~~~Gt~~y~APE~l~~~~~ 355 (358)
....++..|+|||.+.+.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKF 175 (257)
T ss_pred ecCCCCCCccccCHhHhccCCc
Confidence 22344679999999877654
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=219.55 Aligned_cols=172 Identities=27% Similarity=0.363 Sum_probs=146.8
Q ss_pred CcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
|.....||+|+||.||++.. .++..||+|.+........+.+..|+.++..++||||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 34456799999999999975 46889999998665555556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
++|.+++.. ..+++.....++.|++.||.|||+. +++||||||+||++++++.+||+|||++..+.... ..
T Consensus 104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~ 174 (292)
T cd06658 104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PK 174 (292)
T ss_pred CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-cc
Confidence 999998853 3478899999999999999999998 99999999999999999999999999997654322 22
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....|+..|+|||++.+.+++
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~ 196 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYG 196 (292)
T ss_pred CceeecCccccCHHHHccCCCC
Confidence 3346789999999999876653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=218.25 Aligned_cols=173 Identities=23% Similarity=0.374 Sum_probs=151.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.+|+..+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 5688999999999999999964 578999999986655555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|..++.. ..+++.++..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++..+.....
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998863 3478999999999999999999999 999999999999999999999999999987654322
Q ss_pred eeeeecccccCCchhhhccCCCc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
......|++.|+|||.+.+..+
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~ 192 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAY 192 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCC
Confidence 2234578999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=217.13 Aligned_cols=172 Identities=27% Similarity=0.414 Sum_probs=145.1
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|+..+.||+|+||.||+|.. .+|+.+++|.+.... ......+..|++++.+++||||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 477889999999999999976 468899999886432 22235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
++ ++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 5888887642 34589999999999999999999998 99999999999999999999999999998765432
Q ss_pred ceeeeecccccCCchhhhccCCC
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
. ......+++.|+|||++.+..
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~ 175 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAK 175 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCc
Confidence 2 123456789999999987754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=212.25 Aligned_cols=173 Identities=29% Similarity=0.423 Sum_probs=149.4
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|+..+.||+|+||.||+|.. .+++.+++|.+...... ..+.+..|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 577889999999999999976 46889999998755443 456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++.. ...+++..+..++.+++.||.|||+. +++|+||+|+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999874 34578889999999999999999998 99999999999999999999999999998875433
Q ss_pred ceee---eecccccCCchhhhccCCC
Q 018311 332 SHIT---TRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 332 ~~~~---~~~~Gt~~y~APE~l~~~~ 354 (358)
.... ....+++.|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~ 179 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGK 179 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCC
Confidence 2221 2357889999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=218.36 Aligned_cols=175 Identities=25% Similarity=0.337 Sum_probs=145.4
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|+..+.||+|+||.||++.. .+++.|++|.+..... ...+.+..|++++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3678889999999999999976 4578899998865432 23356778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++++|.+++.. .+.+++.....++.|++.||.|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999974 24588899999999999999999998 999999999999999999999999999874211
Q ss_pred CCc--------------eeeeecccccCCchhhhccCCCc
Q 018311 330 GKS--------------HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 330 ~~~--------------~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
... .......|+..|+|||.+.+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 193 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCC
Confidence 100 01123467889999999877654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-27 Score=216.41 Aligned_cols=170 Identities=29% Similarity=0.409 Sum_probs=145.0
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc-----chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-----ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
+|++.+.||+|+||.||+|.. .+++.|++|.+...... ....+..|++++..++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477788999999999999976 46899999998654432 234567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+ +|+|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 999999997431 3689999999999999999999999 99999999999999999999999999998875
Q ss_pred CCCceeeeecccccCCchhhhccC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
.... ......+++.|+|||++.+
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~ 176 (298)
T cd07841 154 SPNR-KMTHQVVTRWYRAPELLFG 176 (298)
T ss_pred CCCc-cccccccceeeeCHHHHhC
Confidence 4321 2233467889999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=218.47 Aligned_cols=175 Identities=26% Similarity=0.360 Sum_probs=145.1
Q ss_pred CCcccceecCCccEEEEEEEEe---CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeC--CEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM---NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRI 246 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 246 (358)
+|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++..++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999864 47899999987643 33346678899999999999999999999988 8899
Q ss_pred EEEeecCCCCHHHHHhcccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC----CCcEEEeee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDR-GYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE----NFDAKISDF 321 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~----~~~~kl~DF 321 (358)
+||||++ ++|.+++....... ..+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 57877775433222 3688899999999999999999999 9999999999999999 999999999
Q ss_pred cCceecCCCCc--eeeeecccccCCchhhhccCC
Q 018311 322 GLAKLLGAGKS--HITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 322 Gla~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~ 353 (358)
|+++.+..... .......+++.|+|||++.+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 190 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA 190 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCC
Confidence 99987654322 123346789999999988764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=215.84 Aligned_cols=173 Identities=31% Similarity=0.407 Sum_probs=148.1
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++.+.||+|+||.||+|... +++.|++|.+.... ....+.+..|++++++++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999764 57899999886432 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|++++.+..+... ...+++.....++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9988777665542 34488999999999999999999998 9999999999999999999999999999887654
Q ss_pred CceeeeecccccCCchhhhccCC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.........++..|+|||++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGD 176 (288)
T ss_pred ccccccCcccccCCcCCchhcCC
Confidence 43334456788999999999877
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=216.59 Aligned_cols=180 Identities=28% Similarity=0.373 Sum_probs=146.3
Q ss_pred CCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|.+.+.||+|+||.||+|.+. .+..|++|.+..... .....+..|+.+++.++|+||+++++++...+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 67888999999999999999774 356789998754432 23456889999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC---cEEEee
Q 018311 247 LVYEYVNNGNLEQWLRGDMC---DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF---DAKISD 320 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~---~~kl~D 320 (358)
++|||+++++|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999875421 123588999999999999999999998 999999999999998755 599999
Q ss_pred ecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 321 FGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 321 FGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
||+++.+...... .......+..|+|||++.+..++
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 199 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT 199 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcC
Confidence 9999887432221 11223445689999999876653
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=211.20 Aligned_cols=175 Identities=29% Similarity=0.472 Sum_probs=146.9
Q ss_pred CcccceecCCccEEEEEEEEeC-----CcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 176 FSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
+++.+.||.|+||.||+|.... +..+|+|.+...... ..+.+..|++++..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3557899999999999998743 478999998655433 4567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++++|.+++.... ...+++.....++.|++.||.|||+. +++|+||||+||++++++.++|+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999987432 12288999999999999999999999 999999999999999999999999999988765
Q ss_pred CCceeeeecccccCCchhhhccCCCc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
..........+++.|+|||.+.+..+
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~ 181 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKF 181 (258)
T ss_pred ccccccccCCCcccccChHHhccCCC
Confidence 43322222347789999999865543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=213.43 Aligned_cols=174 Identities=26% Similarity=0.452 Sum_probs=146.6
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC------cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG------QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
+|+..+.||+|+||.||++.. .+++.+|+|.+..... ...+.+..|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467789999999999999975 6788999998864331 123568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-cEEEeeecCcee
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKL 326 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~-~~kl~DFGla~~ 326 (358)
||||+++++|.+++.+ .+.+++.....++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999874 24588899999999999999999999 999999999999998775 599999999987
Q ss_pred cCCCCc---eeeeecccccCCchhhhccCCCc
Q 018311 327 LGAGKS---HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 327 ~~~~~~---~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+..... .......|+..|+|||++.+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~ 185 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY 185 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCC
Confidence 754311 11234578999999999987665
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=215.92 Aligned_cols=173 Identities=24% Similarity=0.340 Sum_probs=144.4
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|.+.+.||+|+||.||+|.. .++..|++|.+..... .....+.+|+.++..++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46789999999999999999975 4688999999865432 233467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+. ++|.+++... ...+.+.....++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 995 7888777532 24477888899999999999999998 9999999999999999999999999999875432
Q ss_pred CceeeeecccccCCchhhhccCC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.. ......+++.|+|||++.+.
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~ 178 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGA 178 (291)
T ss_pred CC-CCCCccccccccCCceeecC
Confidence 21 22345679999999998763
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-27 Score=212.59 Aligned_cols=175 Identities=25% Similarity=0.374 Sum_probs=145.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-----cchHHHHHHHHHHhcCCCCccccccceEEe--CCEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-----QADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 245 (358)
.+|+..+.||+|+||.||+|.. .++..|++|++..... .....+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999975 4688999998854321 123457889999999999999999998875 3678
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999874 23478889999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCc--eeeeecccccCCchhhhccCCCc
Q 018311 326 LLGAGKS--HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 326 ~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.+..... .......++..|+|||++.+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCC
Confidence 7643211 11233568999999999988754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=213.35 Aligned_cols=176 Identities=30% Similarity=0.510 Sum_probs=145.6
Q ss_pred CCCcccceecCCccEEEEEEEEe-CC---cEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NG---TAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|+..+.||+|+||.||+|... ++ ..+++|.+.... ....+++..|++++.+++||||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 56778899999999999999764 23 368999886543 23346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++++|.+++... .+.+++.....++.|++.|+.|||+. +++|+||||+||++++++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999998742 34588999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeee--ecccccCCchhhhccCCCc
Q 018311 329 AGKSHITT--RVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 329 ~~~~~~~~--~~~Gt~~y~APE~l~~~~~ 355 (358)
........ ....+..|+|||++.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 187 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCc
Confidence 43221111 1223457999999887654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=215.06 Aligned_cols=177 Identities=24% Similarity=0.328 Sum_probs=146.4
Q ss_pred CCCcccceecCCccEEEEEEEEeC-----CcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEe-CCEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 245 (358)
..|+....||+|.||.||+|...+ .+.+|+|+++.... .......+|+.+++.++||||+.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 568889999999999999994322 34789999865432 223556789999999999999999999887 7789
Q ss_pred EEEEeecCCCCHHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC----CcEEEee
Q 018311 246 ILVYEYVNNGNLEQWLRGDMC-DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN----FDAKISD 320 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~----~~~kl~D 320 (358)
+|++||.+. ||.+.++-++. ..+.++...+..|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999955 99998876543 234688899999999999999999998 79999999999999766 8999999
Q ss_pred ecCceecCCCCce--eeeecccccCCchhhhccCCC
Q 018311 321 FGLAKLLGAGKSH--ITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 321 FGla~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~ 354 (358)
||++|.+...-.. ....++-|..|.|||+++|.+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~ 215 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR 215 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccc
Confidence 9999998654433 234577899999999999864
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=218.09 Aligned_cols=170 Identities=26% Similarity=0.345 Sum_probs=146.0
Q ss_pred cccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCC
Q 018311 177 SKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (358)
Q Consensus 177 ~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (358)
.....||+|+||.||++.. .+++.|++|.+........+.+.+|+.++..++||||+++++.+..++..+++|||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 3345799999999999975 468899999986554455567888999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceee
Q 018311 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335 (358)
Q Consensus 256 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~ 335 (358)
+|..++.. ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++..+.... ...
T Consensus 104 ~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 104 ALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred CHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 99997753 3478999999999999999999998 99999999999999999999999999997654322 123
Q ss_pred eecccccCCchhhhccCCCc
Q 018311 336 TRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 336 ~~~~Gt~~y~APE~l~~~~~ 355 (358)
....|+..|+|||++.+.++
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~ 194 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPY 194 (297)
T ss_pred cceecCccccCHHHHccCCC
Confidence 34678999999999987664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=234.35 Aligned_cols=176 Identities=28% Similarity=0.456 Sum_probs=149.3
Q ss_pred CCCcccceecCCccEEEEEEEEeC--Cc--EEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN--GT--AVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~--~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++.+..|+||+|.||.|++|.|.. |+ .||||.++..... ...+|.+|+.+|.+|+|||+++|||+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 344567899999999999998843 43 5899999876644 66899999999999999999999999987 778999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
+|+++.|+|.+.|++. ....|.......++.|||.||.||.++ ++|||||..+|+|+-..-.+|||||||.|.++
T Consensus 189 ~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence 9999999999999872 445577788899999999999999999 99999999999999999999999999999998
Q ss_pred CCCcee--eeecccccCCchhhhccCCCc
Q 018311 329 AGKSHI--TTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 329 ~~~~~~--~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.+.... ....--.+.|+|||.|+...+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kF 292 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKF 292 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccc
Confidence 766542 222333568999999987543
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=215.72 Aligned_cols=172 Identities=27% Similarity=0.407 Sum_probs=144.4
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67888999999999999999764 688999999865432 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
++ ++|.+++... ...+++.....++.|++.||.|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 97 5999988643 23578899999999999999999998 99999999999999999999999999987654221
Q ss_pred ceeeeecccccCCchhhhccCC
Q 018311 332 SHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
. ......++..|+|||++.+.
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~ 178 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGS 178 (291)
T ss_pred c-cccccccccccCCcHHhhcC
Confidence 1 12234578899999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=216.71 Aligned_cols=179 Identities=29% Similarity=0.414 Sum_probs=148.1
Q ss_pred CCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|+..+.||+|+||.||+|... ++..+|+|.+..... ...+++.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 67888999999999999999753 467899998865432 33467889999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHHhcccC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcE
Q 018311 247 LVYEYVNNGNLEQWLRGDMC------------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~Ni 308 (358)
++|||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhhe
Confidence 99999999999999964211 113477888999999999999999998 999999999999
Q ss_pred EEcCCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCc
Q 018311 309 LIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 309 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
++++++.+||+|||+++.+...... ......++..|+|||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 209 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY 209 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC
Confidence 9999999999999999876533221 1223345678999999887765
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=237.06 Aligned_cols=174 Identities=29% Similarity=0.473 Sum_probs=147.5
Q ss_pred CcccceecCCccEEEEEEEEe-C----CcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 176 FSKDNIIGDGGYGVVYRGQLM-N----GTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~-~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
.+..++||+|+||+||+|.|. . ..+||+|.+.... .+..+++..|+-.|.+++|||+++++++|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 345789999999999999762 2 3479999886554 445578999999999999999999999998765 88999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
+||+.|.|.+|++.+ +..+-.+..+.+..|||+||.|||.+ ++|||||.++|||+.+-..+||+|||+|+.+.+
T Consensus 777 q~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999874 45578899999999999999999999 999999999999999999999999999999876
Q ss_pred CCceeee-ecccccCCchhhhccCCCcc
Q 018311 330 GKSHITT-RVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~-~~~Gt~~y~APE~l~~~~~~ 356 (358)
....... ...-.+.|||-|.+...+|+
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~t 878 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYT 878 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCC
Confidence 5443222 12234689999999988886
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=216.35 Aligned_cols=173 Identities=23% Similarity=0.327 Sum_probs=148.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||+||++.. .+++.+|+|.+.... ....+.+..|++++..++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 5678889999999999999976 468889999876543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++.. .+.+++.....++.+++.||.|||+.. +++|+||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999998864 345889999999999999999999632 89999999999999999999999999987653221
Q ss_pred ceeeeecccccCCchhhhccCCCc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.....|+..|+|||++.+..+
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~ 179 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKY 179 (284)
T ss_pred ---cCccccCcccCCHHHHccCCC
Confidence 234679999999999877644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-27 Score=210.10 Aligned_cols=171 Identities=29% Similarity=0.431 Sum_probs=143.9
Q ss_pred ceecCCccEEEEEEEEeCCcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCHH
Q 018311 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLE 258 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~ 258 (358)
++||+|+||.||+|...+++.|++|.+...... ....+..|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999998867999999988655433 4467889999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceee-ee
Q 018311 259 QWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT-TR 337 (358)
Q Consensus 259 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~-~~ 337 (358)
+++... ...+++...+.++.+++.|+.|||+. +++||||||+||+++.++.+||+|||+++.......... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998642 23578889999999999999999998 999999999999999999999999999987653222111 22
Q ss_pred cccccCCchhhhccCCCcc
Q 018311 338 VMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 338 ~~Gt~~y~APE~l~~~~~~ 356 (358)
..++..|+|||++.+.++.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~ 173 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYT 173 (251)
T ss_pred CcceeccCChHhhccCCCC
Confidence 3346679999999876653
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-27 Score=214.42 Aligned_cols=174 Identities=25% Similarity=0.344 Sum_probs=142.6
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHH-HhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEA-IGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++.+.||+|+||.||++.. .+|+.||+|++.... .....++..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 3678889999999999999976 468999999986543 2233455556665 566789999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|++ |+|.+++.........+++..+..++.|++.||.|||++. +++||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 995 7898888654333456899999999999999999999742 7999999999999999999999999999876432
Q ss_pred CceeeeecccccCCchhhhccC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
. ..+...|+..|+|||++.+
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~ 177 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINP 177 (283)
T ss_pred c--ccccccCCccccChhhcCC
Confidence 1 2234678999999999865
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=209.96 Aligned_cols=175 Identities=24% Similarity=0.373 Sum_probs=146.7
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEe-CCEEEEEEe
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQRILVYE 250 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lv~e 250 (358)
.|++.+.||+|+||.||++.. .+++.+++|++.... ....+.+..|++++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 377889999999999999975 457889999985432 2334568889999999999999999988764 446899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++++|.+++... ....+++.++..++.+++.|+.|||+. +++|+||||+||+++.++.++|+|||++..+...
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999999753 234588999999999999999999999 9999999999999999999999999999877432
Q ss_pred CceeeeecccccCCchhhhccCCCc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
. .......|++.|+|||++.+..+
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~ 179 (257)
T cd08223 156 C-DMASTLIGTPYYMSPELFSNKPY 179 (257)
T ss_pred C-CccccccCCcCccChhHhcCCCC
Confidence 2 23345678999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-27 Score=212.83 Aligned_cols=173 Identities=25% Similarity=0.372 Sum_probs=150.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||.|+||.||+|.. .+++.+++|.+.... ......+..|+++++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3678889999999999999976 468899999886543 33346688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998642 588999999999999999999998 99999999999999999999999999998876432
Q ss_pred ceeeeecccccCCchhhhccCCCc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.......|++.|+|||++.+.++
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~ 175 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGY 175 (274)
T ss_pred -cccccccCCccccChhhhccCCC
Confidence 22345678999999999988764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-27 Score=219.14 Aligned_cols=170 Identities=20% Similarity=0.208 Sum_probs=139.6
Q ss_pred ccceecCC--ccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 178 KDNIIGDG--GYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 178 ~~~~lG~G--~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
+.++||+| +|++||++.. .+|+.||+|++..... .....+..|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7899999965 5789999999865432 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++|+|.+++..+. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++++||+.+..+.....
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999986432 23488999999999999999999998 999999999999999999999999987654422111
Q ss_pred e------eeeecccccCCchhhhccC
Q 018311 333 H------ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 333 ~------~~~~~~Gt~~y~APE~l~~ 352 (358)
. ......++..|+|||++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred cccccccccccccceecccChHHhhc
Confidence 0 1122456788999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-27 Score=212.85 Aligned_cols=173 Identities=28% Similarity=0.415 Sum_probs=145.5
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC---c-------chHHHHHHHHHHhcCCCCccccccceEEeCC
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---Q-------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT 243 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~-------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 243 (358)
+|...+.||+|+||.||+|.. .+++.+|+|.+..... . ..+.+..|+.++..++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467789999999999999965 4688999998753211 1 1235778999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
..++||||+++++|.+++.+. +.+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999743 4688899999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCce-eeeecccccCCchhhhccCCC
Q 018311 324 AKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 324 a~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~ 354 (358)
++........ ......|+..|+|||.+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 186 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186 (272)
T ss_pred cccccccccccccccccCCccccCHHHhcccc
Confidence 9875432221 233457899999999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-27 Score=211.91 Aligned_cols=171 Identities=26% Similarity=0.314 Sum_probs=148.9
Q ss_pred CCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
+|++.+.||+|+||.||+|... +++.+++|.+..... ...+.+.+|++++++++||||+++++.+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999764 688999998864332 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+.+++|.+++... ..+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999742 4688999999999999999999998 9999999999999999999999999999887543
Q ss_pred CceeeeecccccCCchhhhccCCC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
. ......|+..|+|||.+.+..
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~ 175 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQG 175 (258)
T ss_pred c--cccccCCChhhcCHHHHcccC
Confidence 2 234467889999999988755
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=231.20 Aligned_cols=177 Identities=28% Similarity=0.438 Sum_probs=152.2
Q ss_pred HhcCCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEe-----CC
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIE-----GT 243 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~-----~~ 243 (358)
..+..|++.++||+|.+|.||+++ ..+++.+|+|++.... ...++.+.|.++++.+ .|||++.++|+|.. ++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 344678899999999999999996 4678889998775443 3456778888999887 69999999999873 58
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
++|||||||.+|+..++.++.. ...+.|....+|+..++.|+.+||.. .++|||||-.|||++.++.+||+|||.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeee
Confidence 8999999999999999988654 56799999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCCC
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
+..+... -...++.+|||.|||||++.-++
T Consensus 170 SaQldsT-~grRnT~iGtP~WMAPEViac~e 199 (953)
T KOG0587|consen 170 SAQLDST-VGRRNTFIGTPYWMAPEVIACDE 199 (953)
T ss_pred eeeeecc-cccccCcCCCcccccceeeeccc
Confidence 9998642 33567799999999999987543
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=215.41 Aligned_cols=163 Identities=22% Similarity=0.372 Sum_probs=137.0
Q ss_pred ceecCCccEEEEEEEEeC--------CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 180 NIIGDGGYGVVYRGQLMN--------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+.||+|+||.||+|.... ..++++|.+........+.+..|+.++..+.||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999996532 234888877554444456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc--------EEEeeecC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD--------AKISDFGL 323 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~--------~kl~DFGl 323 (358)
+++|+|.+++... ...+++...+.++.|++.||.|||+. +|+||||||+||+++.++. +|++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999753 23578899999999999999999998 9999999999999987765 69999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCC
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+...... ....++..|+|||++.+.
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~ 179 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENP 179 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCC
Confidence 8765432 235788999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-27 Score=217.26 Aligned_cols=176 Identities=27% Similarity=0.473 Sum_probs=143.2
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCc----EEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGT----AVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++|+..+.||+|+||.||+|.+. ++. .+|+|.+..... ....++..|+.++..++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56778899999999999999763 343 478888764432 2234688899999999999999999998754 5679
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
++||+++|+|.+++..+ ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.+
T Consensus 86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998743 23578889999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... ......++..|+|||++.+.+++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 189 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFT 189 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCC
Confidence 533221 12234457789999999887653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-27 Score=237.84 Aligned_cols=170 Identities=26% Similarity=0.330 Sum_probs=146.4
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|.+.+.||+|+||.||+|... +++.||+|.+..... .....+..|+.++..++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999874 688999999865432 22356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+.+++|.+++.. .+.+++..++.++.||+.||.|||.. +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 99999999999873 24578889999999999999999998 999999999999999999999999999998654
Q ss_pred CCceeeeecccccCCchhhhcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
... ......+|+.|++||...
T Consensus 157 ~~~-~~~~~~~t~~~~~pe~~~ 177 (669)
T cd05610 157 REL-NMMDILTTPSMAKPKNDY 177 (669)
T ss_pred Ccc-cccccccCccccCccccc
Confidence 322 234578899999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=220.25 Aligned_cols=163 Identities=23% Similarity=0.262 Sum_probs=128.2
Q ss_pred CCCcccceecCCccEEEEEEEEe--CCcEEEEEEecCCC-----CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM--NGTAVAVKKLLNNP-----GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|.+.+.||+|+||+||+|... +++.+|||++.... ......+.+|+++|.+++|+|++..+.. .+..+
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~ 94 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG 94 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence 67999999999999999999764 57778999875331 1224568899999999999999853322 24679
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCcEEEcCCCcEEEeeecCce
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDI-KSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDl-k~~NiLl~~~~~~kl~DFGla~ 325 (358)
+||||+++++|... . ... ...++.+++.+|.|||+. +|+|||| ||+|||++.++.+||+|||+|+
T Consensus 95 LVmE~~~G~~L~~~-~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 95 LVRGWTEGVPLHLA-R----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred EEEEccCCCCHHHh-C----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 99999999999632 1 111 145788999999999998 9999999 9999999999999999999999
Q ss_pred ecCCCCce-e------eeecccccCCchhhhccCC
Q 018311 326 LLGAGKSH-I------TTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 326 ~~~~~~~~-~------~~~~~Gt~~y~APE~l~~~ 353 (358)
.+...... . .....+++.|+|||++.-+
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 87643211 1 1357889999999998654
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=210.50 Aligned_cols=170 Identities=28% Similarity=0.449 Sum_probs=137.2
Q ss_pred ceecCCccEEEEEEEEe----CCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEe-CCEEEEEEeecC
Q 018311 180 NIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQRILVYEYVN 253 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lv~e~~~ 253 (358)
+.||+|+||.||+|... ....+|+|.+.... ....+.+..|+.+++.++||||+++++++.. ++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 23579999875432 2334678889999999999999999998764 556899999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+|+|.+++... ...+++...+.++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999742 23467778889999999999999998 9999999999999999999999999999876432211
Q ss_pred ---eeeecccccCCchhhhccCCCc
Q 018311 334 ---ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 334 ---~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
......+++.|+|||.+.+.++
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~ 179 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKF 179 (262)
T ss_pred eecccccCcCCccccChhHhccCcc
Confidence 1123456778999999887665
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=207.98 Aligned_cols=174 Identities=24% Similarity=0.413 Sum_probs=147.5
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|+..+.||+|+||.||+|.. .+++.+++|.+.... ......+..|+++++.++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999975 468889999886432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-CcEEEeeecCceecCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLLGAG 330 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~-~~~kl~DFGla~~~~~~ 330 (358)
+++++|.+++... ....+++..+..++.+++.||.|||++ +++|+||||+||+++++ +.+||+|||++..+...
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999753 234578899999999999999999998 99999999999999855 46899999999887543
Q ss_pred CceeeeecccccCCchhhhccCCCc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
. ......|+..|+|||.+.+..+
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~ 178 (256)
T cd08220 156 S--KAYTVVGTPCYISPELCEGKPY 178 (256)
T ss_pred c--cccccccCCcccCchhccCCCC
Confidence 2 2234678999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=210.08 Aligned_cols=175 Identities=25% Similarity=0.374 Sum_probs=145.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-----CcchHHHHHHHHHHhcCCCCccccccceEEeC--CEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-----GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 245 (358)
.+|++.+.||+|+||.||+|.. .+++.+++|.+.... ......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999975 568999999874321 22335688899999999999999999998764 568
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999863 24478889999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCc--eeeeecccccCCchhhhccCCCc
Q 018311 326 LLGAGKS--HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 326 ~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.+..... .......|+..|+|||++.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 186 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGY 186 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCC
Confidence 7643111 12234678999999999987643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=211.65 Aligned_cols=172 Identities=27% Similarity=0.454 Sum_probs=138.4
Q ss_pred ceecCCccEEEEEEEEeC-Cc--EEEEEEecCCC-CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQLMN-GT--AVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+.||+|+||.||+|...+ +. .+++|.+.... ....+.+..|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998643 43 46888776433 33446788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 255 GNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 255 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
|+|.+++..... ....+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999875321 113478899999999999999999998 99999999999999999999999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+++...... .......+..|+|||++.+.+++
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~ 189 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYT 189 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCC
Confidence 986432111 11122346689999999877653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=214.15 Aligned_cols=173 Identities=28% Similarity=0.419 Sum_probs=147.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+.|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+..|++++++++||||+++++++..++..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 3466678999999999999975 457889999876443 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.+||+|||++..+....
T Consensus 84 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 999999998853 3578899999999999999999998 99999999999999999999999999998765432
Q ss_pred ceeeeecccccCCchhhhccCCCc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
. ......|+..|+|||++.+..+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~ 178 (277)
T cd06642 156 I-KRNTFVGTPFWMAPEVIKQSAY 178 (277)
T ss_pred h-hhhcccCcccccCHHHhCcCCC
Confidence 1 2233568899999999988754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=214.25 Aligned_cols=173 Identities=24% Similarity=0.370 Sum_probs=149.6
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.+|++.+.||+|+||.||++.. .+++.+++|.+........+.+..|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788899999999999999965 467889999986544444567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++.+ ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++..+.....
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999863 2477889999999999999999999 999999999999999999999999999887654322
Q ss_pred eeeeecccccCCchhhhccCCCc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
......|++.|+|||.+.+..+
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~ 192 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAY 192 (293)
T ss_pred -ccccccCChhhcCchhhccCCC
Confidence 2234578999999999877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=211.50 Aligned_cols=172 Identities=25% Similarity=0.365 Sum_probs=148.7
Q ss_pred CCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
+|+..+.||+|+||.||++... +++.+++|.+..... ...+++.+|++++++++||||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677889999999999999764 688999998866543 34467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
++++|.+++... ...+++.....++.|++.||.|||+ . +++|+||||+||++++++.+||+|||++..+....
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999998743 2568889999999999999999999 7 99999999999999999999999999987764322
Q ss_pred ceeeeecccccCCchhhhccCCCc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
. ....++..|+|||.+.+.++
T Consensus 156 ~---~~~~~~~~y~~PE~~~~~~~ 176 (265)
T cd06605 156 A---KTFVGTSSYMAPERIQGNDY 176 (265)
T ss_pred h---hcccCChhccCHHHHcCCCC
Confidence 1 12778999999999988755
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=208.97 Aligned_cols=177 Identities=29% Similarity=0.437 Sum_probs=148.3
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEe--CCEEEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRILVY 249 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv~ 249 (358)
+|++.+.||.|+||.||++.. .++..+++|.+.... ....+.+..|+++++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477789999999999999965 567899999886433 2234568889999999999999999998764 45689999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH-----EAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-----~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
||+++++|.+++.........+++...+.++.|++.||.||| +. +++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999754334567899999999999999999999 66 9999999999999999999999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
..+..... ......|++.|+|||++.+..+
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~ 187 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSY 187 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCC
Confidence 98764432 1234578999999999987764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=210.73 Aligned_cols=176 Identities=28% Similarity=0.438 Sum_probs=146.8
Q ss_pred CCCcccceecCCccEEEEEEEEe-----CCcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEe--CCEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 245 (358)
..|++.+.||+|+||.||++.+. ++..+|+|.+...... ..+++..|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677899999999999999753 3678999998755443 45679999999999999999999999877 5578
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
+++|||+++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999753 23588999999999999999999998 99999999999999999999999999999
Q ss_pred ecCCCCce--eeeecccccCCchhhhccCCCc
Q 018311 326 LLGAGKSH--ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 326 ~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.+...... ......++..|+|||.+.+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 189 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKF 189 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCC
Confidence 87633221 1122345567999999887664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=208.56 Aligned_cols=175 Identities=23% Similarity=0.394 Sum_probs=148.9
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|++.+.||+|+||.+|++.. .+++.+++|.+.... ....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999965 568899999886432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988643 223478899999999999999999998 99999999999999999999999999998765432
Q ss_pred ceeeeecccccCCchhhhccCCCc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
. ......|++.|+|||++.+..+
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~ 178 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPY 178 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCC
Confidence 2 2234568999999999987764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=213.58 Aligned_cols=173 Identities=28% Similarity=0.359 Sum_probs=145.1
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeC--CEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lv 248 (358)
++|+..+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999874 588999999864432 2224567899999999999999999998877 889999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||++ ++|.+++... ...+++.....++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.+.
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99996 5999988642 23589999999999999999999998 99999999999999999999999999998875
Q ss_pred CCCceeeeecccccCCchhhhccCCC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
... .......+++.|+|||++.+.+
T Consensus 158 ~~~-~~~~~~~~~~~~~aPE~~~~~~ 182 (293)
T cd07843 158 SPL-KPYTQLVVTLWYRAPELLLGAK 182 (293)
T ss_pred CCc-cccccccccccccCchhhcCCc
Confidence 432 1223456789999999987643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=213.35 Aligned_cols=183 Identities=27% Similarity=0.383 Sum_probs=150.9
Q ss_pred HhhHHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEeC-
Q 018311 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG- 242 (358)
Q Consensus 166 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~- 242 (358)
+.++....++|++.+.||+|+||.||++.. .+++.+|+|.+.... .....+..|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 344455668899999999999999999976 568899999885432 2345677899999998 799999999998754
Q ss_pred ----CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEE
Q 018311 243 ----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318 (358)
Q Consensus 243 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl 318 (358)
+..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEE
Confidence 358999999999999998865433445688999999999999999999998 9999999999999999999999
Q ss_pred eeecCceecCCCCceeeeecccccCCchhhhccCC
Q 018311 319 SDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 319 ~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+|||+++.+..... ......|+..|+|||++.+.
T Consensus 170 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 203 (291)
T cd06639 170 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACE 203 (291)
T ss_pred eecccchhcccccc-cccCccCCccccChhhhcCC
Confidence 99999987653221 12345789999999998654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=209.28 Aligned_cols=169 Identities=32% Similarity=0.513 Sum_probs=142.5
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
++|++.+.||+|+||.||++.. +++.+|+|.+... .....+..|+.++.+++||||+++++++.. +..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 4688899999999999999975 6788999988543 234678899999999999999999998865 45799999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+++|.+++... ....+++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 82 KGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 99999999753 234578899999999999999999998 9999999999999999999999999999875432
Q ss_pred eeeecccccCCchhhhccCCCc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
......+..|+|||++.+.++
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~ 174 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKF 174 (254)
T ss_pred -CCCCCCCceecCHHHhccCCc
Confidence 122344678999999987665
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=211.71 Aligned_cols=176 Identities=25% Similarity=0.357 Sum_probs=147.7
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeC--CEEEEEEe
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRILVYE 250 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lv~e 250 (358)
+|+..+.||.|++|.||+|.. .+++.+|+|.+..... ....++.+|++++++++||||+++++++... +..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 577789999999999999986 4678899998864432 3446788999999999999999999988653 46899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++++|.+++.........+++.....++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999998764333345688899999999999999999998 9999999999999999999999999998776432
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. .....++..|+|||.+.+..++
T Consensus 159 ~---~~~~~~~~~y~~pE~~~~~~~~ 181 (287)
T cd06621 159 L---AGTFTGTSFYMAPERIQGKPYS 181 (287)
T ss_pred c---cccccCCccccCHHHhcCCCCC
Confidence 2 2245678899999999887654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=208.18 Aligned_cols=174 Identities=26% Similarity=0.416 Sum_probs=151.6
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|++|.||+|... +++.+++|++..... .....+..|+..+.+++|+||+++++++......+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 35788899999999999999775 589999999865543 3457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
+++++|.+++... ..+++.....++.|++.|+.|||+ . +++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999743 568899999999999999999999 8 9999999999999999999999999999887543
Q ss_pred CceeeeecccccCCchhhhccCCCc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.. ......++..|+|||.+.+..+
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~ 177 (264)
T cd06623 154 LD-QCNTFVGTVTYMSPERIQGESY 177 (264)
T ss_pred CC-cccceeecccccCHhhhCCCCC
Confidence 32 2234578999999999887754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=211.06 Aligned_cols=169 Identities=28% Similarity=0.497 Sum_probs=146.5
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCC---CCccccccceEEeCCEEEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lv~ 249 (358)
.|+..+.||+|+||.||+|.. .+++.+++|.+.... ....+++.+|+.+++.++ |||++++++++......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999976 568899999886543 334467888999999986 999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++++|.+++.. ..+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998863 2588999999999999999999998 999999999999999999999999999988765
Q ss_pred CCceeeeecccccCCchhhhccC
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
... ......|+..|+|||++.+
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~ 175 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITE 175 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhcc
Confidence 432 2344579999999999865
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=208.10 Aligned_cols=168 Identities=28% Similarity=0.439 Sum_probs=138.8
Q ss_pred ceecCCccEEEEEEEEeC----CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
++||+|+||.||+|.+.. +..+|+|.+..... ...+++..|+++++.+.||||+++++++. .+..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999996522 26899998865543 24467889999999999999999999876 4568999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|.+++... ..+++..+..++.|++.||.|||.. +++|+||||+||+++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999743 3588999999999999999999998 99999999999999999999999999998875443322
Q ss_pred ee--ecccccCCchhhhccCCCc
Q 018311 335 TT--RVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 335 ~~--~~~Gt~~y~APE~l~~~~~ 355 (358)
.. ...++..|+|||.+.+..+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKF 175 (257)
T ss_pred ccccCccccccccCHHHhcCCCC
Confidence 21 1233568999999887654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=210.72 Aligned_cols=173 Identities=27% Similarity=0.405 Sum_probs=148.5
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
..|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+..|+.++..+.||||+++++.+.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 4577788999999999999976 458899999886443 23346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++.. ..+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..+....
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998863 3478888999999999999999998 99999999999999999999999999998875433
Q ss_pred ceeeeecccccCCchhhhccCCCc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
. ......++..|+|||++.+.++
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~ 178 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAY 178 (277)
T ss_pred c-ccccccCcccccCHhHhccCCC
Confidence 2 2334578899999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=207.72 Aligned_cols=176 Identities=28% Similarity=0.443 Sum_probs=150.6
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||+||+|.. .++..+++|.+.... ....+.+.+|+++++.++|+||+++++.+...+..+++||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 3688899999999999999975 467889999886443 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++.... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999997532 124588999999999999999999998 99999999999999999999999999998776543
Q ss_pred ce---eeeecccccCCchhhhccCC
Q 018311 332 SH---ITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 332 ~~---~~~~~~Gt~~y~APE~l~~~ 353 (358)
.. ......|+..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~ 181 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQV 181 (267)
T ss_pred cccccccccccCChhhcChHHHccc
Confidence 22 23446789999999998766
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=205.47 Aligned_cols=177 Identities=27% Similarity=0.404 Sum_probs=153.1
Q ss_pred CCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|.+.+.||.|+||.||++... ++..+++|++..... ...+++..|+++++.++|||++++.+.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777899999999999999764 688999999865433 4456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++.........+++.....++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999976432346689999999999999999999998 99999999999999999999999999998875543
Q ss_pred ceeeeecccccCCchhhhccCCCc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.......|++.|+|||.+.+.++
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~ 180 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPY 180 (258)
T ss_pred -ceecceeeeecccChhHhccCCC
Confidence 23445678999999999887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=209.47 Aligned_cols=175 Identities=27% Similarity=0.414 Sum_probs=145.6
Q ss_pred CcccceecCCccEEEEEEEEeC--CcEEEEEEecCCC----------CcchHHHHHHHHHHhc-CCCCccccccceEEeC
Q 018311 176 FSKDNIIGDGGYGVVYRGQLMN--GTAVAVKKLLNNP----------GQADKDFRVEVEAIGH-VRHKNLVRLLGYCIEG 242 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~ 242 (358)
|++.+.||+|+||.||+|.... ++.+|+|.+.... .....++..|+.++.+ ++||||+++++++..+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 6778899999999999998754 6889999875321 1122456678888865 7999999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCCcEEEeee
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDF 321 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~NiLl~~~~~~kl~DF 321 (358)
+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999885432234568889999999999999999996 5 7999999999999999999999999
Q ss_pred cCceecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 322 GLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 322 Gla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
|++....... ......|+..|+|||++.+.++
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~ 190 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPY 190 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCC
Confidence 9998865433 3445678999999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=209.85 Aligned_cols=174 Identities=26% Similarity=0.429 Sum_probs=146.2
Q ss_pred CCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
+|+..+.||+|++|.||+|+.. +|..||+|.+..... .....+..|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999874 688999999865433 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
+ ++|.+++.... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.+.....
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 D-KDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred C-ccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 7 58988886432 234589999999999999999999998 999999999999999999999999999987643221
Q ss_pred eeeeecccccCCchhhhccCCC
Q 018311 333 HITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
......++..|+|||++.+.+
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~ 176 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSR 176 (284)
T ss_pred -ccccccccccccChHHhcCCC
Confidence 123356788999999987654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=210.66 Aligned_cols=173 Identities=27% Similarity=0.431 Sum_probs=145.4
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|+..+.||+|+||.||+|.. .+++.|++|++.... ......+..|++++.+++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 477789999999999999976 468899999886433 22335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+. ++|..++... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++.+....
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 6899888643 234588999999999999999999998 99999999999999999999999999998765332
Q ss_pred ceeeeecccccCCchhhhccCCC
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
. ......+++.|+|||++.+.+
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~ 176 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCK 176 (284)
T ss_pred c-ccccccccccccCCeEEecCC
Confidence 2 223346788999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=211.01 Aligned_cols=172 Identities=28% Similarity=0.333 Sum_probs=145.6
Q ss_pred CCcccceecCCccEEEEEEEE----eCCcEEEEEEecCCC----CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 245 (358)
+|++.+.||+|+||.||++.. .+++.+|+|.+.... ....+.+..|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367789999999999999964 356889999886432 12335678899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
++||||+++|+|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999863 24588899999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCceeeeecccccCCchhhhccCC
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.+............|+..|+|||.+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGG 181 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCC
Confidence 8655443334446789999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=203.90 Aligned_cols=172 Identities=29% Similarity=0.457 Sum_probs=149.7
Q ss_pred CCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|++.+.||+|+||.||++... +++.+++|.+..... ...+.+.+|++++.+++|||++++++++.++...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999764 678999999876543 3446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998742 5689999999999999999999998 99999999999999999999999999999876543
Q ss_pred ceeeeecccccCCchhhhccCCC
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.. .....++..|+|||.+.+..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~ 175 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSG 175 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCC
Confidence 22 23467899999999987664
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=209.78 Aligned_cols=175 Identities=25% Similarity=0.309 Sum_probs=142.8
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCC-CCccccccceEEeCCE-----
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQ----- 244 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~----- 244 (358)
++|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.++..+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688899999999999999976 4688999998754332 23356888999999995 6999999999887655
Q ss_pred EEEEEeecCCCCHHHHHhcccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCcEEEeeec
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCD-RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDFG 322 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~-~~~~kl~DFG 322 (358)
.+++|||+++ +|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 899888643222 34689999999999999999999998 9999999999999998 8999999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCC
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+++.+..... ......+++.|+|||++.+.
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~ 186 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGS 186 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCC
Confidence 9987643221 12234678899999998754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=206.90 Aligned_cols=165 Identities=25% Similarity=0.319 Sum_probs=142.9
Q ss_pred ecCCccEEEEEEEEe-CCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCH
Q 018311 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (358)
Q Consensus 182 lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL 257 (358)
||+|+||.||+|... +++.+++|.+..... ...+.+..|+.+++.++||||+++++.+.++...+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999864 488999998864432 2346788999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeee
Q 018311 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337 (358)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 337 (358)
.+++.+. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+++.+.... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9999742 3488899999999999999999998 99999999999999999999999999998875432 2334
Q ss_pred cccccCCchhhhccCCCc
Q 018311 338 VMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 338 ~~Gt~~y~APE~l~~~~~ 355 (358)
..|++.|+|||++.+..+
T Consensus 152 ~~~~~~~~~PE~~~~~~~ 169 (262)
T cd05572 152 FCGTPEYVAPEIILNKGY 169 (262)
T ss_pred ccCCcCccChhHhcCCCC
Confidence 578999999999887654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=209.57 Aligned_cols=167 Identities=26% Similarity=0.305 Sum_probs=141.2
Q ss_pred ecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCH
Q 018311 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (358)
Q Consensus 182 lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL 257 (358)
||+|+||+||+|.. .+|+.+++|.+.... ......+..|++++..++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999975 468899999885432 12234567899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeee
Q 018311 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337 (358)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 337 (358)
.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..+.... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 99987432 23588999999999999999999998 99999999999999999999999999998764321 2334
Q ss_pred cccccCCchhhhccCCCc
Q 018311 338 VMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 338 ~~Gt~~y~APE~l~~~~~ 355 (358)
..++..|+|||++.+..+
T Consensus 154 ~~~~~~y~~PE~~~~~~~ 171 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVY 171 (277)
T ss_pred ccCCCCcCCHHHhcCCCC
Confidence 568889999999987664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=207.97 Aligned_cols=173 Identities=26% Similarity=0.394 Sum_probs=147.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+-|+..+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|+.++.+++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3466788999999999999975 468899999875433 23346688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++.. ..+++.....++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++..+....
T Consensus 84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 999999998863 3478999999999999999999998 99999999999999999999999999998765432
Q ss_pred ceeeeecccccCCchhhhccCCCc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.......|+..|+|||.+.+...
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~ 178 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAY 178 (277)
T ss_pred -hhhccccCCccccChhhhccCCC
Confidence 12234578899999999877543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=209.44 Aligned_cols=162 Identities=27% Similarity=0.299 Sum_probs=133.1
Q ss_pred eecCCccEEEEEEEE-eCCcEEEEEEecCCCC---cchHHHHHHHHH---HhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEA---IGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 181 ~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~---l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
.||+|+||.||++.. .+++.+|+|.+..... .....+..|..+ +...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999976 4688999998865432 112233444433 344579999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+|+|.+++.. .+.+++.....++.|++.||.|||+. +++||||||+|||+++++.+||+|||++..+....
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999998873 34589999999999999999999998 99999999999999999999999999998765332
Q ss_pred eeeecccccCCchhhhccC
Q 018311 334 ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~ 352 (358)
.....|+..|+|||.+.+
T Consensus 152 -~~~~~~~~~y~aPE~~~~ 169 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQK 169 (279)
T ss_pred -ccCcCCCcCccCHHHhcC
Confidence 233579999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-26 Score=202.54 Aligned_cols=172 Identities=27% Similarity=0.462 Sum_probs=151.3
Q ss_pred CcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
|+..+.||+|+||.||++... ++..+++|++........+.+.+|+++++.++||||+++++.+......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 667789999999999999874 6889999998765554567889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
++|.+++... ...+++.....++.|++.||.|||.. +++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 82 GSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999998743 24689999999999999999999998 999999999999999999999999999988765432
Q ss_pred eeecccccCCchhhhccCCCc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.....|+..|+|||.+.+..+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~ 174 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPY 174 (253)
T ss_pred ccceecCCcccCHHHHcCCCC
Confidence 345678999999999987653
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=217.75 Aligned_cols=175 Identities=23% Similarity=0.260 Sum_probs=148.2
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc---chHHHHHHHHHHhcC-CCCccccccceEEeCCEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 247 (358)
..+|..+.+||+|+||.|.+|+.+ +.+.+|||.+++..-. ..+--..|-++|+.. +-|.++++..+|.+-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357888999999999999999754 4678999998765421 222245678888766 57899999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||+.||||--.+++ -+.+.+..+..++.+||-||-|||++ +|++||||..||+||.+|++||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999888873 45678888999999999999999999 9999999999999999999999999999874
Q ss_pred CCCCceeeeecccccCCchhhhccCCCc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
-.+ ...+.+++|||.|+|||++.=+||
T Consensus 501 i~~-~~TTkTFCGTPdYiAPEIi~YqPY 527 (683)
T KOG0696|consen 501 IFD-GVTTKTFCGTPDYIAPEIIAYQPY 527 (683)
T ss_pred ccC-CcceeeecCCCcccccceEEeccc
Confidence 322 234667999999999999998887
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=210.42 Aligned_cols=173 Identities=29% Similarity=0.447 Sum_probs=141.5
Q ss_pred ceecCCccEEEEEEEEeC-------CcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 180 NIIGDGGYGVVYRGQLMN-------GTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+.||+|+||.||+|+..+ +..+++|.+.... .....++.+|+.+++.++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997632 2578999875443 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-----cEEEeeecC
Q 018311 252 VNNGNLEQWLRGDMC---DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-----DAKISDFGL 323 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~-----~~kl~DFGl 323 (358)
+++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975321 224478899999999999999999998 999999999999999877 899999999
Q ss_pred ceecCCCCce-eeeecccccCCchhhhccCCCc
Q 018311 324 AKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 324 a~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
++.+...... ......++..|+|||++.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 190 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF 190 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCc
Confidence 9876543221 2223456789999999987654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=211.29 Aligned_cols=175 Identities=27% Similarity=0.379 Sum_probs=144.8
Q ss_pred hcCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCC-----
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT----- 243 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 243 (358)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ......+..|++++.+++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3478899999999999999999874 58899999986443 223356778999999999999999999987654
Q ss_pred -----EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEE
Q 018311 244 -----QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318 (358)
Q Consensus 244 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl 318 (358)
..++++||+++ ++.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 78999999975 777777642 23588999999999999999999998 9999999999999999999999
Q ss_pred eeecCceecCCCCceeeeecccccCCchhhhccCC
Q 018311 319 SDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 319 ~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+|||++..+............++..|+|||++.+.
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 192 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE 192 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCC
Confidence 99999988754432222334568899999988754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=206.64 Aligned_cols=166 Identities=27% Similarity=0.374 Sum_probs=142.0
Q ss_pred ecCCccEEEEEEEEe-CCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCH
Q 018311 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (358)
Q Consensus 182 lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL 257 (358)
||+|+||.||++... +++.+++|.+..... ...+.+..|++++.+++||||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999875 489999998865433 3345688899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc-----
Q 018311 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS----- 332 (358)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~----- 332 (358)
.+++... +.+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999742 3588999999999999999999998 999999999999999999999999999887543321
Q ss_pred --eeeeecccccCCchhhhccCCC
Q 018311 333 --HITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 333 --~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.......++..|+|||.+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~ 177 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQG 177 (265)
T ss_pred ccccccCcccCccccCHHHhcCCC
Confidence 1233467889999999987764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=209.96 Aligned_cols=180 Identities=26% Similarity=0.432 Sum_probs=147.6
Q ss_pred hHhhHHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEe-
Q 018311 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIE- 241 (358)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~- 241 (358)
++.++....++|++.+.||+|+||.||+|.. .+++.+|+|.+.... ....++..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3444445567899999999999999999976 567889999875432 3345678899999998 69999999999853
Q ss_pred -----CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcE
Q 018311 242 -----GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (358)
Q Consensus 242 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~ 316 (358)
.+..+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 467899999999999999987532 23478888899999999999999998 99999999999999999999
Q ss_pred EEeeecCceecCCCCceeeeecccccCCchhhhcc
Q 018311 317 KISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 317 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
||+|||+++....... ......|++.|+|||++.
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~ 194 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIA 194 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcC
Confidence 9999999887643211 233467899999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=208.81 Aligned_cols=173 Identities=27% Similarity=0.353 Sum_probs=147.9
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
.|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.++..+.||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 345567999999999999975 5688999998865544445668889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+++|.+++.. ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++....... .
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~ 170 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-P 170 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-c
Confidence 9999999864 3478899999999999999999998 99999999999999999999999999987654322 1
Q ss_pred eeeecccccCCchhhhccCCCcc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......|++.|+|||.+.+.+++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~ 193 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYG 193 (285)
T ss_pred ccccccCCccccCHHHhcCCCCC
Confidence 22345789999999999887653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=208.60 Aligned_cols=176 Identities=30% Similarity=0.419 Sum_probs=148.0
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEeCC------E
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGT------Q 244 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~------~ 244 (358)
.++|++.+.||+|+||.||+|... +++.+++|.+..... ..+++..|+.++.++ +|+||+++++++.... .
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 478999999999999999999864 578899998765432 346788999999999 6999999999997644 4
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccc
Confidence 8999999999999998865332345688999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCC
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
........ ......|+..|+|||++...
T Consensus 161 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 188 (275)
T cd06608 161 AQLDSTLG-RRNTFIGTPYWMAPEVIACD 188 (275)
T ss_pred eecccchh-hhcCccccccccCHhHhccc
Confidence 87643222 23346789999999998653
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=209.40 Aligned_cols=175 Identities=30% Similarity=0.435 Sum_probs=149.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv 248 (358)
++|.+.+.||+|+||.||+|.. .+++.+++|.+.... ....+.+..|.+++.+++ ||||+++++++..++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688889999999999999976 478999999886432 223356788999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
||++++++|.+++.+. ..+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999742 3689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCc-------------------eeeeecccccCCchhhhccCCCc
Q 018311 329 AGKS-------------------HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 329 ~~~~-------------------~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.... .......|+..|+|||++.+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 199 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA 199 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC
Confidence 4332 12234568899999999876653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-27 Score=202.76 Aligned_cols=180 Identities=23% Similarity=0.323 Sum_probs=151.6
Q ss_pred cCCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeC-----CEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQRI 246 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~ 246 (358)
.+||++.+.||+|||+-||+++ ..++..+|+|++.-...+..+..++|++..++++||||++++++...+ ...|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4789999999999999999997 567889999999877767778889999999999999999999987543 4589
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
++++|...|+|.+.+.........+++.+.+.|+.++++||++||+. .++..||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999976555556799999999999999999999997 45699999999999999999999999999876
Q ss_pred cCC---CCc--e---eeeecccccCCchhhhccCC
Q 018311 327 LGA---GKS--H---ITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 327 ~~~---~~~--~---~~~~~~Gt~~y~APE~l~~~ 353 (358)
..- +.. . .......|.-|.|||++.=+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk 213 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK 213 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecc
Confidence 431 110 0 11224578899999998643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=223.93 Aligned_cols=177 Identities=21% Similarity=0.296 Sum_probs=135.1
Q ss_pred cCCCcccceecCCccEEEEEEEE-----------------eCCcEEEEEEecCCCCcchHH--------------HHHHH
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-----------------MNGTAVAVKKLLNNPGQADKD--------------FRVEV 221 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E~ 221 (358)
.++|++.++||+|+||.||+|.. ..++.||||++........++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999953 235679999986543322233 33477
Q ss_pred HHHhcCCCCcc-----ccccceEEe--------CCEEEEEEeecCCCCHHHHHhcccC--------------------CC
Q 018311 222 EAIGHVRHKNL-----VRLLGYCIE--------GTQRILVYEYVNNGNLEQWLRGDMC--------------------DR 268 (358)
Q Consensus 222 ~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~ 268 (358)
.++.+++|.++ ++++++|.. .+..++||||+++++|.++++.... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776554 677777753 3568999999999999999864211 11
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeeecccccCCchhh
Q 018311 269 GYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVT 348 (358)
Q Consensus 269 ~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE 348 (358)
..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..+.........+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 2356778889999999999999998 9999999999999999999999999999876543322222234589999999
Q ss_pred hccC
Q 018311 349 LLRN 352 (358)
Q Consensus 349 ~l~~ 352 (358)
++..
T Consensus 381 ~l~~ 384 (507)
T PLN03224 381 ELVM 384 (507)
T ss_pred hhcC
Confidence 9864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=239.54 Aligned_cols=178 Identities=28% Similarity=0.436 Sum_probs=141.4
Q ss_pred HhcCCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCC-----
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT----- 243 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 243 (358)
.-.++|+..+.||+||||.||+++ .-+|+.+|||++.... ......+.+|+++|++|+|||||+++..+....
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 345678889999999999999996 4589999999996554 222345778999999999999999987653110
Q ss_pred --------------------------------------------------------------------------------
Q 018311 244 -------------------------------------------------------------------------------- 243 (358)
Q Consensus 244 -------------------------------------------------------------------------------- 243 (358)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ----------------------------------EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHH
Q 018311 244 ----------------------------------QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289 (358)
Q Consensus 244 ----------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~y 289 (358)
.+|+-||||+.-.|.+++..+.... ......+++.+|+.||.|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence 2367889998877877776443211 356778999999999999
Q ss_pred HHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC----------------CCCc-eeeeecccccCCchhhhccC
Q 018311 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG----------------AGKS-HITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 290 LH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~----------------~~~~-~~~~~~~Gt~~y~APE~l~~ 352 (358)
+|++ +||||||||.||++++++.|||+|||+|..+. .+.. ...+..+||.-|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 99999999999999999999999999998722 0111 13456899999999999998
Q ss_pred CC
Q 018311 353 MP 354 (358)
Q Consensus 353 ~~ 354 (358)
..
T Consensus 790 ~~ 791 (1351)
T KOG1035|consen 790 TS 791 (1351)
T ss_pred cc
Confidence 76
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=205.85 Aligned_cols=176 Identities=26% Similarity=0.397 Sum_probs=150.6
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|++.+.||+|+||.||++.. .+++.+++|.+.... .....++..|+++++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477789999999999999965 467899999886433 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++.........+++.....++.|++.||.|||+. +++|+||+|.||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999875333345688999999999999999999998 9999999999999999999999999999887654
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......|++.|+|||.+.+.++.
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~ 179 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYS 179 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCC
Confidence 22345689999999999887653
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=223.57 Aligned_cols=176 Identities=23% Similarity=0.300 Sum_probs=144.4
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc---chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
.-|..++.||-|+||+|.++.. .+...+|.|.|++..-- ...-.+.|-.||+....+=||+|+..|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4467788899999999999965 44567899988654321 1123566999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC-
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG- 328 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~- 328 (358)
||++|||+-.+|.+ -+.+.+..+..++.++.+|+++.|.. |+|||||||+|||||.+|++||+|||||.-+.
T Consensus 709 dYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999873 45688888999999999999999999 99999999999999999999999999985331
Q ss_pred --------CCCcee--------------------------------eeecccccCCchhhhccCCCcc
Q 018311 329 --------AGKSHI--------------------------------TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 --------~~~~~~--------------------------------~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.++-+. ....+||+.|+|||++....|+
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~ 849 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT 849 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence 111000 0126799999999999987765
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=243.78 Aligned_cols=177 Identities=29% Similarity=0.369 Sum_probs=149.5
Q ss_pred HhcCCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
..+-+|.....||.|.||.||-|. ..+|...|+|.++-.. ....+...+|..++..++|||+|+++|+=...+..++
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 345667888899999999999995 5779999999775433 3444667889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
.||||++|+|.+.+.. .+..++.....+..|++.|+.|||.+ +||||||||.||+|+.+|.+|+.|||.|+.+
T Consensus 1312 FMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999999863 23355566667788999999999999 9999999999999999999999999999988
Q ss_pred CCCCce---eeeecccccCCchhhhccCCC
Q 018311 328 GAGKSH---ITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 328 ~~~~~~---~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.++... .....+||+.|||||++.|-.
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~ 1414 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTK 1414 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccc
Confidence 655322 224578999999999998753
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=215.73 Aligned_cols=172 Identities=29% Similarity=0.335 Sum_probs=143.9
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeC------
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------ 242 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 242 (358)
..++|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 347899999999999999999975 478999999885432 22335677899999999999999999988643
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
...|+||||+. ++|.+.+.. .++......++.|++.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999995 588887752 177888999999999999999998 99999999999999999999999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+++...... ......|+..|+|||++.+..+
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 194 (353)
T cd07850 164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGY 194 (353)
T ss_pred cceeCCCCC--CCCCCcccccccCHHHHhCCCC
Confidence 998875432 2334578999999999988765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-26 Score=208.36 Aligned_cols=176 Identities=26% Similarity=0.383 Sum_probs=151.6
Q ss_pred hcCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
..+.|+..+.||+|+||.||++... ++..+++|.+..... ..+.+..|++++..++|+||+++++.+...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3467888899999999999999875 688999999865544 45678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++..+...
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999998532 3689999999999999999999998 9999999999999999999999999998766433
Q ss_pred CceeeeecccccCCchhhhccCCCc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.. ......++..|+|||++.+.++
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~ 193 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDY 193 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCC
Confidence 21 2234568899999999987664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-26 Score=207.85 Aligned_cols=171 Identities=30% Similarity=0.363 Sum_probs=144.9
Q ss_pred CcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeC--CEEEEEEe
Q 018311 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRILVYE 250 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lv~e 250 (358)
|++.+.||+|+||.||+|... +++.+++|.+.... ......+..|++++..++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999865 58899999997653 33346688899999999999999999999987 88999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|++ ++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 997 5898888642 24688999999999999999999998 9999999999999999999999999999887654
Q ss_pred CceeeeecccccCCchhhhccCC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.........++..|+|||.+.+.
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~ 176 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGA 176 (287)
T ss_pred CcccccccccccccCCceeeEcc
Confidence 43233445678899999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=204.74 Aligned_cols=175 Identities=24% Similarity=0.406 Sum_probs=146.9
Q ss_pred CCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|+..+.||+|+||.||++... +|..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999764 57889999885432 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-cEEEeeecCceecCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKLLGAG 330 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~-~~kl~DFGla~~~~~~ 330 (358)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++ .+||+|||.+..+...
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998643 223578999999999999999999998 999999999999998886 4699999999887543
Q ss_pred CceeeeecccccCCchhhhccCCCc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.. ......|++.|+|||++.+.++
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~ 179 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPY 179 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCC
Confidence 22 2234578999999999877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=203.23 Aligned_cols=172 Identities=27% Similarity=0.399 Sum_probs=142.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++.+.+..||.|+.|+|+++.. .+|...|||.+.... ....+++...++++.... .|.||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 4455677899999999999976 458899999987554 444577777888776654 8999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
.| ..-+..+|+. ..+++++...-++...+..||.||..++ +|+|||+||+|||+|+.|++|+||||++-.+-+.
T Consensus 172 lM-s~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LM-STCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HH-HHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 99 4456666553 3456888888888899999999999876 9999999999999999999999999999887665
Q ss_pred CceeeeecccccCCchhhhccCC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.. .++..|++.|||||.+.-.
T Consensus 246 kA--htrsAGC~~YMaPERidp~ 266 (391)
T KOG0983|consen 246 KA--HTRSAGCAAYMAPERIDPP 266 (391)
T ss_pred cc--cccccCCccccCccccCCC
Confidence 54 4667999999999988643
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-26 Score=210.65 Aligned_cols=166 Identities=30% Similarity=0.398 Sum_probs=142.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
.+|+..+.||+|+||.||+|.. .+++.|++|.+..... ...+++.+|++++..++||||+++.+++..++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5688899999999999999976 4688999998854332 22356888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+. |+|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 6777776532 24588999999999999999999998 999999999999999999999999999987543
Q ss_pred CCceeeeecccccCCchhhhcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
. ....|++.|+|||++.
T Consensus 168 ~-----~~~~~~~~y~aPE~~~ 184 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVIL 184 (307)
T ss_pred C-----CCccCCccccCceeee
Confidence 2 2457889999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=214.19 Aligned_cols=171 Identities=27% Similarity=0.411 Sum_probs=142.0
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeC-----CEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQR 245 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~ 245 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+..|+.++.+++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 36899999999999999999975 568999999986432 23345678899999999999999999987654 357
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
++++||+. ++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 99999995 588887753 3588999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCce--eeeecccccCCchhhhccC
Q 018311 326 LLGAGKSH--ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 326 ~~~~~~~~--~~~~~~Gt~~y~APE~l~~ 352 (358)
........ ......||+.|+|||++.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLN 183 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhC
Confidence 76543221 1234578999999998765
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=207.90 Aligned_cols=173 Identities=27% Similarity=0.389 Sum_probs=141.9
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++.+.||+|+||.||+|... +++.|++|.+..... ...+.+..|++++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888999999999999999764 688999998854332 233568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCcEEEeeecCceecCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKLLGA 329 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~-~~~~kl~DFGla~~~~~ 329 (358)
|++ ++|.+++... ....+++.....++.|++.||.|||++ +++|+||+|+||++++ ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 5888877532 223357788889999999999999998 9999999999999985 56799999999987643
Q ss_pred CCceeeeecccccCCchhhhccCC
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.. .......+++.|+|||++.+.
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~ 178 (294)
T PLN00009 156 PV-RTFTHEVVTLWYRAPEILLGS 178 (294)
T ss_pred Cc-cccccCceeecccCHHHHhCC
Confidence 21 112335678999999998763
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-26 Score=210.00 Aligned_cols=174 Identities=27% Similarity=0.383 Sum_probs=142.6
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCC-------
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------- 243 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------- 243 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|++++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 6789999999999999999976 4688999998864332 22345667999999999999999999987643
Q ss_pred -EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 244 -QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 244 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
..++||||+. ++|.+++... ...+++.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 4599999995 5888887642 23588999999999999999999998 99999999999999999999999999
Q ss_pred CceecCCCCce---eeeecccccCCchhhhccCCC
Q 018311 323 LAKLLGAGKSH---ITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 323 la~~~~~~~~~---~~~~~~Gt~~y~APE~l~~~~ 354 (358)
++..+...... ......++..|+|||++.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 199 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER 199 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCc
Confidence 99876533221 223456788999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-26 Score=209.14 Aligned_cols=168 Identities=28% Similarity=0.372 Sum_probs=144.8
Q ss_pred cceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCH
Q 018311 179 DNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL 257 (358)
..+||+|+||.||++.. .++..||+|++..........+..|+.++..++|+||+++++.+...+..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46899999999999976 57889999988655444556788999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeee
Q 018311 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337 (358)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 337 (358)
.+++.. ..+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..+.... .....
T Consensus 105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 998753 3478899999999999999999998 99999999999999999999999999988764322 12334
Q ss_pred cccccCCchhhhccCCCc
Q 018311 338 VMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 338 ~~Gt~~y~APE~l~~~~~ 355 (358)
..|++.|+|||++.+.++
T Consensus 176 ~~~~~~y~~pE~~~~~~~ 193 (292)
T cd06657 176 LVGTPYWMAPELISRLPY 193 (292)
T ss_pred cccCccccCHHHhcCCCC
Confidence 678999999999877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=206.67 Aligned_cols=177 Identities=21% Similarity=0.381 Sum_probs=141.5
Q ss_pred CcccceecCCccEEEEEEEEe----CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCC------
Q 018311 176 FSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------ 243 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 243 (358)
|.+.+.||+|+||.||+|.+. +++.+|+|.+.... ....+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456789999999999999753 36889999886543 223456888999999999999999999886532
Q ss_pred EEEEEEeecCCCCHHHHHhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeee
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMC--DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DF 321 (358)
..++++||+.+|+|.+++..... ....+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 24788999999999988753221 223478889999999999999999998 9999999999999999999999999
Q ss_pred cCceecCCCCce-eeeecccccCCchhhhccCCCc
Q 018311 322 GLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 322 Gla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
|+++.+...... ......+++.|++||.+.+..+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 192 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVY 192 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCcc
Confidence 999876543221 1223455678999999887654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-28 Score=224.84 Aligned_cols=172 Identities=25% Similarity=0.322 Sum_probs=149.1
Q ss_pred CCCcccceecCCccEEEEEEEEeCCc-EEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGT-AVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~-~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
.+++....||-|+||.|=+++..+.. .+|+|.+++.. ....+-...|-.+|..++.|.||++|..|.++...||+|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 44566778999999999999875444 37888775432 222334667999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
|-|-||.|...|+ .++.++..+...++.+++.|++|||++ +||+|||||+|++++.+|-+||.|||+|+.++.
T Consensus 500 EaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999998 456788899999999999999999999 999999999999999999999999999999987
Q ss_pred CCceeeeecccccCCchhhhccCCC
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
+.. +-+++|||.|.|||+++++.
T Consensus 573 g~K--TwTFcGTpEYVAPEIILnKG 595 (732)
T KOG0614|consen 573 GRK--TWTFCGTPEYVAPEIILNKG 595 (732)
T ss_pred CCc--eeeecCCcccccchhhhccC
Confidence 664 56789999999999999864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=204.48 Aligned_cols=174 Identities=23% Similarity=0.287 Sum_probs=140.9
Q ss_pred HhhHHHhcCCCccccee--cCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEe
Q 018311 166 LRDLQSATNRFSKDNII--GDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIE 241 (358)
Q Consensus 166 ~~~~~~~~~~~~~~~~l--G~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 241 (358)
..+.....++|++.+.+ |+|+||.||++.. .++..+++|.+........ |+.....+ +||||+++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34445555677777766 9999999999975 5678899998754322111 22222212 79999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-cEEEee
Q 018311 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISD 320 (358)
Q Consensus 242 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~-~~kl~D 320 (358)
.+..++||||+++++|.+++... ..+++.++..++.|++.||.|||+. +++||||||+||+++.++ .++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 99999999999999999999743 3689999999999999999999998 999999999999999998 999999
Q ss_pred ecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 321 FGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 321 FGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
||+++..... ....|+..|+|||++.+.++.
T Consensus 154 fg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~ 184 (267)
T PHA03390 154 YGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYD 184 (267)
T ss_pred CccceecCCC-----ccCCCCCcccChhhhcCCCCC
Confidence 9999876532 234689999999999887764
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-26 Score=210.08 Aligned_cols=172 Identities=31% Similarity=0.399 Sum_probs=142.9
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeC--CEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lv 248 (358)
++|++.+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|+.++.+++|+||+++++++... +..++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 6788999999999999999976 4689999998864332 2223466799999999999999999998754 568999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+. ++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.+.
T Consensus 87 ~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 87 MEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 99996 5898888642 25589999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCceeeeecccccCCchhhhccCC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.... ......+++.|+|||++.+.
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~ 183 (309)
T cd07845 160 LPAK-PMTPKVVTLWYRAPELLLGC 183 (309)
T ss_pred CccC-CCCcccccccccChhhhcCC
Confidence 4322 22334568889999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=203.76 Aligned_cols=172 Identities=24% Similarity=0.254 Sum_probs=141.9
Q ss_pred cCCCccc-ceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEeC----CEE
Q 018311 173 TNRFSKD-NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG----TQR 245 (358)
Q Consensus 173 ~~~~~~~-~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~----~~~ 245 (358)
+++|++. ++||-|-.|.|..|.. .+++++|+|.+... ...++|+++.-.. .|||||.++++|.+. ..+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4556654 6899999999999954 67899999988543 3345677776555 699999999998753 456
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc---CCCcEEEeeec
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID---ENFDAKISDFG 322 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~---~~~~~kl~DFG 322 (358)
.+|||.|+||+|++.++++ ....+++.++..|..||+.|+.|||+. +|.||||||+|+|.. .|..+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999999865 345699999999999999999999999 999999999999985 45679999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+|+.-... ....+.+-||.|.|||++-.+.|.
T Consensus 210 FAK~t~~~--~~L~TPc~TPyYvaPevlg~eKyd 241 (400)
T KOG0604|consen 210 FAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYD 241 (400)
T ss_pred cccccCCC--ccccCCcccccccCHHHhCchhcC
Confidence 99986532 235567889999999999988874
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=205.59 Aligned_cols=171 Identities=29% Similarity=0.421 Sum_probs=143.6
Q ss_pred CcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
|++.+.||.|++|.||+|.. .+|..|++|++.... ......+..|+++++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56678999999999999976 478999999886443 222356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
+ ++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++.+.....
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 4 69999886432 23588999999999999999999998 999999999999999999999999999987653322
Q ss_pred eeeeecccccCCchhhhccCC
Q 018311 333 HITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~ 353 (358)
......+++.|+|||++.+.
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~ 174 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGS 174 (283)
T ss_pred -ccCccccccCCCCCceeecC
Confidence 12234678999999988764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=206.04 Aligned_cols=163 Identities=26% Similarity=0.287 Sum_probs=133.7
Q ss_pred eecCCccEEEEEEEE-eCCcEEEEEEecCCCCc---chHHHHHHH---HHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEV---EAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 181 ~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~---~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
+||+|+||.||+|.. .+++.||+|.+...... ....+..|. +++....||||+.+++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999975 46889999988654321 112233333 34555689999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+|+|.+++.. .+.+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.+....
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999998863 34689999999999999999999998 99999999999999999999999999998764322
Q ss_pred eeeecccccCCchhhhccCC
Q 018311 334 ITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~ 353 (358)
.....|+..|+|||++.+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~ 170 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKG 170 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCC
Confidence 2345799999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-27 Score=216.42 Aligned_cols=174 Identities=26% Similarity=0.415 Sum_probs=144.0
Q ss_pred cCCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCC-Cc------chHHHHHHHHHHhcCCCCccccccceEE-eCC
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP-GQ------ADKDFRVEVEAIGHVRHKNLVRLLGYCI-EGT 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~-~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 243 (358)
..+|-.+.+||+|||++||+|. +...+-||||.-..+. +. ..+-..+|-+|.+.|.||.||++|+++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3567778899999999999994 4567788998754332 11 1123567999999999999999999987 457
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc---CCCcEEEee
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID---ENFDAKISD 320 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~---~~~~~kl~D 320 (358)
.+|-|+|||+|.||.-||+. .+.++++++..|+.||+.||.||... .++|||-||||.||||- ..|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 78999999999999999984 45689999999999999999999986 67899999999999984 468899999
Q ss_pred ecCceecCCCCc------eeeeecccccCCchhhhcc
Q 018311 321 FGLAKLLGAGKS------HITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 321 FGla~~~~~~~~------~~~~~~~Gt~~y~APE~l~ 351 (358)
|||++++..... ..++...||..|++||.+-
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFv 653 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFV 653 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceee
Confidence 999999864332 2456789999999999874
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-26 Score=213.34 Aligned_cols=172 Identities=27% Similarity=0.414 Sum_probs=142.9
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC--CcchHHHHHHHHHHhcC-CCCccccccceEEeC--CEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG--TQRI 246 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~--~~~~ 246 (358)
.++|++.+.||+|+||.||+|... +++.+++|++.... ......+.+|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888999999999999999764 68899999885432 22335577899999999 999999999988653 4689
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||++ ++|..++.. ..+.+.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999996 599988863 2578888999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCc----eeeeecccccCCchhhhccCC
Q 018311 327 LGAGKS----HITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 327 ~~~~~~----~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+..... .......|+..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 187 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGS 187 (337)
T ss_pred cccccccccCcchhcccccccccCceeeecc
Confidence 654332 123346789999999988653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-28 Score=208.66 Aligned_cols=174 Identities=26% Similarity=0.418 Sum_probs=142.8
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEe--------C
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE--------G 242 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------~ 242 (358)
+.|+...+||+|.||+||+|+. .+|++||+|++.-.. ...-....+|+++|..|+|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 5567778999999999999975 567889998764322 2223456789999999999999999998863 2
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
..+|+|+++|+. ||..+|.+. ..+++..+..++..++..||.|+|.. .|+|||+|++|+||+.++.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 347999999954 999988742 24588899999999999999999999 99999999999999999999999999
Q ss_pred CceecCCCCce---eeeecccccCCchhhhccCCC
Q 018311 323 LAKLLGAGKSH---ITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 323 la~~~~~~~~~---~~~~~~Gt~~y~APE~l~~~~ 354 (358)
++|.+...+.. ..+..+-|..|..||.+.|.+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r 204 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR 204 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhccc
Confidence 99887654432 233456689999999999875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=228.72 Aligned_cols=183 Identities=27% Similarity=0.397 Sum_probs=151.6
Q ss_pred HhcCCCcccceecCCccEEEEEEEEe--------CCcEEEEEEecCCCCc-chHHHHHHHHHHhcC-CCCccccccceEE
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHV-RHKNLVRLLGYCI 240 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 240 (358)
...++..+.+.||+|.||.|++|... ....||||.++..... ..+++..|+++|..+ +||||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 33455566779999999999999642 1457999999766544 457799999999998 6999999999999
Q ss_pred eCCEEEEEEeecCCCCHHHHHhccc---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcE
Q 018311 241 EGTQRILVYEYVNNGNLEQWLRGDM---C-------DR--GYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308 (358)
Q Consensus 241 ~~~~~~lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~Ni 308 (358)
.++..++|+||+..|+|.+||+..+ . .. ..++..+.+.++.|||.||+||++. ++|||||.++||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence 9999999999999999999998765 0 01 1388899999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeecCceecCCCCceeeeeccc--ccCCchhhhccCCCcc
Q 018311 309 LIDENFDAKISDFGLAKLLGAGKSHITTRVMG--TFGDFSVTLLRNMPIL 356 (358)
Q Consensus 309 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~G--t~~y~APE~l~~~~~~ 356 (358)
|+.++..+||+|||+||..............| ...|||||.+...-|+
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft 499 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFT 499 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccc
Confidence 99999999999999999876655444333343 3469999999986654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=206.55 Aligned_cols=175 Identities=21% Similarity=0.245 Sum_probs=129.4
Q ss_pred CCCcccceecCCccEEEEEEEEeCC----cEEEEEEecCCCCcchH-----------HHHHHHHHHhcCCCCccccccce
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNG----TAVAVKKLLNNPGQADK-----------DFRVEVEAIGHVRHKNLVRLLGY 238 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~----~~vavK~l~~~~~~~~~-----------~~~~E~~~l~~l~HpnIv~l~~~ 238 (358)
++|++.++||+|+||.||+|...++ ..+++|........... ....+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 6899999999999999999986543 45565543222211111 11223445567789999999997
Q ss_pred EEeCC----EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC
Q 018311 239 CIEGT----QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314 (358)
Q Consensus 239 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~ 314 (358)
+.... ..++++|++ ..++.+++... ...++..+..++.|++.||.|||+. +++||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKL-VENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehh-ccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 76543 346788877 34676666531 2356788899999999999999998 999999999999999999
Q ss_pred cEEEeeecCceecCCCCce------eeeecccccCCchhhhccCCCcc
Q 018311 315 DAKISDFGLAKLLGAGKSH------ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 315 ~~kl~DFGla~~~~~~~~~------~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.+||+|||+|+.+...... ......||+.|+|||++.+..|+
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~ 211 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT 211 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC
Confidence 9999999999887533221 12335799999999999988764
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=212.30 Aligned_cols=172 Identities=27% Similarity=0.393 Sum_probs=143.5
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEe----CCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~ 246 (358)
.+|++.+.||+|+||.||+|.. .++..|++|++.... ....+.+..|+.++.+++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6788899999999999999975 468999999986542 2334667789999999999999999998763 35689
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999995 699998863 34589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCc---eeeeecccccCCchhhhccCC
Q 018311 327 LGAGKS---HITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 327 ~~~~~~---~~~~~~~Gt~~y~APE~l~~~ 353 (358)
...... .......|+..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSL 186 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCC
Confidence 643221 122345789999999998663
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=211.52 Aligned_cols=171 Identities=32% Similarity=0.410 Sum_probs=146.0
Q ss_pred CCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCC-----EEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-----QRI 246 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 246 (358)
+|++.+.||+|+||.||+|... +++.+++|++.... ....+.+..|+.+++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999864 58899999986543 334467889999999999999999999988765 789
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
++|||++ ++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 589888863 33689999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCc--eeeeecccccCCchhhhccCC
Q 018311 327 LGAGKS--HITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 327 ~~~~~~--~~~~~~~Gt~~y~APE~l~~~ 353 (358)
...... .......++..|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSS 181 (330)
T ss_pred ecccccccccccccccccCcCCceeeecc
Confidence 765431 123345688999999999887
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=202.16 Aligned_cols=164 Identities=23% Similarity=0.292 Sum_probs=136.3
Q ss_pred ceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc---chHHHHHHHHHH-hcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAI-GHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+.||+|+||.||+|.. .+++.||+|.+...... ....+..|..++ ...+||||+++++++...+..+++|||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999976 46889999988644321 122344454444 455899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999874 24588899999999999999999998 999999999999999999999999999987543
Q ss_pred eeecccccCCchhhhccCCCc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.....|++.|+|||.+.+..+
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~ 170 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGD 170 (260)
T ss_pred cccCCCCcCccChhhhcCCCC
Confidence 234578999999999988763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=211.28 Aligned_cols=170 Identities=29% Similarity=0.410 Sum_probs=142.9
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeC-----CEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~ 245 (358)
++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+..|+.++..++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 6789999999999999999975 568999999986532 22345677899999999999999999988654 347
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
+++|||+. ++|.+++.. .+.+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 85 YIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 99999995 789888863 34589999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCceeeeecccccCCchhhhccC
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
...... .......++..|+|||++.+
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~ 182 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLN 182 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhc
Confidence 765432 22334578899999998865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=203.31 Aligned_cols=167 Identities=24% Similarity=0.308 Sum_probs=138.2
Q ss_pred CcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCC-CCccccccceEEeC--CEEEEEEe
Q 018311 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVR-HKNLVRLLGYCIEG--TQRILVYE 250 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lv~e 250 (358)
|++.+.||+|+||.||+|.. .+++.+|+|+++.... ........|+.++.++. ||||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56678999999999999975 4688999998865432 22234456888898885 99999999999987 88999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|++ |+|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||++++ +.+||+|||+++.+...
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 6888888642 24689999999999999999999998 9999999999999999 99999999999887543
Q ss_pred CceeeeecccccCCchhhhccC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
.. .....++..|+|||++.+
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~ 172 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLT 172 (282)
T ss_pred CC--cCCCCCCcccCChhHhhc
Confidence 22 233568899999998754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-28 Score=210.01 Aligned_cols=171 Identities=28% Similarity=0.348 Sum_probs=145.1
Q ss_pred CcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeC-----CEEEE
Q 018311 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQRIL 247 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~l 247 (358)
.+..+.||-|.||.||.++. ++|+.||+|++.+-... .-+.+-+|+++|..++|.|++..++..... .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 45568999999999999976 67999999998654332 336677899999999999999999987654 34578
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
++|+|. .||...+. ....++...+.-++.||++||+|||+. +|.||||||.|+|++.+..+||||||+||..
T Consensus 135 ~TELmQ-SDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHH-hhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence 889984 48877765 556788888999999999999999999 9999999999999999999999999999997
Q ss_pred CCCCceeeeecccccCCchhhhccCCC
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
......-++..+-|..|.|||++.|.+
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaR 233 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGAR 233 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcch
Confidence 766665677788899999999999865
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=210.81 Aligned_cols=168 Identities=26% Similarity=0.385 Sum_probs=142.1
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCC-----
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT----- 243 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 243 (358)
..++|++.+.||+|+||.||+|.. .++..||+|++..... ...+.+..|++++.+++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 457899999999999999999964 5789999998854322 23356788999999999999999999887543
Q ss_pred -EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 244 -QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 244 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 7799888753 3488999999999999999999998 99999999999999999999999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccC
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
+++..... .....+++.|+|||++.+
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILN 189 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhC
Confidence 99876432 234567899999999876
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-27 Score=206.78 Aligned_cols=172 Identities=25% Similarity=0.345 Sum_probs=141.2
Q ss_pred cccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEeecC
Q 018311 177 SKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 177 ~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
+....||.|+||+|+|-.+ ..|+.+|||+++.... ..++++..|.+...+- +.||||+++|.+..++..|++||+|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 3457899999999999865 6799999999976554 5667888898876655 6899999999999999999999999
Q ss_pred CCCHHHHHhc-ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 254 NGNLEQWLRG-DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 254 ~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
..+|..+-+. .......+++.-.-.|....+.||.||-..+ .|||||+||+|||++..|.+||||||++-.+-. +
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--S 221 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--S 221 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--H
Confidence 4577664321 1113345788888888888999999999764 899999999999999999999999999987753 3
Q ss_pred eeeeecccccCCchhhhccCC
Q 018311 333 HITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~ 353 (358)
...+..+|+..|||||.+...
T Consensus 222 iAkT~daGCrpYmAPERi~p~ 242 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPS 242 (361)
T ss_pred HHhhhccCCccccChhccCCc
Confidence 346678999999999998654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=209.70 Aligned_cols=173 Identities=27% Similarity=0.327 Sum_probs=142.2
Q ss_pred CCCcc-cceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcc--------------hHHHHHHHHHHhcCCCCccccccc
Q 018311 174 NRFSK-DNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA--------------DKDFRVEVEAIGHVRHKNLVRLLG 237 (358)
Q Consensus 174 ~~~~~-~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~~ 237 (358)
++|.. .+.||+|+||+||+|.. .+++.||+|.+....... ...+.+|++++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 56654 57799999999999975 468999999885432211 124678999999999999999999
Q ss_pred eEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEE
Q 018311 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAK 317 (358)
Q Consensus 238 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~k 317 (358)
++...+..+++|||+. |+|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999996 699998863 34588999999999999999999998 999999999999999999999
Q ss_pred EeeecCceecCCCC-------------ceeeeecccccCCchhhhccCCC
Q 018311 318 ISDFGLAKLLGAGK-------------SHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 318 l~DFGla~~~~~~~-------------~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
|+|||+++.+.... ........+++.|+|||++.+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 209 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE 209 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC
Confidence 99999998765211 01112345688999999997643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=201.47 Aligned_cols=175 Identities=25% Similarity=0.304 Sum_probs=150.6
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC---CCcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 247 (358)
.++|..+.+||+|+|+.|.++++ ++.+.+|+|.+++. ..+..+..+.|-.+.... +||.+|-+..+|.+...+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46789999999999999999975 56788999988643 234445677788777665 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
|.||++||+|--.++ ....++++.+..+...|+.||.|||++ +|+.||||..|+|+|..|++||+|+|+++.-
T Consensus 329 vieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999976665 335699999999999999999999999 9999999999999999999999999999862
Q ss_pred CCCCceeeeecccccCCchhhhccCCCc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
-+....+++++|||.|.|||+++|+-|
T Consensus 402 -l~~gd~tstfcgtpnyiapeilrgeey 428 (593)
T KOG0695|consen 402 -LGPGDTTSTFCGTPNYIAPEILRGEEY 428 (593)
T ss_pred -CCCCcccccccCCCcccchhhhccccc
Confidence 222345788999999999999999877
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=198.15 Aligned_cols=173 Identities=30% Similarity=0.416 Sum_probs=149.6
Q ss_pred CCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeC--CEEEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRILVY 249 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lv~ 249 (358)
+|...+.||+|++|.||+|... +++.+++|.+..... ...+.+..|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999875 688999998865442 3456788999999999999999999999988 8899999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998743 2689999999999999999999998 999999999999999999999999999988765
Q ss_pred CCce-eeeecccccCCchhhhccCCC
Q 018311 330 GKSH-ITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 330 ~~~~-~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.... ......++..|+|||.+.+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~ 179 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEE 179 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCC
Confidence 4321 133467899999999987764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=205.89 Aligned_cols=166 Identities=28% Similarity=0.398 Sum_probs=141.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
+.|...+.||+|+||.||++.. .++..+|+|.+..... ....++..|+++++.++|||++++++++..++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3467788999999999999975 4688999998864322 22356888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||++ |+|.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9996 5888877532 34588999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeeeecccccCCchhhhcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
. ....|++.|+|||++.
T Consensus 178 ~-----~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVIL 194 (317)
T ss_pred c-----ccccCCccccChhhhh
Confidence 2 3457899999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=204.46 Aligned_cols=172 Identities=27% Similarity=0.421 Sum_probs=141.8
Q ss_pred CCCcccceecCCccEEEEEEEEeC-CcEEEEEEecCCCC-cchHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++.+.||+|+||.||+|.+.+ ++.||+|.+..... ....++..|+.++.++. ||||+++++++......+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 668889999999999999998754 88999999865432 23455667787776665 9999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+ . +|+||||+|+||++++++.+||+|||++..+..
T Consensus 95 ~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 984 577777653 23468899999999999999999997 5 899999999999999999999999999987643
Q ss_pred CCceeeeecccccCCchhhhccCCC
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
... .....++..|+|||++.+.+
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~ 190 (296)
T cd06618 168 SKA--KTRSAGCAAYMAPERIDPPD 190 (296)
T ss_pred CCc--ccCCCCCccccCHhhcCCCC
Confidence 222 23346888999999998664
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=209.50 Aligned_cols=175 Identities=26% Similarity=0.365 Sum_probs=145.7
Q ss_pred hHhhHHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEe
Q 018311 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241 (358)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 241 (358)
...++....++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++.+++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3455666779999999999999999999965 5788999999865432 223567789999999999999999998864
Q ss_pred C------CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc
Q 018311 242 G------TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD 315 (358)
Q Consensus 242 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~ 315 (358)
. ...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||++++++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 3 3467888887 7899887753 3488999999999999999999998 9999999999999999999
Q ss_pred EEEeeecCceecCCCCceeeeecccccCCchhhhccC
Q 018311 316 AKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 316 ~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
+||+|||+++..... .....|+..|+|||.+.+
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~ 191 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLN 191 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhC
Confidence 999999999875432 234578899999999866
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=201.26 Aligned_cols=176 Identities=22% Similarity=0.318 Sum_probs=142.5
Q ss_pred CCcccceecCCccEEEEEEEEeC-CcEEEEEEecCCC-----CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNP-----GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
+|.+.+.||+|+||.||++.... +..+++|.++... ......+..|+.++.+++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999997643 3445555543221 22234566799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||||+||++++ +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998875433445689999999999999999999998 9999999999999975 569999999998865
Q ss_pred CCCceeeeecccccCCchhhhccCCCc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
... .......|++.|+|||.+.+..+
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~ 182 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGY 182 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCC
Confidence 432 22334678999999999877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=202.35 Aligned_cols=170 Identities=26% Similarity=0.352 Sum_probs=142.7
Q ss_pred CcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc-chHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEEeec
Q 018311 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
|.+.+.||+|+||.||+|... +++.|++|++...... ......+|+..+.+++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999874 5788999988654322 2233456899999999 999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
+|+|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889999887532 24689999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeeeecccccCCchhhhccCC
Q 018311 333 HITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.....++..|+|||++.+.
T Consensus 155 --~~~~~~~~~~~aPE~~~~~ 173 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRS 173 (283)
T ss_pred --cCCCCCcccccCceeeecC
Confidence 2345788999999988653
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=205.73 Aligned_cols=170 Identities=19% Similarity=0.184 Sum_probs=138.9
Q ss_pred ccceecCCccEEEEEEEEeCCcEEEEEEecCC--CCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCC
Q 018311 178 KDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNN--PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (358)
Q Consensus 178 ~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (358)
+.+.+|.|+++.|+++.. +++.||+|++... .....+.+..|+++++.++||||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 345566666666666655 7899999998654 2334467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce--
Q 018311 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH-- 333 (358)
Q Consensus 256 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~-- 333 (358)
+|.+++.... ...+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+..+......
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999997542 23478889999999999999999999 9999999999999999999999999998766432211
Q ss_pred ----eeeecccccCCchhhhccCC
Q 018311 334 ----ITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 334 ----~~~~~~Gt~~y~APE~l~~~ 353 (358)
......++..|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~ 183 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQN 183 (314)
T ss_pred ccccccccccccccccCHHHhcCC
Confidence 12335677899999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=204.48 Aligned_cols=174 Identities=25% Similarity=0.355 Sum_probs=140.2
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+|+..+.||+|+||.||++.. .+++.+|+|.+.... ......+..|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455678999999999999976 468899999886443 234466888999999996 99999999999999999999999
Q ss_pred cCCCCHHHHHhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 252 VNNGNLEQWLRGD-MCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 252 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
+. +++.++.... ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||+++.+...
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 4665543211 112356889999999999999999999632 8999999999999999999999999999876433
Q ss_pred CceeeeecccccCCchhhhccCC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
. ......|+..|+|||++.+.
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~ 182 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPS 182 (288)
T ss_pred C--ccccccCccCccCHHHhccc
Confidence 2 22345789999999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=207.40 Aligned_cols=170 Identities=27% Similarity=0.354 Sum_probs=138.7
Q ss_pred CCcccceecCCccEEEEEEEEe-C--CcEEEEEEecCCC--CcchHHHHHHHHHHhcC-CCCccccccceEEeC----CE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM-N--GTAVAVKKLLNNP--GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG----TQ 244 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~-~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~----~~ 244 (358)
+|++.+.||+|+||.||++... . +..+|+|++.... ....+.+.+|++++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677899999999999999764 3 6789999886432 22345678899999999 599999999875432 45
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.++++||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999985 699998863 34588999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCce---eeeecccccCCchhhhccC
Q 018311 325 KLLGAGKSH---ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 325 ~~~~~~~~~---~~~~~~Gt~~y~APE~l~~ 352 (358)
+.+...... ......||+.|+|||++.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhC
Confidence 876543221 1234678999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=204.67 Aligned_cols=173 Identities=28% Similarity=0.375 Sum_probs=141.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeC--------
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-------- 242 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-------- 242 (358)
++|++.+.||+|+||.||+|.. .+++.+++|++..... .....+.+|++++.+++||||+++++++...
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 6899999999999999999976 4688999998854332 2234677899999999999999999987543
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
...++||||+. ++|..++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||
T Consensus 88 ~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 88 GSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 34699999995 478777753 234589999999999999999999999 99999999999999999999999999
Q ss_pred CceecCCCCce----------eeeecccccCCchhhhccCC
Q 018311 323 LAKLLGAGKSH----------ITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 323 la~~~~~~~~~----------~~~~~~Gt~~y~APE~l~~~ 353 (358)
+++........ ......|++.|+|||++.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 201 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE 201 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCC
Confidence 99876432211 11235678899999988654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-25 Score=200.32 Aligned_cols=172 Identities=28% Similarity=0.425 Sum_probs=140.6
Q ss_pred CcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc--chHHHHHHHHHHhcC---CCCccccccceEEeCCE-----
Q 018311 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHV---RHKNLVRLLGYCIEGTQ----- 244 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~----- 244 (358)
|++.+.||+|+||.||+|+.. +++.+|+|.+...... ....+..|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999875 4899999998643322 224456677776655 69999999999988776
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.+++|||+. ++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999996 5899988643 223588999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
..+..... .....++..|+|||++.+.++
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~ 183 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSY 183 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCC
Confidence 88754322 233467899999999987764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=195.87 Aligned_cols=165 Identities=27% Similarity=0.321 Sum_probs=142.5
Q ss_pred ecCCccEEEEEEEEe-CCcEEEEEEecCCCCc---chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCH
Q 018311 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (358)
Q Consensus 182 lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL 257 (358)
||+|+||.||++... +++.+++|.+...... ....+..|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999764 5889999988654322 345688899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeee
Q 018311 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337 (358)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~ 337 (358)
.+++... ..+++.....++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 9999742 3588999999999999999999998 99999999999999999999999999998875432 12345
Q ss_pred cccccCCchhhhccCCC
Q 018311 338 VMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 338 ~~Gt~~y~APE~l~~~~ 354 (358)
..++..|+|||.+.+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~ 169 (250)
T cd05123 153 FCGTPEYLAPEVLLGKG 169 (250)
T ss_pred CcCCccccChHHhCCCC
Confidence 67899999999987765
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-25 Score=200.57 Aligned_cols=170 Identities=28% Similarity=0.389 Sum_probs=144.9
Q ss_pred CcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
|++.+.||+|++|.||+|.. .+++.+++|.+...... ....+..|++++++++|+||+++++++..++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45678999999999999976 46889999988654322 3466888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++ +|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||.+..+....
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 64 898888642 24688999999999999999999998 99999999999999999999999999998876543
Q ss_pred eeeeecccccCCchhhhccCC
Q 018311 333 HITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.......++..|+|||.+.+.
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~ 173 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD 173 (283)
T ss_pred ccccCccCcccccCcHHHhcC
Confidence 122335688899999998876
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-25 Score=206.67 Aligned_cols=170 Identities=31% Similarity=0.417 Sum_probs=142.7
Q ss_pred HHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEe-CCEE
Q 018311 170 QSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQR 245 (358)
Q Consensus 170 ~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 245 (358)
....++|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+..|++++..++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34568899999999999999999975 478999999885432 2234667889999999999999999998875 5678
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
++++||+ +++|.+++.. ..+++.....++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999999 6799888863 3477888889999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCceeeeecccccCCchhhhccC
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
..... .....++..|+|||.+.+
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred ccCCC----cCCCcccccccCceeeec
Confidence 65432 223567889999998865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-25 Score=205.80 Aligned_cols=169 Identities=23% Similarity=0.239 Sum_probs=136.7
Q ss_pred ceecCC--ccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDG--GYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G--~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+.||+| +||+||++.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999976 5789999998864332 2336688899999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987542 23488889999999999999999998 99999999999999999999999998654432211110
Q ss_pred ------eeecccccCCchhhhccCC
Q 018311 335 ------TTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 335 ------~~~~~Gt~~y~APE~l~~~ 353 (358)
.....++..|+|||++.+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQD 183 (328)
T ss_pred cccccccccccCccCccChhhhcCC
Confidence 1112356679999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=207.43 Aligned_cols=170 Identities=29% Similarity=0.388 Sum_probs=141.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeC----------
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG---------- 242 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---------- 242 (358)
.+|++.+.||+|+||.||+|.. .+++.|++|++........+.+.+|+++++.++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 6899999999999999999976 56889999998666555567788999999999999999999876543
Q ss_pred ----CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCcEE
Q 018311 243 ----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAK 317 (358)
Q Consensus 243 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~-~~~~~k 317 (358)
...+++|||++ ++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++ +++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 35789999996 599888753 3488899999999999999999998 999999999999997 456789
Q ss_pred EeeecCceecCCCCce--eeeecccccCCchhhhccC
Q 018311 318 ISDFGLAKLLGAGKSH--ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 318 l~DFGla~~~~~~~~~--~~~~~~Gt~~y~APE~l~~ 352 (358)
|+|||+++.+...... ......|+..|+|||++.+
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 192 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS 192 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhC
Confidence 9999999876432221 1233467889999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=202.63 Aligned_cols=188 Identities=24% Similarity=0.305 Sum_probs=157.4
Q ss_pred hHhhHHHhcCCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCCcch-HHHHHHHHHHhcCCCCccccccc
Q 018311 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLLG 237 (358)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~HpnIv~l~~ 237 (358)
...++.....|++...++.+|.||.||+|.|. +.+.|.+|.++....+.+ ..+..|..++..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 45677777788998899999999999999653 345677888876655433 56788999999999999999999
Q ss_pred eEEe-CCEEEEEEeecCCCCHHHHHhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC
Q 018311 238 YCIE-GTQRILVYEYVNNGNLEQWLRGDMC----DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE 312 (358)
Q Consensus 238 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~ 312 (358)
++.. .+..++++.++..|+|..||...+. ....++..+...++.|++.||+|||.+ ++||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 8875 4667899999999999999983321 234577788899999999999999999 9999999999999999
Q ss_pred CCcEEEeeecCceecCCCCceee-eecccccCCchhhhccCCCc
Q 018311 313 NFDAKISDFGLAKLLGAGKSHIT-TRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 313 ~~~~kl~DFGla~~~~~~~~~~~-~~~~Gt~~y~APE~l~~~~~ 355 (358)
..++||+|-.++|++.+.+.+.. ........|||||.+.+.-|
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y 475 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY 475 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhh
Confidence 99999999999999999887743 34566789999999998765
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=201.10 Aligned_cols=164 Identities=29% Similarity=0.390 Sum_probs=139.3
Q ss_pred CcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
|...+.||+|+||.||+|.. .++..+++|.+..... .....+..|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56678899999999999975 4688999998864322 2234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+. |+|.+++.. ....+++.++..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 688887753 234588999999999999999999998 999999999999999999999999999865432
Q ss_pred ceeeeecccccCCchhhhcc
Q 018311 332 SHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~ 351 (358)
.....|+..|+|||++.
T Consensus 174 ---~~~~~~~~~y~aPE~~~ 190 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVIL 190 (313)
T ss_pred ---CCCccccccccChhhcc
Confidence 23467899999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=202.10 Aligned_cols=166 Identities=29% Similarity=0.407 Sum_probs=140.7
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
+.|+..+.||+|+||.||+|.. .++..+++|.+.... .....++..|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4466778999999999999976 467889999885422 223356778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+. |+|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..+..
T Consensus 95 e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 6888877532 34578899999999999999999998 999999999999999999999999999987653
Q ss_pred CCceeeeecccccCCchhhhcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
. ....|++.|+|||++.
T Consensus 168 ~-----~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVIL 184 (308)
T ss_pred c-----ccccCCccccCHHHHh
Confidence 2 3457899999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=198.23 Aligned_cols=170 Identities=29% Similarity=0.438 Sum_probs=144.1
Q ss_pred CcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
|+..+.||+|+||.||+|... +++.+++|.+.... ....+.+..|+.+++.++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455688999999999999764 58999999987553 233466788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
+ ++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 59999997531 4588999999999999999999999 999999999999999999999999999988654322
Q ss_pred eeeeecccccCCchhhhccCC
Q 018311 333 HITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~ 353 (358)
......++..|+|||.+.+.
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~ 173 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS 173 (282)
T ss_pred -ccCccccCcCcCChHHhcCC
Confidence 22334567889999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=204.29 Aligned_cols=166 Identities=27% Similarity=0.377 Sum_probs=138.8
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeC------C
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------T 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 243 (358)
.++|...+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++..++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999975 468999999986432 22335678899999999999999999998754 3
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
..++|+||+. .+|..++. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4699999995 47776552 2478899999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccC
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
++..... .....++..|+|||++.+
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~ 188 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILN 188 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcC
Confidence 9875432 224567889999999876
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-25 Score=206.48 Aligned_cols=174 Identities=21% Similarity=0.312 Sum_probs=146.0
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCC--CCcchHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNN--PGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e 250 (358)
..|+++++||+||-+.||++...+...+|+|++... ..+....|..|+.+|.+|+ |.+|+++++|-..++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 668999999999999999998878888999987433 3445578999999999995 9999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|- ..||.++|++.... ...| .++.+..||+.++.++|.+ ||||.||||.|+|+- .|.+||+|||+|..+...
T Consensus 441 ~G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred cc-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 86 66999999864221 1223 6788899999999999999 999999999999984 468999999999998765
Q ss_pred Cce-eeeecccccCCchhhhccCCCc
Q 018311 331 KSH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 331 ~~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
... ....-+||+.|||||.+.-..+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s 538 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSS 538 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccc
Confidence 544 3445799999999999876543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=218.69 Aligned_cols=175 Identities=21% Similarity=0.221 Sum_probs=125.4
Q ss_pred hcCCCcccceecCCccEEEEEEEEe-C----CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccce------EE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLM-N----GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY------CI 240 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~-~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~------~~ 240 (358)
..++|++.+.||+|+||.||+|... + +..||+|++...... +....| .+....+.++..+... +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3478999999999999999999864 4 689999987543211 111111 1222223333333222 23
Q ss_pred eCCEEEEEEeecCCCCHHHHHhcccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 018311 241 EGTQRILVYEYVNNGNLEQWLRGDMCD----------------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK 304 (358)
Q Consensus 241 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk 304 (358)
.....++||||+++++|.+++...... ........+..++.|++.||.|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 457789999999999999998643210 00112234567999999999999998 99999999
Q ss_pred CCcEEEcC-CCcEEEeeecCceecCCCCceeeeecccccCCchhhhccCC
Q 018311 305 SSNILIDE-NFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 305 ~~NiLl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
|+|||+++ ++.+||+|||+|+.+..+.........||+.|||||.+...
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~ 332 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS 332 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhcc
Confidence 99999985 68999999999998765544455678899999999977543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-26 Score=218.46 Aligned_cols=170 Identities=26% Similarity=0.398 Sum_probs=151.9
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.+|+....+|.|+||.|||++. .+++..|+|.++-......+-.+.|+-+++..+||||+.++|.|...+..|++||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 6788899999999999999964 678999999998877777788889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
.+|+|.+.-+ ..+.+++.+..+.++..++|++|||+. +-+|||||-.|||+++.|.+|++|||.+..++..-
T Consensus 95 gggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 95 GGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred CCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-
Confidence 9999998665 456799999999999999999999999 99999999999999999999999999998876421
Q ss_pred eeeeecccccCCchhhhcc
Q 018311 333 HITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~ 351 (358)
.....+.||+.|||||+..
T Consensus 167 ~KrksfiGtpywmapEvaa 185 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAA 185 (829)
T ss_pred hhhhcccCCccccchhHHH
Confidence 1234589999999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=192.02 Aligned_cols=156 Identities=17% Similarity=0.078 Sum_probs=131.0
Q ss_pred CccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCHHHHHhc
Q 018311 185 GGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG 263 (358)
Q Consensus 185 G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 263 (358)
|.||.||++.. .+++.+|+|++.... .+..|...+....||||+++++++...+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999975 578899999986542 233455555566799999999999999999999999999999999864
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeeecccccC
Q 018311 264 DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343 (358)
Q Consensus 264 ~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~ 343 (358)
. ..+++.....++.|++.||.|||+. +++||||||+||+++.++.++++|||++..+... .....++..
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 2 3488999999999999999999998 9999999999999999999999999988776532 223456788
Q ss_pred CchhhhccCCCcc
Q 018311 344 DFSVTLLRNMPIL 356 (358)
Q Consensus 344 y~APE~l~~~~~~ 356 (358)
|+|||++.+.+++
T Consensus 148 y~aPE~~~~~~~~ 160 (237)
T cd05576 148 YCAPEVGGISEET 160 (237)
T ss_pred ccCCcccCCCCCC
Confidence 9999999877653
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=203.67 Aligned_cols=168 Identities=27% Similarity=0.378 Sum_probs=142.4
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCE-----
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ----- 244 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 244 (358)
.++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++.+++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 478999999999999999999764 57899999886432 2233557789999999999999999998876554
Q ss_pred -EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 245 -RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 245 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 6799998863 3588999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCC
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+...... .....++..|+|||.+.+.
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~ 190 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNW 190 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCC
Confidence 9876433 2345678899999998653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-25 Score=214.84 Aligned_cols=172 Identities=34% Similarity=0.414 Sum_probs=137.8
Q ss_pred CcccceecCCccE-EEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEeecC
Q 018311 176 FSKDNIIGDGGYG-VVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 176 ~~~~~~lG~G~fg-~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
|...+++|.|+-| .||+|.+ .|+.||||++.... .+-.++|+..|+.- +|||||++++.-.++...|++.|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 3445789999876 6899988 67899999985432 23456899999887 6999999999888899999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---C--CcEEEeeecCceecC
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---N--FDAKISDFGLAKLLG 328 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~---~--~~~kl~DFGla~~~~ 328 (358)
.-+|.+++.................+..|++.||++||+. +||||||||+||||.. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5699999976411111111134567889999999999998 9999999999999965 2 569999999999998
Q ss_pred CCCce--eeeecccccCCchhhhccCCCc
Q 018311 329 AGKSH--ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 329 ~~~~~--~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.+... ......||-||+|||++.+.+-
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~ 691 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRK 691 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhcccc
Confidence 76654 3456889999999999988764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-23 Score=180.49 Aligned_cols=169 Identities=31% Similarity=0.473 Sum_probs=145.7
Q ss_pred CcccceecCCccEEEEEEEEeC-CcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 176 FSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
|...+.||+|++|.||++.... ++.+++|.+...... ..+.+..|++.+.+++|+|++++++++...+..++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4557899999999999998754 889999998765544 56788899999999999999999999998899999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+++|.+++.... ..+++.....++.+++.++.|||+. +++|+||++.||+++.++.++|+|||++..+......
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999987432 1178899999999999999999998 9999999999999999999999999999987654311
Q ss_pred eeeecccccCCchhhhc
Q 018311 334 ITTRVMGTFGDFSVTLL 350 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l 350 (358)
......++..|++||.+
T Consensus 155 ~~~~~~~~~~~~~pe~~ 171 (225)
T smart00221 155 LLKTVKGTPFYLAPEVL 171 (225)
T ss_pred cccceeccCCcCCHhHh
Confidence 23446788899999998
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=181.88 Aligned_cols=140 Identities=16% Similarity=0.171 Sum_probs=109.2
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCCc--c-------hHH-----------------HHHHHHHHhcCCCCcc
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ--A-------DKD-----------------FRVEVEAIGHVRHKNL 232 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~HpnI 232 (358)
.+.||+|+||.||+|...+|+.||+|.++..... . ... ...|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999998778999999998654321 1 011 2349999999988877
Q ss_pred ccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCCcEEEc
Q 018311 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL-HEAIEPKVVHRDIKSSNILID 311 (358)
Q Consensus 233 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivHrDlk~~NiLl~ 311 (358)
.....+.. ...++||||++++++..... ....++......++.|++.+|.|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 54333322 23489999999887765432 224588899999999999999999 687 999999999999998
Q ss_pred CCCcEEEeeecCceecC
Q 018311 312 ENFDAKISDFGLAKLLG 328 (358)
Q Consensus 312 ~~~~~kl~DFGla~~~~ 328 (358)
++.++|+|||+|....
T Consensus 153 -~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -CCcEEEEEccccccCC
Confidence 4789999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=188.92 Aligned_cols=174 Identities=20% Similarity=0.254 Sum_probs=143.8
Q ss_pred HhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC--CCc----cccccceEEeCC
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR--HKN----LVRLLGYCIEGT 243 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--Hpn----Iv~l~~~~~~~~ 243 (358)
...++|.+...+|+|.||.|-.|-. ..+..||+|.++.- ....+....|+++|.++. .|+ +|.+.+||.-.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 3468999999999999999999954 45788999987543 334455677999999994 233 678888899999
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-----------
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE----------- 312 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~----------- 312 (358)
..|+|+|.+ |-++++||..+. ..+++...+..|+.|++.+++|||+. +++|-||||+|||+-+
T Consensus 165 hiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence 999999999 779999998753 34578899999999999999999999 9999999999999831
Q ss_pred ---------CCcEEEeeecCceecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 313 ---------NFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 313 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+..+||+|||.|..-.... +.++-|..|.|||+++|-+.
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGw 286 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGW 286 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCc
Confidence 3458999999998865433 56788999999999998763
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=176.23 Aligned_cols=141 Identities=18% Similarity=0.140 Sum_probs=111.8
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCCcc--------------------------hHHHHHHHHHHhcCCCCcc
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA--------------------------DKDFRVEVEAIGHVRHKNL 232 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~HpnI 232 (358)
.+.||+|+||.||+|...+|+.||||.+....... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987789999999987543210 1123578999999999987
Q ss_pred ccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEc
Q 018311 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILID 311 (358)
Q Consensus 233 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~NiLl~ 311 (358)
.....+... ..++||||++++++..... ....++......++.|++.++.++|+ . +|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 554444333 3489999998886544322 12346778899999999999999999 8 999999999999999
Q ss_pred CCCcEEEeeecCceecCC
Q 018311 312 ENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 312 ~~~~~kl~DFGla~~~~~ 329 (358)
++.++|+|||+++.+..
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 89999999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=178.58 Aligned_cols=161 Identities=30% Similarity=0.448 Sum_probs=140.5
Q ss_pred ccEEEEEEEEe-CCcEEEEEEecCCCCcc-hHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCHHHHHhc
Q 018311 186 GYGVVYRGQLM-NGTAVAVKKLLNNPGQA-DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG 263 (358)
Q Consensus 186 ~fg~V~~~~~~-~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 263 (358)
+||.||+|... +++.+++|.+....... .+.+..|++.+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999875 48999999987655444 67899999999999999999999999999999999999999999999874
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeeecccccC
Q 018311 264 DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343 (358)
Q Consensus 264 ~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~ 343 (358)
. ..+++.....++.+++.++.|||+. +++|+||+|+||++++++.++|+|||++....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 2 2278899999999999999999998 99999999999999999999999999999876532 3345678999
Q ss_pred CchhhhccCCCc
Q 018311 344 DFSVTLLRNMPI 355 (358)
Q Consensus 344 y~APE~l~~~~~ 355 (358)
|++||.+.+.++
T Consensus 152 ~~~pE~~~~~~~ 163 (244)
T smart00220 152 YMAPEVLLGKGY 163 (244)
T ss_pred CCCHHHHccCCC
Confidence 999999876544
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-23 Score=197.40 Aligned_cols=169 Identities=23% Similarity=0.277 Sum_probs=140.6
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
+...|.....+|.|+|+.|..|.. .+++..++|.+.+.. .+..+|+.++... +||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356788888899999999999965 567889999886542 2344577666665 6999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE-cCCCcEEEeeecCceecC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI-DENFDAKISDFGLAKLLG 328 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl-~~~~~~kl~DFGla~~~~ 328 (358)
|++.++-+.+.+... .... .++..|+.+++.|+.|||++ ++|||||||+|||+ ++.++++|+|||.++.+.
T Consensus 396 e~l~g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999888877532 2122 67778999999999999998 99999999999999 699999999999999986
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+. ..+.+-|..|.|||++....|+
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt 491 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYT 491 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCC
Confidence 54 3345678899999999988775
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-21 Score=168.59 Aligned_cols=165 Identities=33% Similarity=0.578 Sum_probs=141.9
Q ss_pred ecCCccEEEEEEEEeC-CcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCHHH
Q 018311 182 IGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQ 259 (358)
Q Consensus 182 lG~G~fg~V~~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 259 (358)
||+|.+|.||++.... ++.+++|.+...... ..+.+.+|++.+..++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998754 899999998655432 34678899999999999999999999999899999999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCcEEEeeecCceecCCCCceeeeec
Q 018311 260 WLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKLLGAGKSHITTRV 338 (358)
Q Consensus 260 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~-~~~~kl~DFGla~~~~~~~~~~~~~~ 338 (358)
++.... ..+++..+..++.+++.++.|||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987421 3578899999999999999999999 9999999999999999 89999999999988754321 23346
Q ss_pred ccccCCchhhhccCC
Q 018311 339 MGTFGDFSVTLLRNM 353 (358)
Q Consensus 339 ~Gt~~y~APE~l~~~ 353 (358)
.+...|++||.+...
T Consensus 154 ~~~~~~~~pe~~~~~ 168 (215)
T cd00180 154 VGTPAYMAPEVLLGK 168 (215)
T ss_pred cCCCCccChhHhccc
Confidence 688899999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.9e-23 Score=191.24 Aligned_cols=185 Identities=24% Similarity=0.233 Sum_probs=151.4
Q ss_pred chHhhHHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC------CCcccccc
Q 018311 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR------HKNLVRLL 236 (358)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~ 236 (358)
|.+.-.+..-.+|.+....|+|-|++|.+|.. ..|..||||++.++.... +.=+.|+++|.+|+ --|+++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 44444455668899999999999999999965 457899999998765432 33456999999996 34899999
Q ss_pred ceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-Cc
Q 018311 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FD 315 (358)
Q Consensus 237 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~-~~ 315 (358)
..|...+++|||+|-+ .-+|.+.|++... +-.|....+..++.|+..||..|-.. +|+|.||||.|||+++. ..
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 9999999999999988 6699999986432 23477788899999999999999987 99999999999999875 56
Q ss_pred EEEeeecCceecCCCCceeeeecccccCCchhhhccCCCccc
Q 018311 316 AKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPILV 357 (358)
Q Consensus 316 ~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~ 357 (358)
+||||||.|...+.+. .+...-+-.|.|||+++|.||.+
T Consensus 576 LKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~ 614 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDY 614 (752)
T ss_pred eeeccCcccccccccc---ccHHHHHHhccCcceeecCcccC
Confidence 8999999998876554 23345567899999999999975
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=174.67 Aligned_cols=166 Identities=20% Similarity=0.361 Sum_probs=133.0
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccce-EEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGY-CIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~-~~~~~~~~lv~e 250 (358)
+.|.+.+.||+|.||.+.+|+++ +...+++|.+.. .....++|.+|..---.| .|.||+.-|+. |...+...+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 56888999999999999999875 456778887643 344568899998776666 58999987775 556677788999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE--cCCCcEEEeeecCceecC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI--DENFDAKISDFGLAKLLG 328 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl--~~~~~~kl~DFGla~~~~ 328 (358)
|++.|||..-+.. ..+.+....+++.|+++|+.|+|++ ++||||||.+|||| .+...+||||||+.+..+
T Consensus 103 ~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999876542 3367788899999999999999999 99999999999998 345589999999988764
Q ss_pred CCCceeeeecccccCCchhhhccC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
. .......+..|.+||+..-
T Consensus 175 ~----tV~~~~~~~~y~~pe~~~~ 194 (378)
T KOG1345|consen 175 T----TVKYLEYVNNYHAPELCDT 194 (378)
T ss_pred c----eehhhhhhcccCCcHHHhh
Confidence 2 2334556778999998654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-22 Score=178.96 Aligned_cols=169 Identities=29% Similarity=0.335 Sum_probs=139.9
Q ss_pred CCCcccceecCCccEEEEEE-EEeCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeC------CE
Q 018311 174 NRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------TQ 244 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~ 244 (358)
.+|.....+|.|.- .|.-+ ..-.++.||+|++.... ....++..+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 56777788888887 45555 33467899999885443 33446778899999999999999999998743 35
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.|+|||+| ..+|.+.+.. .++-++..+|+.|+++|++|||+. +|+||||||+||+++.++.+||.|||+|
T Consensus 96 ~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 69999999 5699988762 256678899999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+.-... ...+..+.|..|.|||++.|..|
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ 194 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGY 194 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCC
Confidence 986544 35667889999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-22 Score=171.02 Aligned_cols=166 Identities=26% Similarity=0.400 Sum_probs=139.7
Q ss_pred CCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-CCccccccceEEeC--CEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEG--TQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lv~ 249 (358)
.+|++.+++|+|-+++|+.|. ..+.++++||.+++. ..+.+.+|+++|..|. ||||+++++...++ ....+|+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 678889999999999999995 467788999998654 3466889999999997 99999999998875 3467999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-CcEEEeeecCceecC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLLG 328 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~-~~~kl~DFGla~~~~ 328 (358)
||+.+.|...+.. .++..+......+++.||.|||+. ||+|||+||.|++||.. -.++|+|+|||....
T Consensus 115 E~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 115 EYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999988877653 366778899999999999999999 99999999999999854 569999999999988
Q ss_pred CCCceeeeecccccCCchhhhccCCC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
++.. .+..+.+..|-.||++-..+
T Consensus 185 p~~e--YnVRVASRyfKGPELLVdy~ 208 (338)
T KOG0668|consen 185 PGKE--YNVRVASRYFKGPELLVDYQ 208 (338)
T ss_pred CCce--eeeeeehhhcCCchheeech
Confidence 7664 34445677788899886654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.1e-21 Score=166.41 Aligned_cols=136 Identities=17% Similarity=0.224 Sum_probs=105.6
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-----CCCccccccceEEeCC---EEE-EEE
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-----RHKNLVRLLGYCIEGT---QRI-LVY 249 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~~~~---~~~-lv~ 249 (358)
.+.||+|+||.||. .-.++.. +||++........+++.+|++++..+ .||||+++++++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 57999999999996 3334444 68888665444567799999999999 5799999999998863 434 789
Q ss_pred ee--cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeeCCCCCCcEEEcC----CCcEEEeeec
Q 018311 250 EY--VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL-AYLHEAIEPKVVHRDIKSSNILIDE----NFDAKISDFG 322 (358)
Q Consensus 250 e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~yLH~~~~~~ivHrDlk~~NiLl~~----~~~~kl~DFG 322 (358)
|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+||+
T Consensus 85 e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred cCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 99 5579999999642 24444 35577778777 999999 9999999999999974 3479999944
Q ss_pred Ccee
Q 018311 323 LAKL 326 (358)
Q Consensus 323 la~~ 326 (358)
.++.
T Consensus 155 G~~~ 158 (210)
T PRK10345 155 GEST 158 (210)
T ss_pred CCcc
Confidence 4433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=164.25 Aligned_cols=171 Identities=22% Similarity=0.308 Sum_probs=139.7
Q ss_pred cCCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCC-CccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH-KNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|.+.++||.|+||.+|.|. ..+|..||||.-..... ...+..|.++...|++ ..|..+..+..+.....||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4789999999999999999996 47899999997654432 3457779999998875 778888888888899999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCcEEEeeecCceec
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISDFGLAKLL 327 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~---~~~~kl~DFGla~~~ 327 (358)
++ |.+|++++.- ....++.++++.++.|++.-++|+|.+ +++||||||+|+|..- ...+.++|||||+.+
T Consensus 92 LL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99 8899998763 345688899999999999999999999 9999999999999853 356899999999987
Q ss_pred CCCCc--ee----eeecccccCCchhhhccC
Q 018311 328 GAGKS--HI----TTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 328 ~~~~~--~~----~~~~~Gt~~y~APE~l~~ 352 (358)
.+... |+ .....||..|++--...|
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g 195 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLG 195 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhh
Confidence 64332 22 234789999987655543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=177.19 Aligned_cols=174 Identities=21% Similarity=0.327 Sum_probs=137.9
Q ss_pred CCcccceecCCccEEEEEEEEeCC--cEEEEEEecCCCCcchHHHHHHHHHHhcCCC----CccccccceE-EeCCEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLMNG--TAVAVKKLLNNPGQADKDFRVEVEAIGHVRH----KNLVRLLGYC-IEGTQRIL 247 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----pnIv~l~~~~-~~~~~~~l 247 (358)
+|.+.+.||+|+||.||+|..... ..+|+|............+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999976543 4678887654433322367788888888863 6888888888 47778999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-----CcEEEeeec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-----FDAKISDFG 322 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~-----~~~kl~DFG 322 (358)
||+.+ |.+|.++..... .+.++..+.++|+.|++.+|++||+. +++||||||.|++++.. ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99998 889999775432 56799999999999999999999999 99999999999999765 469999999
Q ss_pred Cce--ecCCCCc--ee-----eeecccccCCchhhhccCCC
Q 018311 323 LAK--LLGAGKS--HI-----TTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 323 la~--~~~~~~~--~~-----~~~~~Gt~~y~APE~l~~~~ 354 (358)
+|+ .+..... .. ...+.||..|+++....+..
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e 213 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE 213 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc
Confidence 998 4321111 01 23466999999999888765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-20 Score=167.69 Aligned_cols=171 Identities=25% Similarity=0.344 Sum_probs=139.2
Q ss_pred CCCcccceecCCccEEEEEEE-EeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
-.|+++++||+|+||+++.|+ +-+++.||||.-. ......++..|-+..+.|. .++|..++-+...+-...||||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368899999999999999995 5689999999642 2233456777888877774 68999988888788888999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-----CcEEEeeecCcee
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-----FDAKISDFGLAKL 326 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~-----~~~kl~DFGla~~ 326 (358)
+ |.+|+|+..- ....++.++++.+|.|++.-++|+|++ .+|.|||||+|+||..- ..+.|+|||+|+.
T Consensus 106 L-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9 8899998753 445699999999999999999999999 99999999999999643 4589999999998
Q ss_pred cCCCCc--ee----eeecccccCCchhhhccCC
Q 018311 327 LGAGKS--HI----TTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 327 ~~~~~~--~~----~~~~~Gt~~y~APE~l~~~ 353 (358)
+.+.+. |+ .....||..||+---..|.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr 211 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGR 211 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccc
Confidence 765432 22 2347899999987655553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=159.03 Aligned_cols=154 Identities=18% Similarity=0.151 Sum_probs=117.3
Q ss_pred ccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcc----hHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEEeec
Q 018311 178 KDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA----DKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 178 ~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~----~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
....|++|+||+||.+.. .+.+++.+.+.....-. ...+.+|+++|.+|. |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 357899999999998866 67788877775444311 124788999999995 5889988886 4569999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDI-KSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDl-k~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
.|.+|.+.+.. ....++.|++.+|.++|+. +|+|||| ||.|||+++++.++|+|||+|.......
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998654321 1134678899999999999 9999999 7999999999999999999998755433
Q ss_pred ce----e--------eeecccccCCchhhhc
Q 018311 332 SH----I--------TTRVMGTFGDFSVTLL 350 (358)
Q Consensus 332 ~~----~--------~~~~~Gt~~y~APE~l 350 (358)
.. . ......+++|++|+..
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~ 177 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVER 177 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHH
Confidence 10 0 1123468888888764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=165.61 Aligned_cols=144 Identities=17% Similarity=0.115 Sum_probs=111.5
Q ss_pred CCcccceecCCccEEEEEEE--EeCCcEEEEEEecCCCCc------------------------chHHHHHHHHHHhcCC
Q 018311 175 RFSKDNIIGDGGYGVVYRGQ--LMNGTAVAVKKLLNNPGQ------------------------ADKDFRVEVEAIGHVR 228 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 228 (358)
-|++.+.||+|+||.||+|. ..+|+.||+|.+...... ....+..|++++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999997 568999999988643210 0123567999999997
Q ss_pred CCc--cccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eeeCCCCC
Q 018311 229 HKN--LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK-VVHRDIKS 305 (358)
Q Consensus 229 Hpn--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-ivHrDlk~ 305 (358)
+.+ +.++++ . ...++||||+++.+|..+... ...+.......++.|++.++.+||+. + ++||||||
T Consensus 109 ~~~i~~p~~~~---~-~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIA---W-RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeE---e-cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 533 233333 2 235899999999888765432 22355566789999999999999999 8 99999999
Q ss_pred CcEEEcCCCcEEEeeecCceecCCC
Q 018311 306 SNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 306 ~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
+||+++ ++.++|+|||++......
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCCc
Confidence 999999 889999999999876543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-20 Score=172.02 Aligned_cols=146 Identities=29% Similarity=0.434 Sum_probs=126.6
Q ss_pred hHHHhcCCCcccceecCCccEEEEEEEEe----CCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-CCccccccceEEeC
Q 018311 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEG 242 (358)
Q Consensus 168 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~ 242 (358)
.+....+.|...++||+|.|+.||++... ..+.||+|.+.... ....+..|+++|..+. +.||+.+.+++..+
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34455678899999999999999999643 46789999886543 3356888999999995 99999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCcEEEeee
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDF 321 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~-~~~~kl~DF 321 (358)
+..++||||++.-+..+++.. ++......++..+..||.++|.. |||||||||.|+|.+. .+.-.|.||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 999999999999999998863 56788899999999999999999 9999999999999974 467889999
Q ss_pred cCce
Q 018311 322 GLAK 325 (358)
Q Consensus 322 Gla~ 325 (358)
|||.
T Consensus 178 gLA~ 181 (418)
T KOG1167|consen 178 GLAQ 181 (418)
T ss_pred hhHH
Confidence 9997
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.8e-20 Score=160.44 Aligned_cols=140 Identities=13% Similarity=0.153 Sum_probs=115.4
Q ss_pred hcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHH---------HHHHHHHHhcCCCCccccccceEEeC
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD---------FRVEVEAIGHVRHKNLVRLLGYCIEG 242 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~HpnIv~l~~~~~~~ 242 (358)
..++|+..++||.|+||.||+++. ++..+|+|.+.+........ +.+|+..+.+++||+|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 358999999999999999999866 57789999987554333222 57899999999999999998886643
Q ss_pred --------CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC
Q 018311 243 --------TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314 (358)
Q Consensus 243 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~ 314 (358)
+..+++|||++|.+|.++.. ++. ....+++.+|..+|.. +++|||+||.|+++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 35789999999999988642 222 2455899999999999 999999999999999988
Q ss_pred cEEEeeecCceecC
Q 018311 315 DAKISDFGLAKLLG 328 (358)
Q Consensus 315 ~~kl~DFGla~~~~ 328 (358)
++|+|||..+...
T Consensus 173 -i~liDfg~~~~~~ 185 (232)
T PRK10359 173 -LRIIDLSGKRCTA 185 (232)
T ss_pred -EEEEECCCccccc
Confidence 9999999887653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=158.97 Aligned_cols=135 Identities=20% Similarity=0.359 Sum_probs=114.2
Q ss_pred ceecCCccEEEEEEEEeCCcEEEEEEecCCCCc--------chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ--------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
+.||+|++|.||+|.+ .|..+++|........ ....+.+|++++..++|+||.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999976543221 113467899999999999998888887778889999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
++|++|.+++... .+ ....++.+++.+|.++|+. +++|+|++|.|||++ ++.++|+|||+++..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999988632 12 7788999999999999998 999999999999999 789999999998864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-19 Score=163.02 Aligned_cols=172 Identities=33% Similarity=0.479 Sum_probs=145.2
Q ss_pred CcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCc---chHHHHHHHHHHhcCCCC-ccccccceEEeCCEEEEEEee
Q 018311 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHK-NLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lv~e~ 251 (358)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556789999999999999876 78899988655433 356789999999999988 799999999777778999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-cEEEeeecCceecCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKLLGAG 330 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~-~~kl~DFGla~~~~~~ 330 (358)
+.++++.+++...... ..+.......+..|++.++.|+|.. +++|||+||+||+++..+ .++++|||+++.+...
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777643211 3588899999999999999999999 999999999999999988 7999999999876544
Q ss_pred Cce-----eeeecccccCCchhhhccCC
Q 018311 331 KSH-----ITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 331 ~~~-----~~~~~~Gt~~y~APE~l~~~ 353 (358)
... ......||..|+|||.+.+.
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~ 183 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGL 183 (384)
T ss_pred CccccccccccccccccccCCHHHhcCC
Confidence 332 34678999999999999873
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-19 Score=155.52 Aligned_cols=147 Identities=19% Similarity=0.148 Sum_probs=112.9
Q ss_pred hhHHHhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCc----------------------chHHHHHHHHHH
Q 018311 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ----------------------ADKDFRVEVEAI 224 (358)
Q Consensus 167 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l 224 (358)
.++......|.+.+.||+|+||.||+|...+|+.||||.+...... ....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444457888999999999999998888999999986543210 011256788889
Q ss_pred hcCCCCc--cccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 018311 225 GHVRHKN--LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRD 302 (358)
Q Consensus 225 ~~l~Hpn--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrD 302 (358)
..+.|++ +...++ ....+++|||+++++|...... .....++.+++.++.++|+. +++|||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGD 150 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCC
Confidence 8888774 333332 3456899999999998764320 23467888999999999998 999999
Q ss_pred CCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 303 IKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 303 lk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|||+||++++++.++|+|||++..+...
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~~ 178 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDHP 178 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCCc
Confidence 9999999999999999999999776543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=178.58 Aligned_cols=138 Identities=22% Similarity=0.378 Sum_probs=112.2
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEe-cCCCC-------cchHHHHHHHHHHhcCCCCccccccceEEeCCEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKL-LNNPG-------QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l-~~~~~-------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 245 (358)
..|...+.||+|+||.||++.+.... +++|+. .+... ...+++.+|++++..++|++++....++.+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 44566789999999999999875443 444432 21111 1124578899999999999999888888777788
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
++||||+++++|.+++. ....++.+++.+|.|||+. +++||||||+|||+ +++.++|+|||+++
T Consensus 412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 99999999999999875 3467889999999999998 99999999999999 67899999999998
Q ss_pred ecC
Q 018311 326 LLG 328 (358)
Q Consensus 326 ~~~ 328 (358)
...
T Consensus 476 ~~~ 478 (535)
T PRK09605 476 YSD 478 (535)
T ss_pred cCC
Confidence 754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-19 Score=154.76 Aligned_cols=132 Identities=22% Similarity=0.402 Sum_probs=108.4
Q ss_pred eecCCccEEEEEEEEeCCcEEEEEEecCCCC-c-------chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG-Q-------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 181 ~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~-~-------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.||+|+||.||++.+ ++..+++|....... . ...++.+|++++..++|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 678899998654321 1 1245678999999999988776666666777789999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
+|++|.+++... . ..++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||+++...
T Consensus 80 ~g~~l~~~~~~~----~-------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEG----N-------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhc----H-------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999999887531 1 07889999999999999 999999999999999 8999999999988753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.9e-17 Score=154.99 Aligned_cols=134 Identities=23% Similarity=0.327 Sum_probs=111.4
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-----C---CccccccceEEe---
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----H---KNLVRLLGYCIE--- 241 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---pnIv~l~~~~~~--- 241 (358)
++|-+.++||=|.|++||+|-. .+.+-||+|+++. .....+....||++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 7899999999999999999954 5567799998744 3344455677999999884 3 369999999974
Q ss_pred -CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC
Q 018311 242 -GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN 313 (358)
Q Consensus 242 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~ 313 (358)
+.++|||+|++ |-+|..++... ..+-++...+..|+.||+.||.|||..+ +|||-||||+|||+..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 56789999999 77999988765 3345888999999999999999999876 99999999999999644
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.8e-18 Score=174.20 Aligned_cols=179 Identities=20% Similarity=0.242 Sum_probs=141.6
Q ss_pred HHHhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC---CCccccccceEEeCCEE
Q 018311 169 LQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 169 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~ 245 (358)
++.....|.+.+.||+|+||.||+|...+|+.||+|.-+....- +|-.-.+++.+|+ -+-|..+...+.-.+..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 33445678888999999999999999888999999987654421 2222334444554 24456666666677888
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-------CCCcEEE
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-------ENFDAKI 318 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~-------~~~~~kl 318 (358)
++|+||.+.|+|.+++. ..+.++|..++.++.|++.-++.||.. +|||+||||+|+||. +.-.++|
T Consensus 770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 99999999999999997 456689999999999999999999999 999999999999994 2345999
Q ss_pred eeecCceecCC-CCceeeeecccccCCchhhhccCCCccc
Q 018311 319 SDFGLAKLLGA-GKSHITTRVMGTFGDFSVTLLRNMPILV 357 (358)
Q Consensus 319 ~DFGla~~~~~-~~~~~~~~~~Gt~~y~APE~l~~~~~~~ 357 (358)
+|||-+-++.. .+........+|-++-++|+..|.|-+|
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtY 882 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTY 882 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCch
Confidence 99999876542 1223556678999999999999999876
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=137.61 Aligned_cols=135 Identities=20% Similarity=0.170 Sum_probs=112.6
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCC--CccccccceEEeCCEEEEEEeecCCCC
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH--KNLVRLLGYCIEGTQRILVYEYVNNGN 256 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lv~e~~~~gs 256 (358)
.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++.+++.+...++..+++|||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 5789999999999998744 7899998755433 4678889999999976 588888888877788999999998877
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 257 LEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 257 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
+..+ +......++.+++.++.++|.....+++|+|++|+||++++.+.+++.|||+++..
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7542 34566778899999999999864347999999999999999999999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.4e-17 Score=140.58 Aligned_cols=137 Identities=22% Similarity=0.255 Sum_probs=97.2
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCCcch--HHH----------------------HHHHHHHhcCCCCc--c
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD--KDF----------------------RVEVEAIGHVRHKN--L 232 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~--~~~----------------------~~E~~~l~~l~Hpn--I 232 (358)
.+.||+|+||.||+|...+++.||||.+........ ... ..|.+.+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 468999999999999887899999998865432111 111 23555555554332 2
Q ss_pred ccccceEEeCCEEEEEEeecCCCCHHHH-HhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEE
Q 018311 233 VRLLGYCIEGTQRILVYEYVNNGNLEQW-LRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILI 310 (358)
Q Consensus 233 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~NiLl 310 (358)
...++. ...+++|||++++++... +... ... .....++.+++.++.++|. . +|+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 233222 346899999998654321 1110 011 5678899999999999998 7 99999999999999
Q ss_pred cCCCcEEEeeecCceecCC
Q 018311 311 DENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 311 ~~~~~~kl~DFGla~~~~~ 329 (358)
+ ++.++|+|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 99999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.6e-18 Score=177.82 Aligned_cols=124 Identities=13% Similarity=0.096 Sum_probs=91.8
Q ss_pred cCCC-CccccccceE-------EeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 018311 226 HVRH-KNLVRLLGYC-------IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297 (358)
Q Consensus 226 ~l~H-pnIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 297 (358)
.++| +||++++++| .....+++++|++ +++|.++|.. ....+++.+++.++.||+.||.|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4456 6888888887 2234567788988 6799999974 234589999999999999999999998 9
Q ss_pred eeeCCCCCCcEEEcCC-------------------CcEEEeeecCceecCCCC---------------ceeeeecccccC
Q 018311 298 VVHRDIKSSNILIDEN-------------------FDAKISDFGLAKLLGAGK---------------SHITTRVMGTFG 343 (358)
Q Consensus 298 ivHrDlk~~NiLl~~~-------------------~~~kl~DFGla~~~~~~~---------------~~~~~~~~Gt~~ 343 (358)
|+||||||+||||+.. +.+|++|||+++...... .......+||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 445666666665421100 000112468899
Q ss_pred CchhhhccCCCcc
Q 018311 344 DFSVTLLRNMPIL 356 (358)
Q Consensus 344 y~APE~l~~~~~~ 356 (358)
|||||++.+.+|.
T Consensus 181 Y~APE~~~~~~~~ 193 (793)
T PLN00181 181 YTSPEEDNGSSSN 193 (793)
T ss_pred eEChhhhccCCCC
Confidence 9999999988874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.4e-16 Score=141.47 Aligned_cols=137 Identities=20% Similarity=0.254 Sum_probs=105.1
Q ss_pred cceec-CCccEEEEEEEEeCCcEEEEEEecCCC-------------CcchHHHHHHHHHHhcCCCCcc--ccccceEEeC
Q 018311 179 DNIIG-DGGYGVVYRGQLMNGTAVAVKKLLNNP-------------GQADKDFRVEVEAIGHVRHKNL--VRLLGYCIEG 242 (358)
Q Consensus 179 ~~~lG-~G~fg~V~~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~~ 242 (358)
...|| .|+.|+||.++.. +..+++|...... ......+.+|++++.+|+|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999774 6778888774321 1122457789999999998885 5666654432
Q ss_pred -C---EEEEEEeecCC-CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEE
Q 018311 243 -T---QRILVYEYVNN-GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAK 317 (358)
Q Consensus 243 -~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~k 317 (358)
. ..++|||++++ .+|.+++.. ..++.. .+.+++.+|.+||+. +|+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 699988753 224443 356889999999999 999999999999999999999
Q ss_pred EeeecCceecC
Q 018311 318 ISDFGLAKLLG 328 (358)
Q Consensus 318 l~DFGla~~~~ 328 (358)
|+|||.++...
T Consensus 183 LIDfg~~~~~~ 193 (239)
T PRK01723 183 LIDFDRGELRT 193 (239)
T ss_pred EEECCCcccCC
Confidence 99999988754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-17 Score=165.55 Aligned_cols=171 Identities=22% Similarity=0.275 Sum_probs=132.2
Q ss_pred ccceecCCccEEEEEEEEe-CCcEEEEEEecCC--CCcch----HHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 178 KDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNN--PGQAD----KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 178 ~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~--~~~~~----~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
..+++|.|.+|.|+.+... ..+..+.|..... ..... ..+..|..+-..+.|||++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999977777532 2333344432210 11111 225567888888999999888887776655555699
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
||++ ||+.++.. ...+...++..++.|++.|+.|+|+. +|.|||||++|+++..+|.+||+|||.+..+.-.
T Consensus 402 ~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 99999873 24688888999999999999999999 9999999999999999999999999998776433
Q ss_pred C-c--eeeeecccccCCchhhhccCCCcc
Q 018311 331 K-S--HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~-~--~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. . +....++|+..|+|||.+.+..|.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~yd 502 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYD 502 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccC
Confidence 2 2 566789999999999999988774
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6e-17 Score=156.46 Aligned_cols=160 Identities=24% Similarity=0.259 Sum_probs=131.5
Q ss_pred eecCCccEEEEEEE----EeCCcEEEEEEecCCCCcc--hHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEEeecC
Q 018311 181 IIGDGGYGVVYRGQ----LMNGTAVAVKKLLNNPGQA--DKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 181 ~lG~G~fg~V~~~~----~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
++|+|.||.|+++. ...|..+|.|.+++..... ......|..++..++ ||.++++...+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999874 3456778888775443211 123445788888887 9999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+|+|...+. ....+.+.........++.+++++|+. +|+|||+|++||+++.+|++|+.|||+.+..-..+.
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 999988776 334466777777888899999999999 999999999999999999999999999998654332
Q ss_pred eeeecccccCCchhhhccC
Q 018311 334 ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~ 352 (358)
.+||..|||||++.|
T Consensus 153 ----~cgt~eymApEI~~g 167 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIING 167 (612)
T ss_pred ----cccchhhhhhHhhhc
Confidence 199999999999984
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.8e-15 Score=144.85 Aligned_cols=141 Identities=22% Similarity=0.259 Sum_probs=98.6
Q ss_pred ceecCCccEEEEEEEEeCCcEEEEEEecCCCCcch------------------------------H----------HHHH
Q 018311 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD------------------------------K----------DFRV 219 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~------------------------------~----------~~~~ 219 (358)
+.||.|++|+||+|++.+|+.||||..++...... + +|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999865421110 0 1334
Q ss_pred HHHHHhcC----CCCccccccceEE-eCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 018311 220 EVEAIGHV----RHKNLVRLLGYCI-EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK-ALAYLHEA 293 (358)
Q Consensus 220 E~~~l~~l----~HpnIv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~l~yLH~~ 293 (358)
|.+.+.++ +|.+-+.+-..+. ..+..++||||++|++|.++..... ... ....++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHhC
Confidence 55444444 2322233322332 2356799999999999988764321 112 23345555555 46778887
Q ss_pred CCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 294 ~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
+++|+|++|.||++++++.++++|||++..+.+
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999988764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.7e-15 Score=132.78 Aligned_cols=168 Identities=22% Similarity=0.326 Sum_probs=130.0
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCC--CCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCC
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNN--PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGN 256 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs 256 (358)
.-+|.+...|+.|+|+|.... +.+|.+... ......+|..|.-.|+.+.||||+.+++.|..+..+.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 456888889999999996544 445655322 23334679999999999999999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeee
Q 018311 257 LEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336 (358)
Q Consensus 257 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~ 336 (358)
|+..|++. ..-..+..++.+++.++++||.|||+. .+-|.---|.+..++||++.+++|.- +-++. +....
T Consensus 274 lynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf-----sfqe~ 344 (448)
T KOG0195|consen 274 LYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQEV 344 (448)
T ss_pred HHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee-----eeecc
Confidence 99999864 223466788999999999999999986 44455557899999999999988752 11111 11223
Q ss_pred ecccccCCchhhhccCCCcc
Q 018311 337 RVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 337 ~~~Gt~~y~APE~l~~~~~~ 356 (358)
...-.|.||+||.++.+|..
T Consensus 345 gr~y~pawmspealqrkped 364 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPED 364 (448)
T ss_pred ccccCcccCCHHHHhcCchh
Confidence 34568999999999998864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.8e-14 Score=142.04 Aligned_cols=145 Identities=18% Similarity=0.219 Sum_probs=93.8
Q ss_pred CCCcccceecCCccEEEEEEEEeC-CcEEEEEEecCCCCcc----------------------------------hH---
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQA----------------------------------DK--- 215 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~----------------------------------~~--- 215 (358)
..|+. +.||.|++|+||+|...+ |+.||||.+++..... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 789999999999999877 9999999987542110 01
Q ss_pred ---HHHHHHHHHhcCC----CCccccccceEEe-CCEEEEEEeecCCCCHHHH--HhcccCCCCCCCHHHHHHHHHHHHH
Q 018311 216 ---DFRVEVEAIGHVR----HKNLVRLLGYCIE-GTQRILVYEYVNNGNLEQW--LRGDMCDRGYLTWEARMKILLGTAK 285 (358)
Q Consensus 216 ---~~~~E~~~l~~l~----HpnIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~i~~ 285 (358)
++.+|...+.+++ +.+.+.+-.++++ .+..+|||||++|+.+.++ +.........+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 1233443333332 3333333333332 3566799999999999874 22211111123333333334443
Q ss_pred HHHHHHhCCCCCeeeCCCCCCcEEEcCCC----cEEEeeecCceecCC
Q 018311 286 ALAYLHEAIEPKVVHRDIKSSNILIDENF----DAKISDFGLAKLLGA 329 (358)
Q Consensus 286 ~l~yLH~~~~~~ivHrDlk~~NiLl~~~~----~~kl~DFGla~~~~~ 329 (358)
... |++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 234 999999999999999888 999999999988764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.8e-13 Score=112.78 Aligned_cols=131 Identities=18% Similarity=0.165 Sum_probs=95.7
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccc-cccceEEeCCEEEEEEeecCCCCH
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV-RLLGYCIEGTQRILVYEYVNNGNL 257 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv~e~~~~gsL 257 (358)
.+.|+.|.++.||+++.. +..+++|....... ....+..|+.++..+.+.+++ +++.. ..+..++|||++++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 367889999999999874 77899997654322 223467899999888665554 34433 33445899999999877
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI--EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
.+.. . ....++.+++.+|..||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5420 1 11235678999999999872 12369999999999999 67899999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.6e-13 Score=126.20 Aligned_cols=119 Identities=24% Similarity=0.312 Sum_probs=88.5
Q ss_pred CCCccccccceEEeC---------------------------CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHH
Q 018311 228 RHKNLVRLLGYCIEG---------------------------TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKIL 280 (358)
Q Consensus 228 ~HpnIv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 280 (358)
+|||||++.++|.+. ..+|+||.-.+ -+|.+|+-. ...+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 699999999987532 24588888774 488888853 235566778889
Q ss_pred HHHHHHHHHHHhCCCCCeeeCCCCCCcEEE--cCC--CcEEEeeecCceecCC-----CCceeeeecccccCCchhhhcc
Q 018311 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILI--DEN--FDAKISDFGLAKLLGA-----GKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 281 ~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl--~~~--~~~kl~DFGla~~~~~-----~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
.|++.|+.|||.+ +|.|||+|++|||+ |+| ..+.|+|||++---.. ......-..-|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999998 333 3578999998743211 1111223356788999999988
Q ss_pred CCCc
Q 018311 352 NMPI 355 (358)
Q Consensus 352 ~~~~ 355 (358)
-.|-
T Consensus 425 a~PG 428 (598)
T KOG4158|consen 425 AVPG 428 (598)
T ss_pred cCCC
Confidence 7763
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.1e-12 Score=111.73 Aligned_cols=82 Identities=20% Similarity=0.062 Sum_probs=70.7
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|+|.+++... ...+++..+..++.|++.||.|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 7899999742 34599999999999999999999998 5 999999999999999 99998865422
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
..||+.|||||++.+.+|.
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~ 82 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYT 82 (176)
T ss_pred ---CCCcccccChHHhcCCCCc
Confidence 2689999999999998874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.3e-12 Score=114.85 Aligned_cols=169 Identities=22% Similarity=0.297 Sum_probs=104.4
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCC---C-------ccccccceE-
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRH---K-------NLVRLLGYC- 239 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H---p-------nIv~l~~~~- 239 (358)
.+...+.||.|+|+.||.++. .+++++|+|...-.. ....+++++|.-....+.+ | .++.-++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 345678999999999999987 458999999874332 2234566666654444332 1 111111111
Q ss_pred --------EeC---C-----EEEEEEeecCCCCHHHHHhc---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 018311 240 --------IEG---T-----QRILVYEYVNNGNLEQWLRG---DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300 (358)
Q Consensus 240 --------~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivH 300 (358)
... . +.+++|+-+ .+||.+++.. .......+....++.+..|+++.+++||+. ++||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 111 1 236677777 6799887542 111112233445567778999999999999 9999
Q ss_pred CCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeeecccccCCchhhhcc
Q 018311 301 RDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 301 rDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
+||||+|++++++|.++|+||+.....+... . ....+..|.+||...
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~-~~~~~~~~~PPe~~~ 215 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---R-CSEFPVAFTPPELES 215 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE---E-GGGS-TTTS-HHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee---e-ccCCCcccCChhhhh
Confidence 9999999999999999999999887754311 1 134567899999763
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.4e-13 Score=138.38 Aligned_cols=168 Identities=22% Similarity=0.200 Sum_probs=127.8
Q ss_pred CCcccceecCCccEEEEEEEEeCCcEEEEEEecCCC-CcchHHHH---HHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP-GQADKDFR---VEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~-~~~~~~~~---~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++...+.||.+.|=.|.+|+...|. |.||.+.+.. .-....|. +|++ ...++|||.+.+..+-....-.|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4556789999999999999998887 8888875554 33334444 3455 556699999999888766667788888
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|. ..+|.|.|. -+..+..-+.+-|+.|++.||.-+|.. +|+|+|||.+||||+.=+-+.|+||..-+..+-.
T Consensus 102 yv-khnLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YV-KHNLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HH-hhhhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 88 458988886 345577778889999999999999999 9999999999999999999999999876654311
Q ss_pred C-c-----eeeeecccccCCchhhhccC
Q 018311 331 K-S-----HITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 331 ~-~-----~~~~~~~Gt~~y~APE~l~~ 352 (358)
. . .-..+...-..|.|||-+-.
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~ 201 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVS 201 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhc
Confidence 1 1 11122233457999998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.6e-13 Score=136.34 Aligned_cols=174 Identities=24% Similarity=0.295 Sum_probs=136.5
Q ss_pred CCcccceecCCccEEEEEEEEe--CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLM--NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~ 249 (358)
.|.+.+.||+|.|+.|-.+... ....+|+|.+.... .........|..+-..+. |+|++.+++...+....++.+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4566778999999999988653 34456666554332 122233445777777776 999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeCCCCCCcEEEcCCC-cEEEeeecCceec
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH-EAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKLL 327 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivHrDlk~~NiLl~~~~-~~kl~DFGla~~~ 327 (358)
+|..+++++..+... .....+.......+.|+..++.|+| .. ++.|||+||+|.+++..+ ..|++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~~~--~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHP--DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred CcccccccccccccC--CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999877311 2113555677888999999999999 77 999999999999999999 9999999999887
Q ss_pred CC--CCceeeeeccc-ccCCchhhhccCC
Q 018311 328 GA--GKSHITTRVMG-TFGDFSVTLLRNM 353 (358)
Q Consensus 328 ~~--~~~~~~~~~~G-t~~y~APE~l~~~ 353 (358)
.. +........+| ++.|+|||...+.
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~ 204 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGK 204 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccch
Confidence 65 33345566788 9999999999883
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.4e-12 Score=123.28 Aligned_cols=124 Identities=28% Similarity=0.475 Sum_probs=102.8
Q ss_pred HhcCCCCccccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-eeCC
Q 018311 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV-VHRD 302 (358)
Q Consensus 224 l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i-vHrD 302 (358)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ..-.+++.-...+.++++.||.|||.. .| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 3568899999999999999999999999999999999975 334588888889999999999999986 44 9999
Q ss_pred CCCCcEEEcCCCcEEEeeecCceecCCCC-ceeeeecccccCCchhhhccCC
Q 018311 303 IKSSNILIDENFDAKISDFGLAKLLGAGK-SHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 303 lk~~NiLl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
|++.|+++|....+||+|||+........ ........-..-|.|||.+.+.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~ 126 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGA 126 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccc
Confidence 99999999999999999999988874311 0111122345679999999885
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.1e-11 Score=105.75 Aligned_cols=143 Identities=21% Similarity=0.246 Sum_probs=106.3
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCC--ccccccceEEeC---CEEEEEEeec
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHK--NLVRLLGYCIEG---TQRILVYEYV 252 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~~---~~~~lv~e~~ 252 (358)
.+.|+.|.++.||+++..+|..+++|....... .....+..|.+++..+.+. ++.+++.+.... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999887678899998754332 1345688899999998753 456666666543 2568999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI-------------------------------------- 294 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-------------------------------------- 294 (358)
++.++.+.+.. ..++......++.+++..|..||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99887664421 23566666777777777777777421
Q ss_pred ---------------CCCeeeCCCCCCcEEEcC--CCcEEEeeecCcee
Q 018311 295 ---------------EPKVVHRDIKSSNILIDE--NFDAKISDFGLAKL 326 (358)
Q Consensus 295 ---------------~~~ivHrDlk~~NiLl~~--~~~~kl~DFGla~~ 326 (358)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999998875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.1e-10 Score=100.91 Aligned_cols=136 Identities=16% Similarity=0.175 Sum_probs=96.6
Q ss_pred ceecCCccEEEEEEEEeC-------CcEEEEEEecCCCC----------------------cchHHH----HHHHHHHhc
Q 018311 180 NIIGDGGYGVVYRGQLMN-------GTAVAVKKLLNNPG----------------------QADKDF----RVEVEAIGH 226 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~-------~~~vavK~l~~~~~----------------------~~~~~~----~~E~~~l~~ 226 (358)
..||.|-=+.||.|...+ +..+|||..+.... ...+.+ ++|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999996542 47899996632110 011222 369999988
Q ss_pred CCC--CccccccceEEeCCEEEEEEeecCCCCHHH-HHhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCC
Q 018311 227 VRH--KNLVRLLGYCIEGTQRILVYEYVNNGNLEQ-WLRGDMCDRGYLTWEARMKILLGTAKALAYL-HEAIEPKVVHRD 302 (358)
Q Consensus 227 l~H--pnIv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~ivHrD 302 (358)
+.. -++...+++ ...++||||+.+..+.. .+++ ..++......+..+++.+|..| |.. ++||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 853 345555543 56789999997654432 2221 2244556677889999999999 777 999999
Q ss_pred CCCCcEEEcCCCcEEEeeecCceecC
Q 018311 303 IKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 303 lk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|++.|||++ ++.+.|+|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4689999999988764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.9e-12 Score=126.61 Aligned_cols=138 Identities=25% Similarity=0.344 Sum_probs=93.7
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
..|..++.+-.|+||.||.++++ ..+.+|.| +.+.. .+.+. ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee-------------------
Confidence 56788899999999999999764 35667773 32211 11111 22222333333
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC-
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK- 331 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~- 331 (358)
||=...++ ..+.++.. ++.+++|||+. +|+|||+||+|.+|..-|++|++|||+.+......
T Consensus 136 --gDc~tllk----~~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 --GDCATLLK----NIGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred --chhhhhcc----cCCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 45455554 22334332 27789999999 99999999999999999999999999987532111
Q ss_pred -----------c--eeeeecccccCCchhhhccCCCc
Q 018311 332 -----------S--HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 -----------~--~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
. ....+++|||.|.|||++..+.|
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy 235 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY 235 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhcc
Confidence 1 12346799999999999987743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.8e-10 Score=94.56 Aligned_cols=143 Identities=20% Similarity=0.310 Sum_probs=105.3
Q ss_pred ccceecCCccEEEEEEEEeCCcEEEEEEecCCC--------CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 178 KDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP--------GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 178 ~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
....+-||+=+.|+++.+ .|+...||.-.... .-..++..+|+++|.+++--.|..-.-++.+...-+++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457888999999999988 67777777421111 112345678999999987656655555666777778999
Q ss_pred eecCC-CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc---EEEeeecCce
Q 018311 250 EYVNN-GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD---AKISDFGLAK 325 (358)
Q Consensus 250 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~---~kl~DFGla~ 325 (358)
||+++ .++.+|+...... .........++..+-..+.-||.. .|+|+||..+||++..++. +-++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99966 4888888754322 122233367788888899999999 9999999999999976553 5899999986
Q ss_pred e
Q 018311 326 L 326 (358)
Q Consensus 326 ~ 326 (358)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 5
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3e-10 Score=95.48 Aligned_cols=132 Identities=23% Similarity=0.410 Sum_probs=97.2
Q ss_pred ceecCCccEEEEEEEEeCCcEEEEEEecCCC-C--c-----chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP-G--Q-----ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~-~--~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
..+++|+=+.+|.+.+. |..+.+|.=.+.. . . ......+|.+++.+++--.|..-+-+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35788999999999774 3445555322211 1 1 113356799999988766665555566778888999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
.+|..|.+++... ...++..+-.-+.-||.. +|+|+||.++|+++..+. +.++||||+..-
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999998888632 134556666677889998 999999999999997765 999999999763
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.2e-12 Score=119.04 Aligned_cols=106 Identities=25% Similarity=0.360 Sum_probs=89.6
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
.+|+.|++|...+|.++|..+.. ....++...+.++.|++.|+.| + +.+|||+||.||+...+.++||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 57899999999999999974432 2346677889999999999999 6 899999999999999999999999999
Q ss_pred ceecCCCC-----ceeeeecccccCCchhhhccCCCcc
Q 018311 324 AKLLGAGK-----SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 324 a~~~~~~~-----~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
........ ....+.-.||.-||+||++.|.-|.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~ 440 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS 440 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh
Confidence 88765443 2345668999999999999998775
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.9e-10 Score=109.40 Aligned_cols=175 Identities=23% Similarity=0.260 Sum_probs=135.1
Q ss_pred CCCcccceecC--CccEEEEEEEE---eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcC-CCCccccccceEEeCCEE
Q 018311 174 NRFSKDNIIGD--GGYGVVYRGQL---MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~--G~fg~V~~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 245 (358)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+.... .....-.+|+.-.+++ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999999854 5688899997543332 2233344577777777 499999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeeCCCCCCcEEEcCC-CcEEEee
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK----ALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISD 320 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~yLH~~~~~~ivHrDlk~~NiLl~~~-~~~kl~D 320 (358)
++-+|++ +.+|.++..... ..++.........+... |+.++|+. +++|-|+||.||++..+ ..++++|
T Consensus 194 fiqtE~~-~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeeccc-cchhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 9999999 578888776432 22455556666666666 99999998 99999999999999998 8899999
Q ss_pred ecCceecCCCCce----eeeecccccCCchhhhccCCCc
Q 018311 321 FGLAKLLGAGKSH----ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 321 FGla~~~~~~~~~----~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
||+...++++... ...+..|...|++||.+++-..
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~ 305 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT 305 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccc
Confidence 9999999865522 2334578889999999988653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.4e-09 Score=96.39 Aligned_cols=141 Identities=13% Similarity=0.091 Sum_probs=101.0
Q ss_pred ceecCCccEEEEEEEEeCCcEEEEEEecCCCCc-ch----------HHHHHHHHHHhcCCCCcc--ccccceEEe-----
Q 018311 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ-AD----------KDFRVEVEAIGHVRHKNL--VRLLGYCIE----- 241 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~-~~----------~~~~~E~~~l~~l~HpnI--v~l~~~~~~----- 241 (358)
+.+-+.....|.+.++ +|+.+.||+....... .. ..+.+|.+.+.+|..-+| ...+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555556777766 6788999976433211 01 136789988888854343 344555543
Q ss_pred CCEEEEEEeecCCC-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-------C
Q 018311 242 GTQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-------N 313 (358)
Q Consensus 242 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~-------~ 313 (358)
....++|||++++- +|.+++.... ...........++.+++..+.-||.. ||+|+|+++.|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23578999999876 8999885321 12345567778999999999999999 9999999999999975 4
Q ss_pred CcEEEeeecCcee
Q 018311 314 FDAKISDFGLAKL 326 (358)
Q Consensus 314 ~~~kl~DFGla~~ 326 (358)
..+.++||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=6e-09 Score=89.64 Aligned_cols=127 Identities=25% Similarity=0.315 Sum_probs=81.4
Q ss_pred EEEEEEEeCCcEEEEEEecCCCCc--------------------------chHHHHHHHHHHhcCCCC--ccccccceEE
Q 018311 189 VVYRGQLMNGTAVAVKKLLNNPGQ--------------------------ADKDFRVEVEAIGHVRHK--NLVRLLGYCI 240 (358)
Q Consensus 189 ~V~~~~~~~~~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~ 240 (358)
.||.|...+|..+|+|..+..... ......+|.+.|.++..- ++.+.+++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 389998888999999976432110 012356799999999765 44555533
Q ss_pred eCCEEEEEEeecC--CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeeeCCCCCCcEEEcCCCcEE
Q 018311 241 EGTQRILVYEYVN--NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY-LHEAIEPKVVHRDIKSSNILIDENFDAK 317 (358)
Q Consensus 241 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~y-LH~~~~~~ivHrDlk~~NiLl~~~~~~k 317 (358)
...++||||++ |..+..+.... ++......++.+++..+.. +|.. +|+|+||.+.|||++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 24579999998 54554433211 1123445667777776665 4677 99999999999999988 999
Q ss_pred EeeecCceecCC
Q 018311 318 ISDFGLAKLLGA 329 (358)
Q Consensus 318 l~DFGla~~~~~ 329 (358)
|+|||.+.....
T Consensus 147 iIDf~qav~~~~ 158 (188)
T PF01163_consen 147 IIDFGQAVDSSH 158 (188)
T ss_dssp E--GTTEEETTS
T ss_pred EEecCcceecCC
Confidence 999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.4e-08 Score=99.88 Aligned_cols=123 Identities=23% Similarity=0.280 Sum_probs=100.0
Q ss_pred EeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHH
Q 018311 195 LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWE 274 (358)
Q Consensus 195 ~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~ 274 (358)
..++.+|.|...+...........+-++.|+.++||||++++..+...+..|+|+|-+. -|..++.+ +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 45677888887765554223445667888999999999999999999999999999874 56666653 3356
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 275 ARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 275 ~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
.....+.||+.||.|||..+ +++|++|.-.-|++++.|+.||++|.++....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 66778899999999999654 89999999999999999999999999886643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.7e-09 Score=97.94 Aligned_cols=127 Identities=22% Similarity=0.316 Sum_probs=95.1
Q ss_pred HHHhcCCCCccccccceEEeC-----CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 018311 222 EAIGHVRHKNLVRLLGYCIEG-----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296 (358)
Q Consensus 222 ~~l~~l~HpnIv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~ 296 (358)
..|-.+.|.|||+++.|+.+. .+..++.|||..|+|.+||++-......+......+++.||..||.|||+. .|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 345556799999999998754 346889999999999999987665666788888899999999999999984 88
Q ss_pred CeeeCCCCCCcEEEcCCCcEEEeeecCcee---cCCCCceeeeecccccCCchhhh
Q 018311 297 KVVHRDIKSSNILIDENFDAKISDFGLAKL---LGAGKSHITTRVMGTFGDFSVTL 349 (358)
Q Consensus 297 ~ivHrDlk~~NiLl~~~~~~kl~DFGla~~---~~~~~~~~~~~~~Gt~~y~APE~ 349 (358)
.|+|+++..+-|++..++-+|+.--.-... .............+-++|.|||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~s 253 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPES 253 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCc
Confidence 999999999999999999888752211100 00000111223455678888875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.7e-09 Score=104.97 Aligned_cols=149 Identities=26% Similarity=0.281 Sum_probs=119.2
Q ss_pred hcCCCcccceecCCccEEEEEEEE--eCCcEEEEEEecCCCCcchHHH--HHHHHHHhcC-CCCccccccceEEeCCEEE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL--MNGTAVAVKKLLNNPGQADKDF--RVEVEAIGHV-RHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~~vavK~l~~~~~~~~~~~--~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 246 (358)
...+|.....||.|.|+.|+.+.. .++..+++|.+.+.......+. ..|+.+...+ .|.+++.+...+......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 345677778899999999999864 4678899998877655444332 3466666666 4889999888888778888
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-CcEEEeeecCce
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAK 325 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~-~~~kl~DFGla~ 325 (358)
+-.||++++++..... ....+.+...+++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||++.
T Consensus 343 ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 9999999999887653 223466777889999999999999998 99999999999999876 889999999987
Q ss_pred ec
Q 018311 326 LL 327 (358)
Q Consensus 326 ~~ 327 (358)
.+
T Consensus 416 ~~ 417 (524)
T KOG0601|consen 416 RL 417 (524)
T ss_pred cc
Confidence 53
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.2e-08 Score=86.81 Aligned_cols=137 Identities=23% Similarity=0.213 Sum_probs=95.6
Q ss_pred CcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCc----------------------chHHHHHHHHHHhcCCCC--c
Q 018311 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ----------------------ADKDFRVEVEAIGHVRHK--N 231 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l~~l~Hp--n 231 (358)
..++..||-|-=+.||.|....|.++|+|.-+..... .....++|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567899999999999999999999999954222110 112346799999988654 5
Q ss_pred cccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 018311 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (358)
Q Consensus 232 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~ 311 (358)
|.+.+++ +...+||||.+|-.|...- ++.+..-.++..|+.-+.-+-.. |+||+|+.+-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 5555554 6778999999886664321 12223333444444444444455 999999999999999
Q ss_pred CCCcEEEeeecCceecC
Q 018311 312 ENFDAKISDFGLAKLLG 328 (358)
Q Consensus 312 ~~~~~kl~DFGla~~~~ 328 (358)
++|.+.++||--+....
T Consensus 237 ~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 237 EDGDIVVIDWPQAVPIS 253 (304)
T ss_pred cCCCEEEEeCcccccCC
Confidence 99999999997665543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.2e-07 Score=83.28 Aligned_cols=107 Identities=21% Similarity=0.256 Sum_probs=83.2
Q ss_pred HHHHHHHHHHhcCCCCc--cccccceEEeC----CEEEEEEeecCCC-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH
Q 018311 215 KDFRVEVEAIGHVRHKN--LVRLLGYCIEG----TQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287 (358)
Q Consensus 215 ~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l 287 (358)
....+|...+..|..-+ ....+++.... ...++|+|++++. +|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 45677888887775433 44555665542 2458999999874 8999887421 155567788999999999
Q ss_pred HHHHhCCCCCeeeCCCCCCcEEEcCCC---cEEEeeecCceecC
Q 018311 288 AYLHEAIEPKVVHRDIKSSNILIDENF---DAKISDFGLAKLLG 328 (358)
Q Consensus 288 ~yLH~~~~~~ivHrDlk~~NiLl~~~~---~~kl~DFGla~~~~ 328 (358)
.-||.. +|+|+|+++.|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999 999999999999999887 89999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.5e-07 Score=78.80 Aligned_cols=140 Identities=16% Similarity=0.122 Sum_probs=101.9
Q ss_pred ecCCccEEEEEEEEeCCcEEEEEEecCCC------CcchHHHHHHHHHHhcCCCCc--cccccceEEe----CCEEEEEE
Q 018311 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNP------GQADKDFRVEVEAIGHVRHKN--LVRLLGYCIE----GTQRILVY 249 (358)
Q Consensus 182 lG~G~fg~V~~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~----~~~~~lv~ 249 (358)
-|+||-+-|++-.. +|+.+-+|+-.+.- +.....|.+|+..+.+|..-+ +......... .-.-+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 35688888999877 44578899764221 335577999999999885433 4444422211 12357899
Q ss_pred eecC-CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc--EEEeeecCcee
Q 018311 250 EYVN-NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD--AKISDFGLAKL 326 (358)
Q Consensus 250 e~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~--~kl~DFGla~~ 326 (358)
|-++ .-||.+++.+.. ....+......+..+++..+.-||+. ++.|+|+-+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9774 368998886432 22356677789999999999999999 9999999999999986666 99999987765
Q ss_pred c
Q 018311 327 L 327 (358)
Q Consensus 327 ~ 327 (358)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 3
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.6e-07 Score=87.74 Aligned_cols=142 Identities=19% Similarity=0.237 Sum_probs=109.0
Q ss_pred cEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEe----CCEEEEEEeecCC-CCHHHH
Q 018311 187 YGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQRILVYEYVNN-GNLEQW 260 (358)
Q Consensus 187 fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~ 260 (358)
-.+.|+|.. .+|..|++|++.............-++.++++.|+|||.+..++.. +..+++|++|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357888854 6899999999954433322222345778899999999999998873 4568999999875 677775
Q ss_pred HhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 261 LRGDMC-----------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 261 l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
-..... .+...++...+.++.|+..||.++|+. |+.-+-|.+.+||++.+..++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 432211 223467888999999999999999999 999999999999999999999998888777654
Q ss_pred CC
Q 018311 330 GK 331 (358)
Q Consensus 330 ~~ 331 (358)
..
T Consensus 446 d~ 447 (655)
T KOG3741|consen 446 DP 447 (655)
T ss_pred CC
Confidence 43
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.3e-07 Score=93.22 Aligned_cols=142 Identities=18% Similarity=0.197 Sum_probs=91.2
Q ss_pred ceecCCccEEEEEEEEeCCcEEEEEEecCCCCcch------------------------------HH----------HHH
Q 018311 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD------------------------------KD----------FRV 219 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~------------------------------~~----------~~~ 219 (358)
+.|+.++-|+||+|++.+|+.||||..+++-.... ++ +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999998765422110 11 223
Q ss_pred HHHHHhcCC-----CCccccccceEE-eCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 018311 220 EVEAIGHVR-----HKNLVRLLGYCI-EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293 (358)
Q Consensus 220 E~~~l~~l~-----HpnIv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~ 293 (358)
|..-+.+++ .+++ .+=.+|+ -.+...|+|||++|-.+.++..... ..++.+.......++..-.-+- .
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f~~q~~~--d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAFLRQLLR--D 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHHHHHHHh--c
Confidence 444333331 2332 2222232 2466789999999988888743211 2233333332222222222222 2
Q ss_pred CCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 294 ~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
++.|.|..|.||+++.+|.+-+.|||+...+.+.
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 8999999999999999999999999999887643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.9e-06 Score=75.54 Aligned_cols=140 Identities=19% Similarity=0.230 Sum_probs=85.0
Q ss_pred ceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCc--cccccceEEeCCEEEEEEeecCCCC-
Q 018311 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN--LVRLLGYCIEGTQRILVYEYVNNGN- 256 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lv~e~~~~gs- 256 (358)
..||+|..+.||+. .+..+++|..... ....+..+|.+++..+..-+ +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 2455677765432 23456788999998886433 3566777777778889999998863
Q ss_pred HHHH---------------------HhcccCCCCCCCHHHHHHHHH----------HHH-HHHHHHHhCC-CCCeeeCCC
Q 018311 257 LEQW---------------------LRGDMCDRGYLTWEARMKILL----------GTA-KALAYLHEAI-EPKVVHRDI 303 (358)
Q Consensus 257 L~~~---------------------l~~~~~~~~~l~~~~~~~i~~----------~i~-~~l~yLH~~~-~~~ivHrDl 303 (358)
+... ++........+... ...+.. .+. ....+|.... .+.++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 1111 11100011111100 000100 001 1123333221 346789999
Q ss_pred CCCcEEEcCCCcEEEeeecCcee
Q 018311 304 KSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 304 k~~NiLl~~~~~~kl~DFGla~~ 326 (358)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998865
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.46 E-value=4.2e-06 Score=73.17 Aligned_cols=138 Identities=14% Similarity=0.181 Sum_probs=90.5
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHH---------HHHHHHHhcCCCCc---cccccceEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDF---------RVEVEAIGHVRHKN---LVRLLGYCI 240 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~Hpn---Iv~l~~~~~ 240 (358)
.++|...+++-.....-|.+-+. +|..+++|.-++......+.| .+++..+.+++..+ .+.++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 46777778887777777777666 678899987655433222222 23444444443222 223222222
Q ss_pred -----eCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc
Q 018311 241 -----EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD 315 (358)
Q Consensus 241 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~ 315 (358)
-....+|+|||++|..|.++.. +++ .++..+..++.-||.. |+.|+|..|.|+++.+++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-
Confidence 1245578999999988866542 222 2445567789999999 999999999999998554
Q ss_pred EEEeeecCceec
Q 018311 316 AKISDFGLAKLL 327 (358)
Q Consensus 316 ~kl~DFGla~~~ 327 (358)
+++.||+..+..
T Consensus 173 i~iID~~~k~~~ 184 (229)
T PF06176_consen 173 IRIIDTQGKRMS 184 (229)
T ss_pred EEEEECcccccc
Confidence 999999887654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.2e-05 Score=71.20 Aligned_cols=155 Identities=20% Similarity=0.222 Sum_probs=98.9
Q ss_pred chHhhHHHhcCCCcccceec---CCccEEEEEEEEeCCcEEEEEEecCCCCcchH------------------------H
Q 018311 164 FTLRDLQSATNRFSKDNIIG---DGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK------------------------D 216 (358)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lG---~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~------------------------~ 216 (358)
.++..+....++..+.+..| .|--+.||+|...++..+|+|+.+.......+ .
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 35555555666666655544 67778999998878999999987543221111 1
Q ss_pred HHHHHHHHhcCC--CCccccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 018311 217 FRVEVEAIGHVR--HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294 (358)
Q Consensus 217 ~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~ 294 (358)
...|..-|.++. +-.+.+-+++ .+..|||||+... . ...+....-.+..++...+..+++..|.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~-g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDD-G---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCC-C---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 123555555553 2222233332 2347999999543 1 1111111222333467777888888888777622
Q ss_pred CCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 295 ~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
++||+||..-|||+. ++.+.|+|||-|.....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 999999999999999 88999999999887653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.8e-06 Score=83.71 Aligned_cols=138 Identities=22% Similarity=0.295 Sum_probs=88.9
Q ss_pred ceecCCccEEEEEEEEeCCcEEEEEEecCCCCcch---------------------------H----------HHHHHHH
Q 018311 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD---------------------------K----------DFRVEVE 222 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~---------------------------~----------~~~~E~~ 222 (358)
+.||.-+.|+||+|+.++|+.||||.-++.-.... + +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 67999999999999999999999997654322110 0 1223333
Q ss_pred HHhc----CCCCc------cccccceEEeCCEEEEEEeecCCCCHHHH--HhcccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 018311 223 AIGH----VRHKN------LVRLLGYCIEGTQRILVYEYVNNGNLEQW--LRGDMCDRGYLTWEARMKILLGTAKALAYL 290 (358)
Q Consensus 223 ~l~~----l~Hpn------Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~i~~~l~yL 290 (358)
-..+ ++|-+ |.+++..+ .....|+||||+|.-+.+. +.+ ..++......-+.+. |+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~-----~~ 314 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEA-----YL 314 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHH-----HH
Confidence 2222 23444 33333222 3567899999999877654 332 224444444433332 22
Q ss_pred HhCCCCCeeeCCCCCCcEEEcC----CCcEEEeeecCceecCC
Q 018311 291 HEAIEPKVVHRDIKSSNILIDE----NFDAKISDFGLAKLLGA 329 (358)
Q Consensus 291 H~~~~~~ivHrDlk~~NiLl~~----~~~~kl~DFGla~~~~~ 329 (358)
++....|++|+|-.|.||++.. ++.+.+-|||+...+..
T Consensus 315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2222239999999999999984 67899999999887754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.24 E-value=9e-06 Score=71.86 Aligned_cols=146 Identities=20% Similarity=0.166 Sum_probs=84.8
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCC--ccccccceEEe---CCEEEEEEeecC
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHK--NLVRLLGYCIE---GTQRILVYEYVN 253 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~---~~~~~lv~e~~~ 253 (358)
.+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3678999999999998866 58899986443 3446677888888877533 34566654433 345789999999
Q ss_pred CCCHHH----------------HHh---cccCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 018311 254 NGNLEQ----------------WLR---GDMCDRGYLTWEA---------RMKI------------LLGTAK-ALAYLHE 292 (358)
Q Consensus 254 ~gsL~~----------------~l~---~~~~~~~~l~~~~---------~~~i------------~~~i~~-~l~yLH~ 292 (358)
+..+.. .+. ............. .... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987777 111 1100111111100 0000 011222 2333332
Q ss_pred C----CCCCeeeCCCCCCcEEEc-CCCcEEEeeecCceec
Q 018311 293 A----IEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLL 327 (358)
Q Consensus 293 ~----~~~~ivHrDlk~~NiLl~-~~~~~kl~DFGla~~~ 327 (358)
. ....++|+|+.+.||+++ +++.+.|.||+.+..-
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 1 234699999999999999 6677789999988663
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.7e-07 Score=96.46 Aligned_cols=173 Identities=21% Similarity=0.230 Sum_probs=117.3
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.+.+.+-+-.|.|+.+..+.- ..|...+.|...... ....+....+-.++...++|.++.....+......+|+++
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH 884 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence 455566777888998888743 234333333322111 1111223333444444567877777666667788999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC-
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA- 329 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~- 329 (358)
|+.+++|...|+.. +..+.+-.......+..+.+|||.. .+.|+|++|.|.|+..++..+++|||+....+.
T Consensus 885 ~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred HhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999998843 2344455555666788899999997 799999999999999999999999985432210
Q ss_pred -----C------------------------CceeeeecccccCCchhhhccCCC
Q 018311 330 -----G------------------------KSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 330 -----~------------------------~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
. .........||+.|.+||.+.|..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~ 1011 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR 1011 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc
Confidence 0 001123467999999999998864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.9e-05 Score=70.93 Aligned_cols=142 Identities=15% Similarity=0.136 Sum_probs=83.5
Q ss_pred eecCCcc-EEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEEeecCCCCHH
Q 018311 181 IIGDGGY-GVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEYVNNGNLE 258 (358)
Q Consensus 181 ~lG~G~f-g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~ 258 (358)
.|-.|.. ..||+.... +..+.+|...... ..++.+|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3444555 789998764 4677777654332 345677888888774 333556777776666789999999987776
Q ss_pred HHH-------------------hcccCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHhC----
Q 018311 259 QWL-------------------RGDMCDRGYLTWE--ARMKILL--------------------GTAKALAYLHEA---- 293 (358)
Q Consensus 259 ~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------~i~~~l~yLH~~---- 293 (358)
... +........+... ....... .+......|-..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 1100000011100 0000000 011112222111
Q ss_pred CCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 294 ~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
..+.++|+|+.|.|||++++..+.|+||+.|..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 134699999999999999988889999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.4e-07 Score=91.00 Aligned_cols=162 Identities=19% Similarity=0.125 Sum_probs=111.9
Q ss_pred CcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCc-cccccceEEeCCEEEEEEeecCC
Q 018311 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN-LVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+....-+++|+++.++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..++.++++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3344567889999999885433333334443221 44556899999999999 77777777777888999999987
Q ss_pred C-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 255 G-NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 255 g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+ +-..... ...-.+...+...+...-.++++|+|+. .-+|+| ||+..+ +..|..||+.+..+....
T Consensus 319 ~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 319 GRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred CccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--
Confidence 6 2211110 0111122333445566667889999986 568998 777655 778999999999987654
Q ss_pred eeeecccccCCchhhhccCCCc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
..+...+|+.|+|||+..+.+|
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~ 407 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTI 407 (829)
T ss_pred ccccCCCCCCCCCchhhccccc
Confidence 3566899999999998887665
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.15 E-value=9.4e-06 Score=70.03 Aligned_cols=104 Identities=22% Similarity=0.231 Sum_probs=80.0
Q ss_pred HHHHHHhcCCC-CccccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 018311 219 VEVEAIGHVRH-KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297 (358)
Q Consensus 219 ~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 297 (358)
.|.-++..+++ +++.+++|+|- . +++.||...+++...- .....-...+|..+.+|+.+++..+.+++......
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG---~-~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG---R-FYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC---C-EEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47778888876 69999999993 2 6788999877654210 00001122679999999999999999999854446
Q ss_pred eeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 298 VVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 298 ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
+.-.|++++|+-+++++.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 778999999999999999999999887554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.14 E-value=6.5e-05 Score=64.97 Aligned_cols=125 Identities=24% Similarity=0.412 Sum_probs=87.3
Q ss_pred CCCcccceecCCcc-EEEEEEEEeCCcEEEEEEecC---CCC------------------cchHHHHHHHHHHhcCC---
Q 018311 174 NRFSKDNIIGDGGY-GVVYRGQLMNGTAVAVKKLLN---NPG------------------QADKDFRVEVEAIGHVR--- 228 (358)
Q Consensus 174 ~~~~~~~~lG~G~f-g~V~~~~~~~~~~vavK~l~~---~~~------------------~~~~~~~~E~~~l~~l~--- 228 (358)
.+++..+.||.|.- |.||+++. +|+.+|+|.... ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999988 678999998321 000 11124677888888875
Q ss_pred CCcc--ccccceEEeC------------------CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHH
Q 018311 229 HKNL--VRLLGYCIEG------------------TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288 (358)
Q Consensus 229 HpnI--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~ 288 (358)
+.++ |+.+||..-. ....+|.||.+... .+. ..-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence 4456 8888887422 01245667664322 122 223456777788
Q ss_pred HHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 289 yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.+|.. +|+-+|+|++|.. .-||+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 99998 9999999999987 4489999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.5e-05 Score=81.30 Aligned_cols=78 Identities=14% Similarity=0.249 Sum_probs=55.9
Q ss_pred cceecCCccEEEEEEEEeCC---cEEEEEEecCCC-CcchHHHHHHHHHHhcCC-CCcc--ccccceEEeC---CEEEEE
Q 018311 179 DNIIGDGGYGVVYRGQLMNG---TAVAVKKLLNNP-GQADKDFRVEVEAIGHVR-HKNL--VRLLGYCIEG---TQRILV 248 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnI--v~l~~~~~~~---~~~~lv 248 (358)
.+.++.|.+..+|+.+..++ ..+++|+..... ......+.+|.+++..+. |+++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999877554 356666643322 123456889999999995 6665 6777777654 467899
Q ss_pred EeecCCCC
Q 018311 249 YEYVNNGN 256 (358)
Q Consensus 249 ~e~~~~gs 256 (358)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.6e-05 Score=65.52 Aligned_cols=129 Identities=19% Similarity=0.290 Sum_probs=84.4
Q ss_pred cccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCcccc-ccceEEeCCEEEEEEeecCCC
Q 018311 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVR-LLGYCIEGTQRILVYEYVNNG 255 (358)
Q Consensus 177 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~-l~~~~~~~~~~~lv~e~~~~g 255 (358)
...+.|++|++|.||+|.+. |..+|+|.-+.+ .....++.|.++|..++-.++.. ++.+. ..++.|||..|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 34578999999999999994 457888865443 33567889999999888666553 33332 334559999888
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC-CC-cEEEcCCCcEEEeeecCceec
Q 018311 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK-SS-NILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 256 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk-~~-NiLl~~~~~~kl~DFGla~~~ 327 (358)
.|.+.-.. .+.+.... ++..-.-|... +|-|..|. |. ||++++ ..+.|+||.-|+..
T Consensus 98 ~L~~~~~~-------~~rk~l~~----vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIG-------GDRKHLLR----VLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhc-------ccHHHHHH----HHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhhc
Confidence 88764431 12233332 33332233334 77777775 33 555544 49999999999853
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.0003 Score=61.09 Aligned_cols=134 Identities=22% Similarity=0.332 Sum_probs=90.7
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCC----------------CcchHHHHHHHHHHhcCC------CCcccccc
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP----------------GQADKDFRVEVEAIGHVR------HKNLVRLL 236 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------HpnIv~l~ 236 (358)
...||+|+.-.||.. .+.....||...... ....++..+|+.-...+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 468999999999964 334456777765444 122355666776655554 78899999
Q ss_pred ceEEeCCEEEEEEeecCC------CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 018311 237 GYCIEGTQRILVYEYVNN------GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (358)
Q Consensus 237 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl 310 (358)
|+..++.-.-+|+|.+.. -+|.+++.+ +.++. .....+ -.-..||-.. .|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~L---~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQAL---DEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHHH---HHHHHHHHHc---CCeecCCCcccEEE
Confidence 999998888999998743 367777753 22444 223333 3345577777 89999999999999
Q ss_pred cCC---C-cEEEee-ecCcee
Q 018311 311 DEN---F-DAKISD-FGLAKL 326 (358)
Q Consensus 311 ~~~---~-~~kl~D-FGla~~ 326 (358)
... . .+.|+| ||-...
T Consensus 152 ~~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred EecCCCceEEEEEeCCCCccc
Confidence 533 2 577787 665444
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00031 Score=65.14 Aligned_cols=78 Identities=10% Similarity=0.055 Sum_probs=55.7
Q ss_pred cccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCC---CccccccceEEe---CCEEEEEEe
Q 018311 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH---KNLVRLLGYCIE---GTQRILVYE 250 (358)
Q Consensus 177 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~~---~~~~~lv~e 250 (358)
...+.||.|..+.||+....+++ +.+|..+. ......+..|.+.|+.|.- -.+.++++++.. .+..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 34578999999999998765554 55565322 1123578889999988853 357788877754 366899999
Q ss_pred ecCCCCH
Q 018311 251 YVNNGNL 257 (358)
Q Consensus 251 ~~~~gsL 257 (358)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9988654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.90 E-value=9.6e-05 Score=66.06 Aligned_cols=31 Identities=26% Similarity=0.486 Sum_probs=26.6
Q ss_pred CCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 296 ~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+.++|+|+.+.||+++++...-|.||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3599999999999998776667999998765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00044 Score=61.59 Aligned_cols=144 Identities=19% Similarity=0.149 Sum_probs=80.9
Q ss_pred cceecCCccEEEEEEEEeC--CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCcc-ccccceEEeCCEEEEEEeecCCC
Q 018311 179 DNIIGDGGYGVVYRGQLMN--GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVYEYVNNG 255 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~e~~~~g 255 (358)
.+.|..|-...+|++...+ +..+.+|....... ...+..+|+.++..+...++ .++++.+ . -.++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~--~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATF--Q--NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEe--C--CcEEEEeeCCC
Confidence 3567778888999997654 57788886543322 22234568888888754333 3333322 2 24799999886
Q ss_pred CHHHH-----------------HhcccCCC-------CCC-CHHHHHHHHH----------------------HHHHHHH
Q 018311 256 NLEQW-----------------LRGDMCDR-------GYL-TWEARMKILL----------------------GTAKALA 288 (358)
Q Consensus 256 sL~~~-----------------l~~~~~~~-------~~l-~~~~~~~i~~----------------------~i~~~l~ 288 (358)
++..- ++...... ... .++....+.. .+...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 65211 11111110 011 1112111111 1111112
Q ss_pred HH----HhC-CCCCeeeCCCCCCcEEEcC-CCcEEEeeecCceec
Q 018311 289 YL----HEA-IEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKLL 327 (358)
Q Consensus 289 yL----H~~-~~~~ivHrDlk~~NiLl~~-~~~~kl~DFGla~~~ 327 (358)
.| ... ....++|+|+.+.|||++. ++.+.++||..|..-
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 22 111 1236999999999999998 578999999988653
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0017 Score=62.38 Aligned_cols=76 Identities=24% Similarity=0.308 Sum_probs=53.0
Q ss_pred cceecCCccEEEEEEEEeCC-cEEEEEEecCC-----C--CcchHHHHHHHHHHhcCC---CCccccccceEEeCCEEEE
Q 018311 179 DNIIGDGGYGVVYRGQLMNG-TAVAVKKLLNN-----P--GQADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~-~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~l 247 (358)
.+.||.|.+..||++...+| +.+.||.-... . +...+.+..|.+.|..+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 36799999999999988776 48999974311 1 123456677888887762 2446666655 4466789
Q ss_pred EEeecCCCC
Q 018311 248 VYEYVNNGN 256 (358)
Q Consensus 248 v~e~~~~gs 256 (358)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0014 Score=59.34 Aligned_cols=139 Identities=14% Similarity=0.087 Sum_probs=76.7
Q ss_pred ecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccc-cccceEEeCCEEEEEEeecCCCCHHH-
Q 018311 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV-RLLGYCIEGTQRILVYEYVNNGNLEQ- 259 (358)
Q Consensus 182 lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv~e~~~~gsL~~- 259 (358)
+..|-...+|+.+. ++..+.+|..........-+..+|.+++..+...+++ +++... . -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 44577788998874 5667888764333222112457788888888644332 333322 2 368999998865431
Q ss_pred -------------H---HhcccCCCCCCCHHH-HHHHHHH---------HHHHHHHHHhC-----CCCCeeeCCCCCCcE
Q 018311 260 -------------W---LRGDMCDRGYLTWEA-RMKILLG---------TAKALAYLHEA-----IEPKVVHRDIKSSNI 308 (358)
Q Consensus 260 -------------~---l~~~~~~~~~l~~~~-~~~i~~~---------i~~~l~yLH~~-----~~~~ivHrDlk~~Ni 308 (358)
. |+........++... ......+ +...+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1 111111111122211 1111111 11112222111 123589999999999
Q ss_pred EEcCCCcEEEeeecCcee
Q 018311 309 LIDENFDAKISDFGLAKL 326 (358)
Q Consensus 309 Ll~~~~~~kl~DFGla~~ 326 (358)
++++++ +.|+||..|..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999998765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0028 Score=59.05 Aligned_cols=145 Identities=14% Similarity=0.138 Sum_probs=81.8
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCc--cccccceE------EeCCEEEEEEe
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN--LVRLLGYC------IEGTQRILVYE 250 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~------~~~~~~~lv~e 250 (358)
.+.++.|.-..+|+++..+| .+.+|...... ...+...|.+++..|...+ +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876555 57778664422 2344556677776664222 33333321 12456789999
Q ss_pred ecCCCCHH-----H------H---HhcccCC---C--C---CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 018311 251 YVNNGNLE-----Q------W---LRGDMCD---R--G---YLTWEARM------------KILLGTAKALAYLHE---- 292 (358)
Q Consensus 251 ~~~~gsL~-----~------~---l~~~~~~---~--~---~l~~~~~~------------~i~~~i~~~l~yLH~---- 292 (358)
|++|..+. + . ++..... . . .-.|.... .....+...+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885431 1 1 1110000 0 0 01111100 011123344555542
Q ss_pred CCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 293 ~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
....+++|+|+.+.|+++++++...|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1235899999999999999888778999998843
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0023 Score=59.12 Aligned_cols=144 Identities=15% Similarity=0.125 Sum_probs=84.4
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCc--cccccce------EEeCCEEEEEEe
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN--LVRLLGY------CIEGTQRILVYE 250 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~------~~~~~~~~lv~e 250 (358)
.+.|..|....+|+....+ ..+++|.... ....++..|++++..+.+.+ +.+++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778778999987644 4688887643 23455667888877774332 3343331 123456789999
Q ss_pred ecCCCCHHH-----------H---Hhccc--CCC-----CCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 018311 251 YVNNGNLEQ-----------W---LRGDM--CDR-----GYLTWEARM----------KILLGTAKALAYLHE----AIE 295 (358)
Q Consensus 251 ~~~~gsL~~-----------~---l~~~~--~~~-----~~l~~~~~~----------~i~~~i~~~l~yLH~----~~~ 295 (358)
+++|..+.. . ++... ... ....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998866421 0 11100 000 111221110 011123334455543 123
Q ss_pred CCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 296 ~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
.+++|+|+.|.|+++++++.+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999987789999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0036 Score=58.50 Aligned_cols=144 Identities=15% Similarity=0.141 Sum_probs=76.8
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCc--cccccc------eEEeCCEEEEEEe
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN--LVRLLG------YCIEGTQRILVYE 250 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~------~~~~~~~~~lv~e 250 (358)
.+.|+.|....+|+.+..+| .+++|... . ...+.+..|..++..|...+ +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 34566777789999887555 57888764 2 12234444555555553212 223222 1123566789999
Q ss_pred ecCCCCHH-----------HH---Hhccc--CC-----CCCCCH-HHHHH-H-----------H-HHHHHHHHHHHhC--
Q 018311 251 YVNNGNLE-----------QW---LRGDM--CD-----RGYLTW-EARMK-I-----------L-LGTAKALAYLHEA-- 293 (358)
Q Consensus 251 ~~~~gsL~-----------~~---l~~~~--~~-----~~~l~~-~~~~~-i-----------~-~~i~~~l~yLH~~-- 293 (358)
+++|..+. .. ++... .. ...+.| ..... + . ..+...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99886431 11 11100 00 001111 11111 1 1 1111122333211
Q ss_pred --CCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 294 --IEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 294 --~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
...+++|+|+.+.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 244899999999999999776668999998854
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0024 Score=59.23 Aligned_cols=143 Identities=21% Similarity=0.226 Sum_probs=81.4
Q ss_pred ceecCCccEEEEEEEEeC-------CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccc-cccceEEeCCEEEEEEee
Q 018311 180 NIIGDGGYGVVYRGQLMN-------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV-RLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv~e~ 251 (358)
+.|..|-...+|+.+..+ ++.+++|...... ....+..+|.+++..+...++. ++++.+. + .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 455566667899987654 4778888754432 2234566788888777533333 4444432 2 368999
Q ss_pred cCCCCHHHH-----------------HhcccCCC-C----CCC--HHHHHH--------------------------HHH
Q 018311 252 VNNGNLEQW-----------------LRGDMCDR-G----YLT--WEARMK--------------------------ILL 281 (358)
Q Consensus 252 ~~~gsL~~~-----------------l~~~~~~~-~----~l~--~~~~~~--------------------------i~~ 281 (358)
++|..+... ++...... . ... +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 888665321 11111110 0 000 111100 111
Q ss_pred HHHHHHHHHHh------CCCCCeeeCCCCCCcEEEcCC----CcEEEeeecCceec
Q 018311 282 GTAKALAYLHE------AIEPKVVHRDIKSSNILIDEN----FDAKISDFGLAKLL 327 (358)
Q Consensus 282 ~i~~~l~yLH~------~~~~~ivHrDlk~~NiLl~~~----~~~kl~DFGla~~~ 327 (358)
.+..-+.++-. .....++|+|+.+.|||++++ +.++++||..|..-
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22223334432 123479999999999999885 88999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0074 Score=57.48 Aligned_cols=163 Identities=15% Similarity=0.134 Sum_probs=101.3
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccce----E--EeCC-EEEEEEe
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGY----C--IEGT-QRILVYE 250 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~----~--~~~~-~~~lv~e 250 (358)
.+.||+|+-+.+|-.....+ . ..|+..........+. +..|... .||-+..=+.| . -+.. ..-++|.
T Consensus 16 gr~LgqGgea~ly~l~e~~d-~-VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD-Q-VAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchhhc-h-hheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 57899999999996533222 2 3355544433322222 2333333 45543321111 1 1122 2567777
Q ss_pred ecCCCC-HHHHHhc--ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 251 YVNNGN-LEQWLRG--DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 251 ~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
.+++.. ...++.- .+..-....|.-.++.+..++.+..-||.. |.+-+|+.++|+|+.+++.+.|.|-..-..-
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 776542 2233321 111223478999999999999999999998 9999999999999999999999986543332
Q ss_pred CCCCceeeeecccccCCchhhhcc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
..+. ...-.+|...|..||.-.
T Consensus 168 ~ng~--~~~cpVg~~eftPPElQ~ 189 (637)
T COG4248 168 ANGT--LHLCPVGVSEFTPPELQT 189 (637)
T ss_pred cCCc--eEecccCccccCCHHHhc
Confidence 2222 233458899999999754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0083 Score=56.41 Aligned_cols=141 Identities=15% Similarity=0.154 Sum_probs=92.6
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCC----------------------CcchH----HHHHHHHHHhcCCCCcc
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP----------------------GQADK----DFRVEVEAIGHVRHKNL 232 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~----------------------~~~~~----~~~~E~~~l~~l~HpnI 232 (358)
..+|..|-=+.||.|...+|..+|||..+-.- ...++ ....|++-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 45677888899999999999999999763210 00111 23457777777765554
Q ss_pred ccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC
Q 018311 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE 312 (358)
Q Consensus 233 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~ 312 (358)
..---... ....|||+|+. ++=+- .+......++...+..+-.+++.-|.-|-+.+ ++||.||.--|+|+ .
T Consensus 229 P~PePIlL--k~hVLVM~FlG-rdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-h 299 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLG-RDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-H 299 (520)
T ss_pred CCCCceee--ecceEeeeecc-CCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-E
Confidence 32222222 23468999995 32211 11112234666777788888888888887664 99999999999998 4
Q ss_pred CCcEEEeeecCceecC
Q 018311 313 NFDAKISDFGLAKLLG 328 (358)
Q Consensus 313 ~~~~kl~DFGla~~~~ 328 (358)
+|.+.|+|-+-+....
T Consensus 300 dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHD 315 (520)
T ss_pred CCEEEEEEccccccCC
Confidence 5788999988776543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.012 Score=54.09 Aligned_cols=32 Identities=34% Similarity=0.485 Sum_probs=26.6
Q ss_pred CCeeeCCCCCCcEEEcCCCc-EEEeeecCceec
Q 018311 296 PKVVHRDIKSSNILIDENFD-AKISDFGLAKLL 327 (358)
Q Consensus 296 ~~ivHrDlk~~NiLl~~~~~-~kl~DFGla~~~ 327 (358)
+.++|+|+.+.||++++++. .-|.||+.+..-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 46899999999999997555 569999998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.019 Score=54.38 Aligned_cols=143 Identities=20% Similarity=0.177 Sum_probs=79.8
Q ss_pred ceecCCccEEEEEEEEeC-----CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccc-cccceEEeCCEEEEEEeecC
Q 018311 180 NIIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV-RLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv~e~~~ 253 (358)
+.|-.|-.-.+|++...+ ++.+.+|......... -+...|..++..+..-++. ++++.+.. + .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 455457778999987532 3578888665443222 2336688888877544443 44454422 2 5799997
Q ss_pred CCCHHHH-----------------HhcccCC-CC-CCCHHHHHHHHHH-----------------HHHHHHHHH----h-
Q 018311 254 NGNLEQW-----------------LRGDMCD-RG-YLTWEARMKILLG-----------------TAKALAYLH----E- 292 (358)
Q Consensus 254 ~gsL~~~-----------------l~~~~~~-~~-~l~~~~~~~i~~~-----------------i~~~l~yLH----~- 292 (358)
+.+|..- +++.... .. ...+.....+..+ +...+..|. .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665321 1111101 01 1112222222211 111122222 1
Q ss_pred CCCCCeeeCCCCCCcEEEcC-CCcEEEeeecCceec
Q 018311 293 AIEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKLL 327 (358)
Q Consensus 293 ~~~~~ivHrDlk~~NiLl~~-~~~~kl~DFGla~~~ 327 (358)
.....++|+|+++.||++++ ++.+.++||..|..-
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 11236899999999999986 478999999988753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0013 Score=60.64 Aligned_cols=134 Identities=16% Similarity=0.080 Sum_probs=88.6
Q ss_pred CCcccceecCCccEEEEEEEEeCCcEEEEEEecCCC--------------------Ccc--hHHHHHHHHHHhcCC-CCc
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP--------------------GQA--DKDFRVEVEAIGHVR-HKN 231 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~--------------------~~~--~~~~~~E~~~l~~l~-Hpn 231 (358)
-+.+++.||-|-=+.||.+-...|++.++|.-+-.. +.. +-...+|...|..|. |-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 457789999999999999988889998888321110 000 112345777887774 222
Q ss_pred -cccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 018311 232 -LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (358)
Q Consensus 232 -Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl 310 (358)
+.+.++ .+..|+|||++.+-.|.+.-+ .....+ +...+..-+.-|..+ |+||+|..-=||++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRH-------VEDPPT---LYDDLMGLIVRLANH---GLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeee-------cCChHH---HHHHHHHHHHHHHHc---CceecccchheeEE
Confidence 223333 357799999998877765332 112222 223333334455556 99999999999999
Q ss_pred cCCCcEEEeeecCce
Q 018311 311 DENFDAKISDFGLAK 325 (358)
Q Consensus 311 ~~~~~~kl~DFGla~ 325 (358)
++++.++++||--..
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999996443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0012 Score=66.18 Aligned_cols=70 Identities=23% Similarity=0.310 Sum_probs=52.8
Q ss_pred HHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce--------eeeecccccCCchhhhccC
Q 018311 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH--------ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 281 ~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~--------~~~~~~Gt~~y~APE~l~~ 352 (358)
.+++.||.|+|.. .++||++|.|++|.++.++..||+.|+.+....++... ...-..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999975 38999999999999999999999999988665431111 0111234568999999876
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.039 Score=51.24 Aligned_cols=30 Identities=23% Similarity=0.434 Sum_probs=26.0
Q ss_pred CCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 296 ~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
.+++|+|+.+.||+++. +.+.|.||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47999999999999987 6789999997644
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.026 Score=53.49 Aligned_cols=79 Identities=20% Similarity=0.210 Sum_probs=48.9
Q ss_pred eecCCccEEEEEEEEeCC-cEEEEEEec----C--CC-CcchHHHHHHHHHHhcCC--CC-ccccccceEEeCCEEEEEE
Q 018311 181 IIGDGGYGVVYRGQLMNG-TAVAVKKLL----N--NP-GQADKDFRVEVEAIGHVR--HK-NLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 181 ~lG~G~fg~V~~~~~~~~-~~vavK~l~----~--~~-~~~~~~~~~E~~~l~~l~--Hp-nIv~l~~~~~~~~~~~lv~ 249 (358)
.||.|....||++...+| +.|+||.-. . .. +...++...|.+.|.... -| .+.+++ +.+++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 478999999999987554 579999542 1 11 223345566777776553 24 334443 33556677999
Q ss_pred eecCCC-CHHHHH
Q 018311 250 EYVNNG-NLEQWL 261 (358)
Q Consensus 250 e~~~~g-sL~~~l 261 (358)
|+++.. .|.+.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999543 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.04 Score=51.75 Aligned_cols=138 Identities=21% Similarity=0.294 Sum_probs=80.1
Q ss_pred ccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCc------cccccceEE--eCC--EEEEEEeecCCC
Q 018311 186 GYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN------LVRLLGYCI--EGT--QRILVYEYVNNG 255 (358)
Q Consensus 186 ~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~--~~~--~~~lv~e~~~~g 255 (358)
.--.+|+.+..+|+. ++|..... ....++..|...+..|.-.+ +..+=|-.. -.+ ..+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 344688888877765 77766544 44566777888887763222 222222111 123 778899999988
Q ss_pred CHHH------------H---Hh----ccc----CCCCCCCHHH-------------HHHHHHHHHHHHHHHHhCC----C
Q 018311 256 NLEQ------------W---LR----GDM----CDRGYLTWEA-------------RMKILLGTAKALAYLHEAI----E 295 (358)
Q Consensus 256 sL~~------------~---l~----~~~----~~~~~l~~~~-------------~~~i~~~i~~~l~yLH~~~----~ 295 (358)
.+.. + |+ +.. .......|.. ......++...+..+.... .
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7762 1 11 100 0011233320 0112333444455444322 2
Q ss_pred CC---eeeCCCCCCcEEEcCCCc-EEEeeecCcee
Q 018311 296 PK---VVHRDIKSSNILIDENFD-AKISDFGLAKL 326 (358)
Q Consensus 296 ~~---ivHrDlk~~NiLl~~~~~-~kl~DFGla~~ 326 (358)
.. +||+|+-+.||+++.+.. +.+.||+-+..
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 23 999999999999998885 89999998754
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.02 Score=52.80 Aligned_cols=75 Identities=16% Similarity=0.240 Sum_probs=47.5
Q ss_pred cccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC---CCccccccceEEeCCEEEEEEeecC
Q 018311 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 177 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
+..+.++-|....+|+.+ .+++.+-||.-. ......|..|.+-|+.|. --.+.+++++....+..+|+|||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 445678889999999987 577888898764 223356777888777773 4457788888887778899999997
Q ss_pred CC
Q 018311 254 NG 255 (358)
Q Consensus 254 ~g 255 (358)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.087 Score=49.14 Aligned_cols=42 Identities=29% Similarity=0.464 Sum_probs=33.8
Q ss_pred HHHHHHhCC-----CCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 286 ALAYLHEAI-----EPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 286 ~l~yLH~~~-----~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
-..||+... .+.++|+|+.+.|++++.+..+-|.||+++..=
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 455666542 246999999999999999988999999998663
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.088 Score=50.79 Aligned_cols=73 Identities=15% Similarity=0.186 Sum_probs=47.9
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCC-------cchHHHHHHHHHHhcCC---CCccccccceEEeCCEEEEE
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG-------QADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lv 248 (358)
.+.||.|..-.||+... .+..++||.-..... ....+-..|.+.|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46789999999999876 445688886531111 12333344566665543 346777777775 556889
Q ss_pred EeecCC
Q 018311 249 YEYVNN 254 (358)
Q Consensus 249 ~e~~~~ 254 (358)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.023 Score=53.41 Aligned_cols=76 Identities=20% Similarity=0.214 Sum_probs=57.3
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
...|++|++. |+++.- ...-.+++.+.++.+.+.-+.-+.... ..-|||+.-.||||+ +|++.|+||-
T Consensus 299 ~y~yl~~kdh-gt~is~--------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPISI--------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Cceeee--------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence 3456777775 555532 123457888889888777777777654 789999999999999 9999999999
Q ss_pred CceecCCC
Q 018311 323 LAKLLGAG 330 (358)
Q Consensus 323 la~~~~~~ 330 (358)
++|.-.++
T Consensus 367 lsRl~~~q 374 (488)
T COG5072 367 LSRLSYSQ 374 (488)
T ss_pred eeecccCC
Confidence 99964443
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.034 Score=53.34 Aligned_cols=74 Identities=18% Similarity=0.198 Sum_probs=48.1
Q ss_pred cceecCCccEEEEEEEEeC-CcEEEEEEecCC-----C-CcchHHHHHHHHHHhcCC--CC-ccccccceEEeCCEEEEE
Q 018311 179 DNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNN-----P-GQADKDFRVEVEAIGHVR--HK-NLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~-~~~vavK~l~~~-----~-~~~~~~~~~E~~~l~~l~--Hp-nIv~l~~~~~~~~~~~lv 248 (358)
.+.||-|.-..||++...+ ++.|+||.-... . +-..++...|.+.|+... -| .+.+++. .+++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 4678999999999998743 567999854211 1 233456666777777653 24 3444443 345666789
Q ss_pred EeecCC
Q 018311 249 YEYVNN 254 (358)
Q Consensus 249 ~e~~~~ 254 (358)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.15 Score=47.56 Aligned_cols=31 Identities=26% Similarity=0.342 Sum_probs=28.3
Q ss_pred CCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 296 ~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
.+++|+|+.+.|+|++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 4799999999999999999999999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.12 Score=48.72 Aligned_cols=143 Identities=17% Similarity=0.176 Sum_probs=76.8
Q ss_pred ceecCCccEEEEEEEEeC----CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccc-cccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV-RLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+.|-.|-.-.+|++...+ +..|.+|....... ..-+..+|..++..+..-++. ++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 445456677899886533 23678876644332 223345688888877654443 4454442 22 58888876
Q ss_pred CCHHH--------------H---HhcccCC-CC-CCCHHHHHHHHHH----------------------HHHHHHH----
Q 018311 255 GNLEQ--------------W---LRGDMCD-RG-YLTWEARMKILLG----------------------TAKALAY---- 289 (358)
Q Consensus 255 gsL~~--------------~---l~~~~~~-~~-~l~~~~~~~i~~~----------------------i~~~l~y---- 289 (358)
..|.. . ++..... .. .-.+.....+..+ +..-+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65421 1 1111100 11 1112222222211 1111211
Q ss_pred HHhC-CCCCeeeCCCCCCcEEEcC-CCcEEEeeecCceec
Q 018311 290 LHEA-IEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKLL 327 (358)
Q Consensus 290 LH~~-~~~~ivHrDlk~~NiLl~~-~~~~kl~DFGla~~~ 327 (358)
+... ...-++|.|+-+.|||+++ ++.++++||..|..-
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 2111 1124799999999999975 578999999988653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.38 Score=52.25 Aligned_cols=143 Identities=18% Similarity=0.244 Sum_probs=77.2
Q ss_pred ceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-------CCCcccccc-ceE----Ee-CC--E
Q 018311 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-------RHKNLVRLL-GYC----IE-GT--Q 244 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~l~-~~~----~~-~~--~ 244 (358)
+.|+ |..-.+|+.+..+|..+++|....... ......|.+.|..| .-|.++.-. |-. .. ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4454 456778988877888899998765432 23344455555544 223333221 211 11 12 4
Q ss_pred EEEEEeecCCCCHHHH-----------------Hhc------ccCCCCCCCHHH-----------------HHHHHHHHH
Q 018311 245 RILVYEYVNNGNLEQW-----------------LRG------DMCDRGYLTWEA-----------------RMKILLGTA 284 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~-----------------l~~------~~~~~~~l~~~~-----------------~~~i~~~i~ 284 (358)
.+-+++|++|..+.+. ++. +......+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999998766541 110 000011122211 112222222
Q ss_pred HHHH-----HHHhCCCCCeeeCCCCCCcEEEcCCC--cEE-EeeecCcee
Q 018311 285 KALA-----YLHEAIEPKVVHRDIKSSNILIDENF--DAK-ISDFGLAKL 326 (358)
Q Consensus 285 ~~l~-----yLH~~~~~~ivHrDlk~~NiLl~~~~--~~k-l~DFGla~~ 326 (358)
.... .+. .....+||.|+.+.|||++.+. .+. |+|||.+..
T Consensus 188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2211 122 2344799999999999998875 555 999998754
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.67 Score=43.52 Aligned_cols=70 Identities=14% Similarity=0.032 Sum_probs=42.8
Q ss_pred ccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCc--ccc---ccc--eEEeCCEEEEEEeecCCCC
Q 018311 186 GYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN--LVR---LLG--YCIEGTQRILVYEYVNNGN 256 (358)
Q Consensus 186 ~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~---l~~--~~~~~~~~~lv~e~~~~gs 256 (358)
.-..||+....++..+++|...... ....++..|.+.+..|.... ++. .-| ....++..+.++++++|..
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3457999988778888888764322 24456777888777663211 222 222 1223456788999998754
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.13 Score=49.22 Aligned_cols=59 Identities=20% Similarity=0.198 Sum_probs=40.2
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeCCCCCCcEEEc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH-EAIEPKVVHRDIKSSNILID 311 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivHrDlk~~NiLl~ 311 (358)
..|+=+|+.|-++..++... ..+++...+++.-.+.|+--+- -. +++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-----~~pe~l~kkva~lg~~AllkMl~vD---NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-----SQPEALVKKVAKLGVNALLKMLIVD---NFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcc-----cChHHHHHHHHHHHHHHHHHHHHhh---cceecccCCCcEEEE
Confidence 35666788898999888642 2334455566655555544322 23 799999999999984
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.14 Score=45.14 Aligned_cols=102 Identities=17% Similarity=0.147 Sum_probs=65.0
Q ss_pred EEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHH
Q 018311 200 AVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK 278 (358)
Q Consensus 200 ~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~ 278 (358)
...+|++....-. ...-|..+.++++++. .|+++..= +....-+++|+|-... ... ..
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------------i~~----~N 145 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------------INF----SN 145 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------------cch----hH
Confidence 3566776544333 3345667788888764 45555521 3345568899883211 111 11
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 279 i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
++.-=..+|.-.|+. ..+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 146 ~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 146 FITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 121114567777864 45899999999999999999999999764
|
The function of this family is unknown. |
| >PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host [] | Back alignment and domain information |
|---|
Probab=94.75 E-value=0.036 Score=33.74 Aligned_cols=27 Identities=19% Similarity=0.294 Sum_probs=12.9
Q ss_pred HHHHHHHHHHHHHHHHHhheeeecccc
Q 018311 21 LIVICLAVVFVVILGVSLWLTFRKKKS 47 (358)
Q Consensus 21 ~i~i~~~~~~~ii~~~~~~~~~r~~~~ 47 (358)
+|+.+++++++++++++.+.+|+||.+
T Consensus 8 IIv~V~vg~~iiii~~~~YaCcykk~~ 34 (38)
T PF02439_consen 8 IIVAVVVGMAIIIICMFYYACCYKKHR 34 (38)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHcccc
Confidence 333344444445555555555555543
|
This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.022 Score=59.08 Aligned_cols=58 Identities=16% Similarity=0.114 Sum_probs=43.0
Q ss_pred eeCCCCCC-cEEEcCCCcEEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCcc
Q 018311 299 VHRDIKSS-NILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 299 vHrDlk~~-NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.|++.+|. |++++.....++.|||.++....+.. ......+||+.|+|||++.+.+|.
T Consensus 499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~ 558 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHG 558 (669)
T ss_pred CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCC
Confidence 44566666 66777777889999999988654432 233457899999999999988764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.34 Score=42.97 Aligned_cols=75 Identities=16% Similarity=0.220 Sum_probs=48.2
Q ss_pred ceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC---CCccccccceEEeCCEEEEEEeecCCCC
Q 018311 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGTQRILVYEYVNNGN 256 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lv~e~~~~gs 256 (358)
+.+--|..-+.|.... ...++-||.- .......|..|+.-|..|. --++.+++.+....+..|+||||++-|.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3444444444454433 4556777742 2223356777777666553 4557788888888999999999998865
Q ss_pred HH
Q 018311 257 LE 258 (358)
Q Consensus 257 L~ 258 (358)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 54
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.0072 Score=65.88 Aligned_cols=135 Identities=12% Similarity=-0.008 Sum_probs=92.4
Q ss_pred HHHHHHhcCCCCccccccceEEe--CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-
Q 018311 219 VEVEAIGHVRHKNLVRLLGYCIE--GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE- 295 (358)
Q Consensus 219 ~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~- 295 (358)
.|...++...|+++.....-... ..+.+..++|+.+|++++.+.+.......+...-+...-.+...+..-+|+...
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 35555666789888765554432 345688999999999999887544333344433333333333666666665432
Q ss_pred -CCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeeecccccCCchhhhccCCC
Q 018311 296 -PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 296 -~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.--+|++||+-|.+|..+..+|+.++|+.++..+.. ...+...+++-|++|++.....
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik 1416 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIK 1416 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHh
Confidence 237899999999999999999999999999544332 2344567888899998876543
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.72 E-value=0.94 Score=43.59 Aligned_cols=74 Identities=18% Similarity=0.282 Sum_probs=43.2
Q ss_pred ceecCCccEEEEEEEEeCC--cE-----EEEEEecCCCCcchHHHHHHHHHHhcCCCCccc-cccceEEeCCEEEEEEee
Q 018311 180 NIIGDGGYGVVYRGQLMNG--TA-----VAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV-RLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~--~~-----vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv~e~ 251 (358)
+.|..|-...+|++...++ .. |.+.. ........-+-.+|.+++..+...++. ++++.+. -+++.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~-~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKK-SSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEe-ccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 4565577889999975433 22 33332 122222222345688898888655554 4444442 3699999
Q ss_pred cCCCCHH
Q 018311 252 VNNGNLE 258 (358)
Q Consensus 252 ~~~gsL~ 258 (358)
++|..|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9887653
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.68 E-value=0.073 Score=49.48 Aligned_cols=53 Identities=25% Similarity=0.285 Sum_probs=35.2
Q ss_pred HHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCCcEEEc-CC-----------------CcEEEeeecCceec
Q 018311 275 ARMKILLGTAKALAYL-HEAIEPKVVHRDIKSSNILID-EN-----------------FDAKISDFGLAKLL 327 (358)
Q Consensus 275 ~~~~i~~~i~~~l~yL-H~~~~~~ivHrDlk~~NiLl~-~~-----------------~~~kl~DFGla~~~ 327 (358)
-...++.||+.-.-.+ .-.++.+.+|-||||.|||+= .+ -.++|.||.+++.-
T Consensus 280 YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 280 YIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred HHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 3456777876544333 323245799999999999983 22 23677888887664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 358 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-32 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-31 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-26 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-04 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-04 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-118
Identities = 93/197 (47%), Positives = 131/197 (66%), Gaps = 2/197 (1%)
Query: 148 PLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLL 207
P PE HLG F+LR+LQ A++ FS NI+G GG+G VY+G+L +GT VAVK+L
Sbjct: 5 PAEEDPEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK 63
Query: 208 NNPGQA-DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC 266
Q + F+ EVE I H+NL+RL G+C+ T+R+LVY Y+ NG++ LR
Sbjct: 64 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 267 DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
+ L W R +I LG+A+ LAYLH+ +PK++HRD+K++NIL+DE F+A + DFGLAKL
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 327 LGAGKSHITTRVMGTFG 343
+ +H+TT V GT G
Sbjct: 184 MDYKDTHVTTAVRGTIG 200
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-107
Identities = 79/211 (37%), Positives = 122/211 (57%), Gaps = 8/211 (3%)
Query: 134 STFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRG 193
S + +++ + S L F + L DL+ ATN F +IG G +G VY+G
Sbjct: 3 SKYSKATNSINDALSSSYLVPFE----SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKG 58
Query: 194 QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253
L +G VA+K+ Q ++F E+E + RH +LV L+G+C E + IL+Y+Y+
Sbjct: 59 VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118
Query: 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN 313
NGNL++ L G ++WE R++I +G A+ L YLH ++HRD+KS NIL+DEN
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDEN 175
Query: 314 FDAKISDFGLAKL-LGAGKSHITTRVMGTFG 343
F KI+DFG++K ++H++T V GT G
Sbjct: 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLG 206
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 7e-92
Identities = 76/193 (39%), Positives = 111/193 (57%), Gaps = 16/193 (8%)
Query: 162 HWFTLRDLQSATNRFSK------DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP----G 211
H F+ +L++ TN F + N +G+GG+GVVY+G + N T VAVKKL
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 212 QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYL 271
+ + F E++ + +H+NLV LLG+ +G LVY Y+ NG+L L + L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPL 130
Query: 272 TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG- 330
+W R KI G A + +LH E +HRDIKS+NIL+DE F AKISDFGLA+
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 331 KSHITTRVMGTFG 343
++ +T+R++GT
Sbjct: 188 QTVMTSRIVGTTA 200
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 7e-65
Identities = 53/192 (27%), Positives = 84/192 (43%), Gaps = 19/192 (9%)
Query: 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA 223
+L + + G +G V++ Q + VAVK + EV +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQ-DKQSWQNEYEVYS 71
Query: 224 IGHVRHKNLVRLLGYCIEG----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKI 279
+ ++H+N+++ +G G L+ + G+L +L+ ++W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHI 126
Query: 280 LLGTAKALAYLHEAI-------EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332
A+ LAYLHE I +P + HRDIKS N+L+ N A I+DFGLA AGKS
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 333 HI-TTRVMGTFG 343
T +GT
Sbjct: 187 AGDTHGQVGTRR 198
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 2e-49
Identities = 48/200 (24%), Positives = 78/200 (39%), Gaps = 29/200 (14%)
Query: 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVE- 222
+ + +IG G YG VY+G L + VAVK ++F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNI 58
Query: 223 -AIGHVRHKNLVRLLGYCIEG-----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR 276
+ + H N+ R + + +LV EY NG+L ++L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSS 113
Query: 277 MKILLGTAKALAYLHEAIE------PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330
++ + LAYLH + P + HRD+ S N+L+ + ISDFGL+ L
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 331 K-------SHITTRVMGTFG 343
+ + +GT
Sbjct: 174 RLVRPGEEDNAAISEVGTIR 193
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-46
Identities = 52/165 (31%), Positives = 85/165 (51%), Gaps = 6/165 (3%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRHKNLVRLLG 237
IG G +G V+R + +G+ VAVK L+ + + +F EV + +RH N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
+ +V EY++ G+L + L R L R+ + AK + YLH P
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+VHR++KS N+L+D+ + K+ DFGL++L A + GT
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTP 203
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-44
Identities = 39/171 (22%), Positives = 74/171 (43%), Gaps = 7/171 (4%)
Query: 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
++G G +G + G + +K+L+ + + F EV+ + + H N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
+ + + EY+ G L ++ W R+ A +AYLH +
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTL 349
+HRD+ S N L+ EN + ++DFGLA+L+ K+ D
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-44
Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 32/221 (14%)
Query: 134 STFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRG 193
+ R + SGLP + +Q IG G YG V+ G
Sbjct: 9 ESLRDLIEQSQSSGSGSGLPLLVQ-----RTIAKQIQ-------MVKQIGKGRYGEVWMG 56
Query: 194 QLMNGTAVAVKKLLNNPGQADKDFRVEVE--AIGHVRHKNLVRLLGYCIEGTQRI----L 247
+ G VAVK + + E E +RH+N++ + I+GT L
Sbjct: 57 KW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112
Query: 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE-----PKVVHRD 302
+ +Y NG+L +L+ L ++ +K+ + L +LH I P + HRD
Sbjct: 113 ITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 303 IKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+KS NIL+ +N I+D GLA + + + G
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-44
Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 20/175 (11%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVE--AIGHVRHKNLVRLLG 237
+G G YG V+RG G VAVK + +K + E E +RH+N++ +
Sbjct: 14 ECVGKGRYGEVWRGS-WQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 238 YCIEG----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
+ TQ L+ Y G+L +L+ L + ++I+L A LA+LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 294 IE-----PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
I P + HRD+KS NIL+ +N I+D GLA + + + G
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 47/176 (26%), Positives = 89/176 (50%), Gaps = 23/176 (13%)
Query: 180 NIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQAD-------KDFRVEVEAIGHVRHKN 231
IG GG+G+V++G+L+ + + VA+K L+ + + ++F+ EV + ++ H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+L G +V E+V G+L L + W +++++L A + Y+
Sbjct: 85 IVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 292 EAIEPKVVHRDIKSSNILIDE-----NFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
P +VHRD++S NI + AK++DFGL++ H + ++G F
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNF 190
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-43
Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 11/165 (6%)
Query: 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+ ++G G +GVV + + VA+K++ + K F VE+ + V H N+V+L G
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
C+ LV EY G+L L G Y T M L ++ +AYLH +
Sbjct: 70 CLN--PVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 299 VHRDIKSSNILIDENFD-AKISDFGLAKLLGAGKSHITTRVMGTF 342
+HRD+K N+L+ KI DFG A T G+
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSA 167
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 34/167 (20%), Positives = 67/167 (40%), Gaps = 14/167 (8%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRHKNLVRLLG 237
+ + G +++G+ G + VK L + + +DF E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 238 YCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
C + ++ G+L L + +K L A+ +A+LH +E
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLH-TLE 131
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
P + + S +++IDE+ A+IS + S + M
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAP 172
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-42
Identities = 59/205 (28%), Positives = 86/205 (41%), Gaps = 32/205 (15%)
Query: 150 SGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNN 209
SGLP R + IG G +G V+RG+ G VAVK
Sbjct: 30 SGLPLLVQ-----RTIARTIV-------LQESIGKGRFGEVWRGKW-RGEEVAVKIF--- 73
Query: 210 PGQADKDFRVEVE--AIGHVRHKNLVRLLGYCI----EGTQRILVYEYVNNGNLEQWLRG 263
+ ++ + E E +RH+N++ + TQ LV +Y +G+L +L
Sbjct: 74 SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN- 132
Query: 264 DMCDRGYLTWEARMKILLGTAKALAYLHEAIE-----PKVVHRDIKSSNILIDENFDAKI 318
R +T E +K+ L TA LA+LH I P + HRD+KS NIL+ +N I
Sbjct: 133 ----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188
Query: 319 SDFGLAKLLGAGKSHITTRVMGTFG 343
+D GLA + I G
Sbjct: 189 ADLGLAVRHDSATDTIDIAPNHRVG 213
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-42
Identities = 52/175 (29%), Positives = 81/175 (46%), Gaps = 21/175 (12%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHVRHKNLVRL 235
IIG GG+G VYR G VAVK ++P Q ++ R E + ++H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
G C++ LV E+ G L + L G + + + + A+ + YLH+
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEAI 126
Query: 296 PKVVHRDIKSSNILIDENFD--------AKISDFGLAKLLGAGKSHITTRVMGTF 342
++HRD+KSSNILI + + KI+DFGLA+ G +
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAY 178
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-39
Identities = 42/169 (24%), Positives = 68/169 (40%), Gaps = 15/169 (8%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD--KDFRVEVEAIGHVRHKNLVRLLG 237
+IG G +G VY G+ +G VA++ + D K F+ EV A RH+N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
C+ ++ L +R + L +I K + YLH
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKL----LGAGKSHITTRVMGTF 342
++H+D+KS N+ D I+DFGL + + G
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-37
Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 12/163 (7%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
IG G +G VY+G+ +G VAVK L Q + F+ EV + RH N++ +GY
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
I V ++ +L L + + I TA+ + YLH ++
Sbjct: 90 TAPQLAI-VTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLLGA-GKSHITTRVMGT 341
HRD+KS+NI + E+ KI DFGLA SH ++ G+
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 53/168 (31%), Positives = 78/168 (46%), Gaps = 21/168 (12%)
Query: 171 SATNRFSKD------------NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFR 218
+A + F + IG G +G V G G VAVK + + F
Sbjct: 6 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFL 62
Query: 219 VEVEAIGHVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARM 277
E + +RH NLV+LLG +E + +V EY+ G+L +LR R L + +
Sbjct: 63 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLL 120
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
K L +A+ YL VHRD+ + N+L+ E+ AK+SDFGL K
Sbjct: 121 KFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR 228
+ +G G +G V + G VAVK+L ++ +DF+ E++ + +
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 229 HKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+V+ G ++ LV EY+ +G L +L+ R L + K
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKG 139
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+ YL + VHRD+ + NIL++ KI+DFGLAKLL K + R G
Sbjct: 140 MEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 15/184 (8%)
Query: 145 APSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVK 204
P P + LG+G W + +G G +GVV G+ VA+K
Sbjct: 1 GPLGSKNAPSTAGLGYGSWEIDPK------DLTFLKELGTGQFGVVKYGKWRGQYDVAIK 54
Query: 205 KLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG 263
+ G + +F E + + ++ H+ LV+L G C + ++ EY+ NG L +LR
Sbjct: 55 MI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 112
Query: 264 DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323
R + +++ +A+ YL + +HRD+ + N L+++ K+SDFGL
Sbjct: 113 ---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL 166
Query: 324 AKLL 327
++ +
Sbjct: 167 SRYV 170
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 55/187 (29%), Positives = 79/187 (42%), Gaps = 16/187 (8%)
Query: 141 HPLTAPSPLSG-LPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGT 199
L P + G + W IG G +G V G G
Sbjct: 165 TRLIKPKVMEGTVAAQDEFYRSGWALNMK------ELKLLQTIGKGEFGDVMLGDY-RGN 217
Query: 200 AVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLE 258
VAVK + + F E + +RH NLV+LLG +E + +V EY+ G+L
Sbjct: 218 KVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 259 QWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318
+LR R L + +K L +A+ YL VHRD+ + N+L+ E+ AK+
Sbjct: 276 DYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKV 330
Query: 319 SDFGLAK 325
SDFGL K
Sbjct: 331 SDFGLTK 337
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 11/168 (6%)
Query: 179 DNIIGDGGYGVVYRGQLMNG---TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVR 234
D +G G +G V +G VA+K L +AD + E + + + + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
L+G C + +LV E G L ++L G R + ++L + + YL E
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK- 129
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
VHRD+ + N+L+ AKISDFGL+K LGA S+ T R G +
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 51/155 (32%), Positives = 80/155 (51%), Gaps = 9/155 (5%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNL 232
+ + IG G +G+V+ G +N VA+K + G + DF E E + + H L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKL 65
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
V+L G C+E LV E++ +G L +LR RG E + + L + +AYL E
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
A V+HRD+ + N L+ EN K+SDFG+ + +
Sbjct: 123 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV 154
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 13/176 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR 228
+G G +G V + G VAVKKL ++ + +DF E+E + ++
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 229 HKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
H N+V+ G C +R L+ EY+ G+L +L+ + + ++ K
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKG 126
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+ YL + +HRD+ + NIL++ KI DFGL K+L K + G
Sbjct: 127 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-32
Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG-----TAVAVKKLLNNPGQADK-DFRVEVEAIGHV 227
F K ++G G +G VY+G + VA+K+L + E + V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
+ ++ RLLG C+ T ++ + + + G L ++R + + + + + AK +
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 130
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
YL + ++VHRD+ + N+L+ KI+DFGLAKLLGA +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-32
Identities = 44/177 (24%), Positives = 82/177 (46%), Gaps = 14/177 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHV 227
+ +G+G +G V + G VAVK L G D + E+E + ++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 228 RHKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
H+N+V+ G C E L+ E++ +G+L+++L + + + + ++K + K
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICK 137
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+ YL + VHRD+ + N+L++ KI DFGL K + K + T +
Sbjct: 138 GMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 46/176 (26%), Positives = 79/176 (44%), Gaps = 13/176 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR 228
+G G +G V + G VAVKKL ++ + +DF E+E + ++
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 229 HKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
H N+V+ G C +R L+ EY+ G+L +L+ + + ++ K
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKG 157
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+ YL + +HRD+ + NIL++ KI DFGL K+L K + + G
Sbjct: 158 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-32
Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 8/148 (5%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
IG G +G V+ G+L + T VAVK P F E + H N+VRL+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ +V E V G+ +LR + L + ++++ A + YL +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLL 327
HRD+ + N L+ E KISDFG+++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREE 263
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 9/148 (6%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLGYC 239
+G G +GVV G+ VAVK + G + +F E + + + H LV+ G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMI--KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ +V EY++NG L +LR L +++ + +A+L + +
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLL 327
HRD+ + N L+D + K+SDFG+ + +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYV 154
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-31
Identities = 43/170 (25%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHV 227
K ++G G +G V++G + V +K + + G+ + + AIG +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
H ++VRLLG C + ++ V +Y+ G+L +R RG L + + + AK +
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGM 128
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
YL E +VHR++ + N+L+ +++DFG+A LL +
Sbjct: 129 YYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 11/168 (6%)
Query: 179 DNIIGDGGYGVVYRGQLMNG---TAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNLVR 234
D +G G +G V +G VA+K L ++ E + + + + +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
L+G C + +LV E G L ++L G R + ++L + + YL E
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK- 455
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
VHR++ + N+L+ AKISDFGL+K LGA S+ T R G +
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-31
Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 9/156 (5%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG-TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKN 231
+ + +G G YG VY G VAVK L + +F E + ++H N
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
LV+LLG C ++ E++ GNL +LR C+R ++ + + + A+ YL
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ +HRD+ + N L+ EN K++DFGL++L+
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 161
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG-----TAVAVKKLLNNPGQADK-DFRVEVEAIGHV 227
F K ++G G +G VY+G + VA+K+L + E + V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
+ ++ RLLG C+ T ++ + + + G L ++R + + + + + AK +
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 130
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
YL + ++VHRD+ + N+L+ KI+DFGLAKLLGA +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 178 KDNIIGDGGYGVVYRGQLMNG---TAVAVKKLLNN--PGQADKDFRVEVEAIGHVRHKNL 232
+D +G G +G V +G VAVK L N + E + + + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
VR++G C E +LV E G L ++L+ ++ + ++++ + + YL E
Sbjct: 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+ VHRD+ + N+L+ AKISDFGL+K L A +++ + G +
Sbjct: 136 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 63/221 (28%), Positives = 94/221 (42%), Gaps = 27/221 (12%)
Query: 129 GNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYG 188
G+ K+ R P T P + EF+ S D ++G G +G
Sbjct: 12 GHLKLPGLRTFVDPHTFEDPTQTVHEFA------KELDAT------NISIDKVVGAGEFG 59
Query: 189 VVYRGQL----MNGTAVAVKKLLNNPGQADK---DFRVEVEAIGHVRHKNLVRLLGYCIE 241
V G+L +VA+K L G +K DF E +G H N++RL G +
Sbjct: 60 EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHR 301
++V EY+ NG+L+ +LR T + +L G A + YL + VHR
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHR 171
Query: 302 DIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
D+ + NILI+ N K+SDFGL ++L T G
Sbjct: 172 DLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 14/176 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKL---LNNPGQADKDFRVEVEAIGH 226
+GDG +GVV RG+ +VAVK L + + +A DF EV A+
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+ H+NL+RL G + ++ V E G+L LR +G+ + + A+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEG 133
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+ YL + +HRD+ + N+L+ KI DFGL + L H +
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 9/150 (6%)
Query: 180 NIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLG 237
+ +G G YG VY G VAVK L + +F E + ++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
C ++ E++ GNL +LR +R ++ + + + A+ YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+HR++ + N L+ EN K++DFGL++L+
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLM 368
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-30
Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 11/154 (7%)
Query: 179 DNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLV 233
+ IIG G G V G+L VA+K L + + DF E +G H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
RL G G ++V EY+ NG+L+ +LR G T + +L G + YL +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
VHRD+ + N+L+D N K+SDFGL+++L
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 180 NIIGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
+G+G +G V+ + N VAVK L A +DF+ E E + ++H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLR-----------GDMCDRGYLTWEARMKILLG 282
R G C EG ++V+EY+ +G+L ++LR G+ G L + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
A + YL VHRD+ + N L+ + KI DFG++
Sbjct: 167 VAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 179 DNIIGDGGYGVVYRGQLMNG----TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLV 233
+ +IG G +G VY G L++ AVK L + F E + H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 234 RLLGYCIEGTQRIL-VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
LLG C+ L V Y+ +G+L ++R + T + + L AK + YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
K VHRD+ + N ++DE F K++DFGLA+ +
Sbjct: 147 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 13/151 (8%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLGY 238
+G G +G V+ G T VAVK L G F E + ++H+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 239 CIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
TQ ++ EY+ NG+L +L+ LT + + A+ +A++ E
Sbjct: 77 V---TQEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+HRD++++NIL+ + KI+DFGLA+L+
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLI 159
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 16/177 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPGQAD-KDFRVEVEAIGHV 227
K +G+G +G V G VAVK L + G ++ E++ + +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 228 RHKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
H+++++ G C + LV EYV G+L +L + + +
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICE 145
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+AYLH +HRD+ + N+L+D + KI DFGLAK + G + R G
Sbjct: 146 GMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 49/181 (27%), Positives = 73/181 (40%), Gaps = 17/181 (9%)
Query: 170 QSATNRFSK-DNIIGDGGYGVVYRG-QLMNGTAVAVK--KLLNNPGQADKDFRVEVEAIG 225
S RF K D IG G + VY+G VA + + F+ E E +
Sbjct: 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 80
Query: 226 HVRHKNLVRLLGYCIEGTQR----ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL 281
++H N+VR + +LV E + +G L+ +L+ + +
Sbjct: 81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCR 136
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITTRVMG 340
K L +LH P ++HRD+K NI I KI D GLA L A + V+G
Sbjct: 137 QILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIG 192
Query: 341 T 341
T
Sbjct: 193 T 193
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTA-----VAVKKLLNNPGQADK---DFRVEVEAIG 225
+ ++ +IG G +G VY+G L + VA+K L G +K DF E +G
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMG 101
Query: 226 HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
H N++RL G + +++ EY+ NG L+++LR G + + +L G A
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAA 158
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+ YL VHRD+ + NIL++ N K+SDFGL+++L T G
Sbjct: 159 GMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 37/167 (22%), Positives = 70/167 (41%), Gaps = 10/167 (5%)
Query: 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIG 225
+ + +G+GG+ V + L +G A+K++L + Q ++ + E +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 226 HVRHKNLVRLLGYCIEGTQR----ILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR-MKIL 280
H N++RL+ YC+ L+ + G L + +LT E + + +L
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT-EDQILWLL 140
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
LG + L +H HRD+K +NIL+ + + D G
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 58/188 (30%), Positives = 89/188 (47%), Gaps = 16/188 (8%)
Query: 141 HPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTA 200
H LT P S P+ L W R+ + +G G +G V+ G T
Sbjct: 241 HRLTTVCPTSK-PQTQGLAKDAWEIPRE------SLRLEVKLGQGCFGEVWMGTWNGTTR 293
Query: 201 VAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQ 259
VA+K L PG F E + + +RH+ LV+L E I V EY++ G+L
Sbjct: 294 VAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLD 350
Query: 260 WLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKIS 319
+L+G+ YL + + A +AY+ VHRD++++NIL+ EN K++
Sbjct: 351 FLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA 405
Query: 320 DFGLAKLL 327
DFGLA+L+
Sbjct: 406 DFGLARLI 413
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 49/149 (32%), Positives = 77/149 (51%), Gaps = 9/149 (6%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLGY 238
+G G +G V+ G T VA+K L PG F E + + +RH+ LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
E I V EY++ G+L +L+G+ YL + + A +AY+
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLL 327
VHRD++++NIL+ EN K++DFGLA+L+
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLI 330
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 12/159 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG----TAVAVKKL-LNNPGQADKDFRVEVEAIGHVR 228
R IG+G +G V++G M+ AVA+K + F E +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H ++V+L+G E I + E G L +L+ + L + + + ALA
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALA 130
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
YL + VHRDI + N+L+ N K+ DFGL++ +
Sbjct: 131 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 50/215 (23%), Positives = 81/215 (37%), Gaps = 22/215 (10%)
Query: 129 GNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYG 188
G + + AP + P + L D +S R+ + +G GG+
Sbjct: 1 GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPE----VLVDPRSR-RRYVRGRFLGKGGFA 55
Query: 189 VVYRGQ-LMNGTAVAVK----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT 243
+ A K LL P Q +K E+ + H+++V G+ E
Sbjct: 56 KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGFHGF-FEDN 113
Query: 244 QRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMKILLGTAKALAYLHEAIEPKVVHR 301
+ +V E +L + + R LT EAR L YLH +V+HR
Sbjct: 114 DFVFVVLELCRRRSLLELHK----RRKALTEPEAR-YYLRQIVLGCQYLHRN---RVIHR 165
Query: 302 DIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
D+K N+ ++E+ + KI DFGLA +
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 200
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-28
Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 25/180 (13%)
Query: 167 RDLQSATNRFSKD-------------NIIGDGGYGVVYRGQLMNG----TAVAVKKLLNN 209
RDL SA KD +IG G +GVVY G+ ++ A+K L
Sbjct: 1 RDLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60
Query: 210 PGQADK-DFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL-VYEYVNNGNLEQWLRGDMCD 267
F E + + H N++ L+G + + Y+ +G+L Q++R
Sbjct: 61 TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--- 117
Query: 268 RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ T + + L A+ + YL E K VHRD+ + N ++DE+F K++DFGLA+ +
Sbjct: 118 QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI 174
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 179 DNIIGDGGYGVVYRGQLMNG----TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLV 233
+ +IG G +G VY G L++ AVK L + F E + H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 234 RLLGYCIEG-TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
LLG C+ ++V Y+ +G+L ++R + T + + L AK + +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
K VHRD+ + N ++DE F K++DFGLA+ +
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 41/168 (24%), Positives = 77/168 (45%), Gaps = 21/168 (12%)
Query: 176 FSKDNI-----IGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADK-DFRVEVEA 223
+++ I +G G +G+VY G T VA+K + ++ +F E
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------GDMCDRGYLTWEARM 277
+ ++VRLLG +G +++ E + G+L+ +LR + + +
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
++ A +AYL+ K VHRD+ + N ++ E+F KI DFG+ +
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 44/152 (28%), Positives = 67/152 (44%), Gaps = 12/152 (7%)
Query: 181 IIGDGGYGVVYRGQLMNG----TAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
I+G+G +G VY G N VAVK + + F E + ++ H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
+G E I + E G L +L + + L + L KA+AYL
Sbjct: 79 IGIIEEEPTWI-IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI-- 132
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
VHRDI NIL+ K+ DFGL++ +
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 42/172 (24%), Positives = 78/172 (45%), Gaps = 8/172 (4%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKK--LLNNPGQADK-DFRVEVEAIGHVRH 229
F + IG G + VYR L++G VA+KK + + + D E++ + + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
N+++ IE + +V E + G+L + ++ + + K + AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+H +V+HRDIK +N+ I K+ D GL + + + + V GT
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GT 199
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 17/169 (10%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK----KLLNNPGQADKDFRVEVEAIGHVRH 229
R+ + +G GG+ + A K LL P Q +K E+ + H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAH 74
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMKILLGTAKAL 287
+++V G+ E + +V E +L + + R LT EAR L
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEAR-YYLRQIVLGC 128
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
YLH +V+HRD+K N+ ++E+ + KI DFGLA +
Sbjct: 129 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 38/149 (25%), Positives = 71/149 (47%), Gaps = 9/149 (6%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLGY 238
+G G +G V+ T VAVK + PG F E + ++H LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
+ I + E++ G+L +L+ D + + A+ +A++ +
Sbjct: 252 VTKEPIYI-ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLL 327
+HRD++++NIL+ + KI+DFGLA+++
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVI 334
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 182 IGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G+G +G V+ + N VAVK L + A KDF+ E E + +++H+++V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGYLTWEARMKILLGT 283
G C +G I+V+EY+ +G+L ++LR +G L + I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
A + YL VHRD+ + N L+ N KI DFG++
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 16/159 (10%)
Query: 180 NIIGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNL 232
+G G +G VY GQ+ VAVK L + D+ DF +E I H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMKILLGTAKALAY 289
VR +G ++ R ++ E + G+L+ +LR L + + A Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 290 LHEAIEPKVVHRDIKSSNILID---ENFDAKISDFGLAK 325
L E +HRDI + N L+ AKI DFG+A+
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 20/169 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG---TAVAVKKLLNNPGQADK-DFRVEVEAIGHV-R 228
N ++IG+G +G V + ++ A+K++ + D DF E+E + +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGYLTWEAR 276
H N++ LLG C L EY +GNL +LR L+ +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 277 MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+ A+ + YL + + +HRD+ + NIL+ EN+ AKI+DFGL++
Sbjct: 145 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 36/171 (21%), Positives = 80/171 (46%), Gaps = 9/171 (5%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADK-DFRVEVEAIGHVRHK 230
++ + IG+G +G + +G +K++ ++ ++ + R EV + +++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N+V+ E +V +Y G+L + + + + + AL ++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKHV 141
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
H+ K++HRDIKS NI + ++ ++ DFG+A++L + + GT
Sbjct: 142 HD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GT 188
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 13/173 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD----FRVEVEAIGHVR 228
R+ + +G GG VY + + VA+K + P + ++ F EV +
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H+N+V ++ E LV EY+ L +++ G L+ + + +
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIK 125
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+ H+ ++VHRDIK NILID N KI DFG+AK L T V+GT
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT 175
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-28
Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 8/178 (4%)
Query: 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDF-RVEVEAIGHV 227
S + IG G YG + + +G + K+L + +A+K EV + +
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 228 RHKNLVRLLGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
+H N+VR I+ T L V EY G+L + +R YL E ++++
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 286 ALAYLHE--AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
AL H V+HRD+K +N+ +D + K+ DFGLA++L S T V GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GT 179
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 48/225 (21%), Positives = 84/225 (37%), Gaps = 24/225 (10%)
Query: 108 QSGSFNNLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLR 167
+ ++ K + G VS + + + + R
Sbjct: 336 GERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTR------DYEIQR 389
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNG----TAVAVKKL-LNNPGQADKDFRVEVE 222
+ R IG+G +G V++G M+ AVA+K + F E
Sbjct: 390 E------RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 223 AIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
+ H ++V+L+G E I + E G L +L+ + L + +
Sbjct: 444 TMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVR---KFSLDLASLILYAYQ 499
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ ALAYL + VHRDI + N+L+ N K+ DFGL++ +
Sbjct: 500 LSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-28
Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 22/164 (13%)
Query: 180 NIIGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNL 232
+G+ +G VY+G L AVA+K L + + +FR E ++H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGYLTWEARMKIL 280
V LLG + +++ Y ++G+L ++L D + L + ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
A + YL VVH+D+ + N+L+ + + KISD GL
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 16/159 (10%)
Query: 180 NIIGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNL 232
+G G +G VY GQ+ VAVK L + D+ DF +E I H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMKILLGTAKALAY 289
VR +G ++ R ++ E + G+L+ +LR L + + A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 290 LHEAIEPKVVHRDIKSSNILID---ENFDAKISDFGLAK 325
L E +HRDI + N L+ AKI DFG+A+
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 35/163 (21%), Positives = 73/163 (44%), Gaps = 22/163 (13%)
Query: 181 IIGDGGYGVVYRGQL--------MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
+G G + +++G ++ T V +K L + F + + HK+L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
V G C+ G + ILV E+V G+L+ +L+ ++ + ++++ A A+ +L E
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 293 AIEPKVVHRDIKSSNILID--------ENFDAKISDFGLAKLL 327
++H ++ + NIL+ K+SD G++ +
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 41/159 (25%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 180 NIIGDGGYGVVYRGQLMNG----TAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
I+G+G +G V G L VAVK KL N+ + ++F E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 234 RLLGYCIEGTQRI-----LVYEYVNNGNLEQWLRG--DMCDRGYLTWEARMKILLGTAKA 286
RLLG CIE + + ++ ++ G+L +L ++ + +K ++ A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+ YL +HRD+ + N ++ ++ ++DFGL+K
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 18/177 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKN 231
F +G GG+GVV+ + ++ A+K++ L N A + EV+A+ + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 232 LVRLLGYCIEGT---------QRILVY---EYVNNGNLEQWLRGDMCDRGYLTWEARMKI 279
+VR +E ++ +Y + NL+ W+ C + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLHI 123
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
L A+A+ +LH ++HRD+K SNI + K+ DFGL + + T
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 29/229 (12%)
Query: 128 GGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLR------DLQSATNRFSKDNI 181
G + ++F S P+ PS + T+ + ++ +
Sbjct: 2 SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV 61
Query: 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRV-EVEAIGHVRHKNLVRLLGYC 239
IG+G +GVVY+ +L +G VA+KK+L DK F+ E++ + + H N+VRL +
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 240 IEGTQRI------LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL-GTAKALAYLHE 292
++ LV +YV + + R + L +K+ + ++LAY+H
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYIHS 174
Query: 293 AIEPKVVHRDIKSSNILIDENFDA-KISDFGLAKLLGAGK---SHITTR 337
+ HRDIK N+L+D + K+ DFG AK L G+ S+I +R
Sbjct: 175 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 16/170 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK----KLLNNPGQADKDFRVEVEAIGHVR 228
F N++G G + VYR + + G VA+K K + G + EV+ ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN-EVKIHCQLK 69
Query: 229 HKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMKILLGTAKA 286
H +++ L Y E + + LV E +NG + ++L+ + EAR +
Sbjct: 70 HPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNR---VKPFSENEAR-HFMHQIITG 124
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
+ YLH ++HRD+ SN+L+ N + KI+DFGLA L T
Sbjct: 125 MLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT 171
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 35/182 (19%)
Query: 176 FSKDNI-----IGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADK-DFRVEVEA 223
+ ++NI IG+G +G V++ + T VAVK L + DF+ E
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR--------------------G 263
+ + N+V+LLG C G L++EY+ G+L ++LR
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 264 DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323
L+ ++ I A +AYL E K VHRD+ + N L+ EN KI+DFGL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 324 AK 325
++
Sbjct: 221 SR 222
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 33/160 (20%), Positives = 70/160 (43%), Gaps = 17/160 (10%)
Query: 180 NIIGDGGYGVVYRGQLMNG----TAVAVKKL-LNNPGQAD-KDFRVEVEAIGHVRHKNLV 233
++G G +G V QL VAVK L + +D ++F E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 234 RLLGYCIEGTQRI------LVYEYVNNGNLEQWLRGDMCDR--GYLTWEARMKILLGTAK 285
+L+G + + ++ ++ +G+L +L L + ++ ++ A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+ YL +HRD+ + N ++ E+ ++DFGL++
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-26
Identities = 44/185 (23%), Positives = 76/185 (41%), Gaps = 28/185 (15%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
F + +IG GG+G V++ + ++G +K++ ++ EV+A+ + H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 233 VRLLGYCIEGTQRI----------------LVYEYVNNGNLEQWLRGDMCDRGYLTWEAR 276
V G + E+ + G LEQW+ L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLA 124
Query: 277 MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
+++ K + Y+H K+++RD+K SNI + + KI DFGL L T
Sbjct: 125 LELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 337 RVMGT 341
R GT
Sbjct: 180 RSKGT 184
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 45/179 (25%), Positives = 79/179 (44%), Gaps = 19/179 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD----FRVEVEAIGHVR 228
+R+ I+G GG V+ + L + VAVK +L D FR E + +
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALN 70
Query: 229 HKNLVRLLGYCIE-GTQRILVY---EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
H +V + L Y EYV+ L + G +T + ++++
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 126
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT--RVMGT 341
+AL + H+ ++HRD+K +NI+I K+ DFG+A+ + + +T V+GT
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 48/179 (26%), Positives = 75/179 (41%), Gaps = 30/179 (16%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADK-DFRVEVEAIGH 226
+G+G +G V + + T VAVK L N ++ D E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR--------------------GDMC 266
V H ++++L G C + +L+ EY G+L +LR D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 267 DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
D LT + ++ + YL E K+VHRD+ + NIL+ E KISDFGL++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 46/174 (26%), Positives = 83/174 (47%), Gaps = 25/174 (14%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQADK-DFRVEVEAI 224
++ + +G+G +G V + + VAVK L ++ + D D E+E +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 225 GHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGYL 271
+ +HKN++ LLG C + ++ EY + GNL ++LR + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 272 TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
T++ + A+ + YL K +HRD+ + N+L+ EN KI+DFGLA+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 39/177 (22%), Positives = 71/177 (40%), Gaps = 14/177 (7%)
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH 226
+ + + + +G G +G V+R + G AVKK+ + + E+ A
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVEELVACAG 106
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+ +V L G EG + E + G+L Q ++ G L + + L +
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQALEG 162
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLLGAGKSHITTRVMGTF 342
L YLH +++H D+K+ N+L+ + A + DFG A L +
Sbjct: 163 LEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 37/165 (22%), Positives = 66/165 (40%), Gaps = 13/165 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKN 231
+S IG GG V++ A+K L Q +R E+ + ++ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 232 L--VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+RL Y I +V E N +L WL+ + + R +A+
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 123
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334
+H+ +VH D+K +N LI + K+ DFG+A + + +
Sbjct: 124 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV 164
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 43/165 (26%), Positives = 68/165 (41%), Gaps = 13/165 (7%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRV----EVEAIGHVRHKNLVRLL 236
+G GG G VY + + VA+K L++ +D FR E G ++ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
+ Q + +N +L LR +G L + I+ AL H A
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHAA--- 153
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
HRD+K NIL+ + A + DFG+A K +GT
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGT 198
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 38/168 (22%), Positives = 69/168 (41%), Gaps = 23/168 (13%)
Query: 182 IGDGGYGVVYRG--QLMNGTAVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLLGY 238
I GG G +Y + +NG V +K L+++ + E + + V H ++V++ +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 239 CIEGTQRI-----LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
+ +V EYV +L++ L + LL AL+YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLHSI 201
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+V+ D+K NI++ E K+ D G + + + GT
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGT 240
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 54/179 (30%), Positives = 80/179 (44%), Gaps = 23/179 (12%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
+ ++G G YG+VY G L N +A+K++ + + E+ H++HKN
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLR--------GDMCDRGYLTWEARMKILLGT 283
+V+ LG E + E V G+L LR + Y +IL G
Sbjct: 81 IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEG- 134
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
L YLH+ ++VHRDIK N+LI+ + KISDFG +K L T GT
Sbjct: 135 ---LKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGT 186
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 37/165 (22%), Positives = 66/165 (40%), Gaps = 13/165 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKN 231
+S IG GG V++ A+K L Q +R E+ + ++ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 232 L--VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+RL Y I +V E N +L WL+ + + R +A+
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 142
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334
+H+ +VH D+K +N LI + K+ DFG+A + + +
Sbjct: 143 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV 183
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 47/173 (27%), Positives = 73/173 (42%), Gaps = 24/173 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQADK-DFRVEVEAIGH 226
+R +G G +G V VAVK L ++ E++ + H
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 227 V-RHKNLVRLLGYC-IEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGYLT 272
+ H N+V LLG C G +++ E+ GNL +LR + + +LT
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 273 WEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
E + AK + +L K +HRD+ + NIL+ E KI DFGLA+
Sbjct: 147 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 46/174 (26%), Positives = 83/174 (47%), Gaps = 25/174 (14%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQADK-DFRVEVEAI 224
++ + +G+G +G V + + VAVK L ++ + D D E+E +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 225 GHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGYL 271
+ +HKN++ LLG C + ++ EY + GNL ++LR + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 272 TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
T++ + A+ + YL K +HRD+ + N+L+ EN KI+DFGLA+
Sbjct: 201 TFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 51/182 (28%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRV-EVEAIG 225
+ + ++ +IG+G +GVV++ +L+ VA+KK+L DK F+ E++ +
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMR 87
Query: 226 HVRHKNLVRLLGYCIEGTQRI------LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKI 279
V+H N+V L + + LV EYV + + R + +
Sbjct: 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLY 146
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA-KISDFGLAKLLGAGK---SHIT 335
+ ++LAY+H + HRDIK N+L+D K+ DFG AK+L AG+ S+I
Sbjct: 147 MYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203
Query: 336 TR 337
+R
Sbjct: 204 SR 205
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 51/189 (26%), Positives = 92/189 (48%), Gaps = 23/189 (12%)
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRV----EV 221
D++S R+ K + +G+G + VY+ + VA+KK+ L + +A E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 222 EAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL 281
+ + + H N++ LL + LV+++ +E L + D + + +K +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAYM 118
Query: 282 G-TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
T + L YLH+ ++HRD+K +N+L+DEN K++DFGLAK G+ T +V
Sbjct: 119 LMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-- 173
Query: 341 TFGDFSVTL 349
VT
Sbjct: 174 ------VTR 176
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-25
Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 17/167 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL----LNNPGQADKDFRVEVEAIGHVR 228
F +G G +G VY + + +A+K L L G + R EVE H+R
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 229 HKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMKILLGTAKA 286
H N++RL GY R+ L+ EY G + + L+ + A A
Sbjct: 68 HPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTA-TYITELANA 121
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333
L+Y H +V+HRDIK N+L+ + KI+DFG + + +
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 165
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 13/181 (7%)
Query: 165 TLRDLQSATN---RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVE 220
LR + S + ++++ IG G G VY + G VA++++ + E
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 221 VEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKIL 280
+ + ++ N+V L + G + +V EY+ G+L D+ + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVC 122
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
+AL +LH +V+HRDIKS NIL+ + K++DFG + +S +T V G
Sbjct: 123 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-G 178
Query: 341 T 341
T
Sbjct: 179 T 179
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 43/183 (23%), Positives = 69/183 (37%), Gaps = 26/183 (14%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADK-DFRVEVEAIGHV-R 228
T F + IG G +G V++ ++G A+K+ G D+ + EV A + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H ++VR E ++ EY N G+L + + Y +LL + L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 289 YLHEAIEPKVVHRDIKSSNILIDEN-------------------FDAKISDFGLAKLLGA 329
Y+H +VH DIK SNI I KI D G + +
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 330 GKS 332
+
Sbjct: 187 PQV 189
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 22/181 (12%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRV----EVEAIGHVR 228
++ ++G+G YG+V + + G VA+KK L DK + E++ + +R
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE--SDDDKMVKKIAMREIKLLKQLR 82
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H+NLV LL C + + LV+E+V++ + L ++ G + K L +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQ-KYLFQIINGIG 138
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVT 348
+ H ++HRDIK NIL+ ++ K+ DFG A+ L A V T
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--------AT 187
Query: 349 L 349
Sbjct: 188 R 188
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 41/187 (21%), Positives = 74/187 (39%), Gaps = 23/187 (12%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
+ F + ++G G +G V + + ++ A+KK+ + + EV + + H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLNHQY 63
Query: 232 LVRLLGYCIEGTQRI-------------LVYEYVNNGNLEQWLRGDMCDRGYLTWEAR-M 277
+VR +E + + EY NG L +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH----SENLNQQRDEYW 119
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
++ +AL+Y+H ++HRD+K NI IDE+ + KI DFGLAK + +
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 338 VMGTFGD 344
G
Sbjct: 177 SQNLPGS 183
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 48/181 (26%), Positives = 77/181 (42%), Gaps = 13/181 (7%)
Query: 165 TLRDLQSATN---RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVE 220
LR + + IG+G G+V + +G VAVK + Q + E
Sbjct: 33 ALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNE 92
Query: 221 VEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKIL 280
V + +H N+V + + G + ++ E++ G L D+ + L E +
Sbjct: 93 VVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT-----DIVSQVRLNEEQIATVC 147
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
+ALAYLH V+HRDIKS +IL+ + K+SDFG + + V G
Sbjct: 148 EAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-G 203
Query: 341 T 341
T
Sbjct: 204 T 204
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 20/180 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRH 229
++ K IG+G YGVV++ + G VA+KK L +P R E+ + ++H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKH 61
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
NLV LL + LV+EY ++ + L D RG + I T +A+ +
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVK-SITWQTLQAVNF 117
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTL 349
H+ +HRD+K NILI ++ K+ DFG A+LL + V T
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV--------ATR 166
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 43/181 (23%), Positives = 80/181 (44%), Gaps = 17/181 (9%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR 228
+ +RF + + G G +G V G+ G +VA+KK++ +P +++ + ++ + +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLH 77
Query: 229 HKNLVRLLGYCIEGTQR--------ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKIL 280
H N+V+L +V EYV + L + R + L
Sbjct: 78 HPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGK---SHITT 336
+++ LH V HRDIK N+L++ + K+ DFG AK L + ++I +
Sbjct: 136 FQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS 194
Query: 337 R 337
R
Sbjct: 195 R 195
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 21/169 (12%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQADK-DFRVEVEAIGH 226
N +G G +G V VAVK L + +K E++ + H
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 227 V-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR----------GDMCDRGYLTWEA 275
+ +H+N+V LLG C G +++ EY G+L +LR +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 276 RMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
+ A+ +A+L +HRD+ + N+L+ AKI DFGLA
Sbjct: 166 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 30/177 (16%)
Query: 176 FSKDNI-----IGDGGYGVVYRGQLMN--------GTAVAVKKLLNNPGQADK-DFRVEV 221
+D + +G+G +G V + + T VAVK L ++ + D D E+
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125
Query: 222 EAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDR 268
E + + +HKN++ LLG C + ++ EY + GNL ++L+
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 269 GYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
L+ + + A+ + YL K +HRD+ + N+L+ E+ KI+DFGLA+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 37/165 (22%), Positives = 66/165 (40%), Gaps = 13/165 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKN 231
+S IG GG V++ A+K L Q +R E+ + ++ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 232 L--VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+RL Y I +V E N +L WL+ + + R +A+
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 170
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334
+H+ +VH D+K +N LI + K+ DFG+A + + +
Sbjct: 171 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV 211
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 2e-24
Identities = 30/200 (15%), Positives = 55/200 (27%), Gaps = 36/200 (18%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK---KLLNNPGQADKDFRVEVEAIGHVRH- 229
+ ++G G + V P A K + EV + +R
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 230 ---------------KNLVRLLGYC-----IEGTQRILVYEYV--------NNGNLEQWL 261
+LV+ + + V N + L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 262 RGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321
L AR+++ L + LA LH +VH ++ +I++D+ ++ F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 322 GLAKLLGAGKSHITTRVMGT 341
GA R
Sbjct: 256 EHLVRDGASAVSPIGRGFAP 275
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 47/173 (27%), Positives = 70/173 (40%), Gaps = 25/173 (14%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQADK-DFRVEVEAIGH 226
NR S +G G +G V VAVK L + ++ E++ + +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 227 V-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR--------------GDMCDRGYL 271
+ H N+V LLG C G +++ EY G+L +LR D L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 272 TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
E + AK +A+L +HRD+ + NIL+ KI DFGLA
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 56/193 (29%), Positives = 81/193 (41%), Gaps = 28/193 (14%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-R 228
QS N + I+G G G V G VAVK++L +E++ +
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDD 67
Query: 229 HKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWL--RGDMCDRGYLTWEARMK-ILLGT 283
H N++R YC E T R + E N NL+ + + + L E +L
Sbjct: 68 HPNVIRY--YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILID-------------ENFDAKISDFGLAKLLGAG 330
A +A+LH K++HRD+K NIL+ EN ISDFGL K L +G
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 331 KSHITTRVMGTFG 343
+S T + G
Sbjct: 182 QSSFRTNLNNPSG 194
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 22/200 (11%), Positives = 43/200 (21%), Gaps = 35/200 (17%)
Query: 169 LQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLL---NNPGQADKDFRVEVEAI 224
L + + G VV+ + A+K N + A
Sbjct: 57 LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA 116
Query: 225 GHVRHKNLVRLLGYC----------IEGTQRI----------------LVYEYV--NNGN 256
+ ++ ++ L+ +
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLEL 176
Query: 257 LEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316
L L RG A + + A L +VH N+ I +
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRL 233
Query: 317 KISDFGLAKLLGAGKSHITT 336
+ D +G +
Sbjct: 234 MLGDVSALWKVGTRGPASSV 253
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-24
Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 11/169 (6%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNL 232
F+K IG G +G V++G VA+K + + + D + E+ + +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
+ G ++ T+ ++ EY+ G+ D+ + G L IL K L YLH
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHS 137
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
K +HRDIK++N+L+ E+ + K++DFG+A L + T +GT
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGT 182
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-24
Identities = 44/178 (24%), Positives = 69/178 (38%), Gaps = 30/178 (16%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADK-DFRVEVEAIGH 226
++G G +G V VAVK L +++ E++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 227 V-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR-------------------GDMC 266
+ H+N+V LLG C L++EY G+L +LR +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 267 DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
D LT+E + AK + +L VHRD+ + N+L+ KI DFGLA
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-24
Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKL----LNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+G G +G VY + N +A+K L L G + R E+E H+RH N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR-EIEIQSHLRHPNILRMY 80
Query: 237 GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMKILLGTAKALAYLHEAI 294
Y +RI L+ E+ G L + L+ G + + A AL Y HE
Sbjct: 81 NY-FHDRKRIYLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEE-LADALHYCHER- 133
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333
KV+HRDIK N+L+ + KI+DFG + + +
Sbjct: 134 --KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 47/181 (25%), Positives = 76/181 (41%), Gaps = 16/181 (8%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL--LNNPGQADKDFRVEVEAIGH 226
++ + + +I+G G V+RG+ G A+K ++ D R E E +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKK 63
Query: 227 VRHKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
+ HKN+V+L E T R +L+ E+ G+L L G E +L
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVV 122
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDA----KISDFGLAKLLGAGKSHITTRVMG 340
+ +L E +VHR+IK NI+ D K++DFG A+ L + G
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-G 177
Query: 341 T 341
T
Sbjct: 178 T 178
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 2e-23
Identities = 47/181 (25%), Positives = 76/181 (41%), Gaps = 16/181 (8%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL--LNNPGQADKDFRVEVEAIGH 226
++ + + +I+G G V+RG+ G A+K ++ D R E E +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKK 63
Query: 227 VRHKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
+ HKN+V+L E T R +L+ E+ G+L L G E +L
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVV 122
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDA----KISDFGLAKLLGAGKSHITTRVMG 340
+ +L E +VHR+IK NI+ D K++DFG A+ L + G
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-G 177
Query: 341 T 341
T
Sbjct: 178 T 178
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-23
Identities = 38/170 (22%), Positives = 75/170 (44%), Gaps = 8/170 (4%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
+ +GDG +G VY+ + G A K + + +D+ VE+E + H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+LLG + ++ E+ G ++ + LT + +AL +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLH 134
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+++HRD+K+ N+L+ D +++DFG++ + +GT
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGT 180
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 4e-23
Identities = 54/183 (29%), Positives = 87/183 (47%), Gaps = 25/183 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNN-----PGQADKDFRVEVEAIGH 226
F K IG+G YGVVY+ + + G VA+KK+ L+ P A R E+ +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA---IR-EISLLKE 58
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+ H N+V+LL + LV+E+++ +L++++ D + L +
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQG 115
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFS 346
LA+ H +V+HRD+K N+LI+ K++DFGLA+ G T V
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-------- 164
Query: 347 VTL 349
VTL
Sbjct: 165 VTL 167
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-23
Identities = 52/188 (27%), Positives = 90/188 (47%), Gaps = 29/188 (15%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKL-LNN-----PGQADKDFRVEVEA 223
Q ++ K +G+G YGVVY+ + G VA+K++ L+ P A R E+
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA---IR-EISL 72
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR--MKILL 281
+ + H N+V L+ LV+E++ +L++ L D G + + + LL
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLL 129
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+ +A+ H+ +++HRD+K N+LI+ + K++DFGLA+ G T V
Sbjct: 130 ---RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV--- 180
Query: 342 FGDFSVTL 349
VTL
Sbjct: 181 -----VTL 183
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-23
Identities = 43/170 (25%), Positives = 83/170 (48%), Gaps = 11/170 (6%)
Query: 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIG 225
+ ++ R ++ +GG+ VY Q + +G A+K+LL+N + ++ EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 226 HVR-HKNLVRLLGYCIEGTQR-------ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM 277
+ H N+V+ G + L+ + G L ++L+ M RG L+ + +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVL 139
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
KI T +A+ ++H +P ++HRD+K N+L+ K+ DFG A +
Sbjct: 140 KIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-23
Identities = 49/167 (29%), Positives = 71/167 (42%), Gaps = 15/167 (8%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHV-RH 229
F + + +G G YG V++ + +G AVK+ +P + KD EV + V +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS-MSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR-MKILLGTAKALA 288
VRL EG L E +L+Q G EA+ L T ALA
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE----AWGASLPEAQVWGYLRDTLLALA 171
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335
+LH +VH D+K +NI + K+ DFGL LG +
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV 215
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-23
Identities = 42/175 (24%), Positives = 74/175 (42%), Gaps = 9/175 (5%)
Query: 174 NRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKN 231
+ + +IG G VV VA+K++ Q + E++A+ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNL----EQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
+V + + LV + ++ G++ + + G L IL + L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
YLH+ +HRD+K+ NIL+ E+ +I+DFG++ L G +V TF
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 8e-23
Identities = 46/178 (25%), Positives = 74/178 (41%), Gaps = 20/178 (11%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLV 233
F +++G G G + + + VAVK++L + EV+ + H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-ILLGTAKALAYLHE 292
R + + + E L+++ + + + +L T LA+LH
Sbjct: 82 RYFCTEKDRQFQYIAIELC-AATLQEY----VEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 293 AIEPKVVHRDIKSSNILIDENFD-----AKISDFGLAKLLGAGKSHITTR--VMGTFG 343
+VHRD+K NILI A ISDFGL K L G+ + R V GT G
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-22
Identities = 51/191 (26%), Positives = 90/191 (47%), Gaps = 32/191 (16%)
Query: 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNN----PGQADKDFRVEVEAI 224
S++++F + +G+G Y VY+G G VA+K++ L++ P A R E+ +
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA---IR-EISLM 57
Query: 225 GHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM------K 278
++H+N+VRL + LV+E+ ++ L+ M R +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEF-----MDNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
+ LA+ HE K++HRD+K N+LI++ K+ DFGLA+ G + ++ V
Sbjct: 113 FQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 339 MGTFGDFSVTL 349
VTL
Sbjct: 170 --------VTL 172
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 47/184 (25%), Positives = 85/184 (46%), Gaps = 15/184 (8%)
Query: 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAI 224
L L+ F ++G+G YG VY+G+ + G A+K + + G +++ + E+ +
Sbjct: 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINML 74
Query: 225 GHV-RHKNLVRLLG-YCIEGTQRI-----LVYEYVNNGNLEQWLRGDMCDRGYLTWEARM 277
H+N+ G + + + LV E+ G++ ++ L E
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIA 132
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
I + L++LH+ KV+HRDIK N+L+ EN + K+ DFG++ L T
Sbjct: 133 YICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT- 188
Query: 338 VMGT 341
+GT
Sbjct: 189 FIGT 192
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-22
Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 10/170 (5%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
F +G+G YG VY+ G VA+K++ ++ E+ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+ G + T +V EY G++ +R LT + IL T K L YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+ +HRDIK+ NIL++ AK++DFG+A L + T + GT
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GT 188
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 46/230 (20%), Positives = 83/230 (36%), Gaps = 53/230 (23%)
Query: 139 SSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQ-LMN 197
H T + G S ++ +R+ + +G+G YG VY+ +
Sbjct: 6 HHHMGTLEAQTQGPGSMSVSAAPS-------ATSIDRYRRITKLGEGTYGEVYKAIDTVT 58
Query: 198 GTAVAVKKLLNNPGQADKDFRVEVEAIG-------------HVRHKNLVRLLGYCIEGTQ 244
VA+K++ R+E E G ++H+N++ L +
Sbjct: 59 NETVAIKRI-----------RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107
Query: 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK 304
L++EY E L+ M ++ L + + H + +HRD+K
Sbjct: 108 LHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLK 159
Query: 305 SSNILIDENFDA-----KISDFGLAKLLGAGKSHITTRVMGTFGDFSVTL 349
N+L+ + + KI DFGLA+ G T + +TL
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI--------ITL 201
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 34/176 (19%), Positives = 73/176 (41%), Gaps = 30/176 (17%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKL------------------LNNPGQADKDFRVEVEA 223
+ G + + + + A+KK ++ + D E++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKN-ELQI 96
Query: 224 IGHVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWL----RGDMCDRGYLT-WEARM 277
I ++++ + G I + ++YEY+ N ++ ++ D ++ +
Sbjct: 97 ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK- 154
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333
I+ + +Y+H E + HRD+K SNIL+D+N K+SDFG ++ + K
Sbjct: 155 CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 3e-22
Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 28/184 (15%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNN-----PGQADKDFRVEVEAIGH 226
++ K IG+G YG V++ + VA+K++ L++ P A R E+ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LR-EICLLKE 57
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAK 285
++HKN+VRL + LV+E+ +Q L+ +K L K
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDF 345
L + H V+HRD+K N+LI+ N + K+++FGLA+ G + V
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV------- 162
Query: 346 SVTL 349
VTL
Sbjct: 163 -VTL 165
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 52/226 (23%), Positives = 87/226 (38%), Gaps = 25/226 (11%)
Query: 129 GNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYG 188
P L S + ++ ++IG G
Sbjct: 49 SQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSS 108
Query: 189 VVYRG-QLMNGTAVAVK-----KLLNNPGQADK---DFRVEVEAIGHVR-HKNLVRLLGY 238
VV R G AVK +P Q ++ R E + V H +++ L+
Sbjct: 109 VVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALAYLHEAIE 295
+ LV++ + G L +L ++ L+ E R M+ LL +A+++LH
Sbjct: 169 YESSSFMFLVFDLMRKGELFDYL----TEKVALSEKETRSIMRSLL---EAVSFLHAN-- 219
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+VHRD+K NIL+D+N ++SDFG + L G+ + GT
Sbjct: 220 -NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GT 262
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-22
Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 27/183 (14%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKL-LNN----PGQADKDFRVEVEAIGHV 227
+ K + +G+G Y VY+G+ VA+K++ L + P A R EV + +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA---IR-EVSLLKDL 57
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKA 286
+H N+V L LV+EY L++ L+ + D G + +K+ L +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRG 112
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFS 346
LAY H KV+HRD+K N+LI+E + K++DFGLA+ V
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV-------- 161
Query: 347 VTL 349
VTL
Sbjct: 162 VTL 164
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.3 bits (233), Expect = 5e-22
Identities = 55/184 (29%), Positives = 92/184 (50%), Gaps = 29/184 (15%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKL-LNN-----PGQADKDFRVEVEAIGHV 227
++ IG+G YGVVY+ Q G A+KK+ L P R E+ + +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT---IR-EISILKEL 57
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR--MKILLGTAK 285
+H N+V+L + +LV+E+++ +L++ L D+C+ G + A+ + LL
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLL---N 111
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDF 345
+AY H+ +V+HRD+K N+LI+ + KI+DFGLA+ G T +
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI------- 161
Query: 346 SVTL 349
VTL
Sbjct: 162 -VTL 164
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-22
Identities = 41/187 (21%), Positives = 75/187 (40%), Gaps = 28/187 (14%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQADKD---FRVE 220
++ + + +G G G V + VA+K K + E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 221 VEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--M 277
+E + + H ++++ + + +V E + G L + L +
Sbjct: 66 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYF 120
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHI 334
+L A+ YLHE ++HRD+K N+L+ +E+ KI+DFG +K+LG S +
Sbjct: 121 YQMLL---AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLM 173
Query: 335 TTRVMGT 341
T GT
Sbjct: 174 RTLC-GT 179
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 8e-22
Identities = 40/184 (21%), Positives = 73/184 (39%), Gaps = 28/184 (15%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQADKD---FRVEVEA 223
+ + +G G G V + VA++ K + E+E
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKIL 280
+ + H ++++ + + +V E + G L + L + +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQM 248
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTR 337
L A+ YLHE ++HRD+K N+L+ +E+ KI+DFG +K+LG S + T
Sbjct: 249 L---LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTL 301
Query: 338 VMGT 341
GT
Sbjct: 302 C-GT 304
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 8e-22
Identities = 52/199 (26%), Positives = 82/199 (41%), Gaps = 24/199 (12%)
Query: 138 PSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATN---RFSKDNIIGDGGYGVVYRGQ 194
P++ L + +P G + +L + FS IG G +G VY +
Sbjct: 15 PTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFAR 74
Query: 195 -LMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250
+ N VA+KK+ + Q++ +D EV + +RH N ++ G + LV E
Sbjct: 75 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134
Query: 251 YVNNGNLEQWLRGDMCD-----RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKS 305
Y G D + L + G + LAYLH ++HRD+K+
Sbjct: 135 Y---------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKA 182
Query: 306 SNILIDENFDAKISDFGLA 324
NIL+ E K+ DFG A
Sbjct: 183 GNILLSEPGLVKLGDFGSA 201
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 48/179 (26%), Positives = 73/179 (40%), Gaps = 19/179 (10%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKN 231
+ +G GG+G V R G VA+K + +P ++ E++ + + H N
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPN 73
Query: 232 LVRLL------GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
+V +L EY G+L ++L G R +L +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISS 132
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDA---KISDFGLAKLLGAGKSHITTRVMGT 341
AL YLHE +++HRD+K NI++ KI D G AK L G T V GT
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GT 186
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-21
Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 20/178 (11%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
F ++G G + V+ Q + G A+K + +P D E+ + ++H+N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALA 288
+V L T LV + V+ G L + +RG T +A ++ +L A+
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRI----LERGVYTEKDASLVIQQVLS---AVK 120
Query: 289 YLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
YLHE +VHRD+K N+L +EN I+DFGL+K+ G ++T GT G
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPG 172
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 52/211 (24%), Positives = 84/211 (39%), Gaps = 35/211 (16%)
Query: 151 GLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK----- 204
G P S G G D + + +IG G + VV R G AVK
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 205 KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGD 264
K ++PG + +D + E ++H ++V LL +V+E+++ +L
Sbjct: 61 KFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL------- 113
Query: 265 MCDR---------GYLTWEAR--MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI--- 310
C Y A M+ +L +AL Y H+ ++HRD+K +L+
Sbjct: 114 -CFEIVKRADAGFVYSEAVASHYMRQIL---EALRYCHDN---NIIHRDVKPHCVLLASK 166
Query: 311 DENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+ + K+ FG+A LG RV GT
Sbjct: 167 ENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-21
Identities = 45/183 (24%), Positives = 78/183 (42%), Gaps = 26/183 (14%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQADK-DFRVEVEAIG 225
+ + +G G + +V + Q G A K +L ++ + + EV +
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 226 HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLG 282
+RH N++ L T +L+ E V+ G L +L ++ LT EA +K +L
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILD 119
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLAKLLGAGKSHITTRV 338
+ YLH ++ H D+K NI++ N K+ DFG+A + AG +
Sbjct: 120 ---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--I 171
Query: 339 MGT 341
GT
Sbjct: 172 FGT 174
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 28/229 (12%)
Query: 122 SQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNI 181
S + G S AP S +P++ G + + ++ F ++
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDG-------SNRDALSDFFEVESE 60
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
+G G +VYR Q A+K L K R E+ + + H N+++L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALAYLHEAIEPK 297
T+ LV E V G L + ++GY + +A +K +L A+AYLHE
Sbjct: 119 TPTEISLVLELVTGGELFDRI----VEKGYYSERDAADAVKQILE---AVAYLHEN---G 168
Query: 298 VVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+VHRD+K N+L + KI+DFGL+K++ + T GT G
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVC-GTPG 215
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-21
Identities = 47/183 (25%), Positives = 80/183 (43%), Gaps = 26/183 (14%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQADKDFRV----EVE 222
+ I+G G VV R AVK + + ++ R EV+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 223 AIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MK 278
+ V H N+++L T LV++ + G L +L ++ L+ E R M+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMR 131
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
LL + + LH+ +VHRD+K NIL+D++ + K++DFG + L G+ +
Sbjct: 132 ALL---EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC 184
Query: 339 MGT 341
GT
Sbjct: 185 -GT 186
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 31/200 (15%), Positives = 58/200 (29%), Gaps = 36/200 (18%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK---KLLNNPGQADKDFRVEVEAIGHVR-- 228
+ ++G G + V P A K + EV + +R
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 229 -----------------------HKNLVRLLGYC--IEGTQRILVYE--YVNNGNLEQWL 261
K ++R+ + R +Y N + L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 262 RGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321
L AR+++ L + LA LH +VH ++ +I++D+ ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 322 GLAKLLGAGKSHITTRVMGT 341
GA +R
Sbjct: 251 EHLVRDGARVVSSVSRGFEP 270
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-21
Identities = 50/196 (25%), Positives = 92/196 (46%), Gaps = 40/196 (20%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKD-FRV----EVEAIGH 226
+++ K IG G +G V++ + G VA+KK+ + N +K+ F + E++ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN----EKEGFPITALREIKILQL 72
Query: 227 VRHKNLVRLLGYCIEGTQRI--------LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK 278
++H+N+V L+ C LV+++ E L G + + + +K
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNVLVKFTLSEIK 127
Query: 279 -ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI--- 334
++ L Y+H K++HRD+K++N+LI + K++DFGLA+ K+
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 335 -TTRVMGTFGDFSVTL 349
T RV VTL
Sbjct: 185 YTNRV--------VTL 192
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-21
Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 28/210 (13%)
Query: 134 STFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRG 193
S+ H S + + L ++ + +++ ++G GG+G VY G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 194 Q-LMNGTAVAVKKL----LNNPGQADKDFRV--EVEAIGHVRHK--NLVRLLGYCIEGTQ 244
+ + VA+K + +++ G+ RV EV + V ++RLL + E
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPD 121
Query: 245 RI-LVYEYVNNGNLEQWLRGDMCD----RGYLT-WEARMKILLGTAKALAYLHEAIEPKV 298
L+ E D+ D RG L AR +A+ + H V
Sbjct: 122 SFVLILERPEPV-------QDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC---GV 170
Query: 299 VHRDIKSSNILIDEN-FDAKISDFGLAKLL 327
+HRDIK NILID N + K+ DFG LL
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFGSGALL 200
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-21
Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 28/188 (14%)
Query: 167 RDLQSATNRFSKD----NIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEV 221
+ L + +F+ IG G Y V R AVK + + +D E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEI 66
Query: 222 EAIGH-VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--M 277
E + +H N++ L +G +V E + G L + + + + EA +
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI----LRQKFFSEREASAVL 122
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNIL-IDENFDA---KISDFGLAKLLGAGKSH 333
+ K + YLH VVHRD+K SNIL +DE+ + +I DFG AK L A
Sbjct: 123 FTIT---KTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 334 ITTRVMGT 341
+ T T
Sbjct: 177 LMTPC-YT 183
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-21
Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 23/163 (14%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK-----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G+G YG V AVK KL P + E++ + +RHKN+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQL 71
Query: 236 LG-YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMK---ILLGTAKALAY 289
+ E Q++ +V EY G E D +A ++ G L Y
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQLIDG----LEY 124
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332
LH +VH+DIK N+L+ KIS G+A+ L +
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 8e-21
Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 24/174 (13%)
Query: 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRVEVEAI---- 224
AT+R+ IG G YG VY+ + +G VA+K + + N + + +
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN--GGGGGGGLPISTVREVA 63
Query: 225 -----GHVRHKNLVRLL----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWE 274
H N+VRL+ + ++ LV+E+V+ +L +L D L E
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAE 120
Query: 275 ARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
++ + L +LH +VHRD+K NIL+ K++DFGLA++
Sbjct: 121 TIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 9e-21
Identities = 41/188 (21%), Positives = 75/188 (39%), Gaps = 21/188 (11%)
Query: 163 WFTLRDLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLL--NNPGQADKDFRV 219
F + + + +G G YG V + A+K + + ++
Sbjct: 26 MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 220 EVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR-- 276
EV + + H N+++L + + LV E G L ++ R +A
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD----EIIHRMKFNEVDAAVI 141
Query: 277 MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSH 333
+K +L + YLH+ +VHRD+K N+L+ +++ KI DFGL+ + K
Sbjct: 142 IKQVLS---GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195
Query: 334 ITTRVMGT 341
+GT
Sbjct: 196 --KERLGT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-21
Identities = 42/175 (24%), Positives = 70/175 (40%), Gaps = 26/175 (14%)
Query: 181 IIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQADK-DFRVEVEAIGHVRHKNLV 233
+G G + +V + + G A K + + + + EV + V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALAYL 290
L T +L+ E V+ G L +L + L+ EA +K +L + YL
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILD---GVNYL 131
Query: 291 HEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
H K+ H D+K NI++ K+ DFGLA + G + GT
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGT 181
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 37/180 (20%), Positives = 64/180 (35%), Gaps = 12/180 (6%)
Query: 173 TNRFSKDNIIGDG--GYGVVYRGQ-LMNGTAVAVKK--LLNNPGQADKDFRVEVEAIGHV 227
+ +IG G V + G V V++ L + + E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
H N+V I + +V ++ G+ + + D + A IL G KAL
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG--MNELAIAYILQGVLKAL 141
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSV 347
Y+H VHR +K+S+ILI + +S + + + F +SV
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV--VHDFPKYSV 196
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 42/180 (23%), Positives = 78/180 (43%), Gaps = 25/180 (13%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK----KLLNNPGQADKDFRVEVEAIGHV 227
++ + +G G + VV R G A K K L+ + + E +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--ARDFQKLEREARICRKL 62
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTA 284
+H N+VRL E + LV++ V G L + + R + + +A ++ +L
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQIL--- 115
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+++AY H +VHR++K N+L+ + K++DFGLA + ++ GT
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GT 170
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 40/150 (26%), Positives = 74/150 (49%), Gaps = 7/150 (4%)
Query: 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGH-VRHKNLVRLLGY 238
IG G YG V + +G +AVK++ + + + K ++++ + +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM-KILLGTAKALAYLHEAIEPK 297
+ E ++ + +++ + + E + KI L T KAL +L E K
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLK 146
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLL 327
++HRDIK SNIL+D + + K+ DFG++ L
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 42/175 (24%), Positives = 76/175 (43%), Gaps = 20/175 (11%)
Query: 178 KDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRL 235
+++++G+G + V L+ AVK + PG EVE + + H+N++ L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALAYLHE 292
+ + E + LV+E + G++ + R + EA ++ + AL +LH
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILS----HIHKRRHFNELEASVVVQDVA---SALDFLHN 129
Query: 293 AIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSH--ITTRVMGTF 342
+ HRD+K NIL ++ KI DF L + I+T + T
Sbjct: 130 ---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 40/181 (22%)
Query: 171 SATNRFSKDNIIGDGGYGVVYRGQ--LMNGTAVAVKKLLNNPGQADKDFRVEVEAIG--- 225
A ++ IG+G YG V++ + G VA+K++ RV+ G
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-----------RVQTGEEGMPL 56
Query: 226 -------------HVRHKNLVRLL----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCD 267
H N+VRL + ++ LV+E+V+ +L +L D
Sbjct: 57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVP 113
Query: 268 RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ E ++ + L +LH +VVHRD+K NIL+ + K++DFGLA++
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 328 G 328
Sbjct: 171 S 171
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 42/183 (22%), Positives = 72/183 (39%), Gaps = 26/183 (14%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQADK-DFRVEVEAIG 225
+ + +G G + +V + + G A K + + + + EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 226 HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLG 282
V H N++ L T +L+ E V+ G L +L + L+ EA +K +L
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILD 126
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLAKLLGAGKSHITTRV 338
+ YLH K+ H D+K NI++ K+ DFGLA + G +
Sbjct: 127 ---GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--I 178
Query: 339 MGT 341
GT
Sbjct: 179 FGT 181
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 41/178 (23%), Positives = 76/178 (42%), Gaps = 21/178 (11%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRH 229
R++ ++G G +G V + + AVK + + + EVE + + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKA 286
N+++L + + +V E G L + R + +A +K +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDE----IIKRKRFSEHDAARIIKQVFS---G 133
Query: 287 LAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+ Y+H+ +VHRD+K NIL+ +++ D KI DFGL+ + R+ GT
Sbjct: 134 ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GT 186
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 53/267 (19%), Positives = 103/267 (38%), Gaps = 29/267 (10%)
Query: 84 HNEKFNDRESEKELIPQENGDDSVQSGSFNNLEKDVVGSQLGEEGGNGKVSTFRPSSHPL 143
H+ + + E + ++ +S S + + + V + R S+ +
Sbjct: 5 HHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAV 64
Query: 144 TAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFS--KDNIIGDGGYGVVYRG-QLMNGTA 200
P+P + H + + ++ K I+G G +G V++ + G
Sbjct: 65 DIPAPPAPFD--------HRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLK 116
Query: 201 VAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQW 260
+A K + + ++ + E+ + + H NL++L +LV EYV+ G L
Sbjct: 117 LAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR 176
Query: 261 LRGDMCDRGY-LT-WEAR--MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI--DENF 314
+ D Y LT + MK + + ++H+ ++H D+K NIL +
Sbjct: 177 I----IDESYNLTELDTILFMKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAK 226
Query: 315 DAKISDFGLAKLLGAGKSHITTRVMGT 341
KI DFGLA+ + GT
Sbjct: 227 QIKIIDFGLARRYKPREKLKV--NFGT 251
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 41/180 (22%), Positives = 75/180 (41%), Gaps = 20/180 (11%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRH 229
T + +G G + VV R +++ G A + + + E ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKA 286
N+VRL E L+++ V G L + + R Y + +A ++ +L A
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDI----VAREYYSEADASHCIQQILE---A 122
Query: 287 LAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ + H+ VVHR++K N+L+ + K++DFGLA + + GT G
Sbjct: 123 VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPG 178
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-20
Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 16/177 (9%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHK 230
+ F +G G +G V+ + +G +K + + Q E+E + + H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKAL 287
N++++ + +V E G L + + L+ MK ++ AL
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN---AL 137
Query: 288 AYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
AY H VVH+D+K NIL + KI DFGLA+L + + H T GT
Sbjct: 138 AYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-HSTNAA-GT 189
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-20
Identities = 46/209 (22%), Positives = 85/209 (40%), Gaps = 28/209 (13%)
Query: 145 APSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAV 203
P + + +G G F + ++ + +G G + VV R G A
Sbjct: 1 GPHM-ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAA 59
Query: 204 K-----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLE 258
K KL + + E ++H N+VRL E + LV++ V G L
Sbjct: 60 KIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 116
Query: 259 QWLRGDMCDRGYLT-WEAR--MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DE 312
+ + R + + +A ++ +L +++AY H +VHR++K N+L+ +
Sbjct: 117 EDI----VAREFYSEADASHCIQQIL---ESIAYCHSN---GIVHRNLKPENLLLASKAK 166
Query: 313 NFDAKISDFGLAKLLGAGKSHITTRVMGT 341
K++DFGLA + ++ GT
Sbjct: 167 GAAVKLADFGLAIEVNDSEA-WHGFA-GT 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 7e-20
Identities = 45/183 (24%), Positives = 74/183 (40%), Gaps = 26/183 (14%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQADK-DFRVEVEAIG 225
+ + +G G + VV + + G A K + ++ + D EV +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 226 HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLG 282
++H N++ L T IL+ E V G L +L ++ LT EA +K +L
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILN 125
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLAKLLGAGKSHITTRV 338
+ YLH ++ H D+K NI++ KI DFGLA + G +
Sbjct: 126 ---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNI 177
Query: 339 MGT 341
GT
Sbjct: 178 FGT 180
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 9e-20
Identities = 43/213 (20%), Positives = 80/213 (37%), Gaps = 26/213 (12%)
Query: 121 GSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDN 180
+Q G VS + + + +R+ +
Sbjct: 8 AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPH--SDWQI------PDRYEIRH 59
Query: 181 IIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+IG G YG V + VA+KK+L + + R E+ + + H ++V++L
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVL 118
Query: 237 ----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+E + +V E + + YLT +L + Y+H
Sbjct: 119 DIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH 173
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
A ++HRD+K +N L++++ K+ DFGLA
Sbjct: 174 SA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-20
Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 24/160 (15%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK---KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLG 237
IG G + V + ++ G VA+K K NP K FR EV + + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL-- 79
Query: 238 Y-CIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMK---ILLGTAKALAYLH 291
+ IE + + L+ EY + G + +L G + EAR K I+ A+ Y H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVS----AVQYCH 131
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331
+ ++VHRD+K+ N+L+D + + KI+DFG + G
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 22/173 (12%)
Query: 177 SKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVR 234
KD +G+G + + + + A AVK + + + + E+ A+ H N+V+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK 70
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALAYLH 291
L + LV E +N G L + + + + + EA M+ L+ A++++H
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFE----RIKKKKHFSETEASYIMRKLV---SAVSHMH 123
Query: 292 EAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+ VVHRD+K N+L ++N + KI DFG A+L + T T
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FT 172
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-19
Identities = 49/176 (27%), Positives = 74/176 (42%), Gaps = 19/176 (10%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
++ +N IG G +G V A KK+ + F+ E+E + + H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALA 288
++RL + T LV E G L + + + +A MK +L A+A
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERV----VHKRVFRESDAARIMKDVL---SAVA 120
Query: 289 YLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
Y H+ V HRD+K N L + K+ DFGLA GK + T+V GT
Sbjct: 121 YCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GT 171
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 37/149 (24%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGH-VRHKNLVRLLGY 238
+G G YGVV + + + +G +AVK++ + K ++++ V V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
+ E ++ +L+++ + + + + KI + KAL +LH + V
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSV 131
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLL 327
+HRD+K SN+LI+ K+ DFG++ L
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYL 160
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 42/186 (22%), Positives = 76/186 (40%), Gaps = 16/186 (8%)
Query: 163 WFTLRDLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK---KLLNNPGQADKDFR 218
F ++R+ ++G G +G V + G AVK K +
Sbjct: 15 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 219 VEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK 278
EV+ + + H N+++L + + LV E G L ++ R + +
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFD----EIISRKRFSEVDAAR 130
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHIT 335
I+ + Y+H+ K+VHRD+K N+L+ ++ + +I DFGL+ A K
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-- 185
Query: 336 TRVMGT 341
+GT
Sbjct: 186 KDKIGT 191
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 41/178 (23%), Positives = 76/178 (42%), Gaps = 21/178 (11%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRH 229
R++ ++G G +G V + + AVK + + + EVE + + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKA 286
N+++L + + +V E G L + R + +A +K +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFS---G 133
Query: 287 LAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+ Y+H+ +VHRD+K NIL+ +++ D KI DFGL+ + R+ GT
Sbjct: 134 ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GT 186
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 25/160 (15%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK-----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G+G YG V + AVAVK + ++ P K E+ + H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF 70
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMK---ILLGTAKALAYLH 291
G+ EG + L EY + G L + + +A+ ++ + YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMA----GVVYLH 122
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331
+ HRDIK N+L+DE + KISDFGLA +
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 26/178 (14%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
+ +G G YG V +G VA+KKL + A + +R E+ + H++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQ 81
Query: 229 HKNLVRLL-----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDR--GYLTWEARMKIL 280
H+N++ LL + LV ++ +L++ + + YL ++ +L
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQ----ML 136
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH-ITTR 337
K L Y+H A VVHRD+K N+ ++E+ + KI DFGLA+ A + + TR
Sbjct: 137 ----KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 187
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 28/180 (15%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
R+ IG G G+V + VA+KKL N A + +R E+ + V
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82
Query: 229 HKNLVRLL-----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCD--RGYLTWEARMKIL 280
HKN++ LL +E Q + +V E ++ NL Q ++ ++ YL + ++L
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLY----QML 137
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS---HITTR 337
+ +LH A ++HRD+K SNI++ + KI DFGLA+ G ++ TR
Sbjct: 138 ----CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-19
Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 27/175 (15%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HK 230
+ + +G G Y V+ + N V VK L P + K R E++ + ++R
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--KPVKKKKIKR-EIKILENLRGGP 91
Query: 231 NLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLR----GDMCDRGYLTWEARMKILLGTA 284
N++ L + R LV+E+VNN + +Q + D+ + +E +L
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYE-----IL--- 140
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITTRV 338
KAL Y H ++HRD+K N++ID E+ ++ D+GLA+ G+ + RV
Sbjct: 141 KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV 191
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 41/169 (24%), Positives = 64/169 (37%), Gaps = 25/169 (14%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD--FRVEVEA------- 223
+ ++ I G YG V G G VA+K++ N
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 224 --IGHVRHKNLVRLLG----YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEAR 276
+ H H N++ L + ++ LV E + +L Q + R ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH---DQRIVIS-PQH 135
Query: 277 MKILL-GTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
++ + L LHEA VVHRD+ NIL+ +N D I DF LA
Sbjct: 136 IQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLA 181
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 25/160 (15%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK-----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G+G YG V + AVAVK + ++ P K E+ + H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF 70
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMK---ILLGTAKALAYLH 291
G+ EG + L EY + G L + + +A+ ++ + YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMA----GVVYLH 122
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331
+ HRDIK N+L+DE + KISDFGLA +
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 7e-19
Identities = 18/155 (11%), Positives = 43/155 (27%), Gaps = 13/155 (8%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRH 229
R+ G ++ VA+ + D + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+ R+L ++V E++ G+L++ + ++ + A A
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADA 144
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
H A V S + + + D ++
Sbjct: 145 AHRA---GVALSIDHPSRVRVSIDGDVVLAYPATM 176
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-19
Identities = 42/213 (19%), Positives = 87/213 (40%), Gaps = 53/213 (24%)
Query: 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHV 227
L++++ ++S +G G +G+V + +G A+KK+L +P R E++ + +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK---NR-ELDIMKVL 57
Query: 228 RHKNLVRLLGYCIEGTQRI--------------------------------------LVY 249
H N+++L+ Y ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILL-GTAKALAYLHEAIEPKVVHRDIKSSNI 308
EYV + L + L+ + + + I + +A+ ++H + HRDIK N+
Sbjct: 118 EYVPD-TLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172
Query: 309 LIDENFDA-KISDFGLAKLLGAGK---SHITTR 337
L++ + K+ DFG AK L + ++I +R
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR 205
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 44/199 (22%), Positives = 76/199 (38%), Gaps = 32/199 (16%)
Query: 163 WFTLRDLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQAD-- 214
+ + + K +G G YG V + + A+K + D
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 215 ------KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDR 268
++ E+ + + H N+++L + LV E+ G L + + +R
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI----INR 140
Query: 269 GYLT-WEAR--MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFG 322
+A MK +L + YLH+ +VHRDIK NIL+ + + KI DFG
Sbjct: 141 HKFDECDAANIMKQILS---GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 323 LAKLLGAGKSHITTRVMGT 341
L+ + R+ GT
Sbjct: 195 LSSFFSKDYK-LRDRL-GT 211
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 40/215 (18%), Positives = 84/215 (39%), Gaps = 13/215 (6%)
Query: 125 GEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSK----DN 180
G+E + + +S + + + ++ +
Sbjct: 104 GDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHE 163
Query: 181 IIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
+G G +GVV+R + G A K ++ + R E++ + +RH LV L
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ + +++YE+++ G L + + + ++ + ++ + K L ++HE V
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 277
Query: 300 HRDIKSSNILIDENFDA--KISDFGLAKLLGAGKS 332
H D+K NI+ K+ DFGL L +S
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 8e-19
Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 25/161 (15%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+G G +G V G+ + G VAVK + + + K R E++ + RH ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKL- 81
Query: 237 GY-CIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMK---ILLGTAKALAYL 290
Y I I +V EYV+ G L ++ C G L E+R IL + Y
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQIL----SGVDYC 132
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331
H VVHRD+K N+L+D + +AKI+DFGL+ ++ G+
Sbjct: 133 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 9e-19
Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 28/180 (15%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
R+ IG G G+V + VA+KKL N A + +R E+ + V
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 119
Query: 229 HKNLVRLL-----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCD--RGYLTWEARMKIL 280
HKN++ LL +E Q + LV E ++ NL Q ++ ++ YL + ++L
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLY----QML 174
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS---HITTR 337
+ +LH A ++HRD+K SNI++ + KI DFGLA+ G ++ TR
Sbjct: 175 ----CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 227
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-19
Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 25/161 (15%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+G G +G V G+ + G VAVK + + + K R E++ + RH ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKL- 76
Query: 237 GY-CIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMK---ILLGTAKALAYL 290
Y I +V EYV+ G L ++ C G + EAR IL A+ Y
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQIL----SAVDYC 127
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331
H VVHRD+K N+L+D + +AKI+DFGL+ ++ G+
Sbjct: 128 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 39/176 (22%), Positives = 66/176 (37%), Gaps = 19/176 (10%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
+ + +G G +GVV+R + G K + + E+ + + H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR----MKILLGTAKAL 287
L+ L + + +L+ E+++ G L + Y EA M+ L
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACE---GL 162
Query: 288 AYLHEAIEPKVVHRDIKSSNILI--DENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
++HE +VH DIK NI+ + KI DFGLA L + T
Sbjct: 163 KHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TTAT 213
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 45/165 (27%), Positives = 65/165 (39%), Gaps = 27/165 (16%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK-----KLLNNPGQADKDF---RVEVEAIGHVRHKNL 232
+G G +G V+ V VK K+L + D +E+ + V H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 233 VRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCD----RGYLT-WEARMKILLGTAKA 286
+++L E LV E +G D+ L A I A
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGSG-------LDLFAFIDRHPRLDEPLAS-YIFRQLVSA 142
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331
+ YL ++HRDIK NI+I E+F K+ DFG A L GK
Sbjct: 143 VGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLV 233
F K + +G G GVV++ +G +A K + A E++ + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
G + + E+++ G+L+Q L+ G + + K+ + K L YL E
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE- 149
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ K++HRD+K SNIL++ + K+ DFG++ L
Sbjct: 150 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 38/166 (22%), Positives = 75/166 (45%), Gaps = 28/166 (16%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
+ + ++IG G YG VY VA+KK+ + + R E+ + ++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLK 83
Query: 229 HKNLVRLLGYCIEGTQRI-----LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK----- 278
++RL I +V E ++ +L++ + + +LT E +K
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI----FLT-EEHIKTILYN 137
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
+L ++HE+ ++HRD+K +N L++++ K+ DFGLA
Sbjct: 138 LL----LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 41/211 (19%), Positives = 78/211 (36%), Gaps = 52/211 (24%)
Query: 167 RDLQSATNRFSKDNI-IGDGGYGVVYRGQ---LMNGTAVAVKKLLNNPGQADKDFRVEVE 222
+ + + F + +G G YG VY+ + + A+K++ + + +
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMS 64
Query: 223 AIGHV------RHKNLVRLLGYCIEGTQRI--LVYEYVNNGNLEQWLRGDM-CDRGYLTW 273
A + +H N++ L + R L+++Y E L + R
Sbjct: 65 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-----AEHDLWHIIKFHRASKAN 119
Query: 274 EARMKILLGTAK--------ALAYLHEAIEPKVVHRDIKSSNILIDENFDA----KISDF 321
+ +++ G K + YLH V+HRD+K +NIL+ KI+D
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 176
Query: 322 GLAKLLGA---GKSHITTRVMGTFGDFSVTL 349
G A+L + + + V VT
Sbjct: 177 GFARLFNSPLKPLADLDPVV--------VTF 199
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 20/162 (12%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
+ +G G YG V G VA+KKL + A + +R E+ + H+R
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMR 82
Query: 229 HKNLVRLL-----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
H+N++ LL ++ LV ++ +L + ++ + L + ++
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK-----LGEDRIQFLVYQ 136
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
K L Y+H A ++HRD+K N+ ++E+ + KI DFGLA
Sbjct: 137 MLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 30/176 (17%), Positives = 70/176 (39%), Gaps = 20/176 (11%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
++ +G G +G+V+R + + K + G + E+ + RH+N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRN 62
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR----MKILLGTAKAL 287
++ L + ++++E+++ ++ + + + E + + +AL
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVC---EAL 115
Query: 288 AYLHEAIEPKVVHRDIKSSNILI--DENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+LH + H DI+ NI+ + KI +FG A+ L G + +
Sbjct: 116 QFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTA 166
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-18
Identities = 52/207 (25%), Positives = 76/207 (36%), Gaps = 37/207 (17%)
Query: 139 SSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQ-LMN 197
+ PL P G P G +D ++ + ++G GG+G V+ G L +
Sbjct: 3 LTKPLQGPPAPPGTPTPPPGG-------KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTD 55
Query: 198 GTAVAVKKL----LNNPGQADKDFRVEVE------AIGHVRHKNLVRLLGYCIEGTQRI- 246
VA+K + + +E H ++RLL + E +
Sbjct: 56 RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW-FETQEGFM 114
Query: 247 LVYEYVNNGNLEQWLRGDMCD----RGYLT-WEARMKILLGTAKALAYLHEAIEPKVVHR 301
LV E D+ D +G L +R A+ + H VVHR
Sbjct: 115 LVLERPLPA-------QDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCHSR---GVVHR 163
Query: 302 DIKSSNILID-ENFDAKISDFGLAKLL 327
DIK NILID AK+ DFG LL
Sbjct: 164 DIKDENILIDLRRGCAKLIDFGSGALL 190
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 6e-18
Identities = 45/230 (19%), Positives = 72/230 (31%), Gaps = 53/230 (23%)
Query: 161 GHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQAD 214
+F L ++ IG G YGVV + A+K K+ +
Sbjct: 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72
Query: 215 KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL----------------- 257
+ + EV + + H N+ RL + LV E + G+L
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 258 --------------------EQWLRGDMCDRGYLTWEAR--MKILLGTAKALAYLHEAIE 295
+ D M+ + AL YLH
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS---ALHYLHNQ-- 187
Query: 296 PKVVHRDIKSSNILI--DENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ HRDIK N L +++F+ K+ DFGL+K + + G
Sbjct: 188 -GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 22/177 (12%), Positives = 52/177 (29%), Gaps = 21/177 (11%)
Query: 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQ------LMNGTAVAVKKLLNNPGQADKDFRVE 220
+ Q + +++G+G + VY N +K
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 221 VEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWL-RGDMCDRGYLTWEARMKI 279
+E + ++ + +LV E + G L + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILI-----------DENFDAKISDFGLAK 325
+ + +H+ +++H DIK N ++ D + + D G +
Sbjct: 178 AMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 34/165 (20%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+G+G +G V VA+K +LL + R E+ + +RH ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKL- 74
Query: 237 GY-CIEGTQRI-LVYEYVNNGNLEQWLRGDMCD----RGYLT-WEARMK---ILLGTAKA 286
Y I I +V EY G++ D + +T E R I+ A
Sbjct: 75 -YDVITTPTDIVMVIEYAG---------GELFDYIVEKKRMTEDEGRRFFQQII----CA 120
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331
+ Y H K+VHRD+K N+L+D+N + KI+DFGL+ ++ G
Sbjct: 121 IEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 41/204 (20%), Positives = 72/204 (35%), Gaps = 37/204 (18%)
Query: 157 HLGWGHWFTLRDLQSATNRFSKD-----NIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNP 210
H G + + + D ++G G G V G A+K L ++
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS- 65
Query: 211 GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRI----LVYEYVNNGNLEQWLRGDM 265
R EV+ ++V +L ++ E + G L +
Sbjct: 66 ----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS----RI 117
Query: 266 CDRGYLTW---EAR--MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAK 317
+RG + EA M+ + A+ +LH + HRD+K N+L +++ K
Sbjct: 118 QERGDQAFTEREAAEIMRDIG---TAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLK 171
Query: 318 ISDFGLAKLLGAGKSHITTRVMGT 341
++DFG AK + T T
Sbjct: 172 LTDFGFAKETTQNA--LQTPC-YT 192
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 44/160 (27%), Positives = 79/160 (49%), Gaps = 18/160 (11%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN--NPGQADKDFRVEVEAIGHVRH 229
R++ + IG+G YG+V +N VA+KK+ + + R E++ + RH
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRH 84
Query: 230 KNLVRLLG----YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
+N++ + IE + + +V + + +L + L+ +L+ + L
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-----QHLSNDHICYFLYQIL 138
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
+ L Y+H A V+HRD+K SN+L++ D KI DFGLA
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 45/165 (27%), Positives = 82/165 (49%), Gaps = 28/165 (16%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL--LNNPGQADKDFRVEVEAIGHVRH 229
++ F +++G+G YGVV G VA+KK+ + P A + R E++ + H +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 230 KNLVRLL----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----I 279
+N++ + E + ++ E + +L + + M L+ + ++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQM-----LS-DDHIQYFIYQT 121
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
L +A+ LH + V+HRD+K SN+LI+ N D K+ DFGLA
Sbjct: 122 L----RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGH-VRHKNLVRLLGY 238
+G G G V++ + G +AVK++ + + + K ++++ + +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
I T + E + + R +G + K+ + KAL YL E + V
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKE--KHGV 146
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLL 327
+HRD+K SNIL+DE K+ DFG++ L
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRL 175
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-17
Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
R+ + +G G YG V G VAVKKL + A + +R E+ + H++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK 86
Query: 229 HKNLVRLL-----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
H+N++ LL +E + LV + +L ++ LT + ++
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK-----LTDDHVQFLIYQ 140
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
+ L Y+H A ++HRD+K SN+ ++E+ + KI DFGLA
Sbjct: 141 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 56/242 (23%), Positives = 84/242 (34%), Gaps = 36/242 (14%)
Query: 119 VVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSK 178
+ SQ P P P + P + + LQ N
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61
Query: 179 D-----NIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKN 231
D ++G G G V + A+K L Q R EVE + +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 116
Query: 232 LVRLLGYCIEGTQRI----LVYEYVNNGNLEQWLRGDMCDRGYLTW---EAR--MKILLG 282
+VR++ +V E ++ G L + DRG + EA MK +
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFS----RIQDRGDQAFTEREASEIMKSIG- 171
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVM 339
+A+ YLH + HRD+K N+L N K++DFG AK + S +TT
Sbjct: 172 --EAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC- 224
Query: 340 GT 341
T
Sbjct: 225 YT 226
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 27/164 (16%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
++ +G G YG+V++ G VAVKK+ + N A + FR E+ + +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELS 66
Query: 229 -HKNLVRLLGYCI-EGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----IL 280
H+N+V LL + + + LV++Y+ +L +R ++ L + ++
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANI-----LE-PVHKQYVVYQLI 119
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
K + YLH ++HRD+K SNIL++ K++DFGL+
Sbjct: 120 ----KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 27/178 (15%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHK 230
+R+ +G GG G+V+ VA+KK+ L +P R E++ I + H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHD 68
Query: 231 NLVRLL-------------GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEAR 276
N+V++ + + +V EY+ +L L +G L E
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE-----QGPLLEEHA 122
Query: 277 MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSH 333
+ + L Y+H A V+HRD+K +N+ I+ E+ KI DFGLA+++ SH
Sbjct: 123 RLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 39/170 (22%), Positives = 69/170 (40%), Gaps = 20/170 (11%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLL-NNPGQADK-DFRVEVEAIGHVRH-KNLVRLLG 237
+G G + VV + G A K L GQ + + E+ + + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALAYLHEAI 294
++ IL+ EY G + + ++ + +K +L + YLH+
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILE---GVYYLHQN- 150
Query: 295 EPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+VH D+K NIL+ D KI DFG+++ +G +MGT
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGT 196
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 49/190 (25%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK-----KLLNNPGQADKDFRV---------------- 219
IG G YGVV + T A+K KL+ G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 220 -----EVEAIGHVRHKNLVRLLGYC-IEGTQR---ILVYEYVNNGNLEQWLRGDMCDRGY 270
E+ + + H N+V+L ++ +V+E VN G + ++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVM-----EVPTLKP 133
Query: 271 LT-WEARMK---ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
L+ +AR ++ G + YLH K++HRDIK SN+L+ E+ KI+DFG++
Sbjct: 134 LSEDQARFYFQDLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 327 LGAGKSHITT 336
+ ++
Sbjct: 187 FKGSDALLSN 196
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 42/154 (27%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY-C 239
IG G +GV + + VAVK + + R E+ +RH N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRF--KEV 84
Query: 240 IEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMK---ILLGTAKALAYLHEAI 294
I + ++ EY + G L + + C+ G + EAR +L ++Y H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERI----CNAGRFSEDEARFFFQQLLS----GVSYCHSM- 135
Query: 295 EPKVVHRDIKSSNILIDENFDA--KISDFGLAKL 326
++ HRD+K N L+D + KI DFG +K
Sbjct: 136 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-16
Identities = 40/221 (18%), Positives = 71/221 (32%), Gaps = 61/221 (27%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKN 231
F +G GG+GVV+ + ++ A+K++ L N A + EV+A+ + H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDM-------------------------- 265
+VR +E E ++ +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 266 -----------------CDRGYLT-------------WEARMKILLGTAKALAYLHEAIE 295
C + L + I + A+A+ +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
++HRD+K SNI + K+ DFGL + + T
Sbjct: 184 -GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.1 bits (181), Expect = 6e-15
Identities = 30/214 (14%), Positives = 58/214 (27%), Gaps = 55/214 (25%)
Query: 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKL-LNNPGQADKDFRVEVEAI------ 224
T + + IG+G +G V++ + T VA+K + + P + + E I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 225 ----------GHVRHKNLVRLLGYCI------------------------------EGTQ 244
R + + L + Q
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK 304
+V E+ G + + IL +LA + HRD+
Sbjct: 137 LFIVLEFEFGGIDL-----EQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLH 189
Query: 305 SSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
N+L+ + K+ K + +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 41/159 (25%), Positives = 64/159 (40%), Gaps = 29/159 (18%)
Query: 181 IIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGY 238
++G G G V + A+K L + R EVE + ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 239 CIEGTQRI----LVYEYVNNGNLEQWLRGDMCDRGYLTW---EAR--MKILLGTAKALAY 289
+V E ++ G L + DRG + EA MK + +A+ Y
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFS----RIQDRGDQAFTEREASEIMKSIG---EAIQY 132
Query: 290 LHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAK 325
LH + HRD+K N+L N K++DFG AK
Sbjct: 133 LHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 45/178 (25%), Positives = 75/178 (42%), Gaps = 34/178 (19%)
Query: 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH----------VRH 229
++G GG+G V+ Q+ G A KKL +K + + V
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKL-------NKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGT 283
+ +V L Y E + LV +N G++ + D E R I+
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVS-- 300
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
L +LH+ +++RD+K N+L+D++ + +ISD GLA L AG++ GT
Sbjct: 301 --GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GT 352
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 42/184 (22%), Positives = 73/184 (39%), Gaps = 38/184 (20%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH-------- 226
F I+G+G + V + A+K L +K ++ + +
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKIL-------EKRHIIKENKVPYVTRERDVM 84
Query: 227 --VRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK----- 278
+ H V+L + + +++ Y NG L +++R G E +
Sbjct: 85 SRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD-ETCTRFYTAE 138
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
I+ AL YLH ++HRD+K NIL++E+ +I+DFG AK+L
Sbjct: 139 IVS----ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191
Query: 339 M-GT 341
GT
Sbjct: 192 FVGT 195
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 49/178 (27%), Positives = 75/178 (42%), Gaps = 37/178 (20%)
Query: 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH----------VRH 229
++G GG+G V Q+ G A KKL +K + + V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKL-------EKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGT 283
+ +V L Y E + LV +N G+L+ + + EAR I
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFP-EARAVFYAAEICC-- 297
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
L LH ++V+RD+K NIL+D++ +ISD GLA + G++ I RV GT
Sbjct: 298 --GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GT 348
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 49/181 (27%), Positives = 73/181 (40%), Gaps = 43/181 (23%)
Query: 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDF---RVEVE----------AIGH 226
IIG GG+G VY + G A+K L DK + +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCL-------DKKRIKMKQGETLALNERIMLSLVST 248
Query: 227 VRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----IL 280
+V + Y ++ + + +N G+L L G + EA M+ I+
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFS-EADMRFYAAEII 302
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
L L ++H VV+RD+K +NIL+DE+ +ISD GLA K H V G
Sbjct: 303 L----GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-G 352
Query: 341 T 341
T
Sbjct: 353 T 353
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 37/176 (21%), Positives = 68/176 (38%), Gaps = 24/176 (13%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRHKN 231
+ +IG G +G V + A+K L D F E + +
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 232 LVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTAK 285
+V+L Y + + + +V EY+ G+L + + E + ++L
Sbjct: 131 VVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS-----NYDVP-EKWARFYTAEVVL---- 179
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
AL +H +HRD+K N+L+D++ K++DFG + +GT
Sbjct: 180 ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 42/171 (24%), Positives = 70/171 (40%), Gaps = 22/171 (12%)
Query: 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRHKNLVRLL 236
+IG G +G V +L A+K L + FR E + + + K + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 237 GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTAKALAYL 290
Y + + LV +Y G+L L L E + +++ A+ +
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLTLLSKF---EDRLP-EEMARFYLAEMVI----AIDSV 191
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
H+ VHRDIK NIL+D N +++DFG L + ++ +GT
Sbjct: 192 HQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 41/171 (23%), Positives = 70/171 (40%), Gaps = 37/171 (21%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH----------VRHK 230
IG G +G V Q A+K + +K VE + + + H
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYM-------NKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 231 NLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTA 284
LV L Y + + + +V + + G+L L+ + E +K +++
Sbjct: 76 FLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ----QNVHFK-EETVKLFICELVM--- 126
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335
AL YL +++HRD+K NIL+DE+ I+DF +A +L T
Sbjct: 127 -ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 40/176 (22%), Positives = 69/176 (39%), Gaps = 22/176 (12%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRHKN 231
F +IG G + V ++ G A+K + + FR E + + + +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 232 LVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTAK 285
+ +L + + + LV EY G+L L G + I++
Sbjct: 123 ITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS----KFGERIPAEMARFYLAEIVM---- 173
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
A+ +H VHRDIK NIL+D +++DFG L A + + +GT
Sbjct: 174 AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 35/160 (21%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH----------VRHK 230
+G G +G V + +G A+K L DK V+++ I H V
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTAK 285
LV+L + + +V EYV G + LR G + E + I+L
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFS-EPHARFYAAQIVL---- 152
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
YLH +++RD+K N+LID+ +++DFG AK
Sbjct: 153 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 26/98 (26%), Positives = 42/98 (42%), Gaps = 9/98 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQAD-KDFRVEVEAIGH 226
+R +G G +G V VAVK L ++ + E++ + H
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 227 V-RHKNLVRLLGYCIEGTQRILV-YEYVNNGNLEQWLR 262
+ H N+V LLG C + ++V E+ GNL +LR
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR 119
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 44/183 (24%), Positives = 69/183 (37%), Gaps = 38/183 (20%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHK 230
F IG G +G + G+ L VA+K + + Q ++R +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD--- 65
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAKALA- 288
+ ++ + G +V E + G +LE D+CDR L T +A
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL--GPSLEDLF--DLCDR---------TFSLKTVLMIAI 112
Query: 289 -------YLHEAIEPKVVHRDIKSSNILI--DENFDAK---ISDFGLAK--LLGAGKSHI 334
Y+H +++RD+K N LI N + I DF LAK + K HI
Sbjct: 113 QLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHI 169
Query: 335 TTR 337
R
Sbjct: 170 PYR 172
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 43/162 (26%), Positives = 63/162 (38%), Gaps = 38/162 (23%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH-----------VRH 229
IG G +G V + AVK L K ++ + H V+H
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVL-------QKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGT 283
LV L + + ++ V +Y+N G L L+ E R + I
Sbjct: 99 PFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQ----RERCFL-EPRARFYAAEIAS-- 150
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
AL YLH +V+RD+K NIL+D ++DFGL K
Sbjct: 151 --ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK 187
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 6e-09
Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 37/164 (22%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH----------VRHK 230
+G G +G V+ + NG A+K L K+ V ++ + H V H
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 231 NLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTA 284
++R+ + Q+I ++ +Y+ G L LR K + L
Sbjct: 67 FIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFP-NPVAKFYAAEVCL--- 117
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
AL YLH +++RD+K NIL+D+N KI+DFG AK +
Sbjct: 118 -ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 7e-09
Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 30/179 (16%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHK 230
+ IG+G +GV++ G L+N VA+K ++ Q ++R G
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT--- 66
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAK---- 285
+ + + EG +LV + + G +LE L +C R + +K + AK
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLD--LCGRKF-----SVKTVAMAAKQMLA 117
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAK-----ISDFGLAK--LLGAGKSHITTR 337
+ +HE +V+RDIK N LI + DFG+ K K HI R
Sbjct: 118 RVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 9e-09
Identities = 47/161 (29%), Positives = 66/161 (40%), Gaps = 37/161 (22%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH----------VRHK 230
+G G +G V + G A+K L K+ + + + H RH
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 231 NLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTA 284
L L Y + R+ V EY N G L L T E R + I+
Sbjct: 66 FLTALK-YAFQTHDRLCFVMEYANGGELFFHLS----RERVFT-EERARFYGAEIVS--- 116
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
AL YLH VV+RDIK N+++D++ KI+DFGL K
Sbjct: 117 -ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 45/150 (30%), Positives = 65/150 (43%), Gaps = 14/150 (9%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDF---RVEVEAIGHVRHKNLVRLLG 237
+G G +G V + G A+K L A + E + + RH L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 238 YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYLHEAIE 295
Y + R+ V EY N G L L + + E R + AL YLH E
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRE----RVFS-EDRARFYGAEIVSALDYLHS--E 267
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAK 325
VV+RD+K N+++D++ KI+DFGL K
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCK 297
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 29/184 (15%), Positives = 63/184 (34%), Gaps = 30/184 (16%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ---------LMNGTAVAVK-KLLNNPGQADKDFRVEVEA 223
++ + G++Y ++K + +++F
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 224 IGHVRH-KNLVRLLGYCI---------EGTQRILVYEYVNNG-NLEQWLRGDMCDRGYLT 272
V K L I + R LV + G +L+ L D+ + L+
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL--DVSPKHVLS 157
Query: 273 WEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI--SDFGLAKLLGAG 330
+ +++ AL +LHE + VH ++ + NI +D +++ + +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
Query: 331 KSHI 334
H+
Sbjct: 215 GKHV 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 37/162 (22%), Positives = 64/162 (39%), Gaps = 38/162 (23%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH-----------VRH 229
+G G +G V+ + A+K L KD + + + H
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKAL-------KKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGT 283
L + + + + V EY+N G+L ++ +R I+L
Sbjct: 78 PFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFD-LSRATFYAAEIIL-- 129
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
L +LH +V+RD+K NIL+D++ KI+DFG+ K
Sbjct: 130 --GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 38/163 (23%)
Query: 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-----------R 228
+IG G Y V +L A+K + K+ + E I V
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVV-------KKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 229 HKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLG 282
H LV L C + R+ V EYVN G+L ++ + L E + I L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLP-EEHARFYSAEISL- 121
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
AL YLHE +++RD+K N+L+D K++D+G+ K
Sbjct: 122 ---ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 5e-08
Identities = 29/106 (27%), Positives = 50/106 (47%), Gaps = 19/106 (17%)
Query: 226 HVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----I 279
V+H +V L+ Y + ++ L+ EY++ G L L G E I
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE----REGIFM-EDTACFYLAEI 130
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
+ AL +LH+ +++RD+K NI+++ K++DFGL K
Sbjct: 131 SM----ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 6e-08
Identities = 41/164 (25%), Positives = 66/164 (40%), Gaps = 39/164 (23%)
Query: 182 IGDGGYGVVY----RGQLMNGTAVAVKKLLNNPGQADKDF---RVEVEAIG------HVR 228
+G G +G V+ A+K L K R V V
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKMERDILVEVN 84
Query: 229 HKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLG 282
H +V+L Y + ++ L+ +++ G+L L T E +K + L
Sbjct: 85 HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS----KEVMFT-EEDVKFYLAELAL- 137
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
AL +LH +++RD+K NIL+DE K++DFGL+K
Sbjct: 138 ---ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 175
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 17/100 (17%)
Query: 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTAKALAYLHEAIEPKVVHR 301
L+ +Y+N G L L R T E ++ I+L AL +LH+ +++R
Sbjct: 136 LILDYINGGELFTHLS----QRERFT-EHEVQIYVGEIVL----ALEHLHKL---GIIYR 183
Query: 302 DIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
DIK NIL+D N ++DFGL+K A ++ GT
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 8e-08
Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 38/163 (23%)
Query: 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-----------R 228
+IG G Y V +L A++ + K+ + E I V
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVV-------KKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 229 HKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLG 282
H LV L C + R+ V EYVN G+L ++ + L E + I L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLP-EEHARFYSAEISL- 164
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
AL YLHE +++RD+K N+L+D K++D+G+ K
Sbjct: 165 ---ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 37/163 (22%), Positives = 63/163 (38%), Gaps = 38/163 (23%)
Query: 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-----------R 228
++G G +G V + AVK L KD ++ + + +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 229 HKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLG 282
L +L C + R+ V EYVN G+L ++ G E I +
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFK-EPHAVFYAAEIAI- 453
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
L +L +++RD+K N+++D KI+DFG+ K
Sbjct: 454 ---GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 41/162 (25%), Positives = 69/162 (42%), Gaps = 38/162 (23%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----------H 229
+G G +G V ++ G AVK L KD ++ + + H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVL-------KKDVILQDDDVECTMTEKRILSLARNH 83
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGT 283
L +L C + R+ V E+VN G+L ++ EAR + I+
Sbjct: 84 PFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ----KSRRFD-EARARFYAAEIIS-- 135
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
AL +LH+ +++RD+K N+L+D K++DFG+ K
Sbjct: 136 --ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 37/162 (22%), Positives = 62/162 (38%), Gaps = 38/162 (23%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-----------RH 229
+G G +G V + AVK L KD ++ + + +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGT 283
L +L C + R+ V EYVN G+L ++ G E I +
Sbjct: 81 PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFK-EPHAVFYAAEIAI-- 132
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
L +L +++RD+K N+++D KI+DFG+ K
Sbjct: 133 --GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 41/174 (23%), Positives = 66/174 (37%), Gaps = 22/174 (12%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHK 230
NR+ IG G +G +Y G + G VA+K + Q +E + ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGG 64
Query: 231 NLV-RLLGYCIEGTQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
+ + EG ++V E + G +LE C R + + + + +
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFN--FCSRK-FSLKTVLLLADQMISRIE 119
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAK---ISDFGLAK--LLGAGKSHITTR 337
Y+H +HRD+K N L+ I DFGLAK HI R
Sbjct: 120 YIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 32/190 (16%), Positives = 66/190 (34%), Gaps = 50/190 (26%)
Query: 182 IGDGGYGVVYRGQLMNGTAV------AVKKLLNNPGQ-----------ADKDFRVEVEAI 224
IG GG+G +Y + + +V VK ++ G A + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 225 GHVRHKNLVRLLGYCIEGTQ----RILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKI 279
+++ + + G + R ++ + G +L++ + + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY--EANAK---------RF 149
Query: 280 LLGTAKALA--------YLHEAIEPKVVHRDIKSSNILIDENFDAKI--SDFGLAK--LL 327
T L+ Y+HE + VH DIK+SN+L++ ++ D+GLA
Sbjct: 150 SRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 328 GAGKSHITTR 337
Sbjct: 207 EGVHKAYAAD 216
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 45/180 (25%), Positives = 67/180 (37%), Gaps = 34/180 (18%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
N+F IG G +G +Y G + VA+K E + ++
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTG 64
Query: 233 V-RLLGYCIEGTQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAKALA-- 288
+ + + +EG +LV + + G +LE C R K+ L T LA
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL--GPSLEDLFN--FCSR---------KLSLKTVLMLADQ 111
Query: 289 ------YLHEAIEPKVVHRDIKSSNILIDENFDAK---ISDFGLAKLL--GAGKSHITTR 337
++H +HRDIK N L+ A I DFGLAK + HI R
Sbjct: 112 MINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 37/171 (21%), Positives = 71/171 (41%), Gaps = 36/171 (21%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVR 228
R+ +IG G +G V + VA+K + N QA E+ + H+R
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLR 151
Query: 229 HK------NLVRLLGY-------CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEA 275
+ N++ +L C+ +E ++ NL + ++ + +G+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICM-------TFELLSM-NLYELIKKN-KFQGFSLPLV 202
Query: 276 RMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA--KISDFGLA 324
R K + L LH+ +++H D+K NIL+ + + K+ DFG +
Sbjct: 203 R-KFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 1e-05
Identities = 66/461 (14%), Positives = 119/461 (25%), Gaps = 148/461 (32%)
Query: 5 LNKSLSK----TYI---GM----QLWVLIVICLAVVFVVIL--GVSLWLTFRKKKSRRAN 51
L ++L + + G+ + WV + +CL+ + + WL + S
Sbjct: 140 LRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKI-FWLNLKNCNSPETV 198
Query: 52 -DML----------------PVSRFPVVSEEIK-EIR--------------VDQVSSSNG 79
+ML S + I+ E+R + V ++
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK- 257
Query: 80 GFSVHNEKFNDRESEKELIPQENGD--DSVQSGSFNNLEKDVVGSQLGEEGGNG---KVS 134
FN K L+ D + + + ++ D L + K
Sbjct: 258 ----AWNAFNLSC--KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311
Query: 135 TFRPSSHPLTAP--SPL--SGLPEFSHLG---WGHW-------------FTLRDLQSATN 174
RP P +P S + E G W +W +L L+ A
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY 371
Query: 175 R--------FSKDNII---------GDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDF 217
R F I D V ++N + L+ + K+
Sbjct: 372 RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV--MVVVNK--LHKYSLVE---KQPKES 424
Query: 218 RVEVEAIGHVRHKNLVRLLGYCIEGTQ--RILVYEYVNNGNLEQWLRGDMCDRGYLTWEA 275
+ + + L R +V Y + Y
Sbjct: 425 TISI-------PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH- 476
Query: 276 RMKILLGTAKALAYLH-EAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKLLGAG--- 330
+ + H + IE R + +D F + KI A
Sbjct: 477 -----------IGH-HLKNIEH--PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN 522
Query: 331 --------KSHIT------TRVMGTFGDFSVTLLRNMPILV 357
K +I R++ DF L + L+
Sbjct: 523 TLQQLKFYKPYICDNDPKYERLVNAILDF---LPKIEENLI 560
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 40/171 (23%), Positives = 69/171 (40%), Gaps = 34/171 (19%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVR 228
+R+ D++IG G +G V + + VA+K + N QA ++EV + +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMN 108
Query: 229 H------KNLVRLLGY-------CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEA 275
+V L + C+ V+E ++ NL LR + ++
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCL-------VFEMLSY-NLYDLLR--NTNFRGVSLNL 158
Query: 276 RMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI--DENFDAKISDFGLA 324
K AL +L E ++H D+K NIL+ + KI DFG +
Sbjct: 159 TRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 36/169 (21%), Positives = 67/169 (39%), Gaps = 34/169 (20%)
Query: 181 IIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVR-------- 228
+G G + V+ + ++N T VA+K + + A E++ + V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDADNTKED 81
Query: 229 ---HKNLVRLLGY----CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL 281
++++LL + G ++V+E V NL ++ RG + +I
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIK-KYEHRGIPLIYVK-QISK 138
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILIDE------NFDAKISDFGLA 324
L Y+H ++H DIK N+L++ KI+D G A
Sbjct: 139 QLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 33/183 (18%), Positives = 61/183 (33%), Gaps = 47/183 (25%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK--KLLNNP-GQADKDFRVE-----VEAIGHVRHKNL 232
IG GG+G++Y A K+ G + + + I +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 233 VRLLG-----YC-----IEGTQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILL 281
+ LG + R +V E + G +L++ +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISG---QNG---------TFKK 150
Query: 282 GTAKALA--------YLHEAIEPKVVHRDIKSSNILIDENFDAKI--SDFGLAKLLGAGK 331
T L Y+HE + VH DIK++N+L+ ++ +D+GL+
Sbjct: 151 STVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
Query: 332 SHI 334
+H
Sbjct: 208 NHK 210
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 358 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.98 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.98 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.98 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.98 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.98 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.98 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.98 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.98 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.98 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.98 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.98 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.98 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.98 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.98 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.98 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.98 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.98 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.98 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.98 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.98 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.98 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.98 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.98 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.98 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.98 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.96 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.96 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.96 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.96 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.96 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.96 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.96 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.96 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.96 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.96 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.96 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.96 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.96 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.96 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.95 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.94 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.94 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.14 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.75 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.66 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.61 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.32 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.1 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.95 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.79 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.73 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.56 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.43 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.41 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.16 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.92 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.73 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.49 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.46 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.11 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 95.05 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.99 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 94.54 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 92.69 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 92.24 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 91.69 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 90.27 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.02 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.55 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 85.84 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 85.82 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.7 | |
| 1zza_A | 90 | Stannin, AG8_1; helix, membrane protein; NMR {Homo | 82.83 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=331.99 Aligned_cols=176 Identities=24% Similarity=0.354 Sum_probs=157.4
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC---CCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.++||+|+||+||+|+. .+++.||+|.+.+. .....+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999976 57899999998543 2334567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
|||++|+|.+++.+. +.+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999743 4599999999999999999999999 999999999999999999999999999998864
Q ss_pred CC-ceeeeecccccCCchhhhccCCCcc
Q 018311 330 GK-SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~-~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. .......+||+.|||||++.+++|.
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~ 212 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSAC 212 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBC
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCC
Confidence 43 2345678999999999999999885
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=329.90 Aligned_cols=180 Identities=27% Similarity=0.460 Sum_probs=156.2
Q ss_pred CCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++|.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++++|.+++..|+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 67888999999999999999863 477899999987666666889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccc---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEE
Q 018311 248 VYEYVNNGNLEQWLRGDM---------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl 318 (358)
|||||++|||.++|+... .....++|.+++.++.|++.||.|||++ +||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 1235699999999999999999999999 9999999999999999999999
Q ss_pred eeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 319 SDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 319 ~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+|||+|+........ ......||+.|||||++.+.+|+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~ 208 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT 208 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC
Confidence 999999987654433 23346799999999999998875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=330.25 Aligned_cols=180 Identities=26% Similarity=0.438 Sum_probs=149.4
Q ss_pred CCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+++..||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56777899999999999999864 478899999987666666889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcE
Q 018311 248 VYEYVNNGNLEQWLRGDMC-----------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~ 316 (358)
|||||++|+|.++|+.... ....++|.+++.|+.|+|.||.|||++ +||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999975432 234699999999999999999999998 99999999999999999999
Q ss_pred EEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCcc
Q 018311 317 KISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 317 kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
||+|||+|+.+..... ...+...||+.|||||++.+.+|+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~ 238 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCC
Confidence 9999999998765433 244567899999999999999885
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=331.49 Aligned_cols=177 Identities=22% Similarity=0.378 Sum_probs=150.5
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999976 5689999999965432 334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
||++|+|.++|... ....+++..++.++.||+.||.|||++ +||||||||+||||++++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999753 334578999999999999999999999 9999999999999999999999999999987532
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.......+||+.|||||++.+++|.
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~ 203 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYN 203 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCC
T ss_pred -cccccccCCCccccCHHHHCCCCCC
Confidence 1234457899999999999999885
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=328.76 Aligned_cols=174 Identities=26% Similarity=0.352 Sum_probs=157.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
..|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+++|+.++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 5699999999999999999986 469999999997555555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++|+|.+++.+ ..+++..+..++.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 224 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 224 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence 99999999864 3489999999999999999999999 99999999999999999999999999999875432
Q ss_pred eeeeecccccCCchhhhccCCCcc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......+||+.|||||++.+.+|.
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~ 248 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYG 248 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred CcccccccCcCcCCHHHHCCCCCC
Confidence 234568999999999999999885
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=324.30 Aligned_cols=180 Identities=23% Similarity=0.373 Sum_probs=154.2
Q ss_pred CCCcccceecCCccEEEEEEEE------eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
.++++.+.||+|+||+||+|.+ .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 4566789999999999999986 246789999997544 334578999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC
Q 018311 247 LVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~ 314 (358)
||||||++|||.++|..... ....++|.+++.|+.|||.||.|||++ +||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 99999999999999975321 124589999999999999999999999 999999999999999999
Q ss_pred cEEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCcc
Q 018311 315 DAKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 315 ~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.+||+|||+|+.+..... ...+...||+.|||||++.+.+|+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s 225 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS 225 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC
Confidence 999999999998754332 234567899999999999998875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=330.38 Aligned_cols=175 Identities=26% Similarity=0.350 Sum_probs=158.3
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
.+.|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 46799999999999999999976 56999999999766666667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
|++|+|.+++.. ..+++..+..++.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999864 3489999999999999999999999 99999999999999999999999999999875432
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......+||+.|||||++.+.+|.
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~ 325 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYG 325 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBC
T ss_pred -ccccccccCcCcCCHHHHCCCCCC
Confidence 234568999999999999999885
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=311.42 Aligned_cols=173 Identities=23% Similarity=0.408 Sum_probs=140.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||+||+|.. .+|+.||+|.+.+.. ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999975 568999999986543 233467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+ +|+|.+++.+ .+.+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 7899999974 35699999999999999999999999 999999999999999999999999999988654
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. .....+||+.|||||++.+.+|.
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~ 189 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYA 189 (275)
T ss_dssp ------------CTTSCHHHHSSSSCC
T ss_pred CC--ccCCeeECcccCChhhhcCCCCC
Confidence 32 34567999999999999998863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=320.04 Aligned_cols=171 Identities=25% Similarity=0.310 Sum_probs=147.5
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
+.|++.++||+|+||+||+|+. .+|+.||||+++.... ..+|+.+++.++|||||++++++.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4577889999999999999986 5689999999965432 246999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-cEEEeeecCceecCCCC
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKLLGAGK 331 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~-~~kl~DFGla~~~~~~~ 331 (358)
++|+|.++|++. +.+++..+..++.|++.||.|||++ +||||||||+||||+.++ .+||+|||+|+.+....
T Consensus 133 ~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999743 4599999999999999999999999 999999999999999987 69999999999876432
Q ss_pred ce----eeeecccccCCchhhhccCCCcc
Q 018311 332 SH----ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~----~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. .....+||+.|||||++.+++|+
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~ 234 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCD 234 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCC
T ss_pred cccceecCCccccCccccCHHHHCCCCCC
Confidence 21 22346899999999999999985
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=316.29 Aligned_cols=172 Identities=28% Similarity=0.435 Sum_probs=143.4
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.+++++.++||+|+||+||+|++.+ .||||.++... ....++|.+|++++++++|||||++++++.+ +.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4678889999999999999998743 58999986443 2334679999999999999999999998754 67899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
||++|+|.++|.. ....+++..++.|+.|+|.||.|||++ +||||||||+||||++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999974 335699999999999999999999998 9999999999999999999999999999987543
Q ss_pred C-ceeeeecccccCCchhhhccCC
Q 018311 331 K-SHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 331 ~-~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
. .......+||+.|||||++.+.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~ 209 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQ 209 (307)
T ss_dssp --------CCCCTTSCCHHHHHCC
T ss_pred CcceeecccccCCCccCHHHhhcc
Confidence 3 2345567999999999999754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=319.88 Aligned_cols=175 Identities=23% Similarity=0.283 Sum_probs=146.8
Q ss_pred CCCcccceecCCccEEEEEEEEe----CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++|++.+.||+|+||+||+|+.. +++.||+|.+.... ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999752 46889999986543 2223468889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
|||||++|+|.+++.+. +.+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999743 4699999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCceeeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.... ......+||+.|||||++.+.+|+
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~ 204 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHT 204 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCC
T ss_pred cCCC-ccccccccCcccCCHHHhccCCCC
Confidence 4432 234567899999999999999885
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=313.38 Aligned_cols=179 Identities=24% Similarity=0.385 Sum_probs=141.4
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCC--------
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-------- 243 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-------- 243 (358)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4688999999999999999976 5689999999865433 33467889999999999999999999987543
Q ss_pred ----EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEe
Q 018311 244 ----QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKIS 319 (358)
Q Consensus 244 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~ 319 (358)
.+|+|||||++|+|.+++..... .....+..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 37999999999999999975321 12345677889999999999999999 99999999999999999999999
Q ss_pred eecCceecCCCCce-----------eeeecccccCCchhhhccCCCcc
Q 018311 320 DFGLAKLLGAGKSH-----------ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 320 DFGla~~~~~~~~~-----------~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
|||+|+.+...... ..+..+||+.|||||++.+.+|.
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~ 208 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS 208 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCC
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC
Confidence 99999987643221 22346899999999999999885
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=308.34 Aligned_cols=171 Identities=27% Similarity=0.370 Sum_probs=144.5
Q ss_pred cccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEe----CCEEEEEE
Q 018311 177 SKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQRILVY 249 (358)
Q Consensus 177 ~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lv~ 249 (358)
++.++||+|+||+||+|.+ .++..||+|++.... ....+.|.+|++++++|+|||||+++++|.+ +..+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5567899999999999976 468899999986432 2334678999999999999999999999875 35589999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCcEEEeeecCceecC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLG 328 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~-~~~~~kl~DFGla~~~~ 328 (358)
|||++|+|.+++.+. +.+++..+..++.|++.||.|||++ .++||||||||+||||+ +++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999743 4589999999999999999999998 12399999999999997 48999999999998754
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. .....+||+.|||||++.+ +|+
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~ 207 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYD 207 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCC
T ss_pred CC---ccCCcccCccccCHHHcCC-CCC
Confidence 32 3456799999999999976 453
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=317.79 Aligned_cols=188 Identities=24% Similarity=0.366 Sum_probs=159.3
Q ss_pred HhhHHHhcCCCcccceecCCccEEEEEEEEeC------CcEEEEEEecCCCCc-chHHHHHHHHHHhcCCC-Cccccccc
Q 018311 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRH-KNLVRLLG 237 (358)
Q Consensus 166 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H-pnIv~l~~ 237 (358)
.++++...++|++.+.||+|+||+||+|.+.. ++.||||++...... ..++|.+|+++|.+++| ||||++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34455666889999999999999999998643 357999999765433 34679999999999965 89999999
Q ss_pred eEEeC-CEEEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 018311 238 YCIEG-TQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK 304 (358)
Q Consensus 238 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk 304 (358)
+|... +.+++|||||++|+|.++|+.... ....+++..++.++.|||.||.|||++ +|||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence 99764 578999999999999999975321 134589999999999999999999999 99999999
Q ss_pred CCcEEEcCCCcEEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCcc
Q 018311 305 SSNILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 305 ~~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
|+|||+++++.+||+|||+|+.+..... ...+...||+.|||||++.+.+|+
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~ 265 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 265 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC
Confidence 9999999999999999999998765443 345567899999999999998885
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=306.10 Aligned_cols=173 Identities=29% Similarity=0.393 Sum_probs=141.1
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCC----EEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT----QRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lv~ 249 (358)
.+|.+.+.||+|+||+||+|++ +|+.||||++.... .....++.|+..+.+++|||||+++++|..++ .+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577789999999999999988 68999999985432 11122344666677899999999999998653 689999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA-----IEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
|||++|+|.++|+. ..++|+.+.+++.|++.||.|||++ ..++||||||||+||||++++++||+|||+|
T Consensus 81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999974 3488999999999999999999975 2458999999999999999999999999999
Q ss_pred eecCCCCce---eeeecccccCCchhhhccCC
Q 018311 325 KLLGAGKSH---ITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 325 ~~~~~~~~~---~~~~~~Gt~~y~APE~l~~~ 353 (358)
+........ .....+||+.|||||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~ 187 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTC
T ss_pred ccccCCCCceeeecccccccccccCHHHhccc
Confidence 987654432 23356899999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=307.54 Aligned_cols=174 Identities=28% Similarity=0.407 Sum_probs=148.6
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEe------CCE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIE------GTQ 244 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~ 244 (358)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 6799999999999999999976 57999999999654432 33567889999999999999999998764 357
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
+|||||||+ |+|.+++.. .+.+++..+..++.|++.||.|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999995 789999973 45699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCC---ceeeeecccccCCchhhhccCCCc
Q 018311 325 KLLGAGK---SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 325 ~~~~~~~---~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+.+.... .......+||+.|||||++.+..+
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~ 239 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE 239 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCC
Confidence 9875432 123456899999999999988654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=295.94 Aligned_cols=175 Identities=22% Similarity=0.335 Sum_probs=148.8
Q ss_pred hHHHhcCCCcccceecCCccEEEEEEEEe----CCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEeC
Q 018311 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (358)
Q Consensus 168 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 242 (358)
.+....++|++.+.||+|+||+||+|+.+ +++.||+|++.... ....+.+|+++|..+ +||||+++++++.++
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 34455688999999999999999999753 46789999986543 345688899999988 699999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-CcEEEeee
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDF 321 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~-~~~kl~DF 321 (358)
+..|+||||+++|+|.+++. .+++.++..++.|++.||.|||++ +|+||||||+|||++.+ +.+||+||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 99999999999999999884 288999999999999999999999 99999999999999876 79999999
Q ss_pred cCceecCCCCc---------------------------eeeeecccccCCchhhhccCCC
Q 018311 322 GLAKLLGAGKS---------------------------HITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 322 Gla~~~~~~~~---------------------------~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
|+|+....... ......+||+.|||||++.+.+
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 222 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP 222 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence 99987653321 1123468999999999998875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=313.05 Aligned_cols=175 Identities=22% Similarity=0.383 Sum_probs=157.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
++|++.+.||+|+||+||+|.. .+|+.||+|.+........+.+.+|+++|+.|+|||||++++++.+++.+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 6899999999999999999976 579999999997665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC--CcEEEeeecCceecCCC
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN--FDAKISDFGLAKLLGAG 330 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~--~~~kl~DFGla~~~~~~ 330 (358)
++|+|.++|.. ..+.+++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 237 ~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 237 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999964 335689999999999999999999999 99999999999999854 89999999999998765
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. .....+||+.|||||++.+.+|.
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~ 334 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVG 334 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBC
T ss_pred C--ceeeeEECccccCHHHhCCCCCC
Confidence 4 34567899999999999999885
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=314.02 Aligned_cols=174 Identities=26% Similarity=0.319 Sum_probs=149.3
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHH---HHHHHHHhcCCCCccccccceEEeCCEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDF---RVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~---~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 245 (358)
.++|++.++||+|+||.||+|+. .+|+.||+|.+.+.. ......+ ..++.++..++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 46799999999999999999976 569999999985321 1122223 3356777888999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
|+|||||+||+|.++|.+. +.+++..+..++.||+.||.|||++ +||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 9999999999999999743 5699999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCceeeeecccccCCchhhhcc-CCCcc
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLR-NMPIL 356 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~-~~~~~ 356 (358)
.+.... ....+||+.|||||++. +.+|.
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~ 369 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYD 369 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCC
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCC
Confidence 876443 45679999999999996 45664
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=273.79 Aligned_cols=195 Identities=45% Similarity=0.792 Sum_probs=170.9
Q ss_pred ccchHhhHHHhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEE
Q 018311 162 HWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCI 240 (358)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 240 (358)
..+++.++....++|++.+.||+|+||.||+|...+++.||+|++..... .....+.+|++++..++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 44788899999999999999999999999999888899999999865432 22346889999999999999999999999
Q ss_pred eCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 018311 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISD 320 (358)
Q Consensus 241 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~D 320 (358)
..+..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+.++|+||||||+|||+++++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999987654556699999999999999999999997667899999999999999999999999
Q ss_pred ecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 321 FGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 321 FGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
||+++.+............||+.|+|||++.+.+++
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 213 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 213 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEEC
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCC
Confidence 999998876555556667799999999999876653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=266.63 Aligned_cols=177 Identities=23% Similarity=0.440 Sum_probs=154.9
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
++|++.+.||+|+||+||+|.. .+++.||+|++........+.+.+|++++.+++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 6788999999999999999987 468999999987666666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 90 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 90 KGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp TTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999752 35689999999999999999999999 999999999999999999999999999998754332
Q ss_pred ee-------------eeecccccCCchhhhccCCCcc
Q 018311 333 HI-------------TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~~-------------~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. .....||+.|+|||++.+.+++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 200 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD 200 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCC
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCC
Confidence 11 1156899999999999988764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=283.12 Aligned_cols=181 Identities=25% Similarity=0.271 Sum_probs=157.2
Q ss_pred hHhhHHHhcCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEE
Q 018311 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240 (358)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 240 (358)
.+.++....++|++.++||+|+||+||+|+.. +++.||+|++.+.. ......+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34555566789999999999999999999875 47889999985421 112234788999999999999999999999
Q ss_pred eCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 018311 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISD 320 (358)
Q Consensus 241 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~D 320 (358)
+.+..|+||||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 99999999999999999999974 235699999999999999999999999 999999999999999999999999
Q ss_pred ecCceecCCCCceeeeecccccCCchhhhcc
Q 018311 321 FGLAKLLGAGKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 321 FGla~~~~~~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
||+|+.+...........+||+.|+|||++.
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHh
Confidence 9999987765555555679999999999997
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=271.03 Aligned_cols=186 Identities=40% Similarity=0.700 Sum_probs=162.8
Q ss_pred hHHHhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 168 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++....++|+..+.||+|+||.||+|.+.+++.||+|++........+.+.+|++++..++||||+++++++...+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 44455689999999999999999999988899999999877666667889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||+++|+|.+++.........+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999876543445689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc-eeeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
..... .......||+.|+|||++.+.++.
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 219 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLT 219 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCC
T ss_pred ccccccccccccCCCccccCHHHhcCCCCC
Confidence 53322 233456799999999999877654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=270.29 Aligned_cols=175 Identities=22% Similarity=0.359 Sum_probs=154.9
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 36899999999999999999986 679999999986543 233456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999999743 4589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+. .....+||+.|+|||++.+.++.
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~ 191 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYD 191 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCC
T ss_pred CC--ccccccCCcceeCcccccCCCcC
Confidence 43 24557899999999999988763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=261.70 Aligned_cols=175 Identities=23% Similarity=0.352 Sum_probs=156.7
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++..++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999975 67899999998765555667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999742 488999999999999999999999 99999999999999999999999999999876543
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. ......||+.|+|||++.+.+|.
T Consensus 171 ~-~~~~~~gt~~y~aPE~~~~~~~~ 194 (297)
T 3fxz_A 171 S-KRSTMVGTPYWMAPEVVTRKAYG 194 (297)
T ss_dssp C-CBCCCCSCGGGCCHHHHHCSCBC
T ss_pred c-ccCCccCCcCccChhhhcCCCCC
Confidence 2 34457899999999999998874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=278.32 Aligned_cols=180 Identities=21% Similarity=0.249 Sum_probs=156.6
Q ss_pred hhHHHhcCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeC
Q 018311 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG 242 (358)
Q Consensus 167 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 242 (358)
.++....++|++.++||+|+||.||+|+.. +++.||+|.+.+.. ......+.+|+.++..++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 444455688999999999999999999874 58899999985421 12234477899999999999999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
+..|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence 999999999999999999864 2488999999999999999999999 99999999999999999999999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCCC
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
+|+.+...........+||+.|+|||++.+.+
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 245 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTT
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccC
Confidence 99988765544556789999999999998765
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=268.70 Aligned_cols=175 Identities=27% Similarity=0.270 Sum_probs=153.5
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC---CCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|+. .+++.||+|.+.+. .......+.+|++++..++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 6789999999999999999986 46899999998643 2234566888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999998743 4588999999999999999999999 999999999999999999999999999987533
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. ......+||+.|+|||++.+.+|.
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~ 183 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDNDYG 183 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBC
T ss_pred CC-CcccccccChhhCChhhhcCCCCC
Confidence 22 234567899999999999988764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=262.44 Aligned_cols=177 Identities=29% Similarity=0.439 Sum_probs=148.6
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc---chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 37899999999999999999976 46889999998644332 336788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++++|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999743 4589999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...........||+.|+|||++.+.++.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 190 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATD 190 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCC
T ss_pred cccccccCccccCccccCHhHhcCCCCC
Confidence 5444445567899999999999998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=278.51 Aligned_cols=181 Identities=24% Similarity=0.256 Sum_probs=156.7
Q ss_pred hHhhHHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEE
Q 018311 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240 (358)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 240 (358)
.+.+.....++|++.++||+|+||.||+|+. .+++.||+|++.+.. ....+.+..|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3445555678899999999999999999987 468999999985421 112234788999999999999999999999
Q ss_pred eCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 018311 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISD 320 (358)
Q Consensus 241 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~D 320 (358)
+.+..|+||||+++|+|.+++.+. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999753 23589999999999999999999999 999999999999999999999999
Q ss_pred ecCceecCCCCceeeeecccccCCchhhhcc
Q 018311 321 FGLAKLLGAGKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 321 FGla~~~~~~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
||+++.+...........+||+.|+|||++.
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHh
Confidence 9999988665544445678999999999997
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=266.30 Aligned_cols=175 Identities=23% Similarity=0.361 Sum_probs=154.3
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc------chHHHHHHHHHHhcCCCCccccccceEEeCCEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 245 (358)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+...... ..+.+.+|+.++..++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 36799999999999999999976 46899999998654321 346789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC----cEEEeee
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF----DAKISDF 321 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~----~~kl~DF 321 (358)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999973 35689999999999999999999999 999999999999998777 7999999
Q ss_pred cCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 322 GLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 322 Gla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
|+++.+..+. ......||+.|+|||++.+.+|.
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 196 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLG 196 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCC
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCC
Confidence 9999876533 23457899999999999988764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=262.38 Aligned_cols=180 Identities=23% Similarity=0.358 Sum_probs=149.8
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCC-------
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------- 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------- 243 (358)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 367899999999999999999875 78999999986543 334577899999999999999999999986543
Q ss_pred --------------------------------------------------EEEEEEeecCCCCHHHHHhcccCCCCCCCH
Q 018311 244 --------------------------------------------------QRILVYEYVNNGNLEQWLRGDMCDRGYLTW 273 (358)
Q Consensus 244 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 273 (358)
..++||||+++|+|.+++.... ......+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 3799999999999999997543 2233567
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc-----------eeeeeccccc
Q 018311 274 EARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS-----------HITTRVMGTF 342 (358)
Q Consensus 274 ~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~Gt~ 342 (358)
..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 77899999999999999999 999999999999999999999999999998765432 1223467999
Q ss_pred CCchhhhccCCCcc
Q 018311 343 GDFSVTLLRNMPIL 356 (358)
Q Consensus 343 ~y~APE~l~~~~~~ 356 (358)
.|+|||++.+.+++
T Consensus 241 ~y~aPE~~~~~~~~ 254 (332)
T 3qd2_B 241 LYMSPEQIHGNNYS 254 (332)
T ss_dssp GGSCHHHHHCCCCC
T ss_pred CccChHHhcCCCCc
Confidence 99999999988764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=273.06 Aligned_cols=175 Identities=25% Similarity=0.285 Sum_probs=151.1
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.++||+|+||.||+|+.. +++.||+|++++.. ....+.+..|..++.++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 67899999999999999999864 57889999986542 22234577899999876 899999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 132 ~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999743 4589999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. .......+||+.|+|||++.+.+|.
T Consensus 205 ~~-~~~~~~~~gt~~Y~aPE~l~~~~~~ 231 (396)
T 4dc2_A 205 RP-GDTTSTFCGTPNYIAPEILRGEDYG 231 (396)
T ss_dssp CT-TCCBCCCCBCGGGCCHHHHTTCCBC
T ss_pred cC-CCccccccCCcccCCchhhcCCCCC
Confidence 22 2235568999999999999998875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=267.36 Aligned_cols=179 Identities=16% Similarity=0.226 Sum_probs=153.5
Q ss_pred hcCCCcccceecCCccEEEEEEE------EeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC---CCccccccceEEeC
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQ------LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR---HKNLVRLLGYCIEG 242 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~ 242 (358)
..++|.+.+.||+|+||.||+|. ..+++.||+|.+... ...++..|++++..++ |+||+.+++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34789999999999999999993 457889999998653 3467788888888887 99999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---------
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMC-DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE--------- 312 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~--------- 312 (358)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999974322 345699999999999999999999998 9999999999999998
Q ss_pred --CCcEEEeeecCceecCC-CCceeeeecccccCCchhhhccCCCcc
Q 018311 313 --NFDAKISDFGLAKLLGA-GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 313 --~~~~kl~DFGla~~~~~-~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
++.+||+|||+|+.+.. ..........||+.|+|||++.+.+|+
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 263 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN 263 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC
Confidence 89999999999987642 223345667899999999999998875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=263.07 Aligned_cols=172 Identities=26% Similarity=0.335 Sum_probs=152.5
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|+. .+|+.||+|.+.... ....+.+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 6789999999999999999986 468999999986432 233466788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999974 34588999999999999999999998 999999999999999999999999999998653
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. ....+||+.|+|||++.+.+|.
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~ 181 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYN 181 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBC
T ss_pred c----cccccCCccccCHhHhcCCCCC
Confidence 2 3457899999999999998774
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=270.40 Aligned_cols=175 Identities=23% Similarity=0.296 Sum_probs=147.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.++||+|+||.||+|+. .+++.||+|.+.+.. ......+..|.+++..+ +||||+++++++.+.+..|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 6899999999999999999986 468999999986431 22345677899999988 799999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 103 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999743 4589999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. .......+||+.|+|||++.+.+|.
T Consensus 176 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~ 202 (353)
T 3txo_A 176 CN-GVTTATFCGTPDYIAPEILQEMLYG 202 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCT
T ss_pred cC-CccccccCCCcCeEChhhcCCCCcC
Confidence 32 2234567899999999999877653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=259.11 Aligned_cols=172 Identities=26% Similarity=0.315 Sum_probs=154.0
Q ss_pred CcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 176 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
|...+.||+|+||.||+|... +|+.||||.+........+.+.+|+.++.+++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 666789999999999999875 7999999999776666677899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCcee
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..... .
T Consensus 127 ~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 197 (321)
T 2c30_A 127 GALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 197 (321)
T ss_dssp CBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-c
Confidence 999999863 3589999999999999999999999 999999999999999999999999999988754322 2
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+.++.
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~ 219 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYA 219 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC
T ss_pred cccccCCccccCHhhhcCCCCC
Confidence 3457899999999999988764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=259.15 Aligned_cols=175 Identities=17% Similarity=0.263 Sum_probs=153.6
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
.++|++.+.||+|+||.||+|... +++.+|+|.+... ......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 368999999999999999999764 5888999988643 33445688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC--CCcEEEeeecCceecCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE--NFDAKISDFGLAKLLGA 329 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~--~~~~kl~DFGla~~~~~ 329 (358)
+++|+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+..
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999964 234589999999999999999999999 9999999999999987 78999999999998865
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+. ......||+.|+|||++.+.++.
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~ 181 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVS 181 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEEC
T ss_pred CC--ccccccCChhhcCcHHhcCCCCC
Confidence 43 24456899999999999987653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=266.45 Aligned_cols=176 Identities=23% Similarity=0.301 Sum_probs=152.9
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 247 (358)
.++|++.+.||+|+||.||+|+. .+++.||+|.+.... ......+..|..++..+ +||||+++++++.+.+..|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 47899999999999999999987 468899999986432 23345677899998876 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||+++|+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 96 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999743 4588999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCceeeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.... ......+||+.|+|||++.+.+|.
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 196 (345)
T 1xjd_A 169 MLGD-AKTNTFCGTPDYIAPEILLGQKYN 196 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred ccCC-CcccCCCCCcccCChhhhcCCCCC
Confidence 4322 234567899999999999998774
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=263.40 Aligned_cols=179 Identities=22% Similarity=0.318 Sum_probs=154.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC-----CCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN-----PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.++..++||||+++++++.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5789999999999999999976 56899999988432 12245778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc---EEEeeecCc
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD---AKISDFGLA 324 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~---~kl~DFGla 324 (358)
||||+++|+|.+++.........+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999988865433344689999999999999999999999 9999999999999986654 999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+.+..... ......||+.|+|||++.+.+|.
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~ 211 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYG 211 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBC
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCC
Confidence 98765332 34456899999999999988764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=267.62 Aligned_cols=180 Identities=27% Similarity=0.413 Sum_probs=153.1
Q ss_pred CCCcccceecCCccEEEEEEEEe--------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeCC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGT 243 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 243 (358)
++|++.+.||+|+||.||+|+.. ++..||+|.+..... ...+++.+|++++..+ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 67899999999999999999763 345799999875543 2346788999999999 8999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~ 311 (358)
..|+||||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence 99999999999999999975421 124588999999999999999999999 999999999999999
Q ss_pred CCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 312 ENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 312 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.++.+||+|||+++.+...... ......||+.|+|||++.+.+|+
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 283 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 283 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC
Confidence 9999999999999987643321 23345678899999999988764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=264.56 Aligned_cols=175 Identities=25% Similarity=0.276 Sum_probs=152.1
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC---cchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|..++.++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57899999999999999999874 588999999965432 2235578899999887 899999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999743 4589999999999999999999999 99999999999999999999999999998743
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
... ......+||+.|+|||++.+.+|.
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 188 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYG 188 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred CCC-CcccccCCCccccCccccCCCCCC
Confidence 222 234567899999999999998774
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=266.96 Aligned_cols=170 Identities=24% Similarity=0.315 Sum_probs=150.9
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++..++||||+++++++.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 6789999999999999999976 458899999985432 234467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+.+|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999974 35689999999999999999999999 999999999999999999999999999998754
Q ss_pred CCceeeeecccccCCchhhhccC
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
.. .....+||+.|+|||++.+
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~ 188 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSS 188 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCC
T ss_pred CC--ceeccCCCccccCCeeecc
Confidence 32 3456789999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-33 Score=258.38 Aligned_cols=174 Identities=25% Similarity=0.369 Sum_probs=153.4
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC------cchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG------QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5688999999999999999986 4689999999865432 13577999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC----cEEEeeec
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF----DAKISDFG 322 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~----~~kl~DFG 322 (358)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999973 35689999999999999999999999 999999999999998887 89999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+++.+.... ......||+.|+|||++.+.+|.
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 195 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLG 195 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCC
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCC
Confidence 999875433 23456899999999999988764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=261.87 Aligned_cols=177 Identities=31% Similarity=0.476 Sum_probs=149.4
Q ss_pred CCCcccceecCCccEEEEEEEEe----CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.+.||+|+||.||+|... .+..||||.+..... ...+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 67899999999999999999873 355699999976533 3446789999999999999999999999998999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 129 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 129 TEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999974 234689999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCce--eeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSH--ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~--~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
..... ......+|+.|+|||++.+.+++
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 232 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEEC
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCC
Confidence 43322 23334567899999999877653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=264.26 Aligned_cols=172 Identities=23% Similarity=0.280 Sum_probs=152.9
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|++++..++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67899999999999999999874 68999999985432 234467888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999743 4589999999999999999999999 999999999999999999999999999998754
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. ....+||+.|+|||++.+.+|.
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~ 216 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYN 216 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBC
T ss_pred C----cccccCCccccCHHHhcCCCCC
Confidence 3 2456899999999999988764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=255.63 Aligned_cols=176 Identities=30% Similarity=0.468 Sum_probs=155.2
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
++|++.+.||+|+||.||+|...+++.||+|++.... ...+++.+|++++.+++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 6789999999999999999998888999999986543 345679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+++|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 89 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 9999999974 335689999999999999999999999 9999999999999999999999999999877544333
Q ss_pred eeeecccccCCchhhhccCCCcc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......||+.|+|||++.+.+++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~ 185 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYS 185 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCC
T ss_pred cccCcccccccCCHHHhcCCCCC
Confidence 34456678899999999877654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=262.46 Aligned_cols=175 Identities=26% Similarity=0.388 Sum_probs=151.1
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++..++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 68999999999999999999764 789999999864432 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 87 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999998863 34589999999999999999999999 99999999999999999999999999998765333
Q ss_pred c-eeeeecccccCCchhhhccCCCc
Q 018311 332 S-HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~-~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
. .......||+.|+|||++.+.++
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~ 184 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREF 184 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSB
T ss_pred cccccCCCccCcCccCcHHhccCCC
Confidence 2 23456789999999999988765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=261.98 Aligned_cols=175 Identities=25% Similarity=0.361 Sum_probs=143.1
Q ss_pred CCCcccceecCCccEEEEEEEE----eCCcEEEEEEecCCC----CcchHHHHHHHHHHhcCCCCccccccceEEeCCEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 245 (358)
++|++.+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+.++..++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 6789999999999999999986 478999999986542 22335577899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
|+||||+++|+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999743 4588999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... .......||+.|+|||++.+.++.
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 199 (327)
T 3a62_A 170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHN 199 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCC
T ss_pred ccccCC-ccccccCCCcCccCHhhCcCCCCC
Confidence 754322 234457899999999999887764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=264.45 Aligned_cols=176 Identities=22% Similarity=0.238 Sum_probs=152.8
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 247 (358)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 367999999999999999999874 47889999986432 23446678899999988 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||+++|+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999743 4589999999999999999999999 9999999999999999999999999999874
Q ss_pred CCCCceeeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.... ......+||+.|+|||++.+.+|.
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 199 (353)
T 2i0e_A 172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYG 199 (353)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBS
T ss_pred ccCC-cccccccCCccccChhhhcCCCcC
Confidence 3222 234567899999999999998874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=263.19 Aligned_cols=176 Identities=24% Similarity=0.359 Sum_probs=153.1
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
..++|++.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 346799999999999999999976 4689999999865432 2345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC---CcEEEeeecCce
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN---FDAKISDFGLAK 325 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~---~~~kl~DFGla~ 325 (358)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++
T Consensus 107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999873 35689999999999999999999999 99999999999999765 459999999998
Q ss_pred ecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.+.... ......||+.|+|||++.+.+|.
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 208 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYS 208 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCC
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCC
Confidence 876433 23457899999999999998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=263.30 Aligned_cols=175 Identities=21% Similarity=0.302 Sum_probs=154.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|++++..++||||+++++++.+.+..++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 6799999999999999999976 468899999987655445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC--CCcEEEeeecCceecCCC
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE--NFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~--~~~~kl~DFGla~~~~~~ 330 (358)
++|+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+...
T Consensus 131 ~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 131 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999874 234589999999999999999999999 9999999999999974 578999999999987654
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. .....||+.|+|||++.+.++.
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~ 228 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVG 228 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBC
T ss_pred cc--eeeeccCCCccCchhccCCCCC
Confidence 32 3446899999999999988764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=252.79 Aligned_cols=177 Identities=22% Similarity=0.364 Sum_probs=156.2
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.++|++.+.||+|+||.||+|+..++..||+|.+.... ...+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 37899999999999999999998888899999986543 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999753 23488999999999999999999999 999999999999999999999999999998766554
Q ss_pred eeeeecccccCCchhhhccCCCcc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.......+|+.|+|||++.+.++.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~ 183 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYS 183 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEE
T ss_pred hcccCCCcCcccCCHHHHhccCCc
Confidence 444556677889999999876653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=258.77 Aligned_cols=179 Identities=30% Similarity=0.472 Sum_probs=143.9
Q ss_pred hcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
..++|++.+.||+|+||.||+|+. +++.||+|.+...... ..+++.+|++++.+++||||+++++++.+.+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 347899999999999999999977 6889999998655432 3357889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||+++|+|.+++.... ....+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 114 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp ECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred ecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 9999999999997421 112388999999999999999999998 8 999999999999999999999999999875
Q ss_pred CCCCceeeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.... .......||+.|+|||++.+.++.
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 217 (309)
T 3p86_A 190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSN 217 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCC
T ss_pred cccc-cccccCCCCccccChhhhcCCCCC
Confidence 4322 223457899999999999988764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-33 Score=256.25 Aligned_cols=173 Identities=25% Similarity=0.371 Sum_probs=148.3
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|++.+.||+|+||+||+|...+++.||+|++..... .....+.+|++++.+++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 378999999999999999999988899999999864432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|++ |+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 100 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 997 588888864 334589999999999999999999999 9999999999999999999999999999987543
Q ss_pred CceeeeecccccCCchhhhccCC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.. ......||+.|+|||++.+.
T Consensus 173 ~~-~~~~~~~t~~y~aPE~~~~~ 194 (311)
T 3niz_A 173 VR-SYTHEVVTLWYRAPDVLMGS 194 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTC
T ss_pred cc-cccCCcccCCcCCHHHhcCC
Confidence 22 23456889999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=277.50 Aligned_cols=178 Identities=25% Similarity=0.326 Sum_probs=155.4
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
..++|++.++||+|+||.||+|.. .+|+.||+|++.... ......+.+|++++..++||||+++++++.+.+..|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 457799999999999999999987 468999999985431 2334567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||+++|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 262 VmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999999753 234589999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCceeeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
..+.. ....+||+.|+|||++.+.+|.
T Consensus 337 ~~~~~--~~~~~GT~~Y~APEvl~~~~~~ 363 (576)
T 2acx_A 337 PEGQT--IKGRVGTVGYMAPEVVKNERYT 363 (576)
T ss_dssp CTTCC--EECCCSCGGGCCHHHHTTCEES
T ss_pred ccCcc--ccccCCCccccCHHHHcCCCCC
Confidence 65432 3456899999999999988764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=261.93 Aligned_cols=172 Identities=23% Similarity=0.401 Sum_probs=151.8
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6899999999999999999986 678999999985321 223457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+ +|+|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 89 E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 78999988743 4589999999999999999999999 999999999999999999999999999988754
Q ss_pred CCceeeeecccccCCchhhhccCCCc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+. .....+||+.|+|||++.+.++
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~ 184 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLY 184 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGG
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCC
Confidence 33 2345689999999999998876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=275.54 Aligned_cols=180 Identities=26% Similarity=0.321 Sum_probs=157.0
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
.++|.+.++||+|+||.||+|+. .+|+.||+|++.... ......+..|++++.+++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 36788899999999999999987 468999999985432 23346688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++.........+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999976443355699999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.... .....+||+.|+|||++.+.+|.
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~ 367 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYD 367 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBC
T ss_pred CCCc-ccccccCCccccChhhhcCCCCC
Confidence 5432 23456899999999999998874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=264.80 Aligned_cols=175 Identities=27% Similarity=0.319 Sum_probs=143.8
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC---cchHHHHHHHHH-HhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEA-IGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.+.||+|+||.||+|+.. +++.||+|.+.+... .....+..|..+ +..++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 67899999999999999999874 578999999865432 223445667766 5678999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999743 4588999999999999999999999 99999999999999999999999999998743
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
... ......+||+.|+|||++.+.+|.
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 217 (373)
T 2r5t_A 191 EHN-STTSTFCGTPEYLAPEVLHKQPYD 217 (373)
T ss_dssp CCC-CCCCSBSCCCCCCCHHHHTTCCCC
T ss_pred cCC-CccccccCCccccCHHHhCCCCCC
Confidence 322 234567899999999999998764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=266.98 Aligned_cols=166 Identities=19% Similarity=0.225 Sum_probs=139.1
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCC--------CcchHHHHHHHHHHhcCC-----------------
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP--------GQADKDFRVEVEAIGHVR----------------- 228 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~----------------- 228 (358)
++|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.+++.++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 6788899999999999999987 78999999996542 223377889999988886
Q ss_pred ---------CCccccccceEEe-------------CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 018311 229 ---------HKNLVRLLGYCIE-------------GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286 (358)
Q Consensus 229 ---------HpnIv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~ 286 (358)
||||+++++++.+ .+..|+||||+++|++.+.+.+ ..+++..+..++.|++.|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHH
Confidence 4555555555543 6889999999999977666642 458899999999999999
Q ss_pred HHHHH-hCCCCCeeeCCCCCCcEEEcCCC--------------------cEEEeeecCceecCCCCceeeeecccccCCc
Q 018311 287 LAYLH-EAIEPKVVHRDIKSSNILIDENF--------------------DAKISDFGLAKLLGAGKSHITTRVMGTFGDF 345 (358)
Q Consensus 287 l~yLH-~~~~~~ivHrDlk~~NiLl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~ 345 (358)
|.||| +. +|+||||||+|||++.++ .+||+|||+|+.+... ...||+.|+
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999 88 999999999999999887 8999999999987542 358999999
Q ss_pred hhhhccCCC
Q 018311 346 SVTLLRNMP 354 (358)
Q Consensus 346 APE~l~~~~ 354 (358)
|||++.|.+
T Consensus 245 aPE~~~g~~ 253 (336)
T 2vuw_A 245 DEDLFTGDG 253 (336)
T ss_dssp CSGGGCCCS
T ss_pred ChhhhcCCC
Confidence 999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=250.97 Aligned_cols=173 Identities=26% Similarity=0.405 Sum_probs=149.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++.+.||+|+||+||+|.. .+++.||+|++..... .....+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5789999999999999999987 4688999999865443 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++ +|.+++.. ..+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9965 66666653 345699999999999999999999999 9999999999999999999999999999987533
Q ss_pred CceeeeecccccCCchhhhccCCC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
. .......||+.|+|||++.+.+
T Consensus 155 ~-~~~~~~~~t~~y~aPE~~~~~~ 177 (292)
T 3o0g_A 155 V-RCYSAEVVTLWYRPPDVLFGAK 177 (292)
T ss_dssp C-SCCCSCCSCGGGCCHHHHTTCS
T ss_pred c-ccccCCccccCCcChHHHcCCC
Confidence 2 2334568899999999998766
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=257.35 Aligned_cols=177 Identities=25% Similarity=0.423 Sum_probs=147.8
Q ss_pred CCCcccceecCCccEEEEEEEE-----eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeC--CEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 246 (358)
++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++.+++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 6789999999999999999974 36889999999766555567899999999999999999999998653 4589
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 90 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999753 23488999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCce--eeeecccccCCchhhhccCCCcc
Q 018311 327 LGAGKSH--ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 327 ~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+...... ......|+..|+|||++.+.+++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFS 195 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCC
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCC
Confidence 7543322 23345678889999999887764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=267.95 Aligned_cols=177 Identities=24% Similarity=0.328 Sum_probs=152.3
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
..++|++.+.||+|+||.||+|.. .+|+.+|+|.+..... ...+.+.+|++++..++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 346799999999999999999975 5789999999865542 2345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc---CCCcEEEeeecCce
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID---ENFDAKISDFGLAK 325 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~---~~~~~kl~DFGla~ 325 (358)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++ +++.+||+|||+++
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999874 34589999999999999999999999 999999999999998 56889999999998
Q ss_pred ecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.+..... ......||+.|+|||++.+.+|.
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~ 191 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYG 191 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBC
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCC
Confidence 8764332 33457899999999999998774
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=254.05 Aligned_cols=177 Identities=23% Similarity=0.359 Sum_probs=152.0
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.++|++.+.||+|+||.||+|++.++..||+|.+.... ...+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 36889999999999999999999888899999986543 34577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 102 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp TTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999752 34589999999999999999999999 999999999999999999999999999987754333
Q ss_pred eeeeecccccCCchhhhccCCCcc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.......+|+.|+|||++.+.++.
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~ 199 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFS 199 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCS
T ss_pred ccccCCccCcccCCHHHhccCCCC
Confidence 333445678899999999877653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=261.74 Aligned_cols=187 Identities=28% Similarity=0.394 Sum_probs=155.8
Q ss_pred hhHHHhcCCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceE
Q 018311 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYC 239 (358)
Q Consensus 167 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 239 (358)
..+....++|++.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.++.+++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 334455688999999999999999999874 347899999875543 3346789999999999999999999999
Q ss_pred EeCCEEEEEEeecCCCCHHHHHhcccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 018311 240 IEGTQRILVYEYVNNGNLEQWLRGDMCD--------------------RGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299 (358)
Q Consensus 240 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv 299 (358)
.+.+..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 9999999999999999999999753211 25689999999999999999999999 999
Q ss_pred eCCCCCCcEEEcCCCcEEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCcc
Q 018311 300 HRDIKSSNILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 300 HrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
||||||+|||++.++.+||+|||+++.+..... .......||+.|+|||++.+.+++
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 254 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT 254 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC
Confidence 999999999999999999999999987654322 233456789999999999877653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=264.63 Aligned_cols=177 Identities=30% Similarity=0.457 Sum_probs=140.6
Q ss_pred CCCcccceecCCccEEEEEEEEe----CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.+.||+|+||.||+|+.. ++..||+|.+..... ...+++.+|+.++.+++||||+++++++...+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 67999999999999999999764 567899999875432 3346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 125 ~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999742 34589999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCcee--eeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHI--TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~--~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... .....+++.|+|||++.+.+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 228 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCC
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcC
Confidence 433221 2223457889999999887764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=258.83 Aligned_cols=176 Identities=26% Similarity=0.376 Sum_probs=142.9
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc---chHHHHHHHHHHhcCCCCccccccceEEeCC----EE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT----QR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~ 245 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|++++.+++||||+++++++.... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 7899999999999999999986 67889999999765332 2356889999999999999999999987654 34
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
|+||||+++++|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 92 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred EEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 9999999999999999743 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCce--eeeecccccCCchhhhccCCCcc
Q 018311 326 LLGAGKSH--ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 326 ~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.+...... ......||+.|+|||++.+.++.
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 197 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD 197 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCC
Confidence 87543322 23446799999999999988764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=253.18 Aligned_cols=172 Identities=26% Similarity=0.363 Sum_probs=145.4
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--------------------------chHHHHHHHHHHhc
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--------------------------ADKDFRVEVEAIGH 226 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~~ 226 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|++++.+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 6899999999999999999976 46889999998654311 12458889999999
Q ss_pred CCCCccccccceEEe--CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 018311 227 VRHKNLVRLLGYCIE--GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK 304 (358)
Q Consensus 227 l~HpnIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk 304 (358)
++||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.|++.||.|||+. +|+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 999999999999986 568999999999999977543 34689999999999999999999999 99999999
Q ss_pred CCcEEEcCCCcEEEeeecCceecCCCCceeeeecccccCCchhhhccCCC
Q 018311 305 SSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 305 ~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
|+|||++.++.+||+|||+++.+..... ......||+.|+|||++.+.+
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~ 213 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETR 213 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCC
Confidence 9999999999999999999998764432 344578999999999998765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=274.47 Aligned_cols=179 Identities=20% Similarity=0.329 Sum_probs=153.5
Q ss_pred HhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
...++|++.+.||+|+||.||+|.+.++..||||+++... ...+++.+|++++.+++||||+++++++. .+..++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3457889999999999999999999888999999997543 45678999999999999999999999986 667899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 263 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred ecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999997431 12478889999999999999999999 9999999999999999999999999999987543
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.........+++.|+|||++.+.+|+
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~ 363 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFT 363 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCC
T ss_pred ceeccCCCcccccccCHHHhccCCCC
Confidence 22223345577899999999877654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=269.38 Aligned_cols=173 Identities=25% Similarity=0.428 Sum_probs=153.8
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|.+.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67999999999999999999874 78999999985432 223467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999973 35689999999999999999999999 999999999999999999999999999998765
Q ss_pred CCceeeeecccccCCchhhhccCCCc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+. .....+||+.|+|||++.+.+|
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~ 192 (476)
T 2y94_A 169 GE--FLRTSCGSPNYAAPEVISGRLY 192 (476)
T ss_dssp TC--CBCCCCSCSTTCCHHHHTTCCB
T ss_pred cc--cccccCCCcCeEChhhccCCCC
Confidence 33 2445689999999999998875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=260.60 Aligned_cols=172 Identities=24% Similarity=0.327 Sum_probs=142.7
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
++|++.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 68999999999999999999874 789999999865433 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc--EEEeeecCceecCCC
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD--AKISDFGLAKLLGAG 330 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~--~kl~DFGla~~~~~~ 330 (358)
++|+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++.....
T Consensus 99 ~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 99 SGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999998742 4589999999999999999999999 9999999999999987765 999999999854322
Q ss_pred CceeeeecccccCCchhhhccCCCc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
. ......||+.|+|||++.+..+
T Consensus 172 ~--~~~~~~gt~~y~aPE~~~~~~~ 194 (361)
T 3uc3_A 172 S--QPKSTVGTPAYIAPEVLLRQEY 194 (361)
T ss_dssp -----------CTTSCHHHHHCSSC
T ss_pred C--CCCCCcCCCCcCChhhhcCCCC
Confidence 2 2345689999999999988775
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-33 Score=260.91 Aligned_cols=174 Identities=29% Similarity=0.413 Sum_probs=136.6
Q ss_pred hcCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ..+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3477999999999999999999875 57899999986543 34568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCcEEEeeecCceec
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISDFGLAKLL 327 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~---~~~~kl~DFGla~~~ 327 (358)
|+++|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999973 35589999999999999999999999 9999999999999975 899999999999876
Q ss_pred CCCCceeeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.... ......||+.|+|||++.+.++.
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 228 (349)
T 2w4o_A 202 EHQV--LMKTVCGTPGYCAPEILRGCAYG 228 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCC
T ss_pred Cccc--ccccccCCCCccCHHHhcCCCCC
Confidence 5322 23457899999999999988764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=272.27 Aligned_cols=176 Identities=25% Similarity=0.256 Sum_probs=143.4
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC---CCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|++++..++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 36799999999999999999976 56899999998643 223345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+|+..
T Consensus 227 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999999743 458999999999999999999998 7 9999999999999999999999999999875
Q ss_pred CCCCceeeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.... ......+||+.|+|||++.+.+|+
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 327 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYG 327 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCC
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCC
Confidence 4322 234567899999999999988764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=261.15 Aligned_cols=171 Identities=23% Similarity=0.331 Sum_probs=144.7
Q ss_pred ccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCCCC
Q 018311 178 KDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGN 256 (358)
Q Consensus 178 ~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs 256 (358)
..+.||+|+||.||+|.. .+|+.||+|.+........+.+.+|++++.+++||||+++++++...+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 357899999999999976 5689999999977655556789999999999999999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE--cCCCcEEEeeecCceecCCCCcee
Q 018311 257 LEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI--DENFDAKISDFGLAKLLGAGKSHI 334 (358)
Q Consensus 257 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl--~~~~~~kl~DFGla~~~~~~~~~~ 334 (358)
|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 173 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 173 LFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 99988642 23588999999999999999999999 99999999999999 5678999999999998765432
Q ss_pred eeecccccCCchhhhccCCCcc
Q 018311 335 TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 335 ~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+.+++
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~ 266 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVS 266 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCC
T ss_pred cccccCCCcEeChhhccCCCCC
Confidence 3345799999999999887654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-33 Score=266.20 Aligned_cols=178 Identities=25% Similarity=0.364 Sum_probs=151.0
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|++.+.||+|+||.||+|.+. +++.||+|.+..... ...+++.+|++++.+++||||+++++++..++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 367888999999999999999875 789999999875432 223467889999999999999999999999899999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....+
T Consensus 193 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999753 23488999999999999999999999 9999999999999999999999999999986543
Q ss_pred Cceee-eecccccCCchhhhccCCCcc
Q 018311 331 KSHIT-TRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~-~~~~Gt~~y~APE~l~~~~~~ 356 (358)
..... ....+++.|+|||++.+.+++
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~ 293 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYS 293 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEE
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCC
Confidence 22111 223467889999999876653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.6e-33 Score=273.53 Aligned_cols=179 Identities=25% Similarity=0.405 Sum_probs=155.6
Q ss_pred hcCCCcccceecCCccEEEEEEEEeC-CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
...+|++.+.||+|+||.||+|.+.. +..||||.+.... ...++|.+|+.++.+++||||+++++++...+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34678889999999999999998754 8899999986543 346789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++|+|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 297 ~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999753 234588999999999999999999999 9999999999999999999999999999987654
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.........+++.|+|||++.+.+|+
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~ 397 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFS 397 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEEC
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCC
Confidence 43334445677899999999877653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=267.27 Aligned_cols=175 Identities=25% Similarity=0.371 Sum_probs=135.6
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeC-----CEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~ 245 (358)
++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++.+++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 6899999999999999999975 47899999998654332 346788999999999999999999998543 568
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
|+||||+ +|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 133 ~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 9999998 6799999873 35699999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCc--------------------------eeeeecccccCCchhhhcc-CCCcc
Q 018311 326 LLGAGKS--------------------------HITTRVMGTFGDFSVTLLR-NMPIL 356 (358)
Q Consensus 326 ~~~~~~~--------------------------~~~~~~~Gt~~y~APE~l~-~~~~~ 356 (358)
.+..... ......+||+.|+|||++. +..|+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 262 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT 262 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCC
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCC
Confidence 8753221 1234568899999999864 44443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.3e-33 Score=263.01 Aligned_cols=189 Identities=24% Similarity=0.366 Sum_probs=156.0
Q ss_pred hHhhHHHhcCCCcccceecCCccEEEEEEEE------eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCcccccc
Q 018311 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLL 236 (358)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~ 236 (358)
....+....++|++.+.||+|+||.||+|++ .+++.||||++..... ...+.+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3445556678999999999999999999974 2457899999976543 2346689999999999 789999999
Q ss_pred ceEEeCC-EEEEEEeecCCCCHHHHHhcccCC------------------------------------------------
Q 018311 237 GYCIEGT-QRILVYEYVNNGNLEQWLRGDMCD------------------------------------------------ 267 (358)
Q Consensus 237 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------ 267 (358)
+++.+.+ ..++||||+++|+|.+++......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998754 489999999999999999754211
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC-c
Q 018311 268 --------------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK-S 332 (358)
Q Consensus 268 --------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~-~ 332 (358)
...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+.... .
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 12288999999999999999999999 99999999999999999999999999998775433 2
Q ss_pred eeeeecccccCCchhhhccCCCcc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.......||+.|+|||++.+.+|+
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~ 273 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYT 273 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCC
T ss_pred hhccccCCCceeEChhhhcCCCCC
Confidence 344567889999999999887764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=251.17 Aligned_cols=173 Identities=28% Similarity=0.416 Sum_probs=146.6
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||.||+|+..+++.||+|++..... ...+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57889999999999999999887899999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++ +|.+++.. ..+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 99998874 235688999999999999999999999 99999999999999999999999999998875322
Q ss_pred ceeeeecccccCCchhhhccCCC
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.......||+.|+|||++.+..
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~ 176 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSK 176 (288)
T ss_dssp --------CCCTTCCHHHHTTCC
T ss_pred -cccccccccccccCchheeCCC
Confidence 1234568899999999997643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.8e-32 Score=248.27 Aligned_cols=185 Identities=42% Similarity=0.681 Sum_probs=159.6
Q ss_pred chHhhHHHhcCCCccc------ceecCCccEEEEEEEEeCCcEEEEEEecCCC----CcchHHHHHHHHHHhcCCCCccc
Q 018311 164 FTLRDLQSATNRFSKD------NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHVRHKNLV 233 (358)
Q Consensus 164 ~~~~~~~~~~~~~~~~------~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv 233 (358)
+++.++...+++|... +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|+.++..++||||+
T Consensus 15 ~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 93 (307)
T 2nru_A 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93 (307)
T ss_dssp CCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeE
Confidence 6778888888888766 8999999999999987 68899999986432 23346788999999999999999
Q ss_pred cccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC
Q 018311 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN 313 (358)
Q Consensus 234 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~ 313 (358)
++++++.+.+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+. +++||||||+||+++++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 94 ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEA 169 (307)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred EEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCC
Confidence 99999999999999999999999999997432 234689999999999999999999999 99999999999999999
Q ss_pred CcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCC
Q 018311 314 FDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 314 ~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~ 353 (358)
+.+||+|||+++........ ......||+.|+|||++.+.
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 210 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE 210 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcCC
Confidence 99999999999887543322 34456899999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-32 Score=251.98 Aligned_cols=170 Identities=28% Similarity=0.286 Sum_probs=142.2
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcc--hHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQA--DKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.++||+|+||+||+|... +++.||||++....... ...+..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999875 78999999986543322 23344556555554 8999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+ +++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 77999988753 34599999999999999999999999 999999999999999999999999999988754
Q ss_pred CCceeeeecccccCCchhhhccC
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
.. ......||+.|+|||++.+
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQG 230 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT
T ss_pred CC--CCcccCCCccccCHhHhcC
Confidence 32 2345679999999999987
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.9e-32 Score=251.13 Aligned_cols=176 Identities=24% Similarity=0.396 Sum_probs=137.6
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++.+++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 36789999999999999999976 468999999986543 3344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 251 YVNNGNLEQWLRGDMC--DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|++ |+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 699999865321 224588999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCceeeeecccccCCchhhhccCC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.... ......||+.|+|||++.+.
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~ 183 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGS 183 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTC
T ss_pred CCcc-cCCCCcccccccCchHhhCC
Confidence 4322 23456899999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-32 Score=263.62 Aligned_cols=174 Identities=31% Similarity=0.451 Sum_probs=149.2
Q ss_pred HhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCC-EEEEEE
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-QRILVY 249 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lv~ 249 (358)
...++|++.+.||+|+||.||+|.+ .++.||||.++... ..+.|.+|++++.+++||||+++++++.... ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 3457788999999999999999988 47899999997543 4578999999999999999999999988765 799999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 267 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp ECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999999854 233478999999999999999999999 999999999999999999999999999987543
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. .....+++.|+|||++.+.+++
T Consensus 342 ~----~~~~~~~~~y~aPE~~~~~~~~ 364 (450)
T 1k9a_A 342 T----QDTGKLPVKWTAPEALREKKFS 364 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCC
T ss_pred c----ccCCCCCcceeCHHHhcCCCCC
Confidence 2 2234678999999999887764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=255.31 Aligned_cols=174 Identities=19% Similarity=0.229 Sum_probs=151.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+..... .+.+..|++++..+ +||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 6799999999999999999985 6789999999865432 34588899999999 999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc-----EEEeeecCcee
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD-----AKISDFGLAKL 326 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~-----~kl~DFGla~~ 326 (358)
+ +++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 99999999753 35699999999999999999999999 9999999999999998887 99999999998
Q ss_pred cCCCCce------eeeecccccCCchhhhccCCCcc
Q 018311 327 LGAGKSH------ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 327 ~~~~~~~------~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+...... ......||+.|+|||++.+.++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 195 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS 195 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCC
Confidence 7543321 12467899999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=260.62 Aligned_cols=181 Identities=27% Similarity=0.386 Sum_probs=153.8
Q ss_pred cCCCcccceecCCccEEEEEEEEe--------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeC
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 242 (358)
.++|.+.+.||+|+||.||+|+.. .+..||+|++..... ....++.+|++++.++ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 368899999999999999999753 235799999876543 2346788999999999 899999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl 310 (358)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 999999999999999999975431 124589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCcc
Q 018311 311 DENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 311 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
++++.+||+|||+++.+..... .......||+.|+|||++.+..++
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 271 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC
Confidence 9999999999999998764332 233445678999999999987764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.8e-32 Score=251.53 Aligned_cols=172 Identities=26% Similarity=0.336 Sum_probs=148.9
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCC--EEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT--QRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lv~ 249 (358)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++.+++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 67999999999999999999874 58999999986543 234567889999999999999999999998765 789999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----cCCCcEEEeeecCce
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLAK 325 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl----~~~~~~kl~DFGla~ 325 (358)
||+++++|.+++.... ....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 9999999999997543 223489999999999999999999999 99999999999999 788889999999999
Q ss_pred ecCCCCceeeeecccccCCchhhhcc
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
.+..... .....||+.|+|||++.
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhh
Confidence 8765432 34567999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=253.11 Aligned_cols=181 Identities=27% Similarity=0.393 Sum_probs=153.3
Q ss_pred cCCCcccceecCCccEEEEEEEE------eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 245 (358)
.++|.+.+.||+|+||.||+|.. .++..||+|.+..... ...+.+.+|++++.+++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 36789999999999999999975 2357899999875433 3346788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 018311 246 ILVYEYVNNGNLEQWLRGDMC--------------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKS 305 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~ 305 (358)
++||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999975422 123488999999999999999999999 999999999
Q ss_pred CcEEEcCCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 306 SNILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 306 ~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+||++++++.+||+|||+++.+...... ......+|+.|+|||++.+.+++
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 230 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT 230 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC
Confidence 9999999999999999999987654432 23345678899999999887653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-33 Score=270.84 Aligned_cols=178 Identities=26% Similarity=0.408 Sum_probs=146.5
Q ss_pred hcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
..++|++.+.||+|+||.||+|.+.++..||||.+.... ...++|.+|++++.+++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 446788999999999999999999888889999987543 345789999999999999999999999865 778999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 260 ~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999997431 23488999999999999999999999 99999999999999999999999999999876543
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
........+++.|+|||++.+.+++
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~ 359 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFT 359 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCC
T ss_pred eecccCCcccccccCHhHHhcCCCC
Confidence 3333445678899999999877654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=251.39 Aligned_cols=177 Identities=24% Similarity=0.343 Sum_probs=138.2
Q ss_pred cCCCcccceecCCccEEEEEEEEeC----CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
.++|++.+.||+|+||.||+|.... +..||+|.+..... ...+.+.+|+.++.+++||||+++++++ ..+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 4789999999999999999997632 45799998865433 3346788999999999999999999987 4567899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.+
T Consensus 93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999753 34588999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCceeeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
............+|+.|+|||++.+.++.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFT 195 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCS
T ss_pred CcccccccccCCCcccccChhhcccCCCC
Confidence 65443344456678899999999877653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.7e-32 Score=247.63 Aligned_cols=169 Identities=30% Similarity=0.452 Sum_probs=143.4
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhc--CCCCccccccceEEeC----CEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH--VRHKNLVRLLGYCIEG----TQRI 246 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~----~~~~ 246 (358)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 36899999999999999999987 7899999998542 33455666666655 7999999999987652 5589
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCcEEEcCCCcEEE
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH--------EAIEPKVVHRDIKSSNILIDENFDAKI 318 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivHrDlk~~NiLl~~~~~~kl 318 (358)
+||||+++|+|.++++. ..+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence 99999999999999953 35899999999999999999999 77 9999999999999999999999
Q ss_pred eeecCceecCCCCcee---eeecccccCCchhhhccCC
Q 018311 319 SDFGLAKLLGAGKSHI---TTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 319 ~DFGla~~~~~~~~~~---~~~~~Gt~~y~APE~l~~~ 353 (358)
+|||+++......... .....||+.|+|||++.+.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 192 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTC
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCc
Confidence 9999998876544332 2345899999999999887
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-32 Score=245.99 Aligned_cols=172 Identities=27% Similarity=0.364 Sum_probs=152.9
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
.++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 367899999999999999999764 4778999999766556678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---cCCCcEEEeeecCceecC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLG 328 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl---~~~~~~kl~DFGla~~~~ 328 (358)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||+++.+.
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999988743 4588999999999999999999999 99999999999999 788999999999999876
Q ss_pred CCCceeeeecccccCCchhhhccCC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
... ......||+.|+|||++.+.
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~ 183 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL 183 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC
T ss_pred Ccc--chhccCCCCCccChHHhccc
Confidence 543 23456799999999998765
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-32 Score=255.93 Aligned_cols=182 Identities=23% Similarity=0.285 Sum_probs=155.7
Q ss_pred chHhhHHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-----CCccccccc
Q 018311 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----HKNLVRLLG 237 (358)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~l~~ 237 (358)
+++.+.....++|++.+.||+|+||.||+|.. .+++.||+|.+... ......+..|+.++..++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 34455555668999999999999999999987 56889999998642 233456778999999886 999999999
Q ss_pred eEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-----
Q 018311 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE----- 312 (358)
Q Consensus 238 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~----- 312 (358)
++...+..++||||+ +++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence 999999999999999 99999999754 224589999999999999999999999 9999999999999975
Q ss_pred --------------------CCcEEEeeecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 313 --------------------NFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 313 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
++.+||+|||+++..... .....||+.|+|||++.+.+|.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~ 237 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWD 237 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCC
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCC
Confidence 889999999999876432 2456899999999999998864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=5e-32 Score=259.00 Aligned_cols=174 Identities=20% Similarity=0.207 Sum_probs=150.3
Q ss_pred CCCcccceecCC--ccEEEEEEEEe-CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDG--GYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G--~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.+.||+| +||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 689999999999 99999999874 68999999986543 22335678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 105 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 105 TSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999754 234589999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCce------eeeecccccCCchhhhccC
Q 018311 329 AGKSH------ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 329 ~~~~~------~~~~~~Gt~~y~APE~l~~ 352 (358)
..... ......||+.|+|||++.+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred cccccccccccccccccccccccCHHHHhc
Confidence 32211 1223578999999999988
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.8e-33 Score=263.32 Aligned_cols=180 Identities=26% Similarity=0.337 Sum_probs=150.6
Q ss_pred CCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|++.+.||+|+||.||+|.+. +++.||||++.... .....++.+|+.++.+++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 67899999999999999999842 46789999986543 233456889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC---cEEEee
Q 018311 247 LVYEYVNNGNLEQWLRGDMC---DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF---DAKISD 320 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~---~~kl~D 320 (358)
+||||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 99999999999999975431 224589999999999999999999999 999999999999998554 599999
Q ss_pred ecCceecCCCC-ceeeeecccccCCchhhhccCCCcc
Q 018311 321 FGLAKLLGAGK-SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 321 FGla~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
||+++.+.... ........||+.|+|||++.+.+|+
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 264 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT 264 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCC
Confidence 99998653221 1223446789999999999887654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=8.9e-33 Score=261.34 Aligned_cols=173 Identities=27% Similarity=0.340 Sum_probs=150.9
Q ss_pred CCCcccceecCCccEEEEEEEE----eCCcEEEEEEecCCC----CcchHHHHHHHHHHhcC-CCCccccccceEEeCCE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 244 (358)
++|++.+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|++++.++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6789999999999999999987 378999999986432 12335567799999999 69999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999743 4588999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCC
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+.+............||+.|+|||++.+.
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 235 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGG 235 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCC
Confidence 98754444444567899999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=255.46 Aligned_cols=175 Identities=26% Similarity=0.356 Sum_probs=152.8
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--------chHHHHHHHHHHhcCCCCccccccceEEeC
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG 242 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 242 (358)
..++|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.++.+++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 347899999999999999999975 56889999998654321 223567899999999999999999999999
Q ss_pred CEEEEEEeecCCC-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeee
Q 018311 243 TQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (358)
Q Consensus 243 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DF 321 (358)
+..++||||+.+| +|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 99999974 34589999999999999999999999 9999999999999999999999999
Q ss_pred cCceecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 322 GLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 322 Gla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
|+++.+..... .....||+.|+|||++.+.++
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 206 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPY 206 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCB
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCC
Confidence 99998765432 345689999999999998876
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-32 Score=249.42 Aligned_cols=177 Identities=25% Similarity=0.439 Sum_probs=150.6
Q ss_pred CCCcccceecCCccEEEEEEEE-----eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeC--CEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 245 (358)
++|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|++++..++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5688899999999999999984 468899999987443 34457789999999999999999999999876 668
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 9999999999999999643 34589999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCce--eeeecccccCCchhhhccCCCcc
Q 018311 326 LLGAGKSH--ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 326 ~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.+...... ......||..|+|||++.+.++.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 207 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY 207 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCC
Confidence 87654432 33456788999999999887653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-32 Score=254.86 Aligned_cols=184 Identities=19% Similarity=0.358 Sum_probs=137.5
Q ss_pred HHhcCCCcccceecCCccEEEEEEEEeCC----cEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCC
Q 018311 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNG----TAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT 243 (358)
Q Consensus 170 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~----~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 243 (358)
....++|++.+.||+|+||.||+|..... ..||+|.+.... ....+.+.+|++++.+++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 34457899999999999999999976433 279999986542 334567899999999999999999999998766
Q ss_pred EE------EEEEeecCCCCHHHHHhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc
Q 018311 244 QR------ILVYEYVNNGNLEQWLRGDMC--DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD 315 (358)
Q Consensus 244 ~~------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~ 315 (358)
.. ++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence 55 999999999999999865432 222589999999999999999999999 9999999999999999999
Q ss_pred EEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 316 AKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 316 ~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+||+|||+++.+...... ......+++.|+|||++.+.+++
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 217 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT 217 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCC
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCC
Confidence 999999999887544322 23345678899999999887764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-32 Score=250.60 Aligned_cols=174 Identities=23% Similarity=0.364 Sum_probs=153.4
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc------chHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|++.+.||+|+||.||+|... +++.||+|.+...... ..+++.+|+.++.+++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 57899999999999999999864 6899999998654321 3577999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC----cEEEeeec
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF----DAKISDFG 322 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~----~~kl~DFG 322 (358)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999974 34588999999999999999999999 999999999999999888 79999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+++.+.... ......||+.|+|||++.+.+++
T Consensus 165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 196 (321)
T 2a2a_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLG 196 (321)
T ss_dssp TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCC
T ss_pred cceecCccc--cccccCCCCCccCcccccCCCCC
Confidence 999876533 23456799999999999988764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=261.37 Aligned_cols=171 Identities=23% Similarity=0.240 Sum_probs=137.6
Q ss_pred CCCccc-ceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHh-cCCCCccccccceEEe----CCEEE
Q 018311 174 NRFSKD-NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIG-HVRHKNLVRLLGYCIE----GTQRI 246 (358)
Q Consensus 174 ~~~~~~-~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~----~~~~~ 246 (358)
++|.+. ++||+|+||.||+|.. .+++.||+|++.. ...+.+|+.++. ..+||||+++++++.. ....|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 6899999999999976 4688999999853 245778888874 4589999999999875 56789
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCcEEEeeecC
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISDFGL 323 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~---~~~~kl~DFGl 323 (358)
+||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence 999999999999999753 234589999999999999999999998 9999999999999987 78999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
++...... .....+||+.|+|||++.+..|.
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 241 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYD 241 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSS
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCC
Confidence 99865332 24467899999999999888764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=253.97 Aligned_cols=173 Identities=31% Similarity=0.473 Sum_probs=146.5
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCC----EEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT----QRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~lv~ 249 (358)
++|++.++||+|+||.||+|++ .++.||||++.... .....+..|+.++.+++||||+++++++.... ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 6899999999999999999987 47899999985432 22344566899999999999999999998743 479999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA-------IEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-------~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
||+++|+|.+++.. ..+++..+..++.|++.||.|||+. +.++|+||||||+|||++.++.+||+|||
T Consensus 102 e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 102 AFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 99999999999974 2388999999999999999999975 13379999999999999999999999999
Q ss_pred CceecCCCCce-eeeecccccCCchhhhccCC
Q 018311 323 LAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 323 la~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~ 353 (358)
+++.+...... ......||+.|+|||++.+.
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 208 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTC
T ss_pred cccccccccCccccccCccCccccCHhhcccc
Confidence 99887654332 23346899999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=248.91 Aligned_cols=180 Identities=24% Similarity=0.380 Sum_probs=154.0
Q ss_pred HHhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 170 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
....++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++..++||||+++++++. .+..++||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 86 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence 33457899999999999999999998888899999986543 34577999999999999999999999876 45689999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++....
T Consensus 87 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp ECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999996431 12588999999999999999999999 999999999999999999999999999998765
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
..........+++.|+|||++.+.++.
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~ 188 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFT 188 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEEC
T ss_pred cccccccCCCCccCccChhhhccCCCC
Confidence 544344455678899999999876653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=247.42 Aligned_cols=176 Identities=30% Similarity=0.450 Sum_probs=154.1
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
++|++.+.||+|+||.||+|...+++.||+|.+..... ..+++.+|++++.+++||||+++++++.+++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 67889999999999999999988888999999875543 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 87 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999753 34588999999999999999999999 9999999999999999999999999999876543322
Q ss_pred eeeecccccCCchhhhccCCCcc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......|++.|+|||++.+.+++
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~ 183 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYS 183 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCC
T ss_pred ccccccccccccChhhhcCCCcc
Confidence 33445678899999999877653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=255.81 Aligned_cols=182 Identities=24% Similarity=0.360 Sum_probs=151.6
Q ss_pred hcCCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCC-CcchHHHHHHHHHHhcC-CCCccccccceEEeCC
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGT 243 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 243 (358)
..++|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3478999999999999999999862 45689999986543 33457789999999999 8999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCD-------------------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK 304 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk 304 (358)
..++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 999999999999999999754211 13478999999999999999999999 99999999
Q ss_pred CCcEEEcCCCcEEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCcc
Q 018311 305 SSNILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 305 ~~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
|+|||++.++.+||+|||+++.+..... .......||+.|+|||++.+.++.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 252 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 252 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC
Confidence 9999999999999999999988754433 234456788999999999887753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=251.27 Aligned_cols=179 Identities=26% Similarity=0.403 Sum_probs=157.2
Q ss_pred hcCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
..++|++.+.||+|+||.||+|... ++..||+|.+... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4478999999999999999999875 4888999998654 3345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999753 335589999999999999999999999 9999999999999999999999999999987665
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.........+|+.|+|||++.+.++.
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~ 190 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFS 190 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred ccccccCCccccCcCChhhhccCCCC
Confidence 55455567788999999999877653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=276.23 Aligned_cols=177 Identities=22% Similarity=0.234 Sum_probs=153.3
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC---CCcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 246 (358)
..++|++.++||+|+||.||+|+. .+++.||||++... .....+.+..|..++..+ +||||+.+++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 346799999999999999999986 46888999998643 123346678899999988 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||+++|+|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+|+.
T Consensus 419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999743 4589999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 327 LGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 327 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
..... ......+||+.|+|||++.+.+|.
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~ 520 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYG 520 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCCCBS
T ss_pred cccCC-cccccccCCCcccCHhhhcCCCCC
Confidence 54322 234567899999999999998875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-32 Score=261.08 Aligned_cols=174 Identities=24% Similarity=0.358 Sum_probs=145.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeC-----CEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~ 245 (358)
++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 7899999999999999999976 46889999999754332 346788999999999999999999999765 578
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
|+||||+. |+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 106 ~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 99999995 699999973 35689999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCce---------------------eeeecccccCCchhhhcc-CCCc
Q 018311 326 LLGAGKSH---------------------ITTRVMGTFGDFSVTLLR-NMPI 355 (358)
Q Consensus 326 ~~~~~~~~---------------------~~~~~~Gt~~y~APE~l~-~~~~ 355 (358)
........ .....+||+.|+|||++. +..|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~ 229 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 229 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCC
Confidence 87543221 235678999999999864 4444
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=247.11 Aligned_cols=172 Identities=30% Similarity=0.394 Sum_probs=144.0
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999874 5899999998655432 23567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998863 34589999999999999999999999 9999999999999999999999999999887533
Q ss_pred CceeeeecccccCCchhhhccCC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
. .......||+.|+|||++.+.
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~ 177 (311)
T 4agu_A 156 S-DYYDDEVATRWYRSPELLVGD 177 (311)
T ss_dssp -----------GGGCCHHHHHTC
T ss_pred c-cccCCCcCCccccChHHHhcC
Confidence 2 233456899999999999873
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=244.49 Aligned_cols=173 Identities=25% Similarity=0.361 Sum_probs=149.6
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC--cchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv 248 (358)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ....++.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 367899999999999999999874 789999999875432 3346688899999999 999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC----------------
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---------------- 312 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~---------------- 312 (358)
|||+++++|.+++.........+++..+..++.|++.||.|||++ +|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999975433335689999999999999999999999 9999999999999984
Q ss_pred ---CCcEEEeeecCceecCCCCceeeeecccccCCchhhhccCC
Q 018311 313 ---NFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 313 ---~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
...+||+|||+++...... ...||+.|+|||++.+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~ 205 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQEN 205 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTC
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCC
Confidence 4479999999999876432 34699999999999876
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=253.33 Aligned_cols=176 Identities=28% Similarity=0.473 Sum_probs=143.5
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCc----EEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGT----AVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++|++.+.||+|+||.||+|.+. +++ +||+|.+.... ....+++.+|+.++.+++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 67899999999999999999863 343 46888875433 345578999999999999999999999998754 789
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
++||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 94 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999753 35589999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... ......||+.|+|||++.+.+|+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 197 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYT 197 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCC
T ss_pred cCCcccccccCCCccccccChHHhccCCCC
Confidence 654332 33445678899999999888764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-32 Score=252.11 Aligned_cols=176 Identities=20% Similarity=0.311 Sum_probs=153.0
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
.++|.+.+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367999999999999999999874 57889999886432 22346688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 120 ~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999988742 4588999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
... .......||+.|+|||++.+.++.
T Consensus 193 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 219 (335)
T 2owb_A 193 YDG-ERKKVLCGTPNYIAPEVLSKKGHS 219 (335)
T ss_dssp STT-CCBCCCCSCCSSCCHHHHHTSCBC
T ss_pred cCc-ccccccCCCccccCHHHhccCCCC
Confidence 332 223456899999999999887764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=252.57 Aligned_cols=177 Identities=26% Similarity=0.373 Sum_probs=153.5
Q ss_pred CCCcccceecCCccEEEEEEEE-----eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEE--eCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI--EGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~~ 246 (358)
++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|++++.+++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6789999999999999999984 468899999997766556677999999999999999999999987 456689
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 999999999999999753 23489999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCce--eeeecccccCCchhhhccCCCcc
Q 018311 327 LGAGKSH--ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 327 ~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
....... ......||+.|+|||++.+.++.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 208 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 208 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEE
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCC
Confidence 7654432 23345688899999999887653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-32 Score=251.52 Aligned_cols=167 Identities=24% Similarity=0.335 Sum_probs=128.2
Q ss_pred cceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEEeecCCCC
Q 018311 179 DNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEYVNNGN 256 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~~gs 256 (358)
.+.||+|+||.||+|.. .+++.||+|.+... ....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999987 46899999998542 3467888999999997 9999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC---cEEEeeecCceecCCCCce
Q 018311 257 LEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF---DAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 257 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~---~~kl~DFGla~~~~~~~~~ 333 (358)
|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+++...... .
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~ 164 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-Q 164 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-C
Confidence 9999974 34689999999999999999999999 999999999999997665 89999999998765432 2
Q ss_pred eeeecccccCCchhhhccCCCcc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......||+.|+|||++.+.+|.
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~ 187 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYD 187 (325)
T ss_dssp -------------------CCCC
T ss_pred cccccCCCcCccCHHHhcCCCCC
Confidence 34456889999999999988764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=256.07 Aligned_cols=175 Identities=25% Similarity=0.396 Sum_probs=137.9
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCC-CCccccccceEEeCC--EE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGT--QR 245 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~--~~ 245 (358)
..++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 347899999999999999999975 5689999999865432 23456778999999997 999999999998654 68
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
|+||||++ |+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999996 699999874 3588999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCC--------------------CceeeeecccccCCchhhhccC-CCc
Q 018311 326 LLGAG--------------------KSHITTRVMGTFGDFSVTLLRN-MPI 355 (358)
Q Consensus 326 ~~~~~--------------------~~~~~~~~~Gt~~y~APE~l~~-~~~ 355 (358)
.+... ........+||+.|+|||++.+ .+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 208 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY 208 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCC
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCC
Confidence 76431 1122345689999999999987 444
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=248.88 Aligned_cols=168 Identities=23% Similarity=0.377 Sum_probs=148.1
Q ss_pred CCCcccceecCCccEEEEEEEEeC-C-------cEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-G-------TAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 245 (358)
++|++.+.||+|+||.||+|.... + ..||+|.+........+.+.+|++++.+++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 678999999999999999997532 3 47999998766556667899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc--------EE
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD--------AK 317 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~--------~k 317 (358)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999753 23488999999999999999999999 9999999999999998887 99
Q ss_pred EeeecCceecCCCCceeeeecccccCCchhhhccC
Q 018311 318 ISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 318 l~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
|+|||+++..... ....||+.|+|||++.+
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIEN 191 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHC
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCC
Confidence 9999999775432 34578999999999987
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=246.07 Aligned_cols=175 Identities=23% Similarity=0.337 Sum_probs=146.8
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|.+.+.||+|+||.||+|.. .++..+|+|++.... ....+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5788999999999999999976 468899999986543 33457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---cCCCcEEEeeecCceecC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLG 328 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl---~~~~~~kl~DFGla~~~~ 328 (358)
+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||+++.+.
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999865433345689999999999999999999999 99999999999999 456889999999998765
Q ss_pred CCCceeeeecccccCCchhhhccCC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
... ......||+.|+|||++.+.
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~~~ 201 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFKRD 201 (285)
T ss_dssp ----------CTTGGGCCHHHHTTC
T ss_pred Ccc--cCcCcccccCcCChHHhccC
Confidence 432 23456899999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=250.76 Aligned_cols=181 Identities=27% Similarity=0.373 Sum_probs=154.3
Q ss_pred cCCCcccceecCCccEEEEEEEE------eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeCCE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 244 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++.++ +||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 47899999999999999999975 3467899999975543 3346788999999999 99999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 018311 245 RILVYEYVNNGNLEQWLRGDMC--------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl 310 (358)
.++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999975421 122489999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 311 DENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 311 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+.++.+||+|||+++........ ......||+.|+|||++.+.+++
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 225 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC
Confidence 99999999999999987654432 33456788999999999877653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-32 Score=263.39 Aligned_cols=172 Identities=28% Similarity=0.317 Sum_probs=141.4
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeC------C
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------T 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 243 (358)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999975 468899999996542 23346688999999999999999999999654 4
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 67999999965 57776652 388999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
|+...... ......||+.|+|||++.+.+|+
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 241 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYK 241 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCCCC
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCCCC
Confidence 99875432 34557899999999999998875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=255.16 Aligned_cols=181 Identities=27% Similarity=0.283 Sum_probs=146.3
Q ss_pred HHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC-----CCcchHHHHHHHHHHhcCCCCccccccceEEeC
Q 018311 169 LQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN-----PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG 242 (358)
Q Consensus 169 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 242 (358)
+....++|++.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|++++.+++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 344557899999999999999999976 56889999988533 234457789999999999999999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCD------------------------------------RGYLTWEARMKILLGTAKA 286 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~~ 286 (358)
+..++||||+++|+|.+++...... ...+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998521110 1123567788899999999
Q ss_pred HHHHHhCCCCCeeeCCCCCCcEEEcCCC--cEEEeeecCceecCCCC---ceeeeecccccCCchhhhccC
Q 018311 287 LAYLHEAIEPKVVHRDIKSSNILIDENF--DAKISDFGLAKLLGAGK---SHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 287 l~yLH~~~~~~ivHrDlk~~NiLl~~~~--~~kl~DFGla~~~~~~~---~~~~~~~~Gt~~y~APE~l~~ 352 (358)
|.|||+. +|+||||||+|||++.++ .+||+|||+++.+.... ........||+.|+|||++.+
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 9999999 999999999999998776 89999999999764322 123456789999999999976
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-32 Score=255.40 Aligned_cols=177 Identities=19% Similarity=0.276 Sum_probs=144.8
Q ss_pred cCCCcccceecCCccEEEEEEEEeC------CcEEEEEEecCCCCcch-----------HHHHHHHHHHhcCCCCccccc
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQAD-----------KDFRVEVEAIGHVRHKNLVRL 235 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~HpnIv~l 235 (358)
.++|++.+.||+|+||.||+|.+.. ++.||+|.+........ ..+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3689999999999999999998754 47899999865542211 123346667788899999999
Q ss_pred cceEEeC----CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc
Q 018311 236 LGYCIEG----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (358)
Q Consensus 236 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~ 311 (358)
++++... ...++||||+ +++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 9998764 4589999999 9999999975 235699999999999999999999999 999999999999999
Q ss_pred --CCCcEEEeeecCceecCCCCce------eeeecccccCCchhhhccCCCcc
Q 018311 312 --ENFDAKISDFGLAKLLGAGKSH------ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 312 --~~~~~kl~DFGla~~~~~~~~~------~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.++.+||+|||+++.+...... ......||+.|+|||++.+.+|+
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 239 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS 239 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC
Confidence 8899999999999887543221 11345699999999999998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=249.00 Aligned_cols=176 Identities=22% Similarity=0.280 Sum_probs=142.6
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc---chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++.+++||||+++++++..++..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 78999999999999999999864 6889999998654322 2367889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 114 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 114 RLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp ECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999743 4588999999999999999999999 999999999999999999999999999988765
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
..........||+.|+|||++.+.++.
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~ 213 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHAT 213 (309)
T ss_dssp ----------CCGGGCCGGGTCC----
T ss_pred cccccccccCCCcCccCHHHHcCCCCC
Confidence 443344567899999999999887654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=246.11 Aligned_cols=176 Identities=29% Similarity=0.400 Sum_probs=146.8
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-----CcchHHHHHHHHHHhcCC---CCccccccceEEeCC
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-----GQADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGT 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~ 243 (358)
.++|++.+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|+.++..++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 47899999999999999999985 578999999985322 122356777888777664 999999999998754
Q ss_pred -----EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEE
Q 018311 244 -----QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318 (358)
Q Consensus 244 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl 318 (358)
..++||||+. |+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 5799999996 6999999754 223489999999999999999999999 9999999999999999999999
Q ss_pred eeecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 319 SDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 319 ~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+|||+++.+.... ......||+.|+|||++.+.+|+
T Consensus 162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 197 (308)
T 3g33_A 162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYA 197 (308)
T ss_dssp CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCC
T ss_pred eeCccccccCCCc--ccCCccccccccCchHHcCCCCC
Confidence 9999998765432 23557899999999999888764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=274.50 Aligned_cols=179 Identities=26% Similarity=0.402 Sum_probs=152.9
Q ss_pred HhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
...++|++.+.||+|+||.||+|.+.++..||||+++... ...++|.+|++++.+++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456788899999999999999999888889999997543 345789999999999999999999999865 67899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++|+|.++|.... ...+++..++.++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++.+...
T Consensus 342 ~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999997431 23488999999999999999999999 9999999999999999999999999999887543
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.........++..|+|||++.+.+|+
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~ 442 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFT 442 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCC
T ss_pred ceecccCCcCcccccCHHHhccCCCC
Confidence 22223345678899999999877653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=252.70 Aligned_cols=171 Identities=22% Similarity=0.339 Sum_probs=143.5
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCC--CccccccceEEeCCEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRH--KNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lv 248 (358)
.++|++.+.||+|+||.||+|...+++.||+|++..... ...+.+.+|+.++.+++| |||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 367999999999999999999888899999999865432 234678899999999986 9999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
||+ .+++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++ ++.+||+|||+++.+.
T Consensus 88 ~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp ECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 994 58899999974 34588999999999999999999999 999999999999997 6789999999999876
Q ss_pred CCCce-eeeecccccCCchhhhccC
Q 018311 329 AGKSH-ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 329 ~~~~~-~~~~~~Gt~~y~APE~l~~ 352 (358)
..... ......||+.|+|||++.+
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp -----------CCCCSSCCHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhh
Confidence 44322 3446789999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=242.89 Aligned_cols=175 Identities=23% Similarity=0.367 Sum_probs=151.9
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++.+++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 47899999999999999999976 458899999986443 223466889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc---EEEeeecCcee
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD---AKISDFGLAKL 326 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~---~kl~DFGla~~ 326 (358)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999988743 4588999999999999999999999 9999999999999976655 99999999988
Q ss_pred cCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 327 LGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 327 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
..... ......||+.|+|||++.+.+++
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 185 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYS 185 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBC
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCC
Confidence 76433 23456899999999999988764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=250.23 Aligned_cols=181 Identities=27% Similarity=0.409 Sum_probs=151.5
Q ss_pred cCCCcccceecCCccEEEEEEEE--------eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeC
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL--------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~--------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 242 (358)
.++|++.+.||+|+||.||+|+. .++..||+|.+..... ...+.+.+|++++.++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 36889999999999999999976 3567899999875533 3346788999999999 899999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl 310 (358)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999975431 123488999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 311 DENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 311 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+.++.+||+|||+++.+...... ......+|+.|+|||++.+.+++
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 237 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 237 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC
Confidence 99999999999999987654332 23345678899999999877653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=242.36 Aligned_cols=174 Identities=23% Similarity=0.381 Sum_probs=149.1
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC------cchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG------QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999875 689999999864431 23577999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC----cEEEeeec
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF----DAKISDFG 322 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~----~~kl~DFG 322 (358)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999742 4589999999999999999999999 999999999999998877 89999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+++.+.... ......||+.|+|||++.+.++.
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 189 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLG 189 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCC
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCC
Confidence 999875432 23456799999999999987764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=253.11 Aligned_cols=176 Identities=26% Similarity=0.436 Sum_probs=145.2
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCc----EEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGT----AVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++|++.+.||+|+||.||+|.+. +++ +|++|.+.... ......+.+|+.++.+++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 67899999999999999999863 344 38888775433 233456778999999999999999999886 466899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999753 34588899999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... ......||+.|+|||++.+.+++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 195 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYT 195 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCC
T ss_pred CcccccccccCCCCcccccChHHhccCCCC
Confidence 654432 34556788899999999887764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=242.69 Aligned_cols=176 Identities=24% Similarity=0.397 Sum_probs=134.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 6789999999999999999986 578999999985432 223467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999742 35689999999999999999999999 999999999999999999999999999998753
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
... ......||+.|+|||++.+.++.
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~ 190 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHG 190 (278)
T ss_dssp ---------------------------
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCC
Confidence 322 23346799999999999887653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=246.45 Aligned_cols=172 Identities=22% Similarity=0.323 Sum_probs=143.7
Q ss_pred CCCccc-ceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKD-NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~-~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++. +.||+|+||.||+|.. .+++.||+|.+..........+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567774 7899999999999975 57899999999776666677899999999885 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc---EEEeeecCceec
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD---AKISDFGLAKLL 327 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~---~kl~DFGla~~~ 327 (358)
|+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+++.+
T Consensus 92 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999743 4588999999999999999999999 9999999999999988776 999999999876
Q ss_pred CCCCc------eeeeecccccCCchhhhccC
Q 018311 328 GAGKS------HITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 328 ~~~~~------~~~~~~~Gt~~y~APE~l~~ 352 (358)
..... .......||+.|+|||++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195 (316)
T ss_dssp -----------------CCSGGGCCHHHHHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhc
Confidence 43211 12234569999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=249.08 Aligned_cols=179 Identities=21% Similarity=0.293 Sum_probs=150.6
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEe----CCEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQRIL 247 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~l 247 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|++++..++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 37899999999999999999986 6789999999876555556778999999999999999999999873 357899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999976444456799999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCce--------eeeecccccCCchhhhccCCC
Q 018311 328 GAGKSH--------ITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 328 ~~~~~~--------~~~~~~Gt~~y~APE~l~~~~ 354 (358)
...... ......||+.|+|||++.+.+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 219 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS 219 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCC
Confidence 421110 012346799999999998765
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=253.40 Aligned_cols=174 Identities=22% Similarity=0.357 Sum_probs=144.8
Q ss_pred HhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeC-------
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------- 242 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------- 242 (358)
...++|++.+.||+|+||.||+|.. .+++.||+|++...... ..+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4457899999999999999999976 67899999998654332 23699999999999999999998543
Q ss_pred -------------------------------CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 018311 243 -------------------------------TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291 (358)
Q Consensus 243 -------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH 291 (358)
...++||||++ |+|.+++.........+++..+..++.|++.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34889999997 5888877654334567999999999999999999999
Q ss_pred hCCCCCeeeCCCCCCcEEEc-CCCcEEEeeecCceecCCCCceeeeecccccCCchhhhccCCC
Q 018311 292 EAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 292 ~~~~~~ivHrDlk~~NiLl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
+. +|+||||||+|||++ +++.+||+|||+++.+..... .....||+.|+|||++.+..
T Consensus 159 ~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~ 217 (383)
T 3eb0_A 159 SL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGAT 217 (383)
T ss_dssp TT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCS
T ss_pred HC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCC
Confidence 98 999999999999998 689999999999998755432 34567899999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=251.25 Aligned_cols=186 Identities=23% Similarity=0.372 Sum_probs=154.9
Q ss_pred hHHHhcCCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEE
Q 018311 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCI 240 (358)
Q Consensus 168 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 240 (358)
++....++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++..++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34445578999999999999999999754 467899999865433 23456889999999999999999999999
Q ss_pred eCCEEEEEEeecCCCCHHHHHhccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC
Q 018311 241 EGTQRILVYEYVNNGNLEQWLRGDM------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314 (358)
Q Consensus 241 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~ 314 (358)
+.+..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence 9999999999999999999986422 1124578999999999999999999999 999999999999999999
Q ss_pred cEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 315 DAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 315 ~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.+||+|||+++........ ......||+.|+|||++.+.+++
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 218 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 218 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCC
Confidence 9999999999876543322 22345678999999999887653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=245.65 Aligned_cols=179 Identities=23% Similarity=0.372 Sum_probs=142.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++.+++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 6799999999999999999976 578999999987533 223466889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.+..
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999875433456689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. .......||+.|+|||++.+.++.
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~~~~~ 214 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHENGYN 214 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCC
T ss_pred CC-ccccccCCCeeEeChHHhCCCCCC
Confidence 32 223456799999999999887653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=247.08 Aligned_cols=174 Identities=28% Similarity=0.437 Sum_probs=150.0
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 367899999999999999999864 6899999999765544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---cCCCcEEEeeecCceecC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLG 328 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl---~~~~~~kl~DFGla~~~~ 328 (358)
+++++|.+++... +.+++..+..++.|++.||.|||+. +++||||||+||++ +.++.+||+|||+++...
T Consensus 88 ~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999998743 4588999999999999999999999 99999999999999 788999999999998754
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. ......||+.|+|||++.+.+++
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~ 185 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYS 185 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCC
T ss_pred CC---ccccccCCCCccChHHhccCCCC
Confidence 32 23446799999999999988764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=243.20 Aligned_cols=173 Identities=27% Similarity=0.443 Sum_probs=149.7
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEe----------
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE---------- 241 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---------- 241 (358)
.++|++.+.||+|+||.||+|... +++.||+|.+.... +.+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 367899999999999999999875 78999999986543 356789999999999999999998864
Q ss_pred ------CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc
Q 018311 242 ------GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD 315 (358)
Q Consensus 242 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~ 315 (358)
....++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 345799999999999999997532 24588999999999999999999999 9999999999999999999
Q ss_pred EEEeeecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 316 AKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 316 ~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+||+|||+++.+..... .....||+.|+|||++.+.++.
T Consensus 161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 199 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYG 199 (284)
T ss_dssp EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCC
T ss_pred EEECcchhheecccccc--ccccCCcccccChhhhccCCCc
Confidence 99999999998765432 3446799999999999987754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=241.69 Aligned_cols=176 Identities=26% Similarity=0.378 Sum_probs=153.3
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++..++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 367899999999999999999874 68999999986433 3345778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..+...
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999998863 34589999999999999999999999 9999999999999999999999999999876533
Q ss_pred Cc-eeeeecccccCCchhhhccCCCc
Q 018311 331 KS-HITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 331 ~~-~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.. .......||+.|+|||++.+.++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREF 184 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSB
T ss_pred cchhcccCCccccCccChHHHhcCCC
Confidence 22 23445789999999999988764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=251.72 Aligned_cols=171 Identities=26% Similarity=0.333 Sum_probs=145.8
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+...... ..+|++++.++ +||||+++++++.+++..|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 46789999999999999999976 46889999999655432 34578888777 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC----CcEEEeeecCcee
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN----FDAKISDFGLAKL 326 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~----~~~kl~DFGla~~ 326 (358)
|+++|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||+.++ +.+||+|||+++.
T Consensus 97 ~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 97 LMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999974 35689999999999999999999999 99999999999998433 3599999999998
Q ss_pred cCCCCceeeeecccccCCchhhhccCCCc
Q 018311 327 LGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 327 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+..... .....+||+.|+|||++.+.+|
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~ 197 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGY 197 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHH
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCC
Confidence 754332 3445789999999999987654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=242.97 Aligned_cols=175 Identities=21% Similarity=0.312 Sum_probs=152.3
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|.+.+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 67899999999999999999874 57889999885432 223456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 95 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 95 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp ECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999988742 4588999999999999999999999 999999999999999999999999999988753
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
... ......||+.|+|||++.+.++.
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~ 193 (294)
T 2rku_A 168 DGE-RKKVLCGTPNYIAPEVLSKKGHS 193 (294)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHTTSCBC
T ss_pred Ccc-ccccccCCCCcCCcchhccCCCC
Confidence 322 23456799999999999887654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=251.74 Aligned_cols=166 Identities=30% Similarity=0.406 Sum_probs=145.7
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc---chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|+..+.||+|+||.||+|.. .+++.||+|++...... ..+++.+|++++.+++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5588899999999999999986 57899999998654332 2356889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+. |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9996 6888888642 34589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCceeeeecccccCCchhhhcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
. ....||+.|+|||++.
T Consensus 207 ~-----~~~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVIL 223 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHH
T ss_pred C-----CcccCCcceeCHhhhc
Confidence 2 3468999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=243.45 Aligned_cols=173 Identities=28% Similarity=0.425 Sum_probs=147.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 6789999999999999999976 457789999885432 223466889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 89 e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 89 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred ecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999999743 4488999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. ......||+.|+|||++.+.++.
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~ 185 (279)
T 3fdn_A 162 S---RRTDLCGTLDYLPPEMIEGRMHD 185 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCC
T ss_pred c---cccccCCCCCccCHhHhccCCCC
Confidence 2 23456899999999999887654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=258.09 Aligned_cols=171 Identities=22% Similarity=0.343 Sum_probs=137.2
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--------cchHHHHHHHHHHhcCCCCccccccceEEeC
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--------QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG 242 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 242 (358)
..++|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|++++.+++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 457899999999999999999976 5678999999864321 11224788999999999999999999975 4
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC---CcEEEe
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN---FDAKIS 319 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~---~~~kl~ 319 (358)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.+ +.+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 668999999999999988863 45689999999999999999999999 99999999999999654 459999
Q ss_pred eecCceecCCCCceeeeecccccCCchhhhccC
Q 018311 320 DFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 320 DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
|||+++.+... .......||+.|+|||++.+
T Consensus 285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~ 315 (419)
T 3i6u_A 285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVS 315 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC-
T ss_pred ecccceecCCC--ccccccCCCCCccCceeeec
Confidence 99999987543 23456789999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=269.19 Aligned_cols=176 Identities=26% Similarity=0.399 Sum_probs=143.3
Q ss_pred CCCcccc-eecCCccEEEEEEEEe---CCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDN-IIGDGGYGVVYRGQLM---NGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~-~lG~G~fg~V~~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
+++.+.+ .||+|+||.||+|.+. ++..||||.++... ....+++.+|++++.+++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999764 45679999997654 3356789999999999999999999999976 568999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 414 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999999974 235689999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCceee--eecccccCCchhhhccCCCcc
Q 018311 329 AGKSHIT--TRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~--~~~~Gt~~y~APE~l~~~~~~ 356 (358)
....... ....+++.|+|||++.+.+|+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~ 517 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFS 517 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCC
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCC
Confidence 4433222 234456899999999877664
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=261.03 Aligned_cols=170 Identities=23% Similarity=0.343 Sum_probs=144.8
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++..++||||+++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 57899999999999999999874 68899999986543 3345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCcEEEeeecCceec
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISDFGLAKLL 327 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~---~~~~kl~DFGla~~~ 327 (358)
|+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+
T Consensus 117 ~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 117 CYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999988743 4588999999999999999999999 9999999999999976 455999999999987
Q ss_pred CCCCceeeeecccccCCchhhhccC
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
.... ......||+.|+|||++.+
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~~ 212 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLRK 212 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHTT
T ss_pred CCCc--cccccCCCcCeeCHHHHcc
Confidence 6443 2445689999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=251.01 Aligned_cols=179 Identities=26% Similarity=0.341 Sum_probs=144.9
Q ss_pred hHhhHHHhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCc-----------chHHHHHHHHHHhcCCCCccc
Q 018311 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ-----------ADKDFRVEVEAIGHVRHKNLV 233 (358)
Q Consensus 165 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~HpnIv 233 (358)
.+.++....++|++.+.||+|+||.||+|...+++.||+|++...... ..+.+.+|++++.+++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 456778888999999999999999999998888999999998543221 126788999999999999999
Q ss_pred cccceEEeC-----CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcE
Q 018311 234 RLLGYCIEG-----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308 (358)
Q Consensus 234 ~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~Ni 308 (358)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999998643 36899999997 689888874 334689999999999999999999999 999999999999
Q ss_pred EEcCCCcEEEeeecCceecCCCCceeeeecccccCCchhhhccC
Q 018311 309 LIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 309 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
|++.++.+||+|||+++...... ......||+.|+|||++.+
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTT
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcC
Confidence 99999999999999998654332 2345689999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=262.12 Aligned_cols=172 Identities=24% Similarity=0.392 Sum_probs=151.4
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999874 78999999986443 33457789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---cCCCcEEEeeecCce
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAK 325 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl---~~~~~~kl~DFGla~ 325 (358)
|||+.+|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999873 35689999999999999999999999 99999999999999 567899999999998
Q ss_pred ecCCCCceeeeecccccCCchhhhccCC
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.+.... ......||+.|+|||++.+.
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~~ 203 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHGT 203 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHTC
T ss_pred Eccccc--ccccCCCCccccCceeecCC
Confidence 876443 23456899999999999873
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=244.35 Aligned_cols=175 Identities=26% Similarity=0.435 Sum_probs=148.7
Q ss_pred CCC-cccceecCCccEEEEEEEE-----eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeC--CE
Q 018311 174 NRF-SKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQ 244 (358)
Q Consensus 174 ~~~-~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~ 244 (358)
++| ++.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+.+|++++.+++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 8899999999999999865 3688999999976543 3346789999999999999999999999874 67
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.++||||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccc
Confidence 89999999999999999642 388999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCce--eeeecccccCCchhhhccCCCcc
Q 018311 325 KLLGAGKSH--ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 325 ~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+........ ......||+.|+|||++.+.+++
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 215 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY 215 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEE
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCC
Confidence 988654432 23456788999999999887653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-31 Score=241.05 Aligned_cols=175 Identities=21% Similarity=0.266 Sum_probs=151.2
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ..+.+.+|+.++..+ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 36799999999999999999985 678999999886443 234578899999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc-----EEEeeecCce
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD-----AKISDFGLAK 325 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~-----~kl~DFGla~ 325 (358)
|+ +++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 87 ~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 99999999753 34589999999999999999999998 9999999999999987776 9999999999
Q ss_pred ecCCCCce------eeeecccccCCchhhhccCCCcc
Q 018311 326 LLGAGKSH------ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 326 ~~~~~~~~------~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.+...... ......||+.|+|||++.+.++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 196 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS 196 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCC
Confidence 87654321 23457899999999999988763
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=241.31 Aligned_cols=171 Identities=32% Similarity=0.518 Sum_probs=137.5
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCC----cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG----QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|.+ .++.||+|.+..... ...+.+.+|++++..++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 6789999999999999999987 588999999865432 23467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eeeCCCCCCcEEEcC--------CCcEEE
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK---VVHRDIKSSNILIDE--------NFDAKI 318 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~---ivHrDlk~~NiLl~~--------~~~~kl 318 (358)
||+++++|.+++.. ..+++..+..++.|++.||.|||+. + ++||||||+||+++. ++.+||
T Consensus 86 e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 86 EFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp ECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEE
Confidence 99999999999853 3588999999999999999999998 6 999999999999986 778999
Q ss_pred eeecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 319 SDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 319 ~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+|||+++...... .....||+.|+|||++.+.+++
T Consensus 158 ~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 192 (271)
T 3dtc_A 158 TDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFS 192 (271)
T ss_dssp CCCCC----------------CCGGGSCHHHHHHCCCS
T ss_pred ccCCccccccccc---ccCCCCccceeCHHHhccCCCC
Confidence 9999998765432 2346799999999999887653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=247.45 Aligned_cols=177 Identities=25% Similarity=0.417 Sum_probs=151.7
Q ss_pred CCCcccceecCCccEEEEEEEE-----eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCC--EEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT--QRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~ 246 (358)
++|++.+.||+|+||.||+|.+ .+++.||+|++........+.+.+|++++.+++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 6788999999999999999984 468899999997766656678999999999999999999999887543 689
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 121 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999753 34589999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCce--eeeecccccCCchhhhccCCCcc
Q 018311 327 LGAGKSH--ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 327 ~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+...... ......++..|+|||++.+.+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 226 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFS 226 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCC
Confidence 7654332 12335677889999999877653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=259.23 Aligned_cols=172 Identities=23% Similarity=0.337 Sum_probs=147.4
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-------------cchHHHHHHHHHHhcCCCCccccccce
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-------------QADKDFRVEVEAIGHVRHKNLVRLLGY 238 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~l~~~ 238 (358)
.++|++.+.||+|+||+||+|.. .+++.||+|.+..... ...+.+.+|+.++.+++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 47899999999999999999986 4578999999865431 234678899999999999999999999
Q ss_pred EEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC---c
Q 018311 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF---D 315 (358)
Q Consensus 239 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~---~ 315 (358)
+.+....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999998743 4589999999999999999999999 999999999999998776 6
Q ss_pred EEEeeecCceecCCCCceeeeecccccCCchhhhccCC
Q 018311 316 AKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 316 ~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+||+|||+++.+.... ......||+.|+|||++.+.
T Consensus 188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 223 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKKK 223 (504)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTTC
T ss_pred EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhccC
Confidence 9999999999876543 23456899999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=246.56 Aligned_cols=176 Identities=28% Similarity=0.473 Sum_probs=141.4
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCc----EEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGT----AVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++|++.+.||+|+||.||+|.+. +++ +|++|.+.... ....+.+.+|+.++.+++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 67999999999999999999863 344 46888775443 345678999999999999999999999998754 789
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
++||+.+|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 94 v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999753 34589999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... ......||+.|+|||++.+.+|+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 197 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYT 197 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCC
T ss_pred cCccccccccCCCccccccCHHHHcCCCCC
Confidence 543322 23345678899999999988764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=254.33 Aligned_cols=177 Identities=27% Similarity=0.424 Sum_probs=137.5
Q ss_pred CCCcccceecCCccEEEEEEEEeC----CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEe-CCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~l 247 (358)
.+|++.+.||+|+||.||+|.+.+ +..||+|.+..... ...+++.+|+.++.+++||||+++++++.. ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 346778999999999999997642 23689998865433 345678999999999999999999998764 467899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.+
T Consensus 169 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999974 234588999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCce---eeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSH---ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~---~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... ......+|+.|+|||++.+.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 274 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 274 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCC
Confidence 543221 22345678899999999887764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=239.72 Aligned_cols=167 Identities=28% Similarity=0.535 Sum_probs=143.5
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcc-------hHHHHHHHHHHhcCCCCccccccceEEeCCEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA-------DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 245 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+....... .+.+.+|++++.+++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 6789999999999999999986 578999999986543321 167889999999999999999999986544
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCcEEEcCCCc-----EEE
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDENFD-----AKI 318 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivHrDlk~~NiLl~~~~~-----~kl 318 (358)
++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+. + |+||||||+||+++.++. +||
T Consensus 97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 799999999999998874 334689999999999999999999998 8 999999999999988776 999
Q ss_pred eeecCceecCCCCceeeeecccccCCchhhhccC
Q 018311 319 SDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 319 ~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
+|||+++.... ......||+.|+|||++.+
T Consensus 171 ~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~ 200 (287)
T 4f0f_A 171 ADFGLSQQSVH----SVSGLLGNFQWMAPETIGA 200 (287)
T ss_dssp CCCTTCBCCSS----CEECCCCCCTTSCGGGSSC
T ss_pred CCCCccccccc----cccccCCCccccCchhhcc
Confidence 99999986543 2445789999999999943
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=243.72 Aligned_cols=177 Identities=28% Similarity=0.441 Sum_probs=146.7
Q ss_pred CCCcccceecCCccEEEEEEEEeC----CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEE-eCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCI-EGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~l 247 (358)
.+|++.+.||+|+||.||+|...+ ...+|+|.+..... ...+.+.+|+.++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 568889999999999999997532 23689998875443 33467889999999999999999999865 4567899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.+
T Consensus 105 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999974 334588999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCc---eeeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKS---HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~---~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
..... .......||+.|+|||++.+.+++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 210 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 210 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCC
Confidence 54332 123446788899999999887764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=242.46 Aligned_cols=176 Identities=26% Similarity=0.407 Sum_probs=149.0
Q ss_pred CCCcccc-eecCCccEEEEEEEEe---CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDN-IIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~-~lG~G~fg~V~~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|.+.+ .||+|+||.||+|... ++..||+|.+..... ...+.+.+|++++.+++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5666666 9999999999999753 578899999976533 3446788999999999999999999999 55678999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.+.
T Consensus 88 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999964 335589999999999999999999999 99999999999999999999999999999886
Q ss_pred CCCcee--eeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHI--TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~--~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... .....||+.|+|||++.+.+++
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 191 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFS 191 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEEC
T ss_pred cCcceeeccccccccccccCHHHhccCCCC
Confidence 544322 2334678999999999876653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=249.81 Aligned_cols=172 Identities=27% Similarity=0.396 Sum_probs=139.8
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999874 7889999998644322 112355799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
++ |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 96 6999988753 34588999999999999999999999 99999999999999999999999999998765332
Q ss_pred ceeeeecccccCCchhhhccCC
Q 018311 332 SHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.......||+.|+|||++.+.
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~ 175 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGS 175 (324)
T ss_dssp ---------CGGGCCHHHHTTC
T ss_pred -cccccccCcccccChhhhcCC
Confidence 223456889999999999873
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=254.20 Aligned_cols=170 Identities=22% Similarity=0.333 Sum_probs=144.1
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCC--CCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVR--HKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lv~ 249 (358)
.+|++.+.||+|+||.||+|...+++.||||.+..... ...+.+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 56899999999999999999887899999999865432 33467889999999996 599999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
| +.+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 136 E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 5688999999743 3588899999999999999999998 999999999999995 58999999999998764
Q ss_pred CCce-eeeecccccCCchhhhccC
Q 018311 330 GKSH-ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 330 ~~~~-~~~~~~Gt~~y~APE~l~~ 352 (358)
.... ......||+.|+|||++.+
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHC
T ss_pred CCccccCCCCCcCCCccChHHhhh
Confidence 4322 3455789999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=252.74 Aligned_cols=175 Identities=25% Similarity=0.352 Sum_probs=150.5
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++..++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 367999999999999999999874 688999999875532 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 112 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999743 35889999999999999999999831 7999999999999999999999999999765322
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......||+.|+|||++.+.+++
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~ 208 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYS 208 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCS
T ss_pred ---cccCCCCCCCeECHHHHcCCCCC
Confidence 23456899999999999988764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=240.14 Aligned_cols=174 Identities=26% Similarity=0.384 Sum_probs=153.9
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++..++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 5688899999999999999976 468899999986544 34457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.+....
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999863 4589999999999999999999999 99999999999999999999999999998876432
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.......||+.|+|||++.+.++.
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~ 197 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYD 197 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred -cccCccCCCcCccCHHHHhcCCCC
Confidence 223456899999999999988764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=241.41 Aligned_cols=173 Identities=27% Similarity=0.433 Sum_probs=151.5
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67899999999999999999874 57789999885432 223467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999743 3588999999999999999999998 999999999999999999999999999987653
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. .....||+.|+|||++.+.++.
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~ 190 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHD 190 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBC
T ss_pred cc---cccccCCCCcCCHHHhccCCCC
Confidence 22 3456899999999999988764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=247.91 Aligned_cols=187 Identities=25% Similarity=0.378 Sum_probs=155.1
Q ss_pred hhHHHhcCCCcccceecCCccEEEEEEEE------eCCcEEEEEEecCCCCc-chHHHHHHHHHHhcC-CCCccccccce
Q 018311 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHV-RHKNLVRLLGY 238 (358)
Q Consensus 167 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~ 238 (358)
..+....++|++.+.||+|+||.||+|.+ .+++.||+|.+...... ..+.+.+|++++.++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 34445568899999999999999999974 34678999998765432 345688999999999 79999999999
Q ss_pred EEeCC-EEEEEEeecCCCCHHHHHhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 018311 239 CIEGT-QRILVYEYVNNGNLEQWLRGDMCD------------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKS 305 (358)
Q Consensus 239 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~ 305 (358)
+...+ ..++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCcc
Confidence 87754 589999999999999999754221 22378999999999999999999999 999999999
Q ss_pred CcEEEcCCCcEEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCcc
Q 018311 306 SNILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 306 ~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+||+++.++.+||+|||+++.+..... .......||+.|+|||++.+.++.
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 228 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 228 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc
Confidence 999999999999999999988754433 234456789999999999887754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=240.07 Aligned_cols=174 Identities=25% Similarity=0.416 Sum_probs=144.4
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++..++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 378999999999999999999874 78999999985432 23346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999999743 3588999999999999999999999 99999999999999999999999999998875
Q ss_pred CCCceeeeecccccCCchhhhccCCCc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
... ......||+.|+|||++.+.++
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~ 187 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLY 187 (276)
T ss_dssp C---------------CCTGGGTTSCC
T ss_pred CCc--ceecccCCccccCHHHHcCCCC
Confidence 432 2345679999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=254.61 Aligned_cols=173 Identities=25% Similarity=0.331 Sum_probs=148.8
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCC--EEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT--QRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lv~ 249 (358)
++|++.++||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++.+++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 67999999999999999999874 58999999986543 234567889999999999999999999998755 789999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----cCCCcEEEeeecCce
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLAK 325 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl----~~~~~~kl~DFGla~ 325 (358)
||+++|+|.+++.... ....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 9999999999997542 223389999999999999999999999 99999999999999 778889999999999
Q ss_pred ecCCCCceeeeecccccCCchhhhccC
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
.+.... ......||+.|+|||++.+
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~ 189 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYER 189 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHH
T ss_pred EccCCC--ccccccCCccccCHHHhhc
Confidence 876433 2345679999999999865
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=239.58 Aligned_cols=171 Identities=20% Similarity=0.298 Sum_probs=148.7
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeC--CEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|.+ +++.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 6789999999999999999988 588999999875532 3346789999999999999999999999876 7789999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||+++|+|.+++... ....+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++...
T Consensus 89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999753 223589999999999999999999998 7 999999999999999999999999987654
Q ss_pred CCCCceeeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. ....||+.|+|||++.+.++.
T Consensus 164 ~~------~~~~~t~~y~aPE~~~~~~~~ 186 (271)
T 3kmu_A 164 QS------PGRMYAPAWVAPEALQKKPED 186 (271)
T ss_dssp SC------TTCBSCGGGSCHHHHHSCGGG
T ss_pred cc------cCccCCccccChhhhccCCCC
Confidence 32 235789999999999987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=247.34 Aligned_cols=177 Identities=28% Similarity=0.460 Sum_probs=143.4
Q ss_pred CCCcccceecCCccEEEEEEEEeC-----CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
++|++.+.||+|+||.||+|.... +..||+|.+..... ....++.+|++++.+++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 678888999999999999997643 24699999875533 234568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||+++|+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 124 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999975 235689999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCce--eeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSH--ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... ......+|+.|+|||++.+.+++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 228 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCC
Confidence 543221 22334568899999999887764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=249.57 Aligned_cols=177 Identities=25% Similarity=0.418 Sum_probs=153.3
Q ss_pred hhHHHhcCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc--------chHHHHHHHHHHhcC-CCCcccccc
Q 018311 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ--------ADKDFRVEVEAIGHV-RHKNLVRLL 236 (358)
Q Consensus 167 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l-~HpnIv~l~ 236 (358)
.......++|++.+.||+|+||.||+|... +|+.||||.+...... ..+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999874 7999999998654321 134577899999998 799999999
Q ss_pred ceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcE
Q 018311 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (358)
Q Consensus 237 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~ 316 (358)
+++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999742 4589999999999999999999999 99999999999999999999
Q ss_pred EEeeecCceecCCCCceeeeecccccCCchhhhccC
Q 018311 317 KISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 317 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
||+|||++..+.... ......||+.|+|||++.+
T Consensus 240 kl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~ 273 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKC 273 (365)
T ss_dssp EECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHH
T ss_pred EEEecCcccccCCCc--ccccCCCCCCccChhhccc
Confidence 999999999876543 2345789999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=261.37 Aligned_cols=172 Identities=23% Similarity=0.376 Sum_probs=148.5
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
.++|++.+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|++++.+++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 36799999999999999999986 478999999985322 234577899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc---CCCcEEEeeecCcee
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID---ENFDAKISDFGLAKL 326 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~---~~~~~kl~DFGla~~ 326 (358)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999988743 4589999999999999999999999 999999999999994 566899999999987
Q ss_pred cCCCCceeeeecccccCCchhhhccCC
Q 018311 327 LGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 327 ~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+.... ......||+.|+|||++.+.
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~~ 198 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRGT 198 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGSC
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCCC
Confidence 65432 24456899999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=246.96 Aligned_cols=174 Identities=26% Similarity=0.385 Sum_probs=147.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEe--------C
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE--------G 242 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------~ 242 (358)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|++++..++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6899999999999999999987 5789999999854432 234678899999999999999999999987 3
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
+..++||||++ |+|.+.+.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccC-CCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 46899999996 588887764 234589999999999999999999999 99999999999999999999999999
Q ss_pred CceecCCCCc---eeeeecccccCCchhhhccCCC
Q 018311 323 LAKLLGAGKS---HITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 323 la~~~~~~~~---~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
+++.+..... .......||+.|+|||++.+..
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 204 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER 204 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCC
Confidence 9998753222 2334568899999999998743
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=249.16 Aligned_cols=172 Identities=21% Similarity=0.355 Sum_probs=151.5
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCc---c--------------hHHHHHHHHHHhcCCCCccccc
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ---A--------------DKDFRVEVEAIGHVRHKNLVRL 235 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~---~--------------~~~~~~E~~~l~~l~HpnIv~l 235 (358)
.++|++.+.||+|+||.||+|.. +++.||+|.+...... . .+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 37899999999999999999988 9999999998533211 1 1789999999999999999999
Q ss_pred cceEEeCCEEEEEEeecCCCCHHHH------HhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcE
Q 018311 236 LGYCIEGTQRILVYEYVNNGNLEQW------LRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNI 308 (358)
Q Consensus 236 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~Ni 308 (358)
++++.+.+..++||||+++|+|.++ +... ....+++..+..++.|++.||.|||+ . +++||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 4421 24669999999999999999999998 8 999999999999
Q ss_pred EEcCCCcEEEeeecCceecCCCCceeeeecccccCCchhhhccCC
Q 018311 309 LIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 309 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+++.++.+||+|||+++..... ......||+.|+|||++.+.
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~ 225 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNE 225 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSC
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCC
Confidence 9999999999999999987543 34557899999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=245.56 Aligned_cols=185 Identities=22% Similarity=0.397 Sum_probs=142.0
Q ss_pred HHHhcCCCcccceecCCccEEEEEEEEe----CCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeC
Q 018311 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG 242 (358)
Q Consensus 169 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 242 (358)
+....++|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++.+++||||+++++++...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3344578999999999999999999764 345899999865432 2346688999999999999999999999865
Q ss_pred C-----EEEEEEeecCCCCHHHHHhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc
Q 018311 243 T-----QRILVYEYVNNGNLEQWLRGDM--CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD 315 (358)
Q Consensus 243 ~-----~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~ 315 (358)
+ ..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence 4 3599999999999999985432 2345699999999999999999999998 9999999999999999999
Q ss_pred EEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 316 AKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 316 ~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+||+|||+++.+...... ......+++.|+|||++.+.++.
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 227 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT 227 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCC
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCcc
Confidence 999999999887544322 23345678899999999988763
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=248.38 Aligned_cols=172 Identities=23% Similarity=0.383 Sum_probs=139.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++.+.||+|+||+||+|.. .+++.||+|++...... ..+.+.+|++++.+++||||+++++++.+++..++|||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 6899999999999999999975 57889999998654322 23567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE-----cCCCcEEEeeecCce
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI-----DENFDAKISDFGLAK 325 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl-----~~~~~~kl~DFGla~ 325 (358)
|++ |+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+ ++++.+||+|||+++
T Consensus 114 ~~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 114 YAE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp CCS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred cCC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 997 5999999743 4589999999999999999999999 99999999999999 455569999999998
Q ss_pred ecCCCCceeeeecccccCCchhhhccCCC
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.+.... .......||+.|+|||++.+.+
T Consensus 186 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~ 213 (329)
T 3gbz_A 186 AFGIPI-RQFTHEIITLWYRPPEILLGSR 213 (329)
T ss_dssp HHC------------CCTTCCHHHHTTCC
T ss_pred ccCCcc-cccCCCcCCccccCHHHhcCCC
Confidence 875332 2334568899999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=246.03 Aligned_cols=172 Identities=28% Similarity=0.447 Sum_probs=144.4
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 67999999999999999999874 5899999998655432 23557889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 105 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999988876 334589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeeecccccCCchhhhccCC
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.. ......||+.|+|||++.+.
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~ 199 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGD 199 (331)
T ss_dssp -------CCCCCTTCCHHHHTTC
T ss_pred cc-ccCCCcCCccccCcccccCC
Confidence 22 33456799999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=250.99 Aligned_cols=181 Identities=23% Similarity=0.371 Sum_probs=152.5
Q ss_pred cCCCcccceecCCccEEEEEEEEeC------CcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeCCE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 244 (358)
.++|++.+.||+|+||.||+|.... ...||+|.+..... ...+.+.+|++++..+ +||||+++++++...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4789999999999999999998632 24799999875543 3346688999999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC
Q 018311 245 RILVYEYVNNGNLEQWLRGDMC----------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~ 314 (358)
.++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 9999999999999999874321 134578999999999999999999999 999999999999999999
Q ss_pred cEEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCcc
Q 018311 315 DAKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 315 ~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.+||+|||+++.+..... .......||+.|+|||++.+.+++
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 244 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 244 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC
Confidence 999999999987654332 234456788999999999877653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=242.43 Aligned_cols=176 Identities=25% Similarity=0.344 Sum_probs=145.5
Q ss_pred CCCcccceecCCccEEEEEEEEeC----CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.+.||+|+||.||+|.+.+ +..||+|.+..... ...+.+.+|+.++.+++||||+++++++.+ +..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence 678999999999999999997643 33699999875532 345678899999999999999999998764 567899
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 91 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 91 MELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999753 34588999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...........+|+.|+|||++.+.++.
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 192 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFT 192 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCC
T ss_pred cccccccccCCCCcceeCchhhccCCCC
Confidence 5443344556778999999999877653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=241.45 Aligned_cols=170 Identities=29% Similarity=0.475 Sum_probs=134.2
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|++.+.||+|+||.||+|... ..||+|.+..... ...+.+.+|++++.+++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 378999999999999999999764 3599999865443 2346788999999999999999999965 5567899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999999964 335689999999999999999999999 9999999999999999999999999999876532
Q ss_pred C-ceeeeecccccCCchhhhcc
Q 018311 331 K-SHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 331 ~-~~~~~~~~Gt~~y~APE~l~ 351 (358)
. ........||+.|+|||++.
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp ----------CCCTTCCHHHHC
T ss_pred cccccccccCCCccccCchhhc
Confidence 2 22344578999999999997
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=242.23 Aligned_cols=180 Identities=26% Similarity=0.397 Sum_probs=150.8
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEe--CCEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRIL 247 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l 247 (358)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++.+++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 368899999999999999999874 689999999865432 334668899999999999999999998865 568899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK-----VVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-----ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
||||+++++|.+++.........+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999976543455689999999999999999999998 7 9999999999999999999999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+++.+..... ......||+.|+|||++.+.+++
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 194 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYN 194 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CC
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCC
Confidence 9988654322 22346799999999999987754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=243.55 Aligned_cols=176 Identities=30% Similarity=0.453 Sum_probs=143.9
Q ss_pred HhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcC--CCCccccccceEEeC----CE
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV--RHKNLVRLLGYCIEG----TQ 244 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~HpnIv~l~~~~~~~----~~ 244 (358)
...++|++.+.||+|+||.||+|+. +++.||+|++... ....+..|.+++..+ +||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 3447899999999999999999987 4899999998532 234455566666554 899999999999887 78
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeCCCCCCcEEEcCCCcEEEe
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI-----EPKVVHRDIKSSNILIDENFDAKIS 319 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~ivHrDlk~~NiLl~~~~~~kl~ 319 (358)
.++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.. .++|+||||||+|||++.++.+||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 9999999999999999964 24889999999999999999999751 3389999999999999999999999
Q ss_pred eecCceecCCCCce---eeeecccccCCchhhhccCCCc
Q 018311 320 DFGLAKLLGAGKSH---ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 320 DFGla~~~~~~~~~---~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
|||+++.+...... ......||+.|+|||++.+..+
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 223 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN 223 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCC
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccC
Confidence 99999887543322 1235689999999999987654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=249.80 Aligned_cols=175 Identities=21% Similarity=0.305 Sum_probs=142.3
Q ss_pred CCCcccceecCCccEEEEEEEEe----CCcEEEEEEecCCCCc-----------chHHHHHHHHHHhcCCCCccccccce
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQ-----------ADKDFRVEVEAIGHVRHKNLVRLLGY 238 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~HpnIv~l~~~ 238 (358)
++|++.+.||+|+||.||+|... ++..+|+|.+...... ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 67999999999999999999874 5788999998655432 11235678889999999999999999
Q ss_pred EEe----CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC
Q 018311 239 CIE----GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314 (358)
Q Consensus 239 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~ 314 (358)
+.. ....++||||+ +++|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 988 78899999999 99999999743 2689999999999999999999999 999999999999999887
Q ss_pred --cEEEeeecCceecCCCCce------eeeecccccCCchhhhccCCCcc
Q 018311 315 --DAKISDFGLAKLLGAGKSH------ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 315 --~~kl~DFGla~~~~~~~~~------~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.+||+|||+++.+...... ......||+.|+|||++.+.+++
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 238 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS 238 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC
Confidence 9999999999887543211 12456899999999999988754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=256.83 Aligned_cols=172 Identities=17% Similarity=0.223 Sum_probs=139.9
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC---CCcchHHHHHHH---HHHhcCCCCcccccc-------ce
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEV---EAIGHVRHKNLVRLL-------GY 238 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~HpnIv~l~-------~~ 238 (358)
.++|++.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 36788899999999999999985 56899999998633 233457788999 556666899999998 55
Q ss_pred EEeCC-----------------EEEEEEeecCCCCHHHHHhcccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 018311 239 CIEGT-----------------QRILVYEYVNNGNLEQWLRGDMCD---RGYLTWEARMKILLGTAKALAYLHEAIEPKV 298 (358)
Q Consensus 239 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 298 (358)
+.+++ ..|+||||+ +|+|.+++...... ...+++..+..++.|++.||.|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 68999999753211 12244578888999999999999999 99
Q ss_pred eeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeeecccccCCchhhhccCC
Q 018311 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 299 vHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+.
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhccc
Confidence 9999999999999999999999999997532 3455678 999999999876
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=249.68 Aligned_cols=170 Identities=27% Similarity=0.375 Sum_probs=141.3
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeC------C
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------T 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 243 (358)
.++|++.+.||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|++++..++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 37899999999999999999976 56899999998654322 345688999999999999999999999765 3
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 8899999874 3488999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccC-CCc
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRN-MPI 355 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~ 355 (358)
++..... .....||+.|+|||++.+ .+|
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~ 203 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRY 203 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCC
Confidence 9986532 345688999999999987 444
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=246.15 Aligned_cols=183 Identities=21% Similarity=0.326 Sum_probs=151.8
Q ss_pred hhHHHhcCCCccc-ceecCCccEEEEEEEEe-CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCC-CCccccccceEEe
Q 018311 167 RDLQSATNRFSKD-NIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVR-HKNLVRLLGYCIE 241 (358)
Q Consensus 167 ~~~~~~~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~ 241 (358)
.......++|.+. +.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++..++ ||||+++++++.+
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3445556778877 89999999999999764 68999999986543 234577889999999995 6999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCcEEE
Q 018311 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKI 318 (358)
Q Consensus 242 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~---~~~~kl 318 (358)
.+..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred CCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence 99999999999999999988643 235689999999999999999999999 9999999999999987 789999
Q ss_pred eeecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 319 SDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 319 ~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+|||+++.+.... ......||+.|+|||++.+.+++
T Consensus 176 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 211 (327)
T 3lm5_A 176 VDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPIT 211 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCC
T ss_pred eeCccccccCCcc--ccccccCCcCccCCeeecCCCCC
Confidence 9999999875432 23456899999999999988764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=244.23 Aligned_cols=173 Identities=28% Similarity=0.459 Sum_probs=139.2
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
++|++.+.||+|+||.||+|++ .++.||+|.+... ...+.+.+|++++.+++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5788899999999999999987 5788999998543 34577899999999999999999999886 45799999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc-EEEeeecCceecCCCCc
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD-AKISDFGLAKLLGAGKS 332 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~-~kl~DFGla~~~~~~~~ 332 (358)
+|+|.+++.... ....+++...+.++.|++.||.|||+....+|+||||||+||+++.++. +||+|||+++.+...
T Consensus 83 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 83 GGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 999999997532 1224788999999999999999999932228999999999999998886 799999999876432
Q ss_pred eeeeecccccCCchhhhccCCCcc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....||+.|+|||++.+.+++
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~ 181 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYS 181 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCC
T ss_pred --cccCCCCCceEChhhhCCCCCC
Confidence 2345799999999999988764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-31 Score=241.42 Aligned_cols=174 Identities=26% Similarity=0.420 Sum_probs=142.1
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEe----------
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE---------- 241 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---------- 241 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... ....+.+.+|+.++.+++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 36789999999999999999986 47899999998542 2334678899999999999999999998865
Q ss_pred ---CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEE
Q 018311 242 ---GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318 (358)
Q Consensus 242 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl 318 (358)
.+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 35689999999999999999752 23477889999999999999999999 9999999999999999999999
Q ss_pred eeecCceecCCCC-------------ceeeeecccccCCchhhhccCC
Q 018311 319 SDFGLAKLLGAGK-------------SHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 319 ~DFGla~~~~~~~-------------~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+|||+++...... ........||+.|+|||++.+.
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT 205 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSC
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC
Confidence 9999998765321 1123456799999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=243.04 Aligned_cols=164 Identities=26% Similarity=0.366 Sum_probs=145.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-CCccccccceEEe--CCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIE--GTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~--~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+... ..+.+.+|++++.+++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999975 67899999998643 3577899999999997 9999999999987 56789999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-cEEEeeecCceecC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKLLG 328 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~-~~kl~DFGla~~~~ 328 (358)
||+++++|.+++.. +++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+++.+.
T Consensus 113 e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998852 78899999999999999999999 999999999999999776 89999999999876
Q ss_pred CCCceeeeecccccCCchhhhccC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
.... .....||+.|+|||++.+
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVD 204 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTT
T ss_pred CCCc--cccccccccccChhhhcC
Confidence 5432 345689999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=248.46 Aligned_cols=175 Identities=27% Similarity=0.397 Sum_probs=143.6
Q ss_pred hcCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc-----chHHHHHHHHHHhcCCCCccccccceEEeCCEE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ-----ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 245 (358)
..++|++.+.||+|+||.||+|... +|+.||+|.+...... ....+.+|++++..++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3478999999999999999999864 5899999998643221 124678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999975 89988874 234588889999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCceeeeecccccCCchhhhccCCC
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.+.... .......||+.|+|||++.+..
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~ 188 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGAR 188 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCS
T ss_pred eccCCc-ccCCcccccccccCchHhhCCC
Confidence 875432 2334568999999999997643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=239.59 Aligned_cols=176 Identities=26% Similarity=0.402 Sum_probs=147.6
Q ss_pred CCcccceecCCccEEEEEEEEeC-C---cEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEE-EEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLMN-G---TAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR-ILV 248 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~~-~---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~-~lv 248 (358)
.|...++||+|+||.||+|.+.+ + ..+|+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999997532 2 3799999865443 3346788999999999999999999999876555 999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+.+|+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.+.
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999975 235688999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCc---eeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKS---HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~---~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.... .......+|+.|+|||.+.+.+++
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 206 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFT 206 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCC
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCC
Confidence 4321 123446788999999999988764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=243.98 Aligned_cols=177 Identities=27% Similarity=0.450 Sum_probs=145.5
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcE--EEEEEecCCC-CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTA--VAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~--vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.+.||+|+||.||+|.. .++.. +++|.+.... ....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 6789999999999999999976 45554 4999886533 33445688999999999 899999999999999999999
Q ss_pred EeecCCCCHHHHHhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcE
Q 018311 249 YEYVNNGNLEQWLRGDM------------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~ 316 (358)
|||+++|+|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997542 1234689999999999999999999999 99999999999999999999
Q ss_pred EEeeecCceecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 317 KISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 317 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
||+|||+++..... .......+++.|+|||++.+.++
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 218 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVY 218 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEE
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccC
Confidence 99999999854321 12234567889999999987765
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=239.80 Aligned_cols=175 Identities=27% Similarity=0.405 Sum_probs=148.7
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
.++|++.+.||+|+||.||+|... +|+.||+|.+.... ..+++.+|+.++..++||||+++++++...+..++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 477999999999999999999874 58999999986542 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.+....
T Consensus 106 ~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 106 CGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999998632 34589999999999999999999999 99999999999999999999999999998875432
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. ......||+.|+|||++.+.++.
T Consensus 180 ~-~~~~~~~~~~y~aPE~~~~~~~~ 203 (314)
T 3com_A 180 A-KRNTVIGTPFWMAPEVIQEIGYN 203 (314)
T ss_dssp S-CBCCCCSCGGGCCHHHHSSSCBC
T ss_pred c-ccCccCCCCCccChhhcCCCCCC
Confidence 2 23456899999999999987754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=236.81 Aligned_cols=176 Identities=28% Similarity=0.402 Sum_probs=147.7
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.+|....+||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++..++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455566999999999999986 568899999997766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCcEEEeeecCceecCCCC
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~-~~~~kl~DFGla~~~~~~~ 331 (358)
++++|.+++.... ....+++..+..++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||+++.+....
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999999997532 233467888999999999999999999 9999999999999987 8999999999998875432
Q ss_pred ceeeeecccccCCchhhhccCCC
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.......||+.|+|||++.+.+
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~ 199 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGP 199 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGG
T ss_pred -CcccccCCCccccChhhhcCCC
Confidence 2234568999999999997654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=247.91 Aligned_cols=172 Identities=28% Similarity=0.314 Sum_probs=138.0
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCC------
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------ 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 243 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36899999999999999999976 4688999999865432 23356889999999999999999999997654
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
..++||||++ |+|.+++.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999996 588888852 378899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
++...... ......||+.|+|||++.+.+|.
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 204 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYK 204 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCC
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCCCC
Confidence 98765432 23456899999999999988764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=242.17 Aligned_cols=172 Identities=30% Similarity=0.438 Sum_probs=148.9
Q ss_pred HHhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhc--CCCCccccccceEEeCC----
Q 018311 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH--VRHKNLVRLLGYCIEGT---- 243 (358)
Q Consensus 170 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~---- 243 (358)
....++|++.+.||+|+||.||+|+. +++.||+|.+... ....+..|.+++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34457899999999999999999987 6899999998532 34567788888876 78999999999998775
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCcEEEcCCCc
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH--------EAIEPKVVHRDIKSSNILIDENFD 315 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~ivHrDlk~~NiLl~~~~~ 315 (358)
..++||||+++|+|.+++.+ ..+++..+..++.|++.||.||| +. +|+||||||+|||++.++.
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred eeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence 78999999999999999974 24889999999999999999999 76 9999999999999999999
Q ss_pred EEEeeecCceecCCCCce---eeeecccccCCchhhhccCC
Q 018311 316 AKISDFGLAKLLGAGKSH---ITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 316 ~kl~DFGla~~~~~~~~~---~~~~~~Gt~~y~APE~l~~~ 353 (358)
+||+|||+++........ ......||+.|+|||++.+.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 226 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 226 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhccc
Confidence 999999999887654432 23456899999999999876
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=251.58 Aligned_cols=170 Identities=28% Similarity=0.385 Sum_probs=140.0
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeC------CEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------TQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~ 246 (358)
.+|++.+.||+|+||.||+|... +++.||||++..... ...+|+++++.++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999874 689999999865432 234699999999999999999988642 2367
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-CcEEEeeecCce
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAK 325 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~-~~~kl~DFGla~ 325 (358)
+||||+++ +|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 77776653322446699999999999999999999998 99999999999999955 678999999999
Q ss_pred ecCCCCceeeeecccccCCchhhhccCC
Q 018311 326 LLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 326 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.+..+.. .....||+.|+|||++.+.
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~ 231 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGA 231 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTC
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCC
Confidence 8754332 3346889999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-30 Score=236.18 Aligned_cols=170 Identities=26% Similarity=0.357 Sum_probs=145.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEe----CCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~ 246 (358)
..|++.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4577888999999999999976 567889999886443 2334668899999999999999999999875 45689
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCcEEEc-CCCcEEEeeecC
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK--VVHRDIKSSNILID-ENFDAKISDFGL 323 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivHrDlk~~NiLl~-~~~~~kl~DFGl 323 (358)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+. + ++||||||+|||++ +++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 999999999999999743 4588999999999999999999998 7 99999999999997 889999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCC
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+....... .....||+.|+|||++.+.
T Consensus 179 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~ 205 (290)
T 1t4h_A 179 ATLKRASF---AKAVIGTPEFMAPEMYEEK 205 (290)
T ss_dssp GGGCCTTS---BEESCSSCCCCCGGGGGTC
T ss_pred cccccccc---cccccCCcCcCCHHHHhcc
Confidence 97655432 3456799999999998764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=239.32 Aligned_cols=175 Identities=25% Similarity=0.407 Sum_probs=145.8
Q ss_pred cCCCcccc-eecCCccEEEEEEEE---eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 173 TNRFSKDN-IIGDGGYGVVYRGQL---MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 173 ~~~~~~~~-~lG~G~fg~V~~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
.++|++.+ .||+|+||.||+|.+ .+++.||+|.+..... ...+++.+|++++..++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788887 999999999999964 3467899999865432 2346789999999999999999999998 567789
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999974 34588999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCcee--eeecccccCCchhhhccCCCc
Q 018311 327 LGAGKSHI--TTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 327 ~~~~~~~~--~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+....... .....|++.|+|||++.+.++
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 197 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKF 197 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEE
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCC
Confidence 76544332 233456789999999987765
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=237.39 Aligned_cols=170 Identities=26% Similarity=0.397 Sum_probs=148.7
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC---------cchHHHHHHHHHHhcCC-CCccccccceEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---------QADKDFRVEVEAIGHVR-HKNLVRLLGYCIE 241 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~ 241 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 37899999999999999999987 4688999999865431 12345778999999995 9999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeee
Q 018311 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (358)
Q Consensus 242 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DF 321 (358)
.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999743 4588999999999999999999999 9999999999999999999999999
Q ss_pred cCceecCCCCceeeeecccccCCchhhhcc
Q 018311 322 GLAKLLGAGKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 322 Gla~~~~~~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
|+++.+..... .....||+.|+|||++.
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 169 GFSCQLDPGEK--LREVCGTPSYLAPEIIE 196 (298)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHH
T ss_pred cchhhcCCCcc--cccccCCccccCHHHhc
Confidence 99998765432 34567999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=242.37 Aligned_cols=172 Identities=22% Similarity=0.342 Sum_probs=144.1
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
.++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|++++..++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 378999999999999999999874 5889999998766666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 98 CPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999988642 34589999999999999999999999 9999999999999999999999999998653211
Q ss_pred ceeeeecccccCCchhhhcc
Q 018311 332 SHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~ 351 (358)
........||+.|+|||++.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~ 190 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVM 190 (302)
T ss_dssp HHC-----CCGGGCCHHHHH
T ss_pred ccccccccCChhhcCCeeec
Confidence 11223467999999999984
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=249.72 Aligned_cols=171 Identities=27% Similarity=0.365 Sum_probs=141.0
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCC------EEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------QRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~l 247 (358)
.+|++.+.||+|+||.||+|+...+..+|+|++...... ..+|+++++.++||||+++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 578999999999999999999877777999998654322 236999999999999999999996543 3789
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCcEEEeeecCcee
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKL 326 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~-~~~~~kl~DFGla~~ 326 (358)
||||++++ +...+.........+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||+|+.
T Consensus 116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999764 4444432222345689999999999999999999999 999999999999999 799999999999998
Q ss_pred cCCCCceeeeecccccCCchhhhccCCC
Q 018311 327 LGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 327 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
+..+.. .....||+.|+|||++.+..
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~ 217 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGAT 217 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCS
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCC
Confidence 754432 33568899999999998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-31 Score=266.07 Aligned_cols=169 Identities=25% Similarity=0.397 Sum_probs=139.7
Q ss_pred ceecCCccEEEEEEEEe---CCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~---~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
+.||+|+||.||+|.+. .++.||||+++.... ...+++.+|++++.+++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 467899999865432 335789999999999999999999999864 568999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce-
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH- 333 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~- 333 (358)
|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999974 34589999999999999999999999 9999999999999999999999999999987644322
Q ss_pred -eeeecccccCCchhhhccCCCcc
Q 018311 334 -ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 334 -~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......||+.|+|||++.+.+|+
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~ 550 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFS 550 (635)
T ss_dssp --------CGGGSCHHHHHHCCCC
T ss_pred ccccCCCCceeeeChhhhcCCCCC
Confidence 23345678899999999887764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=249.18 Aligned_cols=172 Identities=16% Similarity=0.233 Sum_probs=145.5
Q ss_pred CCCcccceecCCccEEEEEEEEeC---------CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCcccc----------
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN---------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVR---------- 234 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~---------- 234 (358)
++|++.+.||+|+||.||+|.... ++.||+|.+... +.+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 689999999999999999998753 789999998643 45788999999999999998
Q ss_pred -----ccceEEe-CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcE
Q 018311 235 -----LLGYCIE-GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308 (358)
Q Consensus 235 -----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~Ni 308 (358)
+++++.. ....++||||+ +++|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 5667766 68899999999 99999999753 135689999999999999999999999 999999999999
Q ss_pred EEcCCC--cEEEeeecCceecCCCCce------eeeecccccCCchhhhccCCCcc
Q 018311 309 LIDENF--DAKISDFGLAKLLGAGKSH------ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 309 Ll~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
|++.++ .+||+|||+++.+...... ......||+.|+|||++.+.+++
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 246 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS 246 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC
Confidence 999998 9999999999887543221 12345899999999999987764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-30 Score=237.25 Aligned_cols=176 Identities=22% Similarity=0.312 Sum_probs=147.2
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC----CcchHHHHHHHHHHhcCCCCccccccceEEe--CCEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQR 245 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 245 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++.+++||||+++++++.. ....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999986 468899999985432 2345678999999999999999999999853 4578
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
++||||++++ |.+++... ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 77777643 345689999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCC-ceeeeecccccCCchhhhccCCC
Q 018311 326 LLGAGK-SHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 326 ~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
.+.... ........||+.|+|||++.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 187 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLD 187 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCS
T ss_pred ccCccccccccccCCCCCCCcChhhccCcc
Confidence 875432 22344567999999999998754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=243.74 Aligned_cols=173 Identities=25% Similarity=0.382 Sum_probs=132.9
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-CCccccccceEE--------eC
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCI--------EG 242 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~--------~~ 242 (358)
..+|++.++||+|+||.||+|.. .+++.||+|++........+.+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 36899999999999999999986 478999999986665555677889999999996 999999999985 33
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeeCCCCCCcEEEcCCCcEEEee
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDENFDAKISD 320 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--ivHrDlk~~NiLl~~~~~~kl~D 320 (358)
...+++|||+. |+|.+++.... ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 45799999995 79999886432 335699999999999999999999998 7 99999999999999999999999
Q ss_pred ecCceecCCCCce-----------eeeecccccCCchhhhc
Q 018311 321 FGLAKLLGAGKSH-----------ITTRVMGTFGDFSVTLL 350 (358)
Q Consensus 321 FGla~~~~~~~~~-----------~~~~~~Gt~~y~APE~l 350 (358)
||+++.+...... ......||+.|+|||++
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222 (337)
T ss_dssp CTTCBCCSSCC------------------------------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence 9999887543221 11245699999999998
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-31 Score=244.48 Aligned_cols=180 Identities=26% Similarity=0.343 Sum_probs=146.8
Q ss_pred CCCcccceecCCccEEEEEEEE------eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|++.+.||+|+||.||+|.+ .++..||+|.+.... .....++.+|+.++.+++||||+++++++...+..+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 6899999999999999999973 357789999986443 234467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCcEEEee
Q 018311 247 LVYEYVNNGNLEQWLRGDMC---DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISD 320 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~---~~~~kl~D 320 (358)
+||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +|+||||||+|||++. +..+||+|
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECc
Confidence 99999999999999975432 124588999999999999999999999 9999999999999984 45699999
Q ss_pred ecCceecCCCCc-eeeeecccccCCchhhhccCCCcc
Q 018311 321 FGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 321 FGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
||+++....... .......||+.|+|||++.+.++.
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 223 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 223 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCC
Confidence 999987643322 223446789999999999877653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-30 Score=249.65 Aligned_cols=173 Identities=18% Similarity=0.229 Sum_probs=147.6
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcC------CCCccccccceEEeCCEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV------RHKNLVRLLGYCIEGTQR 245 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~~~~~~~~~~ 245 (358)
..+|++.+.||+|+||.||+|.. .+++.||||++... ......+.+|++++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 36799999999999999999976 45889999998653 22335677788887766 578999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc--EEEeeecC
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD--AKISDFGL 323 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~--~kl~DFGl 323 (358)
++||||+. ++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999995 6999998754 224489999999999999999999999 9999999999999999987 99999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
++..... .....||+.|+|||++.+.+|+
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~ 277 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYG 277 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCC
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCC
Confidence 9876532 3356899999999999988764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=242.29 Aligned_cols=176 Identities=26% Similarity=0.428 Sum_probs=144.9
Q ss_pred HHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEe-----
Q 018311 169 LQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIE----- 241 (358)
Q Consensus 169 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~----- 241 (358)
+....++|++.+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.++.++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 334458899999999999999999987 578999999986443 3457788999999998 79999999999987
Q ss_pred -CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 018311 242 -GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISD 320 (358)
Q Consensus 242 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~D 320 (358)
.+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 467899999999999999997532 24588999999999999999999999 999999999999999999999999
Q ss_pred ecCceecCCCCceeeeecccccCCchhhhcc
Q 018311 321 FGLAKLLGAGKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 321 FGla~~~~~~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
||++..+.... .......||+.|+|||++.
T Consensus 173 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 173 FGVSAQLDRTV-GRRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp CTTTC--------------CCGGGCCHHHHC
T ss_pred CcCceecCcCc-cccccccCCccccChhhhc
Confidence 99998765322 1234568999999999997
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=238.80 Aligned_cols=171 Identities=30% Similarity=0.394 Sum_probs=139.1
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEE-----------
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI----------- 240 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----------- 240 (358)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++.+++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 378999999999999999999875 48999999987665555677899999999999999999998873
Q ss_pred ---eCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCcE
Q 018311 241 ---EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDA 316 (358)
Q Consensus 241 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~-~~~~~ 316 (358)
.....++||||++ |+|.+++.. +.+++..+..++.|++.||.|||+. +|+||||||+||+++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 699999853 4588999999999999999999999 999999999999997 56799
Q ss_pred EEeeecCceecCCCCce--eeeecccccCCchhhhccC
Q 018311 317 KISDFGLAKLLGAGKSH--ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 317 kl~DFGla~~~~~~~~~--~~~~~~Gt~~y~APE~l~~ 352 (358)
||+|||+++.+...... ......||+.|+|||++.+
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS 198 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcC
Confidence 99999999987543221 2344678999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=241.25 Aligned_cols=169 Identities=22% Similarity=0.352 Sum_probs=141.7
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--------cchHHHHHHHHHHhcCCCCccccccceEEeCC
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--------QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 243 (358)
.++|++.+.||+|+||.||+|.. .+++.||||.+..... .....+.+|++++.+++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 36799999999999999999976 4578999999864321 12235788999999999999999999987654
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc---EEEee
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD---AKISD 320 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~---~kl~D 320 (358)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 8999999999999999873 35689999999999999999999999 9999999999999987654 99999
Q ss_pred ecCceecCCCCceeeeecccccCCchhhhcc
Q 018311 321 FGLAKLLGAGKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 321 FGla~~~~~~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
||+++.+.... ......||+.|+|||++.
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~ 189 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLV 189 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHH
T ss_pred Cccceeccccc--ccccccCCcCccCchhhc
Confidence 99999875432 234567999999999974
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=263.76 Aligned_cols=163 Identities=18% Similarity=0.160 Sum_probs=126.0
Q ss_pred eecCCccEEEEEEE-EeCCcEEEEEEecCCCC----------cchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEE
Q 018311 181 IIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG----------QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 181 ~lG~G~fg~V~~~~-~~~~~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv 248 (358)
..+.|++|.+..+. .-.|+.+++|.+..... ...++|.+|+++|.++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45677777776653 34688899999865421 1235688999999999 699999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||++|++|.++|.. .+.++.. .|+.||+.||.|+|++ +||||||||+||||++++.+||+|||+|+.+.
T Consensus 321 MEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999974 3456654 5889999999999999 99999999999999999999999999999875
Q ss_pred CCCceeeeecccccCCchhhhccCCC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
... ......+||++|||||++.|.+
T Consensus 391 ~~~-~~~~t~vGTp~YmAPE~l~g~~ 415 (569)
T 4azs_A 391 QDC-SWPTNLVQSFFVFVNELFAENK 415 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC----
T ss_pred CCC-ccccCceechhhccHHHhCCCC
Confidence 432 2345689999999999998864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-30 Score=234.29 Aligned_cols=175 Identities=22% Similarity=0.343 Sum_probs=145.1
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceE-EeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC-IEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lv~e 250 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..... .+.+..|++++..++|+|++..+..+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 47899999999999999999986 6788999998654332 23578899999999988877776665 56788899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---cCCCcEEEeeecCceec
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLL 327 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl---~~~~~~kl~DFGla~~~ 327 (358)
|+ +++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||+ ++++.+||+|||+++.+
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 99999998742 34589999999999999999999999 99999999999999 78999999999999987
Q ss_pred CCCCce------eeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSH------ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~------~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... ......||+.|+|||++.+.++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 193 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 193 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCC
Confidence 654321 23457899999999999988764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=264.77 Aligned_cols=180 Identities=23% Similarity=0.335 Sum_probs=147.4
Q ss_pred HHhcCCCcccceecCCccEEEEEEEEeC----CcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCE
Q 018311 170 QSATNRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 170 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 244 (358)
....++|++.+.||+|+||.||+|.+.. +..||+|++..... ...+.+.+|+.++.+++||||+++++++. .+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3345778999999999999999998632 45799998865433 33467889999999999999999999984 567
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.++||||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence 89999999999999999743 33588999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+.+............||+.|+|||++.+.+|+
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 570 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCC
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCC
Confidence 98765444444456778999999999887764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-30 Score=243.77 Aligned_cols=171 Identities=26% Similarity=0.384 Sum_probs=145.9
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeC-----CEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~ 246 (358)
++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|++++.+++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 6899999999999999999976 4688899999875433 2336788999999999999999999998764 3689
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||+. |+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 9999996 699998864 3488999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCce--eeeecccccCCchhhhccCC
Q 018311 327 LGAGKSH--ITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 327 ~~~~~~~--~~~~~~Gt~~y~APE~l~~~ 353 (358)
....... ......||+.|+|||++.+.
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 206 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNS 206 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTB
T ss_pred cCCCCCccccccccccccCCCCCHHhcCC
Confidence 7543222 13456899999999987644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=246.85 Aligned_cols=170 Identities=28% Similarity=0.383 Sum_probs=129.0
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeC------C
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------T 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 243 (358)
.++|++.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|++++..++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 37899999999999999999975 5688999999865432 2346688999999999999999999998754 5
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
..++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 7899988863 4589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccC-CCc
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRN-MPI 355 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~ 355 (358)
++..... .....||+.|+|||++.+ .+|
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~ 207 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHY 207 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSC
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCC
Confidence 9886432 345689999999999987 444
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-31 Score=238.35 Aligned_cols=172 Identities=31% Similarity=0.451 Sum_probs=139.6
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeC-CEEEEEEee
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-TQRILVYEY 251 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lv~e~ 251 (358)
.++|++.+.||+|+||.||+|+. +++.||+|.+.... ..+.+.+|++++.+++||||+++++++... +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 36789999999999999999987 58899999986542 456789999999999999999999987654 478999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 99999999997431 12378899999999999999999999 9999999999999999999999999999876432
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....+++.|+|||++.+.++.
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~ 192 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFS 192 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCC
T ss_pred ---ccCCCccccccCHHHhCCCCCC
Confidence 2234678999999999877653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=238.75 Aligned_cols=176 Identities=29% Similarity=0.428 Sum_probs=139.3
Q ss_pred CCCcccceecCCccEEEEEEEEe--CCc--EEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM--NGT--AVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~--~~~--~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|++.+.||+|+||.||+|++. +++ .||+|.+.... ....+.+.+|++++.+++||||+++++++..+. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 67999999999999999999863 233 68999886542 234567889999999999999999999987654 89
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 97 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 999999999999999753 24488999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCce--eeeecccccCCchhhhccCCCcc
Q 018311 327 LGAGKSH--ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 327 ~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+...... ......+|+.|+|||++.+.+++
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 202 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 202 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEE
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCC
Confidence 7654432 23346778899999999877653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=248.78 Aligned_cols=175 Identities=23% Similarity=0.328 Sum_probs=130.9
Q ss_pred CCCcc-cceecCCccEEEEEEEEe---CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEe--CCEEEE
Q 018311 174 NRFSK-DNIIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRIL 247 (358)
Q Consensus 174 ~~~~~-~~~lG~G~fg~V~~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l 247 (358)
+.|++ .++||+|+||.||+|... +++.||+|++.... ....+.+|+.++.+++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44555 468999999999999865 57889999986432 33568899999999999999999999965 678999
Q ss_pred EEeecCCCCHHHHHhccc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----cCCCcEEE
Q 018311 248 VYEYVNNGNLEQWLRGDM-----CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKI 318 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl----~~~~~~kl 318 (358)
||||+. |+|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999995 58888875321 1123489999999999999999999999 99999999999999 77899999
Q ss_pred eeecCceecCCCCc--eeeeecccccCCchhhhccCCC
Q 018311 319 SDFGLAKLLGAGKS--HITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 319 ~DFGla~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
+|||+++.+..... .......||+.|+|||++.+.+
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 211 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR 211 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCC
Confidence 99999998754322 2334578999999999998854
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-29 Score=232.38 Aligned_cols=175 Identities=22% Similarity=0.343 Sum_probs=148.4
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceE-EeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC-IEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lv~e 250 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..... .+++.+|+.++..++|++++..+..+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 37899999999999999999986 6789999998865432 34688999999999998877666655 56778899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---cCCCcEEEeeecCceec
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLL 327 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl---~~~~~~kl~DFGla~~~ 327 (358)
|+ +++|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+|||+ ++++.+||+|||+++.+
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 9999999974 234589999999999999999999999 99999999999999 58899999999999987
Q ss_pred CCCCce------eeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSH------ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~------~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... ......||+.|+|||++.+.+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 193 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 193 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCC
Confidence 654331 13456899999999999988764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=238.87 Aligned_cols=171 Identities=29% Similarity=0.491 Sum_probs=138.2
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHH--HhcCCCCccccccceEEe-----CCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA--IGHVRHKNLVRLLGYCIE-----GTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~HpnIv~l~~~~~~-----~~~~~ 246 (358)
++|++.+.||+|+||.||+|+. +++.||+|++... ....+..|.++ +..++||||+++++.+.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 6789999999999999999976 7899999998543 23444445444 445899999999986543 34678
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeeeCCCCCCcEEEcCCCcEEEee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI------EPKVVHRDIKSSNILIDENFDAKISD 320 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------~~~ivHrDlk~~NiLl~~~~~~kl~D 320 (358)
+||||+++|+|.+++... ..++..+..++.|++.||.|||+.. .++|+||||||+|||++.++.+||+|
T Consensus 89 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 999999999999999643 2478899999999999999999752 23899999999999999999999999
Q ss_pred ecCceecCCCCc-------eeeeecccccCCchhhhccCC
Q 018311 321 FGLAKLLGAGKS-------HITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 321 FGla~~~~~~~~-------~~~~~~~Gt~~y~APE~l~~~ 353 (358)
||+++.+..... .......||+.|+|||++.+.
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 203 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGA 203 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCC
Confidence 999988754321 122346799999999999873
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=234.86 Aligned_cols=173 Identities=21% Similarity=0.265 Sum_probs=133.7
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc-ch-HHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-AD-KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-~~-~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... .. ..+..+...+..++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 37899999999999999999986 57899999998654322 22 23444555688889999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||++ |+|.+++.........+++..+..++.|++.||.|||++. +++||||||+||+++.++.+||+|||+++.+..
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9996 5998887653334567999999999999999999999842 899999999999999999999999999988754
Q ss_pred CCceeeeecccccCCchhhhc
Q 018311 330 GKSHITTRVMGTFGDFSVTLL 350 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l 350 (358)
.. ......||+.|+|||++
T Consensus 163 ~~--~~~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 163 DV--AKDIDAGCKPYMAPERI 181 (290)
T ss_dssp ---------CCCCCCSCHHHH
T ss_pred cc--cccccCCCccccChhhc
Confidence 32 23345799999999997
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=241.92 Aligned_cols=179 Identities=25% Similarity=0.338 Sum_probs=136.5
Q ss_pred HHHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCE---
Q 018311 169 LQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ--- 244 (358)
Q Consensus 169 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 244 (358)
.....++|++.+.||+|+||.||+|.. .+++.||||++..... ....+..|++.+..++||||+++++++...+.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 345568999999999999999999987 4689999999865433 23456678888889999999999999976433
Q ss_pred ----EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeeCCCCCCcEEEcC-CCcEE
Q 018311 245 ----RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH--EAIEPKVVHRDIKSSNILIDE-NFDAK 317 (358)
Q Consensus 245 ----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--~~~~~~ivHrDlk~~NiLl~~-~~~~k 317 (358)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEE
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEE
Confidence 7899999975 666555433334566889999999999999999999 77 9999999999999997 89999
Q ss_pred EeeecCceecCCCCceeeeecccccCCchhhhccCCC
Q 018311 318 ISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 318 l~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
|+|||+++.+..... .....||+.|+|||++.+..
T Consensus 173 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~ 207 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQ 207 (360)
T ss_dssp ECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCS
T ss_pred EeeCCCceecCCCCC--cccccCCcceeCHHHHcCCC
Confidence 999999998765432 34568899999999997654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-31 Score=240.89 Aligned_cols=177 Identities=23% Similarity=0.376 Sum_probs=132.1
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|+.++.+++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 47899999999999999999975 468899999885433 3344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 251 YVNNGNLEQWLRGDM----CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
|+++++|.+++.... .....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 999999999986421 1235589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCc----eeeeecccccCCchhhhccC
Q 018311 327 LGAGKS----HITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 327 ~~~~~~----~~~~~~~Gt~~y~APE~l~~ 352 (358)
+..... .......||+.|+|||++.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200 (303)
T ss_dssp CC---------------CCCTTCCHHHHHH
T ss_pred eccCCCccchhhhcccCCCccccCHHHhcc
Confidence 654321 12344679999999999865
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=242.03 Aligned_cols=176 Identities=27% Similarity=0.326 Sum_probs=141.4
Q ss_pred HHhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc------chHHHHHHHHHHhcC----CCCccccccce
Q 018311 170 QSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ------ADKDFRVEVEAIGHV----RHKNLVRLLGY 238 (358)
Q Consensus 170 ~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l----~HpnIv~l~~~ 238 (358)
....++|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+..|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34458899999999999999999976 56889999998654322 122345688888888 89999999999
Q ss_pred EEeCCEEEEEEee-cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCcE
Q 018311 239 CIEGTQRILVYEY-VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDA 316 (358)
Q Consensus 239 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~-~~~~~ 316 (358)
+...+..++|||+ +.+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++ +++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 7899999999743 4589999999999999999999999 999999999999999 89999
Q ss_pred EEeeecCceecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 317 KISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 317 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
||+|||+++.+.... .....||+.|+|||++.+..+
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 215 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQY 215 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCB
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCC
Confidence 999999999876432 345679999999999877654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-30 Score=237.72 Aligned_cols=176 Identities=28% Similarity=0.410 Sum_probs=146.0
Q ss_pred cCCCcccceecCCccEEEEEEEE--eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcC---CCCccccccceEE-----
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL--MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHV---RHKNLVRLLGYCI----- 240 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~----- 240 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++..+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 47899999999999999999987 467899999885332 22223466677776655 8999999999987
Q ss_pred eCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEee
Q 018311 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISD 320 (358)
Q Consensus 241 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~D 320 (358)
.....++||||++ |+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999997 6999999754 234589999999999999999999999 999999999999999999999999
Q ss_pred ecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 321 FGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 321 FGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
||+++...... ......||+.|+|||++.+.++.
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 197 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYA 197 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCC
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCC
Confidence 99998765322 23456899999999999887753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=246.55 Aligned_cols=167 Identities=11% Similarity=0.013 Sum_probs=125.4
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC---cchHHHHHHH---HHHhcCCCCcccccc-------ceE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEV---EAIGHVRHKNLVRLL-------GYC 239 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~---~~l~~l~HpnIv~l~-------~~~ 239 (358)
.+|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+ ++|.. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 4588899999999999999986 4789999999976543 2234567774 55555 799988755 444
Q ss_pred EeC-----------------CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 018311 240 IEG-----------------TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR------MKILLGTAKALAYLHEAIEP 296 (358)
Q Consensus 240 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~l~yLH~~~~~ 296 (358)
..+ ...|+||||++ |+|.+++.... ..+.+..+ ..++.|++.||.|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 332 34799999998 89999997531 12344445 67889999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeeecccccCCchhhhccC
Q 018311 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 297 ~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
+|+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNA 265 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTC
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccC
Confidence 9999999999999999999999999999986431 225677799999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-30 Score=242.09 Aligned_cols=169 Identities=27% Similarity=0.363 Sum_probs=141.8
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeCCEE----
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR---- 245 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~---- 245 (358)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|+.++..++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 47899999999999999999976 46899999999754332 246788999999999999999999999876654
Q ss_pred --EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 246 --ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 246 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
++||||+. ++|.+++. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 68988774 2388999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccC-CCc
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRN-MPI 355 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~ 355 (358)
++..... .....||+.|+|||++.+ .++
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~ 219 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHY 219 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCC
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCC
Confidence 9876432 345788999999999987 443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-30 Score=237.34 Aligned_cols=173 Identities=21% Similarity=0.303 Sum_probs=148.0
Q ss_pred cCCCcccceecCCccEEEEEEEE--eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCC------ccccccceEEeCCE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL--MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHK------NLVRLLGYCIEGTQ 244 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp------nIv~l~~~~~~~~~ 244 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... ....+.+.+|++++..++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 37899999999999999999976 36889999998643 23346688899999888665 49999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC------------
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE------------ 312 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~------------ 312 (358)
.++||||+ +++|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 89999999754 224588999999999999999999999 9999999999999987
Q ss_pred -------CCcEEEeeecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 313 -------NFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 313 -------~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
++.+||+|||+++..... .....||+.|+|||++.+.+++
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~ 212 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWS 212 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCC
T ss_pred cccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCC
Confidence 678999999999886433 2356899999999999988764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=238.92 Aligned_cols=171 Identities=24% Similarity=0.391 Sum_probs=143.4
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeC-----CEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQR 245 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~ 245 (358)
.++|++.+.||+|+||.||+|... +|+.||||.+..... .....+.+|++++.+++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 368999999999999999999874 688999999864432 2345678999999999999999999988654 678
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
++||||+. |+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999996 699998864 3588999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCce---------eeeecccccCCchhhhccC
Q 018311 326 LLGAGKSH---------ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 326 ~~~~~~~~---------~~~~~~Gt~~y~APE~l~~ 352 (358)
.+...... ......||+.|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHS
T ss_pred ccccccccccCccccccchhhccccccccCCeeecc
Confidence 87533211 1223578999999998865
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=263.40 Aligned_cols=167 Identities=25% Similarity=0.381 Sum_probs=143.2
Q ss_pred cCCCcccceecCCccEEEEEEEEe--CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCE-----
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM--NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ----- 244 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 244 (358)
.++|++.+.||+|+||.||+|... +++.||||.+..... .....+.+|++++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 378999999999999999999874 589999999865432 334568899999999999999999999987654
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.|+||||+++++|.+++.. .+++..++.++.|++.||.|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999887652 589999999999999999999999 99999999999999886 8999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCC
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
+.+... ....||+.|+|||++.+.+
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~ 253 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP 253 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC
Confidence 987543 4567999999999998764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=245.97 Aligned_cols=175 Identities=22% Similarity=0.300 Sum_probs=147.6
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCC-CccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH-KNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|++.++||+|+||.||+|.. .+++.||||.+..... ..++..|++++..++| ++|..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 37899999999999999999986 5689999998765433 2357889999999987 555566666677889999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---cCCCcEEEeeecCceec
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLL 327 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl---~~~~~~kl~DFGla~~~ 327 (358)
|+ +++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||| +.++.+||+|||+++.+
T Consensus 84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 9999999974 234699999999999999999999999 99999999999999 68899999999999987
Q ss_pred CCCCce------eeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSH------ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~------~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... ......||+.|+|||++.+.+|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s 191 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS 191 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCC
Confidence 654322 12357899999999999998764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=245.10 Aligned_cols=174 Identities=25% Similarity=0.293 Sum_probs=145.6
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC--------CCccccccceEE---
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR--------HKNLVRLLGYCI--- 240 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------HpnIv~l~~~~~--- 240 (358)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... ....+.+.+|++++..++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999975 56889999998643 233466888999999885 788999999987
Q ss_pred -eCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-----
Q 018311 241 -EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF----- 314 (358)
Q Consensus 241 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~----- 314 (358)
.....++||||+ +++|.+++... ....+++..+..++.|++.||.|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence 456789999999 66777776543 2345899999999999999999999853 799999999999998775
Q ss_pred --------------------------------------------cEEEeeecCceecCCCCceeeeecccccCCchhhhc
Q 018311 315 --------------------------------------------DAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLL 350 (358)
Q Consensus 315 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l 350 (358)
.+||+|||+++..... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999987533 3346899999999999
Q ss_pred cCCCcc
Q 018311 351 RNMPIL 356 (358)
Q Consensus 351 ~~~~~~ 356 (358)
.+.+|.
T Consensus 266 ~~~~~~ 271 (397)
T 1wak_A 266 IGSGYN 271 (397)
T ss_dssp HTSCCC
T ss_pred cCCCCC
Confidence 998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=232.09 Aligned_cols=174 Identities=23% Similarity=0.361 Sum_probs=150.1
Q ss_pred HhcCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
...++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++.+++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999874 68899999985432 3345778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC---CcEEEeeecCc
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN---FDAKISDFGLA 324 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~---~~~kl~DFGla 324 (358)
||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999988643 3588999999999999999999999 99999999999999654 47999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCC
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+....... .....||+.|+|||++.+.
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~ 198 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRGT 198 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTTC
T ss_pred eeecCCCc--cccccCcccccChHHhcCC
Confidence 87654332 3345789999999998874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-30 Score=237.68 Aligned_cols=176 Identities=22% Similarity=0.328 Sum_probs=143.9
Q ss_pred hHHHhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCC--CCccccccceEEeCC
Q 018311 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVR--HKNLVRLLGYCIEGT 243 (358)
Q Consensus 168 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~ 243 (358)
.+....++|++.+.||+|+||.||+|...+++.||+|.+..... ...+.+.+|++++.+++ ||||+++++++...+
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 33444578999999999999999999888899999999864432 33467889999999997 599999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
..++||| +.+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+++ +.+||+|||+
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred EEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccc
Confidence 9999999 5688999999743 4588999999999999999999999 9999999999999964 8999999999
Q ss_pred ceecCCCCce-eeeecccccCCchhhhccC
Q 018311 324 AKLLGAGKSH-ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 324 a~~~~~~~~~-~~~~~~Gt~~y~APE~l~~ 352 (358)
++.+...... ......||+.|+|||++.+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTT
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhh
Confidence 9887544322 2345679999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-30 Score=238.62 Aligned_cols=175 Identities=26% Similarity=0.361 Sum_probs=149.4
Q ss_pred HhcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc------chHHHHHHHHHHhcCC--CCccccccceEEe
Q 018311 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ------ADKDFRVEVEAIGHVR--HKNLVRLLGYCIE 241 (358)
Q Consensus 171 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~ 241 (358)
...++|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+..|+.++.+++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999975 56889999998644221 2244667999999996 5999999999999
Q ss_pred CCEEEEEEeecCC-CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCcEEEe
Q 018311 242 GTQRILVYEYVNN-GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKIS 319 (358)
Q Consensus 242 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~-~~~~~kl~ 319 (358)
++..++|||++.+ ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++ +++.+||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence 9999999999976 899999974 24588999999999999999999999 999999999999999 78999999
Q ss_pred eecCceecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 320 DFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 320 DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
|||+++.+.... .....||+.|+|||++.+.++
T Consensus 193 Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 225 (320)
T 3a99_A 193 DFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRY 225 (320)
T ss_dssp CCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCB
T ss_pred eCcccccccccc---ccCCCCCccCCChHHhccCCC
Confidence 999999876432 345679999999999987665
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=246.23 Aligned_cols=172 Identities=28% Similarity=0.342 Sum_probs=132.5
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445567889999999998877778999999998542 235678899999876 8999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCC-------------CcE
Q 018311 253 NNGNLEQWLRGDMCDRGY---LTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-------------FDA 316 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~-------------~~~ 316 (358)
. |+|.+++......... ..+..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999999754322111 12334578999999999999999 99999999999999754 489
Q ss_pred EEeeecCceecCCCCce---eeeecccccCCchhhhccC
Q 018311 317 KISDFGLAKLLGAGKSH---ITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 317 kl~DFGla~~~~~~~~~---~~~~~~Gt~~y~APE~l~~ 352 (358)
||+|||+++.+...... ......||+.|+|||++.+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 99999999988654322 2345689999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-29 Score=234.64 Aligned_cols=171 Identities=19% Similarity=0.215 Sum_probs=123.0
Q ss_pred CCCcccc-eecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEe----CCEEEE
Q 018311 174 NRFSKDN-IIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQRIL 247 (358)
Q Consensus 174 ~~~~~~~-~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~l 247 (358)
++|.+.+ +||+|+||.||+|... +++.||+|.+... ..........+..++||||+++++++.. ....++
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 6788854 6999999999999874 6899999998543 2222223334567799999999999976 455899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCcEEEeeecCc
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISDFGLA 324 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~---~~~~kl~DFGla 324 (358)
||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 104 v~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 104 IMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999753 234689999999999999999999999 9999999999999976 456999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+..... ......||+.|+|||++.+.++.
T Consensus 179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~ 207 (336)
T 3fhr_A 179 KETTQN---ALQTPCYTPYYVAPEVLGPEKYD 207 (336)
T ss_dssp EEC-------------------------CHHH
T ss_pred eecccc---ccccCCCCcCccChhhhCCCCCC
Confidence 876532 23456889999999999877653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=236.96 Aligned_cols=165 Identities=27% Similarity=0.364 Sum_probs=139.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeCCE------
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ------ 244 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------ 244 (358)
++|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+.++..++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 6799999999999999999976 46899999998654322 23568899999999999999999999987653
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.++||||+. ++|.+++. ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999996 68877664 2388999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccC
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
+..... .....||+.|+|||++.+
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp TC------------CCSBCCSCHHHHSC
T ss_pred cCCCCC----ccccccCcCcCCHHHHhC
Confidence 876432 345688999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=239.65 Aligned_cols=176 Identities=26% Similarity=0.308 Sum_probs=146.5
Q ss_pred hcCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-CC-----ccccccceEEeCCE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HK-----NLVRLLGYCIEGTQ 244 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-Hp-----nIv~l~~~~~~~~~ 244 (358)
..++|++.+.||+|+||+||+|.. .+++.||||.+... .....++..|++++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 357899999999999999999976 46789999998643 223456777888888774 44 49999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc--CCCcEEEeeec
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID--ENFDAKISDFG 322 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~--~~~~~kl~DFG 322 (358)
.++||||++ |+|.+++... ....+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999995 6999999754 224589999999999999999999952 23899999999999994 57889999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+++.+... .....||+.|+|||++.+.+|+
T Consensus 207 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~ 236 (382)
T 2vx3_A 207 SSCQLGQR----IYQYIQSRFYRSPEVLLGMPYD 236 (382)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHTTCCCC
T ss_pred Cceecccc----cccccCCccccChHHHcCCCCC
Confidence 99987543 3456899999999999998764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-29 Score=233.36 Aligned_cols=173 Identities=21% Similarity=0.311 Sum_probs=146.3
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CC-cEEEEEEecCCCCcchHHHHHHHHHHhcCCCCc------cccccceEEeCCE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NG-TAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN------LVRLLGYCIEGTQ 244 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~~~~~ 244 (358)
.++|++.+.||+|+||.||+|... ++ ..||+|.+... ....+.+.+|+.++..++|+| ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 378999999999999999999763 34 68999998643 233466788999999887665 8999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE--------------
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI-------------- 310 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl-------------- 310 (358)
.++||||+ +++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence 99999999 77888877653 234589999999999999999999998 99999999999999
Q ss_pred -----cCCCcEEEeeecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 311 -----DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 311 -----~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+.++.+||+|||+++..... .....||+.|+|||++.+.+++
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~ 217 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWA 217 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCC
T ss_pred ccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCC
Confidence 67889999999999886433 2456899999999999988764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=243.19 Aligned_cols=169 Identities=27% Similarity=0.367 Sum_probs=134.9
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.+|...++||+|+||+|+.....+++.||||++..... ..+.+|++++..+ +||||+++++++.+....|+||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 56888899999999997766666899999999865432 2356799999999 7999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-----CCcEEEeeecCceec
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-----NFDAKISDFGLAKLL 327 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~-----~~~~kl~DFGla~~~ 327 (358)
. |+|.+++.... ..+.+..+..++.|++.||.|||+. +|+||||||+|||++. ...+||+|||+++.+
T Consensus 101 ~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 101 A-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp S-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred C-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 5 69999997532 2244445678999999999999999 9999999999999943 336889999999987
Q ss_pred CCCCc--eeeeecccccCCchhhhccC
Q 018311 328 GAGKS--HITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 328 ~~~~~--~~~~~~~Gt~~y~APE~l~~ 352 (358)
..... .......||+.|+|||++.+
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~ 200 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSE 200 (432)
T ss_dssp ------------CCSCTTSCCGGGTSC
T ss_pred cCCCcceeeccccCCCcCccChhhhhc
Confidence 64432 23445789999999999984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=236.71 Aligned_cols=177 Identities=24% Similarity=0.409 Sum_probs=143.8
Q ss_pred hhHHHhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCE
Q 018311 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 167 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 244 (358)
.+.....++|++.+.||+|+||.||+|.... .+|+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3444456889999999999999999998743 48999886432 2233567789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++ ++.+||+|||++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred eEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999742 34588999999999999999999999 999999999999998 679999999998
Q ss_pred eecCCCCc----eeeeecccccCCchhhhccC
Q 018311 325 KLLGAGKS----HITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 325 ~~~~~~~~----~~~~~~~Gt~~y~APE~l~~ 352 (358)
+....... .......||+.|+|||++.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSC
T ss_pred cccccccccccccccccCCCcccccChHHhhh
Confidence 87542211 12234569999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-29 Score=231.34 Aligned_cols=173 Identities=25% Similarity=0.347 Sum_probs=126.4
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-cchHHHHHHHH-HHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVE-AIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+..... ....++..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 6788999999999999999987 4689999999975533 23345556666 7778899999999999999999999999
Q ss_pred ecCCCCHHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 251 YVNNGNLEQWLRGDM-CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
|+++ +|.+++.... .....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9974 8888775311 12456899999999999999999999842 799999999999999999999999999988754
Q ss_pred CCceeeeecccccCCchhhhcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
.. ......||+.|+|||++.
T Consensus 179 ~~--~~~~~~gt~~y~aPE~~~ 198 (327)
T 3aln_A 179 SI--AKTRDAGCRPYMAPERID 198 (327)
T ss_dssp ----------------------
T ss_pred cc--ccccCCCCccccCceeec
Confidence 32 233457999999999983
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-29 Score=234.86 Aligned_cols=173 Identities=21% Similarity=0.261 Sum_probs=145.7
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-----------CCccccccceEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----------HKNLVRLLGYCIE 241 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~ 241 (358)
++|++.+.||+|+||.||+|.. .+++.||+|.+... ....+.+.+|++++.+++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 6899999999999999999986 57889999998643 223456788999988876 8999999999986
Q ss_pred CC----EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc------
Q 018311 242 GT----QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID------ 311 (358)
Q Consensus 242 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~------ 311 (358)
.+ ..+++|||+ +++|.+++... ....+++..+..++.|++.||.|||++. +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence 54 789999999 89999999753 2345899999999999999999999842 899999999999994
Q ss_pred CCCcEEEeeecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 312 ENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 312 ~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
..+.+||+|||+++..... .....||+.|+|||++.+.+++
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~ 213 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWG 213 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCC
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCC
Confidence 4458999999999887532 2346899999999999998764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=226.65 Aligned_cols=170 Identities=25% Similarity=0.333 Sum_probs=126.9
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc-ch-HHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ-AD-KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~-~~-~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
.++|++.+.||+|+||.||+|... +++.||+|.+...... .. +.+..+..++..++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 367888999999999999999874 6899999998755432 22 23444556788889999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
||+ ++.+..+... ....+++..+..++.|++.||.|||+ . +++||||||+||+++.++.+||+|||+++.+.
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5566555542 23458999999999999999999998 5 89999999999999999999999999998765
Q ss_pred CCCceeeeecccccCCchhhhcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
... ......||+.|+|||++.
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERID 197 (318)
T ss_dssp ------------CCTTCCHHHHC
T ss_pred CCc--cccccCCCccccChhhcc
Confidence 432 234567999999999995
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-29 Score=252.48 Aligned_cols=177 Identities=27% Similarity=0.401 Sum_probs=148.8
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEe------CCEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE------GTQR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~~ 245 (358)
++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ....+.+.+|++++.+++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6899999999999999999976 568899999886543 2334678899999999999999999998754 6778
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCc---EEEeeec
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD---AKISDFG 322 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~---~kl~DFG 322 (358)
++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999997532 223588899999999999999999999 9999999999999997665 9999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+++.+.... ......||+.|+|||++.+.+++
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s 201 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYT 201 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCS
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCC
Confidence 999876443 23457899999999999988764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=244.74 Aligned_cols=158 Identities=18% Similarity=0.281 Sum_probs=125.7
Q ss_pred cccceecCCccEEEEEEEEeCCcEEEEEEecCCCCc--------chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ--------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 177 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
...+.||+|+||.||+|.+ .+..+++|+....... ..+.+.+|++++.+++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 6788999987543221 123478999999999999999877777788888999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++++|.+++.. +..++.|++.||.|||++ +|+||||||+|||+++ .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999863 458899999999999999 9999999999999999 99999999999986
Q ss_pred CCCcee------eeecccccCCchhhhccC
Q 018311 329 AGKSHI------TTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 329 ~~~~~~------~~~~~Gt~~y~APE~l~~ 352 (358)
...... .....||+.|||||++.+
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence 532211 246789999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=212.62 Aligned_cols=143 Identities=12% Similarity=0.041 Sum_probs=126.9
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCc---chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++.+++||||+++++++..++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 68999999999999999999874 4899999999755432 2367889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
||+++++|.+++.. + ....+...++.|++.||.|||++ +|+||||||+|||++.++.+||+++|...
T Consensus 111 e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 111 EWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp ECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccccC
Confidence 99999999999853 2 34567889999999999999999 99999999999999999999999887653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=230.36 Aligned_cols=169 Identities=18% Similarity=0.192 Sum_probs=129.4
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC---cchHHHHHHHHHHhcCCC-Cccccccce----------
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRH-KNLVRLLGY---------- 238 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H-pnIv~l~~~---------- 238 (358)
..|...++||+|+||+||+|.+ .+|+.||||++..... ...+.+.+|+.++..++| +|...+..+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4577789999999999999985 5689999999873332 235779999999999987 332221111
Q ss_pred -----------EEe-----CCEEEEEEeecCCCCHHHHHhcc---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 018311 239 -----------CIE-----GTQRILVYEYVNNGNLEQWLRGD---MCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299 (358)
Q Consensus 239 -----------~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iv 299 (358)
+.. ....+++|+++ +++|.+++... ......+++..++.++.|++.||.|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111 12356777766 78999988421 11234577888999999999999999999 999
Q ss_pred eCCCCCCcEEEcCCCcEEEeeecCceecCCCCceeeeecccccCCchhhhcc
Q 018311 300 HRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 300 HrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~ 351 (358)
||||||+|||++.++.+||+|||+++..+.. .....| +.|+|||++.
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~ 280 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTA 280 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhh
Confidence 9999999999999999999999999886432 455678 9999999993
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-26 Score=209.38 Aligned_cols=147 Identities=24% Similarity=0.328 Sum_probs=128.2
Q ss_pred CCCccc-ceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHH-hcCCCCccccccceEEe----CCEEE
Q 018311 174 NRFSKD-NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAI-GHVRHKNLVRLLGYCIE----GTQRI 246 (358)
Q Consensus 174 ~~~~~~-~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~----~~~~~ 246 (358)
++|.+. +.||+|+||.||+|.. .+++.||+|.+.. ...+.+|+.++ ..++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567766 7899999999999976 5689999999853 24577888887 56699999999999987 67789
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCcEEEeeecC
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISDFGL 323 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~---~~~~kl~DFGl 323 (358)
+||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 999999999999999753 234689999999999999999999999 9999999999999998 78999999999
Q ss_pred ceecCCC
Q 018311 324 AKLLGAG 330 (358)
Q Consensus 324 a~~~~~~ 330 (358)
++.....
T Consensus 167 a~~~~~~ 173 (299)
T 3m2w_A 167 AKETTGE 173 (299)
T ss_dssp CEECTTC
T ss_pred ccccccc
Confidence 9887643
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-26 Score=207.79 Aligned_cols=154 Identities=17% Similarity=0.130 Sum_probs=123.3
Q ss_pred HhhHHHhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCc------------------chHHHHHHHHHHhcC
Q 018311 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ------------------ADKDFRVEVEAIGHV 227 (358)
Q Consensus 166 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~------------------~~~~~~~E~~~l~~l 227 (358)
+..+......|.+.+.||+|+||.||+|...+|+.||+|.+...... ....+.+|+.++.++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34445555667788999999999999998877999999998643221 235688999999999
Q ss_pred CCCccccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 018311 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSN 307 (358)
Q Consensus 228 ~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~N 307 (358)
+ | +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.|||+. +|+||||||+|
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence 9 5 777776544 56799999999999987 421 12457999999999999999 99999999999
Q ss_pred EEEcCCCcEEEeeecCceecCCCCceeeeecccccCCchhhhccC
Q 018311 308 ILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352 (358)
Q Consensus 308 iLl~~~~~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~ 352 (358)
||++ ++.+||+|||+|+. +..|+|||++.+
T Consensus 224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 9999 99999999999975 344778887753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4e-22 Score=179.97 Aligned_cols=143 Identities=19% Similarity=0.188 Sum_probs=109.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcE--EEEEEecCCCCcc------------------------hHHHHHHHHHHhc
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTA--VAVKKLLNNPGQA------------------------DKDFRVEVEAIGH 226 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~--vavK~l~~~~~~~------------------------~~~~~~E~~~l~~ 226 (358)
.-|++.+.||+|+||.||+|.. .+|+. ||||.++...... ...+.+|++++.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3466789999999999999987 78988 9999875432110 1357889999999
Q ss_pred CCCCccccccceEEeCCEEEEEEeecCC-C----CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeee
Q 018311 227 VRHKNLVRLLGYCIEGTQRILVYEYVNN-G----NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH-EAIEPKVVH 300 (358)
Q Consensus 227 l~HpnIv~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~ivH 300 (358)
+.|+|+....-+.. +..++||||+.+ | +|.++... .++.....++.|++.||.||| +. +|+|
T Consensus 127 l~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 127 AKEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HHHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred HHhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 98886532222222 356899999942 4 77766532 123456789999999999999 88 9999
Q ss_pred CCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 301 RDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 301 rDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|||||+|||+++ .++|+|||+|......
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 999999999998 9999999999887543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.1e-19 Score=167.82 Aligned_cols=148 Identities=14% Similarity=0.096 Sum_probs=102.8
Q ss_pred HhhHHHhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCC--------------cchHHH--------HHHHHH
Q 018311 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG--------------QADKDF--------RVEVEA 223 (358)
Q Consensus 166 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~--------------~~~~~~--------~~E~~~ 223 (358)
+..+.....-|++.+.||+|+||.||+|...+|+.||||.++.... ...... .+|...
T Consensus 87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n 166 (397)
T 4gyi_A 87 LHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF 166 (397)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence 3444444445899999999999999999988999999998753211 011112 234444
Q ss_pred HhcCCCCccccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 018311 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDI 303 (358)
Q Consensus 224 l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDl 303 (358)
|.++.+.++....-+.. ...+|||||+++++|.++.. . .....++.|++.+|.|||.. +||||||
T Consensus 167 L~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDL 231 (397)
T 4gyi_A 167 MKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDF 231 (397)
T ss_dssp HHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred HHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCC
Confidence 55443333321111111 22379999999988865332 1 23456789999999999998 9999999
Q ss_pred CCCcEEEcCCC----------cEEEeeecCceecC
Q 018311 304 KSSNILIDENF----------DAKISDFGLAKLLG 328 (358)
Q Consensus 304 k~~NiLl~~~~----------~~kl~DFGla~~~~ 328 (358)
||.|||+++++ .+.|+||+-+....
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99999998877 38999999887654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=3.4e-13 Score=121.13 Aligned_cols=145 Identities=13% Similarity=0.059 Sum_probs=112.6
Q ss_pred hcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEEe
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e 250 (358)
....|+....++.|+++.||++.. .+..+++|............+.+|++++..+. +.++.++++++...+..|+|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 335687788888899999999975 46789999875422222345888999998884 6778899999998899999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI------------------------------------ 294 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------ 294 (358)
+++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 91 ~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 91 EADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred ecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999875321 1123467888999999999810
Q ss_pred --------------------CCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 295 --------------------EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 295 --------------------~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
.+.++|+|+++.||+++++..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13599999999999998766678999998865
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.32 E-value=2.1e-12 Score=115.28 Aligned_cols=132 Identities=18% Similarity=0.135 Sum_probs=97.2
Q ss_pred eec-CCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCc--cccccceEEeCCEEEEEEeecCCCCH
Q 018311 181 IIG-DGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN--LVRLLGYCIEGTQRILVYEYVNNGNL 257 (358)
Q Consensus 181 ~lG-~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lv~e~~~~gsL 257 (358)
.++ .|..+.||++...+|..+++|..... ....+..|+.++..+.+.+ +.+++++...++..++||||++|.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 55669999998777788999986543 2245778999988885444 45688888777789999999999887
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 018311 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI------------------------------------------- 294 (358)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------------- 294 (358)
. ... .. ...++.+++..|..||+..
T Consensus 103 ~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 103 L--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp T--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred C--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 4 210 11 1256677777777887641
Q ss_pred ------------CCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 295 ------------EPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 295 ------------~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
...++|+|++|.||+++++..++|+|||.+..-
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 112999999999999988776789999998763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.14 E-value=5.9e-11 Score=111.56 Aligned_cols=142 Identities=12% Similarity=0.163 Sum_probs=104.6
Q ss_pred ccceecCCccEEEEEEEEeCCcEEEEEEec--CCC-CcchHHHHHHHHHHhcCC--CCccccccceEEeC---CEEEEEE
Q 018311 178 KDNIIGDGGYGVVYRGQLMNGTAVAVKKLL--NNP-GQADKDFRVEVEAIGHVR--HKNLVRLLGYCIEG---TQRILVY 249 (358)
Q Consensus 178 ~~~~lG~G~fg~V~~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~---~~~~lv~ 249 (358)
..+.|+.|.++.||+++..+ ..+++|+.. ... ......+.+|.+++..|. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35779999999999998754 577888654 222 122356788999999886 45577888887765 4489999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI----------------------------------- 294 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~----------------------------------- 294 (358)
||++|..+.+. ....++......++.+++..|..||+..
T Consensus 121 e~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99998777431 1123677888889999999999999731
Q ss_pred --------------------CCCeeeCCCCCCcEEEcCCCc--EEEeeecCcee
Q 018311 295 --------------------EPKVVHRDIKSSNILIDENFD--AKISDFGLAKL 326 (358)
Q Consensus 295 --------------------~~~ivHrDlk~~NiLl~~~~~--~kl~DFGla~~ 326 (358)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.66 E-value=3.6e-08 Score=90.23 Aligned_cols=137 Identities=20% Similarity=0.223 Sum_probs=95.9
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-CCc--cccccceEEeCC---EEEEEEeec
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKN--LVRLLGYCIEGT---QRILVYEYV 252 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-Hpn--Iv~l~~~~~~~~---~~~lv~e~~ 252 (358)
.+.++.|.+..||++. ..+++|.-... .....+.+|.+++..+. +.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4678999999999863 45778865322 23467888999998873 333 334443332222 348899999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI-------------------------------------- 294 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-------------------------------------- 294 (358)
+|.+|.+... ..++..+...++.+++..+..||+..
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988865332 12566777778888888888888511
Q ss_pred -----------------CCCeeeCCCCCCcEEEcC--CCcEEEeeecCceec
Q 018311 295 -----------------EPKVVHRDIKSSNILIDE--NFDAKISDFGLAKLL 327 (358)
Q Consensus 295 -----------------~~~ivHrDlk~~NiLl~~--~~~~kl~DFGla~~~ 327 (358)
.+.++|+|+++.||++++ ...+.|+||+.+..-
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 135899999999999998 566899999998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=4.9e-07 Score=82.90 Aligned_cols=137 Identities=16% Similarity=0.149 Sum_probs=90.4
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCC---ccccccceEE-eCCEEEEEEeecCC
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHK---NLVRLLGYCI-EGTQRILVYEYVNN 254 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~-~~~~~~lv~e~~~~ 254 (358)
.+.++.|....||+. +..+++|.-. .......+..|.++|..+.+. .+.+++.++. ..+..+++||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 467888998999987 4567777632 222346788999999998652 2456666654 34557899999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA----------------------------------------- 293 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~----------------------------------------- 293 (358)
..+...... .++......++.+++..|..||+.
T Consensus 98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 887653210 123333344444444444444432
Q ss_pred ----------------CCCCeeeCCCCCCcEEEcC---CCc-EEEeeecCceec
Q 018311 294 ----------------IEPKVVHRDIKSSNILIDE---NFD-AKISDFGLAKLL 327 (358)
Q Consensus 294 ----------------~~~~ivHrDlk~~NiLl~~---~~~-~kl~DFGla~~~ 327 (358)
..+.++|+|+.+.||+++. ++. +.|+||+.+..-
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2335799999999999987 455 589999988763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2e-06 Score=76.84 Aligned_cols=135 Identities=19% Similarity=0.128 Sum_probs=91.1
Q ss_pred eecCCccE-EEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-CCccccccceEEeCCEEEEEEeecCCCCH
Q 018311 181 IIGDGGYG-VVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (358)
Q Consensus 181 ~lG~G~fg-~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~~gsL 257 (358)
.+..|..+ .||+.... ++..+.+|.-.. ....++..|...|..+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445444 68987654 456788886532 23466888999988774 33466888899999999999999999887
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 018311 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI------------------------------------------- 294 (358)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------------- 294 (358)
.+..... ......+..+++..|.-||...
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 6644311 0112233444444444444310
Q ss_pred ------------CCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 295 ------------EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 295 ------------~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999887778999999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=5.7e-07 Score=83.99 Aligned_cols=79 Identities=10% Similarity=-0.019 Sum_probs=52.7
Q ss_pred ccee-cCCccEEEEEEEEe-------CCcEEEEEEecCCC---CcchHHHHHHHHHHhcCC-C--CccccccceEEeC--
Q 018311 179 DNII-GDGGYGVVYRGQLM-------NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVR-H--KNLVRLLGYCIEG-- 242 (358)
Q Consensus 179 ~~~l-G~G~fg~V~~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~~~~-- 242 (358)
.+.| +.|....+|+.... ++..+++|.-.... ......+..|..++..|. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4677 88889999998764 25678888653321 101245777888888774 2 3456777776554
Q ss_pred -CEEEEEEeecCCCCH
Q 018311 243 -TQRILVYEYVNNGNL 257 (358)
Q Consensus 243 -~~~~lv~e~~~~gsL 257 (358)
+..++|||+++|..+
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 346899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.21 E-value=1.6e-05 Score=73.25 Aligned_cols=142 Identities=17% Similarity=0.266 Sum_probs=80.1
Q ss_pred ceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-----CCcccccc-c--eEEeCCEEEEEEee
Q 018311 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----HKNLVRLL-G--YCIEGTQRILVYEY 251 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~l~-~--~~~~~~~~~lv~e~ 251 (358)
+.|+.|..+.||++...+| .+++|..... ..++..|..++..|. .|.++... + +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987554 5888887542 233444555555442 34444311 1 22356778999999
Q ss_pred cCCCCHH--------------HHHhcccC-C--C-------CCCCHHHH-------------------------------
Q 018311 252 VNNGNLE--------------QWLRGDMC-D--R-------GYLTWEAR------------------------------- 276 (358)
Q Consensus 252 ~~~gsL~--------------~~l~~~~~-~--~-------~~l~~~~~------------------------------- 276 (358)
++|..+. ..++.... . . ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986432 11121100 0 0 01122211
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 277 MKILLGTAKALAYLHE----------AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 277 ~~i~~~i~~~l~yLH~----------~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
..+..++..++.+|+. .....++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223345666653 0234899999999999998888999999998865
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=1.5e-05 Score=75.55 Aligned_cols=75 Identities=19% Similarity=0.169 Sum_probs=48.8
Q ss_pred cceecCCccEEEEEEEEe-CCcEEEEEEecCCCC-------cchHHHHHHHHHHhcCCC--Ccc-ccccceEEeCCEEEE
Q 018311 179 DNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-------QADKDFRVEVEAIGHVRH--KNL-VRLLGYCIEGTQRIL 247 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--pnI-v~l~~~~~~~~~~~l 247 (358)
.+.||.|.++.||++... +++.+++|....... .....+..|.+++..+.. |.. .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999653 467899997643211 123456778888887632 333 344432 4556789
Q ss_pred EEeecCCC
Q 018311 248 VYEYVNNG 255 (358)
Q Consensus 248 v~e~~~~g 255 (358)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.95 E-value=2.1e-05 Score=71.07 Aligned_cols=79 Identities=23% Similarity=0.329 Sum_probs=56.9
Q ss_pred CCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCC---ccccccceEEeCCEEEEEEee
Q 018311 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHK---NLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~~~~~~~lv~e~ 251 (358)
+....+.+|.|..+.||+.+..+|+.+.+|+-..........|..|.+.|+.|.-. -+.+++++ + ..++|||+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEe
Confidence 44556789999999999999999999999986555444456688899988877422 23344433 2 34789999
Q ss_pred cCCCCH
Q 018311 252 VNNGNL 257 (358)
Q Consensus 252 ~~~gsL 257 (358)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.0001 Score=67.55 Aligned_cols=140 Identities=14% Similarity=0.139 Sum_probs=91.2
Q ss_pred ccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC---CCccccccceEEeCCEEEEEEeecCC
Q 018311 178 KDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 178 ~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
..+.|+.|.+..+|+... ++..+.+|.-... ....+..|.+.|..|. ...+.+++.++...+..++|||++++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356799999999999976 5667888875432 3566888998888773 35677888888878889999999998
Q ss_pred CCHH--------H---HHhcccCCC----------C--------CCCHHHHH---HHHH----------------HHHHH
Q 018311 255 GNLE--------Q---WLRGDMCDR----------G--------YLTWEARM---KILL----------------GTAKA 286 (358)
Q Consensus 255 gsL~--------~---~l~~~~~~~----------~--------~l~~~~~~---~i~~----------------~i~~~ 286 (358)
..+. . -|+...... + .-+|.... ++.. .++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7541 1 122211100 0 12344321 1111 11111
Q ss_pred -HHHHHh-CCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 287 -LAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 287 -l~yLH~-~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
...|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123321 1246899999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00014 Score=69.38 Aligned_cols=31 Identities=10% Similarity=0.315 Sum_probs=27.6
Q ss_pred CCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 296 ~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
+.++|+|+++.||+++.++ ++|+||+.+..-
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 4899999999999998876 999999998763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0013 Score=60.00 Aligned_cols=157 Identities=11% Similarity=0.105 Sum_probs=84.3
Q ss_pred hhHHHhcCCCcc-----cceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-----CCcccccc
Q 018311 167 RDLQSATNRFSK-----DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----HKNLVRLL 236 (358)
Q Consensus 167 ~~~~~~~~~~~~-----~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~l~ 236 (358)
+++.....+|.. .+.|+.|....+|+....+| .+++|...... ...++..|..++..|. -|.++...
T Consensus 10 ~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~ 86 (322)
T 2ppq_A 10 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRK 86 (322)
T ss_dssp HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred HHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCC
Confidence 344444444543 34577788899999987655 57788775421 2234556777776653 23333211
Q ss_pred -c--eEEeCCEEEEEEeecCCCCHH-----H---------HHhcc--cCCCC---CC---CHHHHHH------------H
Q 018311 237 -G--YCIEGTQRILVYEYVNNGNLE-----Q---------WLRGD--MCDRG---YL---TWEARMK------------I 279 (358)
Q Consensus 237 -~--~~~~~~~~~lv~e~~~~gsL~-----~---------~l~~~--~~~~~---~l---~~~~~~~------------i 279 (358)
| +....+..+++|++++|..+. . -++.. ..... .. .|..... +
T Consensus 87 ~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l 166 (322)
T 2ppq_A 87 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 166 (322)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence 1 122346779999999875431 0 11111 00000 01 1221100 0
Q ss_pred HHHHHHHHHHHHhC----CCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 280 LLGTAKALAYLHEA----IEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 280 ~~~i~~~l~yLH~~----~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
...+...+.+++.. ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 11134455555532 134799999999999998876668999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00046 Score=62.56 Aligned_cols=139 Identities=14% Similarity=0.091 Sum_probs=73.5
Q ss_pred cceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCcc-ccccceEEeCCEEEEEEeec-CCCC
Q 018311 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVYEYV-NNGN 256 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~e~~-~~gs 256 (358)
.+.|+.|....+|++ ..+.+|.-...... ..+...|..++..+...++ .++++. +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678989999999998 45777766433211 1223457777766642223 344433 344457899999 5544
Q ss_pred HHH---------------H---HhcccC-CCCCCCH-HHHHHHHH--------------HHHHHHH----HHHh-CCCCC
Q 018311 257 LEQ---------------W---LRGDMC-DRGYLTW-EARMKILL--------------GTAKALA----YLHE-AIEPK 297 (358)
Q Consensus 257 L~~---------------~---l~~~~~-~~~~l~~-~~~~~i~~--------------~i~~~l~----yLH~-~~~~~ 297 (358)
+.. . ++.... ....... .....+.. .+...+. .+.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 321 0 111100 0000111 11111110 0111111 2211 12345
Q ss_pred eeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 298 VVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 298 ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667789999998865
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0016 Score=59.46 Aligned_cols=143 Identities=15% Similarity=0.108 Sum_probs=81.3
Q ss_pred ceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCC--ccccccce-----EEeCCEEEEEEeec
Q 018311 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHK--NLVRLLGY-----CIEGTQRILVYEYV 252 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~-----~~~~~~~~lv~e~~ 252 (358)
+.++ |....||+....+|+.+++|...... .....+..|..++..+... .+.+++.. ....+..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77889999877677778999875332 2345667788877766321 23334332 22356678999999
Q ss_pred CCCCHH-----H------H---Hhccc----C-CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC-
Q 018311 253 NNGNLE-----Q------W---LRGDM----C-DRGYLTWEAR----MKI---------------LLGTAKALAYLHEA- 293 (358)
Q Consensus 253 ~~gsL~-----~------~---l~~~~----~-~~~~l~~~~~----~~i---------------~~~i~~~l~yLH~~- 293 (358)
+|..+. . . ++... . .....++... ..+ ...+...+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 874321 1 1 11100 0 0111222111 001 11111223333321
Q ss_pred ---CCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 294 ---IEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 294 ---~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999998 4 899999988765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0025 Score=58.45 Aligned_cols=33 Identities=33% Similarity=0.357 Sum_probs=28.2
Q ss_pred CCCeeeCCCCCCcEEEcCC----CcEEEeeecCceec
Q 018311 295 EPKVVHRDIKSSNILIDEN----FDAKISDFGLAKLL 327 (358)
Q Consensus 295 ~~~ivHrDlk~~NiLl~~~----~~~kl~DFGla~~~ 327 (358)
...++|+|+.+.||+++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3479999999999999874 68999999998763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0067 Score=58.45 Aligned_cols=74 Identities=12% Similarity=0.087 Sum_probs=45.6
Q ss_pred cceecCCccEEEEEEEEeC-CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCcc-ccccceEEeCCEEEEEEeecCCCC
Q 018311 179 DNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVYEYVNNGN 256 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~e~~~~gs 256 (358)
.+.|+.|-...+|++...+ +..+.+|........ .-+...|..++..|...++ .++++.+ .+ .+||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 4568888889999998754 467788765332211 1123578888888865454 4566555 22 35999998743
Q ss_pred H
Q 018311 257 L 257 (358)
Q Consensus 257 L 257 (358)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0039 Score=59.60 Aligned_cols=71 Identities=15% Similarity=0.206 Sum_probs=46.8
Q ss_pred cceecCCccEEEEEEEEeC--------CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCcc-ccccceEEeCCEEEEEE
Q 018311 179 DNIIGDGGYGVVYRGQLMN--------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVY 249 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~ 249 (358)
.+.|+.|....+|++...+ +..+.+|..... .....+..|..++..|...++ .++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 4578888889999998753 467888876332 122456678888887743333 45555432 2 3899
Q ss_pred eecCCC
Q 018311 250 EYVNNG 255 (358)
Q Consensus 250 e~~~~g 255 (358)
||++|.
T Consensus 152 e~l~G~ 157 (429)
T 1nw1_A 152 EYIPSR 157 (429)
T ss_dssp CCCCEE
T ss_pred EEeCCc
Confidence 999763
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.029 Score=51.60 Aligned_cols=32 Identities=25% Similarity=0.342 Sum_probs=28.4
Q ss_pred CCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 296 ~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
..++|+|+.+.||++++++.+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47999999999999998888999999887653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.011 Score=55.42 Aligned_cols=142 Identities=15% Similarity=0.140 Sum_probs=79.9
Q ss_pred ceecCCccEEEEEEEEe--------CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCcc-ccccceEEeCCEEEEEEe
Q 018311 180 NIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~--------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~e 250 (358)
+.|..|-...+|++... +++.+.+|+--. .......+.+|.++++.|.-.++ .++++.+. + .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEE
Confidence 56766777889999764 246788886422 22345667789998887743223 45555443 3 29999
Q ss_pred ecCCCCHHH--------------H---HhcccC-CCCCC--CHHHHHHHHHHHH-------------------HHHHHHH
Q 018311 251 YVNNGNLEQ--------------W---LRGDMC-DRGYL--TWEARMKILLGTA-------------------KALAYLH 291 (358)
Q Consensus 251 ~~~~gsL~~--------------~---l~~~~~-~~~~l--~~~~~~~i~~~i~-------------------~~l~yLH 291 (358)
|++|..|.. . |+.... ..+.. -+.+..++..++. ..+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998754421 1 111100 01111 2344444443332 1233332
Q ss_pred ----hC-CCCCeeeCCCCCCcEEEcCC----CcEEEeeecCcee
Q 018311 292 ----EA-IEPKVVHRDIKSSNILIDEN----FDAKISDFGLAKL 326 (358)
Q Consensus 292 ----~~-~~~~ivHrDlk~~NiLl~~~----~~~kl~DFGla~~ 326 (358)
.. ....++|+|+.+.||+++.+ +.+.|+||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 12369999999999999876 7899999998865
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0029 Score=58.97 Aligned_cols=73 Identities=14% Similarity=0.038 Sum_probs=41.4
Q ss_pred cceecCCccEEEEEEEEeC---------CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCcc-ccccceEEeCCEEEEE
Q 018311 179 DNIIGDGGYGVVYRGQLMN---------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILV 248 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv 248 (358)
.+.|+.|..-.+|++...+ +..+.+|...... ....+...|.+++..+...++ .++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3567778888999997654 2577777654322 111234568887777743333 3555433 2 3689
Q ss_pred EeecCCCC
Q 018311 249 YEYVNNGN 256 (358)
Q Consensus 249 ~e~~~~gs 256 (358)
|||++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998753
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.05 E-value=0.02 Score=35.54 Aligned_cols=7 Identities=0% Similarity=0.045 Sum_probs=2.6
Q ss_pred HHHHHHH
Q 018311 21 LIVICLA 27 (358)
Q Consensus 21 ~i~i~~~ 27 (358)
++..+++
T Consensus 12 IA~gVVg 18 (44)
T 2l2t_A 12 IAAGVIG 18 (44)
T ss_dssp HHHHHHH
T ss_pred EEEeehH
Confidence 3333333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.99 E-value=0.05 Score=51.76 Aligned_cols=73 Identities=11% Similarity=0.082 Sum_probs=45.0
Q ss_pred cceecCCccEEEEEEEEeC--------CcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCcc-ccccceEEeCCEEEEEE
Q 018311 179 DNIIGDGGYGVVYRGQLMN--------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVY 249 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~ 249 (358)
.+.+..|-...+|++...+ +..+.++.-.... ...-+..+|.+++..+.-.++ .++++. .. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~--~~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIAD--FP--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEE--ET--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEE--cC--CCEEE
Confidence 3567777788999998753 5778887653322 222234568888777742233 344442 22 27899
Q ss_pred eecCCCC
Q 018311 250 EYVNNGN 256 (358)
Q Consensus 250 e~~~~gs 256 (358)
||++|..
T Consensus 150 efI~G~~ 156 (424)
T 3mes_A 150 EFIDGEP 156 (424)
T ss_dssp ECCCSEE
T ss_pred EEeCCcc
Confidence 9998865
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=94.54 E-value=0.031 Score=34.61 Aligned_cols=16 Identities=25% Similarity=0.075 Sum_probs=6.8
Q ss_pred HHHHHHhheeeecccc
Q 018311 32 VILGVSLWLTFRKKKS 47 (358)
Q Consensus 32 ii~~~~~~~~~r~~~~ 47 (358)
++++++++|++||+.+
T Consensus 26 i~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 26 VLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHCSC
T ss_pred HHHHHHHhheehhhhh
Confidence 3334444444444433
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.69 E-value=0.12 Score=31.62 Aligned_cols=11 Identities=18% Similarity=0.247 Sum_probs=4.7
Q ss_pred HHHHhheeeec
Q 018311 34 LGVSLWLTFRK 44 (358)
Q Consensus 34 ~~~~~~~~~r~ 44 (358)
+.+++|+++||
T Consensus 29 iv~~~~~~~rR 39 (41)
T 2k9y_A 29 LAGVGFFIHRR 39 (41)
T ss_dssp HHHHHHSSSSS
T ss_pred HHHHheeEeee
Confidence 33444444443
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.24 E-value=0.13 Score=33.18 Aligned_cols=28 Identities=18% Similarity=0.456 Sum_probs=20.0
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHhheee
Q 018311 15 GMQLWVLIVICLAVVFVVILGVSLWLTF 42 (358)
Q Consensus 15 ~~~~~~~i~i~~~~~~~ii~~~~~~~~~ 42 (358)
.+.+|++++.++++++++++++..+|+|
T Consensus 6 ~vp~WiIi~svl~GLLLL~Lii~~LwK~ 33 (54)
T 2l8s_A 6 RVPLWVILLSAFAGLLLLMLLILALWKI 33 (54)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCchHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 4678888888888777776666666654
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.69 E-value=0.15 Score=33.02 Aligned_cols=28 Identities=14% Similarity=0.307 Sum_probs=20.0
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHhheee
Q 018311 15 GMQLWVLIVICLAVVFVVILGVSLWLTF 42 (358)
Q Consensus 15 ~~~~~~~i~i~~~~~~~ii~~~~~~~~~ 42 (358)
.+.+|++++.+++++++++++++.+|+|
T Consensus 9 ~vp~wiIi~svl~GLllL~li~~~LwK~ 36 (54)
T 2knc_A 9 AIPIWWVLVGVLGGLLLLTILVLAMWKV 36 (54)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 4578888888888777776666666654
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=90.27 E-value=0.28 Score=30.05 Aligned_cols=28 Identities=14% Similarity=0.307 Sum_probs=20.0
Q ss_pred chhhHHHHHHHHHHHHHHHHHHHhheee
Q 018311 15 GMQLWVLIVICLAVVFVVILGVSLWLTF 42 (358)
Q Consensus 15 ~~~~~~~i~i~~~~~~~ii~~~~~~~~~ 42 (358)
...+|++++.++++++++.+.+..+|++
T Consensus 7 ~vp~wiIi~s~l~GLllL~li~~~LwK~ 34 (42)
T 2k1a_A 7 AIPIWWVLVGVLGGLLLLTILVLAMWKV 34 (42)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 4568888888888777776666666654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.02 E-value=0.061 Score=51.79 Aligned_cols=61 Identities=7% Similarity=0.037 Sum_probs=17.9
Q ss_pred ccceecCCccEEEEEEEEeC-CcEEEE------EEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEe
Q 018311 178 KDNIIGDGGYGVVYRGQLMN-GTAVAV------KKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241 (358)
Q Consensus 178 ~~~~lG~G~fg~V~~~~~~~-~~~vav------K~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 241 (358)
+.+.|| ||+||++.+.. ..+||+ |+.+... .+....+.+|..++..++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345665 99999998754 357888 7665432 2223467788999999999999999887653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.55 E-value=1.4 Score=37.52 Aligned_cols=87 Identities=8% Similarity=0.025 Sum_probs=60.8
Q ss_pred CCCccccccceEEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeeCCCCCC
Q 018311 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA-YLHEAIEPKVVHRDIKSS 306 (358)
Q Consensus 228 ~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~-yLH~~~~~~ivHrDlk~~ 306 (358)
.||++ -..+-.+.+.+.+.++.-+++.=+..++ .++...+++++.+++.... +++ .-+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence 57776 3334456677777777664443333343 2667888888887766555 444 5688889999
Q ss_pred cEEEcCCCcEEEeeecCceecC
Q 018311 307 NILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 307 NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|++++.++.++|.-.|+-..+.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~lp 135 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESLP 135 (219)
T ss_dssp GEEECTTCCEEESCCEETTTBS
T ss_pred eEEEeCCCcEEEEEcCCcccCC
Confidence 9999999999999999865553
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.84 E-value=0.83 Score=28.20 Aligned_cols=28 Identities=14% Similarity=0.154 Sum_probs=12.3
Q ss_pred HHHHHHHHHHHHHHHHHHHhheeeeccc
Q 018311 19 WVLIVICLAVVFVVILGVSLWLTFRKKK 46 (358)
Q Consensus 19 ~~~i~i~~~~~~~ii~~~~~~~~~r~~~ 46 (358)
...+++.+.+++++++++.+++++|+++
T Consensus 13 A~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 13 AAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred EEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 3344554444444444444444433333
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.82 E-value=0.77 Score=28.38 Aligned_cols=7 Identities=0% Similarity=0.154 Sum_probs=3.2
Q ss_pred eeccccC
Q 018311 42 FRKKKSR 48 (358)
Q Consensus 42 ~r~~~~~ 48 (358)
+..||++
T Consensus 33 ~~~RRr~ 39 (44)
T 2ks1_B 33 LFMRRRH 39 (44)
T ss_dssp HHHHTTT
T ss_pred HHhhhhH
Confidence 3455543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.70 E-value=0.86 Score=38.79 Aligned_cols=88 Identities=8% Similarity=0.092 Sum_probs=63.0
Q ss_pred CCCccccccceEEeCCEEEEEEeecCCC-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 018311 228 RHKNLVRLLGYCIEGTQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSS 306 (358)
Q Consensus 228 ~HpnIv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~ 306 (358)
.||+.+.. .+-.+.+.+.+.++.-+.+ ++.. ++ .++...+++++.+++....+++. -+|--|.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 57887765 4555667766666655422 2222 32 26778889999998887765553 478889999
Q ss_pred cEEEcCCCcEEEeeecCceecCC
Q 018311 307 NILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 307 NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
|++++.++.+++.-.|+--.+.+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P 131 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDP 131 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSC
T ss_pred eEEEcCCCCEEEEEccCccCCCC
Confidence 99999999999999987655543
|
| >1zza_A Stannin, AG8_1; helix, membrane protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.83 E-value=1.8 Score=29.49 Aligned_cols=31 Identities=23% Similarity=0.355 Sum_probs=16.0
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHhheeeeccc
Q 018311 16 MQLWVLIVICLAVVFVVILGVSLWLTFRKKK 46 (358)
Q Consensus 16 ~~~~~~i~i~~~~~~~ii~~~~~~~~~r~~~ 46 (358)
.+++.+++|+++++.+-+++..+|.+.|-+|
T Consensus 12 tgvvtv~viliavaalg~li~gcwcylrlqr 42 (90)
T 1zza_A 12 TGVVTVIVILIAIAALGALILGCWCYLRLQR 42 (90)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTTSSCS
T ss_pred cceEEehhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4555555555555444444555555544444
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 358 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-38 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-34 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-34 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-48
Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 8/181 (4%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
+ + IG G +G VY+G+ AV + + Q + F+ EV + RH N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
+GY Q +V ++ +L L + I TA+ + YLH
Sbjct: 68 LFMGYSTAP-QLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH-- 121
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK-SHITTRVMGTFGDFSVTLLRN 352
++HRD+KS+NI + E+ KI DFGLA + SH ++ G+ + ++R
Sbjct: 122 -AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 353 M 353
Sbjct: 181 Q 181
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (399), Expect = 2e-46
Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 21/195 (10%)
Query: 164 FTLRDLQSATNRFSK---------DNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNP 210
FT D A F+K + +IG G +G V G L VA+K L +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 211 GQAD-KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRG 269
+ +DF E +G H N++ L G + T +++ E++ NG+L+ +LR + G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---G 123
Query: 270 YLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329
T + +L G A + YL + VHRD+ + NIL++ N K+SDFGL++ L
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 330 GKSHIT-TRVMGTFG 343
S T T +G
Sbjct: 181 DTSDPTYTSALGGKI 195
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-46
Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 7/181 (3%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
+G G +G V+ G T VAVK L + F E + ++H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
RL + ++ EY+ NG+L +L+ LT + + A+ +A++ E
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353
+HRD++++NIL+ + KI+DFGLA+L+ + + +
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 354 P 354
Sbjct: 186 T 186
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 7e-46
Identities = 44/189 (23%), Positives = 82/189 (43%), Gaps = 11/189 (5%)
Query: 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKL-LNNPGQADKDFRVEVEAIGH 226
++ + F K + +G G GVV++ +G +A K + L E++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+V G + + E+++ G+L+Q L G + + K+ + K
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKG 116
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFS 346
L YL E + K++HRD+K SNIL++ + K+ DFG++ L + +GT S
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMS 171
Query: 347 VTLLRNMPI 355
L+
Sbjct: 172 PERLQGTHY 180
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-44
Identities = 38/168 (22%), Positives = 77/168 (45%), Gaps = 7/168 (4%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+ +G G +GVV G+ VA+K + ++ +F E + + ++ H+ LV+L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
G C + ++ EY+ NG L +L R + +++ +A+ YL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ +HRD+ + N L+++ K+SDFGL++ + + +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (386), Expect = 2e-44
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 16/186 (8%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVR 228
FS IG G +G VY + + N VA+KK+ + Q++ +D EV + +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H N ++ G + LV EY + + L + G + LA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLA 129
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVT 348
YLH ++HRD+K+ NIL+ E K+ DFG A ++ +GT +
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPE 181
Query: 349 LLRNMP 354
++ M
Sbjct: 182 VILAMD 187
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-44
Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 7/170 (4%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
+ + IG G +G+V+ G +N VA+K + +++DF E E + + H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
+L G C+E LV+E++ +G L +LR E + + L + +AYL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLE-- 118
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
E V+HRD+ + N L+ EN K+SDFG+ + + + +T
Sbjct: 119 -EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 167
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 9e-44
Identities = 52/195 (26%), Positives = 86/195 (44%), Gaps = 14/195 (7%)
Query: 167 RDLQSATNRFSKDNI-IGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQAD-KDFRVEV 221
+ L + +I +G G +G V +G VA+K L +AD ++ E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 222 EAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL 281
+ + + + +VRL+G C + +LV E G L ++L G R + ++L
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLH 116
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR--VM 339
+ + YL E VHRD+ + N+L+ AKISDFGL+K LGA S+ T R
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 340 GTFGDFSVTLLRNMP 354
++ +
Sbjct: 174 WPLKWYAPECINFRK 188
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-43
Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 7/182 (3%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
+ +G G +G V+ G T VA+K L + + F E + + +RH+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
+L E +V EY++ G+L +L+G+ YL + + A +AY+
Sbjct: 76 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER- 131
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353
VHRD++++NIL+ EN K++DFGLA+L+ + +
Sbjct: 132 --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 354 PI 355
Sbjct: 190 RF 191
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 7e-43
Identities = 46/176 (26%), Positives = 75/176 (42%), Gaps = 7/176 (3%)
Query: 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHV 227
S + IG G YG + + +G + K+L + + EV + +
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 228 RHKNLVRLLGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
+H N+VR I+ T L V EY G+L + +R YL E ++++
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 286 ALAYLHE--AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM 339
AL H V+HRD+K +N+ +D + K+ DFGLA++L S V
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 176
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 1e-42
Identities = 54/174 (31%), Positives = 83/174 (47%), Gaps = 19/174 (10%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241
IG G +G V+RG+ G VAVK ++ + E+ +RH+N++ + +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 242 G----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI--- 294
TQ LV +Y +G+L +L R +T E +K+ L TA LA+LH I
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 295 --EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI---TTRVMGTFG 343
+P + HRD+KS NIL+ +N I+D GLA + I +GT
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-42
Identities = 40/167 (23%), Positives = 73/167 (43%), Gaps = 7/167 (4%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
+ + +GDG +G VY+ Q A K + + +D+ VE++ + H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+LL ++ E+ G ++ + LT + T AL YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLH 127
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
+ K++HRD+K+ NIL + D K++DFG++ + +
Sbjct: 128 DN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (370), Expect = 3e-42
Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
+ + +G G YG VY G VAVK L + + ++F E + ++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
V+LLG C ++ E++ GNL +LR C+R ++ + + + A+ YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE- 132
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352
+ +HRD+ + N L+ EN K++DFGL++L+ + L
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 353 MPI 355
Sbjct: 191 NKF 193
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 3e-41
Identities = 54/218 (24%), Positives = 83/218 (38%), Gaps = 31/218 (14%)
Query: 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKL-LNNPGQADKDFR 218
L L+ N IG+G +G V++ + T VAVK L DF+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 219 VEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG--------------- 263
E + + N+V+LLG C G L++EY+ G+L ++LR
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 264 -----DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318
L+ ++ I A +AYL E K VHRD+ + N L+ EN KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 319 SDFGLAKLL-GAGKSHITTRVMGTFGDFSVTLLRNMPI 355
+DFGL++ + A +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 219
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-40
Identities = 54/183 (29%), Positives = 77/183 (42%), Gaps = 13/183 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
IG G +G V G G VAVK + + F E + +RH NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 63
Query: 234 RLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
+LLG +E + +V EY+ G+L +LR R L + +K L +A+ YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRN 352
VHRD+ + N+L+ E+ AK+SDFGL K S + LR
Sbjct: 122 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALRE 174
Query: 353 MPI 355
Sbjct: 175 KKF 177
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-40
Identities = 45/209 (21%), Positives = 77/209 (36%), Gaps = 31/209 (14%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQAD-KDFRVEVEAIGH 226
++G G +G V VAVK L ++ + E++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 227 V-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG-------------------DMC 266
+ H+N+V LLG C L++EY G+L +LR +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 267 DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
D LT+E + AK + +L VHRD+ + N+L+ KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 327 LGAGKSHIT-TRVMGTFGDFSVTLLRNMP 354
+ + +++ + L
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGI 242
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-40
Identities = 48/204 (23%), Positives = 78/204 (38%), Gaps = 26/204 (12%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGH 226
NR S +G G +G V VAVK L + + + E++ + +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 227 V-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC--------------DRGYL 271
+ H N+V LLG C G +++ EY G+L +LR D L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 272 TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331
E + AK +A+L +HRD+ + NIL+ KI DFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 332 SH-ITTRVMGTFGDFSVTLLRNMP 354
++ + + + N
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCV 223
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-40
Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 10/173 (5%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKN 231
+ +G+G YG V + AVAVK + + ++ + E+ + H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+ G+ EG + L EY + G L + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG-KSHITTRVMGTFG 343
+ HRDIK N+L+DE + KISDFGLA + + + ++ GT
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-39
Identities = 49/183 (26%), Positives = 75/183 (40%), Gaps = 17/183 (9%)
Query: 170 QSATNRFSK-DNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNN--PGQADKDFRVEVEAIG 225
S RF K D IG G + VY+G VA +L + + F+ E E +
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 226 HVRHKNLVRLLGYCIEGTQR----ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL 281
++H N+VR + +LV E + +G L+ +L+ + +
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCR 119
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILI-DENFDAKISDFGLAKLLGAGKSHITTRVMG 340
K L +LH P ++HRD+K NI I KI D GLA L ++ V+G
Sbjct: 120 QILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIG 175
Query: 341 TFG 343
T
Sbjct: 176 TPE 178
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 140 bits (355), Expect = 2e-39
Identities = 38/169 (22%), Positives = 75/169 (44%), Gaps = 9/169 (5%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
+ + +G G +GVV+R G A K ++ + R E++ + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
V L + + +++YE+++ G L + + + ++ + ++ + K L ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 293 AIEPKVVHRDIKSSNILI--DENFDAKISDFGLAKLLGAGKSHITTRVM 339
VH D+K NI+ + + K+ DFGL L +S T
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 188
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 4e-39
Identities = 42/186 (22%), Positives = 76/186 (40%), Gaps = 12/186 (6%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQADKD-FRVEVEAIGHVR 228
R IG+G +G V++G M+ AVA+K N + ++ F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H ++V+L+G E ++ E G L + + L + + + ALA
Sbjct: 67 HPHIVKLIGVITEN-PVWIIMELCTLGELRSF---LQVRKYSLDLASLILYAYQLSTALA 122
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVT 348
YL + VHRDI + N+L+ N K+ DFGL++ + + ++ +
Sbjct: 123 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 349 LLRNMP 354
+
Sbjct: 180 SINFRR 185
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 4e-39
Identities = 49/185 (26%), Positives = 78/185 (42%), Gaps = 14/185 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRH 229
F +G G +G VY + + +A+K L + R EVE H+RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
N++RL GY + T+ L+ EY G + + L+ + + A AL+Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSY 121
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTL 349
H +V+HRDIK N+L+ + KI+DFG + S T + GT +
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYLPPEM 175
Query: 350 LRNMP 354
+
Sbjct: 176 IEGRM 180
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-38
Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 9/167 (5%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
++++ IG G G VY + G VA++++ + E+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V L + G + +V EY+ G+L D+ + + +AL +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
+V+HRDIKS NIL+ + K++DFG + +S +T V
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-38
Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 22/198 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG---TAVAVKKLLNNPGQAD-KDFRVEVEAIGHV-R 228
N ++IG+G +G V + ++ A+K++ + D +DF E+E + +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEAR 276
H N++ LLG C L EY +GNL +LR L+ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 277 MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
+ A+ + YL + + +HRD+ + NIL+ EN+ AKI+DFGL++ T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 337 RVMGTFGDFSVTLLRNMP 354
++ L
Sbjct: 185 MGRLPVRWMAIESLNYSV 202
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-38
Identities = 44/184 (23%), Positives = 79/184 (42%), Gaps = 15/184 (8%)
Query: 178 KDNIIGDGGYGVVYRGQLMN---GTAVAVKKLLNNPGQAD--KDFRVEVEAIGHVRHKNL 232
+D +G G +G V +G VAVK L N + E + + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
VR++G C E +LV E G L ++L ++ + ++++ + + YL E
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR--VMGTFGDFSVTLL 350
VHRD+ + N+L+ AKISDFGL+K L A +++ + ++ +
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 351 RNMP 354
Sbjct: 183 NYYK 186
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 7e-38
Identities = 46/187 (24%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRH 229
F K ++G G +G VY+G + VA+K+L +A+K+ E + V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
++ RLLG C+ T +++ L+ + + + + + AK + Y
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG-KSHITTRVMGTFGDFSVT 348
L + ++VHRD+ + N+L+ KI+DFGLAKLLGA K + ++
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 349 LLRNMPI 355
+ +
Sbjct: 184 SILHRIY 190
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-37
Identities = 50/178 (28%), Positives = 86/178 (48%), Gaps = 14/178 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGT-----AVAVKKLLNNPGQADK-DFRVEVEAIGHV 227
+ ++ +IG G +G VY+G L + VA+K L + + DF E +G
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
H N++RL G + +++ EY+ NG L+++LR G + + +L G A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGM 123
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG--KSHITTRVMGTFG 343
YL VHRD+ + NIL++ N K+SDFGL+++L ++ T+
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-37
Identities = 48/190 (25%), Positives = 79/190 (41%), Gaps = 16/190 (8%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKL---LNNPGQADKDFRVEVEAIGH 226
+GDG +GVV RG+ +VAVK L + + +A DF EV A+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+ H+NL+RL G + ++ V E G+L +G+ + + A+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDR---LRKHQGHFLLGTLSRYAVQVAEG 123
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH--ITTRVMGTFGD 344
+ YL + +HRD+ + N+L+ KI DFGL + L H + F
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 345 FSVTLLRNMP 354
+ L+
Sbjct: 181 CAPESLKTRT 190
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-37
Identities = 47/185 (25%), Positives = 80/185 (43%), Gaps = 15/185 (8%)
Query: 179 DNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLV 233
+ +IG G +G VY G L++ AVK L + F E + H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 234 RLLGYCIEG-TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
LLG C+ ++V Y+ +G+L + + T + + L AK + +L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK---SHITTRVMGTFGDFSVTL 349
K VHRD+ + N ++DE F K++DFGLA+ + + H T ++
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 350 LRNMP 354
L+
Sbjct: 206 LQTQK 210
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (333), Expect = 3e-36
Identities = 42/169 (24%), Positives = 67/169 (39%), Gaps = 14/169 (8%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKD------FRVEVEAIGH 226
N FS IIG GG+G VY + G A+K L + + R+ + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+V + + + + +N G+L L G +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILG 119
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335
L ++H VV+RD+K +NIL+DE+ +ISD GLA K H +
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 165
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 130 bits (329), Expect = 1e-35
Identities = 37/185 (20%), Positives = 72/185 (38%), Gaps = 11/185 (5%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
+ + +G G +GVV+R G K + + E+ + + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
+ L + + +L+ E+++ G L + + ++ + + + L ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 293 AIEPKVVHRDIKSSNILIDENFDA--KISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLL 350
+VH DIK NI+ + + KI DFGLA L I T + ++
Sbjct: 146 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIV 200
Query: 351 RNMPI 355
P+
Sbjct: 201 DREPV 205
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 1e-35
Identities = 44/186 (23%), Positives = 69/186 (37%), Gaps = 12/186 (6%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRHK 230
F I+G+G + V + L A+K L + E + + + H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
V+L + + Y NG L +++ G AL YL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 124
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA-GKSHITTRVMGTFGDFSVTL 349
H ++HRD+K NIL++E+ +I+DFG AK+L K +GT S L
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 350 LRNMPI 355
L
Sbjct: 182 LTEKSA 187
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-34
Identities = 47/203 (23%), Positives = 81/203 (39%), Gaps = 25/203 (12%)
Query: 174 NRFSKDNIIGDGGYGVVYRG------QLMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGH 226
+R +G G +G V + VAVK L ++ + E++ + H
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 227 -VRHKNLVRLLGYCIE-GTQRILVYEYVNNGNLEQWLRGDMCD------------RGYLT 272
H N+V LLG C + G +++ E+ GNL +LR + + +LT
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 273 WEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332
E + AK + +L K +HRD+ + NIL+ E KI DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 333 HI-TTRVMGTFGDFSVTLLRNMP 354
++ + + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRV 212
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-34
Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 6/166 (3%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHK 230
R++ + IG+G YG+V +N VA+KK+ Q + E++ + RH+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N++ + T + Y+ + L + +L+ + L + L Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
H A V+HRD+K SN+L++ D KI DFGLA++ H
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-34
Identities = 42/195 (21%), Positives = 82/195 (42%), Gaps = 17/195 (8%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQADK-DFRVEVEAIGH 226
+ + +G G +G+VY G T VA+K + ++ +F E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------GDMCDRGYLTWEARMKIL 280
++VRLLG +G +++ E + G+L+ +LR + + +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS-HITTRVM 339
A +AYL+ K VHRD+ + N ++ E+F KI DFG+ + + + +
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 340 GTFGDFSVTLLRNMP 354
S L++
Sbjct: 197 LPVRWMSPESLKDGV 211
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 6e-34
Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 16/173 (9%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
++ +IG+G +GVVY+ +L +G VA+KK+L + + E++ + + H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 234 RLLGYCIEGTQR------ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
RL + ++ LV +YV + L + ++L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSL 135
Query: 288 AYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITTRVM 339
AY+H + HRDIK N+L+D + K+ DFG AK L G+ +++
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 124 bits (312), Expect = 7e-34
Identities = 44/191 (23%), Positives = 79/191 (41%), Gaps = 20/191 (10%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL---------LNNPGQADKDFRVEVEAI 224
+ I+G G VV R AVK + + + EV+ +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 225 GHVR-HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
V H N+++L T LV++ + G L +L ++ L+ + KI+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ + LH+ +VHRD+K NIL+D++ + K++DFG + L G+ V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPS 174
Query: 344 DFSVTLLRNMP 354
+ ++
Sbjct: 175 YLAPEIIECSM 185
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (314), Expect = 7e-34
Identities = 46/197 (23%), Positives = 86/197 (43%), Gaps = 17/197 (8%)
Query: 163 WFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD-FRVE 220
W D++ + + +++G G + V + VA+K + + + E
Sbjct: 1 WKQAEDIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 57
Query: 221 VEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKIL 280
+ + ++H N+V L G L+ + V+ G L + ++G+ T +++
Sbjct: 58 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLI 113
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTR 337
A+ YLH + +VHRD+K N+L DE+ ISDFGL+K+ G + +
Sbjct: 114 FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLST 168
Query: 338 VMGTFGDFSVTLLRNMP 354
GT G + +L P
Sbjct: 169 ACGTPGYVAPEVLAQKP 185
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 2e-33
Identities = 30/166 (18%), Positives = 68/166 (40%), Gaps = 8/166 (4%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVR 234
++ +G G +G+V+R + + K + G + E+ + RH+N++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
L + ++++E+++ ++ + + L + + +AL +LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLH--- 119
Query: 295 EPKVVHRDIKSSNILID--ENFDAKISDFGLAKLLGAGKSHITTRV 338
+ H DI+ NI+ + KI +FG A+ L G +
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-33
Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 26/204 (12%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQL--------MNGTAVAVKKLLNNPGQAD-KDFRVEVEAI 224
+R +G+G +G V + T VAVK L ++ + D D E+E +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 225 GHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC------------DRGYL 271
+ +HKN++ LLG C + ++ EY + GNL ++L+ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 272 TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331
+ + + A+ + YL K +HRD+ + N+L+ E+ KI+DFGLA+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 332 SHITTRV-MGTFGDFSVTLLRNMP 354
+ T + L +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRI 213
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 122 bits (306), Expect = 4e-33
Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 9/171 (5%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRHKN 231
++ IG+G YGVVY+ Q G A+KK+ E+ + ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+L + +LV+E+++ + G L LL +AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+ +V+HRD+K N+LI+ + KI+DFGLA+ G T ++ +
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW 165
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-32
Identities = 42/186 (22%), Positives = 67/186 (36%), Gaps = 13/186 (6%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKD---FRVEVEAIGHV-R 228
F ++G G +G V+ + A+K L + D D VE +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H L + V EY+N G+L ++ L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQ 117
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVT 348
+LH +V+RD+K NIL+D++ KI+DFG+ K G + T GT +
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 349 LLRNMP 354
+L
Sbjct: 174 ILLGQK 179
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 119 bits (299), Expect = 4e-32
Identities = 46/193 (23%), Positives = 83/193 (43%), Gaps = 17/193 (8%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVR 228
++R+ I+G GG V+ + L VAVK L + + FR E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 229 HKNLVRLLGYCIE----GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
H +V + G +V EYV+ L + G +T + ++++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI--TTRVMGTF 342
+AL + H+ ++HRD+K +NI+I K+ DFG+A+ + + + T V+GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 343 GDFSVTLLRNMPI 355
S R +
Sbjct: 179 QYLSPEQARGDSV 191
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-31
Identities = 45/169 (26%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 180 NIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKD-----FRVEVEAIGHVRHKNLV 233
+ +G+G + VY+ + N VA+KK+ KD E++ + + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
LL + LV++++ + LT +L T + L YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
++HRD+K +N+L+DEN K++DFGLAK G+ T +V+ +
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRW 165
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (291), Expect = 1e-30
Identities = 42/169 (24%), Positives = 68/169 (40%), Gaps = 18/169 (10%)
Query: 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKD---FRV 219
++L+D F +G G +G V+ + NG A+K L K
Sbjct: 1 YSLQD-------FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 220 EVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKI 279
E + V H ++R+ G + Q ++ +Y+ G L +
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL----LRKSQRFPNPVAKFY 109
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
AL YLH +++RD+K NIL+D+N KI+DFG AK +
Sbjct: 110 AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 1e-30
Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 9/171 (5%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRHKN 231
F K IG+G YGVVY+ + + G VA+KK+ E+ + + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+LL + LV+E+++ + D + L + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+V+HRD+K N+LI+ K++DFGLA+ G T V+ +
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 167
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 8e-30
Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRHK 230
++ K IG+G YG V++ + VA+K++ ++ E+ + ++HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N+VRL + LV+E+ + + + G L E L K L +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
H V+HRD+K N+LI+ N + K+++FGLA+ G + V+ +
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-29
Identities = 40/181 (22%), Positives = 76/181 (41%), Gaps = 18/181 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRHK 230
+++ K IG G +G V++ + G VA+KK+L N E++ + ++H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 231 NLVRLLGYCIEGTQRI--------LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
N+V L+ C LV+++ + T +++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL----SNVLVKFTLSEIKRVM-- 123
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
L L+ K++HRD+K++N+LI + K++DFGLA+ K+ R
Sbjct: 124 -QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 343 G 343
Sbjct: 183 V 183
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 1e-29
Identities = 47/191 (24%), Positives = 76/191 (39%), Gaps = 19/191 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD------FRVEVEAIGH 226
+++ ++G GG+G VY G + + VA+K + + + +EV +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 227 VR--HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
V ++RLL + +L+ E + +RG L E
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF---ITERGALQEELARSFFWQVL 120
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+A+ + H V+HRDIK NILID N + K+ DFG LL K + T GT
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 174
Query: 344 DFSVTLLRNMP 354
+R
Sbjct: 175 YSPPEWIRYHR 185
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-29
Identities = 48/185 (25%), Positives = 70/185 (37%), Gaps = 12/185 (6%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRH 229
N F ++G G +G V + G A+K L A + E + + RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
L L + V EY N G L L + T E AL Y
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEY 120
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTL 349
LH VV+RDIK N+++D++ KI+DFGL K + + GT + +
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 350 LRNMP 354
L +
Sbjct: 177 LEDND 181
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 4e-29
Identities = 45/196 (22%), Positives = 80/196 (40%), Gaps = 14/196 (7%)
Query: 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM--NGTAVAVKKLLNNPGQADKDFRVEVEA--- 223
L A ++ IG+G YG V++ + + G VA+K++ G+ E
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 224 --IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC--DRGYLTWEARMKI 279
+ H N+VRL C + +++Q L + + E +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM 339
+ + L +LH +VVHRD+K NIL+ + K++DFGLA++ + T V+
Sbjct: 122 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVV 176
Query: 340 GTFGDFSVTLLRNMPI 355
T + +L
Sbjct: 177 VTLWYRAPEVLLQSSY 192
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 9e-29
Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 20/197 (10%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL------LNNPGQADKDFRVEVE 222
++ + + +G G + VV + + G A K + + G + +D EV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 223 AIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
+ ++H N++ L T IL+ E V G L + + ++ LT E + L
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF----LAEKESLTEEEATEFLKQ 121
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA----KISDFGLAKLLGAGKSHITTRV 338
+ YLH ++ H D+K NI++ + KI DFGLA + G +
Sbjct: 122 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNI 176
Query: 339 MGTFGDFSVTLLRNMPI 355
GT + ++ P+
Sbjct: 177 FGTPEFVAPEIVNYEPL 193
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 3e-28
Identities = 41/172 (23%), Positives = 69/172 (40%), Gaps = 9/172 (5%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN--NPGQADKDFRVEVEAIGHVRHK 230
+ +G G YG V G VA+KKL K E+ + H+RH+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N++ LL ++ G + L + ++ K L Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
H ++HRD+K N+ ++E+ + KI DFGLA+ S +T V+ +
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRW 183
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (272), Expect = 5e-28
Identities = 36/181 (19%), Positives = 66/181 (36%), Gaps = 20/181 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
NR+ IG G +G +Y G + G VA+K +E + ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVG 64
Query: 233 VRLLGYCI-EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+ + +C EG ++V E + + + + + + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIH 120
Query: 292 EAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHI------TTRVMGTF 342
+HRD+K N L+ + I DFGLAK ++H + GT
Sbjct: 121 SK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 343 G 343
Sbjct: 178 R 178
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (273), Expect = 9e-28
Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 11/156 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRH 229
++F + +G G +G V + +G A+K L K E + V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
LV+L + + +V EYV G + L G + Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEY 156
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
LH +++RD+K N+LID+ +++DFG AK
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 5e-27
Identities = 38/165 (23%), Positives = 63/165 (38%), Gaps = 19/165 (11%)
Query: 181 IIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGY 238
++G G G V + A+K L Q R EVE + ++VR++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 239 C----IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
++V E ++ G L ++ T +I+ +A+ YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI- 130
Query: 295 EPKVVHRDIKSSNILIDENFD---AKISDFGLAKLLGAGKSHITT 336
+ HRD+K N+L K++DFG AK + S T
Sbjct: 131 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 173
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 7e-26
Identities = 48/190 (25%), Positives = 79/190 (41%), Gaps = 16/190 (8%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKL----LNNPGQADKDFRVEVEAIG 225
F ++G G YG V+ + + G A+K L + + + R E + +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 226 HVRHK-NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
H+R LV L T+ L+ +Y+N G L L R T +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIV 139
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGD 344
AL +LH+ +++RDIK NIL+D N ++DFGL+K A ++ GT
Sbjct: 140 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 345 FSVTLLRNMP 354
+ ++R
Sbjct: 197 MAPDIVRGGD 206
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 102 bits (256), Expect = 1e-25
Identities = 42/173 (24%), Positives = 76/173 (43%), Gaps = 20/173 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKN 231
+ + +G G Y V+ + N V VK L K + E++ + ++R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPN 91
Query: 232 LVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
++ L + R LV+E+VNN + +Q + LT + KAL Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDY 144
Query: 290 LHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
H ++HRD+K N++ID E+ ++ D+GLA+ G+ + + +
Sbjct: 145 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVAS 192
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 100 bits (249), Expect = 6e-25
Identities = 31/175 (17%), Positives = 55/175 (31%), Gaps = 16/175 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH-KN 231
+ IG+G +GV++ G L+N VA+K R E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+ + + EG +LV + + + + + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 292 EAIEPKVVHRDIKSSNILIDENF-----DAKISDFGLAKLLGAGKSHITTRVMGT 341
E +V+RDIK N LI + DFG+ K +
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.7 bits (242), Expect = 2e-23
Identities = 40/155 (25%), Positives = 67/155 (43%), Gaps = 6/155 (3%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD--KDFRVEVEAIGHVRH 229
R+ + +G G YG V G VAVKKL K E+ + H++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+N++ LL + +L ++ LT + ++ + L Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
+H ++HRD+K SN+ ++E+ + KI DFGLA
Sbjct: 137 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 168
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.2 bits (238), Expect = 6e-23
Identities = 50/191 (26%), Positives = 77/191 (40%), Gaps = 23/191 (12%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVRH 229
R+ IG G G+V + VA+KKL N A K E+ + V H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNH 75
Query: 230 KNLVRLLGYCI------EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
KN++ LL E LV E ++ + + L E +L
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQM 128
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ +LH ++HRD+K SNI++ + KI DFGLA+ AG S + T + T
Sbjct: 129 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY 183
Query: 344 DFSVTLLRNMP 354
+ ++ M
Sbjct: 184 YRAPEVILGMG 194
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.5 bits (216), Expect = 4e-21
Identities = 29/159 (18%), Positives = 51/159 (32%), Gaps = 21/159 (13%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVK----------KLLNNPGQADKDFRVEVEAIGHVRH 229
++G+G V+ VK K+ D F V
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+ L +L G + VY + N L + + R + +L + +A
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
+ +VH D+ N+L+ E I DF + +G
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVG 153
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.5 bits (205), Expect = 2e-18
Identities = 26/186 (13%), Positives = 60/186 (32%), Gaps = 17/186 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
R+ +G G + V+ + ++N T VA+K + + + E++ + V +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADN 71
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKIL 280
+ ++L + N + + + +I
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITTRVM 339
L Y+H ++H DIK N+L++ + + +A L A
Sbjct: 132 KQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 340 GTFGDF 345
++
Sbjct: 190 IQTREY 195
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 358 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.98 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.64 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.9 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.74 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.21 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.12 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.73 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-42 Score=310.23 Aligned_cols=175 Identities=26% Similarity=0.388 Sum_probs=153.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5799999999999999999986 568999999986543 23345689999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++|+|.+++. ....+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 85 ~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999986 345699999999999999999999999 99999999999999999999999999999875443
Q ss_pred ce-eeeecccccCCchhhhccCCCc
Q 018311 332 SH-ITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~-~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.. .....+||+.|||||++.+.+|
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~ 182 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREF 182 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSB
T ss_pred ccccccceeeCcCccCHhHhcCCCC
Confidence 32 3456789999999999998876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-41 Score=307.13 Aligned_cols=174 Identities=23% Similarity=0.352 Sum_probs=157.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999975 569999999987655556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++|+|.+++.+ ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 99999998764 3489999999999999999999999 999999999999999999999999999998764432
Q ss_pred eeeeecccccCCchhhhccCCCcc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....+||+.|+|||++.+.+|+
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~ 194 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYG 194 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBC
T ss_pred -cccccccCCCccChhhhcCCCCC
Confidence 34567899999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=305.78 Aligned_cols=176 Identities=30% Similarity=0.469 Sum_probs=146.1
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
++|++.+.||+|+||+||+|.+.+++.||||++... ....++|.+|++++++++||||++++++|..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578889999999999999999988899999998654 3445789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+|+|.+++.. ....+++..++.++.|+|.||.|||++ +|+||||||+|||+++++.+||+|||+++.+......
T Consensus 84 ~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 9999999874 335688999999999999999999999 9999999999999999999999999999987655544
Q ss_pred eeeecccccCCchhhhccCCCcc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......||+.|+|||++.+.+|+
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~ 180 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYS 180 (263)
T ss_dssp -------CTTSCCHHHHTTCCCC
T ss_pred eecceecCcccCChHHhcCCCCC
Confidence 45567899999999999998875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=306.36 Aligned_cols=178 Identities=24% Similarity=0.383 Sum_probs=156.7
Q ss_pred hcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
..++|++.+.||+|+||+||+|.+++++.||||++.... ...++|.+|++++.+++|||||++++++. ++..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEe
Confidence 347889999999999999999999888899999986543 44578999999999999999999999875 4667999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+||||++++.+||+|||+|+.+....
T Consensus 89 ~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999886432 23489999999999999999999998 99999999999999999999999999999987665
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
........||+.|||||++.+.+|+
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~ 188 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFT 188 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEEC
T ss_pred cccccccCCcccccChHHHhCCCCC
Confidence 5555667899999999999988764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-41 Score=308.99 Aligned_cols=178 Identities=26% Similarity=0.408 Sum_probs=158.8
Q ss_pred cCCCcccceecCCccEEEEEEEEe-CCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
.++|++.+.||+|+||+||+|.+. +++.||||++.... ...++|.+|++++++++|||||+++++|.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 467888999999999999999874 58899999986543 3467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+++|+|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 95 ~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 95 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 9999999999753 345689999999999999999999999 99999999999999999999999999999877655
Q ss_pred ceeeeecccccCCchhhhccCCCcc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
........||+.|+|||++.+.+|+
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~ 194 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFS 194 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCS
T ss_pred ceeeccccccccccChHHHcCCCCC
Confidence 5555567799999999999988875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-41 Score=300.81 Aligned_cols=173 Identities=28% Similarity=0.434 Sum_probs=154.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC---CCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||+||+|+. .+++.||+|.+.+. .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4688999999999999999987 46889999998532 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999999743 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. .....||+.|||||++.+.+|.
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~ 182 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHD 182 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCC
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCC
Confidence 32 3467899999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=313.38 Aligned_cols=174 Identities=25% Similarity=0.355 Sum_probs=153.3
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|++.+.||+|+||+||+|.. .+|+.||+|++.... ....+.+.+|+.+|++++|||||+++++|.+++..|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 47899999999999999999986 568999999987543 3344678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
|+++|+|.+++.+. +.+++..+..++.|++.||.|||+ + +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999743 458999999999999999999996 5 899999999999999999999999999997643
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. .....+||+.|+|||++.+.+|+
T Consensus 158 ~---~~~~~~GT~~Y~APEvl~~~~y~ 181 (322)
T d1s9ja_ 158 S---MANSFVGTRSYMSPERLQGTHYS 181 (322)
T ss_dssp H---TC---CCSSCCCCHHHHHCSCCC
T ss_pred C---ccccccCCccccCchHHcCCCCC
Confidence 2 23467999999999999999886
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=302.51 Aligned_cols=172 Identities=28% Similarity=0.450 Sum_probs=143.8
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|++.+.||+|+||+||+|++. ..||||+++... ....++|.+|++++.+++|||||++++++. .+..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 478999999999999999999764 359999986443 344578999999999999999999999875 456899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+++|+|.+++.. ....+++..++.++.|++.||.|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999974 335699999999999999999999999 9999999999999999999999999999887543
Q ss_pred Cc-eeeeecccccCCchhhhccCC
Q 018311 331 KS-HITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 331 ~~-~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.. .......||+.|||||++.+.
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~ 181 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQ 181 (276)
T ss_dssp --------CCCCGGGCCHHHHTTC
T ss_pred CCcccccccccCcccCCHHHHhcc
Confidence 32 244567899999999999764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-41 Score=302.03 Aligned_cols=182 Identities=25% Similarity=0.380 Sum_probs=143.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEe--CCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv 248 (358)
++|++.+.||+|+||+||+|+. .+|+.||+|.+..... ...+.+.+|++++.+++||||+++++++.+ .+.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5789999999999999999976 5689999999865532 234568899999999999999999999865 4568999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI--EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
|||+++|+|.+++.+.......+++..+..++.|++.||.|||++. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999754434567999999999999999999999861 12499999999999999999999999999998
Q ss_pred cCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 327 LGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 327 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+.... .......||+.|||||++.+.+|+
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~ 192 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYN 192 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCC
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCC
Confidence 75432 234567899999999999998875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=303.19 Aligned_cols=176 Identities=24% Similarity=0.355 Sum_probs=152.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||+||+|+. .+++.||||.+.... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5689999999999999999986 568999999985321 234567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999874 34689999999999999999999999 999999999999999999999999999998764
Q ss_pred CCc-eeeeecccccCCchhhhccCCCcc
Q 018311 330 GKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
... ......+||+.|||||++.+.+|+
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~ 188 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSAC 188 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCC
T ss_pred CCcccccccccCCccccCceeeccCCCC
Confidence 332 234567899999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=302.92 Aligned_cols=171 Identities=25% Similarity=0.347 Sum_probs=152.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
+.|++.+.||+|+||+||+|+. .+++.||+|++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4688899999999999999986 568999999997766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++|+|.+++.+. .+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+... .
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~ 164 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-I 164 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-H
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-c
Confidence 999999998642 34599999999999999999999999 9999999999999999999999999999876422 1
Q ss_pred eeeeecccccCCchhhhcc
Q 018311 333 HITTRVMGTFGDFSVTLLR 351 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~ 351 (358)
.......||+.|||||++.
T Consensus 165 ~~~~~~~Gt~~y~APE~l~ 183 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVM 183 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHT
T ss_pred ccccccccccccCCHHHHh
Confidence 1234578999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-39 Score=305.80 Aligned_cols=175 Identities=22% Similarity=0.384 Sum_probs=156.7
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999976 568999999997665555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc--CCCcEEEeeecCceecCCC
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID--ENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~--~~~~~kl~DFGla~~~~~~ 330 (358)
++|+|.+++.. ..+.+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 106 ~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999864 335699999999999999999999999 999999999999995 4688999999999988654
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. ......||+.|||||++.+.+|.
T Consensus 180 ~--~~~~~~gT~~Y~aPEv~~~~~~~ 203 (350)
T d1koaa2 180 Q--SVKVTTGTAEFAAPEVAEGKPVG 203 (350)
T ss_dssp S--CEEEECSCTTTCCHHHHHTCCBC
T ss_pred c--ccceecCcccccCHHHHcCCCCC
Confidence 3 34557899999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=292.44 Aligned_cols=176 Identities=23% Similarity=0.361 Sum_probs=158.4
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 253 (358)
++|++.++||+|+||+||+|++++++.||||+++... ...++|.+|+.++.+++||||++++++|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6789999999999999999999888899999987643 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce
Q 018311 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (358)
Q Consensus 254 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~ 333 (358)
+|+|.+++... ...+++..+.+++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999997643 34588999999999999999999999 9999999999999999999999999999987765555
Q ss_pred eeeecccccCCchhhhccCCCcc
Q 018311 334 ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 334 ~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......||+.|+|||++.+.+|+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~ 179 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFS 179 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCC
T ss_pred eecccCCCCCcCCcHHhcCCCCC
Confidence 55567899999999999988775
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-40 Score=302.67 Aligned_cols=175 Identities=25% Similarity=0.419 Sum_probs=137.7
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
.++|++.+.||+|+||+||+|+. .+++.||||.+..... ...+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46799999999999999999986 4689999999865432 334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc---CCCcEEEeeecCceec
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID---ENFDAKISDFGLAKLL 327 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~---~~~~~kl~DFGla~~~ 327 (358)
|+++|+|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||+. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999973 45699999999999999999999999 999999999999994 5789999999999987
Q ss_pred CCCCceeeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
..+. .....+||+.|||||++.+.+|+
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~ 187 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYS 187 (307)
T ss_dssp --------------CTTSCHHHHTTCCCC
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCC
Confidence 5433 34457899999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=302.44 Aligned_cols=175 Identities=27% Similarity=0.266 Sum_probs=155.8
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|+. .+|+.||+|++.+.. ....+.+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5789999999999999999976 579999999986432 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
|||++|+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++++|.+||+|||+|+.+..
T Consensus 85 ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999743 4588999999999999999999999 999999999999999999999999999998654
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. ......+||+.|||||++.+.+|.
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~ 183 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYG 183 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBC
T ss_pred CC-cccccceeCHHHhhhhhccCCCCC
Confidence 32 234568999999999999999885
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.5e-39 Score=301.61 Aligned_cols=175 Identities=21% Similarity=0.316 Sum_probs=156.6
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
++|++.+.||+|+||.||+|.. .+|+.||||.+........+.+.+|++++++++||||+++++++.+++..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999976 579999999987665555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc--CCCcEEEeeecCceecCCC
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID--ENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~--~~~~~kl~DFGla~~~~~~ 330 (358)
++|+|.+++.. ....+++.++..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 109 ~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999998764 234599999999999999999999999 999999999999997 6789999999999998754
Q ss_pred CceeeeecccccCCchhhhccCCCcc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. ......||+.|||||++.+.+|.
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~~ 206 (352)
T d1koba_ 183 E--IVKVTTATAEFAAPEIVDREPVG 206 (352)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBC
T ss_pred C--ceeeccCcccccCHHHHcCCCCC
Confidence 3 34567899999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-39 Score=298.45 Aligned_cols=177 Identities=28% Similarity=0.461 Sum_probs=140.7
Q ss_pred CCCcccceecCCccEEEEEEEEeC-C---cEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-G---TAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-~---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.++||+|+||+||+|.+.. + ..||||++..... ...++|.+|+++|++++|||||++++++..++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 567788999999999999998642 2 3689998865443 3446799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
||||++|+|.+++.. ..+.+++.+++.++.|++.||.|||++ +|+||||||+||||+.++.+||+|||+|+.+.
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998874 345689999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCcee----eeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHI----TTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~----~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... .....||+.|||||++.+.+|+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 211 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 211 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCC
Confidence 433221 1235679999999999988775
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-39 Score=298.23 Aligned_cols=172 Identities=26% Similarity=0.339 Sum_probs=153.7
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC---CCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4689999999999999999986 56899999998543 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+++|+|..++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999998874 34578889999999999999999999 999999999999999999999999999998754
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. ....+||+.|||||++.+.+|.
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~ 179 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYN 179 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBC
T ss_pred c----cccccCcccccCHHHHcCCCCC
Confidence 3 3457899999999999999885
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-39 Score=297.65 Aligned_cols=168 Identities=29% Similarity=0.378 Sum_probs=148.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc---chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
..|+..+.||+|+||+||+|.. .+++.||||++...... ..+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4588899999999999999976 56889999998755432 2356889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
|||++|+|..++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999877653 35699999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeeecccccCCchhhhccCC
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
.....||+.|||||++.+.
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~ 186 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAM 186 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTT
T ss_pred -----CCccccCccccCHHHHhcc
Confidence 2346899999999999753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-40 Score=297.58 Aligned_cols=177 Identities=25% Similarity=0.400 Sum_probs=147.6
Q ss_pred cCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeec
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 252 (358)
.++|++.+.||+|+||+||+|.++++..||||++... ....++|.+|+.++++++|||||++++++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 3679999999999999999999988889999998644 344578999999999999999999999985 56789999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++|+|..++... ....+++.+++.++.||+.||.|||+. +|+||||||+||||++++++||+|||+|+.+.....
T Consensus 94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999999988653 224589999999999999999999999 999999999999999999999999999998866555
Q ss_pred eeeeecccccCCchhhhccCCCcc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.......||+.|+|||++.+.+|+
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~ 192 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFT 192 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCC
T ss_pred eeeccccccccccChHHHhCCCCC
Confidence 455567899999999999988875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-39 Score=292.19 Aligned_cols=176 Identities=27% Similarity=0.412 Sum_probs=150.0
Q ss_pred CCCcccce-ecCCccEEEEEEEEe---CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNI-IGDGGYGVVYRGQLM---NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~-lG~G~fg~V~~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|.+.+. ||+|+||+||+|.+. ++..||||.+..... ...++|.+|+++|.+++|||||++++++.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 55667774 999999999999753 355799999975543 334679999999999999999999999865 568999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++.. .+..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999864 335689999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCce--eeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSH--ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~--~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
..... ......||+.|||||++.+.+|+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 190 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFS 190 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEEC
T ss_pred ccccccccccccccCccccChHHHhCCCCC
Confidence 54433 23346789999999999887764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-39 Score=288.97 Aligned_cols=169 Identities=27% Similarity=0.374 Sum_probs=143.2
Q ss_pred cccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEe----CCEEEEEE
Q 018311 177 SKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQRILVY 249 (358)
Q Consensus 177 ~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lv~ 249 (358)
+..+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+ +...|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 5567899999999999986 468899999986543 2334678899999999999999999999875 35689999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc-CCCcEEEeeecCceecC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLG 328 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~-~~~~~kl~DFGla~~~~ 328 (358)
||+++|+|.+++.+. ..+++..+..++.|++.||.|||++ .++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999743 4589999999999999999999998 11299999999999996 58999999999998754
Q ss_pred CCCceeeeecccccCCchhhhccCC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
... ....+||+.|||||++.+.
T Consensus 167 ~~~---~~~~~GT~~Y~aPE~~~~~ 188 (270)
T d1t4ha_ 167 ASF---AKAVIGTPEFMAPEMYEEK 188 (270)
T ss_dssp TTS---BEESCSSCCCCCGGGGGTC
T ss_pred CCc---cCCcccCccccCHHHhCCC
Confidence 332 3467899999999999764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-39 Score=292.18 Aligned_cols=177 Identities=28% Similarity=0.463 Sum_probs=144.5
Q ss_pred CCCcccceecCCccEEEEEEEEeCC-----cEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNG-----TAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~-----~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
+.|+..++||+|+||+||+|.+... ..||||++..... ....+|.+|++++.+++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999987542 3799999865443 334578999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||+.+|++.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+||||+.++.+||+|||+|+.+
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998864 335699999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCce--eeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSH--ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... ......||+.|||||++.+.+|+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~ 191 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFT 191 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCC
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCC
Confidence 543322 33446789999999999998875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=290.41 Aligned_cols=174 Identities=26% Similarity=0.379 Sum_probs=154.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC------CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP------GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|++.+.||+|+||+||+|.. .+|+.||||.+.... ....+.+.+|+++|++++|||||++++++.+++..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 6799999999999999999986 578999999985432 123577999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC----cEEEeeec
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF----DAKISDFG 322 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~----~~kl~DFG 322 (358)
+|||||++|+|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 90 iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999743 4599999999999999999999999 999999999999998776 49999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+|+.+..+. ......||+.|+|||++.+.+|.
T Consensus 163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~ 194 (293)
T d1jksa_ 163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLG 194 (293)
T ss_dssp TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBC
T ss_pred hhhhcCCCc--cccccCCCCcccCHHHHcCCCCC
Confidence 999876543 24456899999999999998774
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-39 Score=298.68 Aligned_cols=181 Identities=25% Similarity=0.365 Sum_probs=151.4
Q ss_pred cCCCcccceecCCccEEEEEEEEeCC------cEEEEEEecCCC-CcchHHHHHHHHHHhcC-CCCccccccceEEeCCE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMNG------TAVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~~------~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 244 (358)
.++|++.++||+|+||+||+|++... ..||+|.+.... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 46789999999999999999986432 369999986543 33456789999999998 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 018311 245 RILVYEYVNNGNLEQWLRGDMC-------------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKS 305 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~ 305 (358)
.++||||+++|+|.++|+.... ....+++..++.++.|++.||.|||++ +||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999975421 123589999999999999999999999 999999999
Q ss_pred CcEEEcCCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 306 SNILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 306 ~NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+|||++.++.+||+|||+|+........ ......||+.|||||++.+.+|+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 244 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 244 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC
Confidence 9999999999999999999987654432 34467789999999999988875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=288.12 Aligned_cols=169 Identities=25% Similarity=0.393 Sum_probs=142.4
Q ss_pred ceecCCccEEEEEEEEeC---CcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEeecCC
Q 018311 180 NIIGDGGYGVVYRGQLMN---GTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (358)
Q Consensus 180 ~~lG~G~fg~V~~~~~~~---~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (358)
++||+|+||+||+|.+.+ ++.||||+++... ....++|.+|++++++++|||||+++++|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999997643 4689999986543 2334679999999999999999999999865 567899999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCce-
Q 018311 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH- 333 (358)
Q Consensus 255 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~~- 333 (358)
|+|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+......
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999974 34589999999999999999999999 9999999999999999999999999999987654433
Q ss_pred -eeeecccccCCchhhhccCCCcc
Q 018311 334 -ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 334 -~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
......||+.|||||++.+.+|+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~ 188 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFS 188 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEE
T ss_pred ccccccCCCceecCchhhcCCCCC
Confidence 23346799999999999888764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-38 Score=296.08 Aligned_cols=172 Identities=23% Similarity=0.279 Sum_probs=154.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 249 (358)
++|++.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+++|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999986 579999999985321 234467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~ 329 (358)
||+.+|+|.+++... +.+++..+..++.|++.||.|||++ +||||||||+|||++.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999999743 4589999999999999999999999 999999999999999999999999999998754
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. .....||+.|||||++.+.+|.
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~ 216 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYN 216 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBC
T ss_pred c----cccccCccccCCHHHHcCCCCC
Confidence 3 3457899999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-38 Score=286.35 Aligned_cols=177 Identities=24% Similarity=0.344 Sum_probs=139.7
Q ss_pred cCCCcccceecCCccEEEEEEEEeC----CcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
.++|++.+.||+|+||+||+|.+.. +..||||.+...... ..+.+.+|++++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4679999999999999999997632 457899988654433 3467899999999999999999999985 567899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+||++++++.+||+|||+|+.+
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998764 345689999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCceeeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
............||+.|+|||++.+.+|+
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~ 187 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFT 187 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCS
T ss_pred cCCcceeccceecCcccchhhHhccCCCC
Confidence 65555555667899999999999988875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-38 Score=289.61 Aligned_cols=188 Identities=28% Similarity=0.396 Sum_probs=157.9
Q ss_pred HhhHHHhcCCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCCc-chHHHHHHHHHHhcCCCCccccccce
Q 018311 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGY 238 (358)
Q Consensus 166 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~ 238 (358)
+.+++...++|++.+.||+|+||+||+|++. +++.||||++...... ..++|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4455556788999999999999999999864 3578999998654433 34679999999999999999999999
Q ss_pred EEeCCEEEEEEeecCCCCHHHHHhcccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 018311 239 CIEGTQRILVYEYVNNGNLEQWLRGDMC--------------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298 (358)
Q Consensus 239 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 298 (358)
+...+..+++|||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999964221 123488999999999999999999999 99
Q ss_pred eeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCcc
Q 018311 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 299 vHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
|||||||+|||++.++.+||+|||+|+.+..... .......||+.|+|||++.+.+|+
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t 220 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT 220 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC
Confidence 9999999999999999999999999987754332 234567899999999999998875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-37 Score=280.90 Aligned_cols=176 Identities=26% Similarity=0.361 Sum_probs=144.9
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc---chHHHHHHHHHHhcCCCCccccccceEEeCC----EE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT----QR 245 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~ 245 (358)
++|++.+.||+|+||+||+|+. .+|+.||||.+...... ..+.+.+|+++++.++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 6899999999999999999976 57999999999755432 2356889999999999999999999998643 47
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCce
Q 018311 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (358)
Q Consensus 246 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~ 325 (358)
|+||||+++|+|.+++.. .+.+++.++..++.|++.||.|||++ +|+||||||+|||++.++..+|+|||+++
T Consensus 87 ~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 999999999999998874 34589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCc--eeeeecccccCCchhhhccCCCcc
Q 018311 326 LLGAGKS--HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 326 ~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
....... ......+||+.|||||++.+.+|.
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~ 192 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD 192 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCC
Confidence 7654332 234557899999999999998874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-37 Score=283.69 Aligned_cols=175 Identities=17% Similarity=0.246 Sum_probs=153.4
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
.++|++.+.||+|+||+||+|.. .+++.||+|.+.... .....+.+|+++|..++||||+++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 36899999999999999999976 468899999986543 2345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC--CCcEEEeeecCceecCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE--NFDAKISDFGLAKLLGA 329 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~--~~~~kl~DFGla~~~~~ 329 (358)
|++|+|.+++... ...+++.++..++.|++.||.|||++ +|+||||||+|||++. ...+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999742 33589999999999999999999999 9999999999999975 45899999999998765
Q ss_pred CCceeeeecccccCCchhhhccCCCcc
Q 018311 330 GKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 330 ~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.. ......||+.|+|||.+.+.+|.
T Consensus 157 ~~--~~~~~~~t~~y~ape~~~~~~~~ 181 (321)
T d1tkia_ 157 GD--NFRLLFTAPEYYAPEVHQHDVVS 181 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEEC
T ss_pred CC--cccccccccccccchhccCCCCC
Confidence 43 34556899999999999998874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-37 Score=281.04 Aligned_cols=171 Identities=26% Similarity=0.383 Sum_probs=151.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc---------chHHHHHHHHHHhcCC-CCccccccceEEeC
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---------ADKDFRVEVEAIGHVR-HKNLVRLLGYCIEG 242 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~ 242 (358)
++|++.+.||+|+||+||+|+. .+++.||||++...... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999976 57899999998654321 1235778999999997 99999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
+..|+||||+++|||.+++... +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999743 4599999999999999999999999 99999999999999999999999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCC
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~ 353 (358)
+++.+.... ......||+.|+|||++.+.
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~ 184 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECS 184 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhcc
Confidence 999886543 23457899999999999753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=286.32 Aligned_cols=176 Identities=27% Similarity=0.471 Sum_probs=145.6
Q ss_pred CCCcccceecCCccEEEEEEEEe-CCc----EEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLM-NGT----AVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 247 (358)
.+|++.++||+|+||+||+|.+. +|+ +||+|++.... ....++|.+|++++++++|||||+++++|.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 46899999999999999999763 343 68999886543 4456789999999999999999999999986 45678
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
++||+.+|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8999999999998875 345689999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 328 GAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 328 ~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
...... ......||+.|||||++.+.+|+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 191 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYT 191 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCC
T ss_pred ccccccccccccccCccccChHHHhcCCCC
Confidence 654433 33456799999999999998874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-37 Score=290.95 Aligned_cols=173 Identities=26% Similarity=0.309 Sum_probs=147.7
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHH---HHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFR---VEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~---~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|++.++||+|+||.||+|+. .+|+.||||.+.... ......+. .|+++++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 6799999999999999999986 468999999985321 11222333 3577888889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999743 4588999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCceeeeecccccCCchhhhccC-CCcc
Q 018311 327 LGAGKSHITTRVMGTFGDFSVTLLRN-MPIL 356 (358)
Q Consensus 327 ~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~ 356 (358)
+.... .....||+.|||||++.+ .+|.
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~ 184 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYD 184 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCC
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCC
Confidence 76543 345689999999999974 5553
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-37 Score=286.11 Aligned_cols=175 Identities=23% Similarity=0.301 Sum_probs=151.7
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC---CcchHHHHHHHHHHh-cCCCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIG-HVRHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.+.||+|+||+||+|+. .+++.||||++.+.. ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4688999999999999999976 468999999986432 233455667777665 68999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecC
Q 018311 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~ 328 (358)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 9999999999999743 4588999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
... .......||+.|+|||++.+.+|+
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~ 181 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYN 181 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCC
Confidence 432 234557899999999999999885
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=284.81 Aligned_cols=186 Identities=25% Similarity=0.373 Sum_probs=144.5
Q ss_pred hHHHhcCCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceE
Q 018311 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYC 239 (358)
Q Consensus 168 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 239 (358)
+++...++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+..|..++.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 33444578999999999999999999763 346899999865443 3345677888888776 689999999988
Q ss_pred EeC-CEEEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 018311 240 IEG-TQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSS 306 (358)
Q Consensus 240 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~ 306 (358)
... ...++|||||++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence 764 568999999999999999975321 124588999999999999999999999 9999999999
Q ss_pred cEEEcCCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 307 NILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 307 NiLl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
||||++++.+||+|||+|+........ ......||+.|||||++.+.+|+
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 214 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC
Confidence 999999999999999999987544332 34457899999999999998874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-36 Score=283.81 Aligned_cols=171 Identities=23% Similarity=0.251 Sum_probs=146.4
Q ss_pred CCCccc-ceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhc-CCCCccccccceEEe----CCEEE
Q 018311 174 NRFSKD-NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH-VRHKNLVRLLGYCIE----GTQRI 246 (358)
Q Consensus 174 ~~~~~~-~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~----~~~~~ 246 (358)
++|.+. ++||+|+||.||+|.. .+++.||||++.. ...+.+|+.++.+ ++||||++++++|.+ ...+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 578876 4699999999999976 5789999999853 3567789998765 489999999999875 46689
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC---CCcEEEeeecC
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISDFGL 323 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~---~~~~kl~DFGl 323 (358)
+|||||++|+|.+++... ....+++.++..++.|++.||.|||+. +|+||||||+|||+++ ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 999999999999999753 234699999999999999999999999 9999999999999975 56799999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
|+....... .....||+.|||||++.+.+|+
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~ 191 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYD 191 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGS
T ss_pred eeeccCCCc--cccccCCcccCCcHHHcCCCCC
Confidence 998765432 4557899999999999998874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=279.48 Aligned_cols=178 Identities=27% Similarity=0.444 Sum_probs=148.1
Q ss_pred CCCcccceecCCccEEEEEEEEeC-Cc--EEEEEEecCCC-CcchHHHHHHHHHHhcC-CCCccccccceEEeCCEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN-GT--AVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv 248 (358)
++|++.++||+|+||.||+|.+.+ +. .||||++.... ....++|.+|+++|.++ +||||++++++|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678889999999999999998744 43 57888875443 33456799999999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcE
Q 018311 249 YEYVNNGNLEQWLRGDM------------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (358)
Q Consensus 249 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~ 316 (358)
|||+++|+|.++|+... .....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997531 1235699999999999999999999999 99999999999999999999
Q ss_pred EEeeecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 317 KISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 317 kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
||+|||+|+...... ......||+.|+|||.+.+.+|+
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~ 204 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYT 204 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEEC
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCC
Confidence 999999998764322 23356799999999999988774
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-37 Score=281.93 Aligned_cols=182 Identities=24% Similarity=0.375 Sum_probs=154.3
Q ss_pred hcCCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCCE
Q 018311 172 ATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 172 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 244 (358)
..++|++.+.||+|+||+||+|.+. ++..||||++..... .....|.+|+.++++++||||+++++++...+.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3478889999999999999999763 357899999965432 333568899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEE
Q 018311 245 RILVYEYVNNGNLEQWLRGDM------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl 318 (358)
.++||||+++|+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEE
Confidence 999999999999999886421 1223578999999999999999999999 9999999999999999999999
Q ss_pred eeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 319 SDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 319 ~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+|||+|+.+...... ......||+.|+|||.+.+.+|+
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~ 213 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT 213 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCC
Confidence 999999987543332 33445799999999999988764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-37 Score=276.41 Aligned_cols=171 Identities=32% Similarity=0.453 Sum_probs=140.7
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEe-CCEEEEEEeec
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQRILVYEYV 252 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lv~e~~ 252 (358)
++|++.+.||+|+||.||+|.+ .|.+||||+++.. ...+++.+|++++++++||||+++++++.+ ++..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5688899999999999999998 5789999998653 345779999999999999999999999865 45689999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++|+|.++|.... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp TTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999997532 23488999999999999999999999 9999999999999999999999999999986532
Q ss_pred eeeeecccccCCchhhhccCCCcc
Q 018311 333 HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.....+|+.|+|||++.+.+|+
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t 178 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFS 178 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCC
T ss_pred --CccccccccCCChHHHhCCCCC
Confidence 3345789999999999988875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-36 Score=278.88 Aligned_cols=169 Identities=27% Similarity=0.336 Sum_probs=141.6
Q ss_pred ccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc-----chHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 178 KDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-----ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 178 ~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
.+++||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 368999999999999986 56899999998644321 124688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+.++++..+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 98887766554 345688899999999999999999999 99999999999999999999999999998875433
Q ss_pred ceeeeecccccCCchhhhccCCC
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
. .....+||+.|+|||++.+..
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~ 176 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGAR 176 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCS
T ss_pred c-cccceecChhhccHHHHccCC
Confidence 2 234568999999999987553
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-37 Score=276.21 Aligned_cols=176 Identities=29% Similarity=0.428 Sum_probs=140.3
Q ss_pred CCCcccceecCCccEEEEEEEEeC--C--cEEEEEEecCCC---CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMN--G--TAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~--~--~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 246 (358)
++|++.+.||+|+||+||+|++.. + ..||||++.... ....++|.+|+.++++++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568999999999999999997632 2 378999886543 2334679999999999999999999999965 5678
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
+||||+++|++.+++..+ .+.+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 999999999999988653 34589999999999999999999998 999999999999999999999999999999
Q ss_pred cCCCCce--eeeecccccCCchhhhccCCCcc
Q 018311 327 LGAGKSH--ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 327 ~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+...... ......|++.|+|||++.+++|+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 192 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 192 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEE
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCC
Confidence 8654433 23345688899999999998875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-36 Score=276.47 Aligned_cols=172 Identities=30% Similarity=0.424 Sum_probs=141.0
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHH--HHHHHHhcCCCCccccccceEEeCC----EEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFR--VEVEAIGHVRHKNLVRLLGYCIEGT----QRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~--~E~~~l~~l~HpnIv~l~~~~~~~~----~~~l 247 (358)
.+|.+.+.||+|+||.||+|++ +|+.||||++... ...++. .|+..+..++||||+++++++.+.+ ..|+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4567789999999999999987 7899999998543 233333 4555556789999999999998643 6899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA-----IEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-----~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
|||||++|+|.++|++. .++|..++.++.|++.||.|||+. ...+|+||||||+||||+.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 99999999999999742 488999999999999999999963 12389999999999999999999999999
Q ss_pred CceecCCCCce---eeeecccccCCchhhhccCCC
Q 018311 323 LAKLLGAGKSH---ITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 323 la~~~~~~~~~---~~~~~~Gt~~y~APE~l~~~~ 354 (358)
+++........ ......||+.|+|||++.+..
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 188 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCS
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccc
Confidence 99988654433 234578999999999998753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-36 Score=275.44 Aligned_cols=175 Identities=27% Similarity=0.428 Sum_probs=148.4
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4789999999999999999986 678999999986443 2235778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
|+.+ ++.+++... ....+++..+..++.|++.||.|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9965 555555432 345699999999999999999999999 9999999999999999999999999999887543
Q ss_pred CceeeeecccccCCchhhhccCCCc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.. ......||+.|+|||++.+.++
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~ 179 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKY 179 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSS
T ss_pred cc-cceeecccceeeehhhhccccC
Confidence 32 3445689999999999888765
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=275.62 Aligned_cols=172 Identities=27% Similarity=0.370 Sum_probs=147.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC------cchHHHHHHHHHHhcCC--CCccccccceEEeCCE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG------QADKDFRVEVEAIGHVR--HKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~ 244 (358)
++|++.++||+|+||+||+|.. .+|+.||||++..... .....+.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 6899999999999999999976 5789999999864321 11234668999999886 8999999999999999
Q ss_pred EEEEEeecCC-CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-CCcEEEeeec
Q 018311 245 RILVYEYVNN-GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDFG 322 (358)
Q Consensus 245 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~-~~~~kl~DFG 322 (358)
.++||||+.+ +++.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 688888864 34589999999999999999999999 9999999999999985 5799999999
Q ss_pred CceecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 323 LAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 323 la~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+|+..... ..+...||+.|+|||++.+.+|
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~ 186 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRY 186 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCB
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCC
Confidence 99886533 2456789999999999988765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-36 Score=277.52 Aligned_cols=181 Identities=27% Similarity=0.379 Sum_probs=155.4
Q ss_pred cCCCcccceecCCccEEEEEEEEe------CCcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeCCE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQ 244 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 244 (358)
.++|++.++||+|+||.||+|++. +++.||||+++.... ....++.+|+.++.++ +|||||++++++.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 368889999999999999999763 456899999976543 3345688999999999 69999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 018311 245 RILVYEYVNNGNLEQWLRGDMC--------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl 310 (358)
.++|||||++|+|.++++.... ....+++..+..++.||+.||.|||++ ++|||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 9999999999999999975421 223589999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeeecCceecCCCCc-eeeeecccccCCchhhhccCCCcc
Q 018311 311 DENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 311 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+.++.+||+|||+++....... .......||+.|+|||++.+..++
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 225 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC
Confidence 9999999999999998765443 344557899999999999987764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.7e-36 Score=272.34 Aligned_cols=174 Identities=27% Similarity=0.370 Sum_probs=148.1
Q ss_pred CCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCC--CcchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.++||+|+||+||+|+..+|+.||||++.... ....+.+.+|+.+|++++||||+++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999899999999996543 23357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~ 331 (358)
+.++++..+.. ..+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98777666654 346699999999999999999999998 99999999999999999999999999998875432
Q ss_pred ceeeeecccccCCchhhhccCCCc
Q 018311 332 SHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 332 ~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.......|++.|+|||.+.+..+
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~ 177 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKK 177 (286)
T ss_dssp --------CCCTTCCHHHHTTCCS
T ss_pred -cccceecccchhhhHHHHhCCCC
Confidence 23345679999999999987543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-35 Score=272.68 Aligned_cols=172 Identities=27% Similarity=0.447 Sum_probs=146.0
Q ss_pred cceecCCccEEEEEEEEeCC----cEEEEEEecCCC-CcchHHHHHHHHHHhcCCCCccccccceEEe-CCEEEEEEeec
Q 018311 179 DNIIGDGGYGVVYRGQLMNG----TAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQRILVYEYV 252 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lv~e~~ 252 (358)
.++||+|+||+||+|.+.++ ..||||++.... ....++|.+|++++++++||||++++|++.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999986432 368999986433 3345779999999999999999999999876 46899999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCCCc
Q 018311 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (358)
Q Consensus 253 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~~~ 332 (358)
++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999875 334577889999999999999999999 999999999999999999999999999998764432
Q ss_pred e---eeeecccccCCchhhhccCCCcc
Q 018311 333 H---ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 333 ~---~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
. ......||+.|+|||.+.+.+|+
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~ 212 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFT 212 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCC
T ss_pred ccceecccccccccccChHHHhcCCCC
Confidence 2 22346789999999999988765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-36 Score=274.77 Aligned_cols=181 Identities=27% Similarity=0.382 Sum_probs=149.4
Q ss_pred cCCCcccceecCCccEEEEEEEEeC--------CcEEEEEEecCCCC-cchHHHHHHHHHHhcC-CCCccccccceEEeC
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQLMN--------GTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 242 (358)
.++|++.+.||+|+||.||+|+... +..||||++..... ....++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4689999999999999999997532 24799999876543 3346788899998888 899999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl 310 (358)
+..++||||+++|+|.+++..... ....+++.+++.++.|++.||.|||+. +||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 999999999999999999975431 234689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEeeecCceecCCCCce-eeeecccccCCchhhhccCCCcc
Q 018311 311 DENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 311 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+.++.+||+|||+++........ ......||+.|+|||.+.+.+|+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~ 215 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC
Confidence 99999999999999987643322 34457899999999999998875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-34 Score=266.36 Aligned_cols=175 Identities=27% Similarity=0.379 Sum_probs=143.6
Q ss_pred CCCcccceecCCccEEEEEEEE-eC-CcEEEEEEecCCC--CcchHHHHHHHHHHhcC---CCCccccccceEEe-----
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MN-GTAVAVKKLLNNP--GQADKDFRVEVEAIGHV---RHKNLVRLLGYCIE----- 241 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~----- 241 (358)
++|++.+.||+|+||+||+|.. .+ ++.||||++.... ......+.+|+.+++.| +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 7899999999999999999986 34 5679999985432 22233456677776655 89999999999863
Q ss_pred CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeee
Q 018311 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (358)
Q Consensus 242 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DF 321 (358)
....+++|||++++++...... ....+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+||
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence 2467999999988777655442 345689999999999999999999999 9999999999999999999999999
Q ss_pred cCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 322 GLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 322 Gla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
|+++..... .......||+.|+|||++.+.+|+
T Consensus 161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~ 193 (305)
T d1blxa_ 161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYA 193 (305)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCC
T ss_pred hhhhhhccc--ccCCCcccChhhcCcchhcCCCCC
Confidence 999875432 234567899999999999999885
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.3e-34 Score=261.23 Aligned_cols=174 Identities=21% Similarity=0.266 Sum_probs=148.2
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCC-CccccccceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH-KNLVRLLGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||+||+|.. .+|+.||||.+..... ...+.+|++.+..++| +|++.+++++..+...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 6899999999999999999986 4688999998754332 2346788999999975 8999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcC-----CCcEEEeeecCcee
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-----NFDAKISDFGLAKL 326 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~-----~~~~kl~DFGla~~ 326 (358)
+ +++|.+++.. ....+++.++..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+|+.
T Consensus 83 ~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9 7899998874 334689999999999999999999999 9999999999999964 57899999999998
Q ss_pred cCCCCce------eeeecccccCCchhhhccCCCcc
Q 018311 327 LGAGKSH------ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 327 ~~~~~~~------~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+...... ......||+.|||||++.+.+|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~ 191 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS 191 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCC
Confidence 7543211 23457899999999999998874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-34 Score=267.52 Aligned_cols=170 Identities=28% Similarity=0.386 Sum_probs=139.6
Q ss_pred CCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccccceEEeC------CEEEE
Q 018311 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------TQRIL 247 (358)
Q Consensus 175 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~l 247 (358)
+|+..++||+|+||+||+|+. .+|+.||||++...... ..+|+++|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 578889999999999999987 46899999999655332 23699999999999999999998643 34789
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-cEEEeeecCcee
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKL 326 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~-~~kl~DFGla~~ 326 (358)
|||||+++ +.+.+.........+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999765 4444432222445699999999999999999999998 999999999999999775 899999999998
Q ss_pred cCCCCceeeeecccccCCchhhhccCCC
Q 018311 327 LGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 327 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
+..... .....||+.|+|||++.+..
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~ 198 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGAT 198 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCS
T ss_pred ccCCcc--cccccccccccChHHhhccc
Confidence 765432 34568999999999987653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-34 Score=263.49 Aligned_cols=173 Identities=25% Similarity=0.358 Sum_probs=143.0
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCC--CCcchHHHHHHHHHHhcCCCCccccccceEEe--------C
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN--PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE--------G 242 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------~ 242 (358)
++|++.+.||+|+||+||+|.. .+|+.||||++... .....+++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 7899999999999999999986 57999999998543 23445778899999999999999999998865 3
Q ss_pred CEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeec
Q 018311 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (358)
Q Consensus 243 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFG 322 (358)
+..|+||||+.++++..+.. ....+++.....++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 45799999998776655443 345688899999999999999999999 99999999999999999999999999
Q ss_pred CceecCCCCce---eeeecccccCCchhhhccCC
Q 018311 323 LAKLLGAGKSH---ITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 323 la~~~~~~~~~---~~~~~~Gt~~y~APE~l~~~ 353 (358)
+++.+...... .....+||+.|+|||++.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 196 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCC
Confidence 99887643322 23346799999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-34 Score=268.33 Aligned_cols=172 Identities=26% Similarity=0.377 Sum_probs=141.9
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC-cchHHHHHHHHHHhcCCCCccccccceEEeCC----EEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT----QRIL 247 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~l 247 (358)
.+|++++.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|+++|..++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 6799999999999999999975 6799999999965432 33467889999999999999999999987543 2344
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceec
Q 018311 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (358)
Q Consensus 248 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~ 327 (358)
+++++.+|+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 5566679999999964 2489999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCce--eeeecccccCCchhhhccCC
Q 018311 328 GAGKSH--ITTRVMGTFGDFSVTLLRNM 353 (358)
Q Consensus 328 ~~~~~~--~~~~~~Gt~~y~APE~l~~~ 353 (358)
...... .....+||+.|+|||++...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 187 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNS 187 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTB
T ss_pred cCCCccceeeccccccceechHHHhhcC
Confidence 543322 23557899999999998554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.4e-34 Score=264.62 Aligned_cols=166 Identities=25% Similarity=0.345 Sum_probs=143.7
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-CCccccccceEEeC--CEEEEEE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEG--TQRILVY 249 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lv~ 249 (358)
++|++.++||+|+||+||+|+. .+++.||||++... ..+++.+|+++|..++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6799999999999999999986 57899999998643 3567889999999995 99999999999854 5689999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCC-cEEEeeecCceecC
Q 018311 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKLLG 328 (358)
Q Consensus 250 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~-~~kl~DFGla~~~~ 328 (358)
||+++++|..+. +.+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999987643 3489999999999999999999999 999999999999998655 69999999999876
Q ss_pred CCCceeeeecccccCCchhhhccCCC
Q 018311 329 AGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 329 ~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
... ......||+.|+|||.+.+..
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~ 205 (328)
T d3bqca1 182 PGQ--EYNVRVASRYFKGPELLVDYQ 205 (328)
T ss_dssp TTC--CCCSCCSCGGGCCHHHHTTCC
T ss_pred CCC--cccccccCccccCcccccCCC
Confidence 543 245578999999999988754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-34 Score=266.02 Aligned_cols=169 Identities=26% Similarity=0.357 Sum_probs=140.5
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCC------
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------ 243 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 243 (358)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 47899999999999999999986 5699999999975432 23456889999999999999999999997654
Q ss_pred EEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecC
Q 018311 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (358)
Q Consensus 244 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGl 323 (358)
..|+||||+ +.+|..+.+. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 579999999 6688877653 3589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeeecccccCCchhhhccCCC
Q 018311 324 AKLLGAGKSHITTRVMGTFGDFSVTLLRNMP 354 (358)
Q Consensus 324 a~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~ 354 (358)
|+..... .+...||+.|+|||++.+..
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~ 194 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWM 194 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTT
T ss_pred eeccCCc----cccccccccccCHHHHcCCC
Confidence 9987543 34578999999999998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-33 Score=256.64 Aligned_cols=174 Identities=25% Similarity=0.366 Sum_probs=152.3
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEeCCEEEEEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 250 (358)
++|++.+.||+|+||+||+|+. .+++.||||+++.... .....+.+|+.+++.++||||+++++++.+.+..++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999986 5788999999864432 335778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCceecCCC
Q 018311 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (358)
Q Consensus 251 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~~~~~ 330 (358)
++.+++|..++. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988876 345688999999999999999999999 9999999999999999999999999999987643
Q ss_pred CceeeeecccccCCchhhhccCCCc
Q 018311 331 KSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 331 ~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
.. ......+++.|+|||++.+.++
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~ 178 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKL 178 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSC
T ss_pred Cc-cceeeccccchhhhhHhccCCC
Confidence 32 2334567889999999988764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-34 Score=266.56 Aligned_cols=175 Identities=27% Similarity=0.340 Sum_probs=151.7
Q ss_pred CCCcccceecCCccEEEEEEEE----eCCcEEEEEEecCCC----CcchHHHHHHHHHHhcCCC-CccccccceEEeCCE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHVRH-KNLVRLLGYCIEGTQ 244 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~ 244 (358)
++|++.+.||+|+||+||+|.. .+|+.||||.+.... ....+.+.+|++++.+++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999975 247899999985432 2234567889999999976 899999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.+++|||+.+|+|.+++... +.+.+.....++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999743 3477888999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
+.+............|++.|+|||.+.+.++
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~ 207 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDS 207 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC-
T ss_pred hhhcccccccccccccccccchhHHhhcCCc
Confidence 9876555545566789999999999987654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-33 Score=255.82 Aligned_cols=174 Identities=22% Similarity=0.296 Sum_probs=143.4
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccccc-cceEEeCCEEEEEEee
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL-LGYCIEGTQRILVYEY 251 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l-~~~~~~~~~~~lv~e~ 251 (358)
++|++.+.||+|+||.||+|.. .+|+.||||.+..... .+++..|++++..++|+|++.. .+++.+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 6799999999999999999976 5689999998765432 2457889999999987775555 5555678889999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEc---CCCcEEEeeecCceecC
Q 018311 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID---ENFDAKISDFGLAKLLG 328 (358)
Q Consensus 252 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~---~~~~~kl~DFGla~~~~ 328 (358)
+ +++|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.+.
T Consensus 85 ~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred c-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9 6677776653 345699999999999999999999999 999999999999985 45679999999999876
Q ss_pred CCCce------eeeecccccCCchhhhccCCCcc
Q 018311 329 AGKSH------ITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 329 ~~~~~------~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
..... ......||+.|||||++.+.+|+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 191 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQS 191 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCC
Confidence 54322 23456899999999999998874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.1e-32 Score=258.64 Aligned_cols=171 Identities=29% Similarity=0.313 Sum_probs=135.1
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCC--cchHHHHHHHHHHhcCCCCccccccceEEe------CCE
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE------GTQ 244 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~ 244 (358)
++|++.++||+|+||+||+|.. .+|+.||||++..... ...+.+.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6899999999999999999986 4699999999975432 233568899999999999999999999964 368
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.|+||||+.+ ++.+.+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~-~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccch-HHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 8999999965 5555553 2378999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
+...... ......||+.|+|||++.+.+|.
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~ 196 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYK 196 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCC
T ss_pred hcccccc--ccccccccccccChhhhcCCCCC
Confidence 8865433 34556899999999999998764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.2e-33 Score=258.96 Aligned_cols=171 Identities=26% Similarity=0.355 Sum_probs=142.4
Q ss_pred cCCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCc--chHHHHHHHHHHhcCCCCccccccceEEeC-----CE
Q 018311 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQ 244 (358)
Q Consensus 173 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 244 (358)
.++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+++|+.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 47899999999999999999975 57999999999755432 335688999999999999999999998643 33
Q ss_pred EEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEEeeecCc
Q 018311 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (358)
Q Consensus 245 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla 324 (358)
.+++|+|+.+|+|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 4667778889999999853 3599999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeeecccccCCchhhhccCCCc
Q 018311 325 KLLGAGKSHITTRVMGTFGDFSVTLLRNMPI 355 (358)
Q Consensus 325 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~ 355 (358)
...... .....||+.|+|||++.+..+
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~ 195 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMH 195 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSC
T ss_pred cccCcc----cccccccccccCchhhcCCcc
Confidence 876432 345689999999999887654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.94 E-value=9e-28 Score=225.04 Aligned_cols=174 Identities=21% Similarity=0.193 Sum_probs=137.5
Q ss_pred CCCcccceecCCccEEEEEEEE-eCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-----------CCccccccceEEe
Q 018311 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----------HKNLVRLLGYCIE 241 (358)
Q Consensus 174 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~ 241 (358)
++|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999986 579999999986542 22356778998888775 5789999988764
Q ss_pred --CCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCC----
Q 018311 242 --GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENF---- 314 (358)
Q Consensus 242 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~NiLl~~~~---- 314 (358)
....+++|+++..+......... .....+++..+..++.|++.||.|||+ . +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 45667777776555433322211 244568889999999999999999998 5 899999999999998655
Q ss_pred --cEEEeeecCceecCCCCceeeeecccccCCchhhhccCCCcc
Q 018311 315 --DAKISDFGLAKLLGAGKSHITTRVMGTFGDFSVTLLRNMPIL 356 (358)
Q Consensus 315 --~~kl~DFGla~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~ 356 (358)
.+|++|||.++..... ....+||+.|+|||++.+.+|.
T Consensus 168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~ 207 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWG 207 (362)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCC
T ss_pred cceeeEeecccccccccc----cccccccccccChhhccccCCC
Confidence 3999999999876432 3457899999999999988774
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.6e-24 Score=184.81 Aligned_cols=135 Identities=18% Similarity=0.211 Sum_probs=105.7
Q ss_pred cccceecCCccEEEEEEEEeCCcEEEEEEecCCCCc------------------chHHHHHHHHHHhcCCCCccccccce
Q 018311 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ------------------ADKDFRVEVEAIGHVRHKNLVRLLGY 238 (358)
Q Consensus 177 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~------------------~~~~~~~E~~~l~~l~HpnIv~l~~~ 238 (358)
.+.++||+|+||+||+|...+|+.||||.++..... .......|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457899999999999999888999999987532110 01224568889999999999887654
Q ss_pred EEeCCEEEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEcCCCcEEE
Q 018311 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318 (358)
Q Consensus 239 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ivHrDlk~~NiLl~~~~~~kl 318 (358)
. ..+++|||+++..+.+ ++......++.|++.+|.|||++ +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 2 2379999998765432 23344567899999999999999 99999999999999865 4899
Q ss_pred eeecCceecCCC
Q 018311 319 SDFGLAKLLGAG 330 (358)
Q Consensus 319 ~DFGla~~~~~~ 330 (358)
+|||+|+.....
T Consensus 144 iDFG~a~~~~~~ 155 (191)
T d1zara2 144 IDFPQSVEVGEE 155 (191)
T ss_dssp CCCTTCEETTST
T ss_pred EECCCcccCCCC
Confidence 999999887643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.64 E-value=1e-07 Score=82.86 Aligned_cols=149 Identities=13% Similarity=0.085 Sum_probs=96.5
Q ss_pred hHHHhcCCCcccceecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCC-CCccccccceEEeCCEEE
Q 018311 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRI 246 (358)
Q Consensus 168 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~ 246 (358)
++....+.|+..+..+-++...||+... ++..+.+|+...........+.+|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4444456676665544444578999865 55667888775444334445777888877663 333567788888889999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 018311 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI-------------------------------- 294 (358)
Q Consensus 247 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-------------------------------- 294 (358)
+||++++|..+.+..... .. ...++.+++..+.-||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999988775543210 01 1122333333344444211
Q ss_pred ------------------------CCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 295 ------------------------EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 295 ------------------------~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
.+.++|+|+.+.||++++++.+-|.||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11379999999999999877777999998875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.90 E-value=8.5e-05 Score=63.29 Aligned_cols=143 Identities=17% Similarity=0.149 Sum_probs=84.4
Q ss_pred eecCCc-cEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCC--CccccccceEEeCCEEEEEEeecCCCCH
Q 018311 181 IIGDGG-YGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH--KNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (358)
Q Consensus 181 ~lG~G~-fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lv~e~~~~gsL 257 (358)
.+..|. -+.||+....++..+.+|.-.... ..++..|...+..+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444554 368999988778778888764432 2346667777766632 3356778887888889999999987654
Q ss_pred HH--------------HHhc-ccC--CCCCC--CHHHHHHHH--------------------HHHHHHHHHHHhCC----
Q 018311 258 EQ--------------WLRG-DMC--DRGYL--TWEARMKIL--------------------LGTAKALAYLHEAI---- 294 (358)
Q Consensus 258 ~~--------------~l~~-~~~--~~~~l--~~~~~~~i~--------------------~~i~~~l~yLH~~~---- 294 (358)
.+ .|.+ +.. ....+ .......-. ......+..+....
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence 22 1111 000 00000 000000000 00112233333321
Q ss_pred CCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 295 ~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
.+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 12479999999999999877778999998865
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.74 E-value=7.2e-05 Score=68.60 Aligned_cols=76 Identities=18% Similarity=0.147 Sum_probs=47.2
Q ss_pred cceecCCccEEEEEEEEe-CCcEEEEEEecCC-------CCcchHHHHHHHHHHhcCC-C--CccccccceEEeCCEEEE
Q 018311 179 DNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNN-------PGQADKDFRVEVEAIGHVR-H--KNLVRLLGYCIEGTQRIL 247 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~-~~~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~~~~~~~~l 247 (358)
.+.||.|..-.||++... +++.+++|.-... -+....+...|.+.|..+. + ..+.+++. .+++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence 457899999999999764 4678889864321 1122344556777776552 2 23444443 35666789
Q ss_pred EEeecCCCC
Q 018311 248 VYEYVNNGN 256 (358)
Q Consensus 248 v~e~~~~gs 256 (358)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.21 E-value=0.00099 Score=58.97 Aligned_cols=136 Identities=15% Similarity=0.124 Sum_probs=77.6
Q ss_pred EEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCCCcc-----cccc--ceEEeCCEEEEEEeecCCCCH---
Q 018311 188 GVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-----VRLL--GYCIEGTQRILVYEYVNNGNL--- 257 (358)
Q Consensus 188 g~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~--~~~~~~~~~~lv~e~~~~gsL--- 257 (358)
-.||+++..+|..+++|..+... ...+++..|...+..|...++ +..- ..+...+..+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 37999998899999999876543 345667888888877642222 2221 133456778899999976322
Q ss_pred --HHH---------Hhc----cc-CCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----CCCCCe
Q 018311 258 --EQW---------LRG----DM-CDRGYLTWE-------------------ARMKILLGTAKALAYLHE----AIEPKV 298 (358)
Q Consensus 258 --~~~---------l~~----~~-~~~~~l~~~-------------------~~~~i~~~i~~~l~yLH~----~~~~~i 298 (358)
.++ ++. .. ..+...+.. ....+...+...+..+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 111 111 00 011111111 111112222223333322 223478
Q ss_pred eeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 299 VHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 299 vHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 45899998875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.12 E-value=0.033 Score=48.21 Aligned_cols=159 Identities=11% Similarity=0.072 Sum_probs=81.2
Q ss_pred hHhhHHHhcCCCcccce-----ecCCccEEEEEEEEeCCcEEEEEEecCCCCcchHHHHHHHHHHhcCCC-----Ccccc
Q 018311 165 TLRDLQSATNRFSKDNI-----IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH-----KNLVR 234 (358)
Q Consensus 165 ~~~~~~~~~~~~~~~~~-----lG~G~fg~V~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-----pnIv~ 234 (358)
+.+++.....+|.+++. |..|---+.|+.+..+|+ +++|...... ..+++..|++++..|.. |..+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 45666666777766543 345555778999876665 8888765432 22445556666666532 22222
Q ss_pred cc-c--eEEeCCEEEEEEeecCCCCHHH--------------HHhcc--cC-CC--CCCCHH------------------
Q 018311 235 LL-G--YCIEGTQRILVYEYVNNGNLEQ--------------WLRGD--MC-DR--GYLTWE------------------ 274 (358)
Q Consensus 235 l~-~--~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~--~~-~~--~~l~~~------------------ 274 (358)
.. | +.........++.++.+..... .++.. .. .. ......
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 1 1223456667777766533210 11100 00 00 000000
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEcCCCcEEEeeecCcee
Q 018311 275 ARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (358)
Q Consensus 275 ~~~~i~~~i~~~l~yLH~-~~~~~ivHrDlk~~NiLl~~~~~~kl~DFGla~~ 326 (358)
.....+......+.-.+. ....++||+|+.+.|++++.+...-|.||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 001111112222222221 1234799999999999999888788999998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.73 E-value=0.014 Score=52.71 Aligned_cols=73 Identities=16% Similarity=0.196 Sum_probs=46.4
Q ss_pred cceecCCccEEEEEEEEeCC--------cEEEEEEecCCCCcchHHHHHHHHHHhcCCCCccc-cccceEEeCCEEEEEE
Q 018311 179 DNIIGDGGYGVVYRGQLMNG--------TAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV-RLLGYCIEGTQRILVY 249 (358)
Q Consensus 179 ~~~lG~G~fg~V~~~~~~~~--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv~ 249 (358)
.+.|+-|-.=.+|++...++ +.|.++..- . .....+..+|..+++.+.-.+++ ++++++. + .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEE
Confidence 35788788889999986442 445555443 2 33345567788888877433443 5666553 2 6889
Q ss_pred eecCCCCH
Q 018311 250 EYVNNGNL 257 (358)
Q Consensus 250 e~~~~gsL 257 (358)
||+++..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99976433
|